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09:15 - 09:45 Room C 
1st ESR/EANM Joint Pre-Congress Workshop on PET/CT
WS 1a 
Instrumentation and technique 
A‑001	 09:00 
Welcome on behalf of the ESR 
É. Breatnach; Dublin/IE 
A‑002	 09:07 
Welcome on behalf of the EANM 
P. Bourguet; Rennes/FR 
A‑003	 09:15 
Radiology perspective 
T.R.C. Johnson; Munich/DE 
For PET-CT, the CT exam is generally performed as standard whole-body exam 
from the base of the skull to the upper thighs. Standard parameters are non-ionic 
iodinated intravenous contrast material at 0.5 g/kg bodyweight with a venous delay 
of 70 seconds after injection and 3-5 mm thick continuous axial reconstructions with 
medium soft convolution kernels. CT images frequently contain important diagnostic 
information beyond mere ‘anatomic landmarking’, so generally a diagnostic, contrast 
enhanced normal-dose CT should be performed except if a recent diagnostic CT 
scan is available for fusion. Then, a low-dose CT is sufficient for attenuation cor-
rection. A difference from routine CT protocols is the expiratory position to match 
the respiratory position of PET acquisition. Also, negative oral contrast material 
should be applied and the whole body should be included in the field of view to 
allow effective attenuation correction of PET images. Diagnostic reading has to 
include lung, soft tissue and bone windows. Optimally, the assessment should 
be performed by one reader evaluating CT and PET images simultaneously on 
multiplanar reformats. 
Learning Objectives:
1. To get acquainted with standard CT examination parameters for oncological 
imaging including the requirements for an effective attenuation correction.
2. To see the diagnostic value of CT beyond ‘anatomical landmarking’.
3. To learn effective ways to interpret PET-CT examinations.
A‑004	 09:30 
Nuclear medicine perspective 
T. Beyer; Zurich/CH 
Combined PET/CT images were first proposed as early 1984. Since 1998 PET/
CT became available for broader clinical testing. Since its commercial introduction 
in 2001 more than 5’000 PET/CT systems were installed worldwide. PET/CT is a 
logical and technical consequence of early, manual or semi-automatic efforts to 
align functional and anatomical images for easier and improved diagnosis. PET, or 
positron emission tomography, is an emission tomographic imaging method based 
on the application of radioactively labelled biomolecules in order to measure and 
quantitate signalling or metabolic pathways. CT, computed tomography, on the 
other hand, uses an external ionising radiation transmission source to generate 
projection data of the transmitted radiation, thus helping to generate high spatial 
resolution images of the anatomy of the subject. Both sets of information can be 
combined easily in a PET/CT, whereby both the PET and CT components can be 
operated in close spatial proximity within a single gantry without cross-talk effects. 
Through the combination of CT and PET overall examination times of oncology PET 
studies are reduced by 30%. In addition, PET instrumentation has been advanced 
to include time-of-flight measurements for improved signal-to-noise ratio, extended 
axial field-of-view-coverage for higher sensitivity and novel image reconstruction 
for improved contrast. Today, high-quality one-stop shop staging with PET/CT is 
possible in 10 min, or less. 
Learning Objectives:
1. To illustrate the origin of combined PET/CT imaging.
2. To motivate the strength of PET: high spatial sensitivity, quantification and 
functional information.
3. To appreciate the difference between “contrast” and “tracer” imaging.
4. To highlight novel developments in PET imaging: time of flight (TOF), 
extended axial field-of-view.
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09:45 - 10:15 Room C 
1st ESR/EANM Joint Pre-Congress Workshop on PET/CT
WS 1b 
Radiation exposure 
A‑005	 09:45 
Radiology perspective 
H.-C. Becker; Munich/DE 
Computed tomography is the main contribution to diagnostic medial radiation 
exposure to the public. In the year 2001, CT accounted for only 6% of all radiation-
associated examinations; however, at the same time it accounted for 47% of the 
total radiation exposure. Since the beginning of this century numerous international 
surveys had been performed with the aim to define diagnostic reference levels in 
European countries. Radiation exposure by CT has increased particularly by cardiac 
CT examination, what has caused awareness to utilise all strategies for radiation 
protection in CT. Modern CT scanners are equipped with automated anatomical 
or organ sparing exposure control. It is the CT investigators responsibility to check 
the clinical indication, limit the scan range and decide for the appropriate scan 
protocol with the least radiation exposure. Newer technical developments in CT 
scanner hard and software will enable to further reduce the dose from CT. All these 
strategies are essentially necessary since the number of CT investigations and 
the scope of clinical indications are expanding with advancing medical progress. 
Learning Objectives:
1. To understand the meaning of diagnostic reference values.
2. To become aware of dose intense CT protocols.
3. To learn about strategies for radiation protection in CT.
A‑006	 10:00 
Nuclear medicine perspective 
S.P. Mueller; Essen/DE 
Different radiopharmaceuticals labelled with positron emitting radioisotopes are 
used to study a multitude of molecular processes using a positron-emission-
tomography (PET) scanner which nowadays is typically integrated with a CT 
scanner (PET/CT). This lecture will enable the attendee to comprehend that the 
radiation exposure from PET depends on the biodistribution and kinetics of the 
radiopharmaceutical, the physical half-life of the positron emitting radioisotope 
used for labelling, and the injected activity, leading to an understanding that there 
is no generic “radiation exposure from PET or PET/CT”. 
Learning Objectives:
1. To learn that the comparison of doses for different radiopharmaceuticals 
is based on the concept of the effective dose which expresses the total 
stochastic risk from the non-uniform radiation exposure to individual 
radiosensitive organs in terms of a uniform whole body radiation dose.
2. To understand that the effective dose from certain radiopharmaceuticals 
may be reduced by simple means, e.g. if it is renally eliminated by frequently 
voiding the bladder, and that the effective doses for the most prevalent 
radiopharmaceuticals lie within the typical range of other diagnostic nuclear 
medicine tests and compare favourably to the radiation exposure from the 
CT portion of a whole-body PET/CT scan.
10:15 - 10:30 Room C 
1st ESR/EANM Joint Pre-Congress Workshop on PET/CT
WS 2 
FDG PET 
A‑007	 10:15 
Physiology, normal distribution and pitfalls 
A. Hertel; Fulda/DE 
The successful use of PET/CT imaging with FDG requires thorough understanding of 
FDG physiology, distribution in order to cope with possible and common pitfalls. FDG 
is normally distributed throughout the body following deoxy-glucose consumption and 
excretion. Main organ of uptake is the brain. Excretion via kidneys results in intense 
uptake of the genito-urinary system. Prior to imaging the following questions should be 
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11:45 - 12:30 Room C 
1st ESR/EANM Joint Pre-Congress Workshop on PET/CT
WS 3b 
Lung cancer 
A‑010	 11:45 
Radiology perspective 
F. Gleeson; Oxford/UK 
PET-CT is now recognised as a routine investigation in patients with lung cancer 
prior to radical treatment for attempted cure. However, PET-CT is an expensive 
and limited resource, and its use needs to be targeted to maximise its benefits. This 
presentation will review its use and compare its benefits to CT. It will specifically 
focus on both the added advantages PET has when compared to CT and also the 
value of using the information on PET-CT scans in an additive manner by using the 
information available from both the PET and the CT components of a PET-CT scan. 
Learning Objectives:
1. To learn when PET-CT should be performed in lung cancer.
2. To understand the significance of the CT appearance and PET 
characteristics of lung cancers.
3. To become familiar with the significance of FDG nodal avidity.
4. To become familiar with the ability of PET-CT to detect metastatic disease.
A‑011	 12:07 
Nuclear medicine perspective 
H.C. Steinert; Zurich/CH 
Combined positron-emission tomography and computed tomography (PET-CT) 
has become an established method for staging of patients with non-small-cell lung 
cancer (NSCLC). Glucose use is markedly accelerated in NSCLC, resulting in high 
tumour uptake of the radiolabeled glucose analogue fluorine-18 fluorodeoxyglucose 
(FDG). It has been shown that combined PET-CT imaging is superior in preoperative 
staging to CT alone and PET alone (1). The advantage is mainly based on a more 
sensitive and specific assignment of the lymph-node stage (N stage) and the accu-
rate detection of occult distant metastases. However, limitations of PET-CT imaging 
are well known (FDG negative tumours, FDG uptake in inflammatory cells). New 
PET radiotracers as fluoroethyltyrosine (FET), fluoroalphamethyltyrosine (FMT), 
and deoxyfluorothymidine (FLT) overcome the limitations of FDG. The addition of 
PET-CT to the diagnostic work-up in patients with potentially resectable NSCLC 
has been shown to significantly reduce both the total number of thoracotomies 
and the number of futile thoracotomies (2). PET-CT can also be used for the ac-
curate definition of the radiotherapy treatment field and for monitoring response 
of chemotherapy and radiotherapy. 
Learning Objectives:
1. To understand the role and limitations of PET/CT in staging of lung cancer.
2. To discuss the utility of PET/CT in radiotherapy target definition.
3. To describe the role of PET/CT in therapy monitoring.
4. To compare different PET radiotracers for lung imaging.
13:30 - 14:15 Room C 
1st ESR/EANM Joint Pre-Congress Workshop on PET/CT
WS 4a 
GI tumours 
A‑012	 13:30 
Radiology perspective 
A. Ba-Ssalamah; Vienna/AT 
The use of PET-CT, which is a combination of positron emission tomography 
(PET) and computed tomography (CT), has dramatically grown in the daily clinical 
routine. The synergistic advantage of adding CT is that the attenuation correction 
required for PET can also be derived from the CT data, leading to a more comfort-
able examination and higher patient throughput. Furthermore, the integration of 
both techniques provides precise localisation of lesions on the PET scans, with 
relevant functional information within the anatomic and morphologic reference frame 
provided by contrast-enhanced-CT, thus increasing the sensitivity and specificity 
answered: Is FDG suitable for the underlying cancer involved? Some tumours have 
none or low FDG uptake which should not be included in FDG PET/CT imaging like 
prostate cancer, mucinous gastric cancer, most neuro-endocrine cancers including the 
majority of differentiated primary thyroid cancers and renal cancer. Is the patient properly 
prepared? This requires adequate fasting of at least 10 hours and a sufficiently low 
blood glucose level under 150 mg/dl. Is the suspicious abnormal focus suitable for FDG 
imaging? Routine PET scanner have a physical resolution of around 5 mm. In the lung 
without breath triggering structures in the lower lobes should be larger than 8-10 mm. 
Various organs exhibit a wide range of physiological FDG uptake (salivary glands, 
floor of mouth, brown fat in the neck, atherosclerosis in large vessels, stomach, colon 
and guts, bone marrow). Intense studying of these different conditions requires own 
3D judgment on the dedicated work station by each and every doctor using PET/CT. 
Learning Objectives:
1. To learn about patient preparation is essential for avoiding common pitfalls: 
tumour history, current therapy (chemo affects bone marrow, surgery 
produces uptake in scars), other diseases or habits like smoking (FDG 
uptake in mediastinal lymph nodes due to chronic bronchitis).
2. To become familiar with FDG uptake that can cause benign processes. 
This includes inflammation/abscesses, sarcoidosis or recent radiotherapy 
(inflammatory). Also intense regular brain uptake is suitable for Alzheimer 
diagnosis but not for small brain metastasis (gold standard MRI).
3. To become familiar with proper technique. This includes correct patient 
positioning, check for patient movement and correct positioning when using 
FDG PET/CT for radiotherapy planning (this should be done commonly with 
the radio-oncologist).
11:00 - 11:45 Room C 
1st ESR/EANM Joint Pre-Congress Workshop on PET/CT
WS 3a 
Head and neck including cancer of unknown 
primary (CUP) 
A‑008	 11:00 
Radiology perspective 
S. Bisdas; Tübingen/DE 
Cross sectional techniques, like CT and MRI, as well as hybrid imaging, like PET-
CT, are the main diagnostic radiological approaches in the TNM staging of head 
and neck cancer, including cancer of unknown primary (CUP). 
Learning Objectives:
1. To consolidate knowledge about the first-choice diagnostic modalities for the 
different anatomic sites of head and neck cancer, including CUP syndrome.
2. To appreciate the clinical indications and problems in patients referred for 
head and neck imaging.
3. To understand from a radiological point of view the advantages and 
shortcomings of each modality concerning the T, N, and M staging.
4. To choose the most appropriate diagnostic modality for any head and neck 
disease, including CUP syndrome.
A‑009	 11:22 
Nuclear medicine perspective 
R. Hustinx; Liège/BE 
Most head and neck tumours (HNT) are squamous cell carcinomas, which display highly 
increased FDG uptake with great consistency. On the other hand, recent advances in 
the PET/CT technology have lead to significant improvement in terms of spatial resolu-
tion, with either lower injected dose of tracer or shorter acquisition time. This review 
will first discuss the methodological aspects of PET/CT when applied to HNT imaging. 
Clinical indications will then be reviewed, including the staging of proven tumours, the 
evaluation of carcinomas of unknown origin, the assessment of the response to treat-
ment and the contribution of metabolic imaging to the planning of radiation therapy. 
Learning Objectives:
1. To determine acquisition parameters adapted for HNT imaging, for both the 
PET and the CT part of PET/CT.
2. To recognise the diagnostic performances of FDG PET/CT in the TNM 
staging of HN tumours.
3. To discuss the role of FDG PET/CT in the clinical algorithm for evaluating the 
response to chemoradiotherapy, according to the tumour stage and location.
4. To understand the concept of metabolic target volume in radiation therapy.
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A‑015	 14:37 
Nuclear medicine perspective 
B.J. Krause; Munich/DE 
To understand the potential of molecular imaging with hybrid imaging technologies 
such as PET/CT of imaging urogenital tumours and especially prostate cancer. To learn 
more about the metabolic pathways underlying the choline signal in prostate cancer 
imaging. The role of PET/CT in the detection of recurrent prostate cancer and patients 
with advanced disease. To become familiar with the most common indication of PET/
CT with radioactively labelled choline derivates in prostate cancer patients, i.e. relapse 
of disease and biochemical recurrence. PET/CT with choline derivatives at present is 
the imaging modality with the highest sensitivity to diagnose the recurrence. PET/CT 
with choline derivates has major implications on patient management by allowing to 
individualise the therapeutic strategy, i.e. curative vs. palliative treatment. In localised 
disease curative therapy options such as salvage radiotherapy or salvage lymph-
adenectomy can be considered. In the case of disseminated disease anti-hormonal 
therapy or chemotherapy can be initiated. In the case of radiation therapy choline PET/
CT might enable a custom tailored radiation field for local as well as for distant disease. 
To become familiar with the future developments in molecular imaging prostate cancer: 
(1) new tracers will be introduced which will allow to diagnose prostate cancer with 
higher sensitivity and specificity. (2) New hybrid imaging technologies are emerging 
such as SPECT/CT and especially MR/PET that will also contribute to higher accuracy 
in diagnosing patients with prostate cancer. (3) Molecular imaging techniques have a 
high potential for assessment of therapy response with the view towards individualisa-
tion of therapies in prostate cancer patients. 
15:30 - 16:15 Room C 
1st ESR/EANM Joint Pre-Congress Workshop on PET/CT
WS 5 
Lymphoma 
A‑016	 15:30 
Radiology perspective 
M. O’Connell; Dublin/IE 
From initial staging, to response evaluation to restaging, CT and PET/CT have 
complementary roles. Contrast CT to include solid organ assessment is used at 
initial diagnosis, followed by low dose PET/CT in the initial staging of Hodgkin’s 
disease and in some cases of Non Hodgkin’s Lymphoma. Response evaluation 
is typically performed after two cycles of chemotherapy using low dose PET/CT. 
Protocols for restaging lymphoma vary according to the type of tumour and local 
protocols. Lymphoma can present with unusual patterns in some organ systems 
for example in urinary tract, colon or the central nervous system. This presentation 
also discusses the role of MRI in staging and ultrasound in biopsy. A dual qualified 
reader can read PET and CT components as a one study leading to synergy in 
interpretation of imaging findings and cost benefits. This will also allow a compari-
son with previous MRI, CT and PET/CT imaging studies. It is also important that 
PET/CT readers attend and contribute to Multidisciplinary Team Meetings (MDM) 
in order to ensure the full impact of PET/CT investigations. 
Learning Objectives:
1. To outline the role of CT in staging lymphoma in the era of PET/CT.
2. To examine the role for MRI and ultrasound in lymphoma staging.
3. To outline some of the less common patterns of lymphoma presentation on 
CT that are identified at PET/CT.
A‑017	 15:52 
Nuclear medicine perspective 
A.K. Buck; Munich/DE 
PET and PET/CT are non-invasive, 3-dimensional imaging modalities which have 
become standard of care in patients with malignant lymphomas. These modali-
ties have been extensively studied for staging, restaging, monitoring response to 
therapy, surveillance after definite treatment, and assessment of transformation. 
More recently, PET tracers have been suggested as surrogate markers for cancer 
drug development. 
Learning Objectives:
1. To understand in which clinical scenarios PET and PET/CT imaging are 
superior to standard imaging modalities or other diagnostic tests.
2. To learn the diagnostic accuracy and predictive potential of PET and PET/CT 
for staging/restaging Hodgkin’s disease and non-Hodgkin’s lymphoma.
of the examination. Therefore, for oncologic applications, PET-CT has already 
gained widespread acceptance for the initial staging of cancer, the management 
of recurrent cancer, and for monitoring the response to therapy. The development 
of a large variety of radiotracers is an evolving procedure. The most frequent used 
radiotracer in clinical practice, 18 F FDG, is based on the identification of the fun-
damental aspects of tumour glucose metabolism. New radiotracers, with promising 
potential for PET-CT, are also currently available to visualise specific cellular and 
molecular tumour pathway and more being developed. 
Learning Objectives:
1. To appreciate the advantage of a combined PET-CT technique.
2. To consolidate our knowledge of optimal examination protocols and to be 
aware of the pitfalls that may be encountered using this technique.
3. To understand the indications for PET-CT in the diagnosis, staging, and 
therapy monitoring of a large variety of GI tumours.
4. To become familiar with the different radiotracers to obtain a tailored and 
personalized diagnosis for the large variety of GI tumours.
A‑013	 13:52 
Nuclear medicine perspective 
T.F. Hany; Zurich/CH 
FDG-PET/CT imaging is getting more established in the work-up of several ab-
dominal malignancies of the gastro-intestinal tract. The main advantage lies in the 
comprehensive evaluation of the patient, including all body compartments and 
therefore detection of pivotal, therapy deciding lesions. The performance of FDG-
PET/CT In the evaluation of primary tumours of the GI-tract is characterised by a 
high sensitivity in the detection of distant metastases. Secondary liver tumours like 
metastases from the GI-tract are detected by FDG-PET/CT at a high rate, making 
this imaging technology a primary tool in the evaluation of patients with suspicion 
of recurrent colon cancer. Further, full integration of contrast-enhanced CT proto-
cols improve the diagnostic confidence and reduce the sometimes cumbersome 
diagnostic pathway for patients. FDG-PET/CT can be reliably used for therapy 
response assessment. New tracers like Ga-68-DOTA-TATE or F-18-DOPA will bring 
significantly improved diagnostic confidence in the notoriously difficult evaluation 
of patients with neuroendocrine small bowel tumours. 
Learning Objectives:
1. To understand the correct applications of FDG-PET/CT imaging in GI tumours.
2. To learn the limits of PET/CT imaging in esophageal cancer imaging.
14:15 - 15:00 Room C 
1st ESR/EANM Joint Pre-Congress Workshop on PET/CT
WS 4b 
Urogenital tumours 
A‑014	 14:15 
Radiology perspective 
C. Nicolau; Barcelona/ES 
Integrated positron emission tomography (PET)/CT provides combined metabolic 
and anatomic information of malignancies. The addition of CT to PET for urogenital 
purposes is very useful. CT should be performed with oral and intravenous con-
trast agent administration as a full diagnostic technique. If performed under these 
conditions, this technique can help to avoid PET pitfalls including focal retained 
activity in ureters and urinary bladder, and increased uptake in physiologic and 
benign pelvic processes such as endometrial uptake in the menstrual phase, 
leiomyomatosis, endometriosis or infection. We will describe the use of PET/CT 
in the characterisation, staging and surveillance of urogenital malignancies includ-
ing kidney, prostate, bladder, uterine cervix, endometrium and ovaries. PET/CT is 
internationally accepted as the most useful surveillance imaging tool in patients 
with ovarian cancer, and its use as a problem-solving modality has also rapidly 
grown in the rest of urogenital malignancies. 
Learning Objectives:
1. To learn the appropriate protocols and settings of a diagnostic CT in PET/CT 
for urogenital purposes.
2. To describe advantages and limitations of integrated PET/CT for urogenital 
purposes.
3. To describe the main indications of PET/CT for diagnosis, staging and 
surveillance of urogenital cancers.
4. To discuss the role of PET/CT with respect to other imaging techniques in 
the diagnostic algorithms of urogenital cancers.
W
ednesday
Postgraduate.Educational.Programme
A S9CB D E F G H
shown promising results in the management of various cancers where FDG has 
limited value. These radiotracers have more specific mechanism of uptake and is 
likely be investigated in the near future. 
Learning Objective:
1. To consolidate knowledge of oncological applications, characteristics and 
future aspects of non - FDG PET tracers in the daily clinical practice.
A‑020	 16:45 
Concluding remarks from the ESR and the EANM 
É. Breatnach1, W. Langsteger2; 1Dublin/IE, 2Linz/AT 
A‑021	 17:00 
Test and quiz with evaluation 
É. Breatnach1, W. Langsteger2; 1Dublin/IE, 2Linz/AT 
3. To become familiar with typical imaging findings of vital lymphoma in lymph node 
basins and non-lymphatic tissues (bone, bone marrow, spleen, liver, soft tissues).
4. To understand what kind of pitfalls can reduce the sensitivity and specificity 
of PET/CT.
5. To become familiar with current state of the art data acquisition protocols 
and data postprocessing.
6. To learn about new technological developments that are underway (i.e. new 
radiotracers enabling molecular imaging of lymphoma such as proliferation 
markers and new scanner developments such as PET/MR).
16:15 - 16:45 Room C 
1st ESR/EANM Joint Pre-Congress Workshop on PET/CT
WS 6 
Future aspects 
A‑018	 16:15 
Overview of future developments in CT 
T.R.C. Johnson; Munich/DE 
Computed tomography remains the workhorse of clinical cross sectional imaging 
due to its good availability, enormous speed, high spatial resolution and sufficient 
tissue contrast to evaluate most diseases based on morphology. Compared to 
PET and SPECT, room for improvement remains in sensitivity and specificity 
for certain diseases and, compared to ultrasound and MRI, in dynamic imaging. 
However, already today there are new CT techniques which can provide diagnosti-
cally equivalent information as SPECT or PET but with higher spatial resolution, in 
shorter acquisition time and without radioactive tracers. One of these techniques 
is CT perfusion imaging with repeated low-dose acquisitions of the same organ. 
With this method, a detailed evaluation of brain perfusion is feasible e.g, for stroke 
assessment, or of tumour perfusion, e.g. to assess early therapy response. Another 
option is Dual Energy CT which does not require additional dose but can provide 
additional important diagnostic information similar to PET or SPECT. Examples are 
the evaluation of lung ventilation und perfusion with xenon gas and iodine contrast. 
For oncological imaging, the evaluation of tumour perfusion based on spectral 
identification of iodine is an attractive option to increase specificity without additional 
dose or radioactivity. Similarly, it is feasible to assess myocardial perfusion along 
with coronary CT angiography. For some diseases, even the molecular substrate 
can be identified with this technique, e.g. uric acid in gout patients. These new 
techniques provide significant advantages in oncological imaging and may further 
add to disease characterisation if combined in PET-CT. 
Learning Objectives:
1. To understand the strengths of current CT technology in oncological imaging 
based on morphology.
2. To learn about the diagnostic value of CT beyond anatomical referencing.
3. To appreciate new technology such as dynamic perfusion imaging and Dual 
Energy CT as options to improve disease characterisation.
A‑019	 16:30 
Tracers beyond FDG in daily routine 
M. Beheshti; Linz/AT 
The ability of positron emission tomography (PET) to study different biological 
processes opens up new windows for both researches and daily clinical use. 
Addition of computed tomography (CT) to PET improves detection efficiency and 
results in better localization of the lesions. The aim of this review is to consolidate 
knowledge of oncological applications of PET tracers other than [(18)F]fluoro-
2-deoxy-D-glucose] (FDG) in the daily clinical practice. FDG, as a non - specific 
tracer, has limited value in the assessment of different cancers such as prostate 
cancer, neuroendocrine tumours (NET), brain tumours, hepatocellular Carcinoma 
(HCC), and some types of breast cancers. Hence, due to high sensitivity of PET 
in performing non-invasive functional studies, further investigations and develop-
ments are warranted for defining specific PET radiotracers and theirs clinical ap-
plications regarding different tumour entities. Oncological non-FDG PET tracers 
can be generally categorized into 3 groups: those labeled with F-18, C-11 and 
other non-FDG tracers. Fluorine-18 and C-11 are labeled with different amino 
acids, substrates involved in fatty acid synthesis, protein synthesis, amino acid 
transport substrate and tracers linked to nucleic acid synthesis. These tracers 
are also labeled with specific ligands for receptor imaging. The other non-FDG 
radiotracers can be labeled with Ga-68, Cu-60, Cu-64, etc. and are suggested to 
use in detecting cell hypoxia, bone metabolism and receptor. Many of these have 
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14:00 - 15:30 Room B 
Interactive Teaching Session 
E³ 120 
Commonly missed diagnosis in musculoskeletal 
conditions 
A‑022	 14:00 
Commonly missed diagnosis in musculoskeletal conditions 
F. Kainberger1, K. Bohndorf2; 1Vienna/AT, 
2Augsburg/DE (franz.kainberger@meduniwien.ac.at) 
Many structures of the musculoskeletal system are prone to overuse and degeneration. 
Thus, stress-related injuries may mask the clinical appearance of many other entities. 
Documentation of the patient’s history and the knowledge of certain laboratory findings 
are of enormous help to differentiate overuse syndromes and arthritis from tumours, 
infections, vascular diseases, or others. With standardised imaging protocols all relevant 
anatomic areas have to be included for documenting the effects of biomechanical stress, 
the symmetric manifestation of arthritis, the spread of tumours and infection, or trauma. 
The anatomic distribution of traumatic and stress-related injuries is influenced by 
“kinetic chains”. Bone marrow or soft tissue oedema and many other imaging find-
ings act as footprint patterns for the differential diagnosis. Likewise in inflammatory 
disorders, the distribution pattern is often characteristic for common and uncommon 
forms of rheumatic diseases or of infections. In tumours, the structure (“matrix”) and 
their borders are important features. In conclusion, a standardised diagnostic process 
bases on the analysis of distinct clinical and anatomic patterns. It also includes the 
recognition of patterns of misinterpretation. 
Learning Objectives:
1. To learn about the differential diagnosis between stress injuries, 
inflammatory processes, necrosis and tumours.
2. To recognise the consequences of insufficient consideration of clinical 
information and symptoms in the interpretation of imaging studies.
3. To recognise the consequences of inappropriate imaging requests.
4. To understand the importance of a systematic approach to the interpretation 
of imaging, particularly radiographs.
14:00 - 15:00 Room Z 
The Beauty of Basic Knowledge:  
Interpretation of the Chest Radiograph 
MC 21A 
Interpreting the chest radiograph: basic concepts 
A‑023	 14:00 
Interpreting the chest radiograph: basic concepts 
J. Cáceres; Barcelona/ES (josecac@gmail.com) 
All conventional radiology is based in the interplay of four basic densities: air, fat, 
soft tissues and calcium. The chest radiograph is an excellent method for detecting 
pulmonary abnormalities: we see the process because of the superposition of a soft 
tissue density on the air density of the lung. The silhouette sign can be rephrased 
as: to detect a lesion in conventional radiography, its density should be different 
from that of the surrounding tissues. The modern approach to conventional chest 
radiograph aims to detect the presence of abnormalities and to decide if additional 
procedures are necessary. 
Learning Objectives:
1. To review the significance of radiographic densities.
2. To evaluate the role of the chest radiograph in the detection of diseases.
3. To understand the role of chest radiography as a filter for cross-sectional 
imaging.
16:00 - 17:30 Room B 
Interactive Teaching Session 
E³ 220a 
Common radiological problems: incidental 
abdominal masses 
A‑024	 16:00 
A. The incidental adrenal mass 
R.H. Reznek; London/UK (r.h.reznek@qmul.ac.uk) 
With the increasing use of abdominal cross-sectional imaging, incidental adrenal 
masses are being detected more often. The important clinical question is whether 
these lesions are benign adenomas or malignant primary or secondary masses. Benign 
adrenal masses such as lipid-rich adenomas, phaeochromocytomas, myelolipomas, 
adrenal cysts and adrenal haemorrhage have pathognomonic cross-sectional imaging 
appearances. However, there remains a significant overlap between imaging features 
of some lipid-poor adenomas and malignant lesions. The nature of incidentally detected 
adrenal masses can be determined with a high degree of accuracy using computed 
tomography and magnetic resonance imaging alone. Positron emission tomography is 
also increasingly used in clinical practice in characterising incidentally detected lesions 
in patients with cancer. The performance of the established and new techniques in CT, 
MRI and to a lesser extent PET, that can be used to distinguish benign adenomas and 
malignant lesions of the adrenal gland will be reviewed. 
Learning Objectives:
1. To appreciate the range of adrenal pathology that can present incidentally 
and recognise their imaging features.
2. To appreciate the need to characterise these lesions in the clinical context of 
the patient’s management.
3. To become familiar with the specialised CT and MRI techniques required to 
establish the true nature of an incidentally detected indeterminate adrenal 
mass.
A‑025	 16:45 
B. Renal mass 
M. Prokop; Nijmegen/NL (M.Prokop@rad.umcn.nl) 
With the increasing use of imaging, incidentally detected renal masses are very com-
mon. While masses detected by CT or MR usually can be properly classified, renal 
masses detected by ultrasound frequently require further workup. The following con-
siderations determine the diagnostic workup: simple cysts are very common but may 
present atypically. Renal cell carcinomas may be cystic but usually display at least a 
small solid component. Renal cell carcinomas have a bad prognosis when metastasized 
but metastases hardly every develop before the tumour has reached 3 cm in diameter. 
Differentiation between solid tumours by imaging alone is exceedingly difficult, save 
for the identification of angiomyolipomas in adults. This course will discuss suitable 
diagnostic algorithms based on the initial presentation of the mass. Typical imaging 
findings of various benign and malignant renal masses will be presented. The role 
of the Bosniak classification will be illustrated. Newer developments such as a wait-
and-see approach or primary biopsy for small solid renal masses will be discussed. 
Learning Objectives:
1. To learn how to detect and characterise a renal mass.
2. To understand how to apply adequate protocols according to the clinical 
situation.
16:00 - 17:30 Room C 
Interactive Teaching Session 
E³ 220b 
Lung cancer: what the radiologist must report 
A‑026	 16:00 
A. Staging 
A.R. Larici; Rome/IT (anna.larici@rm.unicatt.it) 
Definition of stage is essential for an accurate management of neoplastic patient. A 
recent review of NSCLC (non-small cell lung cancer) staging system has underlined 
limitations of the previously accepted classification. Staging system is based on the 
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assessment of disease extent. Non-invasive imaging modalities (CT and PET-CT) 
play a central role in this attempt and in providing indications for further invasive 
procedures. Radiologists should know what to report and how to perform a proper 
radiological work-up to define the correct stage in each patient. They should also be 
aware of the actual role of invasive modalities (transbronchial and transesophageal 
ultrasound, mediastinoscopy) in staging lung cancer. 
Learning Objectives:
1. To learn about the new lung cancer staging system.
2. To understand the proper use of different imaging modalities and invasive 
procedures for staging lung cancer.
3. To understand the rationale of lung cancer staging.
4. To understand the value of diagnostic and invasive procedures (chest x-ray, 
CT and PET/CT) during lung cancer follow-up.
5. To learn diagnostic criteria and imaging pitfalls during the management of 
tumour recurrence and treatment complications.
A‑027	 16:45 
B. Follow-up 
N. Howarth; Chêne‑Bougeries/CH (nigel.howarth@grangettes.ch) 
Carcinoma of the lung is one of the most frequent neoplasms in the Western world. 
Most radiologists know how to diagnose lung cancer. With advances in imaging 
technology and treatment options, it is essential to know how to evaluate response 
to treatment and complications. In treated patients, signs of recurrence should be 
distinguished from undercurrent diseases and post-radiotherapy changes. The value 
of diagnostic (chest x-ray, CT and PET/CT) and invasive procedures (bronchoscopy, 
radiofrequency ablation) will be discussed. Integrated PET/CT imaging has an 
established role in the management of cancer patients and is now recommended 
for all patients with curative non-small cell lung cancer. PET/CT provides informa-
tion essential for staging and prognosis, for choice of management and monitoring 
of treatment and for the detection of recurrence. Radiologists should understand 
important aspects of molecular imaging to improve their contribution to patient 
management. Imaging pitfalls must be recognised to avoid both false-positive and 
false-negative interpretation. Specific examples will be discussed to demonstrate 
how the combined information of images of human anatomy upon which biological 
information within body structures is added improves delineation of disease, can 
guide surgical and radiation planning and biopsy, help in the management of tumour 
recurrence and of treatment complications. The need for close collaboration with 
nuclear medicine specialists will be promoted. 
Learning Objectives:
1. To learn about the new lung cancer staging system.
2. To understand the proper use of different imaging modalities and invasive 
procedures for staging lung cancer.
3. To understand the rationale of lung cancer staging.
4. To understand the value of diagnostic and invasive procedures (chest x-ray, 
CT and PET/CT) during lung cancer follow-up.
5. To learn diagnostic criteria and imaging pitfalls during the management of 
tumour recurrence and treatment complications.
16:00 - 17:30 Room D1 
KISS (Keep It Simple and Straightforward): Musculoskeletal MRI 
CC 216 
The hand and wrist 
Moderator: 
R. Schmitt; Bad Neustadt a. d. Saale/DE 
A‑028	 16:00 
A. How I do it 
J.-L. Drapé; Paris/FR (jean‑luc.drape@cch.aphp.fr) 
MRI of hand and wrist require some specificities: high spatial resolution, perfect 
immobility, and homogeneous fat suppression. These goals are reached with: 
phased array dedicated wrist coil, extended arm upon the head close to the center 
of the magnet, firm contention devices, avoid obliquity of the wrist (magic angle 
phenomenon) and small field of views (FOV) with high spatial resolution and short 
acquisition times. In case of “mysterious” painful wrist a first axial STIR or T2 FSE 
FS sequence (“bone scan” sequence) is compared with an axial FSE T1 sequence 
to assess both soft tissues and bones. A coronal 3D PD FS may be added to assess 
ligaments and cartilage. Intravenous injection of gadolinium is not mandatory but 
is often helpful for mechanical pathologies. The three planes may be systemati-
cally acquired. Some indications need to modify the protocol. Wrist ligaments: MR 
arthrography with very thin 3D slices, tendon ruptures: retractions may be extensive 
and require two successive coil positioning, synovial cyst: thin 3D sagittal T2-wi 
FS to depict tiny pedicles, Kienböck disease: intravenous gadolinium injection in 
coronal and sagittal planes (subtraction may be helpful), carpal tunnel syndrome: 
double obliquity slices along the median nerve, dynamic studies to detect tendon 
instability (pronosupination or metacarpophalangeal joint flexion), rheumatoid 
arthritis: T1 FS sequences with gadolinium to assess polysynovitis, eventually MR 
angiography and bilateral study, finger pathologies: dedicated microcoil with small 
FOV (up to 2 cm) if the abnormalities remain focal. 
Learning Objectives:
1. To understand the influences of patient positioning, scan parameters and 
magnet/coil technology on image quality.
2. To learn how to optimise scan protocols to maximise patient throughput 
without compromising diagnostic quality.
3. To recognise how and when to modify scan protocols to answer specific 
clinical questions.
A‑029	 16:25 
B. Normal variants and pitfalls 
J. Hodler; Zurich/CH 
The wrist and hand are characterised by variability of bones, fibrocartilage, 
ligaments, muscles and neurovascular structures. Coalitions (most commonly 
lunotriquetral, prevalence of 0.1%), ulnar impaction positive variance of the ulna, 
carpe bossu and an accessory medial lunate facet associated with osteoarthritis 
are typical variants of bone. The triangular fibrocartilage complex (TFCC) and the 
interosseous ligaments often present with small defects. Radial TFCC defects are 
present in 64% of symptomatic but also in 46% asymptomatic wrists. In addition, 
their prevalence increases with age, apparently without increasing symptoms. 
Accessory muscles are common and may clinically mimick a neoplasm. Disease 
may also be mimicked by imaging artifacts. Magic angle effects cause increased 
tendon signal and may thus lead to the incorrect diagnosis of tendinopathy. The 
lunate appears to be more dorsally tilted on sagittal MR images than on standard 
radiographs (radiolunate angle ~20° larger on MR images). This value increases to 
~37° if the wrist is positioned in ulnar deviated as is commonly the case when the 
wrist is examined in the “superman position”, with the arm above the head. Magic 
angle artefacts are commonly encountered in the wrist. The extensor and flexor 
pollicis longus are especially prone to such artefacts, due to their oblique course 
approaching the critical 55° with regard to the B0 field. In conclusion, variability is 
rather the rule than the exception in the hand and wrist. Only part of the findings 
have clinical meaning. Technical aspects add another dimension of variability. 
Learning Objectives:
1. To become familiar with the normal anatomy.
2. To be able to identify normal variants.
3. To appreciate the range of pitfalls that may simulate pathology.
A‑030	 16:50 
C. Identifying and reporting abnormal findings 
L. Cerezal; Santander/ES (lcerezal@gmail.com) 
Wrist pain and dysfunction are common disabling complaints that may be caused 
by a broad spectrum of disorders. These injuries may be the result of a single 
incident, such falling on an outstretched hand, or the result of repeated overuse, 
especially ongoing athletic or occupational activities. Diagnosis and management 
of wrist disorders represent one of the most clinically challenging processes. Clini-
cally, they are usually nonspecific, and similar findings can be found among the 
different pathologic conditions in the wrist, so accurate diagnosis is a key element 
for successful treatment plan. Outcome may be improved by timely implementation 
of various treatment options. Recent advances in diagnostic imaging have improved 
our ability to establish a noninvasive anatomic diagnosis. In this presentation, we 
review MR imaging findings of the most common injuries of the wrist, with special 
emphasis on key findings for an accurate diagnosis and its differential diagnosis. 
Finally, we will review the proper terminology to describe pathological findings 
and how to structure a radiological report clearly and concisely allowing efficient 
communication with clinicians. 
Learning Objectives:
1. To review the imaging appearances of common abnormalities.
2. To understand the use of terminology to describe pathological findings.
3. To learn how to structure a radiological report to ensure clarity and brevity.
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A‑034	 16:51 
C. Solid organ trauma 
J. Cazejust; Paris/FR (julien.cazejust@sat.aphp.fr) 
In abdominal trauma, spleen and liver are the most frequently affected organs. 
Initial FAST-US is especially dedicated to patient with haemodynamic instability, 
in which the presence of a massive haemoperitoneum prompts for surgery without 
any further examination. In other cases, the management of the patient is more 
and more conservative, associating supportive care and interventional radiology, 
while surgery is seldom performed. The severity of the injury is best assessed by 
multidetector CT, which can only be performed in a patient with controlled hae-
modynamic parameters. MDCT protocol should adapt to the purposes: thin slices 
allow multiplanar reconstruction, iodine injection provides detection of bleeding, as 
well as road mapping when intervention is necessary. Arterial phase is mandatory, 
although bleeding can sometimes be more conspicuous on portal venous phase. 
Hepatic or splenic lesions range from simple contusion or minor laceration to organ 
fracture (linear lesion > 3 cm), vascular avulsion or complete devascularisation, 
according to the AAST classification. The optimal patient selection for angiog-
raphy and embolisation is still matter of debate. However, intervention might be 
necessary shortly after CT when active bleeding is seen in a haemodynamically 
unstable patient; or in case of any vascular lesion (post-traumatic false aneurysm 
or arteriovenous fistula). Many different types of embolic materials are available 
(temporary material such as gelfoam pledget or permanent material such as coils, 
particles, occlusion device, glue or onyx). In all cases, a close follow-up is neces-
sary, as well as multidisciplinary concertation with regard to potential recurrence. 
Learning Objectives:
1. To review causes and imaging appearances of solid organ trauma.
2. To review various IR methods of treatment.
3. To review results and appropriate follow-up strategies.
Panel discussion: 
Do we need IR in the ER? 17:14 
Does it make sense to have a level one trauma centre without IR on call day and 
night and an interventional angio suite in close relation to the emergency rooms? 
What is the optimal size of population as basis for a trauma centre? When is IR 
the first choice in the trauma patient and what are the most important limitations 
of emergency IR in the trauma patient? 
16:00 - 17:30 Room E1 
Special Focus Session 
SF 2 
Child abuse: right images, right behaviour, right 
words 
Moderator: 
M.I. Argyropoulou; Ioannina/GR 
A‑035	 16:00 
Chairman’s introduction 
M.I. Argyropoulou; Ioannina/GR (margyrop@cc.uoi.gr) 
Imaging is important in the diagnostic approach of child abuse. Its role is to identify 
lesions typical of child abuse, to date and to evaluate the extent of injury and to 
elucidate imaging findings mimicking non-accidental trauma. Skeletal injuries such 
as classic metaphyseal lesions, posterior rib fractures, spinous process, scapular 
and sternal fractures represent a strong radiologic indicator of abuse. Radiographic 
skeletal survey, using high detail preferentially digital imaging systems represent an 
important part of the diagnostic work up of these patients. Bone scintigraphy, CT 
and MRI may offer additional valuable information. Central nervous system injuries 
are life threatening and represent the principle cause of fatalities of the abused 
child. Subdural haemorrhagic collections of different ages, retinal haemorrhage, 
subarachnoid haemorrhage, cortical contusion, hypoxic ischaemic injury and diffuse 
axonal injury represent lesions that may be found in the context of child abuse. 
The imaging modalities that are useful to detect these lesions are CT and MRI. In 
the radiologic report all abnormalities should be described separately and in detail 
and the differential diagnosis should be given. But how far the radiologist can go, in 
suggesting the diagnosis of abuse? The radiologic report is a document that can be 
used in the court. How the radiologist’s testimony should be prepared for the court? 
16:00 - 17:30 Room D2 
Interventional Radiology 
RC 209 
The trauma patient 
Moderator: 
A. Nicholson; Leeds/UK 
A‑031	 16:00 
Chairman’s introduction 
A. Nicholson; Leeds/UK (tonynick@tonynick.karoo.co.uk) 
In this session we would like to explore the patient journey from accident to the 
emergency room and onto definitive imaging and intervention either by surgery or 
by image guided. Outcomes will be considered and the evidence presented. By 
the end of the session delegates will have a better understanding of team working, 
imaging organisation and appropriateness of intervention. 
A‑032	 16:05 
A. Imaging modalities and logistics 
J. Ferda; Plzen/CZ (ferda@fnplzen.cz) 
The imaging of the trauma stratifies the severity and the treatment strategy. The 
leading modalities in low-energy trauma are x-ray and ultrasound. The different 
approach has to be used in high-energy trauma - the silent life-threatening injury 
must be actively searched. Although the first examination on the site of the accident 
could estimate whether the severe trauma is present, the imaging must confirm 
or exclude it. Besides fast transport to the trauma centre has the extraordinary 
impact on survival the diagnostic algorithm. The installation of CT, ultrasound 
and x-ray directly within the emergency department is extremely important for the 
trauma management. If the focused assessment sonography for trauma (FAST) 
is replaced by whole body CT, the life-threatening injury is detected at fastest. 
Protocol includes imaging of non-enhanced CT head and cervical spine followed 
by the contrast-enhanced CT of the entire thorax, abdomen and pelvis, in cases of 
lower extremities trauma covering whole body. CT could be performed also under 
resuscitation, because whole imaging takes about three to five minutes. Following 
findings listed recently according to their impact on survival must be confirmed 
or excluded: intracranial injury, cervical spine trauma, aortic injury, overpressure 
pneumothorax, severe bleeding in the abdominal cavity, organs injury, peripheral 
vascular trauma, bone trauma; the trauma team including anaesthesiologist, sur-
geon and radiologist discusses the findings and plans of the treatment. 
Learning Objectives:
1. To understand appropriate triage of trauma patients to imaging.
2. To learn the appropriate imaging techniques.
3. To review imaging appearances.
A‑033	 16:28 
B. Management of arterial trauma 
M. Katoh; Homburg/DE (marcus.katoh@uks.eu) 
Over the last two decades, spiral-CT has become a highly reliable imaging modal-
ity to diagnose haemorrhage in trauma, while the role of catheter angiography has 
changed from a diagnostic to a therapeutic modality. Traumatic injuries of the heart 
and aorta lead to sudden death occurring at the accident site, whereas uncontrollable 
haemorrhage from larger arteries and parenchymal organs is the most frequent cause 
of mortality during the first 4 h following severe trauma. In patients with ruptured aorta 
or major arteries, stenting and temporary balloon occlusion may contribute to saving 
lives, while transcatheter embolisation may prevent exsanguination in haemorrhage 
from visceral organs, arteriovenous fistulas, and secondary onset haemorrhage. 
However, a haemodynamically stable patient is a prerequisite for all angiographic 
interventions. Definite haemostasis using the above-mentioned techniques can be 
obtained in 80-100% (major and periphery arteries) and 82-100% (visceral organs), 
respectively. Possible complications following angiographic haemostatic interven-
tions depend very much on the treated vessel bed but are, in general, as low as 5%. 
Learning Objectives:
1. To understand potential treatment options and when to treat and when not 
to treat.
2. To learn about the different embolisations and other interventional treatment 
techniques.
3. To review results and possible complications.
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to current best practice, restriction of opinions to one’s own expertise, expression 
of opinions that take into consideration all of the material facts, and the readiness 
to change that opinion if additional information becomes available. Any unusual, 
contradictory or inconsistent features of the case should be highlighted. The expert 
should highlight whether a proposition is a hypothesis (in particular a controversial 
hypothesis) or an opinion deduced in accordance with peer-reviewed technique, 
research and experience accepted as a consensus in the scientific community. 
He/she should indicate whether the opinion is provisional (or qualified), stating the 
qualification and the reason for it, and identify what further information is required to 
give an opinion without qualification. When there is a range of opinion on any ques-
tion to be answered by the expert, (a) the range of opinion should be summarised, 
(b) highlight whether that range of opinion includes an ‘unknown cause’ (because of 
limited facts of the case or limited research/peer-reviewed publications), and (c) give 
reasons for the opinion expressed. Reprints of scientific publications will assist the 
court, but will also enable the attorneys to undertake a more robust cross examination! 
Learning Objectives:
1. To learn about imaging findings in relation to whether or not abuse has 
occurred.
2. To understand in which cases the diagnosis of child abuse should be raised 
in the radiology report.
3. To become familiar with the terms that should be used when highly specific 
imaging indicators are identified in an otherwise normal infant.
Panel discussion: 
The radiologist at the eye of the storm 17:14 
Imaging plays a central role in the diagnosis of child abuse. Is there 
any risk of the radiologist having a detrimental impact on either the wel-
fare of the patient or the judicial process by either under-diagnosing 
or over-diagnosing child abuse? 
16:00 - 17:30 Room E2 
State of the Art Symposium 
SA 2 
Ovarian cancer: update and what’s next 
Moderator:
R. Forstner; Salzburg/AT 
A‑039	 16:00 
Chairman’s introduction 
R. Forstner; Salzburg/AT (r.forstner@salk.at) 
Ovarian cancer continues to be a challenge to radiologists and clinicians, as it is 
one of the most lethal female tumours. This is mainly due to its diagnosis in an 
advanced stage in the majority of patients. However, new developments can be 
observed: new insights in tumour biology, advances in imaging and new concepts 
of ovarian cancer treatment and surveillance. Furthermore, a multidisciplinary 
expert team approach has also substantially changed the management of patients 
with suspected ovarian cancer. The findings of radiology are becoming pivotal in 
a more individualised patient care. The role of radiology includes (a) characterisa-
tion of sonographically indeterminate adnexal masses, (b) staging as guidance 
for surgery and treatment planning (including identification of sites of non optimal 
resectabilty) in suspected ovarian cancer, (c) assessment of recurrent disease, and 
(d) in selected cases image-guided biopsy. In this session we provide an update 
on the aetiology and current concepts of treatment of ovarian cancer and on the 
contribution of radiology in characterisation and staging in patients with the working 
diagnosis of ovarian cancer. The panel discussion will focus on the role of radiology 
in multidisciplinary conferences in suspected ovarian cancer. 
Session Objectives:
1. To learn about new concepts in etiology and treatment of ovarian cancer.
2. To become familiar with optimised imaging protocols to diagnose ovarian 
cancer.
3. To learn about the value of CT and PET/CT as a basis for treatment planning 
in ovarian cancer.
4. To appreciate the role of the radiologist in multidisciplinary consensus 
conferences.
Session Objectives:
1. To learn about current imaging practices in the evaluation of suspected child 
abuse.
2. To learn about imaging changes which permit a firm diagnosis of child 
abuse.
3. To become familiar how to construct a comprehensive report providing 
evidence of child abuse.
A‑036	 16:05 
How to image and detect patterns of skeletal injury indicating child abuse 
P.K. Kleinman; Boston, MA/US (Paul.Kleinman@childrens.harvard.edu) 
In infants, skeletal injury may form the basis for the diagnosis of abuse. The first 
step is the acquisition of a skeletal survey utilising meticulous technique adhering 
to a rigorous imaging protocol. A proper interpretation is ensured when the radiolo-
gist is familiar with the various patterns of skeletal injury, their specificity for abuse 
and those entities which may simulate inflicted injury. Appreciation of the lesion 
morphology, the fundamental pathologic alterations and mechanism of injury are 
essential in assessing the significance of the findings and placing them in the clinical 
context. Dating fractures poses a significant challenge, but in most cases, injuries 
can be placed in a certain time frame, especially if a follow-up skeletal survey is 
obtained. Although radiography forms the basis of skeletal imaging, ultrasound, CT, 
scintigraphy and MRI may clarify findings and optimise diagnosis and management. 
The radiology report must be constructed with care and the language should be 
crafted with the expectation that the radiologist may be called to testify in court, a 
daunting challenge in an often highly adversarial environment. 
Learning Objectives:
1. To learn about the appropriate imaging protocols and quality for skeletal 
survey in suspected child abuse.
2. To learn about patterns of skeletal injury typical of child abuse.
3. To become familiar with findings that point to alternative diagnoses.
A‑037	 16:28 
Imaging strategies to fully determine intracranial injury resulting from 
child abuse 
C. Adamsbaum, C. Rey-Salmon; Paris/FR (c.adamsbaum@svp.ap‑hop‑paris.fr) 
Radiologists play a key role in the early diagnosis of abusive head trauma (AHT). 
Symptoms are various and may range from coma to asymptomatic children. Changing 
elements of the history provided previous injuries, bruising in non-ambulatory children 
and delay in seeking care raise a high index of suspicion. The most common finding 
in AHT is of multifocal subdural haematomas over the cerebral hemispheres, the 
convexity, the posterior interhemispheric fissure and the posterior fossa. The haema-
tomas are often associated with hypoxic-ischaemic injury and retinal haemorrhages. 
CT is the first diagnostic examination to be used for patients with acute injury. It can 
reveal intracranial haemorrhage, fracture and soft tissue swelling with a high degree of 
sensitivity. CT should be repeated after a time interval if the findings are doubtful or if 
there is a discrepancy with the neurological picture. MRI (including T1, T2, T2*, diffusion 
sequences and cervical spine examination) is required to fully determine intracranial 
injury as it can exquisitely demonstrate hypoxic-ischaemic injuries by showing areas 
of cytotoxic oedema. It is impossible to date precisely a haematoma whose pattern is 
influenced by numerous factors. However, the main point is to determine the presence 
of ‘age-different’ lesions. This not only provides a strong argument for the diagnosis 
but also suggest repetitive violence and thereby, a high risk for further injury unless 
protective action is undertaken. Brain imaging must be performed in all siblings younger 
than 2 years, living in the same conditions as the index case. 
Learning Objectives:
1. To learn about imaging protocols designed to:
 a) detect acute treatable conditions
 b) depict fully and determine the timing of all injuries.
2. To become familiar with imaging findings that are highly suggestive of  
child abuse.
3. To learn about head trauma that may simulate child abuse.
A‑038	 16:51 
What is the information required by any court and how the radiological 
reports should be phrased 
S. Chapman; Birmingham/UK (stevechapman@doctors.org.uk) 
This presentation will describe the role of a paediatric radiologist as an expert witness 
(as opposed to a witness to fact). The expert has an overriding duty to the court that 
takes precedence over any obligation from whom the expert has received instruc-
tions or by whom the expert is paid. Particular duties include advice that conforms 
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a crucial role in identifying patients with unresectable disease thus triaging them 
to neo-adjuvant chemotherapy rather than primary surgery. Accurate evaluation 
of CT images and a detailed reporting of the site, volume and extent of metastatic 
disease guide the surgeon to areas of disease they may be difficult to identify 
surgically leading to an optimal cytoreductive surgery. MRI is best reserved as a 
problem solving modality. Multiphase dynamic contrast-enhanced MRI and diffusion 
weighted MRI improve the evaluation of pelvic side wall invasion and detection of 
small peritoneal and serosal implants leading to higher staging accuracy compared 
to CT and standard multiplanar T2W sequences. The role of PET/CT in primary 
staging of ovarian carcinoma is controversial. However, PET/CT is the integrated 
functional/anatomical modality of choice in detecting relapse with its greatest utility 
in women with rising CA 125 levels and negative CT results. Furthermore, PET/CT 
can modify the assessment of the distribution of recurrent ovarian cancer, which 
may, in turn, alter patient management. 
Learning Objectives:
1. To understand the role of CT in staging of ovarian cancer with emphasis on 
treatment selection and treatment planning.
2. To appreciate the added value of dynamic contrast-enhanced and diffusion-
weighted MRI in staging ovarian cancer.
3. To understand the role of PET/CT in staging of primary ovarian cancer and 
detection of tumour recurrence.
Panel discussion: 
The illustrated role of the radiologist in multidisciplinary consensus 
conferences 17:14 
Multidisciplinary cancer conferences have become standard of care. They serve to 
optimise treatment and as educational forums. It is therefore important to know the 
role of the radiologist in this multidisciplinary setting for a patient with suspected 
ovarian cancer. What are the considerations for defining the individualised, ap-
propriate treatment regimen in ovarian cancer? Furthermore, in which setting may 
radiology alter treatment by providing image-guided biopsy. 
16:00 - 17:30 Room F1 
Functional Imaging of Tumours: How to do it
MC 222 
Basics you should know 
Moderator: 
J. Stoker; Amsterdam/NL 
A‑043	 16:00 
A. Tumour angiogenesis and perfusion parameters 
D. Sahani; Boston, MA/US (dsahani@partners.org) 
Angiogenesis is an essential process whereby tumours derive vascular supply from 
adjacent tissue to sustain tumour growth and metastatic spread. Newer targeted 
antiangiogenic therapies differ significantly from current therapies for cancer in that 
they their mechanism of action is not cytotoxic. The methods of dose selection are 
either invasive, such as biopsy and histology, or time consuming, such as tumour 
shrinkage and time to disease progression, both of which take months to assess 
and fraught with other limitations. Moreover, cancer is a very variable disease, 
which means that some patients will respond to a particular therapy while others 
will not. There is, therefore, a great need to establish surrogate markers for drug 
response that are both rapid and reliable, not only for clinical trials of new drugs 
but also to aid in the selection of optimal treatment for individual patients. Angio-
genic vasculature is typically dilated, tortuous, disorganised and more permeable 
and the flow within tumours is spatially and temporally heterogeneous. Although 
microvessel density count has been established as a prognostic indicator for 
many cancers, it is invasive, has several other limitations and often impractical. 
On the other hand, imaging is non-invasive and can assess much larger volumes 
than can biopsies. Dynamic CT and MRI using a kinetic model can derive tumour 
vascular characteristics by capturing temporal changes in contrast enhancement 
reflecting the tumour vascular physiology. Various approaches for data acquisition 
and processing have been described with their inherent benefits and limitations. 
Learning Objectives:
1. To understand the mechanism and triggers of tumour angiogenesis.
2. To know the physiological parameters of tissue microcirculation.
3. To understand the principles of dynamic contrast enhanced imaging.
A‑040	 16:05 
Ovarian cancer: update and role of radiology 
J.A. Spencer; Leeds/UK (johnaspencer50@hotmail.com) 
Ovarian cancer is known as the ‘silent killer’. It is usually diagnosed late and most 
women have disease disseminated to the peritoneum (and/or pleura) at presenta-
tion. Standard treatment comprises cytoreductive surgery followed by platinum-
based chemotherapy. An alternative is neoadjuvant chemotherapy followed by 
interval debulking surgery (IDS) then completion chemotherapy. Data from the 
EORTC 55971 trial show this to be as effective as the standard of care. There are 
strong genetic predispositions to ovarian, fallopian tube and primary peritoneal 
cancers. There is linkage with breast cancer in women with BRCA gene mutations 
and with colon cancer with the HNPCC gene. Ongoing trials are screening women 
in the general population and at high risk of the disease. These use the serum 
tumour marker CA125 followed by US as screening tools. MR imaging is an effective 
tool to assess sonographically indeterminate adnexal masses and offers an earlier 
diagnosis of cancer than interval reassessment with US. CT is the most commonly 
used modality for assessment of disease extent prior to surgery. Image-guided 
biopsy is necessary prior to starting neoadjuvant chemotherapy. The EORTC 55955 
and MRC (UK) OV05 trials of women with treated ovarian cancer have shown no 
outcome advantage for women treated early at ‘CA125 relapse’ of disease versus 
later with clinical or CT evidence of relapse. This questions the role of CA125 in 
follow-up and argues against investigation of the ‘CA125 +ve, CT -ve’ woman with 
more expensive and scarce imaging resources such as CT-PET and DCEMR. 
Learning Objectives:
1. To become familiar with clinical features of ovarian cancer.
2. To learn about the etiology of ovarian cancer, including genetic 
predisposition and the current research into screening.
3. To become familiar with new concepts of treatment ovarian cancer and 
surveillance of the treated patient and their impact for the use and choice of 
imaging modalities.
A‑041	 16:28 
Imaging of adnexal masses: is it feasible to diagnose ovarian cancer? 
I. Thomassin-Naggara; Paris/FR (isabelle.thomassin@tnn.aphp.fr) 
Adnexal masses can be depicted by many imaging modalities (US, CT, MR and 
PET-FDG). However, the characterisation of adnexal tumours is mainly based on 
two techniques: US and MRI. For complex adnexal masses, MR imaging add to 
conventional criteria of malignancy common to all imaging modalities (bilaterality, 
tumour diameter larger than 4 cm, predominantly solid mass, cystic tumour with 
vegetations, and secondary malignant features, such as ascites, peritoneal involve-
ment, and enlarged lymph nodes) specific features based on the characterisation of 
the solid tissue (including vegetation, thickened irregular septa, and solid portion) 
of the adnexal tumour. Signal intensity of solid tissue on T2 sequence (fibrous tis-
sue), perfusion (neoangiogenesis), and diffusion (cellularity) are combined to make 
a decision tree analysis. Low T2 signal, absence of high b1000 signal, and time 
intensity curve type 1 are predictive of benignity whereas high T2 signal and time 
intensity curve type 3 are predictive of malignancy. Combining common classical 
features and specific MR features for predicting malignancy, MR imaging has a high 
degree of accuracy (96%) for characterising complex adnexal tumours. This high 
diagnostic confidence rate may help young women wishing to preserve childbear-
ing potential to opt for conservative surgery and avoid the systematic removal of 
benign complex adnexal masses in menopausal women. 
Learning Objectives:
1. To understand the role of ultrasonography in assessing and managing 
complex adnexal lesions.
2. To learn how to optimise the MRI protocol and how to improve the 
characterisation of indeterminate complex adnexal masses.
3. To understand the added value of functional sequences (DCE MRI and DWI) 
in diagnosing adnexal masses.
A‑042	 16:51 
Staging ovarian cancer: what technique is the best? 
E. Sala; Cambridge/UK (es220@radiol.cam.ac.uk) 
Although ovarian cancer is formally staged surgically, the FIGO committee encour-
ages the use of imaging techniques to assess the important prognostic factors such 
as resectable disease and lymph node status. Therefore, cross-sectional imaging 
by means of CT, MRI and PET/CT plays a crucial role in staging, treatment selec-
tion and treatment planning in patients with ovarian cancer. CT is the modality of 
choice for staging ovarian carcinoma as it is a relatively quick, readily available 
whole body imaging technique and has a reported accuracy of 70-90%. CT plays 
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cancer, US should be used in order to guide the biopsy of the probably malignant 
lesion and also in order to stage the disease, locally as well as in the axilla. Local 
staging should include the size of the lesion as well as the presence or absence of 
multifocal, multicentric or contralateral disease. US is also the technique of choice 
to determine the lymph node status of the patient. After a breast MRI is performed 
for a more accurate map of the disease’s extension, second-look ultrasound is also 
very frequently used to evaluate all the additional lesions detected by breast MR, 
with a very high diagnostic yield. 
Learning Objectives:
1. To review the efficacy of US in screening for breast cancer.
2. To appreciate the additional role of US in staging of breast cancer.
3. To review its accuracy in diagnosis of breast cancer with different clinical 
presentations.
A‑047	 16:30 
B. The role of US in premalignant and benign lesions 
I. Günhan-Bilgen; Izmir/TR (isilbilgen@hotmail.com) 
The goal of breast US is to make a more specific diagnosis than can be made 
with clinical findings and mammography (MG) alone and to prevent as many un-
necessary biopsies as possible and to find cancers missed by MG. In addition to 
its well known role of distinguishing cystic from solid masses, US can differentiate 
among types of normal tissues and characterise complex cysts and solid nodules. 
Benign solid nodules may have specific US findings such as pure and intensely 
hyperechoic texture, oval shape, parallel orientation, circumscribed margin and 
presence of a complete thin capsule. Also, the absence of any malignant finding is 
necessary. Specific benign diagnosis will be reviewed in the lecture. Premalignant 
breast lesions are atypical ductal hyperplasia (ADH), atypical lobular hyperplasia 
(ALH), lobular carcinoma in situ (LCIS), phylloides tumour, radial scar and juvenile 
papillomatosis. Specific premalignant diagnosis will be reviewed in the lecture. To 
increase US specificity, it is necessary to improve US technique by following US 
guidelines published by ACR. Use of dynamic procedures (movement of the breast, 
focal compression), Doppler US, compound imaging (in evaluation of margin and 
internal echotexture), tissue harmonic imaging (in visualisation of a lesion against 
a fatty background) and elastography (in differentiation of complicated cysts from 
solid nodules) are helpful if used appropriately. In addition to its role in the detection 
and characterisation of lesions, US is also used to guide interventional procedures, 
such as cyst aspiration, abscess drainage, biopsy and galactography. 
Learning Objectives:
1. To learn the US features of benign and premalignant lesions.
2. To understand the role of US in the management of premalignant and 
benign lesions.
3. To learn how to avoid unnecessary biopsies.
A‑048	 17:00 
C. New technologies in US 
R. Salvador; Barcelona/ES (rafasalvador@telefonica.net) 
The European and American guidelines include breast ultrasound in a restricted 
diagnostic scenario for breast cancer diagnosis. The fourth edition of the European 
guidelines (2006) reviewed in 2008 refers to US in only twice. ACR in its 2007 ACR 
Practice guideline reduces breast ultrasound examination to seven situations. 
Evaluation of the axilla and ultrasound as a screening tool on high risk women is 
considered an area of research. The progression of US makes guidelines become 
obsolete very fast. Its application still remains pending on the results of clinical 
trials. Image smoothing on sono-CT or multiple frequency transducers will produce 
images, eventually with more diagnostic information. Second tissue harmonics 
will produce sharper and more clear images. CAD systems, Doppler and contrast 
Doppler will help in diagnosis. 3D with the new software and automatic probes 
constitute a very promising work in progress. They will make a dramatic change in 
our workload. The radiologist will be released of performing the exam, to review the 
images in the workstation. Sonoelastography has evolved from the manual to the 
actual automatic shearwave. This system measures the transversal transmission 
of sound in biologic tissues. It is a new and promising technology, probably more 
objective and non-operator dependant, that is able to differentiate benign from ma-
lignant conditions. All of these systems will be reviewed and evaluated for its actual 
situation. The problem now is how to introduce new terms, new descriptors, and 
new technologies in the BI-RADS system, once clinical evidence is demonstrated. 
Learning Objectives:
1. To understand the new technologies in breast US.
2. To appreciate advantages and disadvantages of these methods.
3. To understand the potential role of new technologies in breast imaging.
A‑044	 16:30 
B. Diffusion imaging 
B. Taouli; New York, NY/US (bachir.taouli@mountsinai.org) 
Diffusion-weighted MRI (DWI) is a promising technique in oncology. It can be used 
for in vivo quantification of the combined effects of capillary perfusion and diffusion. 
Using echoplanar imaging (EPI), DWI is possible with fast imaging times minimis-
ing the effect of gross physiologic motion from respiration and cardiac movement. 
In this lecture, we will discuss the acquisition, post-processing and quantification 
methods and results of DWI in abdominal and pelvis tumours. We will also review 
the mechanisms associated with diffusion changes in tumours. MRI-pathologic 
correlation will be shown. Finally, limitations and future directions of the technique 
will be reviewed. 
Learning Objectives:
1. To understand the physical basis of diffusion.
2. To understand the basis of diffusion measurement with MRI.
3. To understand why diffusion imaging provides information on the structure 
and viability of solid tumours.
A‑045	 17:00 
C. Metabolic imaging using PET/CT 
G. Antoch; Düsseldorf/DE (antoch@med.uni‑duesseldorf.de) 
Diagnostic potentials - as well as limitations - associated with morphological 
cross-sectional imaging on the one hand and functional imaging on the other are 
increasingly well understood. It has become obvious that in many cases both 
kinds of imaging complement one another. Hence, hybrid PET/CT imaging must 
be considered one of the most promising new developments in medical imaging. 
However, some questions have to be raised and challenges have to be met to avoid 
overrating PET/CT in oncology. PET/CT with [18 F]-2-fluoro-2-deoxy-D-glucose 
(FDG) as a radioactive tracer has been reported to be more accurate than either 
imaging modality alone and sometimes even more accurate than CT and PET 
read side by side. However, the clinically important question should rather be the 
following: Does this higher accuracy have an impact on patient management? 
Furthermore, some tumours do not have an increased glucose metabolism making 
them FDG-PET negative. The most recently launched line of PET/CT scanners 
combines high-definition PET with high-end multislice CT. These imaging systems 
not only provide a higher diagnostic accuracy based on detection of smaller le-
sions with CT and PET, but also offer integration of complex CT protocols into the 
PET/CT scan. These protocols include CT perfusion, three-dimensional CT image 
reconstruction or virtual fly-through. The aim of this talk is to give an overview 
concerning PET/CT in oncology. The mechanism of radionuclide uptake, different 
tracers, the indications of PET/CT in oncology and its accuracy will be addressed. 
Learning Objectives:
1. To understand why uptake of the tracer provides information on the viability 
of solid tumours.
2. To learn whether PET/CT is able to give reliable quantitative information.
3. To know whether PET/CT is a valuable tool for tumour response to 
treatment.
16:00 - 17:30 Room F2 
Breast 
RC 202 
Breast US 
Moderator: 
E. Azavedo; Stockholm/SE 
A‑046	 16:00 
A. The role of US in screening, diagnosis and staging of breast cancer 
J. Camps Herrero; Valencia/ES (juliacamps@ono.com) 
Breast ultrasound (US) is an invaluable adjunct to mammography and also the 
most frequent modality used for guidance in interventional procedures and in the 
evaluation of additional lesions seen in breast MRI. Its role as a diagnostic tool in 
breast cancer will center the discussion of this talk. US B-Mode’s value as a screen-
ing technique has not been established, although new advances in sonography 
(volumetric ultrasound) will very possibly change this view. US signs have been 
validated throughout many published papers in the literature and are very helpful in 
order to decide the management of palpable and non-palpable lesions, their positive 
and negative predictive value being very high. After a diagnosis of invasive breast 
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to gain additional functional information. Functional imaging techniques such as 
diffusion tensor imaging and tractography as well as fMRI are increasingly used 
and relied on in clinical practice. With diffusion tensor imaging and tractography 
the location, course and integrity of the major white matter tracts can be depicted, 
while with fMRI the brain’s cortical function is visualised. Despite major technical 
advances, these techniques are still time consuming, labour intensive and have 
several limitations. They therefore need to be used and interpreted with care. The 
purpose of this lecture is to review the functional anatomy of the brain in a clinically 
relevant context and to illustrate when additional functional imaging techniques may 
be indicated. The most important eloquent brain areas are addressed and include 
the motor, visual and language systems. 
Learning Objectives:
1. To learn classic neurological and other clinical symptoms in correlation to 
brain anatomy.
2. To understand which neurological/clinical symptoms the patient might have 
based on the imaging findings.
3. To consolidate which imaging techniques are the best to answer the clinical 
question based on the patient’s clinical/neurological symptoms.
16:00 - 17:30 Room I/K 
Cardiac 
RC 203 
Cardiac imaging: what’s up Doc? 
Moderator: 
C. Peebles; Southampton/UK 
A‑052	 16:00 
A. 3 T cardiac imaging: twice as good? 
M. Gutberlet; Leipzig/DE (matthias.gutberlet@herzzentrum‑leipzig.de) 
Routine clinical cardiac MRI requires speed and efficiency as a result of physical 
motion. Consequently, the challenges and benefits of rapid MRI are nowhere more 
apparent than in the field of cardiovascular MR imaging. To meet these challenges, 
one must balance the competing constraints of signal-to-noise ratio (SNR), contrast-
to-noise ratio (CNR), spatial resolution, temporal resolution, scan time, and image 
quality. One of the main determinants of SNR is the static magnetic field strength. 
Hence, cardiovascular MRI at 3.0 T or more holds the promise to overcome some 
of the SNR limitations and to extend the capabilities of cardiac MRI. All studies in 
cardiac MRI at higher field strength have proven the feasibility of cardiac MRI for 
the comprehensive assessment of cardiac morphology and function. The studies 
demonstrated a significant SNR increase, but also outlined image-quality problems 
associated with B1-field inhomogeneities and specific absorption rate (SAR) con-
straints. With regard to acquisition speed, parallel imaging MRI capabilities form 
an important enabling factor, especially if enough SNR is available. Therefore, the 
combination of higher field strength and parallel imaging strategies may help to 
overcome several of the present limitations in cardiac MRI like cardiac perfusion 
and coronary artery imaging. The present indications, advantages and limitations 
of cardiac MRI at 3.0 T will be discussed. 
Learning Objectives:
1. To learn the advantages of cardiac MR at 3 T.
2. To understand how to optimise protocols and reduce artefacts.
3. To be aware of areas that need improvement.
A‑053	 16:30 
B. Cardiac CT: how low can dose go? 
S. Leschka; St. Gallen/CH (sebastian.leschka@kssg.ch) 
The risks associated with the exposure of ionising radiation has raised increasing 
concerns in the radiological community. The recent years have shown an overall 
increase in the use of CT for the imaging of the heart and the coronary arteries. 
The downside of this increased use of cardiac CT is the increase in the collective 
radiation dose with cardiac CT which have been reported to be associated with 
an effective radiation dose of 20 mSv or more. Increased awareness of the radia-
tion dose with cardiac CT led to the development of several effective radiation 
dose reduction strategies including prospective ECG gating technique, anatomy 
and ECG-based tube current modulation, high pitch acquisition, and adaptation 
of the CT scanning parameters to the body habitus. However, the dose reduction 
strategies should be selected carefully on an individual patient basis in order to 
avoid serious image quality impairment by noise and artefacts. The lecture outlines 
the different radiation dose saving techniques currently used in clinical practice, 
16:00 - 17:30 Room G/H 
Neuro 
RC 211 
Introduction to the brain 
Moderator: 
T. Stosic‑Opincal; Belgrade/RS 
A‑049	 16:00 
A. Brain anatomy made easy 
T.A. Yousry; London/UK (t.yousry@ion.ucl.ac.uk) 
The anatomy of the brain is often perceived as being complicated. Especially the cortex is 
seen as an irregular arrangement of variable structures, which are difficult to differentiate 
and to identify. We will review the overall subdivision of the brain into lobes and describe 
their boundaries and their major gyri and sulci. We will then describe the location of spe-
cific functions. 1. Primary sensorimotor cortex: motor is located in the precentral gyrus, 
sensory in the postcentral gyrus around the central sulcus (CS), hence the importance 
of always correctly identifying the CS. We will present 4 interlocked methods to identify 
the CS in the axial plane (a) knob, (b) lateral axial, (c) medial axial, (d) gyral/cortical 
thickness and 3 to identify it in the sagittal plane (a) lateral sagittal, (b) hook, (c) medial 
sagittal. 2. Primary auditory cortex (A1): centred at the postero-medial part of Heschl’s 
gyrus (HG), we will present simple landmarks in each of the 3 planes: (a) axial: adhaesio 
interthalamica, (b) sagittal: omega/heart shape of HG, (c) coronal: omega shape of HG. 
3. Primary visual cortex (V1): Centred on the calcarine sulcus, we will discuss the char-
acteristic shape that allows the identification of this structure in all 3 planes. At the end 
of this lecture, you will know the subdivision of the cortex; the methods and landmarks 
necessary to identify the primary sensorimotor, speech, auditory, and visual areas. 
Learning Objectives:
1. To recapitulate basic brain anatomy.
2. To be able to correlate different anatomic locations to CT and MR images.
3. To consolidate knowledge of the important landmarks for anatomic 
structures on images.
A‑050	 16:30 
B. Pattern recognition and normal variants to know 
M.M. Thurnher; Vienna/AT (majda.thurnher@meduniwien.ac.at) 
Magnetic resonance imaging (MRI) has undergone a rapid development in the 
last decade with numerous new techniques. Nevertheless, pattern recognition of 
brain lesions based on signal intensities on conventional MR sequences (T1- and 
T2-weighted, FLAIR) is the first step in diagnostic “work up”. Good examples for 
pattern recognition are lesions with T1-shortening (“bright” on T1WI) such as: fat 
containing lesions (lipoma), melanoma, lesions with colloid content, calcifications, 
and haemorrhagic metastatic lesions. T2-shortening (“dark” on T2WI) in enhanc-
ing lesions is suggestive of lymphoma and certain infections (tuberculosis, fungal 
abscesses). Flow void (absence of signal) reflects high velocity flowing blood or 
CSF, and will help in diagnosing vessel abnormalities and related pathologies. The 
purpose of this lecture is to refresh knowledge on patterns and normal variants 
useful for clinical practice. A simplified “pipeline” consisting of easy consecutive 
steps will be introduced. 
Learning Objectives:
1. To learn important normal variants of different structures and lesions in the 
brain.
2. To learn about recognition patterns that might be helpful in suggesting the 
most likely etiology of common brain lesions.
3. To consolidate the key imaging findings in different types of lesions and 
normal variants.
A‑051	 17:00 
C. Clinical symptoms correlated to brain anatomy 
M. Smits; Rotterdam/NL (marion.smits@erasmusmc.nl) 
Diagnostic neuro-imaging heavily depends on a thorough understanding of brain 
anatomy in relation to the brain’s function. Clinical neurological symptoms and 
deficits not only give us an indication of the brain area(s) involved but may also 
direct us towards the use of specific imaging techniques, such as diffusion tensor 
imaging and tractography, as well as functional magnetic resonance imaging (fMRI). 
Specific imaging findings, on the other hand, may direct clinical management in 
a neurologically intact patient, such as the decision to resect a brain tumour in 
or near an eloquent brain area. Again, specific imaging techniques may be used 
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A‑056	 16:05 
Evaluation of tumour response to therapy: the role of radiology 
M. O’Connell; Dublin/IE (oconnellm@mater.ie) 
Evaluation of response to treatment allows an early assessment of tumour response 
typically after 2-4 cycles of chemotherapy. This evaluation is most commonly per-
formed with PET/CT during therapy for high grade non-Hodgkin’s lymphoma. This 
review presentation looks at the potential roles that CT, regional MRI and whole 
body MRI do and could play in response evaluation from a radiology perspective. 
The presenter is a radiologist who is clinical director of a medium volume PET/
CT centre. The talk focuses on discrepancies between CT and PET findings in 
tumour response and on tumours or situations where CT is the primary modality 
to determine tumour response. Potential roles for whole body MRI in response 
evaluation and assessment of solid tumours by MRI are examined. At a general 
level, the role of the radiologist as part of the multidisciplinary oncology meeting 
(MDM), including when and where to use image-guided biopsy in response evalu-
ation and the use of RECIST versus PRECIST criteria is discussed. The aim of the 
presentation is to outline the role of CT in tumour response evaluation in the era 
of PET/CT and to explore potential roles particularly for whole body MRI in tumour 
assessment. The presenter hopes to encourage radiologists to get fully involved 
in MDM discussions regarding CT, MRI and PET/CT evaluation. 
Learning Objectives:
1. To learn the standard method (tumour measurements) for the evaluation of 
tumour response to treatment.
2. To understand the limits of international standard.
3. To become familiar with methods that provide functional or structural 
information, like perfusion CTMR or DW-MRI.
A‑057	 16:23 
Evaluation of tumour response to therapy: the role of nuclear medicine 
A. Chiti; Milan/IT (arturo.chiti@humanitas.it) 
The high costs and possible side effects of chemotherapy and radiation therapy 
treatments favour the use of effective ways to monitor the treatment efficacy in 
oncology. Molecular imaging demonstrated to be effective in evaluating the response 
after and during the course of therapy, in order to assess chemo-sensitivity and 
chemo-resistance of a particular neoplasm. The use of PET-CT in this setting can 
vary from very sophisticated and complex quantitative evaluation to simple qualita-
tive analyses. In malignant lymphoma, international criteria for monitoring response 
to therapy have recently been revised, and FDG now plays a central role in defining 
tumour response. In a variety of solid tumours, studies have indicated that FDG 
PET-CT may provide early and accurate assessment of tumour response, suggest-
ing that it could play a significant role in personalising the treatment of malignant 
tumours. Performed during and after therapy for HL and aggressive NHL, FDG 
PET results have a high prognostic value and correlate with survival. FDG PET 
has been incorporated into revised response criteria for aggressive lymphomas, 
and several ongoing trials are under way to investigate the value of treatment 
adaptation based on early FDG PET results for HL and aggressive NHL. Many 
technical aspects must be taken in consideration to avoid critical errors in evaluat-
ing response. From patient preparation to image acquisition a series of possible 
pitfalls must be avoided. In the clinical practice, the most widely used parameter 
is the SUV, which can improve the accuracy of qualitative image assessment in 
many clinical settings. 
Learning Objectives:
1. To understand why PET-CT can be used to assess tumour viability.
2. To become familiar with the principles of signal quantification and to discuss 
its advantages and limits.
3. To learn about the incoming tracers that might enhance the role of PET-CT 
in the evaluation of tumour response.
A‑058	 16:41 
Alzheimer’s disease: the role of radiology 
J. Alvarez-Linera; Madrid/ES (jalinera@ruberinternacional.es) 
Neurobiological changes in Alzheimer’s disease (AD) occur in an stereotypical 
pattern that begins in the medial temporal lobe (MTL) years before the clinical 
manifestation (brain reserve). Brain atrophy is a marker of neurodegeneration that 
reflects the neurobiological disorder and is correlated with the neuropsychological 
changes at all stages of the disease. Other imaging markers may reflect changes 
in microstructural (diffusion), functional (perfusion) or metabolic (MRS) domains 
that would provide additional information but are awaiting wider validation. In the 
early stages of AD, the most effective MRI markers are those that reveal atrophy 
in MTL, particularly the measures of the hippocampus. The MTL atrophy mea-
the required conditions in whom they may be successfully used, and how these 
techniques could be implemented in the daily clinical practice. 
Learning Objectives:
1. To review the different dose reduction techniques used on cardiac CT.
2. To understand the clinical impact, if any, of dose reduction.
3. To recognise when the dose is too low and the noise too high.
A‑054	 17:00 
C. Cardiac post-processing: latest tricks 
B.J. Wintersperger; Toronto, ON/CA (Bernd.Wintersperger@uhn.on.ca) 
Proper linking of the data acquisition to the patients ECG is among the crucial 
prerequisites for successful cardiac imaging. While cardiac CT data acquisition 
itself does not impose any effect on the patients’ ECG, inherent physical effects in 
the MR environment does show impact on the ECG trace and may hamper proper 
R-peak delineation. In addition, patient-related factors such as arrhythmia might 
affect image quality (IQ). Dose saving strategies in cardiac CT limit the possibilities 
of retrospective IQ optimisation and as such more emphasis is recommended prior 
to data acquisition which is mainly related to patient selection/heart rate control. In 
cardiac MR a high amplitude ECG without influence of magnetic or scanning effects 
is of outmost importance. Arrhythmia also remains a challenge that might be over-
come by arrhythmia-rejection algorithms or real-time imaging. Suboptimal contrast 
enhancement ought to be avoided by proper planning and timing as the majority of 
post-processing algorithms is based on signal behaviour. In the unfortunate situation 
of suboptimal contrast enhancement often only the use of standard post-processing 
tools is possible while semi-automated tools for cardiac post-processing may fail or 
necessitate substantial user interaction. The use of straight forward visualisation 
techniques is recommended for diagnosis while complex visualisation tools may add 
on confidentiality but are mainly suited for case presentations. Coronary evaluation 
is typically performed using centerline tools allowing for the easy assessment of 
CAD. While these tools potentially allow for estimation of the degree of diameter 
and area stenosis, accuracy though may still be limited. 
Learning Objectives:
1. To learn how to reduce ECG trigger artefacts on CT and MR.
2. To learn how to compensate for suboptimal contrast enhancement.
3. To learn how to choose appropriate visualisation techniques.
16:00 - 17:30 Room L/M 
Professional Challenges Session
PC 2 
Radiology and nuclear medicine: really a joint 
venture 
Moderators:
É. Breatnach; Dublin/IE 
P. Bourguet; Rennes/FR
A‑055	 16:00 
Chairmen’s introduction 
É. Breatnach1, P. Bourguet2; 1Dublin/IE, 2Rennes/FR (ebreatnach@mater.ie) 
This is the second session between ESR and EANM at each Society’s Annual 
Congress. Few would argue but that patient’s interests are best served by cross-
fertilisation and open communication between specialties. This is particularly true 
for radiology and nuclear medicine. This session elaborates on clinical scenarios 
where cross-fertilisation between both specialties is particularly important. The 
session will elaborate the radiologist and nuclear medicine perspectives on two 
common clinical scenarios, i.e. tumour response to therapy and evaluation of 
Alzheimers disease. 
Session Objectives:
1. To appreciate how nuclear medicine and radiology provide complementary 
information.
2. To learn how each method can enhance the mutual performance of the 
radiologist and nuclear medicine physician.
3. To learn about recent advances in the field of tumour evaluation and early 
detection of Alzheimer’s disease.
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shown on MDCT-images in the axial, coronal, and sagittal plane. Variants of the nor-
mal anatomy, which are important to describe and to know are also shown. Some of 
these variants are also delineated on MR images. In the second part of the lecture, the 
different expressions of congenital malformations of the external and middle ear will 
be explained. The different findings of the severity of the malformations will be shown 
and their importance for further clinical-therapeutical procedures will be explained. 
Learning Objectives:
1. To review the normal anatomy of the external auditory canal and middle ear.
2. To become familiar with the most frequent malformations of the middle ear.
3. To learn about imaging protocols.
A‑061	 16:30 
B. Cholesteatoma and chronic infection 
F. Veillon; Strasbourg/FR (Francis.Veillon@chru‑strasbourg.fr) 
Imaging investigation of cholesteatoma is required before surgery. If no surgery has 
been performed previously, CT will provide information about the location of the 
lesion (epi, pro, meso, retro, hypotympanum), the partial or total destruction of the 
ossicles, and possible extension to the inner ear. If there is no doubt about any of 
these factors CT is sufficient. In doubtful cases an MRI examination is performed 
to confirm or refute the presence of cholesteatoma using T1 sequences without IV 
contrast medium, and diffusion weighted imaging with or without high resolution 
T2, depending on the age of the patient. In postoperative recurrent cholesteatoma, 
MRI is becoming the modality of first choice for detecting cholesteatomas, appear-
ing : low in signal on T1 sequences, high in signal on diffusion weighted imaging. 
However, care is required since performing diffusion weighted imaging without T1 
may lead to false positives. A granuloma with a slightly or markedly increased T1 
signal is often associated with a high signal on diffusion. Measurement of ADC is 
useful for detecting cholesteatomas, infected cholesteatomas or abscess. Finally 
whilst MRI is the first examination in the follow-up of postoperative patients, the 
use of contrast medium is not necessary in most of the cases. 
Learning Objectives:
1. To learn about different causes of hearing loss within the external auditory 
canal and middle ear.
2. To learn about a template for a structured report.
A‑062	 17:00 
C. Implants and postoperative findings in the middle ear 
B. Verbist; Leiden and Nijmegen/NL 
Many conditions which affect the function of the middle ear may require surgical 
intervention. Postoperative imaging will be requested either to evaluate complete 
removal of diseases (eg in cholesteatoma) or because of new, persisting or recurrent 
complaints of the patient (e.g. vertigo after stapes replacement). In this presenta-
tion, different surgical procedures will be reviewed including the indications for a 
certain surgical approach as well as the different types of prosthesis. The normal 
postoperative imaging appearance of the most common surgical techniques will be 
shown. It will be discussed whether CT or MRI should be performed to answer the 
clinical questions. An overview of possible failures and complications will be given. 
Learning Objectives:
1. To become familiar with typical implants.
2. To review expected and unexpected postoperative findings.
3. To learn about a template for a structured report.
16:00 - 17:30 Room P 
Vascular 
RC 215 
Extracranial vascular malformations: imaging 
strategies prior to endovascular therapy 
Moderator: 
J.E. Jackson; London/UK 
A‑063	 16:00 
Chairman’s introduction 
J.E. Jackson; London/UK (james.jackson@imperial.nhs.uk) 
The management of patients with vascular malformations is often suboptimal. The 
reasons for this are many but include confusion regarding classification, uncertainty 
about the most appropriate imaging of the various forms of malformation and a 
sures are helping to propose new diagnostic criteria for AD, allowing a diagnosis 
of probable AD in predementia stages, when memory loss criteria are attached 
to Imaging criteria (MRI or PET) or measures of amyloid/tau in CSF. The use of 
atrophy markers (global or MTL) increases the effectiveness in clinical trials (both by 
reducing the size of the sample and increasing the statistical power) and is therefore 
contributing significantly to the development of new treatments. The association of 
multiple markers of structural and functional imaging (MRI and PET) and the use 
of advanced computational analysis techniques will allow better management of 
AD but it needs a broader validation and know the most efficient combination of 
biomarkers at each stage of the disease, including the preclinical period. 
Learning Objectives:
1. To become familiar with the early signs that enable the detection of 
Alzheimer’s disease.
2. To understand the specific role of MRI and to learn the appropriate protocols.
3. To learn about the new developments in radiological detection of Alzheimer’s 
disease.
A‑059	 16:59 
Alzheimer’s disease: the role of nuclear medicine 
K. Tatsch; Karlsruhe/DE (Klaus.Tatsch@klinikum‑karlsruhe.de) 
Scientists, researchers and clinicians all benefit from molecular imaging in dementia 
providing exciting new insights into their basic biology and pathophysiology. Tar-
geting specific aspects of neurotransmission, metabolism, inflammation or plaque 
formation - just to mention some of the current molecular approaches - increasingly 
gains impact on establishing the correct diagnosis, following the course of dementia 
or developing CNS drugs. This talk will highlight the molecular targets and major 
PET and SPECT tracers for application in dementia, and will update on the results 
of the clinical imaging studies published in recent years. Typical imaging patterns of 
Alzheimer‘s disease (AD) will be discussed, including also the diagnostic discrimi-
nation from other types of neurodegenerative dementias such as frontotemporal 
dementias, Lewy body dementia, and others. Assessment of MCI patients and the 
probability of transition in manifest dementia (predominantly AD) will be addressed 
together with its prognostic relevance. Furthermore, recent advances in analysing 
tools which further improved the high diagnostic accuracy already reached by visual 
assessments will be presented. Even though in competition with other modalities, 
‚standard FDG‘ PET has shown to be a robust and both, sensitive and specific 
marker in the diagnostic work-up of dementia. FDG information will be markedly 
extended in clinical practice by specific amyloid imaging in the near future when 
these tracers are approved and thus generally available. 
Learning Objectives:
1. To become familiar with the nuclear medicine method that enables detection 
and evaluation of Alzheimer’s disease.
2. To learn about the potential development of functional studies using nuclear 
medicine.
3. To understand how nuclear medicine and radiology can provide 
complementary information.
Panel discussion: 
The advantages of working together for nuclear  
medicine and radiology 17:17 
16:00 - 17:30 Room N/O 
Head and Neck 
RC 208 
An insight into middle ear pathologies 
Moderator: 
T.J. Vogl; Frankfurt a. Main/DE 
A‑060	 16:00 
A. Normal anatomy and congenital malformations of the middle ear 
C. Czerny; Vienna/AT (christian.czerny@meduniwien.ac.at) 
Imaging of the middle ear is either performed by CT and/or MRI. As the normal middle 
and external ear consists mostly of bony structures and air, CT in the bone-window-level 
setting is the method of choice to delineate the normal anatomic structures. Especially, 
high-resolution MDCT in bone-window-level setting excellently depicts even subtle 
normal as well as abnormal osseous structures. However, pathologic conditions are 
also well delineated such as those of inflammation or cholesteatoma. In this lecture, 
the normal anatomic structures of the external and middle ear will be explained and 
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symptoms may require explanation and reassurance only. Lesions with a mainly 
cutaneous element may be treated with laser. Deeper lesions are usually treated 
with several episodes of sclerotherapy. Agents such as alcohol, polidocanol and 
STD will be discussed and the relative advantages and issues explained. Informed 
consent is vital, and the approach to this will be outlined. High flow lesions are fre-
quently associated with severe cosmetic changes, invasion of surrounding tissues, 
haemorrhage, and high output cardiac failure. Lesions may be life threatening. In 
the extremities peripheral ischaemia and ulceration due to steal of blood by the 
arteriovenous malformation is common. Informed consent will again be discussed, 
as potential for major complications is high. Key to endovascular management of 
these lesions is an understanding of the nidus, arterial inflow and venous outflow. 
The role of liquid and solid embolic agents and specifics of transarterial, venous 
and direct approaches will be discussed. 
Learning Objectives:
1. To learn the principles of endovascular treatment including sclerosing and 
embolisation materials and catheterisation techniques.
2. To discuss the hazards and complications of treatment.
3. To discuss the endpoints of treatment.
Panel discussion: 
Who should decide management? 17:14 
AVMs pose a major problem regarding classification and treatment. A case report 
discussed by the panellists demonstrates how these patients should be ap-
proached. The importance of establishing an interdisciplinary outpatient clinic is 
also presented. The most important organisational steps for providing an efficient 
clinical service are given. In addition, the most common pitfalls and complications 
of treatment are illustrated. 
16:00 - 17:30 Room Q 
Computer Applications 
RC 205 
Computer-aided detection/diagnosis 
Moderator: 
E. Pietka; Gliwice/PL 
A‑067	 16:00 
Chairman’s introduction 
E. Pietka; Gliwice/PL (epietka@polsl.pl) 
Computer-aided detection/diagnosis (CAD) is recognised as a workstation or a 
system developed in order to assist the radiologists (clinicians) in performing their 
daily diagnostic tasks. Clinically implemented CADs are available at workstations 
and (if DICOM compliant) may serve as a plug-in to PACS. The three-layer CAD 
system includes: (1) image analysis procedures whose development requires 
a medical and technical knowledge, (2) a database module that is managed by 
experienced radiologists and IT professionals, and (3) graphical user interface 
(GUI) that enables a user-friendly access to the data, the processing tools, and 
the results. A modern CAD development involves a multidisciplinary team whose 
members are experts in medical and technical fields. A close collaboration of all 
experts is required at all stages of system life-cycle. At each stage the physicians 
knowledge and experience are indispensable. It includes medical analysis of the 
diagnostic problem, data collection, image analysis evaluation, and clinical verifica-
tion. Design, testing, and evaluation have to be successful in order to ensure CAD 
implementation in a daily clinical routine. In this session three experts will share their 
experiences in the area of the overall CAD architecture, its evaluation, validation 
and acceptance by clinicians, advantages and restrictions of solutions and clini-
cal implementation in lung, breast and colon cancer. Reading paradigm (primary, 
concurrent, second) in oncology as well as results of CAD clinical implementation 
will be presented. Perspectives in clinical CAD implementation in diagnosis and 
treatment will be discussed. 
Session Objectives:
1. To understand what the radiologist should know about CAD.
2. To understand the role of the radiologists in CAD development.
3. To learn about the main challenges for CAD implementation.
4. To understand the impact on radiological practice.
poor understanding of the indications for intervention. This session will concen-
trate upon these important topics and will also address some technical aspects 
of endovascular therapy. 
A‑064	 16:05 
A. Pathology, correct anatomical classification and clinical work-up 
H. Kubiena; Vienna/AT (harald.kubiena@meduniwien.ac.at) 
Patients presenting with vascular malformations mostly are nomadic and hopeless 
individuals looking for help. Finally having reached a “multidisciplinary specialist-
group” after a sometimes long and misleading trip throughout the ocean of “single-
players” of different specialities these patients do not ask for any more diagnostics 
- they strongly claim for therapy. Vascular malformations are congenital lesions, 
although merely seen at birth they become evident throughout the individuals 
growth. These developmental errors can affect all components of the vascular tree 
in any area of the body. The therapeutic goal must be defined rather as “control” 
than “cure” of this disease. To make this point understandable for both patients and 
collegues a fundamental understanding of the pathogenesis and natural course 
must be created. In special cases of complex vascular malformations the precise 
diagnosis and the information about all potential side-effects as well as risk-factors 
of progression enables these patients to manage their daily life. Therefore, indica-
tions for treatment vary depending on the specific type of slow flow or high flow 
lesion, location, pain, functional and cosmetic impairments and general side-effects 
of each particular lesion, since no single specialist has enough knowledge to 
diagnose or treat vascular anomalies beyond the border of his distinct speciality 
multidisciplinary working-groups emerged at these interdisciplinary interfaces. Their 
common language in classifying and their overall understanding of pathogenesis, 
prognosis offer these mostly hopeless patients a custom-fit treatment addressing 
their symptoms. 
Learning Objectives:
1. To understand the pathology of capillary, venous, lymphovenous and 
arteriovenous malformations.
2. To understand the haemodynamics of vascular malformations.
3. To discuss the clinical symptoms and the indications for treatment.
A‑065	 16:28 
B. Imaging of capillary, venous, lymphovenous and arteriovenous 
malformations 
L. Schultze Kool; Nijmegen/NL (l.schultzekool@rad.umcn.nl) 
Imaging of vascular malformations should be directed by clinical assessment of the 
type of malformation to be expected, clinical symptoms and need for treatment. In 
order to make the proper decision of the required imaging modality or treatment, it 
is essential that the (interventional) radiologist is a member of a dedicated vascular 
malformation team. Imaging needs to be tailored to the individual patient although 
general rules can be applied. Duplex ultrasound together with a clinical assess-
ment is often sufficient to make a proper diagnosis. This is especially true for the 
paediatric population. If more information about the extent of the lesion is needed, 
MR is often used in case of low flow lesions (venous/lymphatic), and MRA or CTA 
in case of high flow lesions. Angiography is mandatory if an AVM is diagnosed 
and treatment is planned. High frame rate imaging and selective injections are the 
only options for a proper evaluation of the nidus architecture of the AVM. There 
are exceptions that warrant deviating from the above general rules. In this lecture, 
both the general rules and the exceptions will be discussed. 
Learning Objectives:
1. To consolidate knowledge of the various imaging techniques including their 
potential for visualising the anatomy and haemodynamics.
2. To learn criteria for classification of vascular malformations.
3. To learn reporting standards for vascular malformations.
A‑066	 16:51 
C. Technical aspects of endovascular treatment 
P.C. Rowlands; Liverpool/UK (peter.rowlands@rlbuht.nhs.uk) 
Vascular malformations are uncommon conditions with a wide spectrum of ap-
pearance and symptoms. Incorrect diagnosis and management is common. Best 
outcomes are obtained in centres with a high caseload and multidisciplinary 
management. The disciplines include interventional radiology, plastic surgery, 
dermatology, anaesthesiology, vascular surgery and others. Accurate diagnosis 
by clinical assessment and non-invasive imaging is key to procedural planning. 
Low flow and high flow lesions are managed very differently and are discussed 
separately below. Low flow lesions may be associated with symptoms varying 
from trivial to significantly affecting quality of life. Patients with lesions with mild 
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A‑070	 16:51 
C. CAD in oncology: from principles to clinical implementation 
E. Neri; Pisa/IT (neri@med.unipi.it) 
CAD has been developed to help radiologists in detecting pathology. In the era 
of screening radiologists are asked to read a large amount of x-ray, CT and MRI 
examinations; readers fatigue increases the risk of interpretation errors; therefore, 
systems that help radiologists in detecting pathology are welcome. CAD is the 
natural solution; however, is it ready to be used in the clinical and especially in 
the screening setting? How it works? CAD uses algorithms that identify specific 
shapes and densities into a DICOM image. The CAD compares this features with 
an internal database and through a learning curve reach a decision and marks 
the pathological findings. Which are the oncological applications of CAD. Three 
fields actually seems to be well established and promising: detection of polyps in 
CT colonography, breast lesions in x-ray mammography, and nodules in CT of the 
lungs. These 3 oncological applications of CAD will be discussed in the presentation. 
Learning Objectives:
1. To review the principles of current CAD systems in the detection of lung, 
breast and colon cancer.
2. To understand the reading paradigm (primary, concurrent, second) in 
oncologic applications of CAD.
3. To understand the results of CAD clinical implementation.
4. To learn about future perspectives of CAD in oncology (which other 
applications?).
Panel discussion: 
The take-home points 17:14 
1. Modern CAD system architecture
2. Open source solutions: advantages and restrictions
3. CAD clinical implementation
4. Future perspectives of CAD 
18:30 - 18:50 Room A 
Plenary Session 
OL 
Opening Lecture 
Presiding:
Y. Menu; Paris/FR 
A‑071	 18:30 
Water: radiologists' best friend? 
D. Le Bihan; Gif‑sur‑Yvette/FR (denis.lebihan@gmail.com) 
At the onset of the 21st century humankind is focusing its attention on a very 
small molecule, as controlling CO2 in the atmosphere is becoming a major goal, 
economically, socially and politically. Yet, there is another small molecule which is 
going to play a more prominent role in the near future. H2O, especially in its liquid 
form, the ‘Blue Gold’, is just indispensable to our lives. Water makes 60 to 70% of 
the human body weight and is crucial to the working of the biological machinery. 
Still, how such a tiny molecule with its 105° ‘magic’ angle could have been at the 
origin of life remains largely a mystery. Different organisms have adopted different 
strategies in the way they get the most out of water, depending on their environ-
ment, and water contributes to the biodiversity. Faulty mechanisms in the use of 
water by tissues may lead to severe diseases or death. Clearly, water deserves to 
be seen as the prime ‘biological molecule’, and radiologists have long recognised 
its importance from the days of ‘dry’ (bone and air) radiology to the advent of CT 
which allowed contrast from ‘wet’ tissues to be explored. With MRI one went one 
step further, as magnetisation of water is the sole source of contrast. Life has led 
to intelligence, and recent MRI studies have suggested that water may also actively 
contribute to the mechanisms underlying brain function. Could the ‘molecule of life’ 
also be the ‘molecule of the mind’? Clearly, water must be radiologists' best friend. 
Learning Objectives:
1. To comprehend how the structure of the water molecule makes it important 
to life.
2. To understand the importance of water in biological and cellular processes.
3. To become familiar with the different ways water is responsible for image 
contrast in radiology.
A‑068	 16:05 
A. The role of CAD in modern-day imaging 
A. Todd-Pokropek; London/UK (A.Todd@ucl.ac.uk) 
The use of CAD in medicine is an important and growing area of research. Firstly 
good data must be acquired including not just images but associated information. 
The first step in that of preprocessing, notably (but not only) noise reduction. The 
data are then passed onto the segmentation step. Often this step is semi-automatic 
requiring some manual intervention. Conventional edge detection methods are not 
often of value, but Active Shape and Appearance Models, the use of Markov Ran-
dom Fields etc are commonly used. The next step is that of feature extraction both 
of shape and texture. These data are then submitted to one of several classifiers 
such as Artificial Neural Networks (including MTANNs) Support Vector Machines 
(SVM) and data reduction using Principle and Independent Component Analysis, 
and Multiple voting techniques such as ADABoost are also of value. The output 
may simply be returned to the observer (clinician) or as further input for a decision 
support system. Examples considered will be in breast imaging (mammography), 
lung nodule detection, virtual colonoscopy and lumber spine. The use of the CAD 
system as a simultaneous assistant or as a second reader is important. The use 
of CAD in therapy is of increasing important. The assessment of such CAD system 
(evaluation and validation) is still controversial. The difficulty of bringing systems 
both instrumentation and software for use in clinical practice in often underestimated 
and there have been some notable failures. Some example of ‘failures’ will be given. 
Learning Objectives:
1. To review several current CAD systems and architecture from a general 
point of view.
2. To understand the problems of evaluation, validation and acceptance by 
clinicians.
3. To learn about potential future applications such as assessment of therapy.
4. To become familiar with the potential implications of advances such as the 
Grid.
A‑069	 16:28 
B. Emergence of open-source software 
O. Ratib; Geneva/CH 
In the recent years, open source software (OSS) has grown in numerous areas 
of software development including in highly specialised markets such as medical 
applications. This new paradigm in software development has proven to be cost 
effective and successful in many areas including medical imaging applications. It is 
particularly promising in advanced image display and analysis applications where 
the rapid increase in demand cannot be matched by traditional expensive com-
mercial solutions. The evolution of radiology imaging modalities from 2D sectional 
acquisition to 3D volumetric acquisition and even higher dimensions with functional 
data and the emergence of multimodality scanners such as PET/CT scanners calls 
for new and innovative display and visualisation tools. By combining multiple new 
technologies and open-source projects it is possible to develop a new generation 
of high-performance 3D DICOM viewers that were traditionally only accessible 
on expensive 3D workstations restricting their use to specialist radiologists. An 
example of such open source project is the OSIRIX software for multimodality 
image analysis and processing. It provides the necessary tools for navigating and 
processing very large datasets of multimodality imaging. It can be implemented 
outside radiology departments and provide a solution for increasing needs and 
requirements of clinicians, surgeons and other specialists. Open source software 
platform can provide cost-effective framework for the development and wide dis-
tribution of advanced image processing and image analysis tools. It can ensure 
sustainability and large diffusion of specialised analysis tools that would otherwise 
be very difficult to distribute and maintain outside its original development lab. 
Learning Objectives:
1. To learn about the advantages and restrictions of open-source solutions.
2. To understand how open-source solutions could be implemented.
3. To learn about specific open-source tools.
4. To understand the legal aspects of clinical applications of open-source 
software.
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(CRC) screening. The reason was that the data from the major multicenter trials 
showing benefits in CRC screening by the use of CTC are not applicable to the 
average Medicare population because of the differences in age; and the older the 
age the larger the number of polyps with a consequent increase in colonoscopy 
referral, leading to exam duplication. This is the same policy of almost all the pri-
vate contractors in the US as well as the European countries, where both private 
and public payers are not covering CTC for CRC screening. Reason is that even 
optical colonoscopy is not considered a screening test in Europe, where authori-
ties recommend the use of faecal occult blood test (FOBT). In some European 
countries, for example in Italy, CTC is integrated into mass screening projects 
performed with FOBT as a substitute of barium oenema in the case of incomplete 
optical colonoscopy performed in individuals with a positive FOBT. The situation 
is different for other clinical conditions and, in particular, for those patients with a 
previous incomplete optical colonoscopy, due to obstructing neoplasm, aberrant 
anatomy, previous surgery, etc., where CTC is fully reimbursed. And the same 
occurs in most countries when there is an absolute contraindication to invasive 
colonoscopy or preoperative cancer staging and localisation is needed. 
Learning Objectives:
1. To become familiar with differences in reimbursement for CTC within 
and outside Europe, and to detail how this differs for symptomatic and 
asymptomatic patients.
2. To understand how differences in reimbursement impact on implementation 
of CTC.
3. To understand broader political issues related to reimbursement, namely 
turf-battles with other health professionals.
4. To become familiar with potentially imminent changes in reimbursement.
A‑075	 09:09 
Quality, training and accreditation 
D. Burling; London/UK (burlingdavid@yahoo.co.uk) 
CT colonography has evolved rapidly and disseminated widely over the last decade. 
The ability to provide an accurate whole colon examination with near perfect comple-
tion rates, use of reduced laxative bowel preparations and extra-colonic organ review 
has attracted very considerable interest amongst the wider radiological and gastro-
enterological community. Inclusion of CT colonography in several core radiological 
training programmes confirms its evolution from super-specialist technique (performed 
in only a few centres) to mainstream. However, evidence supports highly variable 
performance, which is perhaps unsurprising given the complexity of both technique 
and interpretation methods - both which require specific training. Notably, attendance 
at a training workshop generally represents the beginning of a radiologist’s experi-
ence of CT colonography. Indeed, most delegates rapidly progress from unconscious 
to conscious incompetence, acknowledging the need for a planned implementation 
strategy prior to offering CT colonography in their routine clinical practice. Thankfully 
a decade of intensive research and large volume clinical experience has equipped 
the radiological community with knowledge and experience to inform successful CT 
colonography implementation strategies. By combining this experience with training 
and accreditation practices developed for colonoscopy, the prospect of a robust quality 
assurance framework is realistic and necessary to reassure both service commissioners 
and the general public alike. Step one: the publication of international CT colonography 
standards, co-authored by eminent radiologists from across Europe and beyond has 
been achieved. This talk will review the likely next steps. 
Learning Objectives:
1. To learn about trial data that quantify the benefit of training individuals to 
interpret CTC.
2. To become familiar with a quality framework necessary for optimised CTC 
data acquisition, interpretation, and patient satisfaction, with reference to the 
BSGAR/RCR/ESGAR guidelines.
3. To learn how the above may be implemented practically.
4. To learn about issues around potential accreditation for CTC, both practical 
and political.
A‑076	 09:27 
CAD: friend or foe? 
S. Halligan; London/UK (s.halligan@ucl.ac.uk) 
Computer-assisted detection (CAD) for CT colonography is now widely available 
in Europe from a number of different vendors. This presentation will detail factors 
that potential users will need to know in order to properly evaluate CAD systems, 
use them in clinical practice, and evaluate their likely impact. The different ways in 
which the performance of CAD systems can be assessed will be discussed and the 
difference between weak methodologies (e.g. internal validation) and more valid 
assessments (e.g. external validation) will be explained. The different possibilities 
08:30 - 10:00 Room A 
State of the Art Symposium 
SA 3 
The 3 P’s of CT colonography: polyps, protocols 
and politics 
Moderator: 
S. Halligan; London/UK 
A‑072	 08:30 
Chairman’s introduction 
S. Halligan; London/UK (s.halligan@ucl.ac.uk) 
Now that the diagnostic performance of CT colonography has been well-established, 
this state-of-the-art symposium will deal with issues related to the implementation CT 
colonography in day to day clinical practice. The lecturers will deal with the diagnostic 
performance of CT colonography, the technical requirements necessary to obtain high 
quality diagnostic data, the factors that underpin a high-quality service (including reader 
training), how implementation differs across different countries, and the possible impact 
of new developments, including computer-assisted detection (CAD). 
Session Objectives:
1. To review current technical prerequisites for acquisition of high-quality CTC 
data and its visualisation.
2. To learn about political and turf-battle issues surrounding implementation of 
CTC technology.
3. To recognise the characteristics of a high-quality service, both for patients 
and doctors.
4. To understand the benefit of CAD assistance for data interpretation.
A‑073	 08:33 
CT colonography in 2011: how far has it come 
P. Lefere; Roeselare/BE (radiologie@skynet.be) 
Two decades ago spiral CT technology initiated a new era in diagnostic imag-
ing with virtual colonoscopy or CT colonography (CTC) as a major innovation. 
Introduced by David Vining in 1994, CTC was rapidly endorsed as a potential 
tool for colorectal cancer screening. After an initial pioneering period defining the 
basic CTC principles, the advent of multi-slice CT significantly improved spatial 
and temporal resolution, allowing for isotropic image reconstruction with detailed 
3D rendering of the colonic wall and very short acquisition times, reducing motion 
artefacts. Furthermore, application and refinement of (ultra-) low dose technique 
almost completely tackled the issue of radiation dose. These improvements have 
resulted in the perfect optical colonoscopy imitator with reliable fly through of the 
colon in a timely manner. Consecutively, the primary 3D reading paradigm with 2D 
problem-solving is getting more and more adepts, although in experienced hands 
primary 2D-read with 3D-problem solving is a solid contender. To improve depiction 
of the colonic wall new 3D visualisation methods were developed. These technical 
improvements with the application of state-of-the-art CTC technique have resulted 
in a very good performance of polyp detection. In three multi-centre studies, totalis-
ing 3775 patients, sensitivity ranged between 78-91% and 90-92% and specificity 
between 84-93% and 84-98% for lesions > 6 mm and > 10 mm, respectively. 
Finally, it may be expected that further refinements of CAD, laxative-free CTC with 
electronic cleansing and dual energy CT will bring CTC to the next level and will 
enhance it as the reliable and cost-effective tool for colorectal cancer screening. 
Learning Objectives:
1. To review the evolution of CT colonography since its introduction, with 
a focus on data acquisition and methods of data visualisation and 
interpretation.
2. To review the currently achievable test characteristics of CTC (sensitivity, 
specificity, accuracy) via reference to current trial data.
3. To become familiar with imminent developments that may further enhance 
CTC test characteristics.
A‑074	 08:51 
Current status of reimbursement 
A. Laghi; Latina/IT (andrea.laghi@uniroma1.it) 
Current status of reimbursement for CT colonography (CTC) is extremely het-
erogeneous, both within and outside Europe. In the US, in 2009, the Centers for 
Medicare and Medicaid Services denied coverage for CTC for colorectal cancer 
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astinitis and extension of infection from adjacent spaces (neck, pharynx, pleura or 
retroperitoneum). Typical cases including the role of radiologic findings with respect 
to sensitivity and specificity, and important differential diagnosis will be discussed. 
The distinction between a parapneumonic pleural effusion and an empyema based 
on radiologic findings is often impossible. Features suggesting a “complicated” 
course requiring interventional or even surgical treatment at some point will be 
discussed. Features of empyema and lung abscess at CT will be illustrated as well 
as CT indices of severity of empyema and its effect on the underlying lung that allow 
some prediction of functional outcome after surgical decortication. An empyema 
necessitatis describes a chronic empyema that attempts to decompress through 
the chest wall. Infectious agents include tuberculosis, actinomyces, staphylococcus 
and various types of fungi. It has to be differentiated from other mostly neoplastic 
diseases that cross fascial planes such as lymphoma or Pancoast tumour. 
Learning Objectives:
1. To review the most common conditions or infectious agents that cause non-
pulmonary thoracic infections.
2. To learn about the role of various imaging techniques including ultrasound, 
CT and MRI for the assessment of chest wall, pleural or mediastinal 
infections.
3. To be aware of the differential diagnosis and to know about imaging features 
that are helpful in this matter.
08:30 - 10:00 Room C 
Abdominal and Gastrointestinal 
RC 301 
Abdominal lymphoma 
Moderator: 
A. Rahmouni; Creteil/FR 
A‑079	 08:30 
A. Solid organs 
E. de Kerviler; Paris/FR (eric.de‑kerviler@sls.aphp.fr) 
Most lymphomas arise in lymph nodes or other lymphatic tissues. Extranodal 
lymphomas arise in tissues normally devoid of lymphoid tissue. Involvement of 
so-called extranodal organs is a common finding after staging investigation, how-
ever, and a substantial part of NHL even arises in these sites. The latter form is 
often referred to as primary extranodal NHL. Splenic lymphoma is common in both 
Hodgkin disease and non-Hodgkin lymphomas but it may be difficult to detect by 
imaging techniques because lymphoma nodules in the spleen are often smaller 
than 1 cm. Splenic enlargement alone is not a good indicator of lymphomatous 
involvement. Primary hepatic lymphoma is rare compared with disseminated 
diseases at both nodal and extranodal sites. Several forms of hepatic involve-
ment can be seen including mass lesions/nodules, diffuse infiltrative form and 
extrahepatic involvement of the hepatic ligament. Lymphomatous involvement of 
liver hilum nodes often infiltrates along the hepatic artery and portal vein toward 
the head of the pancreas and produces an infiltrative bulky mass that involves the 
liver, pancreas and duodenum. Primary pancreatic lymphoma is very rare and can 
be difficult to differentiate from pancreatic adenocarcinoma. Definitive pathological 
diagnosis of lymphomas is often obtained using image-guided biopsy. This non-
invasive procedure is important as the prognosis and management of lymphomas 
differ greatly from that of adenocarcinoma or metastatic diseases. Staging (Ann 
Arbor classification or modifications) and response to therapy is primarily by CT. 
Indications for 18 F-PET/CT include lymphomas that are routinely FDG avid, diffuse 
large B-cell lymphomas and Hodgkin disease. 
Learning Objectives:
1. To review the pathways of spread in liver and spleen lymphoma.
2. To learn the various imaging features of liver and spleen lymphoma and their 
differential diagnoses.
3. To learn to identify the accuracy of each imaging modality to assess staging 
and response to therapy.
A‑080	 09:00 
B. Hollow abdominal viscera 
R.M. Mendelson; Perth/AU (richard.mendelson@health.wa.gov.au) 
Primary gastrointestinal lymphomas are nearly always NHLs, classified pathologi-
cally by the REAL/WHO system. Correlation of radiological morphology with histol-
ogy is relatively poor, but characteristic subtypes are discussed. The key issue is 
differentiating indolent and aggressive lymphomas. Most gastric lymphomas are 
for integrating the CAD system into day to day clinical workflow will be explained, 
particularly second-read CAD and concurrent CAD. Finally, the clinical impact of 
CAD and the different reading paradigms will be quantified with reference to the 
peer-reviewed indexed literature. 
Learning Objectives:
1. To understand what CAD is and how it is integrated into clinical interpretation 
of CTC.
2. To review trial data that quantifies the benefit of CAD assistance to 
observers tasked with interpreting CTC.
3. To learn which observer groups may benefit most from CAD, and its impact 
on training schedules.
Panel discussion: 
In 2011, should CTC now be the primary method of colorectal investigation 
in my hospital? 09:45 
CTC is now established in clinical practice but other viable methods for colonic 
investigation remain; namely barium enema and colonoscopy. CTC has attracted 
most attention as a screening method for colorectal cancer and adenomas, but 
a role is also advocated for symptomatic patients, not only because it can detect 
symptomatic cancer but because disease outside the colon may underpin symp-
toms. The panel will debate whether the barium enema should be abandoned 
completely and, if so, will discuss the relative positioning of CTC and colonoscopy 
for investigation of symptomatic patients. 
08:30 - 10:00 Room B 
Interactive Teaching Session 
E³ 320a 
Thoracic infections: what the radiologist must 
report 
A‑077	 08:30 
A. Pulmonary infections 
T. Franquet; Barcelona/ES (tfranquet@santpau.es) 
Community acquired pneumonia (CAP) is a major health care problem because 
of their high morbidity and mortality rates. Patients exposed to non-hospital risks 
who develop pneumonia have been traditionally categorised as having community-
acquired pneumonia (CAP). Healthcare-associated pneumonia (HCAP) is a new 
designation for pneumonias affecting individuals residing in non-hospital health 
care facilities, patients undergoing outpatient procedures or therapies, and patients 
who have been recently discharged from the hospital setting. When the diagnosis 
of CAP or HCAP is suspected, imaging studies are mandatory for the evaluation 
of affected patients. A nosocomial pneumonia is defined as one not acquired in a 
hospital or a long-term care facility. It occurs most commonly among ICU patients, 
predominately in individuals requiring mechanical ventilation. Pulmonary infection 
is a major cause of morbidity and mortality in patients with impaired immune func-
tion. Increasing numbers of patients are becoming immunosuppressed, because 
of solid organ and hematopoietic stem cell transplantation, the use of immunosup-
pressive agents for treating a host of inflammatory diseases, or congenital and 
acquired diseases such as acquired immune deficiency syndrome (AIDS). Mildy 
impaired host immunity as it occurs in chronic debilitating illness, diabetes mellitus, 
malnutrition, alcoholism, advanced age, prolonged corticosteroid administration 
and chronic obstructive lung disease have also been regarded as predisposing 
factors of pulmonary infections. The rapid diagnosis and treatment of pulmonary 
infections are essential. Combination of pattern recognition with knowledge of the 
clinical setting is the best approach to pulmonary infectious processes. 
Learning Objectives:
1. To learn how to recognise pulmonary infections in immunocompetent and 
immunodepressed patients.
2. To learn how to recognise infections of the chest wall, pleura and 
mediastinum.
A‑078	 09:15 
B. Non-pulmonary chest infections 
C. Schaefer-Prokop; Amersfoort/NL (cornelia.schaeferprokop@gmail.com) 
Acute mediastinitis is a potentially life threatening but fortunately rare condition that 
requires prompt diagnosis and treatment. Spontaneous or iatrogenic oesophageal 
rupture is the by far most common cause. Other causes include post-surgical medi-
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ask the patient for those information. At the time of MR imaging plain films and/
or results of an ultrasound exam of the shoulder, if possible, should be available. 
However, only such prerequisites allow to run a tailored examination protocol and 
to support the orthopaedic colleague with the needed answers for further adequate 
therapy. The patient has to be placed in the magnet in a pleasant situation to avoid 
artefacts due to patients movement, which usually cause motion artefacts. It is very 
important to explain to patients to keep quiet during the whole examination, because 
artefacts may need repetitions of sequences, and lead so to prolongation of total 
examination time. Furthermore, they make diagnosis more difficult and eventually 
more or less inaccurate. Lastly, sequence repetitions decrease patient throughput 
and therefore cost effectiveness. Imaging in three orientations (axial, paracoronal-
parallel to the supraspinatus tendon, and parasagittal - parallel to the glenoid cavity) 
using T1W (PDW) and/or T2W sequences have to be performed. In case of specific 
questions regarding lesions of the labrum intraarticular administration of contrast 
agent (MR arthrography) should be considered, which is sometimes (different from 
country to country) possible after discussion with referring orthopaedic surgeon only. 
Learning Objectives:
1. To understand the influences of patient positioning, scan parameters and 
magnet/coil technology on image quality.
2. To learn how to optimise scan protocols to maximise patient throughput 
without compromising diagnostic quality.
3. To recognise how and when to modify scan protocols to answer specific 
clinical questions.
A‑083	 08:55 
B. Normal variants and pitfalls 
M. Reijnierse; Leiden/NL (m.reijnierse@lumc.nl) 
MR arthrography is superior to other imaging techniques in the evaluation of the 
glenohumeral joint. Knowledge of normal anatomy on MR arthrography is essential 
to identify pathology. Three glenohumeral ligaments (GHL) have been described, the 
superior GHL, the middle GHL and the inferior GHL complex, formed by an anterior 
band, a posterior band and an axillary recess of the joint. The number of ligaments 
is variable in any person and their size varies considerably. The SGHL is present in 
90-97% of shoulder studies and is variable origin. The MGHL is present in 73-92%. 
The IGHL is present in almost 100% of shoulder studies. The MGHL is the least 
constant in size and it can be absent in up to 27% of individuals. A well-recognised 
variant is the Buford complex, which represents a cordlike thickening of the MGHL, 
with absence of the anterior superior portion of the labrum. This variant is seen in 
up to 6.5% of patients. Other normal variants that can be diagnostic pitfalls include 
the anterosuperior sublabral foramen and hyaline cartilage under the labrum. 
Learning Objectives:
1. To become familiar with the normal anatomy.
2. To be able to identify normal variants.
3. To appreciate the range of pitfalls that may simulate pathology.
A‑084	 09:20 
C. Identifying and reporting abnormal findings 
S. Waldt; Munich/DE (Waldt@roe.med.tum.de) 
MR imaging (MRI) and MR arthrography are the primary diagnostic imaging modali-
ties applied to patients with degenerative, traumatic and sports-related shoulder le-
sions. In this categorical course the characteristic MR imaging and MR arthrographic 
features of articular pathologies of the shoulder, in particular, instability-associated 
injuries, rotator cuff tears and biceps tendon lesions are discussed. Beside lesion 
detection the radiological analysis comprises the understanding of the underlying 
pathomechanism and recognition of possible interrelations between different type 
of lesions (for example, secondary impingement and associated lesions of the 
posterosuperior labrum). The use of classification systems for specific lesions is 
introduced in order to improve the radiological report. A reasonable structure for 
written reports is discussed comprising a brief and clear description of pathological 
findings with subsequent interpretation and categorisation of findings with a view 
of therapeutic decision making. 
Learning Objectives:
1. To review imaging appearances of instability lesions, rotator cuff tears and 
pathology of the biceps tendon.
2. To understand the use of terminology and classification systems to describe 
and categorise these common abnormalities.
3. To recognise underlying pathomechanisms and understand therapeutic 
consequences.
B-cell, MALT type. Radiological features depend on histological grade. Small intes-
tine lymphoma patterns are categorised as multiple nodules, infiltrative, polypoid, 
endo-exoteric and mesenteric-invasive. Rare primary colonic lymphomas may 
be focal or diffuse. Gastrointestinal lymphomas are great mimickers with a wide 
differential diagnosis including: in the stomach, Menetrier’s disease, hypertrophic 
gastritis and carcinoma; in the small intestine, Crohn's disease, mastocytosis and 
metastatic disease (nodular form); inflammatory disease and carcinoid (infiltra-
tive form); GISTs and serosal metastases (cavitating form); TB, Crohn's disease, 
carcinoid and carcinoma (fistulation). However, ‘aneurysmal dilatation’ strongly 
indicates lymphoma. The ‘hamburger’ sign of mesenteric lymph node enlargement 
is characteristic. Staging (Ann Arbor classification or modifications) and response 
to therapy is primarily by CT. Indications for 18F -PET or PET/CT include lympho-
mas that are routinely FDG avid, diffuse large B-cell and Mantle cell lymphomas. 
PET’s role in other NHLs is less clear. PET can show occult advanced disease, 
assess therapeutic response, detect relapse, and differentiate fibrosis/necrosis 
from tumour. Although there is no convincing evidence that baseline FDG uptake 
intensity is an independent prognostic factor, changes in uptake reflect chemo-
therapeutic response; post-therapy residual uptake correlates with poor prognosis. 
Post-therapy negative PET has high NPV for residual disease. Interim PET may 
be more accurate that end-of-therapy PET for predicting progression-free survival. 
Learning Objectives:
1. To know the various imaging features of gastrointestinal tract lymphoma.
2. To recognise the differential diagnostic criteria from other diseases.
3. To learn to identify the accuracy of each imaging modality to assess staging 
and response to therapy.
A‑081	 09:30 
C. Genitourinary tract involvement 
J.A. Spencer; Leeds/UK (johnaspencer50@hotmail.com) 
Lymphoma can involve any part of the genitourinary (GU) tract. Manifestations 
include a focal mass, multifocal masses or a diffuse process. Lymphoma is one 
of the great mimics. When should one suspect a diagnosis of lymphoma? 1. With 
immunocompromised patients, e.g. after organ transplantation from post-transplant 
lymphoproliferative disorder (PTLD) or with HIV infection. 2. In childhood and ado-
lescence when lymphoma is relatively more common and, with multifocal masses in 
the same organ, e.g. the testis or kidney. 3. Bland homogeneous masses. 4. Diffuse 
processes infilling whole anatomic spaces, e.g. the perinephric space. 5. Disease 
crossing several tissue planes. 6. Bulky disease with few symptoms. The primary 
modality for investigation will be determined by the symptoms or clinical signs which 
prompt medical attention. Obtaining a tissue diagnosis at the earliest possible op-
portunity is key to planning therapy. The radiologist can do this by a variety of routes 
using US or CT guidance and should alert the surgeon to the need for deep biopsies 
when a submucosal process seems likely. With prior lymphoma the likelihood that 
any new GU problem reflects disease recurrence is guided by expected behaviour of 
the original disease. Comparison of the new specimen with material from the original 
diagnosis is important. Relapse in extranodal sites such as the GU tract may indicate 
transformation to a high grade lymphoma. Overall, diffuse large B-cell lymphoma 
(DLBCL) is the predominant diagnosis. CT is the mainstay of monitoring treatment 
response. CT-PET has a role for assessment of residual masses. 
Learning Objectives:
1. To recognise the varied imaging features of genitourinary tract lymphoma.
2. To understand the differential diagnostic criteria from other diseases.
3. To learn to select appropriate imaging modalities in diagnosis, staging and 
assessment of response to therapy.
08:30 - 10:00 Room D1 
KISS (Keep It Simple and Straightforward): Musculoskeletal MRI 
CC 316 
The shoulder 
Moderator: 
A. Oktay; Izmir/TR 
A‑082	 08:30 
A. How I do it 
J. Kramer; Linz/AT (kramer@ctmri.at) 
The first step prior to the examination of an optimal evaluation of the shoulder by 
MR imaging consists of a sufficient recommendation with some information of the 
patients history and clinical complaints. Not rarely the radiologist himself has to 
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A‑087	 08:58 
State-of-the-art CT/MR/PET in the treated neck 
F.A. Pameijer; Utrecht/NL (f.a.pameijer@umcutrecht.nl) 
Tissue changes in the treated neck by surgery and/or radiotherapy (RT) make the 
detection of residual or recurrent tumour more difficult. Clinical evaluation of the 
neck is also hampered by these changes. Therefore, any (non-invasive) method 
helping in the detection of recurrence is welcome. In order to evaluate the treated 
neck, radiologists should be familiar with expected post-RT findings. Histological 
changes post-RT will be discussed in combination with imaging examples. This 
knowledge will enable radiologists to recognise non-expected findings post-RT. 
Non-expected post-RT findings can be caused either by tumour recurrence, or 
by complications of treatment (e.g. chondro-radionecrosis). Imaging examples 
will be shown. Especially after surgery, including various types of neck dissection, 
lymphatic drainage patterns of the head and neck are altered. It is important that 
radiologists are aware of these changes. Imaging examples will be shown. CT 
and/or MR-findings in the treated neck may be inconclusive. In these cases, there 
may be an additional role for metabolic (PET) imaging. At present, the position of 
metabolic imaging in the imaging protocol for the treated neck is unclear. Information 
from the recent literature will be discussed. Also, examples from daily practice will 
be shown, with emphasis on the importance of base-line imaging after treatment 
and the timing of such base-line scans. This knowledge will help in understanding 
the current indications and limitations of post-treatment metabolic (PET) imaging 
of the head and neck. 
Learning Objectives:
1. To become familiar with expected post-radiation CT/MR findings.
2. To become familiar with patterns of lymphatic spread after surgery.
3. To understand the indications and limitations of post-treatment metabolic 
(PET) imaging of the head and neck.
A‑088	 09:21 
New techniques and protocols: perfusion, diffusion, spectroscopy and 
new PET tracers 
V. Vandecaveye; Leuven/BE (vincent.vandecaveye@uz.kuleuven.ac.be) 
Computed tomography (CT), magnetic resonance imaging (MRI), and [18F]fluo-
rodeoxyglucose positron emission tomography (FDG-PET) are the main imaging 
modalities in head and neck cancer. However, the dependency on morphological 
and size-related criteria of anatomical imaging and the limited spatial resolution and 
FDG-avidity of inflammation of metabolic imaging may reduce diagnostic accuracy. 
New PET-tracers, including 11C-methionine, 18-fluorothymidine (FLT) and 18 F-
misonidazole (FMISO) that target more specific tumour binding sites compared to 
FDG, are developed in order to improve specificity in tumour detection or treatment 
follow-up or to visualise specific prognostic tumour characteristics. While FMISO-
PET may hold important prognostic information pre-treatment by depicting tumour 
hypoxia associated with treatment resistance, 11C-methionine and FLT may be used 
for more specific tumour depiction and early response assessment. Functional MRI 
sequences are developed aiming to improve lesion characterisation, nodal staging 
and treatment follow-up. Most frequently used techniques are diffusion-weighted 
MRI (DWI), dynamic-contrast-enhanced MRI (DCE-MRI) and MRI-spectroscopy 
(MRS). Although MRS may have value in nodal staging and treatment assessment, 
currently its main disadvantage is the limited spatial resolution. DWI measures 
differences in water mobility between different tissue microstructures quantified 
by the apparent diffusion coefficient, while DCE-MRI measures tissue perfusion 
using permeability measurements or semi-quantitative perfusion parameters. 
DWI is researched and gradually clinically implemented for locoregional staging, 
differentiation of tumour recurrence from post-treatment complication and early 
treatment follow-up. DCE-MRI mainly shows additional value for early assessment 
of treatment response, but also as a prognostic imaging modality as pre-treatment 
tumour perfusion may correlate with hypoxic status of the tumour. 
Learning Objectives:
1. To understand the physiological basis and rationale for use of the different 
and new functional imaging modalities and tracers in head and neck cancer.
2. To have an overview of the currently possible clinical applications and 
compare the advantages and disadvantages of the different modalities for 
pre and post-treatment imaging.
3. To have an overview of potential future applications for treatment prediction 
and early treatment follow-up.
4. To recognise the potentially synergistic value between functional MRI 
techniques and nuclear imaging techniques.
08:30 - 10:00 Room D2 
Special Focus Session 
SF 3d 
Head and neck oncology: the three musketeers (CT, 
MR, PET) 
Moderator: 
A. Borges; Lisbon/PT 
A‑085	 08:30 
Chairman’s introduction 
A. Borges; Lisbon/PT (borgalexandra@gmail.com) 
An increasing number of functional and metabolic imaging options reflecting relevant 
aspects of tumour biology have rapidly been incorporated into clinical trials and, pro-
gressively, into clinical practice. While tumour staging according to the TNM system still 
rules most decisions regarding treatment choice in head and neck cancer, biological 
information from the tumour and its microenvironment has proven to have important 
predictive and prognostic value heading for a tailored and individualised patient’s 
management. CT, MR and PET are the mainstay imaging modalities to access tumour 
extent, both of the primary tumour, lymphatic and distant metastases and for early 
depiction of recurrence during patient’s follow-up. Hypoxia and angiogenesis, the 
major driving forces for tumour aggressiveness, long linked to chemo and irradiation 
treatment failure, can now be imaged both by PET (18 F-MISO or 60Cu ATSM) or 
MRI (BOLD and PWI, respectively). This information is being used to define biological 
tumour volumes, to tailor conformational and intensity modulated radiation treatments 
and to select patients for specific treatments such as radiosensitizers, hypoxia selective 
cytotoxic and antiangiogenic drugs. Overexpression/amplification of EGFR (epidermal 
growth factor receptor) are common genetic abnormalities in SCC linked to increased 
cell proliferation and worse prognosis. Imaging techniques reflecting cell proliferation/
density (18 F-FLT -desoxyfluorothymidine- and diffusion-weighted MRI) can be used 
to select patients for treatment with EGFR inhibitors. This special focus session will 
review the use of these imaging modalities both prior, during and after treatment of 
head and neck cancer focusing on their specific advantages and accuracies in these 
different settings. 
Session Objectives:
1. To become familiar with the premises behind the choice of CT, MR and PET 
in different anatomic areas of the head and neck.
2. To understand the added value of each technique in the diagnosis, follow-up 
and prognostic prediction of head and neck cancer.
3. To be able to tailor an imaging protocol taking into account risk-benefit and 
cost-effectiveness.
4. To become familiar with the clinical application of hybrid imaging and new 
PET tracers.
A‑086	 08:35 
State-of-the-art CT/MR/PET as baseline modalities 
S. Bisdas; Tübingen/DE (sotirios.bisdas@med.uni‑tuebingen.de) 
Contrast-enhanced CT and MRI are routinely used in order to determine the precise 
localisation, size and anatomic extent of the primary lesion. On the other hand, 
positron emission tomography (PET) is the most sensitive and specific technique 
for in vivo imaging of metabolic pathways and receptor-ligand interactions in the 
tissues. A common question is which of these techniques should be used in a 
particular patient. The most widely used technique is CT, as it has a number of 
important advantages over MRI, like wide availability, relative low cost and short 
examination time. However, CT also has a number of disadvantages compared to 
MRI: relative low soft tissue contrast resolution, severe image quality degradation 
by dental fillings or other metallic foreign objects, and radiation exposure. PET in 
combination with CT and/or MRI has a good sensitivity and specificity for the de-
tection of primary tumour and for nodal staging as well as for detection in a single 
examination distant metastases, occult tumours, second synchronous tumours, and 
for radiotherapy planning. By combining PET with CT and MRI studies, either se-
quentially or synchronous performed, the diagnostic accuracy is significantly higher. 
Learning Objectives:
1. To understand the advantages and shortcomings of each modality.
2. To learn the state-of-the-art CT/MR/PET protocols for routine imaging work-
up in head and neck.
3. To be able to select the appropriate modality for staging of head and neck 
cancer according to the needs of the clinician and treatment planning.
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A‑091	 09:30 
C. Emergencies of non-gynaecologic origin 
D. Akata; Ankara/TR (dakata@hacettepe.edu.tr) 
During routine clinical practice, radiologist must often evaluate a wide range of cases 
with acute abdominal and pelvic pain. Ultrasound (US) is the primary imaging modal-
ity of choice to evaluate pelvic pain in the female patient. Computed tomography 
(CT) is mostly performed if ultrasound findings are equivocal or if the abnormality 
extends beyond pelvis. Conditions such as appendicitis, diverticulitis, pyelonephritis 
and renal calculi may develop in women of childbearing age with clinical features 
that mimic obstetric and gynaecologic emergencies. Pelvic pain is a diagnostic 
problem especially in pregnant woman. Ultrasound scanning has certain limitations 
secondary to increasing gestational age. CT is not appropriate due to radiation dose. 
In those situations, it has been proven that magnetic resonance (MR) imaging is a 
valuable adjunct to delineate the pathology. In non-pregnant woman the radiological 
evaluation is less difficult. Still, a multimodality approach may be needed in certain 
cases. In this lecture, radiological features of non-gynaecologic emergencies such 
as acute appendicitis, diverticulitis, renal calculi and pyelonephritis will be discussed. 
Learning Objectives:
1. To understand the causes and imaging diagnosis of common non-
gynaecologic emergencies.
2. To recognise how these may mimic gynaecologic disease.
3. To understand the use of a multimodality approach to solve the problem.
08:30 - 10:00 Room E2 
Foundation Course: Paediatric Radiology 
E³ 320b 
Genitourinary problems: common daily practice 
Moderator: 
V. Donoghue; Dublin/IE 
A‑092	 08:30 
A. Imaging strategy in urinary infections 
M. Riccabona; Graz/AT (michael.riccabona@medunigraz.at) 
The purpose is to discuss the role of imaging and the potential of different methods 
applicable in childhood UTI - with a focus on US. The imaging task in UTI has changed, 
and new questions arouse for radiology. In addition, growing economical demands 
pressurise radiology to restrict imaging to those conditions where an evident benefit 
has been demonstrated. This efficacy-oriented approach is difficult in children due 
to the lack of evidence-based data. Thus, controversies exist on if, when and how 
to investigate childhood UTI, trying to minimise procedures and reduce burden on 
children and health budgets without missing important conditions that may pose a 
threat to the kidney. Furthermore, modern imaging with new methods, applications and 
potential (e.g. contrast-enhanced voiding urosonography = ce-VUS) may influence 
the imaging algorithm. Therefore, the clinical demand and the value of established as 
well as new imaging for treatment have to be understood and balanced. Most of the 
proposed imaging algorithms heavily relay on modern US including Doppler options, 
recommend scintigraphy for the assessment of renal function and scarring, and define 
the indications for MCU (or ce-VUS) from these findings, additionally considering 
patient’s age, gender and presentation, with respect to the individual clinical context. 
Imaging in childhood UTI has changed, some well-established methods and rules 
persist. Basically, detection of renal involvement is the centre point of acute imaging, 
with extended exploration, e.g. by MCU or MRI, in those who have complications, 
scars/upper UTI, and other risk factors such as malformations. 
Learning Objectives:
1. To learn about the role, the importance and the information obtained from 
ultrasonography.
2. To learn about the technique and indications of voiding cystourethrography, 
as well as the role and potential of nuclear medicine examinations.
3. To learn about an imaging algorithm for the imaging approach based on 
existing ESUR & ESPR recommendations.
A‑093	 09:00 
B. Urinary tract dilatation: what should be done, to whom and when? 
F.E. Avni; Brussels/BE (Freddy.Avni@erasme.ulb.ac.be) 
The in utero and post-natal follow-up of foetuses with urinary tract dilatation has 
provided lots of information about the proper management of urinary tract malforma-
tions. Nowadays, affected neonates are evaluated following standardised charts 
Panel discussion: 
The three musketeers were actually FOUR 09:44 
CT, MR and PET: how to choose between modalities in head and neck cancer 
patients. An increasing number of imaging modalities reflecting functional and 
metabolic aspects of tumours have rapidly been incorporated into clinical practice. 
These modalities provide additional information on tumour vascularisation/ angio-
genesis (CT and MR perfusion); on tumour metabolism, hypoxia and proliferation 
(PET using different radioactively labelled substances) and on tumour architecture 
and cellular density (DWI). Hybrid imaging, PET-CT and, in the near future PET-MR, 
can provide morphologic, metabolic and functional information in a one-stop-shop 
examination. The choice of the best modality (ies) to answer specific questions 
in the diagnosis, follow-up and in the prediction of response to treatment and 
prognosis will be addressed. 
08:30 - 10:00 Room E1 
Genitourinary 
RC 307 
Gynaecologic emergency and its mimics 
Moderator: 
K. Kinkel; Chêne‑Bougeries/CH 
A‑089	 08:30 
A. Imaging of emergencies in pregnancy 
G. Masselli; Rome/IT (gabrielemasselli@libero.it) 
Acute abdominal and pelvic pain in pregnant women may be the manifestation of various 
gynaecological and non-gynaecological conditions. The correct diagnosis of the causes 
of acute pain during pregnancy is critical to minimise maternal-foetal morbidity and 
mortality. Although ultrasound (US) is the primary imaging investigation in the diagnostic 
evaluation of the pregnant patient, the role of magnetic resonance (MR) imaging in the 
evaluation of foetal and maternal diseases in pregnant patients continues to expand. 
MR imaging offers different potential advantages in comparison to US for evaluating 
acute abdominal and pelvic pain; these include multiplanar imaging capabilities, a 
higher soft tissue contrast and the ability to detect and distinguish blood from other 
fluid collections. When US is equivocal or nondiagnostic, MR imaging is a valuable 
complement to determine the exact aetiology of acute abdominal pain. The intrinsic 
safety and the accuracy of MRI in diagnosing abdominal and pelvic disease make it an 
excellent choice for triage of pregnant patients with acute abdominal and pelvic pain. 
MR imaging provides important information that influences patient management, and it 
is important for the radiologist to recognise the MR imaging appearance of the common 
causes of acute abdominal and pelvic pain during pregnancy. This lecture will discuss 
the use of MR imaging for maternal diseases that cause acute abdominal and pelvic 
pain during pregnancy. Moreover, this lecture will discuss the different MR imaging 
techniques to use, and will show how to detect and to differentiate the gynaecologic 
and non-gynaecologic causes of pain during pregnancy. 
Learning Objectives:
1. To learn the most common causes of gynaecologic pain in pregnancy.
2. To understand how to diagnose non-gynaecologic causes of pain in 
pregnancy.
A‑090	 09:00 
B. Emergencies of gynaecologic origin 
A.G. Rockall; London/UK (andrea.rockall@bartsandthelondon.nhs.uk) 
In this lecture, the role of imaging in the evaluation of gynaecologic emergencies 
will be presented. A combined approach using both clinical findings and imaging 
features is necessary. Accurate evaluation is important as failure to make a diagno-
sis may lead to serious consequences. Presenting symptoms, such as pelvic pain 
or vaginal bleeding or discharge, may overlap with pregnancy-related emergencies 
and with non-gynaecologic abdominal emergencies. The range of conditions to be 
considered include ovarian cyst emergencies (cyst rupture, haemorrhage or torsion), 
infective conditions (Bartholins’ or vulval abscess, pelvic inflammatory disease or 
tubo-ovarian abcess) and acute bleeding (from inflammation, neoplasm, or trauma). 
Pain may be related to the menstrual cycle, as in endometriosis or ruptured corpus 
luteum, or may be unrelated, such as in fibroid or ovarian torsion or pelvic inflam-
matory disease. The imaging features of these acute abnormalities will be reviewed 
and discussed in the context of the differential diagnoses. 
Learning Objectives:
1. To understand the causes of common gynaecologic emergencies.
2. To understand the imaging diagnosis of common gynaecologic emergencies.
Friday
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the choice of b-factors on WB-MRI will all be analysed. Emerging applications of 
WB-MRI and of WB-DWI will be exposed, especially regarding onco-haematological 
malignancies. WB-MRI can allow combination of morphologic and functional data 
on a whole body scale. Optimisation of MR instrumentation, standardisation of MR 
protocols and future studies on specific diseases are under way. 
Learning Objectives:
1. To understand the technical specificities of whole body DWI.
2. To know how to apply whole body DWI in the detection and functional 
assessment of tumours, including haematological malignancies.
3. To learn about the developments of whole body DWI for tumour staging and 
response assessment.
A‑096	 09:00 
B. Quality and quality control in DCE-MRI and DCE-CT 
V.J. Goh; Northwood/UK (gohmcglone@hotmail.com) 
Dynamic contrast enhanced MRI and CT provide valuable information of the anti-
vascular effect of anti-angiogenic and vascular disruptive agents. The quality of 
DCE-MRI or DCE-CT data is influenced by patient, acquisition and post-processing 
factors. For example, patient habitus, scanner type, acquisition parameters, contrast 
agent and administration profile, signal to noise, input function, kinetic model, and 
processing software affect the accuracy of quantification. Multisite acquisition and 
processing provide challenges to multicentre implementation of DCE techniques 
within and outside the context of clinical trials: standardised acquisition and process-
ing on the same scanner and software platform, while ideal may not be possible. 
Quality control is essential to maintain accuracy and consistency of standards 
across all sites. A consensus-based, practical approach to quality control of DCE-
MRI and CT in early phase clinical trials will be presented. 
Learning Objectives:
1. To understand the differences obtained with different imaging techniques.
2. To understand the differences obtained with different processing software.
3. To know the limitations of multi-site acquisition or processing.
A‑097	 09:30 
C. Synthesis: functional imaging for tumour management 
V. Vilgrain; Clichy/FR (valerie.vilgrain@bjn.aphp.fr) 
The major functional imaging tools for tumour management are obtained with 
dynamic contrast-enhanced imaging, diffusion-weighted MR imaging, and MR 
elastography. These acquisitions allow understanding of tumour angiogenesis 
and perfusion, and tumour architecture. Dynamic contrast material-enhanced 
imaging allows assessment of perfusion parameters. Diffusion-weighted MR 
imaging provides information that reflects tissue cellularity and the integrity of 
cellular membranes. MR elastography evaluates the mechanical properties of 
tissue such as stiffness and viscosity. To date, tumour detection is mainly based 
on morphologic features. However, changes in perfusion parameters have been 
shown as early parameters of liver metastases detection in patient with colorectal 
carcinoma or breast carcinoma. Tumour characterisation is usually based on mor-
phologic features. Yet, perfusion parameters have been shown to correlate with 
microvascular density and tumour differentiation helping tumour characterisation. 
Furthermore, apparent coefficient diffusion (diffusion-weighted MR imaging) and 
stiffness and viscosity (MR elastography) are significantly different in benign and 
malignant tumours. Despite these differences, these last parameters usually do 
not allow definitive subtyping. Functional imaging starts playing a major role in 
non-surgical treatment follow-up especially with targeted cancer therapy. Changes 
in perfusion parameters, apparent coefficient diffusion, and stiffness and viscosity 
are observed in responders. Interestingly, these changes appear promptly after 
treatment initiation. These functional variables are not included in RECIST 1.1 but 
might be part of response criteria in the next future. Many examples of functional 
imaging for tumour management will be provided. 
Learning Objectives:
1. To understand the potential of functional imaging in tumour detection.
2. To understand the potential of functional imaging in tumour characterisation.
3. To learn about the future use of functional imaging in treatment planning and 
follow-up.
(among others, thanks to the ESUR-ESPR working group). At birth, a confirmatory 
ultrasound is performed in order to evaluate the type and degree of the malforma-
tion. Urinary tract dilatation are separated into mild, moderate and marked. Mild 
and moderate dilatation will be followed by US. Voiding cystogram and functional 
studies will be performed only if the dilatation is significant or persists. The prog-
nosis is usually good. Patients with marked dilatation would be managed more 
“aggressively”. Their work-up would be initiated as soon as diagnosed in order to 
diagnose cases that need therapeutic manoeuvre. For them voiding cystogram, 
anatomical and functional studies cannot be skipped and are important for the 
prognosis. Long-term follow-up are needed to prevent further damage. 
Learning Objectives:
1. To learn which infants with antenatal diagnosis of urinary tract dilatation 
require imaging and when.
2. To become familiar with the most important differential diagnosis.
3. To learn about the imaging strategies in these infants.
A‑094	 09:30 
C. Renal and pararenal masses: basic rules 
P. Tomà; Rome/IT (paolo.toma@opbg.net) 
The differential diagnosis of renal and pararenal masses firstly depends on the 
age of the child. Wilms tumour (nephroblastoma) is the most common abdominal 
tumour in 1-8 years old (80% of cases in children less than 5 years old - peak age 
3.6 years). Renal non-Wilms tumours represent a significant proportion of renal 
tumours in children, especially in children aged less than 6 months or greater than 
12 years. Neuroblastoma most commonly arises from the adrenal gland but can 
arise anywhere along sympathetic chain; it is the most common tumour in children 
under 2 years of age (90% of cases in children less than 5 years - mean age < 2 
years). Adrenal adenomas and carcinomas also occur in childhood. US is the initial 
imaging modality to investigate an abdominal mass in children. CT or MRI is used 
to confirm the US findings and not uncommonly add new, valuable information. 
Concerning Wilms tumour there is a very diverse approach to treatment according 
to geographical location. This variation in therapeutic attitude has consequences 
for the choice of imaging modality at diagnosis. Neuroblastoma staging includes 
also 123I-MIBG, and laboratory investigations (bilateral bone marrow aspirates with 
histochemical tests and urine catecholamine level measurements). We focus on 
the points under discussion: revision to the staging of neuroblastoma, the problems 
inherent in distinguishing nephrogenic rests from Wilms tumour and the approach 
regarding small lung nodules in children with Wilms tumour. 
Learning Objectives:
1. To understand the imaging findings of paediatric renal and pararenal 
masses.
2. To learn how and when to use sonography, CT and MRI in investigation and 
differential diagnosis.
3. To learn about the role of imaging in staging renal and pararenal 
malignancies.
08:30 - 10:00 Room F1 
Functional Imaging of Tumours: How to do it 
MC 322 
Functional and ultra structural MR 
Moderator: 
L. Martí‑Bonmatí; Valencia/ES 
A‑095	 08:30 
A. Diffusion imaging and whole body MRI 
A. Luciani, C. Lin, F. Pigneur, C. Haioun, E. Itti, A. Rahmouni; Creteil/FR 
It is now well accepted that treatment strategies and patients prognosis rely in 
large part on initial tumour staging. Early response assessment in cancer patients 
further enables adapted treatment selection treatment response on imaging. Recent 
instrumentation MR developments, including routine high field imaging, phased 
array coils and parallel imaging bring whole body MR imaging to clinical practice. 
Moreover, both optimised morphologic imaging and functional data previously 
obtained on specific dedicated examinations can be provided on a whole body 
scale. The aim of this lecture will be to review technical requirements of whole 
body MR imaging, with special focus on dynamic contrast-enhanced MRI (DCE-
MRI), diffusion weighted imaging on a whole body scale (WB-DWI), and MRI us-
ing continuous rolling platform. The combination of phased array coils, enabling 
parallel acquisitions, the selection of dynamic contrast enhanced sequences, and 
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A‑100	 08:58 
Decreasing the number of BI-RADS 3 in clinical settings 
L.J. Pina Insausti; Pamplona/ES (ljpina@unav.es) 
It is important to minimise the number of lesions classified as BI-RADS 3. In a clinical 
setting we can support our diagnoses using more additional imaging techniques 
than in a screening setting. The ways to decrease the BI-RADS 3 lesions are as 
follows. 1. Careful review of previous imaging studies: if the lesion had a benign 
appearance and was seen on previous studies, it should be classified as BI-RADS 
2. 2. Palpation: the physical examination may be crucial to classify a lesion. 3. 
History of breast cancer and other clinical conditions: BI-RADS category 3 should 
be avoided as much as possible for BRCA carriers, patients having a recently 
diagnosed breast cancer or if pregnancy is planned. 4. Radiologist’s experience: 
unexperienced radiologists tend to use more of this category. 5. Complementary 
studies: spot compressions and magnifications views can show suspicious signs 
that were not detected on conventional views, upgrading to BI-RADS 4 or 5. US 
can classify a mass as a cyst (category 2). Sonoelastography can also play a role. 
Very high spatial resolution breast MRI can be useful to evaluate the margins of 
the lesion more accurately, upgrading the lesion to category 4 or 5. 6. Size of the 
lesion: an important requirement to choose follow-up for a probably benign lesion 
is to ensure that, in case of being a malignant lesion, it will be an early diagnosis.
Finally, the patient’s age is important: the typical appearance of a benign lesion in 
a young low-risk woman (< 30) can make unnecessary periodic follow-up. 
Learning Objectives:
1. To appreciate the reasons for inconsistency of cancer incidence between 
published studies.
2. To understand the difficulties of using some of the specific descriptors and 
their current limitations.
3. To become familiar with the way to integrate imaging modalities to reduce 
uncertainty.
4. To recognise the influence of clinical data in the management of a BI-RADS 
3 lesion.
A‑101	 09:21 
Management of BI-RADS 3 lesions 
F. Sardanelli; Milan/IT (f.sardanelli@grupposandonato.it) 
The principle of BI-RADS 3 imaging finding should be that of “quasi-benign” type, 
i.e. with a very low associated risk of malignancy (< 2%), opening the possibility of 
a short-term imaging follow-up as an alternative to imaging-guided needle biopsy. 
However, a number of issues should be regarded as relevant to radiologists and 
patients. 1. BI-RADS 3 cancer prevalence is highly variable due to (1.1) different 
prevalence in the study population (symptomatic/asymptomatic, clinical/screening 
setting; high-risk [BRCA1, BRCA2, family history, etc.], intermediate risk [dense 
breasts; previous breast cancer or high-risk lesions], relatively low risk) and/or 
(1.2) radiologists' differences in classification. 2. When needle biopsy is optioned, 
vacuum-assisted biopsy under stereotactical guidance for mammographic only 
findings (typically, microcalcifications) and core-biopsy for sonographic findings 
should be used; fine needle aspiration cytology should be avoided due to the high 
probability of benign lesions which need larger tissue samples. 3. When short-term 
follow-up (typically, 6 months) is optioned, the same technique on which the BI-
RADS 3 lesions was initially detected should be used. 4. In the screening setting, 
short-term follow-up option is commonly not considered and the reader is forced to 
give a dichotomic reading (recall/not recall). 5. The choice between the two options 
should be clearly discussed with the patient, including the psychological cost of 
waiting six months to get a conclusive report, and a really informed consent should 
be obtained. 6. Till now, there is insufficient evidence for using tomosynthesis or 
MRI for evaluating mammographic or sonographic BI-RADS 3 findings. 
Learning Objectives:
1. To learn about the management options of a BI-RADS 3 lesion.
2. To appreciate the costs to the patient of different management options.
3. To appreciate the costs to the organisation of different management options.
Panel discussion: 
BI-RADS 3: biopsy or watch? 09:44 
The premise behind the BI-RADS 3 classification is to identify a group of low risk 
lesions that can be safely placed on follow-up rather than biopsy. In practice this 
can be very difficult and is anachronistic to the principles of the European population 
screening programmes where the radiology objective is to diagnose or discharge. 
The panel will discuss these dilemmas. 
08:30 - 10:00 Room F2 
Special Focus Session 
SF 3a 
The BI-RADS 3 controversy 
Moderator: 
M.G. Wallis; Cambridge/UK 
A‑098	 08:30 
Chairman’s introduction 
M.G. Wallis; Cambridge/UK (matthewwallis492@btinternet.com) 
Starting in the late 1980s an American College of Radiologists task force developed 
the concept of guidelines to standardise mammography reporting: breast imag-
ing reporting and data system (BI-RADS). There is evidence that over time there 
have been improvements in consistency of use, sensitivity, specificity and positive 
predictive value. However, BI-RADS 3 ‘probably benign; short interval follow-up 
recommended; less than 2% risk of malignancy’ has always been the most difficult 
and controversial, with the highest levels of discordance between classification and 
recommendation, wide variation in both intra- and inter-observer agreement and 
a 2007 literature review demonstrating PPV for malignancy of between 0 and 8%. 
Management of breast disease has moved on a great deal since the 1990s. In 
the main driven by increasing specialisation associated with population screening 
programmes. Nowadays a specialist breast radiologist works with a wide variety of 
needle options at his hip to such an extent that the breast Multi-Disciplinary Team 
increasingly feels that failure to obtain a non-operative diagnosis of discrete lesions 
is unacceptable. In this setting, and mindful of the medico legal consequences of 
‘delayed diagnosis’, is there still room to allow a patient to leave the one stop clinic 
without a definitive diagnosis? As the leaders of the diagnostic team we also have 
to take account of the emotional and psycho-social consequences for our patients 
as well as the financial costs to patient and the healthcare economy. 
Session Objectives:
1. To consolidate knowledge of BI-RADS classification with respect to grade 3.
2. To appreciate the potential variability in interpretation of BI-RADS 3.
3. To appreciate the management options and their implications for both patient 
and organisation.
A‑099	 08:35 
Defining lesions to follow-up 
P. Skaane; Oslo/NO (per.skaane@ulleval.no) 
Breast imaging reporting and data system (BI-RADS) was developed for standardis-
ing reporting and include mammography, ultrasound, and MRI. BI-RADS category 3 
“probably benign finding - short-interval follow-up suggested” should have less than 
2% risk of malignancy. Category 4 has been subgrouped into 4 A, 4B, and 4C, and 
this influence the classification of BI-RADS 3. Mammographic BI-RADS 3: three 
nonpalpable findings in this category include clusters of punctate microcalcifica-
tions, well-circumscribed and noncalcified solitary masses, and benign-appearing 
asymmetric density. Digital mammography will increase detection of amorphous 
microcalcifications and the number of BI-RADS 3 (or 4 A) lesions. Intramammary 
lymph nodes and calcified fibroadenomas are BI-RADS 2 lesions. Ultrasonographic 
BI-RADS 3: a most important BI-RADS 3 lesion is a solid oval mass (“tumour”) 
with gently lobulations, circumscribed margins, and parallel orientation. Using strict 
criteria, the negative predictive value is approaching 99%. Two other lesions are 
nonpalpable “complicated cyst” and clustered microcysts. The “complex” cyst, i.e., 
a mass with cystic and solid components, should be classified as BI-RADS 4. MRI 
BI-RADS 3: there is lack of evidence which MRI findings should be categorised 
BI-RADS 3. Nonmass-like enhancement (NMLE) and enhancement kinetics are 
unique to MRI. Lesions less than 5 mm (“foci”) need no assessment. A challenge is 
MRI-detected tumours < 10 mm as morphologic analysis is of limited value. Benign 
kinetic curves may justify short-term follow-up. In high-risk women, MRI-guided 
vacuum-assisted biopsy should be considered. In conclusion, BI-RADS 3 is justified 
in diagnostic settings but should be avoided or kept at a minimum in screening. 
Learning Objectives:
1. To understand the mammography features of BI-RADS 3 classification.
2. To understand the ultrasound features of BI-RADS 3 classification.
3. To understand the MRI features of BI-RADS 3 classification.
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08:30 - 10:00 Room G/H 
New Horizons Session 
NH 3 
Quantum leaps in MRI: teslas, pulses, tracers 
Moderator: 
O. Clément; Paris/FR 
A‑102	 08:30 
Chairman’s introduction 
O. Clément; Paris/FR (olivier.clement@inserm.fr) 
What will be the routine MR machine in 10 years? Which field strength? Which 
coils? Which gradient design? Which contrast agents? Which combination will 
allow a gain in sensitivity to allow molecular imaging? Can hybrid imaging be a 
solution? The goal of this session is to review the technical developments in field 
strength, pulse, RF coils and contrast agents, and to discuss the necessary choices 
for future MR scans. 
Session Objectives:
1. To review the different perspectives of progress in MRI.
2. To understand that the progress is both instrumental and chemical with new 
probes.
3. To envisage a scenario where MRI will offer molecular imaging capacities.
A‑103	 08:35 
What will be the standard machine and field of the future? 
L. Darrasse; Orsay/FR (luc.darrasse@u‑psud.fr) 
Improving the sensitivity has still been an essential issue in MRI, because the signal 
from nuclear spins relies on extremely weak magnetic interactions dominated by thermal 
fluctuation. To push the signal-to-noise ratio upward, the basic routes have been (i) to 
increase the field strength, (ii) to improve the signal detection with radiofrequency coils 
and (iii) to enhance the signal dynamically with contrast agents or alternative preparation 
techniques. The first route is the most obvious one, driven by the trends in analytical 
MR spectroscopy and small-animal MRI. Going up to or even above 7 T represents a 
considerable challenge, both technically and in view to renew the MR equipment market. 
However, this way is limited by safety issues, radiofrequency penetration concerns 
and susceptibility artefacts. Alternatively, improving the radiofrequency system relies 
on a complex electrodynamics background, where tissue conductivity and different 
sources of noise have to be considered. During the last half-period of MRI development, 
radiofrequency coil arrays have appeared as a powerful mean to improve the signal-
to-noise and to accelerate the spatial encoding process, even able to overcome some 
pitfalls with high-field MRI. Finally, the topics of an optimal field strength has always 
been highly controversial because the contrast mechanisms, on which the diagnostic 
information is mainly founded, are essentially field-dependent. Basically, the contrast 
mechanisms tend to be dominated, respectively, by macromolecular cross-relaxation 
at low field, and by susceptibility-weighted diffusion at high field. An emerging ques-
tion is then to address different pathologies or organs with either general-purpose or 
dedicated MRI systems. 
Learning Objectives:
1. To learn about the possibilities of gaining a jump in signal.
2. To understand the respective strategies of field increase and coil 
improvements.
3. To consider the probable system in 2020.
A‑104	 08:58 
Will new technologies allow a jump in sensitivity? 
J. Hennig; Freiburg/DE (Juergen.Hennig@uniklinik‑freiburg.de) 
Imaging technologies have made breathtaking progress for several decades and 
in all aspects of medical imaging - MR, CT, US and PET. Amongst the current 
developments in MRI there are several areas which hold promise to redefine the 
boundaries of sensitivity. Ultrahighfield MRI with field strengths of 7 T and more 
starts to reveal insights into tissue microstructure so far inaccessible to MR (or 
any other technique). This is still under intense technological development with 
some key issues to resolve notably safety issues related to the high radiofrequency 
power. The unique contrast and resolution does hold promise for highly relevant 
applications such as neurodegenerative disease, small vessel disease, MS and 
others - although definite clinical studies for a ‚killer application‘ are still lacking. 
13C-Hyperpolarisation of metabolites such as pyruvate, succinate, bicarbonate, 
etc. lead to an increase in detection sensitivity by factors of 10-100,000. Finally, the 
development of targeted probes is progressing extremely rapidly and for all imaging 
modalities. Most of this work is aimed at preclinical research, but the tremendous 
impact of the new insight in translational research promises to be of high impact 
for clinical application. Will these technologies allow a jump in sensitivity? Yes and 
no. Image quality, contrast and sensitivity will grow significantly. The biggest impact 
will, however, lie in the combination of the new possibilities with other data - imag-
ing as well as non-imaging. A true change in paradigm will only be achieved if the 
current parcellated knowledge about various aspects of the disease is unified into 
a comprehensive picture. 
Learning Objectives:
1. To review the recent developments in RF-coils and gradients.
2. To learn about the new measurements technologies.
3. To envision how these new tools will allow a huge gain in sensitivity.
A‑105	 09:21 
Will new MR contrast probes compete with PET? 
S. Aime; Turin/IT (silvio.aime@unito.it) 
Purpose: Molecular imaging is a new science that will have a tremendous impact 
in the development of innovative diagnostic tools. In the first stage of its enrolment, 
it has relied massively on PET/SPECT and optical imaging technologies because of 
the superior sensitivity of their probes. In the long-term, MRI/MRS approaches may 
recover a central role, provided that further sensitivity improvements will be attained. 
Methods and Materials: High sensitivity MRI probes have been designed and 
tested for molecular imaging applications. In the case of paramagnetic based 
systems they rely on improved design of the coordination cage as well as on the 
encapsulation/incorporation in proper nanocarriers. For multiple detection studies, 
CEST as well Hyperpolarized C-13 containing molecules have been considered. 
Results: As molecular imaging is the evolution of biologists’ in vitro work that 
has revolutionized the way living cells and intact tissues were investigated, MRI 
multiplex-visualization of biological processes appears to be a key task for the 
forthcoming years for an efficient translation of such outstanding achievements. 
The search for frequency-encoding MRI contrast agents represented by CESTand 
Hyperpolarized C-13 containing molecules have opened the interesting perspective 
of detecting more than one agent in the same anatomical region. This task is largely 
precluded to nuclear probes. Moreover merging MRI and nanotechnology allows 
the attainment of high sensitivity systems also with the classical relaxation agents. 
Conclusion: Recent achievements in amplification procedures allow to tackle the 
intrinsic insensitivity of MRI probes to make them more competitive in the arena of 
molecular imaging applications. 
Learning Objectives:
1. To review the recent developments in MR contrast agents.
2. To understand the principle of CEST agents.
3. To understand the role of the new contrast probes in molecular imaging.
Panel discussion: 
What is ready for our next machine? 09:44 
MRI has experienced tremendous developments in the last 20 years to become an 
indispensable clinical tool. The success story still goes on with major developments 
in the design of new hardware and specific contrast probes, resulting in a potentially 
huge gain in sensitivity and potentially competing with other imaging modalities like 
PET. Will all these technologies develop at the same pace? Will contrast probes be 
ready when the machine can use them? Will the tendency for higher fields continue? 
08:30 - 10:00 Room I/K 
Cardiac 
RC 303 
Systematic approach to congenital heart disease 
(CHD) 
Moderator: 
A.P. Parkar; Bergen/NO 
A‑106	 08:30 
A. Vascular rings and other congenital vascular things 
A.J.B.S. Madureira; Porto/PT (ajbmadureira@gmail.com) 
The cardiac tube appears around the third week of embryonic development and 
develops into a structure with several segments (truncus arteriosus, bulbus cordis, 
ventricle, atrium, and sinus venosus). The truncus arteriosus divides into the aorta 
and pulmonary trunk. Six paired aortic arches develop that terminate in dorsal aor-
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Learning Objectives:
1. To learn how to examine CHD with MDCT.
2. To compare the advantages and limitations of MDCT in comparison to MRI.
3. To understand the role of CT in differentiating various types of CHD.
4. To learn how to control radiation dose.
08:30 - 10:00 Room L/M 
Special Focus Session 
SF 3c 
Tumour response to treatment: RECIST, desist or 
insist? 
Moderator: 
R.H. Reznek; London/UK 
A‑109	 08:30 
Chairman’s introduction 
R.H. Reznek; London/UK (r.h.reznek@qmul.ac.uk) 
The use of imaging to monitor response to treatment has become central in the 
care of patients with cancer. It is crucial therefore that radiologists involved in the 
management of patients with cancer understand the place of imaging within the 
clinical context of the management of patients with cancer; that they are aware of 
the criteria of the accepted current criteria for assessing response and are familiar 
not only with new developments in imaging that act as a surrogate end-point for 
evaluating the success of treatment but are also aware of how imaging is used to 
predict the likely response early in the patient’s pathway. This session will concen-
trate on all these aspects on the use of cancer imaging in monitoring response to 
treatment in patients with cancer. 
Session Objectives:
1. To understand the clinical importance of monitoring the response to 
treatment in patients with cancer.
2. To appreciate the need for standard response criteria and how they have 
been derived.
3. To become familiar with the range of morphological and functional imaging 
criteria available to monitor response.
A‑110	 08:35 
Monitoring response to treatment in patients with cancer: why and how. 
The oncologist’s view 
P. Johnson; Southampton/UK (johnsonp@soton.ac.uk) 
We are in the era of targeted cancer therapy, whether by small molecules derived 
from knowledge of the molecular pathogenesis of tumours, or from biological 
therapies emerging from our understanding of immunology and cell biology. These 
approaches convey new challenges for the monitoring of response. Small molecule 
therapeutics often stabilise tumours for significant periods without producing clear 
reduction of masses, and for these the assessment of surrogate endpoints takes 
on increasing importance. The measurement of pharmacodynamics is central to 
early phase trials in which confirmation of on-target effects is required to determine 
the biologically effective dose, and in many cases this is best done by functional 
imaging. Biological therapeutics such as monoclonal antibodies and cellular im-
munotherapy also need novel approaches for the determination of their actions in 
vivo, particularly as they are frequently tested in the setting of low level disease. 
Randomised trials are underway to assess the contribution of functional imaging, 
in particular CT-PET as a means to guide therapy. The emerging data suggest 
that there are broad variations in accuracy, both according to the disease in ques-
tion and the context in which studies are performed, even before factors such as 
imaging quality control and standardised reporting are included. For the future, 
standardisation of techniques and common quality control will play a vital part in 
advancing our understanding in this rapidly evolving field. 
Learning Objectives:
1. To learn how new anticancer treatments are being developed and applied in 
the clinic.
2. To understand how surrogate endpoints are assuming an increasing 
importance in this process.
3. To appreciate how imaging can contribute to this and how important it is to 
have a reproducible system.
tas. There is regression of portions of these arches, but several remnants normally 
persist. Any failure in this process can result in congenital anomalies of the aorta 
or pulmonary vessels. These anomalies can be categorised into aortopulmonary 
anomalies, systemic arterial anomalies, and pulmonary artery anomalies. The 
aortopulmonary anomalies comprise truncus arteriosus, hemitruncus arteriosus, 
aorticopulmonary window, patent ductus arteriosus, and transposition of the great 
arteries. The systemic arterial anomalies include the anomalies of the aortic arch, 
of which the most common is a left aortic arch with aberrant right subclavian artery. 
Double aortic arch is the most common cause of a vascular ring and is characterised 
by left and right aortic arches arising from the ascending aorta and encircling the 
trachea and oesophagus. A right aortic arch can have three “subtypes”: aberrant 
left subclavian artery, mirror image branching, or isolated subclavian artery. The first 
type is the most common one and is the second most common cause of vascular 
ring. Aortic coarctation, pseudocoarctation and interruption of the aortic arch are 
other systemic arterial anomalies. The most important pulmonary artery anomalies 
are idiopathic dilatation of the pulmonary trunk, absence or proximal interruption of 
a pulmonary artery, pulmonary arterial stenosis, and pulmonary sling. 
Learning Objectives:
1. To understand the embryology of the aortic arch.
2. To review the imaging findings and clinical significance of vascular rings in 
the chest.
3. To learn how to diagnose the most common congenital anomalies of the 
pulmonary arteries.
A‑107	 09:00 
B. MRI: getting more specific 
A.M. Taylor; London/UK (a.taylor@ich.ucl.ac.uk) 
Cardiovascular magnetic resonance (CMR) imaging has become integrated into 
the assessment pathways for congenital heart disease in both paediatric and adult 
patients. CMR provides a powerful tool, giving anatomical and haemodynamic 
information that echocardiography and catheterisation alone do not provide. Extra-
cardiac anatomy, including the great arteries, systemic and pulmonary veins, can be 
delineated with high spatial resolution. Vascular and valvular flow can be assessed, 
shunts can be quantified, and myocardial function can be measured accurately 
and with high reproducibility, regardless of ventricular morphology. Finally, CMR 
surpasses both catheterisation and echocardiography in providing high resolution, 
isotropic, three-dimensional (3D) datasets. This allows for reconstruction of data in 
any anatomical imaging plane, giving complete visualisation of complex congenital 
cardiac anomalies, without the use of ionising radiation. In the congenital heart 
disease, CMR can be justified for any patient in whom clinical or echocardiographic 
data are insufficient for monitoring, decision-making or surgical planning. Due to 
the complexity of both the anatomy and physiology of congenital heart disease, it is 
essential to have a systematic approach for CMR when assessing these patients. 
Learning Objectives:
1. To understand the advantages of MRI in CHD.
2. To learn how to use dedicated MRI techniques (e.g. flow measurements) in 
CHD.
3. To learn which MR parameters have a prognostic value in CHD.
A‑108	 09:30 
C. MDCT: the expanding role 
A. Küttner; Frankfurt a. Main/DE (Kuettner@radiologen‑frankfurt.de) 
With the development of novel CT scanners, especially the Dual Source CT, novel 
strategies of examining congenital heart disease became possible. Especially 
newborns and infants younger 3 years of age are difficult to examine, since compli-
ance cannot be expected. Also young children are especially susceptible to ionizing 
radiation and should be exposed as little as possible. In a first step the course will 
illustrate the underlying technical principle how to examine children in < 1 sec with 
sub mSv exposure. Also the course will teach how to avoid sedation in children 
of any age. In a second step the course will show how to apply contrast media in 
children of all ages and what strategy to use. In a third step the course will show 
how to appropriately choose scanning parameters for the CT scan since the size 
and weight varies considerable in children as there are small to date newborns 
with < 2 kg body weight up to adolescents with a body weight > 60 kg. Since little 
comprehensive data is available how to examine with an optimal compromise 
between sufficient image quality and unnecessary radiation overexposure the 
data of the Erlangen study will be presented and discussed. In a forth part typical 
indications for the exam are shown and how to interpret the exam. Also limits for 
the exams are shown. In a final step a comparison with MRI is shown which method 
is used for which pathology. 
Friday
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08:30 - 10:00 Room P 
Contrast Media 
RC 306 
Contrast media: always as safe as we wish? 
Moderator: 
S.K. Morcos; Sheffield/UK 
A‑113	 08:30 
Chairman’s introduction 
S.K. Morcos; Sheffield/UK (sameh.morcos@sth.nhs.uk) 
Extracellular water soluble contrast media (CM) are either iodine (I) or gadolinium 
(Gd) based. They have similar pharmacokinetics and excreted mainly by the kidneys 
with biological half life around 90 minutes. They do not cross intact blood brain 
barrier, minimal cell penetration and are not metabolised inside the body. Iodin-
ated CM are classified into high-osmolar, low-osmolar and iso-osmolar contrast 
agents. Osmolality, iconicity and viscosity are important physicochemical factors 
which influence the safety of these agents. Gd-CM are either linear or macrocyclic 
and available as ionic or non-ionic preparations. The stability of the Gd-CA is an 
important safety feature of these agents particularly in patients with reduced renal 
function. The macrocyclic agents have high kinetic stability whereas the non-ionic 
linear preparations have low kinetic and thermodynamic stability. Contrast media 
adverse effects can be divided into acute and delayed reactions. Acute reactions 
are allergic like and usually develop within one hour of CM administration. Delayed 
reactions develop after an hour and within a week of CM administration. Acute 
reduction in renal function referred to as contrast-induced nephropathy (CIN) 
may develop after contrast administration in patients with pre-existing risk factors. 
Patients with advanced reduction in renal function may develop the complication 
of nephrogenic systemic fibrosis (NSF) after administration of low stability Gd-CM. 
In this session contrast-induced nephropathy and nephrogenic systemic fibrosis 
will be discussed. Measures to reduce the incidence these adverse effects will 
also be presented. 
Session Objectives:
1. To understand optimised and integrated approaches for management of 
currently available contrast agents.
2. To review the advantages and disadvantages of different contrast media.
3. To learn about the safety of patients and professionals.
A‑114	 08:35 
A. Iodinated CM: whether CIN is a SIN, and how to avoid it 
R.W.F. Geenen; Alkmaar/NL (r.w.f.geenen@mca.nl) 
The pathophysiology of CIN is complex and not well understood. Basically, a 
misbalance between vasodilatation and vasoconstriction takes place inside the 
kidney after intra-arterial or intravenous CM administration. Furthermore, increased 
oxygen demand of tubular cells due to increased reabsorbtion of sodium and water 
is a second mechanism, leading to transient medullar ischaemia. Identifying the 
patient at risk is the first step in prevention. Knowledge of the patient‘s medical 
record and a recent basic kidney function are mandatory. High-risk patients should 
receive prevention. Two major topics in CIN prevention are the questions whether 
iso-osmolar CM cause significantly less CIN than low-osmolar CM and whether 
hydration schedules with NaHCO3 give significantly less CIN than hydration sched-
ules with NaCl 0.9%. 
Learning Objectives:
1. To understand the physiology of iodinated contrast media.
2. To understand CIN mechanisms.
3. To learn about pertinent safety issues.
A‑115	 08:58 
B. MR contrast agents: rumble in the jungle 
G. Heinz-Peer; Vienna/AT (gertraud.heinz@meduniwien.ac.at) 
Currently up to 50% of all MRI examinations worldwide are performed using contrast 
agents, either an extracellular agent or an organ-specific agent. The extracellular 
MRI contrast agents are chelates that contain the paramagnetic ion gadolinium 
which strongly affects the relaxation properties of water protons, leading to changes 
in tissue contrast. Gd-DTPA was the first extracellular agent to be introduced in 
clinical practice. Since the introduction of Gd-DTPA in 1988, various gadolinium 
chelates with different chemical properties became available for clinical use. 
For many years, it was believed that gadolinium-based contrast agents (GBCA) 
A‑111	 09:00 
Principles in the use of conventional/anatomic imaging for response 
assessment 
L. Schwartz; New York, NY/US (lschwartz@columbia.edu) 
The standard way to assess a patient’s response to chemotherapy is to use com-
puted tomography (CT) to measure tumour size using uni-dimensional (RECIST) 
or bi-dimensional (WHO) criteria. This methodology has changed little in the past 
30 years despite the emergence of new therapies and advances in imaging tech-
nology. Measuring the changes in the size of tumours in one or two dimensions 
does not always capture the effects of novel therapies on primary tumours and 
metastases. Radiographic changes in the size of tumours treated, for instance, 
with epidermal growth factor receptor tyrosine kinase inhibitors such as gefitinib 
or erlotinib or inhibitors of angiogenesis such as bevacizumab do not necessarily 
occur at the same magnitude or speed as observed in those individuals treated 
with standard cytotoxic therapies. With these newer agents, tumours respond by 
undergoing cystic change, central necrosis, and density changes that may not be 
captured by conventional measurements of the largest lesion diameter. 
Learning Objectives:
1. To understand and appreciate the use of conventional/anatomic imaging for 
response assessment in clinical practice as well as in clinical trials.
2. To understand general and disease-specific challenges associated with 
response assessment at imaging.
3. To recognise potential improvement in imaging and image post-processing 
for response assessment.
A‑112	 09:25 
PET in monitoring response 
W. Weber; Freiburg/DE 
PET imaging and specifically PET/CT with the glucose analogue fluorodeoxy-
glucose (FDG) has been evaluated in a significant number of studies to monitor 
tumour response in patients undergoing chemotherapy, radiotherapy or targeted 
therapies. The clinical value of for differentiation of residual or recurrent viable 
tumour and therapy-induced fibrosis or scar tissue has been established for ma-
lignant lymphomas and various solid tumours. Furthermore, there are now several 
reports suggesting that quantitative assessment of therapy-induced changes in 
tumour FDG-uptake may allow prediction of tumour response to chemotherapy 
and targeted drugs very early in the course of therapy. In non-responding patients 
treatment may be adjusted according to the individual phenotype of the tumour 
tissue. Current studies investigate whether FDG-PET can be used to “personalise” 
treatment and to reduce the side effects and costs of ineffective therapy. In addi-
tion to FDG, several other imaging probes are in clinical studies to monitor tumour 
response to therapy. These include among others [18F]fluorothymidine (FLT) for 
imaging of cellular proliferation, [18F]fluoromisonidazole for assessment of tumour 
hypoxia and radio-labelled RGD-peptides for angiogenesis imaging. Preclinical 
and early clinical trials with these imaging probes are encouraging, but need to be 
confirmed in larger clinical trials. 
Learning Objectives:
1. To understand how image acquisition and reconstruction influence visual 
and quantitative analysis of PET studies.
2. To describe current criteria for assessing tumour response in lymphoma and 
solid tumours and recognise the limitations of these criteria.
3. To understand how differences between scanner models can influence 
response assessment by PET.
Panel discussion: 
Why does the radiologist need to understand the importance of monitoring 
response and how it is done? 09:45
Monitoring the response to treatment has become a critical part of the management 
of patients with cancer. The markedly improved diagnostic performance of cross-
sectional imaging in delineating the extent of malignancy has meant that imaging 
has become increasingly important as a surrogate end-point. These two factors 
have resulted in an increasing need for a standardisation of the criteria of response 
both in therapeutic trials and in clinical practice. It is vital that all radiologists imaging 
patients with cancer are familiar with the limitations, pitfalls and strengths of these 
changing criteria and also are aware of the possibility of using imaging to evaluate 
the changing molecular make-up of the cancer. 
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stent-grafts is steadily increasing. Therefore, knowledge of this treatment option is 
fundamental to provide basis for procedure planning and a meaningful radiological 
reporting. Imaging plays a crucial role in the assessment of patients with aortic 
aneurysms. Eligibility for endovascular treatment depends very much on detailed 
anatomical knowledge of the aorta, its branches and vascular access through the 
iliac arteries. We will review the role of imaging modalities: US, CT, MR for detection 
and evaluation of anatomy of thoracic and abdominal aneurysms. The strength and 
weakness of each modality will be reviewed and inclusion criteria for endovascular 
aortic aneurysm repair will be presented. The precise sizing of the stentgraft obtained 
from the images is certainly one of the most critical points of the endovascular pro-
cedure and a condition of its success. Although it is a minimally invasive treatment 
it is associated with complications. There is a strong need for general radiologists to 
know about the most prevalent normal and abnormal findings of the post-treatment 
aorta. The session will end with discussion addressing the central role of imaging in 
pre- and post-treatment evaluation of the patients with aortic aneurysms. 
Session Objectives:
1. To learn about the leading role of interventional radiology in management of 
patients with aortic aneurysms.
2. To understand the importance of pre and post-procedural imaging.
3. To understand the role of the radiologist in the management and follow-up 
process.
A‑118	 08:35 
Endovascular treatment of thoracic aortic aneurysms 
J.-P. Beregi; Lille/FR (jean‑paul.beregi@chru‑lille.fr) 
Indications for and experience with placement of endovascular stent grafts in the 
thoracic aorta are still evolving. Recent advances in imaging technologies have 
drastically boosted the role of pre-procedural imaging. The accepted diagnostic gold 
standard, digital subtraction angiography, is now being challenged by the state-of-
the-art computed tomography angiography (CTA), magnetic resonance angiography 
(MRA) and trans-oesophageal echocardiography (TEE). Among these, technological 
advancements of multidetector computed tomography (MDCT) have propelled it to 
being the default modality used, optimising the balance between spatial and temporal 
resolutions and invasiveness. MDCT angiography allows the comprehensive evalu-
ation of thoracic lesions in terms of morphological features and extent, presence of 
thrombus, relationship with adjacent structures and branches as well as signs of 
impending or acute rupture, and is routinely used in these settings. In this presentation, 
we review the current state-of-the-art radiological imaging for thoracic endovascular 
aneurysm repair (TEVAR), especially focusing on the role of MDCT angiography. 
After analysing the technical aspects for optimised imaging protocols for thoracic 
aortic diseases, we will discuss pre-procedural determinants of candidacy, and how 
to formulate interventional plans based on cross-sectional imaging. 
Learning Objectives:
1. To learn about etiology, clinical presentation and indications for treatment.
2. To understand which imaging information is required for management of 
thoracic aortic aneurysms.
3. To learn about the outcomes and drawbacks of stentgrafting.
A‑119	 08:58 
Endovascular treatment of abdominal aortic aneurysms 
R. Morgan; London/UK (robert.morgan@stgeorges.nhs.uk) 
The purpose is to present the essential principles of endovascular repair of abdominal 
aortic aneurysms (EVAR). Abdominal aortic aneurysms (AAA) larger than 5.5 cm should 
be treated. Inclusion criteria for EVAR include satisfactory aneurysm neck morphology 
and suitable access vessels. Preprocedural imaging involves CTA from the diaphragm 
to the femoral arteries. Several devices may be used to cover a wide range of anatomy. 
EVAR procedures are generally performed as combined procedures by teams of 
vasculr surgeons and interventional radiologists. Patients are followed up indefinitely 
by CTA (or ultrasound) and plain radiography. The periprocedural mortality is three 
times lower compared with surgery. Late mortality rates are similar between surgery 
and EVAR. Quality of life issues favour EVAR in the short and medium term. Early 
published series reported high complication and reintervention rates for EVAR, although 
these have reduced with increased experience and improved device technology. 
Conclusion: EVAR has become a favoured alternative to open surgical repair of AAA in 
many European centers. Further refinements to the technique and devices are ongoing. 
Learning Objectives:
1. To learn about etiology, clinical presentation and indications for treatment.
2. To understand which imaging information is required for management of AAA.
3. To learn about the outcomes and drawbacks of stentgrafting.
were nearly a 100% safe which led to a liberal and off label use of these agents. 
Nephrogenic systemic fibrosis (NSF) was first identified in 1997, but reported in 
the peer-reviewed literature in 2000. The disease typically affects patients with end-
stage renal disease, including those on regular dialysis treatment. First publications 
reporting an association between GBCA and NSF appeared in 2006. According 
to Medwatch, 589 people developed GBCA-associated NSF between 1997 and 
2007. Most of these cases were associated with the administration of linear chelate 
GBCA. The proposed trigger for NSF is transmetallation of the gadolinium chelate 
whereby free gadolinium is released from the chelate in exchange for endogenous 
metals such as zinc, copper, and calcium with subsequent binding to human tissue. 
The exact pathogenesis is unclear, but it is likely that cofactors may be involved. 
Learning Objectives:
1. To understand the spectrum and mechanisms of MR contrast agents.
2. To understand the pathophysiology behind NSF.
3. To learn about clinical safety issues to consider beyond NSF.
A‑116	 09:21 
C. PET tracers: established tracers and those on the horizon 
F.C. Gärtner, M. Schwaiger; Munich/DE 
There is a large number of PET radio-pharmaceuticals in research, but only a 
limited number have reached clinical application. The success of clinical PET 
depends primary on the use of 18F deoxyglucose (FDG), which was introduced as 
brain tracer in the late 1970s. Since tumour tissue displays high glucose uptake, 
FDG became an important diagnostic and prognostic biomarker in cancer. Beyond 
FDG, tracers of various biologic processes in tumours are currently evaluated. The 
most promising are FLT, FET, 18F Choline. 18F-labelled compounds are preferred 
because of the 2 hrs physical half-life, which allows distribution to sites without 
cyclotron. Experimental compounds address angiogenesis, hypoxia, apoptosis 
and extra-cellular matrix. With the introduction of 68Ga-generators, 68Ga -labelled 
receptor ligands are being used for detection of neuro-endocrine tumours. In 
cardiology, PET tracers are available for perfusion, metabolism and innervations. 
Gene-reporter imaging has been used to monitor cell-based therapies in neurol-
ogy. One of the most promising applications of molecular imaging principles is the 
targeting of amyloid deposition in the patients with Alzheimer’s disease. It is hoped 
that early diagnosis of the neurodegeneration may lead to better therapies. The 
advent of hybrid-imaging will be associated with the need for multimodal contrast 
agents exploiting the imaging characteristics of the involved instrumentation for 
more differentiated visualisation of structure, physiology, and biology. 
Learning Objectives:
1. To understand the working mechanism and radiation of current clinical 
tracers.
2. To become familiar with the potential clinical indications and applications.
3. To learn about potential new tracers.
Panel discussion: 
What specific precautions are mandatory in order to guarantee contrast 
media safety to patients and healthcare professionals? 09:44 
Current contrast agents are safer than previous products. However there are still 
safety aspects to consider, including patient’s kidney function, thyroid metabolism, 
allergy, radiation exposure, or specific medical history, and there is no such thing 
as total or complete safety. While these simple precautions may appear obsolete in 
the era of sophisticated technical approaches, these issues are still quite complex 
and crucial in maintaining a high safety level. The discussion will give guidelines 
and tips for achieving a high level of safety when using contrast agents. 
08:30 - 10:00 Room Q 
Special Focus Session 
SF 3b 
The ABC of EVAR 
Moderator: 
M. Szczerbo‑Trojanowska; Lublin/PL 
A‑117	 08:30 
Chairman’s introduction 
M. Szczerbo-Trojanowska; Lublin/PL (ewamak@MRI.am.lublin.pl) 
Treatment of aortic aneurysms have been revolutionised two decades ago by the 
introduction of endovascular methods. They became a favoured alternative to open 
surgical repair nowadays. The number of patients with aortic aneurysms treated with 
Friday
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Session Objectives:
1. To learn how cutting edge research can translate into clinical application in 
the field of neuroradiology.
2. To understand imaging strategy in common diseases like demyelinating 
diseases and stroke.
3. To evaluate whether functional imaging of the brain can lead to potential 
application for clinical practice in the near future.
A‑122	 10:35 
White is white: a simple guide to demyelinating diseases 
V. Dousset; Bordeaux/FR (vincent.dousset@chu‑bordeaux.fr) 
Magnetic resonance imaging (MRI) is the best tool to explore white matter disorders 
(WMD), including the most common demyelinating disease: multiple sclerosis (MS). 
The formation of demyelinating lesions is related to an “inflammatory attack”. New 
techniques as diffusion tensor imaging (DTI), perfusion weighted imaging and 
USPIO enhancing can explore earlier and more specifically lesions formation. 
Acute demyelinating lesions may resolve (remyelination) or persist as “chronic 
black holes”. Chronic demyelinating lesions lead to axonal injury and Wallerian 
degeneration. A diffuse neurodegenerative process leading to cerebral atrophy is 
actually a major landmark in MS. Conventional MRI sequences allows visualisation 
of white matter lesions (seen as hyper T2/FLAIR lesions, low signal T1 lesions and 
possible gadolinium contrast enhancement), presently the basis of MS diagnosis. 
MS follow-up is usually clinic but imaging could provide prognosis and therapeutic 
parameters (“surrogate markers”) even if disease progression and axonal loss are 
independent from “lesion load”. MR spectroscopy, DTI or magnetization transfer 
imaging (MTI) provide measurement of diffuse tissue damage in clinical research, 
and may correlate to disease progression, as well as brain volume measurement. 
After exclusion of alternative diagnosis (MRI “red flags” as other WMD), MRI le-
sions dissemination in space and time criteria are the main points in MS diagnosis. 
The widely used revised McDonald criteria may be replaced by more simple and 
efficient MAGNIMS criteria. Such criteria could allow starting “modifying disease 
treatments” as soon as the first “clinical isolated syndrome”. 
Learning Objectives:
1. To understand the MRI-targeted biological landmarks in demyelinating diseases.
2. To know how to classify the appropriate techniques for diagnosis, prognosis, 
therapeutic evaluation and for clinical research.
3. To understand the input of MRI in the diagnosis of multiple sclerosis. 
Interlude (1) 10:55
A‑123	 11:00 
Functional imaging: useful tool for the radiologist or crystal ball for the 
psychiatrist? 
A. Krainik; Grenoble/FR (akrainik@chu‑grenoble.fr) 
Since blood oxygenation level-dependent (BOLD) signal changes have been ob-
served using MRI and modulated using neuronal stimuli, functional MRI (fMRI) has 
quickly become the most popular non-invasive functional neuroimaging technique 
in clinical practice and cognitive neuroscience. Indeed, high-field MR scanners and 
BOLD-sensitive sequences are now widely accessible in both clinical and research 
settings. BOLD signal that relies on deoxyhaemoglin concentration is detectable 
without injection of external contrast media. The colourful activation maps combined 
with three-dimensional brain anatomy may have also made this imaging method as 
much attractive as controversial. Numerous applications of fMRI have been suggested 
in medicine. After a 15-year long history in clinical practice and thousands of scientific 
papers even in prestigious journals, the role of fMRI remains mostly dedicated to 
map eloquent cortex before a neurosurgical procedure. In fact, BOLD fMRI is chal-
lenging because the relationship between the neuronal response to a stimulus and 
the activation blobs relies on neurovascular coupling, haemodynamic response, MR 
signal detection, and complex time-series analyses. Besides an obvious and partially 
elucidated complexity, and several concerns on the interpretation of experimental 
paradigms in cognitive neuroscience, fMRI is based on a robust physiological and 
physical framework. BOLD signal is reproducible across subjects and MR scanners. 
fMRI requires a rigorous methodology to acquire and analyse data, an advanced 
knowledge in sulcogyral and functional neuroanatomy to estimate spatial displace-
ment and reorganisation in patient with focal lesion, and a solid experience in BOLD 
imaging to distinguish artefacts and potential confounds from appropriate results. 
Learning Objectives:
1. To know the key points of quality in fMRI.
2. To know the main pitfalls in fMRI interpretation.
3. To learn more about advances in fMRI of brain perfusion.
Interlude (2) 11:20
A‑120	 09:21 
The role of imaging in follow-up 
K.A. Hausegger; Klagenfurt/AT (klaus.hausegger@lkh‑klu.at) 
The goal of surveillance after EVAR is to prevent late rupture eurysm. High pressure 
ELs (type I and type III EL) are risk factors for late rupture therefore have to be treated. 
Type-II, IV and type V (endotension) ELs are low pressure ELs with a low rupture risk. 
Thus, it is essential not only to detect ELs but also to classify ELs correctly. Until recently 
stent graft surveillance has been performed with contrast enhanced multislice CT 
(MSCT), typically 1, 3, 6 and 12 months after EVAR and thereafter in yearly intervals. 
However, although MSCT proved to be a very effective in FU cumulative radiation 
exposure, repetitive contrast medium load and increasing work load have to be seen 
critically. Therefore, alternative surveillance protocols especially including ultrasound 
have been evaluated. Several studies have shown that a risk-adjusted follow-up regime 
might be most efficient. Patients with low risk of aneurysm-related mortality after EVAR 
have a normal 1- and 6-month MSCT scan and sack shrinkage at 12 months. In these 
patients regular contrast enhanced US in yearly intervals have been proven to be safe 
for further FU. A one yearly non-enhanced low-dose CT or a plain film may be recom-
mended to detect distortion or migration of the stent-graft. Patients with a persistent 
type II EL after one year need to be followed more closely and imaging modality is 
chosen depending on the character of the EL. In most cases EL classification can be 
made correctly by MSCT or US; however, sometimes DSA may be needed. 
Learning Objectives:
1. To learn about the follow-up imaging strategy.
2. To compare the advantages and limitations of US and CT.
3. To understand the role of MRI.
Panel discussion: 
The key role of imaging in endovascular aortic aneurysm repair 09:44 
Many patients with aortic aneurysms are currently treated endovascularly. Therefore 
the number of patients imaged pre and post-procedurally is increasing. Radiologists 
evaluating aortic aneurysms with different modalities should know the key imaging 
features to look for in pre-treatment as well as follow-up examinations. 
10:30 - 12:00 Room A 
ESR meets France 
EM 1 
From neurosciences to clinical practice 
Presiding:
Y. Menu; Paris/FR 
J.‑P. Pruvo; Lille/FR 
A‑121	 10:30 
Introduction 
J.-P. Pruvo; Lille/FR (jppruvo@chru‑lille.fr) 
Neuroimaging is one of the fields of radiology with the most exciting recent ad-
vances. Moreover, these advances show dramatically important clinical applica-
tions. Some are useful for the specialised neuroradiologist, but most are critical 
for the general radiologist as well. In this session, we will try to address some of 
the most relevant issues: white matter disorders are common diseases. Expertise 
of the radiologist is important in detecting the disease, and in the evaluation of the 
activity after treatment. With this respect, standardisation of criteria is desirable 
for appropriate medical decisions. Functional Imaging is a fascinating insight into 
the human brain. It opens new horizons and has found many applications in the 
evaluation of psychiatric diseases, and in the planning before treatment of brain 
lesions, among other potential applications. Although it is obvious that we ignore 
much more than we know, this field is already one of the most exciting topics in 
neuroradiology. Although these methods are still in the field of specialists, everybody 
should be aware of the possibilities of functional imaging of the brain and its recent 
developments. Stroke is by excellence a clinically relevant problem. Because it is 
an emergency situation, time really matters, and we have more than one imaging 
tool to explore these patients, it is mandatory to provide strong recommendations 
and guidelines for the radiologist, in accordance with the clinical situation and 
with the treatment options. At the end of this session, the attendees will be aware 
of important advances in the domain of neuroradiology, and will take home very 
important landmarks for their own clinical practice.
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Learning Objectives:
1. To learn about the common causes of abdominal pain in children.
2. To understand the importance of ultrasonography and to learn when CT or 
MRI might be required.
3. To learn about issues relating to radiation dose in the paediatric abdominal 
and pelvic CT.
A‑126	 11:00 
B. Jaundice in children: common causes and imaging strategy 
D. Pariente; Le Kremlin‑Bicêtre/FR (daniele.pariente@bct.aphp.fr) 
Jaundice is rare in children but imaging has a major role to establish the cause 
which differs according to age. In the neonatal period the leading cause is biliary 
atresia (BA) which consists of the obliteration of the extrahaepatic bile duct (BD) 
without dilatation of intrahaepatic BD and requires urgent surgical treatment to 
reduce the need for liver transplantation. BA must be considered when there are 
persistent white acholic stools and firm hepatomegaly. US shows the absence of 
dilated BD and in a few cases a cyst at the porta hepatis or findings of the splenic 
malformation syndrome, but often it is not conclusive. MRCP has not yet proved 
to be reliable for the diagnosis of BA. Other neonatal cholestases include medical 
intrahepatic causes which can be identified by biological tests or histological find-
ings and rare causes of extrahepatic obstruction with dilated BD such as lithiasis, 
choledochal cyst or spontaneous perforation of BD. In childhood, US easily identi-
fies all causes of extrahepatic obstruction by showing dilated BD; the main causes 
include choledochal cyst (the most frequent congenital malformation, defined by 
an abnormally long common bilio-pancreatic channel), cholelithiasis, tumoural 
compression, sclerosing cholangitis, portal vein obstruction, postsurgical or post-
traumatic stenosis… In all these cases, in our experience, MRCP has become 
the modality of choice and has replaced invasive procedures which are nowadays 
reserved for treatment. MDCT may be useful in rare instances, for example, to 
differentiate calculi and aerobilia after surgery. Imaging protocols and illustrative 
cases will be presented. 
Learning Objectives:
1. To learn the common causes of jaundice in the various paediatric age 
groups.
2. To learn about the imaging strategies.
3. To become aware of complications following therapy and their investigation.
A‑127	 11:30 
C. Neonatal bowel obstruction: the role of the radiologist 
S. Ryan; Dublin/IE (stephanie.ryan@cuh.ie) 
Neonatal bowel obstruction generally presents within hours of birth. The diagnosis 
of bowel obstruction is clinical but imaging is vital to determine the cause. The plain 
radiograph will distinguish upper from lower intestinal obstruction. The radiograph 
alone is diagnostic in duodenal atresia and jejunal atresia and the baby may be 
taken directly to surgery. If the radiograph shows multiple dilated loops of bowel, 
more than 4 loops, then the obstruction is distal ileal or colonic. The radiograph 
may give some clues as to the possible cause, such as a large fluid level in the 
dilated loop proximal to an atresia. Contrast enema, usually with low osmolar water 
soluble contrast, is used in most cases, however, to determine the cause of lower 
intestinal obstruction because the management of this is different for different 
causes of obstruction. Meconium ileus and ileal atresia are the commonest ileal 
causes of obstruction and Hirschprung’s disease and meconium plug syndrome 
are the commonest colonic causes of obstruction. Colonic atresia is rare and 
imperforate anus is a clinical diagnosis. Radiologically guided reduction is used 
to treat meconium ileus. Intestinal obstruction in the older neonate may be due 
to volvulous, pyloric stenosis, duodenal stenosis or omphalomesenteric band. In 
the baby born prematurely, obstruction may be caused by stricture secondary 
to necrotising enterocolitis. Radiographs and contrast studies are also used to 
evaluate these conditions. 
Learning Objectives:
1. To learn about the most common causes of neonatal obstruction.
2. To understand the role of plain radiography in establishing the diagnosis.
3. To know when upper and lower GI contrast studies are indicated and the 
contrast medium used.
A‑124	 11:25 
Stroke around the clock: will the challenger (CT perfusion) beat the 
champion (diffusion MRI)? 
X. Leclerc; Lille/FR (xleclerc@chru‑lille.fr) 
In patients admitted for a suspected stroke, time management is the most important 
criterion for therapeutic decisions. Less than four hours and a half, all patients 
admitted in emergency for an acute neurological deficit without impairment of 
consciousness (NIH < 25) and presented with a brain ischaemia of less than one 
third of the territory of the middle cerebral artery should receive IV thrombolysis. 
Brain imaging must exclude bleeding and quantify the extent of ischaemic damages. 
Between 4.5 and 6 hours after onset of symptoms, intravenous thrombolysis and/
or intraarterial mechanical or chemical thrombolysis may be indicated in selected 
cases. The assessment of ischaemic penumbra and vessel permeability is par-
ticularly important for the therapeutic decision. This may be evaluated either by 
MRI or CT. MRI is the technique of choice that should be used whenever possible 
because of the absence of irradiation and iodine-related side effects, the optimal 
anatomical coverage, the detection of lacunar infarct and its sensitivity for evalu-
ating ischaemic brain damages of the posterior fossa. Imaging protocol should 
include FLAIR (fluid attenuated inversion recovery), T2*, diffusion/perfusion and 
MR angiographic sequences. In case of unstable patient or if MRI is not available, 
a non-contrast CT scan must be performed and completed by perfusion CT and 
CT angiography. The main advantages of this technique are the short time of data 
acquisition and the absolute quantification of perfusion due to the linear relation 
between attenuation and concentration. 
Learning Objectives:
1. To understand the medical challenges in patients with stroke, and why and 
when imaging should be performed to decide on a specific treatment.
2. To understand the appropriate protocols for CT and MRI in patients with 
stroke and to recognise the main results.
3. To learn about the respective possibilities and limits of CT and MRI, their 
complementarities or concurrence, and to learn whether imaging strategy 
can be tuned to machine availability.
Panel discussion 11:45 
10:30 - 12:00 Room E2 
Foundation Course: Paediatric Radiology 
E³ 420 
Common digestive problems in children: the 
radiologist as a key player 
Moderator: 
A. Paterson; Belfast/UK 
A‑125	 10:30 
A. Abdominal and pelvic pain: a practical approach 
S.G.F. Robben; Maastricht/NL (s.robben@mumc.nl) 
Many paediatric abdominal emergencies present with abdominal or pelvic pain. Any 
delay in diagnosis and treatment may result in death or severe morbidity. These 
diseases are highly age-dependent. Newborn infants may have congenital diseases 
as Hirschsprung‘s disease or meconium ileus or may develop necrotising entero-
colitis, incarcerated inguinal herniation and midgut volvulus. Infants and preschool 
children have intussusceptions, urinary tract infections and (rare) haemolytic uremic 
syndrome. Children and adolescents have appendicitis, genito-urinary infections, 
ovarian torsion and Henoch Schonlein purpura. Considering radiation dose in chil-
dren and the excess value of ultrasonography (US) in small individuals, US plays 
an important role as initial diagnostic modality in paediatric patients with abdominal 
pain. Sensitivity and specificity for US in diagnosing intussuception, midgut volvulus, 
urinary tract abnormalities and appendicitis is over 90%. Conventional abdominal 
radiographs or fluoroscopy is valuable in Hirschsprung‘s disease, meconium ileus, 
malrotation and necrotising enterocolitis. I consider CT as an additional technique 
when the initial techniques (US and conventional radiography) are inconclusive. 
MRI is seldom indicated in paediatric patients with abdominal emergencies because 
of motion artefacts in anxious children and sometimes limited MR capacity. Delay 
in diagnosis of the above-mentioned diseases may be devastating, ranging from 
life-long disability to death. Therefore, it is important to consider these diagnoses 
and to initiate prompt adequate diagnostic work-up. 
Friday
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A‑130	 14:30 
B. Unresolving pneumonia: when and how to image, and clinical 
consequences 
K. Foster; Birmingham/UK (katharine.foster@bch.nhs.uk) 
Pneumonia is a common cause of attendance to hospital. Chest infections in 
children are usually viral and self limiting, but sometimes chest infections can be 
prolonged or repeated. There are many underlying causes for this, for example, 
congenital anatomical causes, underlying patient susceptibility, inhaled foreign 
bodies and unusual organisms. One of the more common causes seen in hospital 
is when pneumonia has become complicated by empyema. Very rarely other con-
ditions such as Kawasaki’s disease or tumours can masquerade as pneumonia. 
This session will review these conditions together with the benefits and limitations 
of plain radiography. It will also consider times when other imaging modalities such 
as CT and ultrasound can help to guide diagnosis and treatment. 
Learning Objectives:
1. To learn about the role of plain radiography.
2. To learn about the value of ultrasonography and to outline the instances 
when CT is helpful.
3. To be aware of the complications and how the radiologist can contribute to 
management.
A‑131	 15:00 
C. Common cardiac disorders in children: the basic role of imaging 
C.J. Kellenberger; Zurich/CH (christian.kellenberger@kispi.uzh.ch) 
In children, congenital heart disease (CHD) is more frequent than acquired heart 
disease. Diagnosis and subsequent management of patients with CHD relies 
heavily on different and often multiple complementary imaging modalities. Serial 
assessment of the morphology and function of the heart and thoracic vessels is 
needed at various stages of care. Although chest radiography is frequently used for 
monitoring the cardiorespiratory status and complications that may arise during clini-
cal care or intervention, it rarely provides a complete diagnosis. Echocardiography, 
as first line imaging modality, often provides all information required for diagnosis 
and follow-up, especially in small children with good acoustic windows. Contrast-
enhanced computed tomography (CT) and magnetic resonance (MR) imaging are 
valuable for detailed three-dimensional evaluation of the extracardiac vasculature 
and cardiac anatomy. In addition to being radiation free, MR has the advantage 
to provide both morphologic and functional information with the use of different 
techniques including ECG gated gradient-echo cine imaging, gadolinium-enhanced 
angiography and velocity-encoded phase-contrast imaging. A comprehensive MR 
evaluation including quantitative measurements of ventricular volumes and function 
as well as blood flow in vessels and across valves can give important information 
on long-term sequelae of the underlying cardiac defect, the significance of residual 
lesions, and potential complications of surgery. It is also valuable for planning 
and timing of future interventions. Today, CT and MR have become the next line 
of investigation when echocardiography does not provide sufficient information, 
while catheter angiography is reserved for the assessment of coronary arteries, 
measurements of pulmonary vascular resistance and interventional procedures. 
Learning Objectives:
1. To learn whether plain radiography still plays a role in diagnosis.
2. To become familiar with the technique of cardiac CT and when best to use it.
3. To learn when MRI should be used and the sequences required.
14:00 - 15:00 Room Z 
The Beauty of Basic Knowledge: Interpretation of the Chest 
Radiograph 
MC 21B 
Lobar collapse 
A‑132	 14:00 
Lobar collapse 
J. Cáceres; Barcelona/ES (josecac@gmail.com) 
It is important to recognise lobar collapse in the chest radiograph, because it is 
often caused by bronchogenic carcinoma. A hilar mass and lobar collapse are 
findings strongly suggestive of a primary tumour. The most common signs of loss 
of volume of a lobe are increased opacity of the affected lung, displacement of 
fissures, displacement of the hilum and elevation of diaphragm. Imaging findings 
vary depending of the affected lobe. 
12:15 - 12:45 Room A 
Plenary Session 
HL 1 
Josef Lissner - Honorary Lecture 
Presiding: 
Y. Menu ; Paris/FR 
A‑128	 12:15 
The chest radiograph: a perfect design 
J. Cáceres; Barcelona/ES (josecac@gmail.com) 
Over the past years, diagnostic imaging has witnessed a veritable explosion in 
the modalities available for studying patients. When applied to the study of the 
thorax, they contribute to earlier detection of abnormalities and greater diagnostic 
accuracy. Yet, the conventional radiographic examination of the chest continues to 
be the most commonly performed imaging study and, when properly interpreted, 
continues to demonstrate a wealth of information. For a correct interpretation of 
the chest radiograph, several premises should be met by the radiologist: a proper 
knowledge of the anatomy and semiology of the thorax, stressing the need for a 
lateral projection, understand the importance of reviewing previous studies and 
try to avoid unnecessary cross-sectional studies. 
Learning Objectives:
1. To understand how to re-evaluate the role of the chest radiograph in 
diagnostic imaging.
2. To review basic principles of interpretation.
3. To understand the importance of the lateral projection and of previous 
studies.
14:00 - 15:30 Room E2 
Foundation Course: Paediatric Radiology 
E³ 520 
Thoracic diseases: common, important and 
potentially devastating 
Moderator: 
C.E. de Lange; Oslo/NO 
A‑129	 14:00 
A. Investigating a child with a “cough”: a pragmatic approach 
C.M. Owens, S. Cacaci; London/UK (owensc@gosh.nhs.uk) 
This lecture will address the radiological approach to imaging children of all age 
groups presenting with cough. This is a common symptom with very diverse 
causes, from acute viral infection to complex vascular and intrinsic congenital 
tracheal anomalies and can be the presenting symptom of acute (rapidly fatal 
if not managed adequately) and chronic effects of foreign body aspiration. The 
various causes of cough vary with age and whether cough is acute, sub-acute 
or chronic. This has effects on radiological investigations deployed, and thence 
on subsequent clinical management. We will present a pragmatic approach to 
radiological investigations in this diverse set of patients, using simple algorithms 
and illustrate the more important (and often rarer) causes of cough with discussion 
around deployment of examinations that are fit for purpose using ALARA principles. 
Guidance on imaging algorithms and CT technique will be given to children with 
this important presenting symptom of myriad diverse pathological processes. The 
attendee will learn the value and optimal use of imaging with tips on optimising 
CT technique as fit for purpose. 
Learning Objectives:
1. To learn about the differential diagnoses in the very young child and in older 
children.
2. To learn which imaging modalities best help to determine the final diagnosis 
in the various age groups.
3. To understand radiation protection requirements in chest CT examinations.
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A‑135	 16:28 
Clinical examples of dual energy CT 
L.S. Guimarães; Viseu/PT (luis.s.guimaraes@gmail.com) 
Dual energy (DE) computed tomography (CT) allows the discrimination of different 
materials, which has several clinical applications. The ability to differentiate calcium 
from uric acid renal stones allows the identification of patients that will benefit from 
drugs that alkalinise urine. A musculoskeletal application of the same technique 
is in tophaceous gout, where the crystals can be differentiated from bone. Post-
processing of CT angiography images can be facilitated using DE techniques to 
identify and remove the calcium signal. Such an approach removes both bones and 
calcified plaques. “Virtual non-contrast” images can be obtained by identifying and 
removing the iodine-containing voxels of contrast-enhanced CT images, simulating 
non-contrast images and potentially eliminating the need for some non-contrast 
acquisitions, but it should be realised that small misclassifications could result in 
missing tiny caliceal tip stones, for example. DECT also allows the utilisation of 
low energies without the prejudice of unacceptable noise. Since iodine signal is 
significantly higher at low energies, disease conspicuity can be improved. This is 
particularly beneficial in the liver (for hepatocellular carcinoma identification), in the 
pancreas (for visualisation of hypo- and hypervascular lesions), and in enterography 
(to increase the identification of hyperenhancement). The approach for displaying 
the enhanced iodine signal may be one of blending information from the two ener-
gies (into a single grey-scale image), or via an iodine-only view. Further validation 
of dual energy techniques and their limitations is needed to understand the patient 
populations in which such techniques can be utilised and where conclusions based 
on dual energy data can be trusted. 
Learning Objectives:
1. To learn about the clinical applications of dual energy CT imaging.
2. To learn about the value of clinical applications in diagnosis.
3. To better understand the clinical situations where dual energy CT should be 
used.
A‑136	 16:51 
CT contrast perfusion 
K.A. Miles1, V.J. Goh2; 1Brighton/UK, 2Northwood/UK 
(gohmcglone@hotmail.com) 
CT perfusion imaging is a quantitative technique that employs rapid sequences of 
CT images after bolus administration of intravenous contrast material to measure 
a range of physiological processes related to the microvasculature of tissues. CT 
perfusion parameters can provide surrogates for tissue hypoxia as well as the 
physiological processes such as vasodilatation that represent vascular responses 
to hypoxia. Although the basic techniques for DCE-CT have been available for 
decades, more recently a range of technological advances have contributed to the 
greater applicability of perfusion CT in the clinical environment including wider CT 
detectors, shorter gantry rotation times, ‘table-toggling’, radiation dose reduction and 
software corrections for image mis-registration due to respiratory or other patient 
motion. Consensus guidelines are now available for the acquisition and processing 
of CT perfusion studies for the brain and body. To date, the main applications of 
CT perfusion imaging in stroke have been the confirmation of stroke diagnosis and 
extent, identification of penumbra and selection of patients for thrombolysis. The 
main applications in oncology have been in lesion characterisation, risk-stratification 
and assessment of treatment response. 
Learning Objectives:
1. To learn about how CT contrast perfusion is performed technically.
2. To better understand the clinical data the perfusion provides.
3. To have a good understanding of the most important applications of CT 
perfusion.
Panel discussion: 
Will CT surprise us again? 17:14
What clinical situations benefit from dual energy or contrast perfusion imaging? 
Can contrast perfusion imaging benefit from dual energy techniques? 
What are the three most important clinical applications of DE and CT perfusion 
imaging? 
Learning Objectives:
1. To learn the signs that identify lobar collapse.
2. To learn specific signs applied to different lobes.
3. To understand the significance of lobar collapse in the adult.
16:00 - 17:30 Room A 
New Horizons Session 
NH 6 
Not just Hounsfield numbers: CT aimed at the fifth 
dimension? 
Moderator: 
J.M. Boone; Sacramento, CA/US 
A‑133	 16:00 
Chairman’s introduction 
J.M. Boone; Sacramento, CA/US (jmboone@ucdavis.edu) 
Computed tomography (CT) systems have provided three-dimensional (x, y, z) data 
since their clinical introduction in the 1970s. This session will address the extension 
of CT imaging into the fourth and fifth dimensions. The rapid acquisition capabilities 
of modern CT scanners open the door to the fourth dimension - time - where a 
time-course CT scan can provide clinical information about blood flow, perfusion 
and other physiological measures regarding organ function. The door to the fifth 
dimension - energy - is opened by dual energy image acquisition techniques, which 
are made possible by dual source CT scanners or rapidly switching x-ray source 
CT scanners. Dual energy CT images can be manipulated to provide quantitative 
information with regard to the elemental composition of tissues, which, in turn, 
can be used to differentiate between bone and iodine contrast, with many other 
applications possible as well. Modern CT scanners now provide multidimensional 
data sets characterised as I (x, y, z, t, E), and the additional information provided 
by these five-dimensional data sets provide genuinely useful clinical information 
which add to the diagnostic potential of computed tomography. 
Session Objectives:
1. To learn about CT capabilities beyond just imaging.
2. To better understand dual energy CT capabilities.
3. To better understand the potential of CT perfusion.
A‑134	 16:05 
Basic principles of dual energy CT 
W.A. Kalender; Erlangen/DE (willi.kalender@imp.uni‑erlangen.de) 
X-ray computed tomography (CT) usually measures the attenuation of the patient 
or object cross-section in question at a fixed chosen voltage value; the result is 
presented as the linear attenuation coefficient µ expressed in Hounsfield units 
(HU). Dual energy CT (DECT) acquires data at two different mean energies and 
evaluates the differences in attenuation. Dual energy CT imaging has been a topic 
since the 1970s. The acquisition modes have changed over the years from two 
separate scans at different voltages to single scans with rapid kV-switching, and 
dual source CT operating with different voltages and pre-filtrations. These concepts 
will be explained in detail including future options of energy-discriminating detec-
tors. The basic physics principles remain the same for all acquisition schemes. 
The two independent measurements allow separating two tissue characteristics 
contributing to attenuation. For example, low and high effective atomic number 
material densities can be determined in the so-called basis material decomposition. 
Arbitrary combinations such as monoenergetic or electron density and effective 
atomic number images can then be provided. These will be illustrated and explained 
by examples such as differentiation between plaque and contrast agent or virtual 
unenhanced abdominal organ imaging. DECT meanwhile offers quite a number of 
accepted clinical applications which will be covered in a separate talk. 
Learning Objectives:
1. To learn the basic principles of dual energy imaging.
2. To learn the acquisition modes of dual energy imaging in CT.
3. To better understand the dose consequences of dual energy CT.
Friday
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ous lesions (adenomas) and curable early-stage cancer, screening for CRC has 
high potential for reducing incidence and mortality of the disease. Nevertheless, 
the benefit of population-based CRC screening needs to be weighed against 
potential risks, psychological distress and required resources since only a minor-
ity of the population develops the disease and may thus benefit from screening. 
Several industrialised countries offer faecal occult blood testing as a primary 
screening tool, with positive test results being followed up by colonoscopy. Some 
countries, such as the United States and Germany, also offer colonoscopy as a 
primary screening tool. While the results of randomised controlled trials regarding 
screening colonoscopy are still outstanding, there is evidence from observational 
studies that support its effectiveness in population-based CRC screening. Recent 
evidence suggests that colonoscopy, when performed in the community setting, 
is more effective in protecting from neoplasms in the left colon and rectum than 
in the right colon. Decision-analytic models support the (cost)-effectiveness of 
screening colonoscopy but results vary, among others, according to compliance, 
(country-specific) cost estimates and screening schedules. 
Learning Objectives:
1. To learn about the incidence and prevalence of colorectal cancer and its 
precursors in the target population of screening.
2. To understand the rationale for colorectal cancer screening.
3. To become familiar with estimated (cost) effectiveness of colorectal cancer 
screening when using optical colonoscopy as a primary screening tool.
A‑140	 16:23 
Facts from the statistician (true for once?): how accurate is CT 
colonography 
A. Laghi; Latina/IT (andrea.laghi@uniroma1.it) 
The issue of diagnostic accuracy of CTC for CRC and polyps has been debated 
for a long time, because of the conflicting results published in the literature. Those 
results led researchers to design three important studies: two large, multicenter 
trials testing the performance of CTC in comparison with CC in asymptomatic 
individuals (ACRIN and IMPACT) and one randomised, double-arm trial (SIGGAR) 
conducted on symptomatic patients with the aim to detect CRC. Both the ACRIN 
and IMPACT reported per-patient sensitivity of 90% for polyps > 10 mm and 78-84% 
for polyps larger than 6 mm; per-patient specificity was extremely high, over 85%, 
independent of lesion size. The major drawback of the ACRIN was represented 
by the poor positive predictive value (PPV) (23% for polyps ≥10 mm); a definitely 
better PPV was documented in the IMPACT trial (62% for lesions larger than 6 mm) 
as well as in studies obtained in high-experienced centers. However, the negative 
predictive value in both the ACRIN and the IMPACT was rather high, approaching 
100%; this is extremely important in order to reassure negative patients about the 
significance of the examination. Excellent results were also obtained in the Munich 
Colorectal Cancer Prevention Trial, a single-center study where around 300 as-
ymptomatic subjects underwent low-dose CTC in comparison with other screening 
tests (CC, sigmoidoscopy and FOBT). Despite the good results there are still some 
open issues: the significance of diminutive (< 6 mm) polyps, the management of 
intermediate (6-9 mm) lesions and the detection rate for non-polypoid, flat lesions. 
Learning Objectives:
1. To learn data from meta-analysis on VC accuracy.
2. To become familiar with the results of recent multi-centre trials.
3. To understand the performances of VC on the identification of small polyps 
and non-polypoid lesions.
A‑141	 16:41 
When optical beats virtual 
J.F. Riemann; Ludwigshafen/DE (riemannj@garps.de) 
Optical colonoscopy is the gold standard in detecting and removing precancerous 
lesions and early colon and rectal cancer. Sensitivity and specificity of the pro-
cedure are over 95% up to 100%. The new HD-TV colonoscopes with additional 
virtual chromoendoscopic techniques such as NBI, FICE or iSCAN significantly 
have improved the precise diagnosis prior to histology. These improvements not 
only enable the gastroenterologist to completely excise lesions with sophisticated 
new resection techniques (EMR, ESR) but also let him predict the final pathology 
according to internationally accepted classifications (i.e. Kudo´s classification for 
polyps). Limitations of optical colonoscopy are due to “blind” regions of the colon 
(both flexures), poor bowel cleansing and unexperienced examiners. Withdrawal 
time and adenoma detection rates are further quality markers for a sufficient 
colonoscopy. The acceptance rate of the screening colonoscopy is limited due 
to several reasons one of the most important being the opportunistic way of the 
invitation. Interval cancers play an important role if one ore more of the described 
quality parameters fail. Further technical improvements like broadening of the field 
16:00 - 17:30 Room B 
Interactive Teaching Session 
E³ 620a 
Cancer of the uterus and cervix: what the 
radiologist must report 
A‑137	 16:00 
Cancer of the uterus and cervix: what the radiologist must report 
B. Hamm1, H. Hricak2; 1Berlin/DE, 2New York, NY/US (bernd.hamm@charite.de) 
MR imaging is the method of choice for staging uterine malignancies. The main 
criterion for local staging of endometrial cancer is the depth of myometrial invasion. 
Diagnostic accuracy can be improved by performing a dynamic contrast-enhanced 
study in addition to T2-weighted imaging. Staging of cervical cancer is based on 
high-spatial-resolution axial and sagittal T2-weighted imaging, on which invasion 
of the parametrium can be assessed with a high degree of accuracy. Especially for 
cervical cancer, MR imaging can replace numerous other diagnostic tests and allow 
more accurate pre-treatment staging while reducing costs. In addition, MR imaging 
is used in planning radiotherapy and in post-radiotherapy follow-up. Lymph node 
staging on MR lymphography remains unreliable and may potentially be improved 
by the addition of diffusion-weighted imaging. 
Learning Objectives:
1. To become familiar with imaging features in staging cervical and uterine 
cancer.
2. To understand the impact of imaging on modern patient treatment.
3. To understand the imaging findings on follow-up.
16:00 - 17:30 Room C 
ESR meets Gastroenterologists 
EM 2 
Optical and virtual colonography: friends or 
enemies? 
Presiding:
R. Hultcrantz; Stockholm/SE 
Y. Menu; Paris/FR 
A‑138	 16:00 
Chairmen’s introduction 
R. Hultcrantz1, Y. Menu2; 1Stockholm/SE, 2Paris/FR (Rolf.Hultcrantz@ki.se) 
Colonoscopy is a very useful and important method to examine the colon. In recent 
years virtual colonoscopy has become a popular alternative to optical colonoscopy. 
Disorder of the colon includes colorectal cancer, which is one of the most common 
cancers worldwide and presents a threat to life since the mortality is almost 50%. 
Colorectal cancer screening has been shown to be an efficient method to find early 
forms of colorectal cancer and also to reduce mortality in this disease. In this ses-
sion we will discuss the various methods used to examine the colon, how useful 
they are and the economy behind using them.
Session Objectives:
1. To understand the respective roles of OC and VC in colorectal diseases.
2. To become familiar with technical innovations and new diagnostic 
opportunities offered by OC.
3. To understand the clinical value of VC.
A‑139	 16:05 
Facts from the statistician (true for once?): incidence, prevalence, 
rationale for screening, standard results of optical colonoscopy 
U. Haug; Heidelberg/DE (u.haug@Dkfz‑Heidelberg.de) 
Facts from the epidemiologist: Incidence, prevalence, rationale for screening, 
standard results of optical colonoscopy. Colorectal cancer (CRC) is the third most 
common cancer in the world, with about 1 million new cases and more than 500.000 
deaths per year. Incidence of CRC strongly increases by age and is higher in men 
than in women. The lifetime risk differs between countries and is about 7% in the 
United States. Because most cases of CRC develop from removable precancer-
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stabilisation complex system a dual echo T2/DP sequence could be performed in 
a sagittal-oblique plane drawing an imaginary line which on an axial image used as 
reference plane, is done perpendicular to popliteous tendon. Gradient echo (GE) 
sequences are useful in cartilage and traumatic pathology. T2-weighted sequences 
understimate cartilage thickness since cortex and cartilage have the same signal. 
PD sequences may have the similar signal for cartilage and adjacent joint fluid, 
obscuring defects; fat suppression solves this. If available, acquisitions performed 
in orthostatism could give further information in the assessment of meniscal and 
patello-femural pathology. 
Learning Objectives:
1. To understand the influences of patient positioning, scan parameters and 
magnet/coil technology on image quality.
2. To learn how to optimise scan protocols to maximise patient throughput 
without compromising diagnostic quality.
3. To recognise how and when to modify scan protocols to answer specific 
clinical questions.
A‑144	 16:25 
B. Normal variants and pitfalls 
S.J. Eustace; Dublin/IE (seustace@iol.ie) 
This talk will review appearances of normal anatomic variants identified at MRI 
of the knee including discoid meniscus, transverse meniscal ligaments meniscal 
flounce, ossicles, and pseudotears. Subsequently the talk will focus on diagnostic 
pitfalls reflecting both imaging technique and variations in anatomy such as the 
effect of motion, imaging plane and anatomic variations in patella shape. 
Learning Objectives:
1. To become familiar with the normal anatomy.
2. To be able to identify normal variants.
3. To appreciate the range of pitfalls that may simulate pathology.
A‑145	 16:50 
C. Identifying and reporting abnormal findings 
M. Maas; Amsterdam/NL (m.maas@amc.uva.nl) 
MRI of the knee is one of the most frequent performed investigations, thus indicating 
that common abnormalities need to be familiar to the general radiologist. A simple 
and straightforward method of enabling assessment of clinically relevant anatomical 
entities is based upon a (pre)structured radiology report. Use of speech recognition 
facilitates implementation of pre-structured reporting in a KISS manner. Since one 
now is enabled to structure the report, using digital tools, terminology used should 
be discussed between the reporting radiology department and the clinical partners. 
It is mandatory that the important message, the clinical relevance of the information 
that radiologists put in their report, is understood by the referring clinician in the 
same manner as it was meant to be. We should consider the background of our 
referring physician, and tailor our report, both in chosen terminology as well as 
detailed information. When working in a centre in which both specialised orthopaedic 
surgeons as well as general practitioners (GPs) or sports physicians are referring 
for MRI, each of the three needs a tailored report, especially considering advise 
for secondary referral: GPs and sports physicians will need different approach, 
compared to medical specialists. Also, the knowledge of terminology used should 
be considered. The presentation focuses on common encountered pathologies, 
considering common abnormalities. Emphasis is given to common abnormalities, 
and pitfalls that should be dealt with. Some sports specific entities are discussed. 
Implication of clinical correlation is stressed. The presentation will include case-
based clinical illustrations. 
Learning Objectives:
1. To review the imaging appearances of common abnormalities.
2. To understand the use of terminology to describe pathological findings.
3. To learn how to structure a radiological report to ensure clarity and brevity.
of view and the “Third Eye” colonoscope are under investigation. At the moment, 
however, the combination of both, exact diagnostic and sufficient therapeutic action 
at the same time, is the reason why optical beats virtual in this particular indication. 
Learning Objectives:
1. To learn about the precise diagnostic and therapeutic options concerning 
early colorectal cancer and its precursor lesions.
2. To understand the technical progress of the newest generation of 
colonoscopes.
3. To become familiar with the few limitations of the procedure.
4. To consolidate knowledge of the most important diseases of the large bowel.
A‑142	 16:59 
When virtual beats optical 
S.A. Taylor; London/UK (csytaylor@yahoo.co.uk) 
Since its evolution CT colonography has been advocated as a safe well tolerated 
alternative to colonoscopy, particularly in the context of colorectal cancer screening. 
Notably perforation rates are lower than those of colonoscopy and cardiovascular 
effects are less. However, patient preference studies have produced mixed results 
and it is not clear if standard CTC will increase compliance with screening. Fur-
thermore, issues over apparent inferior sensitivity for polyp detection compared to 
colonoscopy, need for prolonged radiologist education and radiation dose exposure 
have been cited as barriers to widespread implementation in a screening context. 
Technical developments in recent years are beginning to address these issues. 
Use of reduced laxative regimes supplemented with faecal tagging have shown 
good results with superior patient acceptability. Software developments have also 
speeded up dataset analysis -notably panoramic or “virtual pathology” 3D views 
reducing or eliminating hidden areas within the colon. Furthermore, computer-aided 
detection software is increasingly fit for purpose and good data show a positive ef-
fect on radiologist performance both in the research setting and day to day clinical 
practice. This presentation will review the data on patient preference and safety 
and highlight developments in those areas in which CTC holds advantages over 
conventional endoscopic techniques. Discussion will focus not only on colon cancer 
screening but also the on data supporting CTC in older symptomatic patients who 
are at higher risk of adverse events during colonoscopy. 
Learning Objectives:
1. To review the patient safety of CT colonography and conventional 
colonoscopy.
2. To review advanced computer techniques for maximising visualisation of 
the colon during CT colongraphy including 3D visualisation methods and 
computer aided detection.
3. To review the data on CT performance with particular emphasis on patient-
friendly reduced laxative regimens.
4. To consider patient preference data.
Panel discussion: 
Integrated strategy? What about the outsiders (capsule, DNA, PET, …) 17:17 
16:00 - 17:30 Room D1 
KISS (Keep It Simple and Straightforward): Musculoskeletal MRI 
CC 616 
The knee 
Moderator: 
J. Labuscagne; Bunbury, WA/AU 
A‑143	 16:00 
A. How I do it 
A. Barile; L’Aquila/IT (antonio.barile@cc.univaq.it) 
MRI of the knee has to be performed with patient in supine position with knee in 
semiflexion (15-20°). The use of a dedicated coil is mandatory. Standard exam 
include: (a) spin echo (SE) T1 or proton density (PD)-weighted sequence in 
sagittal plane to evaluate menisci and cruciate ligaments; (b) SE T1-weighted 
sequence in coronal plane to evaluate marrow and anatomy; (c) dual-echo T2/
DP in axial plane to evaluate lateral and medial supporting structures, patella and 
the location of fluid collections; (d) a fat-suppressed sequence short tau inversion 
recovery (STIR) or fast spin echo (FSE) T2-weighted in a coronal plane to easily 
detect marrow oedema. For the evaluation of anterior cruciate ligament (ACL) a 
PD sequence with or without fat saturation could be performed in a sagittal-oblique 
plane parallel to the orientation of ACL. For the evaluation of the postero-lateral 
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requires chest tube drain in less than 10% of cases. Sustained complete tumour 
response has been reported in about 85-90% of the target lesions; lesion size 
represents the most important risk factor for tumour local recurrence. Data regard-
ing long-term survival are now being published, reporting promising outcomes. 
According to the RAPTURE study, the 2-year cancer-specific survival was 73% 
in patients with NSCLC, 68% in patients with colorectal metastases, and 67% in 
patients with other metastases, with corresponding overall survival rates of 48%, 
66% and 64%, respectively. The use of RFA in combination with systemic chemo-
therapy for lung metastasis is now under investigation. Initial results report about 
30% 5-year survival rate in patients with colorectal metastasis. The association 
between RFA and radiotherapy should also be considered in selected patients. 
Learning Objectives:
1. To learn about indications and patient selection.
2. To understand the technique and complications.
3. To review the results of RF ablation to date.
16:00 - 17:30 Room E1 
Musculoskeletal 
RC 610 
Metabolic bone diseases 
Moderator: 
J. Freyschmidt; Bremen/DE 
A‑149	 16:00 
A. Metabolic bone disease for the practicing radiologist 
M. Sundaram; Cleveland, OH/US (sundarm@ccf.org) 
Osteoporosis, osteomalacia, hyperparathyroidism and Paget’s disease have con-
ventionally been considered the disease entities that comprise metabolic bone dis-
ease. The lecture will follow this convention and discuss the imaging characteristics 
that suggest osteoporosis in the elderly or anorexia nervosa in younger patients by 
the distribution of fractures and marrow changes as well as the role of bone mineral 
density evaluations in osteoporosis. Oncogenic osteomalacia will be discussed in 
the context of appropriate imaging for detecting the tumour and emphasise the 
basic biochemical abnormality that most radiologists should be familiar with that 
leads to the diagnosis. Radiologists most frequently encounter hyperparathyroid-
ism in renal osteodystrophy with over a million patients worldwide kept alive by 
dialysis. Dialysis-induced imaging changes such as amyloid and the spectrum of 
findings from long-term dialysis will be shown and demonstrated. Paget’s disease 
is on the decline. Its distinctive MRI signal characteristics in uncomplicated cases, 
in contrary to most bone lesions encountered in clinical practice, will be explained. 
Learning Objectives:
1. To get an overview of the entities that are considered in the realm of 
metabolic bone disease.
2. To understand common, less common and rare findings.
3. To learn about some imaging findings that occur as a consequence of 
treatment.
A‑150	 16:30 
B. Latest advance in osteoporosis 
C.R. Krestan; Vienna/AT (christian.krestan@meduniwien.ac.at) 
Osteoporosis is of great socioeconomic impact, as approximately 30% of all 
postmenopausal women have osteoporosis in developed countries. Ageing of 
populations worldwide will be responsible for a major increase of the incidence 
of osteoporosis in postmenopausal women. In 1994, the WHO Working Group 
defined osteoporosis according to measurements of bone mineral density (BMD) 
using dual energy x-ray absorptiometry (DXA) as a bone density T score at or 
below 2.5 standard deviations (T score) below normal peak values for young 
adults. The relative risk of a fracture is between 1.3 and 1.6 for each unit decline 
in spine or total hip T score. Due to limitations of the T-score concept a 10-year 
risk calculating tool has been developed by the WHO to determine intervention 
thresholds. Fragility fractures are, however, not only related to bone mineral density 
(BMD). Trabecular bone microarchitecture is a significant determinant of the bone’s 
mechanical properties and is thus of major clinical relevance in predicting fracture 
risk. Trabecular bone structure analysis can be based on images from multide-
tector computed tomography, high-resolution peripheral computed tomography, 
highresolution MRI and projection radiography. Advantages and disadvantages 
of the different methods depend on radiation, costs, availability and a reasonable 
time for in vivo scanning. Grading of vertebral fractures can be done using a visual 
16:00 - 17:30 Room D2 
Interventional Radiology 
RC 609 
RF ablation beyond the liver 
Moderator: 
A. Adam; London/UK 
A‑146	 16:00 
A. RF ablation in bone 
A.D. Kelekis; Athens/GR (akelekis@med.uoa.gr) 
The purpose of this refresher course is to demonstrate bone ablation. The main 
aim of thermal tumour ablation is to destroy the tumour using ionic movement to 
kill the malignant cells without damaging adjacent vital structures. Multiple sources 
of energy have been used to induce cell death. RF energy is an electromagnetic 
one. Radio waves emanate from the non-insulated distal portion of the electrode. 
Heat is produced by resistive forces (i.e., ionic agitation) surrounding the electrode 
as the radio waves attempt to find their ground. Other type of ablations (using dif-
ferent wave lengths) include microwave, electoporosis, laser and radiofrequency 
ablation is still seeking its place among bone interventional techniques. This 
presentation is an overview, in an area of non-vascular interventions in the spine 
and the appendicular skeleton. It will explain the patient selection, indication and 
possible approaches to a bone lesion. Available material will be discussed, as 
well as possible combinations of them in order to yield maximum results, while 
reducing possible drawbacks. 
Learning Objectives:
1. To learn about indications, patient selection and preprocedural imaging.
2. To understand the technique.
3. To review the results and complications.
A‑147	 16:30 
B. RF ablation in the kidney 
M.A. Farrell; Waterford/IE (michaela.farrell@hse.ie) 
Over the last two decades, open nephron sparing surgery has become the pre-
ferred surgical alternative to nephrectomy for treatment of patients with a single, 
small (< 5 cm) localised renal mass and a normal contralateral kidney. Because 
25-49% of newly diagnosed small renal masses are identified incidentally on cross-
sectional imaging, often in elderly patients, less invasive surgical nephron sparing 
alternatives have been advocated, including laproscopic partial nephrectomy and 
laproscopic cryoablation, for select tumours in an effort to reduce surgical mortality 
and morbidity while preserving renal function. Percutaneous image-guided abla-
tion offers potential advantages over surgical methods including the minimally 
invasive nature of the procedure, less mortality and morbidity than surgery, shorter 
hospital stay, and quicker recovery. Local tumour control rates of up to 95% have 
been reported for small tumours. Central tumours and tumours greater than 3 cm 
in diameter are more difficult to successfully treat with local tumour progression 
occurring 25% of central tumours. Tumours larger than 3 cm in diameter typically 
require overlapping ablations and incomplete treatment can result from residual 
tumour at the ablation interfaces. While in some reports, local tumour progression 
occurred in up to 20% of tumours larger than 3 cm, in contrast, others have shown 
that all exophytic tumours, despite their size, can successfully be treated using 
multiple overlapping ablations and complete treatment may require more than one 
ablation session. The most clinically relevant and potentially avoidable complica-
tion is ureteral injury with resultant obstruction of the intrarenal collecting system. 
Learning Objectives:
1. To learn about indications and patient selection.
2. To become familiar with currently available therapeutic alternatives.
3. To review the results of RF ablation compared with other treatments.
A‑148	 17:00 
C. RF ablation in the chest 
I. Bargellini; Pisa/IT (irenebargellini@hotmail.com) 
Percutaneous image-guided radiofrequency ablation (RFA) represents as a safe 
and effective minimally invasive procedure in selected patients with unresectable or 
medically inoperable lung malignancies. When adequately performed, in selected 
patients, the procedure is associated with over 95% immediate technical success 
rate and relatively low incidence of major (8-15%) and minor complications (20-
40%). Pneumothorax represents the most frequent complication (up to 60%) but 
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presentation, the worse the outcome in adulthood. AVN is a significant complica-
tion. CT/MR assists orthopaedic planning. Imaging strategy: plain radiographs. 
Small children localise pain poorly. Whole limb radiographs may be needed. US 
detects hip effusions but cannot differentiate pus from effusion. Nuclear medicine 
may need sedation for scanning phase. A full bladder may obscure the pelvis. 
MR is sensitive for soft tissue pathology and marrow disease included in the area 
imaged. Radiographs are needed before MR, which is insensitive for bone detail. 
Other causes: spinal problems - discitis, avulsions of muscle origins, trauma - tod-
dler's fracture, diffuse bone disease, localised bone disease; blind areas: spine, 
pelvis/sacroiliac joints. 
Learning Objectives:
1. To learn about the imaging approach to the child with suspected 
developmental hip dysplasia.
2. To become familiar with the differential diagnosis in the older child with a limp.
3. To learn which imaging modalities best help to arrive at a diagnosis.
A‑153	 16:30 
B. Non-accidental injury: a radiologist’s nightmare 
P.K. Kleinman; Boston, MA/US (Paul.Kleinman@childrens.harvard.edu) 
Skeletal injuries are the most common findings noted on imaging studies in cases 
of child abuse. In infants, certain lesions, such as the classic metaphyseal lesion 
and posteromedial rib fractures are sufficiently characteristic to point strongly to 
the diagnosis of inflicted trauma. Other fractures are less specific for abuse, but 
when correlated with other imaging findings and clinical information, their pres-
ence may add strong support for the diagnosis. Many of the most specific injuries 
produce subtle radiographic alterations, and meticulous technique, adhering to a 
strict imaging protocol, is vital in providing optimal detection of the fractures. In 
recent years, increasing attention has been given to those conditions that may 
simulate inflicted injury. A variety of normal variants, naturally occurring diseases 
and accidental injuries may be confused with the findings of child abuse. Other 
conditions, real or hypothetical, may be suggested by consultants in medico-legal 
proceedings. To be credible, a witness must be prepared to counter reckless and 
irresponsible testimony given by uninformed or biased medical „experts“. To ensure 
that investigators and finders of fact are provided with testimony that is clear, con-
cise and accurate, the radiologist must be fully informed and prepared to address 
the radiologic alterations and their significance to a reasonable medical certainty. 
Learning Objectives:
1. To learn in detail the investigation of a child with suspected non-accidental 
injury.
2. To learn about the typical skeletal injuries seen on plain radiography and the 
differential diagnosis.
3. To understand when further imaging is required and which imaging modality 
is best.
A‑154	 17:00 
C. Bone and joint infection and inflammation: pearls and pitfalls 
M. Alison, B. Tilea, R. Azoulay, G.-H. Sebag; Paris/FR 
(guy.sebag@rdb.ap‑hop‑paris.fr) 
Acute osteomyelitis and septic arthritis are diagnostic and therapeutic emergency 
in children. Diagnosis remains challenging because of their variable expression 
(acute, subacute, chronic stages, causative agents and hosts). Imaging strategy 
relies on a multimodality approach including radiographs and ultrasonography as 
first line examinations with a complementary role for bone scintigraphy and MRI. 
MRI is especially useful for misleading challenging presentations (such as axial 
skeleton, pelvis and calcaneus osteomyelitis) and for detection of reversible os-
teocartilaginous ischaemia requiring urgent surgical drainage. Juvenile idiopathic 
arthritis (JIA) is an heterogeneous group of chronic inflammatory disorders that are 
classified on their mode of onset (systematic, pauci and polyarticular diseases). It is 
a diagnosis of exclusion and imaging plays a major role in the differential diagnosis. 
Radiographic scoring systems of JIA are different from adult scoring systems with 
less emphasis on joint space narrowing. Doppler-ultrasonography and MRI play an 
increasing role in a the assessment of disease activity and response to treatment. 
Learning Objectives:
1. To learn about the imaging approach to a child with suspected osteomyelitis 
and septic arthritis and to outline the classical features.
2. To learn how best to investigate a child with suspected arthropathy and the 
specific findings.
3. To understand the differential diagnoses of bone and joint infections.
semiquantitative scoring method. Vertebral morphometry is based on radiographs 
or scans from DXA-machines calculating ratios of vertebral heights with normal 
values to identify vertebral fractures. 
Learning Objectives:
1. To become familiar with what the radiologist ought to know about the WHO 
definition of osteoporosis and vertebral fracture risk.
2. To understand the standard techniques and newer diagnostic techniques 
that provide insights into the structure of trabecular bone.
3. To analyse the pros and cons of these techniques.
4. To describe methods of grading and quantitative morphometric assessment.
A‑151	 17:00 
C. Rickets, osteomalacia, hyperparathyroidism and renal osteodystrophy 
J.E. Adams; Manchester/UK (judith.adams@manchester.ac.uk) 
Diagnostic imaging features of rickets relate to defective osteoid mineralisation & 
include widened growth plates, splayed/poorly mineralised metaphyses (rachitic 
rosary) with bone softening (tri-radiate pelvis, deformity of long bones [bow legs, 
knock knees, varus/valgus deformity femoral neck]). In adults diagnostic feature 
is Looser’s zone (linear radiolucency, perpendicular to cortex, sclerotic margins), 
which occur most commonly: medial femoral neck, pubic rami, lateral scapular 
borders & ribs. If cause of rickets/osteomalcia is vitamin D deficiency (nutritional, 
lack of sunlight, malabsorption, chronic liver/renal disease) or low calcium intake, 
low serum calcium stimulates secondary hyperparathyroidism (2HPT)(check for 
sub periosteal cortical erosions lateral margins middle phalanges 2nd & 3rd fingers). 
Other causes (hypophophosphataemia, ‘oncogenic’, low alkaline phosphatase 
[hypophosphatasia] and severe acidosis) will not have 2HPT. Primary HPT (third 
most common endocrine disorder after thyroid disease & diabetes): 80% due to 
PTH adenoma, 15% to genetically-determined multiple endocrine abnormalities 
[MEA] syndromes & 5% PTH carcinoma. Imaging features include bone cysts 
[brown ‘tumours’], chondrocalcinosis, nephrocalcinosis, renal calculi & superiosteal 
erosions. As diagnosis often made on raised serum calcium with asymptomatic/
mild disease there may not be any diagnostic imaging features present. Chronic 
kidney disease (CKD) results in azotaemic osteodystrophy (AZO), a complex 
bone disorder. The active metabolite 1.25 (OH)2 vitamin D is not formed in kidney 
so serum calcium falls; this stimulates 2HPT. Phosphate is retained & calcium x 
phosphate ratio raised, resulting in metastatic calcification in arteries & soft tis-
sues, often related to bursae adjacent to large joints. There may be bone sclerosis 
(‘rugger jersey spine’) or osteopenia. 
Learning Objectives:
1. To recognise the imaging features of rickets, osteomalacia, 
hyperparathyroidism and renal osteodystrophy.
2. To learn the various causes of vitamin D deficiency and other disorders that 
result in rickets and osteomalacia.
3. To appreciate the role of imaging in renal osteodystrophy.
16:00 - 17:30 Room E2 
Foundation Course: Paediatric Radiology 
E³ 620b 
Common musculoskeletal disorders: how to avoid 
the traps! 
Moderator: 
A.C. Offiah; Sheffield/UK 
A‑152	 16:00 
A. Imaging a child with a limp 
A. Sprigg; Sheffield/UK (alan.sprigg@sch.nhs.uk) 
Limping is due to many causes. Clinical assessment determines imaging strategy. 
Sepsis and obscured trauma are easily missed, later presenting hip dislocation 
< 3years. Despite clinical diagnosis and neonatal US scanning some children 
present late with a limp (Trendelenburg gait). Do not be reassured by a 'normal' 
neonatal US report. Plain radiographs are the best modality. Arthrogram and CT 
assist surgical management of late presenting DDH. AVN - Perthes aged 3-11. Initial 
radiographs may be normal. Best diagnostic film - frog view both hips. Nuclear 
medicine or MR help detect early cases. Management aims to keep the femoral 
head covered by the acetabulum. Slipped capital femoral epiphysis age > 11 yrs. 
Clinical misdiagnosis is common - referred pain between hip and knee. Early signs 
of SCFE are subtle on a true AP view - a frog view is best. The greater the slip at 
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great need for early, accurate and reliable imaging indicators of tumour response 
to anti-angiogenic drugs which is ultimately defined by overall survival rate, but is 
mostly based on changes in number and size of measurable tumour “targets”, i.e. 
blood vessels. Thanks to its characteristics of high temporal and spatial resolution in 
limited fields and lack of ionising radiation and side effects (i.e. easy repeatability), 
contrast-enhanced US (CEUS) is currently the simplest and also most reliable imaging 
modality for detection, analysis and quantification of intratumoural macro- and micro-
vascularity (up to 40 μm in diameter). Even minimal changes can be easily detected 
and quantified with CEUS during anti-angiogenic treatments: early disappearance 
(or severe reduction) of tumoural vascularisation is highly predictive of complete (or 
significant) response even before tumour volume decreases. Initial clinical studies 
were conducted on hypervascular hepatic metastases (e.g. metastases from GISTs), 
but recently also hypovascular hepatic metastases and primary cancers of differ-
ent organs are being assessed. For the quantitative analysis of tumour vascularity 
changes several parameters (peak intensity, time-to-peak intensity, area under the 
curve, etc). are currently being investigated and specific perfusion software connected 
to working stations are being developed and clinically tested. 
Learning Objectives:
1. To know the advantages of DCE-US.
2. To learn how to extract the parameters on true cases.
3. To learn useful tricks for performing and processing good quality 
examinations.
16:00 - 17:30 Room F2 
Breast 
RC 602 
Breast MRI today 
Moderator: 
W.A. Kaiser; Jena/DE 
A‑158	 16:00 
Chairman’s introduction 
W.A. Kaiser; Jena/DE (Werner.Kaiser@med.uni‑jena.de) 
The clinical application of MR-mammography (MRM) in the last 26 years has 
shown that this imaging tool has had significant diagnostic advantages in the 
field of breast diagnosis, e.g. the proof of small breast cancers, the differentiation 
between scar and recurrent tumours, the detection of multifocality/multicentricity, 
the search for primary tumours, the delineation of implants, etc. The clinical use 
of MR-mammography is steadily increasing. However, many still describe a “high 
sensitivity but a low specificity”, which is wrong. Achieving a high quality is not an 
easy task; a lot of teachers have to be learned and considered. This refresher 
course is focussing on high quality concerning technical and diagnostic aspects, 
especially focussing the question of improving specificity. 
A‑159	 16:05 
A. How to set up a high quality breast MRI unit 
C.S. Balleyguier, S. Canale, E. Zareski, F. Bidault, B. Boulet, S. Delaloge, 
G. Aboud, B. Boyer, C. Dromain; Villejuif/FR (balleyguier@igr.fr) 
Breast MRI has become a key examination in the strategy of breast imaging. 
The input of breast MRI is its great sensitivity to detect breast malignant tumours, 
nevertheless false positives are still common. Quality of acquisition parameters is 
mandatory to obtain high quality images and to avoid artifacts. The key points are as 
follows: 1. Indications for the examinations should be precisely defined i.e. staging 
of known cancer, screening of high risk patients, etc. Training of the officers who 
organize appointments is of utmost importance. 2. Appropriate patient positioning. 
Many pitfalls are related to inappropriate basic technique; training for technicians 
is mandatory. 3. Reliable protocol includes examination of both breasts with T1w 
and T2w sequences with and or without fat suppression, dynamic acquisition after 
contrast injection should provide as the best compromise between spatial and 
temporal resolution. The role of new sequences such diffusion-weighted imaging 
sequences has to be defined. 4. Standardisation of image interpretation should be 
homogenously shared within the imaging team. Reports should be established ac-
cording to the BI-RADS principles. The role of CAD should be precisely defined as 
an adjunct and not as a substitute to expert reading. 5. Quality control includes the 
combination of technical checking: double reading and cooperation with clinicians 
in order to provide an adequate number of radiologic and pathologic correlation. 
Because breast MRI is a continuous process, all the key points should be concur-
rently optimized. Any failure would jeopardize the whole procedure. 
16:00 - 17:30 Room F1 
Functional Imaging of Tumours: How to do it 
MC 622 
Dynamic contrast-enhanced (DCE) imaging 
Moderator: 
A. Ba‑Ssalamah; Vienna/AT 
A‑155	 16:00 
A. DCE-CT 
J. Votrubová1, H. Mírka2; 1Prague/CZ, 2Plzen/CZ (jana.votrubova@homolka.cz) 
Dynamic contrast enhanced computed tomography (DCE-CT) is a noninvasive 
method showing haemodynamic changes in living tissue in various oncologic and 
non-oncologic applications. Recently, it has gained an increased popularity for 
studying malignant tumour blood supply and formation of new vessels, also known 
as angiogenesis, that plays a critical role in the growth of cancer. Technical remarks: 
Repeated rapid CT scans are acquired at the same location to allow determination 
of time-attenuation curves (TAC). Several quantitative parameters are assessed: 
tumour blood flow (TBF) (ml/min/100 g), tumour blood volume (TBV) (ml/100 g), 
permeability surface product (PSP) (ml/min/100 g) and mean transit time (MTT) (s) 
are calculated using dedicated perfusion software. Indication: Perfusion CT may be 
used by the distinction of benign from malignant lesions when conventional methods 
are unreliable, may improve staging by demonstrating occult hepatic metastases, 
may guide biopsy to the tumour region most likely to be of highest grade. Several 
tumours with higher perfusion are more sensitive to the chemoradiation than that 
with lower perfusion. Findings at DCE-CT images after chemoradiotherapy are 
a significant predictor of early tumour response and overall survival. Its applica-
tions have been stimulated by the development of anti-angiogenesis therapy for 
monitoring the effects of therapy and additionally may be used as a noninvasive 
tool in detection of hepatic toxicity of chemotherapy. In the future, new prognostic 
information could impact clinical management. Studying the response of cancers by 
measuring changes in their blood flow may provide useful information on oncologic 
patients for managing cancers in the future. 
Learning Objectives:
1. To know the advantages of DCE-CT.
2. To learn how to extract the parameters on true cases.
3. To learn useful tricks for performing and processing good quality 
examinations.
A‑156	 16:30 
B. DCE-MR 
A.R. Padhani; Northwood/UK (anwar.padhani@stricklandscanner.org.uk) 
Before undertaking DCE-MRI examinations in the therapy assessment setting it is 
important to know the time of expected maximal antivascular effects, demonstrating 
recovery and additive effects if applicable. Identification of potential confounding 
variables that could alter DCE-MRI kinetics irrespective of treatment effects need to 
be identified. The choice of suitable lesions in important and robust data acquisition 
protocols that are able to deal effectively with physiological motions are needed. 
Consideration on the use of an appropriate input function is vital. Successful QA 
and QC steps should ensure that failed examination rates are minimal. Data analy-
sis requires validated, fit for purpose software that incorporates data traceability. 
Kinetic parameters measures must be clinical meaningful and if possible closely 
linked to underlying physiological processes. Measurement error and causes of 
variability should be known. 
Learning Objectives:
1. To know the advantages of DCE-MRI.
2. To learn how to extract the parameters on true cases.
3. To learn useful tricks for performing and processing good quality 
examinations.
A‑157	 17:00 
C. DCE-US 
L. Solbiati; Busto Arsizio/IT (lusolbia@tin.it) 
Neoangiogenesis is a key stage in the development of malignant tumours and their 
invasive potential is strongly linked to their vascularisation. Modern chemotherapy 
is largely based on anti-angiogenic substances: new target drugs and treatment 
protocols are continuously introduced in clinical practice, often with severe prob-
lems related to modalities of use, costs and side effects. Consequently, there is a 
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16:00 - 17:30 Room G/H 
State of the Art Symposium 
SA 6 
Brain tumour: imaging and response 
Moderator:
M. Stajgis; Poznan/PL 
A‑162	 16:00 
Chairman’s introduction 
M. Stajgis; Poznan/PL (stajgis@o2.pl) 
Over the last years, novel therapies for patients with brain tumours are being 
inplemented worldwide. One can observe a shift in imaging from merely anatomi-
cal details information towards providing tumour physiology data. Number of new 
MRI techniques have been developed and are currently used in advanced brain 
tumour imaging, monitoring and prediction of treatment response. Where and when 
to use them? In which order? 
Session Objectives:
1. To become familiar with the role of different MR techniques in advanced 
brain tumour imaging.
2. To consolidate knowledge of monitoring and prediction of treatment 
response in patients with brain neoplasms.
3. To learn how to differentiate necrosis, pseudo-progression and true recurrent 
brain tumour with advanced MR imaging.
A‑163	 16:05 
Advanced brain tumour imaging: complete imaging protocol 
M. Law; Los Angeles, CA/US (meng.law@usc.edu) 
Advanced imaging is now widely utilised in the research and clinical settings. In 
the clinical setting, qualitative, semi-quantitative and quantitative approaches 
such as review of colour-coded maps to ROI analysis and analysis of signal 
intensity curves are being applied in practice. We will also compare the relative 
advantages for T1 DCE MRI with T2* DSC MRI in the estimation of perfusion 
and permeability metrics in the clinic as well as some more automated histogram 
analysis methods. The role of advanced imaging in the characterisation of tumour 
biology and different pathologies will be reviewed. Differentiating between recur-
rent tumour and therapeutic necrosis is often a challenge. We will review the role 
of advanced imaging and also the effects of anti-angiogenic therapies on tumour 
microvasculature/microenvironment resulting in changes in diffusion, perfusion 
and MRS. Pseudophenomenon has made conventional imaging with gadolinium 
contrast agent almost obsolete necessitating mechanistic techniques to differenti-
ate entities such as pseudoprogression which is seen more commonly as a result 
of therapy with temozolomide and radiation for high grade gliomas as well as 
pseudo-response and pseudo-pseudoprogression. Lastly to combine and apply 
these different imaging techniques in a multi-parametric algorithmic fashion in the 
clinical setting can be shown to increase our diagnostic specificity and confidence. 
Learning Objectives:
1. To become familiar with different advanced MR techniques used in brain 
tumour imaging.
2. To learn the role of permeability, perfusion, diffusion imaging and MR 
spectroscopy in characterising brain tumour biology and differential 
diagnostics.
3. To become familiar with a complete imaging protocol, which can be 
implemented in a multi-parametric algorithm fashion in brain tumour 
diagnosis.
A‑164	 16:28 
Monitoring and prediction of treatment response 
P.C. Maly Sundgren; Lund/SE (Pia.Sundgren@med.lu.se) 
High-grade gliomas have a poor survival rate despite improvements in surgery, 
radiation and chemotherapy. A contributing factor to the poor survival is the inability 
of currently available imaging techniques to accurately delineate the tumour which 
results that targeted focal treatment my not be effective. Conventional imaging is 
not able to give an early assessment of the effectiveness of radiation and/or che-
motherapy. Early identification of patients with a poor treatment response or who 
suffer from tumour recurrence can be of great advantage: it provides the opportunity 
to adjust individual more rapidly, and sparing patients unnecessary morbidity, and 
Learning Objectives:
1. To review the techniques and interpretation criteria.
2. To discuss the use of contrast agents and CAD in breast MRI.
3. To know the advantages and limitations of 3T MRI for breast imaging.
A‑160	 16:28 
B. Evidence-based controversies 
F. Sardanelli; Milan/IT (f.sardanelli@grupposandonato.it) 
An evidence-based consensus on indications to breast MRI was recently reached 
by an interdisciplinary working group promoted by the European Society of Breast 
Cancer Specialists (EUSOMA). There was a general agreement on MRI for screen-
ing high-risk women, evaluating the response to adjuvant chemotherapy, evaluating 
suspected implant rupture, searching for occult primary cancer, evaluating sus-
pected recurrence when conventional imaging is inconclusive. A limited consensus 
was obtained for the use of preoperative MRI in women with invasive lobular cancer, 
at high risk, with mammography/ultrasonography discrepancy in tumour size, and 
in patients candidate to partial breast irradiation. The debate on preoperative MRI 
has been fuelled by the publication of the results of the COMICE study, a large 
randomised study which showed a non-significant impact of MRI on re-excision 
rate (19% in both arms). Thus, we have now a large evidence for a superior MRI 
ability for ipsilateral and contralateral staging and for impact on surgical treatment 
on about 15-20% of patients (with potential overdiagnosis and overtreatment), 
without a demonstration of a positive impact on patient outcome. In this context, 
recommendations for preoperative MRI include: clear patient information; high-
quality studies; mandatory verification/localisation of MRI additional findings with 
impact on patient treatment using targeted sonography or MR-guidance; treatment 
delay no longer than 1 month; decision on changes of treatment planning by a 
multidisciplinary team; attention paid to methods for translating MRI 3D information 
on disease extent to the operating theatre. 
Learning Objectives:
1. To become familiar with current controversies in clinical applications of breast MRI.
2. To review literature on the role of MRI in breast cancer staging and 
screening in high risk patients.
3. To evaluate the potential impact of overdiagnosis in breast MRI.
A‑161	 16:51 
C. How to improve the specificity of breast MRI 
J. Veltman; Nijmegen/NL (j.veltman@zgt.nl) 
Breast MRI has shown diagnostic sensitivities of 94-99% for invasive breast cancer; 
however, specificities have been reported significantly lower with values between 37% 
and 86%. The specificity of breast MRI is in a routine clinical setting based on the evalu-
ation of morphologic features and relative “slow” dynamic characteristics of enhancing 
lesions. The only moderate specificity that is achieved using these characteristics can 
result in a significant number of false positive findings during, for instance, screening 
or pre-operative imaging. These findings will often require short-term follow-up, target 
ultrasound with biopsy or even MRI-guided biopsy. Fast dynamic imaging, spectroscopy 
and diffusion weighted imaging (DWI) have been described to have potential for improv-
ing the specificity of breast MRI. The use of fast dynamic imaging sequences result 
in a more accurate evaluation of the initial enhancement of the lesion. In combination 
with pharmacokinetic modelling this can result in a more quantitative evaluation of 
enhancement. In proton-MR spectroscopy (MRS) the presence of a choline signal, a 
cell-membrane precursor, in breast lesions can be used to differentiate benign from 
malignant lesions. The specificity of MRS varies between 67 and 100% in literature 
(average 87%). DWI has also shown potential in differentiating between benign an 
malignant lesions, but, like with other techniques, varying specificity values are reported 
ranging between 46% and 93%. In this presentation the value of these techniques for 
improving the performance of breast MRI will be discussed. 
Learning Objectives:
1. To become familiar with literature on MRI specificity.
2. To understand the value of ultrafast sequences.
3. To appreciate the value of spectroscopy and diffusion-weighted imaging.
Panel discussion: 
Do we find too many cancers with MRI? 17:14 
Preoperative staging of breast cancer has become one of the main indications of 
breast MRI. Studies have shown that MRI changes management in a significant 
percentage of patients, leading to a higher number of mastectomies. This has 
caused concern, especially in the surgical community. The debate is on the pos-
sibility and potential harms of overdiagnosis as well as cost effectiveness and 
patient selection issues in preoperative staging. 
Friday
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16:00 - 17:30 Room I/K 
Chest 
RC 604 
Bedside chest imaging 
Moderator: 
H. Prosch; Vienna/AT 
A‑166	 16:00 
A. Bedside chest radiography: technical aspects and correct interpretation 
E. Eisenhuber; Vienna/AT (eisenhuber@gmail.com) 
Although bedside chest radiograph is one of the less elaborate imaging examina-
tions in our diagnostic armamentarium, it remains the most frequent radiologic 
procedure performed in intensive care patients. Despite its limitations chest imag-
ing is an important tool in the management of the critically ill patient. Though the 
advent of digital radiography has vastly contributed to improved image quality of 
the bedside radiographs, optimal positioning and technique remain a real challenge 
for the performing technologist. In addition, the interpretation of chest radiography 
in the critically ill patient poses a challenge for the radiologist, because findings are 
frequently unspecific and lung opacifications have similar appearances in a variety 
of different cardiopulmonary pathologies. Clinical information and an interdisciplinary 
approach are therefore crucial for optimal interpretation of these chest radiographs. 
The American College of Radiology has established expert recommendations for the 
use of bedside chest radiography. Current recommendations suggest that routine 
daily chest radiographs should be reserved for patients with acute cardiopulmonary 
problems and in patients receiving mechanical ventilation. Acquisition of a portable 
chest radiograph is recommended after insertion of endotracheal tubes, central 
venous catheters, pulmonary artery catheters, chest tubes, and nasogastric tubes. 
Therefore, knowledge of correct positioning of catheters, tubes, and monitoring 
devices and of various malpositions and associated complications is essential for 
the interpreting radiologist. 
Learning Objectives:
1. To learn about the technical requirements of portable chest units.
2. To understand key imaging findings in different clinical settings.
3. To understand potential limitations of bedside chest radiography and how to 
avoid common pitfalls.
A‑167	 16:30 
B. Bedside thoracic ultrasonography: how far can it go? 
K. Vidmar Kocijancic; Ljubljana/SI (ksenija.vidmar@sb‑izola.si) 
Chest ultrasonography (CHUS) is a useful imaging tool in patients at intensive 
care units, because of its simplicity and reproducibility. However, there are some 
limitations such as low specificity of some crucial sonographic signs and limited 
searching area (soft tissues, pleural cavity and lung consolidations). The ICU patient 
can be examined in supine or sometimes in lateral or partly lateral position using 
intercostal spaces as an acoustic window. Supine analysis of the anterior chest wall 
rules out pneumothorax, while lateral approach detects clinically relevant pleural 
effusion and parenchymal consolidations. CHUS is a method of choice in detec-
tion as well as in characterisation and volume estimation of free and/or loculated 
pleural fluid. With CHUS we can explore and characterise lung consolidations from 
the moment they reach the visceral pleura. They can be in contact with pleural 
line or can be observed through an effusion. However, in case of subcutaneous 
emphysema and/or diffuse oedema of soft tissues the lung parenchyma can not 
be reliably assessed. Also, in the question of pulmonary embolisms in critically ill 
patient, CHUS could be contributive. Sometimes small pleural effusion can be vis-
ible with some peripheral lung tissue consolidations indicating minute pulmonary 
infarction. Typical pulmonary infarction is triangular tissue consolidation with air 
bronchogram and absence of Doppler blood flow signals within consolidated lungs 
but CECT for confirmation is mandatory. CHUS exploration of the diaphragm can 
reliably evaluate respiratory movements since pleural effusion even substantial 
does not affect the amplitude of diaphragmatic excursion. 
Learning Objectives:
1. To understand the advantages and limitations of bedside thoracic 
ultrasonography.
2. To learn about the US findings of pleural and parenchymal diseases suitable 
for bedside ultrasonography.
3. To review current guidelines for estimation of pleural effusion volume.
delay in initiation of other maybe more effective treatment. In recent years, different 
functional imaging approaches such as dynamic contrast-enhanced (DCE) and 
dynamic susceptibility-weighted contrast (DSC) MRI, diffusion-weighted imaging 
and spectroscopy have been complementary used for diagnosis and treatment 
response. In this lecture different advance MR and CT imaging methods as well as 
the traditional way of monitoring to assess treatment response will be discussed. 
In addition, a novel recently published promising technique will be described - the 
parametric response mapping (PRM), a novel voxel-wise analytical method of 
monitoring physiological and environmental changes in a tumour volume during 
treatment will be presented and compared to the traditional methods used. Finally, 
the aim of the lecture is to consolidate the present knowledge and novel ideas in 
brain tumour imaging for future monitoring of treatment response and the possibility 
and limitations for future individualisation of cancer therapy. 
Learning Objectives:
1. To gain an understanding of the present traditional model for the treatment 
cycle for brain tumours and how they are monitored.
2. To learn about different imaging biomarkers for early assessment of brain 
tumour treatment response that might result in individualisation of cancer 
therapy.
3. To consolidate present knowledge and ideas in brain tumour imaging for 
future brain tumour therapy and monitoring of response.
A‑165	 16:51 
Radiation necrosis and pseudo-progression vs recurrent tumour 
M. Essig; Heidelberg/DE (m.essig@dkfz‑heidelberg.de) 
Pseudophenomenon has made conventional imaging with gadolinium contrast 
agent almost obsolete necessitating mechanistic techniques to differentiate 
entities such as pseudoprogression which is seen more commonly as a result of 
advanced multimodal therapeutic concepts. Advanced, non-enhanced and contrast 
enhanced MR imaging techniques include MR-spectroscopy, perfusion MR imaging, 
dynamic contrast enhanced MRI and diffusion tensor MR. In the presentation we 
will analyse the application of those techniques in brain tumour assessment with 
focus on the post-therapeutic brain to differentiate therapy induced from tumour-
induced changes. The results of the available studies in literature, all with relatively 
limited patient numbers, indicate that the combination of functional MRI proved to 
be useful in the post-therapeutic workup of gliomas, lymphomas and metastatic 
disesease. The typical patterns of tumour recurrence and the different therapy-
induced effects will be presented. In perfusion (DSC-MRI) and dynamic contrast 
enhanced magnetic resonance imaging (DCE-MRI) the signal intensity measure-
ments of the tumour reflect a composite of tumour perfusion, vessel permeability, 
and the extravascular-extracellular space. In contrast to conventional enhanced 
MRI, which simply presents a snapshot of enhancement at one time point, both 
techniques permits a fuller depiction of the wash-in and wash-out contrast kinetics 
within tumours, and this provides insight into the nature of the bulk tissue proper-
ties on its microvascular level. With the strong demand in drug development the 
identification of biomarkers that can assess tumour microvascular properties non-
invasive dynamic MRI is the method of choice to assess tumour response and to 
identify atypical tumour response findings. 
Learning Objectives:
1. To identify the different aspects of therapy-induced MRI findings.
2. To differentiate therapy-induced changes from tumour recurrence by the use 
of modern MRI techniques.
3. To identify technical aspects of functional MRI techniques in brain tumour 
imaging.
Panel discussion: 
Try to understand the clinical question and you will know which imaging is 
appropriate 17:14 
We are witnessing a change in brain tumour imaging from merely providing anatomi-
cal details toward the characterisation of tumour biology and physiology. A number 
of advanced MRI techniques serve as powerful tools in therapeutic decisions and 
prognosis. How and when should we use them? In which sequence? All of them? 
To answer these questions, the understanding of clinician questions and value of 
particular MRI studies is essential. 
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the pelvic floor muscles should relax and the pelvic floor descends normally less 
than 3 cm below the PCL. Based on the static and dynamic MR imaging sequences 
a vast array of morphologic and functional pelvic floor disorders can be depicted. 
Learning Objectives:
1. To review the technique and imaging protocols of dynamic pelvic MRI.
2. To understand relevant anatomical structures and classification systems for 
defining normal and abnormal findings.
3. To review normal findings in asymptomatic volunteers.
A‑171	 16:28 
Indications and spectrum of pathological findings 
F. Maccioni; Rome/IT (francesca.maccioni@uniroma1.it) 
Functional abnormalities of the pelvic floor represent a significant health-care 
problem, as they affect approximately 15% of older multiparous women. Moreover, 
nearly 300.000 surgeries in United States are annually performed to correct those 
disorders. The success of medical and surgical therapies relies on the correct 
classification of dysfunction and identification of the pelvic compartments involved. 
Clinical classifications of pelvic floor abnormalities are primarily topographic, rather 
than functional. However, as the pelvic floor muscles tend to act as a unique func-
tional entity, their dysfunction usually leads to dysfunction of more than one organ 
system (genitourinary or gastrointestinal), resulting in a wide spectrum of symptoms 
variably associated, including dysuria, urinary incontinence, uterine prolapse, anal or 
pelvic pain, obstructed defaecation, rectal prolapse or faecal incontinence. Because 
of the variability of symptoms and complexity of physio-pathological mechanisms, 
diagnosis of pelvic floor disorders is usually achieved by combining different diag-
nostic tools. Dynamic MRI of the pelvic floor has emerged as an alternative and 
effective modality for assessing and understanding of these disorders. It currently 
offers a complete morphological and functional evaluation of all three compartments 
at the same time. Constipation and pelvic organ prolapse are the most common 
indications for a dynamic MRI. The physio-pathological features of the main pelvic 
floor disorders and their MRI findings will be shown in detail. MR images and mov-
ies, with particular regard to posterior pelvic floor abnormalities, such as rectocele, 
rectal invagination and prolapse, enterocele, descending perineal syndrome and 
spastic pelvic floor syndrome, will be illustrated and discussed. 
Learning Objectives:
1. To review the current indications of dynamic pelvic floor imaging.
2. To understand the spectrum of pathological findings.
3. To understand the clinical relevance of abnormal findings.
A‑172	 16:51 
Dynamic imaging of the pelvic floor: MR imaging or conventional 
technique? 
S. Halligan; London/UK (s.halligan@ucl.ac.uk) 
The ability to perform and interpret dynamic pelvic floor imaging is essential for the 
modern gastrointestinal (and indeed urogynaecological) radiologist. The other speak-
ers in this session will be reviewing indications, pathologic findings, clinical relevance, 
and MR technique. Although I will detail the MR and fluoroscopic techniques used 
at my institution, I will focus on the specific technical and diagnostic advantages and 
disadvantages of both dynamic pelvic MR and conventional fluoroscopic evacuation 
proctography (defecography). Many practitioners wising to initiate this type of imaging 
will wish to know what modality to chose and existing practitioners using fluoroscopy 
will possibly be interested in migrating their practice to MR. I will illustrate what imaging 
findings are best imaged by each technique, continually referencing this to whether the 
finding is ultimately important to the referring clinician or not. Using examples from our 
own research programme and clinical practice, I will illustrate why we have migrated 
our practice exclusively to dynamic MR. 
Learning Objectives:
1. To review the current role of MR imaging and conventional techniques in 
dynamic pelvic imaging.
2. To appreciate the advantages and limitations of both techniques.
3. To learn which technique is useful for which clinical situation.
Panel discussion: 
Does dynamic pelvic MR imaging replace conventional 
defecography? 17:14 
Although dynamic pelvic MR imaging is increasingly used for imaging pelvic floor 
disorders, the crucial question is whether the technique can completely replace 
conventional techniques. Although MR imaging provides excellent soft-tissue 
contrast which is a particular advantage when imaging the pelvis, it has to be 
acknowledged, that the examination is performed in supine position and not in 
physiological sitting position. 
A‑168	 17:00 
C. Radiologic-guided bedside interventions of the thorax 
F. Gleeson; Oxford/UK (fgleeson@mac.com) 
This presentation will review the ultrasound appearances of pleural disease in ward 
and ITU-based patients, and will discuss the indications for pleural procedures 
and the complications associated with them. The use of colour Doppler to aid the 
diagnosis of effusions will be discussed, as will the identification of septations and 
the need for intrapleural fibrinolytic therapy. The advantages of guided versus 
blind drain insertion will be presented, and the benefits of large versus small bore 
drains will also be discussed. 
Learning Objectives:
1. To review current clinical indications for ultrasound-guided intervention of the 
thorax.
2. To learn how to perform bedside intervention of the thorax.
3. To review potential complications of thoracic bedside interventions.
16:00 - 17:30 Room L/M 
Special Focus Session 
SF 6 
Dynamic MR imaging of the pelvic floor: easy and 
useful 
Moderator: 
D. Weishaupt; Zurich/CH 
A‑169	 16:00 
Chairman‘s introduction 
D. Weishaupt; Zurich/CH (dominik.weishaupt@triemli.stzh.ch) 
Pelvic floor function and structure is complex. Imaging has a key role in guiding the 
clinician in managing patients with incontinence, constipation, difficult rectal evacuation 
and pelvic organ prolapse. Dynamic imaging is of particular interest for assessment of 
the pelvic floor since this kind of imaging gives a near physiological data set of what is 
happening and gives us a better understanding of the multifactorial causes of pelvic 
floor dysfunction. Whereas conventional evacuation proctography was over years 
standard of reference for dynamic imaging of the pelvic floor, dynamic MR imaging 
of the pelvic floor is gaining increasing acceptance among radiologists and clinicians. 
However, dynamic MR imaging of the pelvic floor is (due to the architecture of most 
the clinically MR magnets) usually performed in supine position which does exclude 
the axial load on the pelvic floor. The lack of a physiological patient positioning during 
dynamic pelvic floor MR imaging is still brought into discussion if dynamic MR imaging 
of the pelvic floor can replace conventional techniques or not. 
Session Objectives:
1. To review the current status and technique of dynamic pelvic imaging.
2. To learn about indications and imaging findings of dynamic pelvic imaging.
3. To understand the role of dynamic pelvic imaging in the light of conventional 
techniques.
A‑170	 16:05 
How I do it 
C.S. Reiner; Zurich/CH (caecilia.reiner@usz.ch) 
The pelvic floor is a complex anatomic and functional unit. In clinical routine a simple 
anatomic concept of the female pelvic floor has gained acceptance. Especially for 
treatment planning, the female pelvic floor may be separated into three functional 
compartments: the anterior compartment (bladder and urethra), the middle compart-
ment (vagina, cervix, uterus, and adnexa), and the posterior compartment (anus 
and rectum). Intact structure of the pelvic floor is a basic prerequisite for a normal 
mechanism of defecation and continence. Over the last years, MR imaging has 
gained increasing acceptance as imaging modality for evaluation of the pelvic floor, 
which enables a global and integrated approach to the pelvic floor. Using static T2-
weighted sequences the morphology of the pelvic floor can be visualised in great 
detail. A rapid half-Fourier T2-weighted, balanced steady state free precession 
(bSSFP), or gradient-recalled echo (GRE) sequence are used to obtain sagittal 
images while the patient is at rest, during pelvic squeeze, during pelvic strain and 
to document the evacuation process. On these images the radiologist identifies 
the pubococcygeal line (PCL) (which represents the level of the pelvic floor). In 
normal findings, the base of the anterior and the middle compartment are above 
the PCL at rest, and the pelvic floor elevates during contraction. During straining, 
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A‑175	 17:00 
C. Oncology 
M.G. Pomper; Baltimore, MD/US (mpomper@jhmi.edu) 
Although most clinical diagnostic imaging studies employ anatomic techniques 
such as computed tomography (CT) and magnetic resonance (MR) imaging, much 
of radiology research currently focuses on adapting these conventional methods 
to physiologic imaging as well as on introducing new techniques and agents for 
studying processes at the cellular and molecular levels in vivo, i.e. molecular 
imaging. Molecular imaging promises to provide new methods for the detection 
of minimal changes in diseased tissue and support for personalised therapy. 
Although molecular imaging has been practiced for over 20 years in the context 
of nuclear medicine, other imaging modalities have only recently been applied to 
the noninvasive assessment of physiology and molecular events. Nevertheless, 
there has been sufficient experience with specifically targeted contrast agents and 
high-resolution techniques for MR imaging and other modalities that we must begin 
moving these new technologies from the laboratory to the clinic. Several projects 
relevant to oncology will be discussed with emphasis on how they were/will be 
moved from the bench to the clinic. 
Learning Objectives:
1. To understand the rationale of probes for oncology.
2. To understand how these probes can be used in visualisation of neoplastic 
diseases.
3. To understand the potential clinical value of these probes.
16:00 - 17:30 Room P 
Vascular 
RC 615 
Non-traumatic acute aortic dissection and 
malperfusion syndromes 
Moderator: 
A.‑M. Belli; London/UK 
A‑176	 16:00 
Chairman’s introduction 
A.-M. Belli; London/UK (Anna.Belli@stgeorges.nhs.uk) 
Aortic dissection is increasingly managed by endovascular means. It is important 
for all radiologists to understand the benefits and disadvantages of varying imaging 
modalities in the differential diagnosis and the fundamental anatomical requirements 
for assessing suitability for endovascular repair. The causes, detection, classifica-
tion and complications of aortic dissection will be discussed followed by a panel 
discussion of imaging strategies which give the best information for diagnostic 
work-up, endograft planning and monitoring of patients during and after treatment. 
A‑177	 16:05 
A. Predisposing factors for developing non-traumatic acute aortic 
dissections 
V. Bérczi; Budapest/HU (Berczi@hotmail.com) 
Aortic dissection, a highly lethal disease, is defined as longitudinal cleavage of 
the aortic media by a dissecting column of blood. The mortality rate of untreated 
aortic dissection is 1-2% per hour for the first 24-48 hours, or 75% within the first 
2 weeks, and 90% at 1 year. Predisposing factors include hypertension, inherited 
arteriopathies characterised by cystic medial necrosis, pre-existing aortic aneu-
rysm, a bicuspid aortic valve, aortic coarctation, different vasculitides, the use of 
cocaine (due to its effect on aortic connective tissue and also by producing severe 
hypertension). Hereditary diseases include Marfan’s syndrome (dedifferentiation 
of vascular smooth muscle cells, enhanced elastolysis of aortic wall components, 
defective fibrillin in the extracellular matrix), Ehlers-Danlos syndrome (hereditable 
connective tissue disorders leading to tissue fragility), annuloaortic ectasia and 
familial aortic dissection (elastolysis, deposits of mucopolysaccharid-like materi-
als, cyctic medial degeneration). Acquired conditions, such as hypertension, alter 
arterial wall composition in numerous ways, causing smooth muscle cell necrosis 
and fibrosis of elastic structures, leading to stiffness and vulnerability to pulsatile 
forces, thereby creating a substrate for aneurysms and dissections. Other acquired 
conditions include inflammation and autoimmune processes, causing nutrient 
deficiency and destroying the medial layers of the aortic wall. Pregnancy-related 
dissection is extremely rare. Beside discussion of the predisposing factors, a brief 
16:00 - 17:30 Room N/O 
Molecular Imaging 
RC 606 
Clinical potential of molecular imaging: between 
dream and reality 
Moderator: 
G. Frija; Paris/FR 
A‑173	 16:00 
A. Molecular imaging from bench to bedside 
F.M.A. Kiessling; Aachen/DE (fkiessling@ukaachen.de) 
With the introduction of targeted therapeutics and personalised therapy regimen 
there is increasing need to improve diagnosis of diseases in a way that insight into 
pathophysiological and molecular regulation is provided. In this context, molecular 
imaging can be of tremendous help in basic research, drug development and the 
clinics. Many interesting approaches of molecular imaging have been tried in small 
animal models. New methods and tools have been identified, which are easy 
enough to handle, aceptable in its costs and, most importantly, reliable enough to 
be translated to clinical practice. Unfortunatenly, as soon as they have entered the 
clinics they are often not classified as molecular imaging anymore. Among those are 
MR-spectroscopy, SPIO/USPIO enhanced liver and RES imaging but also contrast 
agents like Gd-EOB-DTPA and most applications for PET/SPECT. Other interesting 
applications such as targeted ultrasound imaging are already established tools in 
preclinical research and very close to first clinical use. Near infrared optical imaging 
is another example of a rapidly developing technology and first clinical devices and 
dyes (e.g. to detect arthritic lesions) are availibe now. It can be expected that with 
the availability of targeted and activatable probes the acceptance and the use of 
optical imaging methods will further rise. Most proably, this will initially happen in 
context with intraoperative diagnosis and endoscopy. In summary, it is the aim of 
this talk to give a realistic overview on the available molecular imaging tools and 
on their potential for preclinical research and patient use. 
Learning Objectives:
1. To understand the principles of molecular imaging research.
2. To understand how probes are tailored towards clinical applications.
3. To appreciate the required steps for clinical development and approval.
A‑174	 16:30 
B. Cardiovascular disease 
L. Hofstra; Utrecht/NL (leonard.hofstra@gmail.com) 
Cardiovascular diseases remain the number one cause of morbidity and mortality, 
both in the developed and developing countries, and in men and women alike. It is 
expected that these numbers will continue to increase in the coming decades due 
to escalating proportions of obesity and the aging population. Atherosclerosis is the 
major cause for cardiovascular disease. Since in about 50% of cases a stroke or 
acute myocardial infarction is the first symptom of atherosclerosis, it is of paramount 
importance to identify patient at high risk. A first step in the identification is the use of 
clinical risk profiling, such as the Framingham Risk score, which has an area under 
the curve (AUC) of about 0.8 using ROC analysis. However, clinical risk profiling 
alone is not sufficient to identify individual patients at imminent risk to develop a 
cardiovascular event in the near future. A next step in a more precise identification 
of the patient at risk is the development of serum biomarkers for atherosclerotic 
disease. However, so far serum biomarkers have failed to contribute substantially 
to improve the AUC in the prediction of cardiovascular events using ROC analysis. 
A major step forward in risk stratification is provided by the rapid development of 
cardiac computed tomography, which offers a rapid visual access to the coronary 
tree, at low radiation dose and in a patient friendly manner. However, for the iden-
tification of the vulnerable plaque we need to go beyond anatomical imaging, and 
use molecular imaging tools. In the lecture I will discuss the different targets for 
molecular imaging within the vulnerable plaque, such as inflammation, apoptosis 
and angionenesis. Imaging of these substrates of plaque vulnerability may offer 
opportunities for a precise identification of the patient at risk, at the individual level. 
Learning Objectives:
1. To understand potential mechanisms for cardiovascular disease.
2. To understand how these probes can be used in visualisation of 
cardiovascular disease.
3. To learn about the potential clinical value of these probes.
Postgraduate.Educational.Programme
S48 A B C D E F G H
16:00 - 17:30 Room Q 
RTF - Radiology Trainees Forum 
TF 1 
Highlighted Lectures 
Moderators: 
D. Bulja; Sarajevo/BA 
P.R. Kornaat; Leiden/NL 
A‑180	 16:00 
Musculoskeletal trauma in children 
I. Boric; Zagreb/HR (igor.boric1@zg.t‑com.hr) 
The aim of the lecture is to familiarise the audience with the specific paediatric 
conditions in trauma radiology. It will be described the major pathophysiologic 
differences in childhood and the consecutive altered injury pattern. The standard 
radiological imaging protocol for various involved body regions and different trauma 
settings/varying queries will be described, with suggestion for standardised diag-
nostic algorithams in some typical settings. Special regard will be given to radiation 
protection and the potential of imaging modalities such as ultrasound, multi-detector 
CT as well as MRI in paediatric trauma patients. The roll of the lecture is to provide 
some basic guidelines for young radiologists and general radiologists who less 
often have to deal with paediatric patients. 
Learning Objectives:
1. To become familiar with the major pathophysiologic differences in childhood 
trauma
2. To standardised diagnostic algorithm in some typical settings in field of 
pediatric trauma.
A‑181	 16:30 
Basic principles in the interpretation of signal intensities on T1- and T2-
weighted images 
G. Wilms; Leuven/BE (Guido.Wilms@uz.kuleuven.ac.be) 
The signal intensities of normal structures and pathological findings on conven-
tional T1- and T2-weighted MR images depend on many factors. The amount of 
water, proton density, chemical structure and/or binding, presence or absence 
of flow (of blood or CSF), calcification, fat, blood degradation products, melanin, 
mucine and even air are all factors that influence the signal characteristics. T1- and 
T2-lenghtening is the rule in most tumoural, vascular and infectious lesions and 
therefore is rather unspecific. T1- and T2-shortening can be due to the presence of 
fat (lipoma), melanin (melanoma and metastasis of melanoma), mucine (metastasis 
of sigmoid carcinoma), colloid material (colloid cyst, Rathke cleft cyst) and even 
calcification (falx!). T1-shortening with T2-lengthening can be due to cholesterine 
(cholesterol granuloma, craniopharyngioma), high protein content (tumoural 
cysts), and methaemoglobin (late haemorrhage, thrombus). T1-lengthening and 
T2-shortening is almost exclusively due to deoxyhaemoglobin. Acute haemor-
rhage and meningioma can be iso-intense on T1-weighted images, while some 
meningiomas and micrometastases can be iso-intense on T2-weighted images. 
Absence of signal can be due to high-velocity flowing blood (aneurysm, AVM, hy-
pervascular tumours), high velocity flowing CSF (normal pressure hydrocephalus, 
cortical bone or extensive calcification, air and a large amount of iron (coils, clips). 
It is concluded that the simple use of a combination of T1- and T2-signal intensities 
on conventional MR images can be used to arrive at the diagnosis and differential 
diagnosis of brain lesions. 
Learning Objectives:
1. To learn the types of the different signal intensities on conventional T1- and 
T2-weighted MR images.
2. To correlate the signal intensities with biochemical and pathological findings, 
with the implications of specific MR effects and artifacts.
3. To use the combination of T1- and T2-signal intensities to arrive at the 
diagnosis and differential diagnosis of brain lesions.
description of variant anatomy (aortic spindle, ductus diverticulum) and structures 
causing diagnostic dilemma (pericardial recess, left inferior pulmonary vein, left 
superior intercostal vein and right atrial appendage) will be given. 
Learning Objectives:
1. To learn how to determine the incidence and mortality.
2. To analyse the clinical and pathologic changes of aortic dissection.
3. To understand the natural history.
A‑178	 16:28 
B. Acute aortic dissections: detection and classification 
J. Lammer; Vienna/AT (johannes.lammer@akhwien.at) 
The most commonly used classification is the Stanford classification: in type A dis-
sections the ascending aorta is involved, in type B dissection the ascending aorta 
is not involved. The De Bakey classification subdivides the dissection in a type I 
dissection which involves the entire aorta, a type II dissection which involves the 
ascending aorta, and a type III dissection of the descending aorta only. In 2001, 
Erbel et al. published (European Heart Journal; 22: 1642-1681) a new classification. 
Class 1: classical aortic dissection with an intimal flap between true and false lumen. 
Class 2: intramural haematoma. Class 3: discrete dissection without haematoma, 
eccentric bulge at tear site. Class 4: penetrating aortic ulcer, Class 5: iatrogenic and 
traumatic dissection. Clinical symptoms: the typical patient with aortic dissection is 
male, in his 1960s with a history of hypertension who suffers with abrupt onset of a 
sharp, ripping chest pain. Malperfusion of organs: compression of the true lumen 
may cause malperfusion of the coronary and cerebral arteries, the spinal cord, all 
abdominal organs and the limbs. This malperfusion may change the symptoms. 
Imaging: contrast-enhanced CT is the imaging modality of choice. The report has 
to describe the classification, the entry site, the grade of true lumen compression, 
organ malperfusion, pericardial and pleura effusions, and false lumen ectasia. 
However, aortic valve insufficiency which can be a complication of type A dissec-
tions are demonstrated by echocardiography, transesophageal ultrasound or MRI. 
Learning Objectives:
1. To learn how to diagnose aortic dissection.
2. To understand the pros and cons of different imaging modalities.
3. To learn the classification.
A‑179	 16:51 
C. Acute aortic dissections: imaging of complications 
M.H.K. Hoffmann, A.-C. Fischer; Ulm/DE (martin.hoffmann@uniklinik‑ulm.de) 
Complications occurring after acute aortic dissections should be separated into 
those related to the disease per se and those related to post-treatment conditions. 
Life-threatening complications related to the disease should be familiar as immedi-
ate consequences for treatment may ensue. Most of these are either located in the 
aortic root or related to mal-perfusion syndromes. The aortic root with very thin walled 
structures of the sinus of valsalva is located within the pericardial sac. The structure 
is prone to rupture and may produce life-threatening pericardial tamponade or pres-
ent clinically as sudden onset of severe aortic regurgitation. All imaging modalities 
suitable for diagnostic workup in such conditions have to be rapidly accessible and 
performable. This precludes lengthy MR imaging procedures and renders ultrasound 
and CT as the mostly used modalities. The condition that has to be recognised as 
the most important inductor of malperfusion syndromes in the descending aorta is 
the progression of dissection into aortic branches and the true lumen collapse. Both 
conditions are easily discernible with CT imaging. Complications related to treatment 
should be sub-classified into those after pure surgical treatment and those related 
to endograft repair. The acute surgical complication with most deleterious effects is 
related to spinal cord ischaemia. The condition also applies to endograft repair. It is 
therefore beneficial for the radiologist involved either in pre-surgical imaging or inter-
ventional treatment to acquire thorough knowledge of the spinal cord blood supply. 
Endograft complications of interest encompass endoleak formations, stent migrations 
and endoluminal stent collapse. 
Learning Objectives:
1. To learn the most common complications.
2. To learn the most appropriate imaging strategy for diagnosis.
3. To understand the clinical significance of the most common complications.
Panel discussion: 
Which imaging modality is best for endovascular management? 17:14
The various imaging modalities for establishing the diagnosis of acute non-traumatic 
dissections will be discussed. The panellists will present recommendations for 
diagnostic work-up with special respect to differential diagnosis such as acute 
myocardial infarction and acute pulmonary embolism. Also, the problem of sizing 
the endograft and planning the procedure will be addressed. The panellists will 
discuss strategies for detection of complications and for monitoring patients fol-
lowing treatment. 
Friday
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A‑182	 17:00 
Plain film criteria: quality of the x-rays 
H. Bosmans; Leuven/BE (hilde.bosmans@uz.kuleuven.ac.be) 
The quality of radiographs is determined by many parameters from both techni-
cal and clinical origin. During the presentation, we will make an overview of the 
particular features of x-ray tubes and plain films that affect the quality of the radio-
logical image. The training session will start from very simple x-ray tubes and film, 
and gradually introduce more sophisticated, state-of-the-art technology. We will 
briefly explain concepts such as focal spot, heel effect, beam quality, filters, grid, 
film sensitivity, automatic exposure control, etc. from a practical point of view. The 
European Commission and selected research groups have developed criteria to 
judge the quality of the images and we will show how they can be used to improve 
the daily practice. A more technical evaluation of quality is possible with images 
of test objects, some of which are very straightforward and interesting if problems 
have to be retrieved. X-ray quality should be at a high level every day. Therefore 
quality control procedures have a role. One example evaluates the stability of the 
imaging chain by means of acquisitions of homogeneous blocks of PMMA. We 
will illustrate typical findings with repercussions on the radiological practice, and 
show that the fight against artefacts is a never ending process. Both with film and 
digital detectors, radiologists should be aware that quality management and quality 
control procedures are needed. Quality has to be organized, and quality control 
procedures have to be automated and included in the routine practice. 
Learning Objectives:
1. To become familiar with the basic principles of x-ray imaging, from the tube 
to the film.
2. To understand the technical quality of a radiograph and how technology and 
its proper use influence the radiological quality.
3. To illustrate the role of quality control procedures in the daily practice.
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A‑186	 09:21 
Chest 
C. Schaefer-Prokop; Amersfoort/NL (cornelia.schaeferprokop@gmail.com) 
There are diverse underlying causes for “diagnostic mistakes”. Missed lesions due 
to inadequate technique, “satisfaction of search” or lack of perception have to be 
differentiated from interpretative mistakes of lesions that have well been seen but 
erroneously interpreted due to the lack of experience, misconception or overlap of 
findings that complicates the differential diagnosis. Each of these underlying reasons 
require a different approach to avoid them or reduce their risk of occurrence. The first 
type of mistake arises more often when interpreting chest radiographs and refers to 
the detection of mostly small focal parenchymal densities but also to the interpretation 
of mediastinal and hilar contours. By analysing typical cases, visual “tricks”, helpful 
display techniques and strategies for systematic review and analysis will be outlined 
that are thought to be helpful in reducing the risk of “missing” a lesion. The second type 
of mistake mostly represents a problem of interpreting parenchymal abnormalities seen 
on CT. Since the lung has limited means to “react” against an injury, many radiologic 
findings are aspecific. Interpretation of pathology of parenchymal changes is based 
on pattern analysis, the knowledge of disease distribution and additional findings of 
pleura and mediastinum. In many cases, an interdisciplinary approach of radiologists 
and clinicians is essential for correct interpretation. Cases will be analysed to illustrate 
difficult differential diagnosis occuring in daily routine (e.g., infectious pneumonia versus 
organising pneumonia) and key features helping in going into the right interpretative 
direction will be outlined. Emphasis will lie on focal lung disease rather on the inter-
pretation of diffuse interstitial lung diseases. 
Learning Objectives:
1. To learn about visual tricks and strategies to overcome typical perception 
errors in chest radiography.
2. To become familiar with overlaps of morphologic findings of focal 
parenchymal lesions frequently occuring in daily routine when interpreting 
thoracic CT.
3. To recognise those additional findings that represent the “helpful clue” for 
correctly narrowing the differential diagnosis.
Panel discussion: 
What have we learned from our mistakes? 09:44
Interpreting the results of imaging studies is more and more challenging and time 
consuming due to the large volume of data to evaluate, compare and post-process. 
Moreover, errors in the interpretation of imaging studies can have significant effects 
on patient care, particularly in acute medicine and oncology. So the question is how 
to be aware of the potential pitfalls that may be encountered in the realisation and 
the interpretation of imaging studies and how to avoid them or to learn from them. 
08:30 - 10:00 Room B 
Organs from A to Z: Pancreas 
MC 719 
Imaging inflammation and function 
Moderator: 
O. Akhan; Ankara/TR 
A‑187	 08:30 
A. Acute pancreatitis 
P.R. Ros; Cleveland, OH/US (Pablo.Ros@UHhospitals.org) 
Acute pancreatitis remains a potentially life threatening condition with an overall 
mortality rate of 5%. Its outcome is strongly related to a precise and timely diagnosis, 
a correct estimate of severity and subsequent appropriate treatment. Radiologic 
imaging, particularly CT, plays a key role in staging the severity and therefore helps 
guiding therapeutic decisions. Management of interstitial or edematous pancreatitis 
is supportive while severe or necrotising pancreatitis requires intense monitoring and 
specific therapies. The latter has a higher mortality and guarded prognosis, since 
it may lead to organ failure, infection, pseudocyst formation and extrapancreatic 
parenchymal and vascular complications. A number of severity indices have been 
established to determine the prognosis of acute pancreatitis, based both on clinical 
and imaging criteria. A CT-based severity index has become the main prognostic 
method to predict outcomes. This course reviews relevant imaging findings of 
various stages of acute pancreatitis and its complications by CT, including special 
conditions such as groove pancreatitis and autoimmune pancreatitis. Currently 
established and modified severity indices are reviewed to learn how to estimate 
prognosis and guide therapy. 
08:30 - 10:00 Room A 
Special Focus Session 
SF 7 
My ‘most beautiful’ mistakes 
Moderator: 
M. Zins; Paris/FR 
A‑183	 08:30 
Chairman’s introduction 
M. Zins; Paris/FR (mzins@hpsj.fr) 
Interpreting the results of imaging studies is more and more challenging and time 
consuming due to the large volume of data to evaluate, compare and post-process. 
Radiology errors are inevitable, affect all radiologists and may be defined as a 
mistake that has management implications for the patient. Errors can be broadly 
classified into technical errors, active errors (errors in perception, judgment or 
knowledge) and errors of communication. The majority of errors are false-negative 
interpretations and occur during interpretation of CT examinations. Good communi-
cation between the referring physician and the radiologist is essential. Unfortunately, 
only a small minority of radiologists keep a personal record of their errors. Patient 
safety should benefit from the repeat organisation of “error meetings” through the 
act of collective learning. Radiologists and radiology departments must continue 
to improve the process of recording and addressing errors. 
Session Objectives:
1. To understand the potential pitfalls that may be encountered in interpreting 
imaging exams with emphasis on acute medicine and oncology.
2. To recognise the different types of errors: technical errors (latent or system 
related) or active errors (errors in perception, judgment or knowledge).
3. To learn about methods to facilitate identification of errors in order to 
minimise their occurrence.
A‑184	 08:35 
Abdomen 
A.H. Freeman; Cambridge/UK (a.h.freeman@talk21.com) 
Making a mistake in radiology may result in catastrophic effects for the patient. It 
is therefore crucial that as radiologists we are honest with ourselves, prepared to 
review our mistakes and errors with an open mind, and thus pass this knowledge 
onto future generations of radiologists. Mistakes may come about through techni-
cal, observational and deductive errors and these will be reviewed utilising two 
separate cases. 
Learning Objectives:
1. To understand the potential pitfalls that may be encountered in interpreting 
abdominal imaging exams.
2. To become familiar with technical errors in the realisation of abdominal 
imaging exams that contribute to misinterpretation.
3. To be aware of the spectrum of factors that contribute to active errors 
(detection, characterisation) in interpretation of abdominal imaging exams.
A‑185	 08:58 
GU 
L.E. Derchi; Genoa/IT (derchi@unige.it) 
Radiologists do make mistakes, diagnostic errors can be the cause of severe 
consequences to patients or, luckily, in many cases, they can be corrected. Learn-
ing from mistakes is quite important since understanding why a mistake has been 
made help to avoid it in the future. During this lecture a series of mistakes made 
in the field of GU will be presented and causes which have lead to each of them 
will be analysed. 
Learning Objectives:
1. To understand the potential pitfalls that may be encountered in interpreting 
GU imaging exams.
2. To become familiar with technical errors in the realisation of GU imaging 
exams that contribute to misinterpretation.
3. To be aware of the spectrum of factors that contribute to active errors 
(detection, characterisation) in interpretation of GU imaging exams.
S
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08:30 - 10:00 Room C 
CLICK (Clinical Lessons for Imaging Core Knowledge): Common 
Clinical Cases 
CC 718 
Dyspnea 
Moderator: 
M. Rémy‑Jardin; Lille/FR 
A‑190	 08:30 
A. Clinical considerations 
J. Neuwirth; Prague/CZ (neuwirthj@gmail.com) 
Dyspnoea is defined as an awareness of difficulty in breathing. Individual sensation is 
described as “shortness of breath”, “breathlessness” or tightness in the chest. Clinical and 
diagnostic approach differs according to severity and speed of onset. It can be chronic, 
acute or hyperacute = life threatening. Hyperacute dyspnoea can be caused by pulmonary 
embolism, tension pneumothorax, severe metabolic acidosis, florid pulmonary oedema, 
status asthmaticus, severe upper airway obstruction and ARDS. Dyspnoea is the most 
common complaint of patients with cardiopulmonary diseases and 60% of dyspnoea is 
caused by cardiac, pulmonary or mixed cardiopulmonary aetiology. Clinical differential 
diagnosis list is long. The pulmonary causes are airway mass including angio-oedema, 
epiglottitis, laryngeal obstruction, asthma, bronchitis, chest wall trauma, effusion, emphy-
sema, metastatic disease, pneumonia, pneumothorax, pulmonary embolism, pulmonary 
hypertension and restrictive lung dinase. The cardiovascular aetiology includes: ar-
rhythmia, coronary artery disease, intracardiac shunt, left ventricular failure, myxoma, 
pericardial and valvular disease. Less frequent aetiology includes drug-induced, neuro-
psychogenic or haematological diseases or by increase of abdominal pressure. Rare 
causes are: neuromuscular, CNS disorders, myopathy, neuropathy, phrenic nerve and 
diaphragmatic disorders, spinal cord disorders, altitude, anaemia, metabolic problems, 
anaphylaxis and sepsis. The priority diagnoses include COPD, heart failure, pneumonia 
and pulmonary embolism. The imaging methods are most decisive and conclusive in the 
last two. The plain chest film is requested just after check-out of vital signs, consciousness, 
pulse dimetry, oxygen mask and arterial blood gas in life threatening dyspnoea. CT and 
CT angiography are more frequently used in acute setting as well. 
Learning Objectives:
1. To learn more about the clinical conditions causing shortness of breath.
2. To be informed about the clinician’s way of thinking in the process of 
differential diagnosis.
3. To become familiar with the potential role of imaging in the establishment of 
the final diagnosis and planning of therapy.
A‑191	 09:00 
B. Imaging techniques and typical findings 
H. Prosch; Vienna/AT (helmut.prosch@meduniwien.ac.at) 
Dyspnoea is a common symptom in patients presenting to the emergency room. 
In almost two-thirds of all cases, dyspnoea is caused by either a pulmonary or a 
cardiovascular disorder. Imaging in patients with dyspnoea depends mainly on 
the clinical presentation and the medical history of the patient. Chest radiographs 
are a cost-effective and rapid test for the evaluation of patients with dyspnoea, 
with a fair sensitivity and specificity. For this reason, chest radiographs are usually 
performed early in the diagnostic evaluation of patients with acute and chronic dys-
pnoea. Chest radiographs enable the diagnosis of frequent causes of dyspnoea of 
pulmonary origin, such as pneumonia, pneumothorax, pleural effusions, interstitial 
lung diseases, and emphysema. The diagnosis of cardiovascular disorders, such 
as pulmonary venous hypertension, cardiomyopathy, as well as valvular diseases, 
is also facilitated by chest radiographs. If chest radiographs, clinical studies, and 
laboratory tests, however, are non-diagnostic or equivocal, CT is indicated. CT 
offers high sensitivity and specificity for the evaluation of pulmonary embolism 
and for diseases of the pulmonary parenchyma and the airways. High-resolution 
CT represents the method of choice for the evaluation of suspected diffuse lung 
disease. Additional expiratory scans are useful for the evaluation of mosaic perfu-
sion and air-trapping. 
Learning Objectives:
1. To learn about the available imaging modalities to be used for the evaluation 
of dyspnea patients.
2. To become familiar with the technical imaging considerations and the proper 
diagnostic algorithm.
3. To know more about the typical imaging findings.
Learning Objectives:
1. To review the clinical and imaging classification of acute pancreatitis and its 
implications for patient management.
2. To understand the role of cross-sectional techniques and how to provide 
prognostic information.
3. To understand the role of imaging in clinical decisions regarding 
complications.
A‑188	 08:55 
B. Chronic pancreatitis 
G. Morana; Treviso/IT (gmorana@ulss.tv.it) 
Chronic pancreatitis (CP) is an inflammatory disease of the pancreas, with irrevers-
ible morphologic changes and fibrotic replacement of the gland, which progressively 
result in loss of exocrine and endocrine function. CP is morphologically character-
ised by irregular sclerosis associated with destruction and permanent loss of the 
exocrine parenchyma which may be either focal, segmental or diffuse. The primary 
symptoms of CP are abdominal pain and maldigestion, which may be physically 
and socially debilitating, although it is acknowledged that chronic pancreatitis can 
occasionally be painless. A classification based on the causes of CP is useful 
in order to better define the therapeutic interventions. However, morphological 
changes of the pancreatic ducts are the main rule of thumb for the classification 
in order to better compare the results of the treatment. Imaging techniques have 
a role both on the diagnosis - especially in the early phases of the disease - and 
on the classification of CP, either for the grading of the disease, to explain the 
aetiology - even for rare forms - and to differentiate the focal mass from ductal 
adenocarcinoma. CT, MRI and ERCP have a specific role in the assessment of 
CP, due to the different capacity of the techniques to explore the pancreatic gland. 
However, thanks to heavily T2w sequences, MRI has a competitive role with ERCP, 
which actually has more an interventional role in case of obstructive CP. Finally, 
MRI thanks to secretin test and DWI sequences is able to give a non-invasive 
assessment of pancreatic exocrine function. 
Learning Objectives:
1. To review the imaging findings and classification of chronic pancreatitis.
2. To understand the pros and cons of imaging techniques including ECRP.
3. To learn about the rare forms of CP such as auto-immune and groove 
pancreatitis.
4. To pick up clues on how to differentiate from adenocarcinoma.
5. To learn how to measure exocrine pancreatic function.
A‑189	 09:20 
C. Management of complications of pancreatitis 
C.D. Becker; Geneva/CH (Christoph.Becker@hcuge.ch) 
Complications of pancreatitis may include fluid collections and pseudocysts, vas-
cular complications such as arterial pseudoaneurysm or thrombosis of the portal 
venous system, and stenosis of common bile duct and pancreatic duct. Inflammatory 
fluid collections in the context of acute pancreatitis often resolve spontaneously. 
Drainage may become necessary in the presence of clinical complications such 
as abdominal pain, compression of adjacent organs by large pseudocysts, or if 
superinfection of a pseudocyst occurs. Depending on clinical, morphologic, or tech-
nical factors, drainage may be accomplished with image- guided external catheter 
placement, by endoscopic internal (transgastric) drainage or by internal surgical 
drainage. Arterial pseudoaneurysm carries the risk of acute intra- or extraperitoneal 
bleeding, and transarterial embolisation is usually indicated when pseudoaneurym 
is detected. Strictures of the common bile duct secondary to chronic pancreatitis 
may require percutaneous or endoscopic retrograde intervention. 
Learning Objectives:
1. To review interventional techniques that are used to manage fluid collections 
in the setting of pancreatitis.
2. To compare the results with those obtained by surgical and/or endoscopic 
approach.
3. To learn about algorithms used for clinical decision making, and for 
treatment evaluation and follow-up.
4. To understand major shortcomings and complications and how to avoid 
them.
Discussion 09:45 
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ants include the presence of accessory muscles, a low-lying peroneus brevis muscle 
belly, pseudosubluxation of the peroneus brevis tendon, and a bifurcated or mildly 
crescentic peroneus brevis tendon. Accessory muscles in the ankle area include in 
the lateral aspect the peroneal tertius and peroneal quartus, in the medial aspect the 
flexor digitorum accessorius longus, and posteriorly the peroneocalcaneus internus, 
tibiocalcaneus internus and accessory soleus. As variations are commonly seen in 
asymptomatic ankles, matching with clinical symptoms is important. Pitfalls include 
pseudoloose bodies in the ankle joint, pseudolipomas, and artefacts such as the „magic 
angle“ effect, chemical shift, susceptibility, motion, „ghost“ and partial volume averaging. 
Knowledge of normal anatomy, pitfalls and variants, aids radiologists in making the 
precise diagnosis of various disorders. 
Learning Objectives:
1. To become familiar with the normal anatomy.
2. To be able to identify normal variants.
3. To appreciate the range of pitfalls that may simulate pathology.
A‑195	 09:20 
C. Identifying and reporting abnormal findings 
A. Cotten; Lille/FR (anne.cotten@chru‑lille.fr) 
Ankle and foot disorders are common and can affect a wide variety of patients and 
many different anatomical structures. A precise and complete analysis of all these 
structures is therefore required, and an appropriate terminology of the pathological 
features has to be used in the report. This lecture will review the MR appearances 
of the most common disorders (traumas, microtraumas, infection, rheumatisms, 
tumours, etc.) affecting the bones, joints and soft tissues of the ankle and foot. 
Learning Objectives:
1. To review the imaging appearances of common abnormalities.
2. To understand the use of terminology to describe pathological findings.
3. To learn how to structure a radiological report to ensure clarity and brevity.
08:30 - 10:00 Room D2 
Genitourinary 
RC 707 
CTU and MRU: urinary tract imaging 
Moderator: 
R. Manfredi; Verona/IT 
A‑196	 08:30 
A. CTU/MRU in acute obstruction 
T. Meindl; Munich/DE (thomas.meindl@med.uni‑muenchen.de) 
A variety of pathological processes that involve the upper urinary tract (UUT) may cause 
acute urinary obstruction: impacted calculi, neoplasms, intra- and extraluminal ureter 
compression, coagulopathy, fibrosis and surgery. Clinically acute obstruction leads to 
significant flank pain and renal colic that urges the clinician to immediate diagnostic 
work-up and appropriate treatment. Radiological imaging procedures include ultraso-
nography, intravenous urography, computed tomography (CT) and magnetic resonance 
(MR) imaging. Among the cross-sectional examinations, multi-detector CT is the mo-
dality of choice for clarifying the underlying cause of acute obstruction. Unenhanced 
(low-dose) CT is the new imaging standard for detection of calculi. Contrast-enhanced 
CT allows diagnosis of virtually all pathologies leading to obstructive nephropathy. 
After intravenous contrast media application, several contrast-phases can be imaged 
including the excretory phase for depiction of the UUT. Since radiation dose is a major 
drawback, imaging protocols have to be optimised and must be tailored to the clinical 
question. Magnetic resonance urography reveals the possibility of imaging the urinary 
tract without the need for contrast media by means of heavily T2-weighted sequences. 
These static urograms provide information about the grade and site of obstruction, 
independent of the excretory function of the kidneys. After injection of gadolinium 
chelates, one or more urograms can be acquired during contrast media excretion. In 
the context of acute obstruction, MR urography is preferred in paediatric, young and 
pregnant patients. Patients with renal impairment are examined with T2-weighted 
sequences without the need for contrast media. Magnetic resonance urography is 
complementary to CT in challenging cases. 
Learning Objectives:
1. To learn the technical tips for MRU and CTU in acute obstruction.
2. To understand the value of cross-sectional urography compared to IVP.
3. To review the appearance of major diseases like urinary stones, clots, etc.
4. To understand the drawbacks of each method and which one should be 
used first.
A‑192	 09:30 
C. Interactive case discussion 
J. Andreu; Barcelona/ES (jandreus@gmail.com) 
The aetiology of dyspnoea is varied. It may be due to pulmonary or pleural disease, 
cardiac pathology or extrathoracic causes. Imaging is an useful adjunct in the diag-
nosis of majority of cases of dyspnoea. In this lecture we will present selected cases 
which will demonstrate the usefulness of different imaging modalities, emphasising 
when cross-sectional imaging is indicated. 
Learning Objectives:
1. To review typical cases illustrating the role of imaging modalities in the 
differential diagnosis of dyspnea cases.
2. To motivate the audience by the use of voting pads to be involved in the 
diagnostic process.
3. To highlight the conclusion that may be drawn on the basis of the discussed 
cases.
08:30 - 10:00 Room D1 
KISS (Keep It Simple and Straightforward): Musculoskeletal MRI 
CC 716 
The ankle and foot 
Moderator: 
M. Shahabpour; Brussels/BE 
A‑193	 08:30 
A. How I do it 
M. Zanetti; Zurich/CH (marco.zanetti@balgrist.ch) 
We use two various standard MR imaging protocols for the evaluation of foot and 
ankle abnormalities. For hindfoot abnormalities, MR imaging is performed with the 
foot in neutral position and the patient is supine. T1-weighted spin-echo images are 
obtained in the coronal plane and in the transverse oblique plane (45° between the 
coronal and transverse planes). T2-weighted fast spin-echo images are obtained in 
the coronal plane and in the transverse plane. A fast spin-echo short tau inversion 
recovery (STIR) sequence is obtained in the sagittal plane. The protocol is modi-
fied when patients are referred specifically for flexor tendon abnormalities. Such 
patients are prone positioned to avoid magic angle artefacts. Alternatively to the 
prone body position, the foot can be plantarflexed in supine body position. In our 
experience this position is less comfortable and results in more motion artefacts 
than the well tolerated prone body position. For forefoot abnormalities, MR imag-
ing is performed in the prone body position with plantarflexed foot. The reason 
for prone patient positioning is the higher conspicuity of Mortons Neuroma in the 
prone position compared to the supine position. The protocol consists of a sagittal 
T1-weighted spin-echo sequence, a transverse (perpendicular to the metatarsals) 
T1-weighted spin-echo MR sequence, and a transverse T2-weighted turbo spin-
echo sequence. A coronal short inversion time inversion recovery (STIR) images 
is used as a screening sequence for bony lesions. Contrast enhanced T1-weighted 
fat-suppressed spin-echo MR images are obtained for rheumatic diseases. 
Learning Objectives:
1. To understand the influences of patient positioning, scan parameters and 
magnet/coil technology on image quality.
2. To learn how to optimise scan protocols to maximise patient throughput 
without compromising diagnostic quality.
3. To recognise how and when to modify scan protocols to answer specific 
clinical questions.
A‑194	 08:55 
B. Normal variants and pitfalls 
A.H. Karantanas; Iraklion/GR (akarantanas@gmail.com) 
MR imaging is recognised as the modality of choice in the diagnosis of many diseases 
of the ankle and foot. In order to better depict pathology, detailed knowledge of the 
normal anatomy is important. The proper depiction of normal anatomy requires recogni-
tion of the anatomic variants. Osseous variants include a flat or convex retromalleolar 
fibular groove, hypertrophy of the peroneal tubercle and retrotrochlear eminence, 
presence of various accessory bones such as the os naviculare and os peroneum 
and variation of the calcaneal apophysis ossification. Variants of the subtalar joints 
include a missing anterior facet, fusion of the anterior and middle facets and articula-
tion between talar head and cuboid bone. At the posterior talocalcaneal articulation, 
variations exist regarding the curvature of the medial side of the joint. Soft tissue vari-
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08:30 - 10:00 Room E1 
Musculoskeletal 
RC 710 
Bone marrow oedema and bone marrow oedema-
like lesions 
Moderator: 
B. Vande Berg; Brussels/BE 
A‑199	 08:30 
Chairman’s introduction 
B. Vande Berg; Brussels/BE (bruno.vandeberg@uclouvain.be) 
The term bone marrow oedema was introduced to describe ill-defined bone marrow 
hypointensity on T1Wi and hyperintensity on T2Wi and water sensitive sequences. 
Bone marrow edema can be found in many similar unrelated disorders, such as 
bone contusions, osteonecrosis, inflammatory or degenerative disease, being a 
non-specific MRI abnormality representing a diagnostic challenge for radiologist. 
Recently has been demonstrated that bone marrow oedema might be a prognosis 
marker for OA (osteoarthritis) and inflammatory disease, and could be used as a 
powerful predictive tool for treatment options. Therefore our role as radiologist is to 
try to increase specificity to help patient management and decrease progression. 
The aim of this refresher course is to describe MR imaging features of bone marrow 
edema in different important and frequent disorders: osteoarthritis, inflammatory 
diseases and trauma. 
A‑200	 08:35 
A. BME and osteoarthritis 
F.W. Roemer; Augsburg/DE (f.w.roemer@gmx.de) 
Subchondral bone marrow lesions (BMLs) are a hallmark of osteoarthritis (OA) on 
MRI. Radiologically, BMLs in OA are understood as non-cystic subchondral areas 
of ill-defined hyperintensity on T2w images and of hypointensity on T1w images, 
but only water-sensitive fat-suppressed sequences depict the lesions to their maxi-
mum extent. BMLs are observed regularly in conjunction with adjacent cartilage 
alterations. Higher grades of cartilage loss are associated with higher prevalence 
and greater volume of concomitant BMLs. As the disease progresses, an increase 
in BML volume is seen in the same region subchondrally in many patients, which 
is positively correlated with an increase in cartilage loss and radiographic joint 
space narrowing. Cysts are strongly associated with BMLs in the same subregion 
and develop within non-cystic BMLs. The published data on the natural history of 
BMLs are ambiguous but recent reports showed that the majority of subchondral 
BMLs may regress or resolve completely. Note that progression and regression of 
BMLs may be observed within the same knee simultaneously. Histologic correlation 
studies showed that the lesions consisted of a mixture of different tissue patterns 
with only little oedema. Specific changes in bone mineralisation and remodelling 
in areas of BMLs have been shown, and they appear sclerotic compared to unaf-
fected regions from the same individual. Differential diagnoses of OA-related BMLs 
include traumatic bone contusions and fractures with or without disruption of the 
articular surface. Osteonecrosis, inflammation, idiopathic BMLs, red marrow and 
post-surgical alterations should also be considered. 
Learning Objectives:
1. To learn about the basic physiopathology of OA and its relation with BME.
2. To analyse the distribution and natural history of BME in OA.
3. To understand the differential diagnosis and relevance of BME in staging OA 
and as a marker of prognosis.
A‑201	 08:58 
B. BME and early inflammatory disease 
A.J. Grainger; Leeds/UK (andrew.grainger@leedsth.nhs.uk) 
Marrow oedema is identified as a feature of many forms of inflammatory and 
mechanical arthritis, but has been most studied in the inflammatory arthritides 
and particular in rheumatoid arthritis. It was first reported as a feature of RA as 
far back as 1986. Work has been undertaken both using human specimens and 
specimens from animal models which suggest that marrow oedema seen on MRI 
in RA corresponds to areas of inflammation been associated with invading pannus, 
lymphocytic aggregates and hypervascularity. There is also evidence that the mar-
row lesions seen on MRI in ankylosing spondylitis correspond to histopathological 
inflammatory change. Marrow oedema has been shown to be an important predictor 
A‑197	 09:00 
B. Chronic/intermittent obstruction 
M.-F. Bellin; Le Kremlin‑Bicêtre/FR (marie‑france.bellin@bct.aphp.fr) 
The recent technological advances of CTU and MRU have had an exceptional 
impact on the assessment of chronic/intermittent obstruction. Imaging studies 
should help answer the clinical questions raised concerning the presence, level, 
and cause of obstruction. In this session, the recommended techniques of CTU 
and MRU will be described and their relative merits and limitations reviewed. 3D 
CT images should be used as an adjunct to the transverse images, instead of a 
replacement, because volume-rendered images best depict the lumen and not the 
wall of the urinary tract. Thin-section reformatted CT images likely are as sensi-
tive as transverse images in the detection of urinary tract abnormalities. MRU is 
being increasingly used because it provides excellent anatomic and functional 
imaging in a single setting. It has proved particularly valuable in pregnant women 
and children. The relative advantages of static-fluid MRU and excretory MRU 
will be discussed. The main aetiologies of chronic/intermittent obstruction will be 
illustrated, including intraluminal diseases (stones, clots, etc.), wall abnormalities 
(transitional cell carcinomas, tuberculosis, etc.) and extraluminal diseases (pelvic 
and retroperitoneal tumours, retroperitoneal fibrosis, GI tract diseases, etc.) UPJ 
syndrome is the most common site of urinary tract obstruction in children. Vessels 
crossing a ureteropelvic junction obstruction contribute to the degree of hydrone-
phrosis in up to 46% of these patients. Demonstration of these vessels and their 
location anterior or posterior to the obstruction facilitates surgical planning. At the 
end of the lecture, attendees will become familiar with moderate or severe urinary 
obstruction and their various features and causes. 
Learning Objectives:
1. To learn the technical tips for MRU and CTU in chronic obstruction.
2. To review the appearance of major diseases like PU junction, prostate 
masses, chronic inflammation and extrinsic compression.
3. To understand the advantages and disadvantages of each method.
A‑198	 09:30 
C. Tumours: CTU/MRU 
N.C. Cowan; Oxford/UK (nigel.cowan@nds.ox.ac.uk) 
1. Technological advances in both computed tomography (CT) and magnetic 
resonance (MR) imaging have improved the diagnostic imaging of the urinary 
tract, surpassing ultrasound and the intravenous urogram. Multidetector computed 
tomography urography (CTU) is defined as CT examination of the kidneys, ureters 
and bladder with at least one imaging series acquired during the excretory phase 
of contrast enhancement. MR urography (MRU) can be performed using heavily 
T2-weighted sequences without contrast material or T1 spoiled gradient - recalled 
echo sequences during the excretory phase after administration of gadolinium-
based contrast material. In adults, CTU or MRU is now the preferred examination. 
Technical aspects of image acquisition and processing will be explored and technical 
tips relating to protocol design given. 2. The typical and atypical appearances of 
upper urinary tract urothelial tumours and bladder cancers will be demonstrated. 
A method of fluoroscopic biopsy of upper tract tumours is described for validation 
of the imaging diagnosis. 3. Early and accurate diagnosis of urinary tract tumours 
helps optimise prognosis but conventional investigative pathways are complicated 
and lengthy, utilising multiple imaging tests and many diagnostic algorithms exist 
without rigorous evaluation. CTU offers a single imaging test of high diagnostic 
accuracy with the potential to replace multiple alternative imaging tests in the 
diagnostic pathway, improve patient experience, improve diagnostic performance 
and accelerate diagnosis. MRU is a promising technique that may be used for 
the initial evaluation of patients at high risk for developing upper-tract urothelial 
carcinoma when CTU or intravenous urography is contraindicated. 
Learning Objectives:
1. To learn the technical tips for MRU and CTU in the detection of urothelial 
tumours.
2. To review the typical and atypical appearance of urothelial tumours.
3. To understand why CTU/MRU are complementary tools to other imaging 
methods.
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rhage and periventricular echodensities. The posterior fontanelle approach improves 
the detection of grade II haemorrhage in 30% more cases than the anterior fonta-
nelle, and the mastoid fontanelle approach is essential for diagnosing cerebellar 
haemorrhage. Ventricular dilatation is the main complication of intraventricular 
haemorrhage and resolves spontaneously in approximately 65% of cases. The main 
challenge with periventricular echodensities is to differentiate them from classical 
periventricular leukomalacia. When cysts appear during follow-up, the diagnosis 
is straightforward. MRI is considered to be more sensitive than US for evaluating 
white-matter damage. Congenital brain malformations including ventricular dilatation 
of diverse aetiologies, corpus callosus agenesis and posterior fossa malformations 
are usually diagnosed prenatally. MRI complements US for this purpose. Acquired 
abnormalities arise mainly from infections and hypoxic-ischaemic injury. Although 
MR is considered the gold standard, US still plays an important role in the study of 
hypoxic-ischaemic lesions when used to its full capacity. Depending on the duration 
and severity of the hypoxic insult, patterns different from those seen in premature 
infants may be observed. 
Learning Objectives:
1. To learn about the technique of neonatal neurosonography and outline its 
limitations.
2. To become familiar with the common abnormalities seen in the premature 
infant.
3. To learn about the common congenital and acquired abnormalities in the 
term infant.
A‑204	 09:00 
B. Common congenital cerebral abnormalities 
A. Rossi; Genoa/IT (andrearossi@ospedale‑gaslini.ge.it) 
Brain malformations are conditions where the brain has not formed properly during 
pregnancy. These problems in brain structure are almost often (with some excep-
tions) associated with neurological and developmental problems. Often, brain 
malformations are part of syndromic complexes that require a multidisciplinary 
approach. Malformations may be caused by inherited genetic defects, spontane-
ous mutations within the genes of the embryo, or effects on the embryo due to 
the mother’s infection, trauma, or drug use. Classification schemes are currently 
shifting from a morphological to a genetic approach. The most frequent congenital 
brain abnormalities may be categorised into anomalies of the corpus callosum and 
telencephalic commissures, holoprosencephalies and related entities, malforma-
tions of the cerebral cortex, and malformations of the cerebellum. These congenital 
brain defects are diagnosed either from direct physical examination or from imaging 
studies including CT and MRI. Prenatal MRI offers a viable method to improve 
detection and characterisation of these entities in utero. 
Learning Objectives:
1. To learn about the common supra- and infratentorial congenital 
abnormalities.
2. To learn when MRI is required and the appropriate imaging protocol.
3. To learn if and when CT is still useful in the investigation of congenital 
anomalies.
A‑205	 09:30 
C. CNS infection and inflammation: signs you should not miss 
M.I. Argyropoulou; Ioannina/GR (margyrop@cc.uoi.gr) 
Different neuroimaging patterns of CNS infection may be found in neonates and 
young children. In the neonatal period parenchymal calcifications with or without 
ventriculomegaly are suggestive of intrauterine infection. Cytomegalovirus causes 
additionally striatal vasculopathy and gyral abnormalities and herpes simplex en-
cephalomalacia. Herpetic infection in older children involves the orbital surface of the 
frontal lobes, the temporal lobes and the insula and causes haemorrhagic lesions. 
Ischaemic or haemorrhagic infarcts may be suggestive of varicella zoster infection. 
Involvement of the pontine tegmentum, the anterior horns and the ventral roots of 
the spinal cord is observed after enterovirus infection. HIV infection may appear as 
basal ganglia and deep white matter atrophy, as diffuse brain atrophy or even as 
necrotising encephalopathy. Brain abscess may appear as mass lesion presenting 
peripheral enhancement and restricted diffusion. Diffuse meningeal enhancement 
may be suggestive of viral or bacterial meningitis, while basal cistern enhancement 
is suggestive of tuberculous meningitis. Acute disseminated encephalomyelitis is a 
parainfectious condition appearing with multiple peripheral ill-defined simultaneously 
enhancing white matter lesions. Involvement of the basal ganglia, the thalami and 
the cortex may also be seen. Spinal cord lesions appear as longitudinal swelling 
over more than three vertebral segments. Multiple sclerosis (MS) presents with 
multiple lesions perpendicular to the long axis of the lateral ventricles. Larger le-
sions with open ring enhancement are suggestive of tumefactive MS. Spinal cord 
of future joint damage in patients with rheumatoid arthritis. In addition to predicting 
bone destruction for erosion, marrow oedema is independently predictive of joint 
space loss and therefore cartilage destruction. It also correlates well with other 
measures of disease activity. We have applied dynamic contrast enhancement 
techniques to show that treatment with anti-TNF therapy brings about a reduction 
in contrast uptake in areas of marrow oedema in patients with RA. In the serone-
gative arthritides marrow oedema in the spine in ankylosing spondylitis has been 
shown to be predictive of future changes and of response to treatment. Diffusion 
weighted imaging of marrow lesions in ankylosing spondylitis can also be used to 
show a treatment response, seen as a change in the apparent diffusion coefficient. 
Learning Objectives:
1. To become familiar with the imaging pattern of seronegative and rheumatoid 
arthritis distribution.
2. To understand the relationship between BME and early diagnosis of 
inflammatory disease.
3. To analyse whether BME helps in patient management, diagnosis and 
follow-up.
A‑202	 09:21 
C. BME and trauma 
O. Hauger; Bordeaux/FR (olivier.hauger@chu‑bordeaux.fr) 
Bone marrow oedema, also referred as bone contusion or bone bruise, is frequently 
identified at magnetic resonance imaging after an injury to the musculoskeletal 
system. It may result from a direct blow to the bone, compressive forces from 
adjacent bones impacting one another, or from traction forces that occur during 
an avulsion injury. Its location reflects the mechanism of injury, which allows for a 
focused search for predictable patterns of associated internal derangements. It is 
seen in any joint but are particularly common in the knee reflecting mechanisms 
such as pivot shift, hyperextension, contrecoup or dashboard injuries, as well as 
lateral patellar dislocation. In a context of trauma, bone marrow oedema, identified 
at MR imaging as areas of poorly marginated signal intensity alteration (best seen 
on fat-suppressed sequences) in the cancellous bone and marrow, represents 
areas of oedema and haemorrhage secondary to trabecular injury. It can be seen 
as soon as one hour after trauma and usually resolves in the following six to eight 
months, except in case of subsequent chondral lesion. 
Learning Objectives:
1. To learn about BHE physiopathology in trauma scenario, direct and indirect 
mechanism.
2. To recognise BME as a footprint that allows other soft tissue injuries to be 
ruled out.
3. To analyse whether BME can be a value tool for follow-up.
Panel discussion: 
Can we still use the term BME or should we be more specific? 09:44
The term bone marrow oedema was introduced to describe ill-defined bone marrow 
hyperintensity on T2 weighted images. Since then many studies have demonstrated 
that it can be found in many similar unrelated disorders, such as bone contusions, 
osteonecrosis, inflammatory or degenerative disease, and that it is a non-specific 
MRI abnormality. It has been demonstrated that bone marrow oedema might be 
a prognosis marker for OA (osteoarthritis) and inflammatory disease, and could 
be used as a powerful predictive tool for treatment options. Therefore our role is 
to increase specificity to help patient management and decrease progression. 
08:30 - 10:00 Room E2 
Foundation Course: Paediatric Radiology 
E³ 720 
Paediatric neuroimaging: let’s make it simple! 
Moderator: 
J.F. Schneider; Basle/CH 
A‑203	 08:30 
A. Neurosonography in the neonate: rules of thumb 
G. Enriquez; Barcelona/ES (genriquez@vhebron.net) 
Sonography is an essential tool for studying the neonatal brain. Brain scans are 
usually performed via the anterior fontanelle; however, a more complete assess-
ment of the brain can be achieved using the posterior and mastoid fontanelles, 
high-resolution linear array transducers and colour or power Doppler. The most 
common lesions in premature infants are intraventricular/periventricular haemor-
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A‑208	 08:58 
B. CT and MRI perfusion 
F. Berger; Munich/DE (Frank.Berger@med.uni‑muenchen.de) 
At initiation, tumours in a pre-vascular phase are supplied by oxygen and nutrients 
that diffuse from pre-existing normal vessels. When the tumour reaches a critical 
size of approximately 1-4 mm diameter, the resultant ischaemia leads to secretion 
of angiogenic factors. These factors, such as vascular endothelial growth factor 
(VEGF), recruit and maintain tumour vessels. “New” vessels (neovasculature) 
exhibit increased blood volume and permeability compared with normal vessels. 
Various new specific therapies in oncology target tumour vasculature or tumour neo-
angiogenesis. It is not uncommon that these targeted therapies have pronounced 
cytostatic and not predominantly cytotoxic effects. This limits the usefulness of 
size-based morphological tumour response assessments. Of newer magnetic 
resonance imaging (MRI) modalities, perfusion MRI has emerged as a valid marker 
of tumour-induced blood vessels and their function. MRI perfusion measures the 
vascularity within a tumour, as well as its component heterogeneous parts. Of 
parameters which can be measured to date, blood volume and permeability are 
commonly applied in patient studies. Blood volume measures the aggregate size 
of the vascular space, while the permeability function informs about the integrity 
of vessels and their ‚leakiness‘ to contrast agents. We will describe the use of MR 
perfusion to monitor such new therapies and discuss its specific advantages and 
limitations in comparison to CT perfusion protocols. PET-based strategies for tar-
geted treatment-monitoring in oncology will be briefly mentioned, with prospect on 
the significance of combined vascular and metabolic imaging for further optimising 
non-invasive response assessment in specific anticancer therapies. 
Learning Objectives:
1. To learn about established morphological-based strategies for tumour 
response monitoring: RECIST and WHO criteria with their limitations in 
targeted treatment surveillance.
2. To learn about the latest antiangiogenic/antivascular treatment strategies in 
oncology.
3. To learn about perfusion imaging protocols, specific advantages and 
technical challenges when utilising CT or MRI.
4. To learn about the significance of CT or MR perfusion imaging in oncology, 
typical applications and future strategies for improvement of non-invasive 
treatment monitoring in oncology.
A‑209	 09:21 
C. MR diffusion and PET/CT 
C. Della Pina; Pisa/IT (mclotilde@virgilio.it) 
After a brief review of physical and technical principles of diffusion-weighted MR 
imaging and PET-CT, the lecture describes the ability of these techniques in evalu-
ating functional parameters in tumour tissue. Diffusion-weighted sequences have 
been used in an attempt to further increase the diagnostic capability of baseline 
and dynamic MR study by providing functional information. Diffusion-weighted 
MR imaging is based on the random microscopic movement of molecules that 
can be quantified by means of apparent diffusion coefficient (ADC). In the early 
post-treatment period after loco-regional therapies, tumours may not change in 
size. Recent studies demonstrated that water diffusion can be used to differentiate 
viable and cellular regions from necrotic area in the tumour, regardless morphologic 
or dimensional changes. Moreover, new classes of antitumour therapy have been 
developed that have an antiproliferative effect, inducing a delay in tumour shrink-
age. Diffusion MR imaging can be promising in this clinical setting as a biomarker 
to predict early response to systemic chemotherapy. On the other hand, PET/CT, 
combining the functional and the structural imaging approach, was shown to be su-
perior regarding conventional imaging modalities in the identification of intrahepatic 
and extrahepatic metastases. Less experience and less publications are available 
for PET-CT in monitoring tumour response after interventional therapies, but the 
ability of PET-CT to measure early metabolic changes could make this technique 
useful in the development of novel anticancer drugs. 
Learning Objectives:
1. To become familiar with the physical and technical principles of DWI and 
PET/CT in tumours.
2. To recognise the qualitative and quantitative information of the different 
modalities.
3. To review imaging findings after percutaneous and intra-arterial treatments 
of liver malignancies.
4. To appreciate the clinical role of these techniques in monitoring tumour 
response.
involvement is characterised by lesions well or ill-defined lesions extending over 
less than one vertebral segment. 
Learning Objectives:
1. To recognise how best to image the child with suspected CNS infection or 
inflammation.
2. To understand the imaging findings and the main differential diagnoses.
3. To learn about the complications and their investigation.
08:30 - 10:00 Room F1 
Abdominal and Gastrointestinal 
RC 701 
Tumour evaluation: beyond morphology 
Moderator: 
O. Lucidarme; Paris/FR  
A‑206	 08:30 
Chairman’s introduction 
O. Lucidarme; Paris/FR (olivier.lucidarme@psl.ap‑hop‑paris.fr) 
Until now, in oncology, only the RECIST criteria based on anatomical measurement 
of the tumour size are used for drug trials or in clinical practice because this is a 
standardised way to assess the tumour response that allows the calculation of the 
progression-free survival (PFS) or the time to progression (Ttp) that are usually ac-
cepted as surrogate end point for overall survival. However, tumour follow-up evaluation 
using only morphology is usually delayed and with the emergence of new numerous 
and very expensive targeted therapies there is now a need to move beyond morphol-
ogy to find new ways to assess tumour responses or progression not only for clinical 
trials but also in clinical practice to maintain or to change quickly a treatment. This is 
the aim of the functional imaging using ultrasound, CT, MRI or PET. The ultimate goal 
of these technique is to find biomarkers able to predict the likely course of disease, 
irrespective of treatment (prognostic biomarkers) or able to forecast the likely response 
to treatment (predictive biomarkers); before (baseline values of a parameter) or during 
the treatment (dynamic variation of the parameter during the follow-up). During this 
session the presenters will discuss the technical issues and the results obtained today 
using ultrasound with share-waves or microbubbles, functional CT, dynamic contrast 
enhanced MRI, diffusion weighted MRI and PET-CT. The candidate biomarkers will 
be presented as well as the limits and the problems that are still to be overcome. 
A‑207	 08:35 
A. US and CEUS 
M. Claudon; Vandoeuvre‑les‑Nancy/FR (m.claudon@chu‑nancy.fr) 
For tumour evaluation, the main advantages of ultrasound (US) associate a high 
frame rate and a large range of data and parameters potentially extracted from 
the signal backscattered from tissues. Beyond morphology, elastography is a first 
modality, based on in vivo estimation of the mechanical properties of tissues. Data 
on displacement or strain of tissues and lesions can be obtained by manual exter-
nal compression, but shear wave generation techniques allow for a quantitative 
and more precise estimation of their visco-elastic properties. In oncology, clinical 
evaluation included first breast. Contrast-enhanced US (CEUS) is obtained after 
intravenous administration of microbubbles which are pure blood pool contrast 
agents. CEUS is capable for detection, characterisation and follow-up of tumour 
lesions, based on enhancement profiles during bolus, destruction-replenishment, 
or contrast burst depletion imaging. Quantification of perfusion in normal tissues 
and lesions may be obtained by extracting various blood flow and blood volume-
related parameters from time-intensity curves. Protocols have entered validation 
processes to improve reproducibility. As a predictive technique, CEUS is a promis-
ing tool for monitoring changes of haemodynamic parameters and evaluating the 
early response during chemotherapy or antiangiogenic treatment. It is helpful in 
the guidance and follow-up of lesions treated by radiofrequency or cryoablation. 
Recent advances of US and CEUS include 3D/4D real-time imaging with matrix 
technology, and the evaluation of targeted agents, to be released on site after 
bubble destruction by the US beam. 
Learning Objectives:
1. To learn about enhancement characteristics of the liver and the various focal 
liver lesions.
2. To understand in which situations US and CEUS are expected to be 
appropriate.
3. To understand the role of US and CEUS in comparison to CT and MRI.
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Learning Objectives:
1. To learn about the differences in training in IR and methods of training 
harmonisation in Europe.
2. To learn about a syllabus for European IR training.
3. To understand the optimum timing and methodology for delivering IR 
training.
A‑212	 08:58 
Turf battles facing IR 
J.A. Reekers; Amsterdam/NL (J.A.Reekers@amc.uva.nl) 
Interventional radiology, being part of general radiology, has traditionally always 
been a medical specialty to support clinicians. It is about 15 years ago that IR 
procedures were gradually changing from an extension of a clinicians treatment, 
to become stand-alone treatments replacing traditional surgical techniques. 
Interventional radiologists moved more towards the clinical site, not only making 
the diagnosis but also controlling the indications for treatment. This became very 
clear at the turning of the century as one of the pillars of vascular surgery, being 
aneurysm surgery, became the new playing ground for interventional radiologists. 
A major turf battle was born. Next to this well know turf battle there are many oth-
ers emerging at the horizon. Gynaecologist wanting to perform UFE, GE-doctors 
performing biliary interventions, cardiologist doing renal stenting, but also urologist, 
trauma physicians and many others are moving towards image-guided minimal 
invasive treatment. Is the consequence of all these battles that IR by interventional 
radiologists should/will disappear? Not at all, at least when we stop fighting these 
battles. Recognition of IR as an independent clinical medical speciality, with his 
own needs, training and certification, is the most important way forward. Being the 
best equipped, best trained, image-guided treatment specialist is essential. Making 
service and financial alliances with other more traditional medical specialties is also 
important. The old adagio, if you cannot beat them, join them, is still valid. But join 
them on equal terms from the strong position as well trained clinical interventionalist. 
Learning Objectives:
1. To understand reasons for turf battles.
2. To learn how to resolve conflict with other specialities.
3. To learn about conflicts with diagnostic radiology.
A‑213	 09:21 
Future directions in IR 
M.J. Lee; Dublin/IE (mlee@rcsi.ie) 
The dramatic growth of interventional radiology (IR) over the last 15 years and 
its increasing impact on patient care have made IR a vital component of modern 
healthcare. IR is in a strong place; however, there are vital areas that require nur-
turing. Clinical practice in interventional radiology is a must for IR to continue to 
grow and fulfil its potential. Outpatient clinics, day case and inpatient beds should 
all be part of IR work plans. Teaching is an important part of any clinical discipline 
and interventional radiologists need to ensure that IR plays a prominent role in 
the undergraduate and postgraduate curricula of medical schools. Research is 
also important and has been gathering momentum and critical mass over the last 
10 years. In Europe, IR remains strong under the stewardship of CIRSE. CIRSE 
holds the largest IR meeting, with an attendance of over 5000 delegates, annu-
ally. Recently, IR has been recognised as a sub-speciality under the umbrella of 
diagnostic radiology at UEMS. This is an important milestone with great potential. 
In fact, CIRSE have recently run the first sub-certification examination (European 
Board of Interventional Radiology-EBIR) in Interventional Radiology in Europe in 
October 2010. Importantly, the examination was endorsed by ESR and by the IR 
Division of UEMS. I believe EBIR is an incredibly important examination which 
will supercede national boundaries and give IR a more secure footing in Europe. 
Interventional radiology is emerging into the light, I believe it has a bright future. 
Learning Objectives:
1. To learn about ways to guide IR in a safe direction.
2. To learn about subcertification in IR.
3. To understand the importance of recognition by UEMS.
4. To understand the issue of working in multidisciplinary teams.
Panel discussion: 
What does an interventional radiologist need to know? 09:44
Some years ago, interventional radiologists (IRs) could have been seen as skilled 
physicians interested in the performance of complex vascular procedures. This is not 
the case anymore and now IRs are (or should be) fully involved in the multidisciplinary 
management of patients. This new scenario needs specific training, recognition 
among other specialists and institutional boards as well as specific subcertification. 
Panel discussion: 
How can you easily implement some functional imaging into your 
practice? 09:44
Through clinical cases the speakers will discuss or debate the best use of the 
available functional imaging techniques, pitfalls and limitations and how they can 
be optimally used in combination with correlative anatomic imaging modalities ac-
cording to the clinical questions (staging, restaging, assessment of response and 
prediction of patient prognosis before and after neoadjuvant therapy). 
08:30 - 10:00 Room F2 
Professional Challenges Session 
PC 7 
Professional issues in interventional radiology: 
education, training and standards 
Moderators: 
J.I. Bilbao; Pamplona/ES 
J.H. Peregrin; Prague/CZ 
A‑210	 08:30 
Chairmen’s introduction 
J.I. Bilbao1, J.H. Peregrin2; 1Pamplona/ES, 2Prague/CZ (jibilbao@unav.es) 
Interventional radiology (IR) is the part of clinical radiology based on the per-
cutaneous or endoluminal treatment of widespread conditions. The procedures 
performed by the interventional radiologists require a deep level of knowledge of 
clinical imaging and specific training in patient management and care. Technical 
skills are also needed because complex devices and materials are used in some 
procedures. Therefore, specific training programmes are required to address the 
training needs for the interventional radiologist. A multidisciplinary approach is 
required (based on team work) with defined levels in patient care. IR procedures 
have become the treatment of choice for many conditions as an alternative for 
some surgical procedures. Even for some conditions without a defined treatment 
are now being treated by IR. Thus, it is a discipline with a great deal of interaction 
with other clinical specialities that requires a clear definition. IR specialists have to 
receive recognition in the patient care process and their activity has to be known by 
the medical community. The recognition of IR as a subspecialty of clinical radiology 
by the UEMS will contribute to the development of specific training programmes in 
the European community and will promote training centres with certified specialists. 
Session Objectives:
1. To know more about the specific training needed for interventional radiology 
(IR).
2. To learn about the interaction between IR and other specialties.
3. To understand the relevance of the recognition of IR as a UEMS division 
within the section of Radiology.
A‑211	 08:35 
Education and training in IR 
A.-M. Belli; London/UK (Anna.Belli@stgeorges.nhs.uk) 
Interventional radiology (IR) procedures are complex and require specific training 
to ensure good results. In the UK, a curriculum for subspecialty training was es-
tablished in 1998 specifying the required knowledge, training and core procedures 
expected of trainees. This curriculum has undergone several reforms since that 
time. However, training is not uniform throughout Europe and this stimulated the 
development of a Europe wide IR training document to ensure similar training in 
all countries as a way of ensuring good medical practice. Radiology training is 
based on 3 years of common radiology training and 2 years of subspecialty train-
ing with an option for further specialist training in the 6th year. Regular appraisals 
and assessments of trainees’ performance should guide progress at local train-
ing institutions with the aim that competence is assessed formally at the end of 
training by a European Board examination. This qualification will be recognised 
thoughout Europe and ensures that the required proficiency in IR procedures has 
been attained. Competence in the core skills for IR occurs during the first 3 years 
of training. In the next 2 years, trainees undertake modular training depending on 
their areas of interest and ultimate goals. The majority of this training is practical, 
supervised training in interventional suites and theatres, with clinical exposure. 
Simulators play a role alongside the more traditional training methods and allow 
early training in a more forgiving environment away from the patient. Development 
and validation of such simulation models is progressing. 
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discrimination of individual x-ray quanta, i.e. the detectors can ‘see’ the colour of 
the x-rays. Different materials attenuate the energy spectrum in their own charac-
teristic way. By comparing the measured spectra with the spectrum emitted from 
the x-ray tube the penetrated material can be characterised. Colour x-ray imaging 
can be used in breast imaging to detect, for example the uptake of an iodinated 
contrast agent to show the vasculature of a tumour while reducing the impact of the 
structures from the surrounding tissue. It can also be used to estimate the breast 
density and as a material decomposition technique to separate the digital mam-
mogram into compositional images, showing different material types separately. 
Colour x-ray imaging can, for example be realised with pulse height discrimination 
in a photon counting detector, multiple exposures with different x-ray tube settings 
or filtering the x-ray beam before or after the object. The most simple form of colour 
x-ray is dual energy where two images are acquired at different x-ray energies.
Learning Objectives:
1. To learn the benefits of colour x-ray imaging.
2. To get an overview of available methods for colour x-ray imaging and their 
respective advantages and drawbacks.
08:30 - 10:00 Room I/K 
Chest 
RC 704 
Non-small cell lung cancer 
Moderator: 
J. Vilar; Valencia/ES 
A‑217	 08:30 
A. Update in TNM classification 
S. Diederich; Düsseldorf/DE (s.diederich@marien‑hospital.de) 
Lung cancer staging is based on imaging techniques in combination with tissue 
diagnosis and surgical exploration. The TNM staging system describes the local 
tumour extent (T1-T4), presence or absence of lymph node metastases (N0-N3) 
and distant metastases (M0/M1). Different combinations of T-, N- and M-factors 
translate into tumour stages (stages IA-IV). Therapeutic decisions and assessment 
of prognosis are based on these tumour stages. Recently, the TNM system has 
been modified: tumour size is now used more precisely for T staging: tumours 
<= 2 cm: T1a, > 2-3 cm: T1b, > 3-5 cm: T2a, > 5-7 cm: T2b, > 7 cm: T3. Satellite 
tumour nodules in the same lobe are now classified as T3 (previously T4) and in a 
different lobe of the ipsilateral lung as T4 (previously M1). Satellite nodules in the 
contralateral lung (previously M1) and pleural or pericardial metastases (previously 
T4) are now classified as M1a, whereas distant metastases outside the chest are 
classified as M1b (previously M1). Also, the TNM staging system should now be 
applied not only to non-small cell lung cancer (NSCLC) but also to small cell lung 
cancer (SCLC). During this refresher course the different T-, N- and M-stages will 
be presented including the recent changes and examples will be presented and 
discussed with the audience. Therapeutic strategies in different tumour stages 
will be described and key decisions highlighted. The accuracy of different imaging 
procedures and findings will be presented and the role of biopsy in specific clinical 
scenarios will be discussed. 
Learning Objectives:
1. To understand the principles of TNM classification for lung cancer.
2. To understand the relationships between tumour stage, prognosis, and 
therapeutic strategies.
3. To become familiar with the recent changes of TNM classification for lung 
cancer.
A‑218	 09:00 
B. PET/CT in lung cancer 
N. Howarth; Chêne‑Bougeries/CH (nigel.howarth@grangettes.ch) 
Integrated PET/CT imaging has an established role in the management of cancer 
patients and is now recommended for all patients with curative non-small cell 
lung cancer. PET/CT provides information essential for staging and prognosis, 
for choice of management and monitoring of treatment and for the detection of 
recurrence. Recent technical developments in PET/CT permit rapid examinations 
with improved resolution. Compared with standard CT or stand-alone PET, the 
added value of fused imaging is uncontested. The clinical influence of preoperative 
PET/CT is currently undergoing extensive evaluation. Radiologists should benefit 
from an understanding of important aspects of molecular imaging to improve their 
contribution to patient management. With the increasing use of PET/CT in the 
08:30 - 10:00 Room G/H 
EFOMP Workshop 
New technology in diagnostic radiology:  
advances in breast imaging 
EF 1 
Advances in technology for breast imaging 
Moderators: 
S. Christofides; Nicosia/CY 
A. Del Guerra; Pisa/IT 
Welcome address 	 08:30
S. Christofides; Nicosia/CY 
Y. Menu; Paris/FR 
A‑214	 08:40 
Breast tomosynthesis 
P.R. Bakic; Philadelphia, PA/US (Predrag.Bakic@uphs.upenn.edu) 
Digital breast tomosynthesis (DBT) is an imaging modality which allows for three dimen-
sional visualisation of breast tissue based upon the tomographic reconstruction using 
a limited number of x-ray projections. Early clinical studies indicated higher specificity 
and sensitivity compared to mammography, thus suggesting DBT as a candidate for 
replace mammography for early cancer screening. There are still several open issues 
in DBT, as, e.g. visualisation of microcalcifications, breast density estimation, use of 
contrast-enhanced DBT, and optimisation of DBT acquisition and reconstruction. This 
lecture will review published results of DBT clinical trials and discuss the open ques-
tions related to the use of DBT in quantitative imaging. In addition, we will discuss the 
use of simulation in DBT optimisation and validation. Validation of DBT is a challenging 
task due to its technological complexity. Clinical trials represent the gold standard for 
validation. They are, however, long, costly, and involve repeated exposure of women 
to radiation. Pre-clinical DBT validation may be performed using simulation of breast 
anatomy and image acquisition. Such approach offers ground truth about simulated 
tissues and flexibility to vary anatomy and/or acquisition parameters. The use of simula-
tion in DBT validation will be illustrated by the examples of DBT geometric accuracy 
estimation and optimisation of DBT reconstruction parameters. 
Learning Objectives:
1. To become familiar with the current research topics in digital breast 
tomosynthesis.
2. To compare the performance of digital breast tomosynthesis with 
mammography in terms of early cancer screening.
3. To learn about the use of breast anthropomorphic computer phantoms and 
acquisition simulation in validation of digital breast tomosynthesis.
A‑215	 09:05 
Breast CT 
W.A. Kalender; Erlangen/DE (willi.kalender@imp.uni‑erlangen.de) 
X-ray computed tomography (CT) has been proposed and evaluated recently as a 
potential alternative method for breast imaging. Efforts so far showed success with 
respect to contrast-enhanced dynamic imaging, but suffered from limited spatial 
resolution. Respective efforts and clinical results will be reviewed. The new concept 
presented here builds upon micro-CT scanning approaches and aims at providing 
both high spatial resolution at around 100 µm for micro-calcification imaging and 
advanced dynamic scan capabilities with continuous acquisition and scan times of 
about 10 seconds for differential diagnosis of lesions. To achieve this, spiral scan 
modes, slipring technology, high-resolution detectors and high-power micro-focus 
x-ray tubes are demanded. The concept has been evaluated and confirmed by simu-
lations and basic experiments; feasibility studies are expected by the end of 2011. 
Learning Objectives:
1. To review the state of the art in CT of the breast.
2. To inform about concepts for dedicated CT scanners of the breast.
A‑216	 09:30 
X-ray colour in breast imaging 
C. Ullberg; Danderyd/SE (christer.ullberg@xcounter.se) 
Colour x-ray imaging can best be described as the x-ray analogy to optical colour 
imaging. In optical imaging the wavelength - the energy - of the light gives the dif-
ferent colours that we see. Emerging x-ray detector technologies enable energy 
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maintenance of confidentiality of patient information. In contrast, more hierarchi-
cal cultures often defer to elders for decision-making whereas communal cultures 
may involve community leaders in a shared decision-making process. Gender 
and religious issues can also affect the provision of high-quality procedures with 
same gender care being a requirement within some cultural groups and gowning 
procedures that maintain cultural values frequently being an expectation. In addi-
tion, in many countries in the developing world, radiation still has mystique and fear 
associated with it, affecting participation in screening programs and recruitment to 
medical radiation technology educational programs. This presentation will present 
findings from a variety of countries and cultures that will help to contextualise these 
issues through a cross-cultural imaging lens. 
Learning Objectives:
1. To understand the concept of culture in relation to healthcare delivery from a 
technologist’s and patient’s perspective.
2. To understand the impact of culture on patient health outcomes.
3. To understand the knowledge, skills and attitudes needed by a culturally 
competent health practitioner.
4. To consider the impact of global differences in ethical codes, scopes of 
practice, educational and professional practice expectations.
A‑221	 09:15 
B. Basic technique for image interpretation 
C. Patrick; Poole/UK (Cheryl.Patrick@poole.nhs.uk) 
First line image interpretation is now commonly used in the United Kingdom. For 
many years radiographers have used a system commonly known as “Red Dot” in 
order to identify to the referring clinician that an abnormality has been recognised 
on a radiographic image. This has more recently evolved into radiographer com-
ment where the radiographers’ experience in recognising abnormalities can help 
referring clinicians. Junior doctors are often inexperienced at image interpretation, 
thus this system can assist in ensuring that a higher percentage of fractures and 
injuries are observed and the appropriate treatment obtained. This presentation 
will demonstrate the fundamentals of basic image interpretation of the cervical, 
thoracic and lumbar spine in a trauma situation. It will include basic anatomy, 
mechanism of injury, common fractures and soft tissue signs. Using these principles 
this will encourage radiographers to use the comment system, both developing the 
radiographer’s role and helping to improve patient care. 
Learning Objectives:
1. To be familiar with the principles of image interpretation.
2. To gain knowledge of common abnormalities and injuries of the C/T and L 
spine.
3. To appreciate the role of the radiographer in image interpretation.
4. To consolidate knowledge of normal and abnormal radiographic 
appearances of the spine.
08:30 - 10:00 Room N/O 
Head and Neck 
RC 708 
Suprahyoid neck 
Moderator: 
D. Pereira Coutinho; Lisbon/PT 
A‑222	 08:30 
A. Anatomy-guided differential diagnoses 
C.R. Habermann; Hamburg/DE (c.habermann@uke.uni‑hamburg.de) 
Two fasciae cross the suprahyoid neck: the superficial cervical fascia (SCF) and 
the deep cervical fascia (DCF). The latter can be divided into three parts and 
these layers define different fascial spaces or compartments. The descriptions of 
these compartiments in the literature vary almost as much as those of the fasciae 
themselves. In addition, the names of the formed compartiments vary within the 
literature. Despite these controversies, the knowledge of these compartiments is 
inestimable for correct differential diagnosis of pathologies that arise in the su-
prahyoid neck. With the utilisation of cross-sectional imaging, it has been noticed 
that growth of some tumours appears restricted by fasciae and knowledge of the 
anatomy of these fasciae allows not only prediction of growth patterns. By allocation 
of a tumour to a certain compartiment the number of differential diagnosis drop 
dramatically due to the fact that in different compartiments different types of tissue 
occur. In addition, the exact localisation of infectious disease of the suprahyoid neck 
may predict further intracranial or mediastinal spread. Even though the number 
management of cancer patients, imaging pitfalls must be recognised to avoid both 
false-positive and false-negative interpretation. The principles and good practices 
of PET/CT will be explained. Normal distribution of FDG, pitfalls and normal vari-
ants will be presented. Specific examples will be discussed to demonstrate how 
the combined information of images of human anatomy upon which biological 
information within body structures is added improves delineation of disease, can 
guide surgical and radiation planning and biopsy. Advances in technology result in 
new training requirements for radiologists who should promote close collaboration 
with nuclear medicine specialists. 
Learning Objectives:
1. To review clinical indications and limitations of PET/CT for lung cancer 
staging and management.
2. To learn about future developments of PET/CT in lung cancer staging.
3. To understand the need for a complete integration of the nuclear medicine 
specialist and the radiologist in PET/CT examinations.
A‑219	 09:30 
C. Radiofrequency ablation of NSCLC: current status 
F. Deschamps; Villejuif/FR (Frederic.Deschamps@igr.fr) 
Percutaneous radiofrequency ablation (RFA) is a safe and effective treatment 
for patients with small non-small cell lung cancer (NSCLC). The low morbidity, 
including pneumothorax requiring chest tube drainage (10%), breathing impair-
ment pain and hospital stay make it possible in patients who have comorbidities 
that make them not surgical candidate anymore or in single lung patients. A series 
of 75 primary NSCLC (75% stage IA and 25% stage IB) patients demonstrated a 
median survival of 29 months with a 1, 3, and 5 years overall survival of 78%, 36%, 
and 27%. Median survival for stage IA was 30 months and 25 months for stage 
IB. Better survival was reported for tumours 3 cm or smaller with a survival rate 
close to 50% at 5 years. This is probably because the maximal ablation diameter 
is slightly larger than 40 mm with the electrode needles available now. Compared 
with RFA, larger and more circular zones of thermal necrosis with faster growth 
of the ablation zone can be achieved with microwave ablation (MWA) in a swine 
lung model. Early trials have demonstrated promising results for MWA and gives 
hope for better rate of complete ablation for larger tumour. Follow-up imaging of 
the ablation volume on CT is essentially based on morphologic evaluation. This 
method of evaluation has some drawbacks, namely late discovery of incomplete 
treatment. PET-CT appears promising to provide early evaluation of treatment 
response. Sensitivity and specificity of PET has been reported superior to CT in 
early detection of incomplete ablation. 
Learning Objectives:
1. To be able to define the best candidates for lung radiofrequency ablation.
2. To understand the results of radiofrequency ablation for primary tumours and 
lung metastases.
3. To review different imaging patterns of ablated lesions in the lung.
08:30 - 10:00 Room L/M 
Radiographers 
RC 714 
Radiography as a profession and a science 
Moderators: 
N. Kinsman; Poole/UK 
C. van Kuijk; Amsterdam/NL 
A‑220	 08:30 
A. Cultural competence in the practice of radiography: international 
implications 
C. Cowling1, L. Boyd2, M.D. Ward3; 1Rockhampton/AU, 
2Toronto, ON/CA, 3St. Louis, MO/US 
At its core, radiography is the acquisition of radiographic images to help diag-
nose and treat patients within clinical practice. There are, however, many factors 
which impact on the success of procedures and resultant quality of images. The 
operator-client relationship is often influenced by cultural values and norms which 
can vary considerably. Optimal images are dependent both on operator skill and 
client compliance which comes with a sense of trust critical to the fiduciary relation-
ship. This can be difficult to achieve within the physical environment of a radiology 
department and can also be impeded by cultural expectations and cultural conflict. 
Western societies that stress individual rights tend to focus on health practices that 
are embedded in this worldview such as the requirement for informed consent and 
S
aturday
Postgraduate.Educational.Programme
A S61CB D E F G H
08:30 - 10:00 Room P 
Vascular 
RC 715 
Vascular imaging: diabetes and vascular occlusive 
disease 
Moderator: 
M. Sapoval; Paris/FR 
A‑225	 08:30 
A. Metabolic syndrome, diabetes and vascular disease: what do we need 
to know? 
E. Minar; Vienna/AT (erich.minar@meduniwien.ac.at) 
The metabolic syndrome refers to the clustering of cardiovascular risk factors includ-
ing diabetes, obesity, dyslipidaemia and hypertension. The association between 
metabolic syndrome and cardiovascular diseases raises important questions about 
the underlying pathological processes. Insulin resistance and visceral obesity have 
been recognised as the most important pathogenic factors. Metabolic syndrome 
generally precedes and is often associated with type 2 diabetes. Cardiovascular 
risk reduction in individuals with metabolic syndrome should include (1) control of 
obesity, diet and physical activity and (2) control of the individual components of 
metabolic syndrome, especially atherogenic dyslipidaemia, hypertension, hypergly-
caemia and prothrombotic state. Appropriate management of metabolic syndrome 
should be able to prevent the progression from impaired glucose tolerance to frank 
diabetes and thus to prevent the increasing prevalence of type 2 diabetes and 
vascular diseases. Each 1% increase in HbA1c is associated with a 28% increase 
in risk of incident PAD. Diabetes is also highly associated with progression of PAD 
and especially with the development of critical limb ischemia. Rigorous control of 
blood glucose prevents the microvascular complications of diabetes, although 
similar benefits on the macrocirculation have not been ascertained. Patients with 
diabetes and PAD should have an aggressive control of blood glucose levels with 
a HbA1c goal of < 7.0% or as close to 6% as possible. In the new TASC paper this 
recommendation is graded as C, meaning that it is based on evidence obtained 
from expert committee reports or opinions and/or clinical experiences of respected 
authorities, while there are no applicable studies of good quality. 
Learning Objectives:
1. To learn the principles of metabolic syndrome and diabetes.
2. To understand how both diseases affect the vascular system.
3. To learn which vascular territories are primarily affected.
A‑226	 09:00 
B. Imaging strategies in the diabetic foot syndrome 
R. Iezzi; Rome/IT (r.iezzi@rad.unich.it) 
Peripheral arterial disease (PAD) is a common cardiovascular complication in patients 
with diabetes. In contrast to non-diabetic PAD, it is more prevalent and, because of the 
distal territory of vessel involvement and its association with peripheral neuropathy, 
it is more commonly asymptomatic. Diabetic PAD thus may present later with more 
severe disease and have a greater risk of amputation. The pervasive influence of 
diabetes on the atherothrombotic milieu of the peripheral vasculature is unique. The 
abnormal metabolic state accompanying diabetes results in changes in the arterial 
structure and function. The proatherogenic changes include increases in vascular 
inflammation and derangements in the vascular cellular components, alterations in 
blood cells and haemostatic factors. These changes are associated with an increased 
risk for accelerated atherogenesis as well as poor outcomes. In contrast to the focal 
and proximal atherosclerotic lesions of non-diabetic PAD, in diabetic patients the 
lesions are more likely to be more heavily calcified, diffuse, and distal, sparing the 
proximal vessels and mainly affecting the more distal arteries in the calf and, in a 
later stage, the foot. By identifying a patient with subclinical disease and instituting 
preventative measures, it may be possible to avoid acute, limb-threatening ischaemia. 
The primary imaging modality to be used should be duplex ultrasound, due to its 
non-invasive nature, lower risks and costs. CT-angiography and MR-angiography 
are now replacing DSA as standard imaging methods, providing a non-invasive 
assessment of the localisation and extension of a vascular lesion and allowing an 
accurate planning of endovascular and/or surgical treatment. 
Learning Objectives:
1. To review the typical lesions encountered in the diabetic foot syndrome.
2. To understand the underlying pathophysiology.
3. To learn imaging strategies for the evaluation of the diabetic foot syndrome.
of spaces in the literature varies from seven to fourteen, the use of seven spaces 
or compartiments seems to be helpful for a sufficient diagnostic approach using 
cross-sectional imaging. Anatomic landmarks and the radiologic appearance in a 
non-pathologic suprahyoid neck and a pathologic involvement of the suprahyoid 
compartiments will be reviewed extensively in a coherent manner. 
Learning Objectives:
1. To identify CT and MR imaging landmarks of the neck spaces.
2. To recognise the CT and MR imaging findings of normal anatomical 
structures in each space.
3. To understand the use of neck spaces as a basis for the differential 
diagnosis of pathologic conditions in the neck.
A‑223	 09:00 
B. Suprahyoid neck lesions in daily clinical practice 
V. Chong; Singapore/SG (dnrcfhv@nus.edu.sg) 
The anatomy of the suprahyoid neck is complex and the spectrum of diseases 
is wide. To improve studies of the neck, radiologists should become increasingly 
more familiar with the anatomy and expected pathology in the various spaces. 
This familiarity provides crucial information required for the selection of treatment 
options and therapeutic planning. In addition, radiologists should be aware of 
situations when diagnostic inaccuracies may lead to serious consequences and 
complications. For example, surgical approach to a deep lobe parotid tumour as 
though it is a parapharyngeal lesion will in all likelihood result in facial nerve injury. 
MRI artefacts such as complex flow-induced increase in signals may be mistaken 
as a lesion prompting an unnecessary operation. An awareness of such pitfalls 
helps to improve the quality of imaging studies. This presentation highlights some 
pertinent anatomical knowledge that may help to improve the diagnostic accuracy 
of neck studies and at the same time explain the existence of pitfalls that may ruin 
imaging studies. 
Learning Objectives:
1. To learn the anatomic basis of imaging abnormalities.
2. To understand the pathological basis of image interpretation.
3. To learn the potential pitfalls of radiological diagnosis.
A‑224	 09:30 
C. Tips and tricks for suprahyoid neck lesions 
A. Trojanowska; Lublin/PL (agnieszka30@yahoo.com) 
Three layers of the deep cervical fascia define the suprahyoid neck compartments, 
which include: prevertebral, retropharyngeal, carotid, masticator, parapharyngeal 
and pharyngeal mucosal space. Knowledge of the structures inherent to these 
spaces will provide the radiologist with an accurate basis for differential diagnosis. 
Also, expanding lesions will distort or displace adjacent structures and fascia in 
predictable fashion, which is crucial in defining the site of origin. Both MRI and 
CT are frequently used in the imaging of suprahyoid neck lesions. The introduc-
tion of functional imaging has also given some benefits. Primary and secondary, 
benign and malignant processes occupying major suprahyoid neck spaces will be 
discussed, with regard to crucial findings necessary for appropriate treatment selec-
tion and treatment planning. Since correct diagnosis requires close collaboration 
with ENT surgeons, clinical findings will also be discussed, together with practical 
information needed for surgery. 
Learning Objectives:
1. To become familiar with the most frequent pathologies in the suprahyoid neck.
2. To review the proper imaging technique.
3. To learn how to differentiate between benign and malignant lesions.
4. To learn about a template for the ‘perfect’ report.
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A‑229	 09:00 
B. MR spectroscopy 
L. Astrakas; Ioannina/GR (astrakas@cs.uoi.gr) 
In vivo proton MR spectroscopy is a non-invasive MR technique that is routinely used 
to assess a number of paediatric neurologic conditions. It is based on the fact that 
protons belonging to different metabolites resonate at slightly different frequencies 
(chemical shift). Using water suppression and volume localisation techniques we 
can obtain a spectrum (single voxel) or spectra (SI) containing metabolite peaks 
corresponding to predetermined anatomical site(s). In paediatrics the majority of 
spectroscopy is performed in the brain and the metabolites detected usually are: 
N-acetyl aspartate, N-acetyl aspartyl glutamate, creatine and phosphocreatine, 
Choline containing compounds (free choline, acetylcholine, phosphocholine, 
cytidine diphosphate choline and glycerophosphocholine), myoinositol, myoino-
sitol monophosphate and glycine, aminoacids (glutamine, glutamate and GABA), 
lactate, lipids and macromolecules. These metabolites participate in fundamental 
metabolic pathways and their levels are being disturbed by various pathologies. 
Thus, MR spectroscopy has a vast field of application including paediatric tumours, 
infarction, hypoxia, ischaemia, infection, inflammation, metabolic disorders neuro-
logical disorders and trauma. In many cases, it can redirect or narrow differential 
diagnoses; in selected instances, it may provide the key finding that points to a 
final diagnosis. However, MR spectroscopy alone is usually not specific, but can be 
very helpful especially in combination with other clinical, diagnostic and other MR 
methods. Finally, particular caution is needed in data evaluation because spectral 
appearance and concentrations of the most prominent metabolites are affected by 
(a) experimental and preprocessing factors and (b) brain development. 
Learning Objectives:
1. To become familiar with the basic principles of proton MR spectroscopy.
2. To understand what proton MR spectroscopy can offer to the diagnosis and 
monitoring of various paediatric diseases.
3. To understand how MR spectroscopy combines with other MR techniques.
A‑230	 09:30 
C. Vascular diseases: the role of CTA, MRA, angiography (DSA) 
N. Girard, X. Combaz; Marseille/FR (nadine.girard@ap‑hm.fr) 
Stroke in children is most often of ischaemic origin and thrombophlebitis is the 
second cause of stroke in children. Stroke is considered as rare compared to 
the adult population. However, numerous aetiologies impose to look for a cause 
through series biological investigations. The goal of brain imaging is to confirm 
the diagnosis of stroke, to evaluate the extension of ischaemia and mostly to 
participate in the search of a cause for the stroke. Prognostic is mostly related to 
the aetiology. A lot of cases are performed under general anaesthesia leading to 
limited indications of MRA in the acute phase compared to adult. The role of CTA 
at the acute phase is mostly to confirm thrombophlebitis and is the primary method 
to assess intracranial vessels at the acute phase of haemorrhage of arterial or 
venous origin. It is also the primary method to assess arterial vessels at the neck 
level (especially when dissection is suspected). CTA permits to confirm or rule out 
arterial lesion that was suspected on MR: indeed, cases with pitfalls are numerous 
with MR angiography. The role of MRA, also always performed in the acute phase 
or follow-up of vascular diseases, is not as clear as CTA role because of artefacts 
especially in young children. The role of angiography (DSA) is finally limited to 
prove vasculitis when the other methods are not contributive and in cases of arte-
rial or arterio-venous malformation to plan the treatment (endovascular procedure 
versus surgery or radiosurgery). 
Learning Objectives:
1. To become familiar with the specific presentation of cerebral vascular 
diseases in children.
2. To compare and appreciate specific indications for CTA, MRA and DSA.
3. To understand the best imaging approach depending on clinical 
presentation.
A‑227	 09:30 
C. Imaging prior to revascularisation: CTA, MRA or DSA? 
S.O. Schönberg; Mannheim/DE (Baerbel.Reichhard@umm.de) 
The choice of the appropriate modality for imaging of the peripheral vascular 
system strongly depends on the type of disease. In the acute setting of lower leg 
ischaemia caused by embolism or thrombosis on top of a pre-existing high-grade 
stenosis CT angiography frequently is the imaging modality of choice due to its 
24-hour availability and robustness with reasonable accuracy in the upper leg 
exceeding 90%. With the introduction of dual energy CT, visualisation of lower leg 
arteries and highly calcified areas has improved. For elective patients, contrast-
enhanced MR-angiography (CE-MRA) is the technique of choice, in patients with 
renal insufficiency preferably at 3 Tesla with a single dose of macrocyclic contrast 
agents. Recent continuous table-movement techniques have substantially reduced 
complexity and scan time and extended the spectrum to the emergency stetting. 
Time-resolved CE-MRA improves the detection of small arteries in the lower leg 
and reduces artefacts from venous overlay. Accuracy of state-of-the-art CE-MRA 
exceeds 95% compared to digital subtraction angiography (DSA). New fast spin-
echo and steady-state free precession MRA techniques without contrast media are 
promising, particularly in areas without motion. DSA should be restricted to the 
display of the target lesion, inflow and run-off during the interventional procedure 
as well as to the in-detail visualisation of the anastomosis site prior to surgical 
revascularisation particularly in the lower calf. 
Learning Objectives:
1. To learn the anatomy of the arterial system of the lower leg and its variants.
2. To review appropriate imaging protocols for each modality.
3. To review the pros and cons of MRA, CTA and DSA in the diabetic foot 
syndrome prior to revascularisation.
08:30 - 10:00 Room Q 
Paediatric 
RC 712 
Advanced brain imaging 
Moderator: 
C. Venstermans; Edegem/BE 
A‑228	 08:30 
A. Diffusion tensor MRI 
A. Righini; Milan/IT (neurorad@icp.mi.it) 
Diffusion tensor imaging (DTI) studies demonstrate progressive apparent diffusion 
coefficient (ADC) decrease within grey and white matter areas starting from foetal 
life as sign of brain maturation; meanwhile, fractional anisotropy (FA) increases in 
some white matter structures. Changes in FA and ADC, together with radial and 
axial diffusivity values, during cell proliferation-migration and during myelination, 
well correlate with modifications known from developmental histologic studies. 
Acute ADC decrease (i.e. ischaemia) can be detected already in foetal stroke and 
its measure is pivotal in monitoring neonatal hypoxic-ischaemic encephalopathy. 
ADC calculation allows also to assess acute osmotic and metabolic anomalies in 
neonate (i.e. hypernatremia, hypoglycaemia, etc.). Early FA decrease, with radial 
and axial diffusivity changes, is observed in white matter areas as sign or early 
wallerian degeneration after acute brain damage. Chronic regional white matter 
FA reduction is detectable in sequelae of periventricular leukomalacia or adjacent 
to malformative cortex. Also, in children with neurodevelopmental delay (autism, 
ADHD, dyslexia, etc.). FA reduction and radial or axial diffusivity changes have been 
demonstrated, but in these conditions not on a single case basis rather in cohort 
quantitative studies. Finally, building fiber tracking and colour coded (RGB) maps 
from DTI data may help in better characterising suspected structural anomalies 
on a single case basis (i.e. corpus callosum, hippocampal fornix, optic radiation, 
cerebellar peduncles malformations, etc.). However, the potentials of fiber tracking 
applications still need to be fully exploited, especially in view of future higher spatial 
resolution image acquisitions. 
Learning Objectives:
1. To understand the relationship of ADC-FA values with the structural 
characteristics of the normal developing brain.
2. To understand ADC-FA value changes in paediatric CNS diseases.
3. To learn about the potential impact of fibre tracking in clinical paediatric 
neuroradiological practice.
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Learning Objectives:
1. To become familiar with the characteristic high-resolution CT manifestations 
of granulomatous pulmonary infections.
2. To learn about the most helpful findings in distinguishing South American 
blastomycosis (paracoccidioidomycosis) from tuberculosis and other 
granulomatous and non-granulomatous pulmonary infections.
Interlude: The world is in love with Brazil 11:20
A‑234	 11:25 
Congenital lung disease in children: state-of-the-art imaging 
P.A. Daltro; Rio de Janeiro/BR (daltro.pedro@gmail.com) 
Congenital pulmonary malformations may involve the lung parenchyma, bronchi, 
arterial supply, and venous drainage. The pulmonary developmental abnormali-
ties that most commonly result in clinically significant complications in neonates 
and children are hypogenetic lung syndrome, bronchopulmonary sequestration 
(BPS), congenital lobar emphysema (CLE), bronchial atresia, congenital cystic 
adenomatoid malformation (CCAM), and bronchopulmonary foregut cysts. It 
should be noted that there is often considerable overlap between these conditions 
and that multiple lesions may be identified in the same patient either separately 
or as hybrid lesions. The aim of this presentation is to illustrate the characteristic 
imaging manifestations of the most important congenital lung diseases and their 
main differential diagnosis. Emphasis will be given to pre-natal diagnosis using 
ultrasound or magnetic resonance imaging (MRI) and post-natal diagnosis using 
MRI or low dose CT in multidetector scanners. 
Learning Objectives:
1. To review the characteristic imaging manifestations of the most important 
congenital lung diseases in children and their main differential diagnosis.
2. To understand the role of ultrasound and magnetic resonance imaging (MRI) 
in the pre-natal diagnosis of congenital lung diseases.
Panel discussion 11:45
10:30 - 12:00 Room E2 
Foundation Course: Paediatric Radiology 
E³ 820 
What should we know about antenatal imaging? 
Moderator: 
C. Adamsbaum; Paris/FR 
A‑235	 10:30 
A. Foetal imaging: current practice and evidence base 
C. Garel; Paris/FR (catherine.garel@trs.aphp.fr) 
Ultrasonography (US) is the primary screening modality in prenatal imaging. Its 
diagnostic accuracy is usually very high so that the indications for foetal MRI should 
be very rare. In some countries, because US is considered of secondary importance 
and is not exploited as much as it could be, there is a progressive shift from US to 
MRI as a prenatal imaging modality. Consequently, there are many discrepancies 
regarding the relative contributions of foetal US and MRI in the prenatal literature. 
The main indications for foetal MRI will be discussed, with emphasis on the central 
nervous system, which remains the main field of application. In daily practice, the 
technique of foetal MRI has not changed during the last decade and most diagnoses 
can be assessed using T1, T2 and T2* sequences. The basic technique and patient 
preparation will be described. New techniques, based on a functional or a metabolic 
approach, have been developing during the past few years but their impact on 
daily practice is still very limited. Many studies have underlined the high diagnostic 
contribution of foetal MRI compared with US. However, the diagnostic accuracy of 
MRI has not been studied in large series. Comparison between pre- and postnatal 
data or between foetal MRI and pathological findings make it possible to define the 
main limits of foetal MRI. Regarding the brain, migration or cortical development 
disorders are often overlooked or underdiagnosed. A tight collaboration between 
colleagues practicing prenatal US and MRI should increase diagnostic accuracy, 
both modalities being complementary. 
Learning Objectives:
1. To learn when MRI is recommended for the assessment of foetal 
abnormalities.
2. To become familiar with patient preparation, the technique and the value of 
the various sequences used.
3. To understand the main limits of MRI in imaging of the foetus.
10:30 - 12:00 Room B 
ESR meets Brazil 
EM 3 
Thoracic imaging: a Brazilian approach 
Presiding: 
M.A. Gomes da Silva; Sao Paulo/BR 
Y. Menu; Paris/FR 
A‑231	 10:30 
Introduction 
S.C.M. Tramontin1, M.A. Gomes da Silva2; 1Ponta Grossa/BR, 2Sao Paulo/BR 
(clinicamanoel@ig.com.br) 
Founded on September 15, 1948, the Brazilian College of Radiology comprises 
23 Regional Societies and ten thousand associates. The college is a branch of the 
Brazilian Medical Association (AMB) acting as its Scientific Department of Radiol-
ogy, Imaging Diagnosis and Radiotherapy. It collects, under the same umbrella 
medical professionals and legal entities in the field of diagnosis and treatment using 
imaging methods and/or ionising radiation. 
Session Objectives:
1. To get an introduction to the practice of radiology in Brazil.
2. To understand the importance of radiology as a method for diagnosing 
diseases in Brazil.
3. To become familiar with the great technological advances of radiology in 
recent years in Brazil.
A‑232	 10:35 
Granulomatous interstitial lung disease: HRCT path correlation 
C.I.S. Silva; Salvador/BR (c.isabela.silva@gmail.com) 
Granulomatous interstitial lung diseases are a group of lung diseases in which 
granulomas are an important component of the histologic findings. The most com-
mon conditions are hypersensitivity pneumonitis and sarcoidosis. Hypersensitivity 
pneumonitis is very common in Brazil because of the warm and humid climate in 
most regions and a large number of birds. The prevalence of sarcoidosis in Brazil 
seems to be lower than that in North America and Europe. Other ubiquitous causes 
of granulomatous interstitial lung disease include intravenous talcosis, drug reac-
tions, and some forms of vasculitis (e.g. Churg-Strauss syndrome). The aim of 
this presentation is to illustrate the characteristic high-resolution CT and histologic 
manifestations of the most common granulomatous interstitial lung diseases and 
to summarise the main differential diagnosis based on the pattern and distribution 
of abnormalities seen on high-resolution CT. 
Learning Objectives:
1. To become familiar with the characteristic high-resolution CT and histologic 
findings of the most common granulomatous interstitial lung diseases 
(hypersensitivity pneumonitis and sarcoidosis).
2. To learn about the most helpful features in distinguishing the granulomatous 
interstitial diseases from other parenchymal lung diseases.
Interlude: Brazilian masterminds 10:55
A‑233	 11:00 
Granulomatous pulmonary infections 
A.S. Souza Jr.; São José do Rio Preto/BR (asouzajr@gmail.com) 
The most common granulomatous lung diseases are fungal infections and tuber-
culosis. These infections are particularly prevalent in Brazil, the most common 
fungal infection being paracoccidioidomycosis (South American blastomycosis). 
Histoplasmosis and coccidioidomycosis may occur but they are uncommon. 
Paracoccidioidomycosis is the most frequent endemic systemic mycosis in Latin 
America, being seen particularly in Brazil, Argentina, Colombia, and Venezuela. 
The lungs are the main target organ of P. Brasiliensis organisms, and infection of 
the lungs is the leading cause of morbidity and mortality in these patients. Fungal 
infections need to be considered not only in patients living in endemic regions 
but also in patients who have travelled to these areas. Although the prevalence 
of pulmonary tuberculosis has decreased in Brazil in recent years it remains one 
of the most important causes of pulmonary morbidity and mortality. The aim of 
this presentation is to discuss the radiologic manifestations of the granulomatous 
pulmonary infections with emphasis in paracoccidioidomycosis and tuberculosis 
and to summarise the main differential diagnosis. 
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10:30 - 12:00 Room G/H 
EFOMP Workshop 
New technology in diagnostic radiology:  
advances in breast imaging 
EF 2 
Screening and diagnostic breast imaging 
Moderators: 
K. Faulkner; Wallsend/UK 
J. Vassileva; Sofia/BG 
A‑238	 10:30 
QA, image quality and dose in screening with digital mammography 
H. Bosmans; Leuven/BE (hilde.bosmans@uz.kuleuven.ac.be) 
The European Commission states in its council recommendation of 2 December 
2003 that mammography screening in women aged 50-69 is justified if performed 
in accordance with the European Guidelines on Quality Assurance (QA). This 
recommendation and the Directive 97/43/Euratom on medical exposures made QA 
an important part of screening programmes. Physico-technical aspects of digital 
mammography are to be included in QA programmes. As with film-screen systems, 
both acceptance tests, (half) yearly tests and constancy tests are necessary. Ac-
ceptance tests and yearly tests evaluate the performance of the system and the 
dose settings from blocks of PMMA. Special attention is given to the spatial char-
acteristics of the (digital) detector, the noise properties and the signal-difference-
to-noise-ratio. In the European guidelines, performance is ultimately assessed from 
contrast threshold values for a series of disk diameters. We discuss the use of the 
CDMAM phantom along with alternative approaches such as detectability indices 
d’ (Monnin, Verdun, Marshall et al.) for systems in our QA network. The automatic 
exposure controller should ultimately be tested in real cases. Patient dose inves-
tigations are more important than before. In digital mammography, and especially 
with direct digital detectors, patient dose surveys can be automated. Constancy 
checks have to guarantee an optimal quality every day. We will illustrate typical 
artefacts that occur with digital detectors and viewing stations. Daily homogeneity 
tests of the detector along with an automatic evaluation of DICOM tags allow both 
the detection of sudden problems as well as a long-term follow-up of performance. 
Learning Objectives:
1. To learn about the particular aspects of QA in digital mammography.
2. To learn about contrast-detail analysis and alternative tests to assess system 
performance.
3. To learn about the implementation, the results and the added-value of 
patient dose surveys in digital mammography.
A‑239	 11:00 
MRI diagnostic breast imaging 
K. Gilhuijs; Utrecht/NL (k.g.a.gilhuijs@umcutrecht.nl) 
Magnetic resonance imaging (MRI) is a highly sensitive technique that provides 
complementary information to conventional breast imaging (i.e. mammography and 
ultrasonography) for the detection of multinodular disease and for the assessment 
of primary tumour extent. The use of MR breast imaging has increased consider-
ably in the past decade. Although its use is well established for some indications, 
e.g. detection of unknown primary and assessment of uncertain disease extent, 
breast MRI is still under investigation for other applications such as preoperative 
assessment in patients eligible for breast conserving therapy on the basis of con-
ventional imaging and clinical examination. Despite its superior ability to visualise 
disease spread, recent studies have shown increased rates of mastectomy without 
reduction in positive surgical margins or local recurrence rates. Nonetheless, a 
shift in paradigm is occurring, focusing on the use of breast MRI to reduce involve-
ment of healthy tissue in breast-conserving therapy. This paradigm involves new 
methodology to optimise the transfer of information to the surgeons and radiation 
oncologists. New technological developments, such as diffusion-weighted imag-
ing (DWI) and magnetic resonance spectroscopy (MRS) provide new insights to 
establish a link with underlying biology of the tumour. Contrast-enhanced MRI, DWI 
and MRS are examined for their ability to extract prognostically relevant information 
to individualise therapy to individual patients and tumours. This overview aims to 
summarise the current status of breast MR imaging and new developments geared 
towards providing therapists with patient-tailored information for treatment decision, 
treatment guidance and therapy response.
A‑236	 11:00 
B. Ventricular enlargement and beyond 
E.H. Whitby; Sheffield/UK (e.whitby@sheffield.ac.uk) 
This talk will review the current literature and clinical use of foetal MRI in cases with 
ventriculomegaly. The initial part will discuss antenatal ultrasound in the detection, 
categorisation and diagnosis at the 20-week anomaly scan. The role of foetal MRI 
will be discussed including which cases may benefit most from foetal MRI when 
the resource is limited. The timing of the foetal MR with relation to gestational 
age and the value of further foetal MR scans at a later gestational age will also 
be discussed. This is still a controversial and debated area especially when the 
resource is limited or there are financial constraints. The current literature will be 
discussed on the issues around foetal MRI in cases with ventriculomegaly both 
isolated ventriculomegaly and ventriculomegaly associated with other abnormalities. 
Finally, this section will conclude by looking at the common associated abnormali-
ties seen in cases referred with ventriculomegaly. The final section will discuss 
the role of foetal MR in imaging the posterior fossa, an area often difficult with 
ultrasound especially in the later stages of pregnancy. Again the current literature 
will be discussed and the use of foetal MR in clinical practice. The concluding time 
will be used to summarise the referral pathway used by local centre in the UK. This 
will differ with other UK centres and centres worldwide. Hopefully, time will allow 
an open discussion on this at the end of the session. 
Learning Objectives:
1. To learn about the differential diagnoses of ventriculomegaly identified on 
foetal ultrasonography.
2. To learn when MR should be performed and its value when compared to 
ultrasonography.
3. To understand the value of MRI in assessing posterior fossa abnormalities.
A‑237	 11:30 
C. Common chest and abdominal problems 
A. Darnell1, C. Martín2; 1Barcelona/ES, 2Sabadell/ES (andarnel@clinic.ub.es) 
Prenatal diagnosis involves obtaining genetic, anatomic, biochemical and physi-
ological information about the foetus and analysing whether there are any altera-
tions that might have repercussions during the foetal period or after birth. Magnetic 
resonance imaging (MRI) has been useful in the diagnosis of foetal anomalies for 
many years. Thoracic abnormalities play an important role in infant morbidity and 
mortality. Survival after birth depends largely on adequate lung development dur-
ing gestation, and various pulmonary problems can affect foetuses. Heart defects 
are present in 8 of 1000 live births, and up to 25% of these are associated with 
other malformations. Other thoracic anomalies (tracheoesophageal malformations, 
chest wall defects, and tumours, amongst others) can also cause morbimortality. 
Congenital abdominal anomalies can affect many organs. It is essential to determine 
the location and morphological characteristics of the lesion to ensure an accurate 
diagnosis. MRI‘s excellent contrast resolution between tissues is very useful in the 
diagnosis of these conditions. Prenatal diagnosis also makes it possible to detect 
anomalies that can be difficult to recognise clinically in newborns but require early 
treatment to minimise possible complications.This presentation stresses the im-
portance of diagnosing chest and abdominal problems before birth and analyses 
the usefulness of MRI in this context. 
Learning Objectives:
1. To learn about the MR protocol when investigating the foetal chest.
2. To recognise the situations in which MRI is helpful in assessing chest 
abnormalities.
3. To understand the value of MRI when compared to ultrasonography in 
assessing congenital renal and gastrointestinal abnormalities.
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A‑243	 11:30 
Structured reporting: improving the quality of radiology reports 
C.E. Kahn; Milwaukee, WI/US (kahn@mcw.edu) 
The radiology report communicates the results of an imaging procedure and 
provides the enduring legal record of the procedure. Structured reporting uses 
standardised language and predefined formats to create reports. Structured reports 
can integrate information collected during the imaging procedure, such as clini-
cal data, technical parameters, measurements, annotations, and key images. In 
this presentation, well defined structured reporting describes its advantages and 
disadvantages, and identifies the motivations for its adoption. This session will 
discuss how structured reporting can make it easier to retrieve reported informa-
tion, evaluate the appropriateness of exams, and aggregate data across health 
care enterprises. Structured reporting can support radiology quality improvement, 
research, and education, and has the potential to improve the quality of commu-
nication between radiologists and their referring colleagues. 
Learning Objectives:
1. To define structured reporting and its potential role in radiology.
2. To become familiar with current efforts to promote structured reporting of 
imaging procedures.
3. To learn how structured reporting can improve the quality of radiology 
reports.
12:15 - 12:45 Room A 
Plenary Session 
HL 2 
Pierre et Marie Curie - Honorary Lecture 
Presiding: 
Y. Menu ; Paris/FR 
A‑244	  
Beyond morphology and into physiology: newer spine imaging techniques
M.M. Thurnher; Vienna/AT 
There are major challenges to imaging the spinal cord. A number of technical is-
sues needed to be resolved before the advanced techniques could be used as an 
adjunct to the clinical evaluation. Small size of the cord, macroscopic motion related 
to physiological CSF pulsations, breathing and swallowing, and local field inhomo-
geneities lead to reduction of the image resolution and cause disturbing artifacts. 
Despite these challenges there are a number of potential solutions that have been 
introduced in the last decade. Diffusion weighted imaging (DWI), diffusion tensor 
imaging (DTI), fiber tractography (FT) and functional BOLD (fMRI) of the spinal 
cord has seen progressive translation from the laboratory to the clinic. The results 
of recent studies show that significant changes in DTI metrics are present in the 
cervical spinal cord of patients with demyelinating diseases and other myelopathies, 
in the absence of spinal cord signal abnormality at conventional MR examinations. 
There is no doubt that in the future advanced techniques will provide an excellent 
set of biomarkers for understanding neuroplasticity of the spinal cord and response 
to therapies. This lecture will focus on evolution of spinal cord imaging and update 
you on the clinical applications of advanced techniques in imaging the spinal cord.
12:30 - 13:30 Room Z 
The Beauty of Basic Knowledge: Interpretation of the Chest 
Radiograph 
MC 21C 
Air-space disease 
A‑245	 12:30 
Air-space disease 
J. Cáceres; Barcelona/ES (josecac@gmail.com) 
Air-space disease is secondary to occupation of the acini and alveoli by oedema, 
exudates or malignant cells. It presents in the chest radiograph as ill-defined densi-
ties which tend to coalesce. The presence of an air bronchogram is pathognomonic. 
When the disease is widespread it shows the typical “butterfly” appearance. Air-
Learning Objectives:
1. To learn about the current status, indications and new developments in 
breast MRI.
2. To learn about processing, analysis and transfer of information from MRI to 
clinical decision making.
3. To understand the limitations and current opportunities for breast MRI.
A‑240	 11:30 
Is there a future for radioisotope breast imaging? 
S. Ziegler; Munich/DE (sibylle.ziegler@tum.de) 
No abstract available 
10:30 - 12:00 Room Z 
Standards and Audit 
How to write better reports 
Moderator: 
E.J. Adam; London/UK 
A‑241	 10:30 
How to write a good radiological report 
L.P. Lawler; Dublin/IE (llawler@mater.ie) 
The pixel data set of modern imaging is transformed into a life altering insight 
for the individual patient through the radiologic report. A good report is patient 
and service centred, and forms the basis of the reciprocal relationship between 
radiologist and referring clinician. It is a creative process with serious scientific 
purpose and becomes part of the permanent record in a person’s life. Its primary 
role is communication of diagnostic and procedure-related imaging information 
but it has many vital adjunct roles in quality service delivery. In current practice 
of multidisciplinary care the report content must be of value to all the stakehold-
ers beyond radiology. Structured reports must have uniformity where possible to 
permit data-mining and audit whilst preserving the individual radiologist practice 
and style and the individual nature of each patient’s health. Report design has 
a particular role in modern alerting and safety-net systems when unexpected or 
critical imaging findings are discovered. The properly written report can be vital in 
medico-legal defence to reflect good practice. Ultimately guidelines and standards 
on reporting must be meaningful to the users and appropriate to local resources, 
systems and needs. 
Learning Objectives:
1. To comprehend the role of the modern radiological report.
2. To understand the role of the report in communication and patient safety.
3. To become familiar with structured report formulations.
A‑242	 11:00 
Structured reporting: European perspective 
R. Silverio; Grosseto/IT (rsilverio@sirm.org) 
In the last decade, we observe an increasing interest in structured report (SR). This 
is a part of the DICOM standard, where the technical and clinical information are 
organised in a standard format so that it can be retrieved and reused for clinical, 
statistical and research scopes. Structured reports have three important features: 
a “structured” format, with fixed paragraphs, heading and subheading in which 
to describe technical data and clinical findings, impressions and conclusions; a 
consistent, “itemised” organisation, leading to a better way of reporting, even with 
automated speech recognition systems; and the possibility, or rather the need, 
of a common, shared language. When defined terms from a standard lexicon 
are associated with imaging reports, the information in the report becomes more 
accessible and reusable. Moreover, SR allows the interoperability between the 
DICOM world and the complex sphere of the e-health (electronic patient record, 
patient care, etc). It is possible to convert a radiological report created as SR in a 
CDA2 (Clinical Document Architecture) document. This clinical document will be 
used in every computerised healthcare application, as well in the several regional 
e-health projects (EPSOS, ELGA, Calliope, Renewing Health, etc). promoted by 
European Community. Integrating the Healthcare Enterprise (IHE) initiative is as 
a key partner in fostering the adoption of structured report. In short, question of 
whether SR will be adopted by radiologists is now a question of “when”, not “if.” 
Learning Objectives:
1. To become familiar with structured report.
2. To keep up to date on the developments of e-health projects in Europe.
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Learning Objectives:
1. To learn the different causes of ischaemic abdominal emergencies and 
principles for treatment by interventional radiology.
2. To learn the causes and the optimal imaging strategy for preparing 
treatment.
3. To understand the principles, techniques and results of interventional 
radiology for the treatment of acute abdominal bleeding.
A‑248	 16:30 
B. The black bowel 
P. Rogalla; Toronto, ON/CA (Patrik.Rogalla@uhn.on.ca) 
Ischaemic bowel disease represents a life threatening disease that requires im-
mediate clinical attention once diagnosed. Expansion of cardiac surgery, surgical 
interventions in elderly and high-risk patients has created an increasing demand 
for early diagnostic workup if bowel ischaemia is clinically suspected. Multi-row 
detector CT with multiplanar reformations including further projection techniques 
plays a leading role in early detection of bowel ischaemia if blood work and clinical 
presentation are equivocal or contradictory. Optimal sequencing of intravenous 
contrast media injection and the scanning delay represents a prerequisite for reli-
able diagnostic outcomes. Knowledge of typical patterns of the disease, early and 
late signs of ischaemic bowel disease is mandatory for radiologist in charge. The 
course will help to understand physiological principles and causes of ischaemic 
bowel disease. Diagnostic performance of current imaging tests and how to integrate 
them into clinical practice will be discussed. 
Learning Objectives:
1. To understand the underlying physiological principles and causes of 
ischaemic bowel disease.
2. To become familiar with typical signs of bowel ischaemia and how to use 
them.
3. To understand the diagnostic performance of current imaging tests and how 
to integrate them into clinical practice.
A‑249	 17:00 
C. Clinical management: what you need to know 
D.E. Malone; Dublin/IE (dmalone@ucd.ie) 
Acute mesenteric insufficiency (AMI) is due to arterial or venous occlusion. Arterial 
AMI is an emergency. The typical patient is elderly, may have atrial fibrillation and 
has recent onset intense visceral pain disproportionate to clinical signs. CT is the 
mainstay of diagnosis and may be supplemented by CT angiography (CTA). Waste 
no time if arterial AMI is suspected. Average mortality rates of 71% (59-93%) have 
been reported and symptom duration before therapy is an independent predictor 
of mortality. Age > 70 years, metabolic acidosis and renal failure are other danger 
signs. Interrupt routine CT lists; ensure that these patients are scanned as soon as 
possible - neutral oral contrast and high-dose IV contrast are essential. CT appear-
ances should be correlated with serum lactate as acute arterial occlusion without 
reperfusion may produce falsely 'normal' bowel wall thickness. Early diagnosis and 
aggressive surgical intervention combining bowel resection with revascularisation 
offer the best prognosis. Venous AMI may present with a more chronic, intermittent 
course of pain, fever, abdominal tenderness and ascites. Therapy is bowel resection 
and anticoagulation. Ischaemic colitis occurs in elderly patients with atherosclerosis 
spontaneously or after aortic aneurysm repair. There are fewer systemic manifesta-
tions, bloody diarrhoea predominates; it may spontaneously resolve. CT or contrast 
enema is established imaging options. Chronic mesenteric ischaemia presents with 
'intestinal angina' and weight loss. Doppler US, CTA/MRA are diagnostic. Surgical 
or interventional therapy is feasible; the correct choice varies with individual patient 
anatomic and co-morbidity considerations. Endovascular therapy may have higher 
re-intervention rates, reducing cost-effectiveness. 
Learning Objectives:
1. To review the clinical signs of ischaemic bowel disease.
2. To analyse the clinical management of patients with suspected bowel 
ischaemia with focus on workflow.
3. To analyse cost-effectiveness and clinical outcome of early diagnosis and 
interventional treatment options.
space disease may be divided into acute or chronic. The most common causes of 
acute disease are pneumonia, pulmonary infarct and pulmonary edema. Among 
the chronic causes are alveolar cell carcinoma, tuberculosis, sarcoidosis and other 
systemic diseases. 
Learning Objectives:
1. To learn to recognise air-space disease.
2. To learn about a differential diagnosis of the most common conditions.
3. To evaluate imaging management of air-space disease.
13:30 - 14:00 Room A 
Plenary Session 
GL 
Guest Lecture
Presiding: 
Y. Menu ; Paris/FR 
A‑246	 13:30 
Slicing through Antiques & Works of Art 
M. Ghysels; Brussels/BE (marc.ghysels@skynet.be) 
This invited lecture explores the groundbreaking use of CT for studying antiquities 
and artworks from a wide range of cultures, irrespective of their age or material. 
Dr. Marc Ghysels, a former interventional radiologist, comes from a family of art-
ists and collectors. About ten years ago he set up a private radiology practice in 
Brussels where he analyses antiquities and artworks. Over the years he has built 
an international reputation among collectors and art dealers as well as museum 
curators and experts working in auction rooms. Art specialists call on his radiologi-
cal skills and knowledge to authenticate antiquities, and more specifically to show: 
what methods were used to make the works, what damage they have suffered over 
the years, how much restoration has been done, and to expose the many tricks 
used by forgers to deceive not only the discerning eye of the collector but also the 
methods of scientific analysis more commonly used than CT scans. His presentation 
will highlight the prominent role of CT as a nondestructive test to explore selected 
artworks made in wood, terracotta, stone, and ivory. 
16:00 - 17:30 Room A 
Radiology in Abdominal Emergencies 
CC 1017 
Missing perfusion: abdominal ischaemic disease 
Moderator: 
O. Chan; London/UK 
A‑247	 16:00 
A. Mesenteric angiography: diagnostic and therapeutic approach 
J. Lammer; Vienna/AT (johannes.lammer@akhwien.at) 
Acute abdominal organ ischaemia may be caused by hypovolaemic shock, spasm 
(ergotism), embolisation and aortic dissection. Embolisation is the most common 
cause. It occurs typically in elderly patients with atrial fibrillation, after myocardial 
infarction or due to a thoracic aortic aneurysm (TAA). The primary diagnosis is 
made by CT with contrast enhancement which can also demonstrate cardiac 
thrombi or a TAA. Interventional treatment can be performed with a thrombectomy 
device or fibrinolysis with recombinant tissue plasminogen activator (rt-PA; 10 mg 
loading dose, 5 mg/hr infusion dose). Acute aortic dissection may cause dynamic 
compression of the true lumen with occlusion of the ostium of the visceral arteries 
(floating visceral sign). The primary diagnosis is made by CT. Occlusion of the 
primary entry tear with a thoracic aortic stentgraft may decompress the false lumen 
followed by reexpansion of the true aortic lumen followed by reperfusion of the 
visceral arteries. Chronic abdominal ischaemia in younger patients may be due to 
fibromuscular dysplasia, Takayasu arteritis or neurofibromatosis. In the elderly it is 
usually caused by arteriosclerosis. The patient may have post-prandial abdominal 
pain (angina abdominalis), diarrhoea and/or weight loss. Due to the collateral circu-
lation, symptoms usually occur only if more than one of the major arteries (celiac 
trunk, superior and inferior mesenteric artery) is narrowed. The diagnosis can be 
made by color Doppler ultrasound (CDUS), CT and MR with contrast enhancement. 
Endovascular treatment is done by PTA and stent placement. 
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3. To learn what to include in the report of CNS infections for the treatment 
planning.
4. To learn how to report follow-ups and treatment monitoring of CNS 
infections.
16:00 - 17:30 Room C 
CLICK (Clinical Lessons for Imaging Core Knowledge): Common 
Clinical Cases 
CC 1018 
Palpable abdominal mass 
Moderator: 
F. Caseiro‑Alves; Coimbra/PT 
A‑252	 16:00 
A. Clinical considerations 
D. Akata; Ankara/TR (dakata@hacettepe.edu.tr) 
Finding of a palpable mass in the abdomen always raises the possibility of an im-
portant clinical problem. A potentially life-threatening process, especially malignancy 
is the major concern. The list of differential diagnosis of “abdominal mass” is a very 
long one. In the process of differential diagnosis the most common approach is to 
evaluate the patient according to the gender, age, patient history and co-existing 
clinical and laboratory findings. The accompanying symptoms and signs and the 
location of the abdominal mass are the key indicators in the clinician’s way of think-
ing in the process of differential diagnosis. For instance, a palpable mass with acute 
abdomen or intestinal obstruction will be assessed differently than a mass found 
incidentally. Imaging is commonly required to confirm or ascertain the diagnosis. 
Cross-sectional imaging is required to accurately evaluate a palpable abdominal 
mass in most situations. Ultrasound and computed tomography have each been 
used successfully in evaluating patients with palpable abdominal mass. Although 
each modality is appropriate in most situations, the advantages and disadvantages 
of each modality in certain situations will be addressed and the appropriateness 
criteria will be reviewed in this lecture. Knowledge of a detailed clinical history is as 
important to the radiologist as to the clinician. Its impact on the diagnostic accuracy 
in the interpretation of the images will also be addressed. 
Learning Objectives:
1. To learn more about the clinical conditions causing abdominal space 
occupying lesions.
2. To be informed about the clinician’s way of thinking in the process of 
differential diagnosis.
3. To become familiar with the potential role of imaging in the establishment of 
the final diagnosis and planning of therapy.
A‑253	 16:30 
B. Imaging techniques and typical findings 
M. Prokop; Nijmegen/NL (M.Prokop@rad.umcn.nl) 
A palpable abdominal mass has a long list of benign and malignant differential 
diagnoses. These diagnoses may be as different as a hydatid cyst of the liver, a 
volvolus, an aneurysm, or a giant renal cell carcinoma. The diagnostic approach is 
based on two major steps: first, the affected organ must be indentified. Second, the 
differential diagnosis must be established based on imaging characteristics. The 
choice of ultrasound, CT or MRI should be based on location and size of the mass. 
Despite the fact that ultrasound is frequently used as a first step, the overview and 
anatomic orientation in large masses may be hampered, making ultrasound a better 
technique for image-guided biopsy than for primary diagnosis. In the vast majority 
of cases, multidetector CT is the first technique of choice. A thin-section protocol 
should be used to allow for high-quality multiplanar imaging. A pre-contrast scan is 
usually not required but can be helpful in suspected hemorrhage. For most upper 
and middle abdominal masses, biphasic imaging in the arterial and portal phase is 
recommended in order to establish the relation of the mass to the vasculature and 
to assess vascularity. In the small pelvis, MR is the superior imaging technique. 
Otherwise, MRI is mainly used for problem-solving. This course will discuss how to 
use the various imaging tool efficiently to narrow the differential diagnosis, decide 
about the need for biopsy and establish a suitable therapy. 
Learning Objectives:
1. To learn about the available imaging modalities to be used for the evaluation 
of patients with a palpable abdominal mass.
2. To become familiar with the technical imaging considerations and the proper 
diagnostic algorithm.
3. To know more about the typical imaging findings.
16:00 - 17:30 Room B 
Interactive Teaching Session 
E³ 1020 
Infections of the central nervous system: what the 
radiologist must report 
A‑250	 16:00 
A. “Dangerous” viral and prion infections 
G. Wilms; Leuven/BE (Guido.Wilms@uz.kuleuven.ac.be) 
The most common viral infection of the brain is herpes encephalitis (HSV1). It is a 
necrotising encephalitis with a a mortality of more than 50%. On imaging studies 
lesions will be seen in the “limbic system”, i.e. the temporal lobes, hippocampi, 
insular cortex and cingulate gyrus. They appear as hypodensity on CT, T2- and 
FLAIR hyperintensity on MRI, possibly with haemorrhagic transformation. Diffu-
sion is restricted in the early phase. Enhancement occurs at a later stage. Hu-
man immunodeficiency virus (HIV) infection is a multifocal giant-cell encephalitis 
eventually leading to a progressive leuco-encephalopathy. On MR atypical focal 
or diffuse symmetrical signal abnormalities are seen neither with mass-effect nor 
with enhancement and typically sparing the U-fibers. Spectroscopy can show an 
increase of myo-inositol. Progressive multifocal leuco-encephalopathy (PML) is 
due to reactivation of the JC polyomavirus in immunocompromised patients, 10% 
of which are HIV positive. On MRI “scalloped” multifocal asymmetrical lesions are 
seen with minimal mass-effect and without enhancement. New treatments of HIV, 
especially highly active antiretroviral therapy (HAART) can lead to a paradoxical 
worsening of patients due to the immune reconstitution inflammatory syndrome 
(IRIS). On MRI mass lesions are seen with diffuse patchy enhancement. Cerebral 
toxoplamosis appears as multiple enhancing lesions with marked perilesional 
oedema. Calcification is possible. Prion diseases are caused by a proteinaceous 
infectious particle leading to Creutzfeld-Jacob disease in humans. Diffusion 
weighted MR-images show high signal intensities in the cortex and the basal 
ganglia. Abnormalities on T2-weighted images and FLAIR occur at a later stage 
where atrophy is mostly prominent. 
Learning Objectives:
1. To be familiar with the imaging pattern of most common viral and prion CNS 
infections.
2. To learn how recognise and differentiate between the different viral and prion 
CNS infections.
3. To learn how to report detected viral and prion CNS infections.
4. To have knowledge about follow-ups and treatment monitoring of viral and 
prion infections.
A‑251	 16:45 
B. Bacterial and parasitic infections 
E.T. Tali; Ankara/TR (turgut.tali@gmail.com) 
Most of the CNS infections can be treated successfully as long as they are detected 
early. Radiological evaluations play important role in the diagnosis, subsequent 
treatment and treatment monitoring. Bacteria, fungi and parasites may cause 
CNS infections. Infections in newborn and infants differ from the adults. MRI is 
the modality of choice. Radiological findings may vary according to the causing 
agent, location and the stage of the infections (for cerebritis; surrounding oedema, 
mass effect, capsule (thicker rim border near cortex, thinner near ependyma) 
hypointense on T2WI, hyperintense on T1WI) with central necrotic area, satellite 
lesions, daughter rings, petechial haemorrhage, heterogeneous enhancement of 
the rim. DWI shows high signal intensity while ADC maps show low signal. MRS 
shows lactate and amino acids. Reports should include comments for differential 
diagnosis among the radiological findings for the infections. Treatment can also 
be monitored by MRI (for cerebritis: decrease in oedema; decrease in mass ef-
fect; decrease in degree of enhancement, shrinking cavity, gliosis; decrease in 
DWI high intensity and increase in ADC low signal and also turning of lactate and 
amino acids to normal at MRS). Reports should include comments for the success 
or failure of the treatment. 
Learning Objectives:
1. To learn how to report detected and recognised bacterial and parasitic CNS 
infections basically.
2. To learn how to assist clinicians for the diagnosis and differential diagnosis 
of bacterial and parasitic CNS infections.
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susceptibility effects, increased radiofrequency (RF) field inhomogeneity and more 
pronounced magnetic shielding effects. In the mean time, many investigators have 
proposed strategies to optimise imaging protocols and to decrease SAR levels 
and to reduce artefacts including optimised coil and hardware design, in combina-
tion with parallel imaging and modulation of refocusing flip angles. Many clinical 
applications in neurology and angiography for high field MRI that were recently 
being investigated showed benefits over 1.5 T. However, as of to date, virtually no 
prospective comparative studies have been performed and published that could 
help to estimate whether or not there would be any clinical benefit of 3.0 T MSK over 
1.5 T. Although many authors described the improved SNR of MSK imaging at 3.0 
T allowing for higher spatial resolution this has not been prospectively investigated 
with comparison to 1.5 T. Further studies have to show whether the improvement 
in speed and resolution will also translate into increased patient throughput and 
earlier depiction of disease in MSK applications at 3.0 T. 
Learning Objectives:
1. To become familiar with artefacts and pitfalls of MSK MRI at 3 T.
2. To recognise and address MR safety issues at 3 T.
3. To identify where 3 T is of most benefit in MSK imaging.
A‑257	 17:00 
C. New techniques and applications 
S. Trattnig; Vienna/AT (siegfried.trattnig@meduniwien.ac.at) 
MRI of MSK structures has significantly improved in recent years due to the develop-
ment of clinical high-field MR systems operating at 3 Tesla with high signal-to-noise 
ratios. Further improvement was achieved by higher gradient strengths and the 
application of dedicated coils. This allows high resolution isotropic 3D imaging which 
provides identical resolution when reformatting in all planes. This isotropic imaging 
can be used in visualisation of cartilage lesions and repair, ACL reconstructions, 
complex meniscal tears and labral tears in the shoulder and hip. In addition to the 
evaluation of gross cartilage morphology by MRI, there is growing interest in the 
visualisation of ultra structural components of cartilage and other structures such as 
menisci by MRI. Several MR techniques were developed, which allow detection of 
biochemical changes that precede the morphological degeneration in cartilage. For 
visualising the loss of glycosaminoglycans delayed gadolinium-enhanced MRI of 
cartilage (dGEMRIC) can be used. For the quantification of collagen matrix content 
and organisation cartilage T2 mapping has become useful. Further new biochemi-
cal MR techniques comprise diffusion-weighted imaging, magnetisation-transfer 
and a variant: chemical exchange saturation transfer (CEST) methods. All of these 
techniques benefit from the higher SNR and higher resolution capabilities at 3 T. 
New developments are ultrashort-TE techniques at 3 T which help to visualise MSK 
structures, which based on their inherent low T2 relaxation times did not provide 
signal such as cortical bone and tendons. 
Learning Objectives:
1. To learn the role of 3 T in the application of new techniques in MSK imaging.
2. To appreciate future clinical applications of new MSK techniques at 3 T.
3. To learn how to apply new techniques in routine practice.
16:00 - 17:30 Room D2 
Genitourinary 
RC 1007 
Imaging of the scrotum and penis 
Moderator: 
S. Özbek; Izmir/TR 
A‑258	 16:00 
A. Acute scrotum 
B. Brkljacic; Zagreb/HR (boris.brkljacic@zg.htnet.hr) 
Ultrasound is the best imaging modality for evaluation of acute scrotal conditions. 
MRI is used only rarely, when US findings are equivocal and in cases of suspected 
infarction. CT is used exceptionally, for example, to detect air in the scrotal wall. 
High-frequency transducers with modern software like compound imaging and 
native harmonic, and very good colour sensitivity for low flow in small vessels 
provide excellent insight into testicular morphology and vascularisation. It is very 
important to distinguish testicular torsion from the acute inflammation, as it has 
important therapeutic and even medicolegal consequences. In testicular torsion 
rapid diagnosis is vital, and salvage rate is directly related to timely operation. 
Torsion is more common in younger patients and orchiepididymitis is more com-
mon in adults. Infection usually starts at the epididymis and then spreads to testis 
A‑254	 17:00 
C. Interactive case discussion 
A.H. Freeman; Cambridge/UK (a.h.freeman@talk21.com) 
The patient presenting with an abdominal mass represents a common clinical 
problem. Clearly, the differential diagnosis is large and obviously will depend on 
the age and sex of the patient as well as location of the mass. Of course history 
and clinical examination are mandatory, but formal diagnosis will usually rest on 
radiological interpretation. Contrast examinations have now been replaced by 
cross-sectional imaging and endoscopy and it behoves the clinical radiologist to 
be aware of the advantages and limitations of these methods in order to reach a 
diagnosis. Particular difficulty may be encountered when the mass is so large that 
it is difficult to determine the organ of origin. The purpose of this interactive case 
discussion is to explore the relative merits of ultrasound, CT, MR and endoscopy 
in establishing a diagnosis in two different cases. The cases concerned are: 1. 
A 21-year-old man who presents with a right iliac fossa mass, but is otherwise 
asymptomatic. 2. A 54-year-old woman who presents with anaemia and a large 
upper abdominal mass. Active audience participation will be encouraged by means 
of key pads in order to respond to issues raised during the debate. 
Learning Objectives:
1. To introduce typical cases illustrating the role of imaging modalities in the 
differential diagnosis of palpable abdominal mass cases.
2. To motivate the audience by the use of voting pads to be involved in the 
diagnostic process.
3. To highlight the conclusion that may be drawn on the basis of the discussed 
cases.
16:00 - 17:30 Room D1 
KISS (Keep It Simple and Straightforward): Musculoskeletal MRI 
CC 1016 
The basics of MSK MRI at 3 T 
Moderator: 
A. Baur‑Melnyk; Munich/DE 
A‑255	 16:00 
A. Optimising protocols 
C. Glaser; Munich/DE (christian.glaser@nyumc.org) 
The most straightforward expectation from 3 T MRI scanners is a gain in SNR that 
could be translated in improving spatial resolution and/or reducing imaging time at 
an at least constant CNR. Together with field strength, susceptibility effects, chemi-
cal shift and T1 increase and T2 and T2* decrease. Also, relaxation properties of 
contrast agents are modulated. RF power deposition is higher at 3 T and is often 
a limiting factor in sequence parameter optimisation. Hence, the need to optimise 
MRI sequence protocol parameters at 3 T. For cartilage, muscle, synovial fluid 
and fat, T1 increases by between 14% and 22%, T2 decreases by between 10% 
and 37% and R1 of Gd Chelates decrease by 5% to 10% when B0 increases from 
1.5 T to 3 T. In most applications reduced T2 and increased T1 work synergistically 
towards a reduced SNR. Since the change in relaxation times is not linear for the 
different tissues, CNR varies with field strength, too. A relatively straight forward 
approach is to lengthen TR in order to compensate for longer T1 and to shorten 
TE to compensate for shorter T2 (*). In non-fat-sat images bandwidth needs to be 
increased to control chemical shift effects. Because of the better fat and water peak 
separation, 3 T often helps improve frequency-based fat saturation but may also 
be greatly impaired by field inhomogeneities in the presence of metallic materials. 
Field strength (B0) and appropriate dedicated multi-element coils are the hardware 
prerequisites to bring high resolution (HR) isotropic imaging into clinical routine. 
Learning Objectives:
1. To understand the physical differences of MSK MRI at 1.5 T and 3 T.
2. To learn how to optimise MSK sequence parameters at 3 T.
3. To recognise the value of high-resolution and isotropic imaging at 3 T.
A‑256	 16:30 
B. Pitfalls, strengths and weaknesses 
T.C. Mamisch; Berne/CH (mamisch@bwh.harvard.edu) 
MRI (3.0 T) has gained increasing acceptance for whole-body imaging. Since 
the introduction of 3.0 T MR systems to clinical human imaging, several difficul-
ties have been described beyond a simple SNR gain including increased energy 
deposition (as denoted by the specific absorption rate (SAR)), increased magnetic 
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16:00 - 17:30 Room E1 
Musculoskeletal 
RC 1010 
Hip through the ages 
Moderator: 
E.C. Kavanagh; Dublin/IE 
A‑261	 16:00 
A. The paediatric hip 
D.J. Wilson; Oxford/UK (david.wilson@noc.anglox.nhs.uk) 
Depending on the age of the child, hip symptoms may predict a variety of diseases. 
In the infant, developmental dysplasia and infection should be considered. After 
the age of 4, irritable hip most commonly due to transient synovitis is the common-
est disease but infection is the more worrying condition. Perthes disease affects 
some and this condition overlaps into those over 8 who may have a slipped upper 
femoral epiphysis. Fractures and rare cases of osteonecrosis and chondrolysis are 
a concern in the adolescent. In the young and indeed in most cases, ultrasound 
provides a useful first line test. Aspiration of effusion may be both diagnostic and 
therapeutic. In the older child and, especially when SUFE is a risk, conventional 
radiographs with an external rotated “frog leg” view is very important. Despite 
the logistics problems in children, there is an important role for MRI especially in 
cases where the initial imaging does not explain the symptoms. I will review the 
imaging pathways and provide examples of common diseases. I will also discuss 
how to manage the difficult case and show recent audit data on detection rates 
and clinical management. 
Learning Objectives:
1. To understand the age-specific diseases of the hip in children.
2. To appreciate the strengths and weaknesses of each imaging method.
3. To understand how imaging is used in the management of children’s hip 
problems.
A‑262	 16:30 
B. The hip in the young athlete 
C.W.A. Pfirrmann; Zurich/CH 
Femoroacetabular impingement (FAI) is a common condition in the young athlete. 
FAI refers to a conflict between the proximal femur and the acetabulum. Both an 
abnormal shape of the proximal femur (FAI of the „Cam-Type“: Aspheric femoral 
head with a laterally increasing radius and/or a waist deficiency of the femoral neck) 
and the acetabulum (FAI of the „Pincer-Type“: Acetabular retroversion or a deep 
acetabulum) or a combination of the two may be present. For a long period the FAI 
may be asymptomatic and the only clinical finding will be an impaired internal rota-
tion of the hip joint. Later as the disease progresses, cartilage damage (outside-in 
abrasion of the acetabular cartilage/cartilage delamination) and labral tears occur. 
Labral tears are most common in the anterosuperior aspect of the acetabulum. 
A typical labral tear is an incomplete detachment with a tear located at the base 
of the labrum. Anatomic variants such as a sulcus may be present and should be 
distinguished from tears. A sulcus is common at the junction of the labrum with the 
transverse ligament and is generally located beyond the equator of the hip joint. 
Insufficiency fractures about the hip commonly occur in the region of the femoral 
neck. Another site vulnerable to overuse is the symphysis pubis. Often, a bone 
marrow oedema pattern around the symphysis pubis is observed. A characteristic 
finding is the „Secondary cleft sign“, which reflects a partial tear of the adductor 
tendon aponeurosis at the symphysis pubis. 
Learning Objectives:
1. To understand the mechanisms of injury of the hip.
2. To recognise the imaging pattern of abnormalities of the hip.
3. To become familiar with femoroacetabular impingement.
4. To learn about the typical injuries to tendon attachments around the hip.
A‑263	 17:00 
C. The ageing hip 
A.H. Karantanas; Iraklion/GR (akarantanas@gmail.com) 
Understanding age-related changes is essential for interpretation of imaging 
studies. Age is a risk factor strongly correlated with osteoarthritis (OA) which is 
the most common hip joint disease seen in adults. The diagnosis of OA is based 
on a combination of radiographic findings and characteristic subjective symptoms. 
The lack of a radiographic consensus definition has resulted in a variation of the 
that is painful and hypervascularised on colour Doppler imaging. In cases of 
torsion B-mode findings are non-specific, while on colour Doppler flow is absent 
in complete torsion, but may be present and diminished in incomplete torsion, 
or increased in intermittent torsion. In cases of trauma ultrasound is important 
to diagnose haematoma, haematocele to evaluate integrity of testis and assess 
whether the testicular fracture is present or if the surgery is needed in cases of 
testicular rupture. Imaging is helpful in cases of rare causes of the acute scrotum, 
such as Fournier gangrene, testicular appendage torsion, vasculitis, and also in 
evaluation non-scrotal causes of symptoms, like in cases of renal colic, abdominal 
inflammatory and traumatic conditions, etc. 
Learning Objectives:
1. To learn the imaging signs of testicular torsion.
2. To review the appearance of acute and subacute orchiepididymitis.
3. To understand the role of imaging, especially ultrasound, in testicular 
trauma.
A‑259	 16:30 
B. Scrotal tumours 
L.E. Derchi; Genoa/IT (derchi@unige.it) 
A scrotal mass is an important clinical problem and a source of anxiety to the 
patient. Radiologists play an important role in the management of these cases, 
since imaging is required to provide information about precise anatomical location 
of the lesion, its size and extension and, possibly, to elucidate the nature of the 
disease. The US and MRI findings of the many different scrotal tumours will be 
presented in this lecture. Special attention will be given to two topics. The first are 
the possibilities offered by imaging to differentiate among the different pathologies, 
especially to differentiate between benign and malignant lesions. The second will 
be the problem of the small, non-palpable, indeterminate testicular mass. Such 
lesions have been shown to be relatively frequent. Prevalence of malignancy varies 
widely in the literature, and orchidectomy seems not justified in all cases. The use 
of contrast-enhanced MRI and of advanced US techniques (contrast-enhanced 
US and elastography) may help to narrow the differential. Furthermore, the use of 
intraoperative US to guide removal of non-palpable testicular nodules can help to 
perform conservative surgery in lesions with no malignant potential. 
Learning Objectives:
1. To understand the typical imaging appearance of benign and malignant 
scrotal tumours.
2. To review differential diagnosis of intra and extratesticular scrotal tumours 
and the impact of imaging.
A‑260	 17:00 
C. Imaging of the penis 
M. Bertolotto; Trieste/IT (bertolot@univ.trieste.it) 
Ultrasonography (US) is the first-line imaging modality in patients with penile dis-
ease. Using high-end equipment after pharmacologically induced erection penile 
anatomy is well defined and virtually all clinically significant penile vessels can be 
evaluated in normal and in impotent men. The superior soft-tissue contrast resolu-
tion afforded by MR imaging provides an opportunity to advance imaging evaluation 
of the penis in selected cases. In the clinical practice, erectile dysfunction is the most 
frequent penile abnormality which is investigated with Doppler US. The clinical role 
of this evaluation, however, reduced after the introduction of oral medications for 
impotence. Differentiation among different forms of erectile dysfunction is mainly 
based on evaluation of Doppler waveform changes in the cavernosal arteries. 
Peyronie’s disease is the most frequent cause of penile induration. Imaging is often 
required to evaluate the extension of the plaques, involvement of the penile septum, 
and relationship between the plaques and penile vasculature. In patients with penile 
traumas, imaging allows accurate evaluation of albugineal tears, extra-albugineal 
and cavernosal haematomas, vascular lesions producing high flow priapism and 
other pathological changes. Compared with US, MR imaging has some advantages 
in identification of small albugineal tears, and is more accurate in identification of 
urethral or spongiosal involvement. Other situations in which penile imaging can 
be required are circumscribed or diffuse cavernosal fibrosis, tumours, priapism, 
severe inflammation, and evaluation of postsurgical complications. Most of these 
conditions are first investigated with US; MR imaging is optimal for tumour staging. 
Learning Objectives:
1. To learn the most frequent penile diseases that can be diagnosed by 
imaging.
2. To understand the respective roles of US and MRI and the technical 
challenges of imaging.
3. To know how imaging influences treatment and follow-up.
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A‑265	 16:25 
B. Endocrine and other solid pancreatic tumours 
C.J. Zech; Munich/DE (Christoph.Zech@med.uni‑muenchen.de) 
Endocrine tumours of the pancreas are derived form the APUD cell system. They 
often show early clinical sign related to the hormones produced by these tumours. 
The usually very specific symptoms raise the suspicion of an endocrine tumour of 
the gastro-entero-pancreactic tract and initiate imaging studies for tumour detection. 
In this setting usually the pancreas is among the most frequent tumour sites. Since 
endocrine active tumours of the pancreas usually show a strong vascularisation, 
they can be differentiated from other solid tumours of the pancreas - including ad-
enocarcinoma of the pancreas. Metastases in the pancreas are very rare - however, 
they represent a potential differential diagnosis either for non-functioning neuro-
endocrine tumours or for adenocarcinoma of the pancreas. Since the evaluation 
of the whole pancreas is crucial, transabdominal ultrasound plays an only limited 
role for the detection of endocrine pancreatic tumours. Usually MRI and CT - alone 
or in combination with specific nuclear medicine tracers in PET - are needed for 
accurate diagnosis and staging of these tumours. 
Learning Objectives:
1. To understand the clinical manifestations, pathology and imaging findings of 
functioning and non-functioning endocrine tumours.
2. To learn about imaging protocols and to address management options of 
these tumours.
3. To review prognostic information.
4. To learn about other causes of solid pancreatic tumours, including 
metastases, and the role of imaging in management.
A‑266	 16:50 
C. Congenital and developmental anomalies 
M. Karcaaltincaba; Ankara/TR (musturayk@yahoo.com) 
Pancreas develops from ventral and dorsal buds during embryologic development. 
Radiologic imaging plays an important role in the diagnosis of congenital and 
developmental anomalies of pancreas, which can involve either pancreatic duct 
or pancreas parenchyma. The spectrum of congenital pancreatic duct anomalies 
include the failure of fusion of ventral and dorsal pancreatic ducts, so-called pan-
creatic divisum, which can be complete or partial. Parenchymal anomalies and 
variants include cystic dystrophy of duodenum, annular and ectopic pancreas, 
dorsal (distal) pancreas agenesis, circumportal pancreas, short pancreas, bifid tail 
of pancreas, fusion of pancreas and spleen. These can cause symptoms (groove 
pancreatitis and duodenal obstruction) or can be asymptomatic. Dependent stomach 
and dependent intestine signs can allow diagnosis of dorsal pancreas agenesis. 
Variations in the fat accumulation of pancreas can cause diagnostic problems and 
knowing embryology of pancreas can help in diagnosis. The role of ultrasonography, 
CT, MRI and MRCP in the diagnosis of anomalies of pancreas will be illustrated. 
A variety of pancreas anomalies can be diagnosed with CT and MRI and this ap-
proach can obviate invasive diagnostic procedures. 
Learning Objectives:
1. To review the elements of pancreatic embryology that are necessary to 
understand abnormalities and variants of the pancreas.
2. To learn about the most common variants in the pancreatic ducts, like 
complete or partial pancreas divisum, and abnormal localisations of 
pancreatic tissues like cystic dystrophy of the duodenum, annular and 
aberrant pancreas.
3. To learn about the role of these abnormalities in determining diseases.
4. To learn how imaging should be used to derive the appropriate diagnosis.
Discussion 17:15 
published incidences and prevalence of OA. The progression of OA traditionally 
has been measured using radiographic joint space width (JSW). Weight-bearing 
radiographs centered on the hip are the most reproducible and reliable ones. The 
sequence of degeneration includes the following radiographic findings: joint space 
narrowing, osteophyte formation, subchondral sclerosis, and cyst formation. Cur-
rent definitions of radiological OA based on reduced JSW and osteophytes display 
predictive validity for clinical hip OA. Radiographs are also useful for assessing 
developmental dysplasia and other congenital disorders which may lead to early 
OA. There are cases though, that radiographs show minor changes and the clini-
cal suspicion of early disease can be confirmed with more sophisticated imaging 
methods, such as CT and MRI. CT is helpful for additional measurements such 
as femoral and acetabular abnormal version which might lead to OA. Femoroac-
etabular impingement has been shown to cause labral and chondral lesions and 
leads to OA. Prompt recognition of abnormal head-neck junction on radiographs 
enables proper conservative or surgical treatment planning. MR arthrography is 
the method of choice for assessing the labra whereas CT arthrography might be 
used as an alternative for articular cartilage assessment. 
Learning Objectives:
1. To become familiar with the radiographic assessment of the ageing hip.
2. To understand the MRI findings of degenerative hip disease.
3. To review the various disorders which predispose for early osteoarthritis.
4. To recognise the advantages and disadvantages of CT and MR arthrography 
of the ageing hip.
16:00 - 17:30 Room E2 
Organs from A to Z: Pancreas 
MC 1019 
Cystic tumours, endocrine neoplasms and 
congenital anomalies 
Moderator: 
I. Lupescu; Bucharest/RO 
A‑264	 16:00 
A. Cystic tumours 
R. Pozzi-Mucelli; Verona/IT (roberto.pozzimucelli@univr.it) 
Cystic tumours of the pancreas include a variety of masses which can be classified 
into cystic tumours of the exocrine pancreas, cystic tumours of the endocrine pan-
creas, cystic tumour-like lesions of the exocrine pancreas. In order to simplify the 
approach only the relatively common cystic tumours - the intrapapillary mucinous 
tumours (IPMT), the serous cystoadenoma (SC) and the mucinous cystoadenoma 
(MC) - will be considered. IPMT are characterised by ductal dilatation. Imaging 
characteristics of IPMT are best displayed at MR-cholangiopancreatography. On 
the basis of the extent, these tumours can be divided into IPMT of the main duct 
(or central), IPMT of the secondary ducts (or peripheral) and mixed IPMT. Central 
and mixed IPMT have a malignant behaviour and therefore need to be treated 
surgically, while peripheral IPMT have a benign behaviour and, in general, need 
only follow-up. SC are characterised by a microcystic architecture in most cases. 
Imaging features are typical in cases of microcystic appearance and consist of 
small amounts of fluids interspersed within multiple septae of a “sponge like” mass. 
The differential diagnosis with a mucinous cystoadenoma is difficult in cases with 
a oligo-macrocystic appearance. MC appears as a uni-oligolocular cystic mass, 
with a simil-ovaric stroma in the tail of the pancreas. Imaging features include a 
cystic mass with a definite wall and inner septae. When calcifications and enhanc-
ing nodules are present, a mucinous cystoadenocarcinoma has to be suspected. 
Therefore, a careful evaluation of imaging features of pancreatic cystic tumours is 
needed to differentiate benign form malignant masses. 
Learning Objectives:
1. To understand the classification and management of cystic pancreatic 
tumours using rad/path correlation.
2. To learn how to provide a differential diagnosis and how, when and why 
imaging techniques should be used.
3. To review pathological and imaging findings of intra-ductal cystic tumours.
4. To learn how to deal with the incidental pancreatic cyst.
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cancer death in women, indicating that there is room and need! for improvement. 
Magnetic resonance imaging (MRI) of the breast has been introduced a decade 
ago. Over recent years, it has become increasingly evident that breast MRI by far 
the most powerful breast imaging technique that is currently available. Across all 
different clinical and screening scenarios, MRI has been shown to be superior to 
mammography - be it for diagnosing primary or recurrent, invasive or intraductal, 
familial or sporadic breast cancer, irrespective of a woman‘s breast density. And yet 
is the technique only slowly adopted in clinical practice. Arguments against the use 
of breast MRI include costs, frequency of false positive diagnoses, lack of trained 
radiologists, lack of minimally invasive biopsy capabilities, lack of evidence by 
randomised controlled clinical trials, and, last, fear of overtreatment. In this lecture, 
these concerns are reviewed, discussed and weighted against the advantages of 
screening and diagnostic applications of breast MRI. 
Learning Objectives:
1. To learn about results of breast cancer screening studies involving breast MRI.
2. To learn current indications for MRI screening.
3. To understand technical MR imaging strategies for screening.
A‑270	 16:51 
The evolving role of the radiologist 
P. Brader; Vienna/AT (peter@brader.md) 
In the past two decades, enormous strides have been made in medical imag-
ing and many new technologies and agents are now available for breast cancer 
research, clinical trials and patient care. Advances in experimental and clinical 
breast imaging are likely to improve our knowledge of how breast cancer arises at 
the cellular level, which will help not only to identify and locate tumours but also to 
assess the activity of biological processes within these tumours. This recent and 
concomitant progress, in imaging in general, and in breast imaging in particular, has 
been facilitated by the convergence of molecular cell biology, pathology, chemistry, 
physics and engineering in a multimodality and multidisciplinary way. The challenge 
for radiology is to begin thinking at the molecular level. It is, therefore, important 
that the next generation of radiologists become more involved in multidisciplinary 
research and clinical work, and that younger radiologists receive special training 
in diagnostic imaging and nuclear medicine, as well as a solid understanding of 
physics, radiochemistry, pathology and biology. Applying this approach to breast 
cancer patients should allow earlier detection, stratification of patients for treatment, 
and objective evaluation of new therapies. The outcome will be considerably better 
management and care of those with breast cancer. 
Learning Objectives:
1. To learn about novel developments in the field of breast imaging, especially 
those aimed at treating and characterising.
2. To understand what is happening functionally and structurally at the 
molecular level for breast cancer imaging.
3. To learn about design and development of molecular imaging probes for 
breast cancer imaging.
Panel discussion: 
Breast imaging 2025: blood test or still imaging? 17:14
Breast cancer is the leading cause of cancer death among women worldwide. 
Imaging plays a key role in the early detection of breast cancer. Mammography is 
an accepted screening modality with some limitations such as over-treatment. To 
overcome these limitations research is going on to characterise breast cancer more 
accurately. Currently researchers are working on different strategies spanning the 
spectrum from tomography- based systems to MRI and even molecular imaging. 
This panel discussion will focus on these different strategies. The auditorium will 
learn if in 2025 imaging still plays a major role in breast cancer detection or whether 
a simple blood test will eventually solve the problem. 
16:00 - 17:30 Room F1 
New Horizons Session 
NH 10 
Breast imaging in 2025 
Moderator: 
T.H. Helbich; Vienna/AT 
A‑267	 16:00 
Chairman’s introduction 
T.H. Helbich; Vienna/AT (Thomas.Helbich@meduniwien.ac.at) 
Breast cancer is the leading cause of cancer death among women world wide. 
Imaging plays a key role in the early detection of breast cancer. Mammography is 
an accepted screening modality with some limitations such as over treatment. To 
overcome this limitations, research is going on to characterise breast cancer more 
accurately. Currently researchers are working on different strategies spanning the 
spectrum from tomography-based systems to MRI and even more molecular imag-
ing. This panel discussion will focus on these different strategies. The auditorium 
will learn if in 2025 imaging still plays a major role in breast cancer detection or a 
simple blood test will eventually solve the problem. 
Session Objectives:
1. To learn about new breast imaging modalities for 2025.
2. To learn whether these imaging modalities can influence breast cancer 
screening in 2025.
3. To understand whether today’s polemics will remain true in 2025.
A‑268	 16:05 
Is mammography still an accepted modality for breast cancer imaging in 
2025? 
M.J. Yaffe; Toronto, ON/CA (martin.yaffe@sunnybrook.ca) 
X-ray mammography is currently the only imaging modality that when used in routine 
screening has been demonstrated to contribute to reduced mortality in women in 
the age range 40-74. But, the accuracy of mammography is limited with respect 
to both sensitivity and specificity. Digital mammography has provided increased 
sensitivity in women with dense breasts and three-dimensional methods such 
as digital breast tomosynthesis or dedicated breast CT promise to yield further 
improvement. However, these techniques are dependent on detecting rather 
gross physical changes as masses, microcalcifications or architectural distortions 
develop and, therefore, their ultimate potential is limited. It is likely that before 2025, 
detection tools that are more specifically targeted to molecular characteristics or 
early functional changes associated with cancer will be clinically available. These 
may be either in the form of an imaging test, based on a specific biomarker for the 
cancer or possibly an innocuous test designed to sense a circulating biomarker 
in the blood or urine. In the latter case, a positive test would be followed by an 
imaging study to provide localisation for therapy. Such tests could not only detect 
the presence of disease but would also provide prognostic information to guide 
the type and aggressiveness of therapy so that overtreatment could be avoided. 
Promising imaging techniques based on targeted imaging with ultrasound, x-ray 
contrast agents, MR and radio-labelled agents are already under investigation. 
By exploiting new molecular or functional signals one of these is almost certain to 
replace mammography before 2025. 
Learning Objectives:
1. To understand the current performance of mammography, including its 
benefits, strengths and limitations.
2. To become familiar with the potential for improvement in breast cancer 
imaging.
3. To examine possible strategies for evolution of the paradigm for screening 
and imaging in breast cancer management.
A‑269	 16:28 
Breast cancer screening with MR imaging and nothing else 
C.K. Kuhl; Aachen/DE (ckuhl@ukaachen.de) 
Regarding the early diagnosis of breast cancer, population-based mammographic 
screening has been shown to help reduce breast cancer mortality. Mammographic 
screening, reduced post-menopausal hormone intake and the development of 
new, targeted therapies all contributed to the reduction of breast cancer mortality 
that has been observed in the last couple of years. Still breast cancer is one of 
the most frequent cancers overall, and it continues to be the leading cause of 
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Learning Objectives:
1. To review frequently used response evaluation criteria in solid tumours (e.g. 
RECIST).
2. To evaluate the development and optimisation of new imaging parameters 
as biomarkers of treatment response and optimised monitoring of tumour 
therapy in multi-center EORTC clinical trials.
3. To present an innovative medicine initiative as a roadmap for future 
collaboration between EORTC and ESR, combining different imaging 
modalities.
A‑273	 16:24 
Can we assess cell density of tumours with imaging techniques? 
D.-M. Koh; Sutton/UK 
Imaging is increasingly used to define endpoints of clinical trials in oncology. Tumour 
cellular density may be inferred by diffusion-weighted MR imaging (DW-MRI) and 
measurement of the T2 relaxation time. DW-MRI is unique as the mechanism of 
contrast is based on differences in the mobility of water between tissues, which can 
be quantified by the apparent diffusion co-efficient (ADC). Tumours are frequently 
more cellular compared with their tissue of origin which impedes water diffusion, 
resulting in increased conspicuity on DW-MRI and lower ADC values. Studies have 
shown negative correlations between histopathologically determined cell density 
and ADC in several tumour types, including prostate cancer, soft tissue sarcomas 
and cerebral tumours. DW-MRI is sensitive for tumour detection, especially for 
disseminated peritoneal disease, liver and bone metastases. Whole body DW-MRI 
with background suppression (DWIBS) is an emerging technique that has shown 
substantial promising for staging of lung cancer, prostate cancer, lymphoma and 
multiple myeloma. Effective treatment results in reduction in cell density due to cell 
lysis, apoptosis and necrosis, leading to a rise in ADC value. ADC increase has 
been observed within 30 days of anti-tumour treatment (including chemotherapy 
and radiotherapy); and as early as one to two weeks after treatment. Quantitative 
ADC measurements may also be prognostic as tumours with higher pre-treatment 
ADC have been shown to respond poorer to chemotherapy and radiotherapy. 
Nevertheless, a number of challenges still have to be overcome to qualify ADC 
as a response and prognostic biomarkers in a multi-centre setting across different 
imaging platforms. 
Learning Objectives:
1. To show that MRI-derived parameters (e.g. apparent diffusion coefficient, T2 
relaxation time) are good indicators of tumour cell density.
2. To evaluate the role of diffusion-weighted imaging to assess tumour growth 
and metastases (whole body imaging).
3. To show the prognostic role of imaging parameters with regard to potential 
metastatic activity and tumour aggressiveness.
4. To demonstrate that diffusion imaging can be used to monitor cytotoxic 
treatment response.
A‑274	 16:42 
Which imaging techniques are useful to evaluate tumour angiogenesis? 
D. Sahani; Boston, MA/US (dsahani@partners.org) 
Angiogenesis is an essential process whereby tumours derive vascular supply from 
adjacent tissue, to sustain tumour growth and metastatic spread. Newer targeted 
antiangiogenic therapies differ significantly from current cytotoxic therapies for 
cancer. The methods of dose selection are either invasive, such as biopsy and 
histology, or time consuming, such as tumour shrinkage and time to disease pro-
gression, both of which take months to assess and fraught with other limitations. 
Moreover, cancer is a very variable disease, which means that some patients will 
respond to a particular therapy while others will not. There is, therefore, a great need 
to establish surrogate markers for drug response that are both rapid and reliable, 
not only for clinical trials of new drugs but also to aid in the selection of optimal 
treatment for individual patients. Although functional imaging has been a domain 
of nuclear medicine (PET), dynamic CT and MRI using a kinetic model can derive 
tumour vascular characteristics. It has been demonstrated that tumour contrast 
uptake characteristics correlate with recognised marker of tumour angiogenesis. 
By capturing temporal changes in contrast enhancement reflecting the tumour 
vasculature, functional imaging techniques can facilitate diagnosis, risk-stratification 
and therapeutic monitoring. Various imaging technique and protocols have been 
used with each having its own advantages and limitations. Similarly, various post-
processing methods such as semi-quantitative or quantitative analysis can be used 
to produce functional maps. Other novel imaging techniques such as multi-energy 
CT, diffusion MR and MR spectroscopy also have potential in assessing tumour 
biology and response. 
16:00 - 17:30 Room F2 
Professional Challenges Session 
PC 10 
Imaging as the number one tool for oncology trials 
Moderators: 
F. Meunier; Brussels/BE
P.M. Parizel; Antwerp/BE 
A‑271	 16:00 
Chairmen’s introduction 
F. Meunier1, P.M. Parizel2; 1Brussels/BE, 2Antwerp/BE 
(francoise.meunier@eortc.be) 
Multiparametric imaging techniques provide a non-invasive insight into tumour 
cell density, vascularisation, and biochemistry. Imaging data have the potential to 
provide information on disease profiling pertaining to diagnosis, prognosis, selection 
of therapy, monitoring of response to therapy, and pharmacokinetic information of 
drugs. Undoubtedly, these methods hold great promise, but how can we stan-
dardise these techniques, in terms of acquisition parameters and image analysis 
(post-processing), and validate imaging parameters as biomarkers in multicenter 
international cancer trials. Beginning with a review of the frequently used response 
evaluation criteria in solid tumours (RECIST), the development and optimisation 
of new imaging parameters as biomarkers of treatment response and optimised 
monitoring of tumour therapy in multicenter EORTC clinical trials will be presented. 
DW-MRI is sensitive for tumour detection; ADC is affected by the different cellular 
density of a tumour. Still, a number of challenges need to be overcome to qualify 
ADC as a response and prognostic biomarker in a multicenter setting. The large 
variety in primary tumours and imaging methods, as well as the large variety and 
continual evolution of imaging equipment, point towards the need for a concerted 
design of imaging protocols in order to assure that these protocols are applicable 
to multicenter trials. Furthermore, reliable evaluation of imaging data requires 
imagers experienced in the area of the definite cancer targeted in this trial and in 
the use of imaging tools for lesion quantification. From this session, a roadmap 
for future collaboration between EORTC and ESR combining different imaging 
modalities will emerge. 
Session Objectives:
1. To prove that advanced multiparametric imaging techniques play a crucial 
role in the diagnosis, staging, treatment monitoring and follow-up of 
oncological patients.
2. To explore avenues for future collaboration between EORTC and ECR.
3. To suggest input of radiologists in the design and implementation of multi-
center trials.
A‑272	 16:06 
The EORTC Imaging Group: vision and strategy on cancer imaging 
S. Stroobants; Antwerp/BE (Sigrid.Stroobants@ua.ac.be) 
Response to cancer treatment is evaluated by subsequent assessments of target 
lesions and is defined as a significant decrease in measurable tumour dimensions 
(WHO, RECIST). The new targeted therapeutics which cause cytostasis rather 
than cytotoxicity have challenged volume-based response criteria and tumour 
regression is increasingly recognised as an unreliable end point. New imaging 
modalities looking at tumour biology, like positron emission tomography (PET) or 
diffusion weighted (DW) and dynamic contrast enhanced (DCE) magnetic reso-
nance imaging (MRI) or increasingly used to identify subpopulation of patients most 
likely to respond. Recently, new response criteria were introduced that incorporate 
FDG-PET (RECIST 1.1 for solid tumours and new Cheson criteria for lymphomas). 
Since imaging is becoming increasingly important in novel trial design, the EORTC 
decided to invest in an imaging platform. EORTC has established a medical im-
aging exchange infrastructure allowing to store imaging data linked to the clinical 
databases. A functional imaging expert group is set up to review protocols, organise 
central review and develop specific initiatives for imaging biomarker validation. 
EORTC is part of the QuicCONCEPT consortium that within the EU innovative 
medicine initiative (IMI) will try to validate the use of novel PET probes and DW-MRI 
as biomarkers for apoptosis and proliferation. Functional imaging techniques can 
only evolve successfully into biomarkers that are clinically valuable and important 
for drug development, when there is agreement on the standards for measure-
ment and analysis and working groups are set up in collaboration with the different 
professional organisations (ESR, EIBIR, EANM) to set up imaging guidelines. 
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conditions such as TTTS in twin pregnancies and foetal demise. The living foetus 
can also suffer from abnormal blood supply to the CNS, and thus showing small 
or even large hemispheric infarcts. Other diffusion technique, DTI is also used to 
demonstrate the white matter formation of the foetal brain. MRS is also used in the 
evaluation of the foetal brain. The values of the NAA, Choline and the existence of 
lactate are different than the values in the paediatric and adult brain. 
Learning Objectives:
1. To explore the new imaging techniques for the study of the foetal brain.
2. To understand the use of diffusion-weighted imaging in the foetal brain.
3. To become familiar with the accurate use of T1-weighted sequences in the 
foetal brain.
4. To understand the possibilities of tractography in the fetal brain.
A‑277	 16:30 
B. Normal findings and pitfalls in paediatric neuroimaging 
A. Rossi; Genoa/IT (andrearossi@ospedale‑gaslini.ge.it) 
The paediatric central nervous system is a complex structure undergoing rapid 
development. As such, there is a rapid, continuous modification of what is “normal” 
in relation with age and the stage of development. Knowledge of the normal patterns 
of brain development in the clinically relevant ages from 0 to 18 years is necessary 
to interpret neuroimaging findings correctly. Knowledge of embryology and normal 
variants is also greatly helpful. MR imaging equipment and parameters need to 
be adjusted and optimisation for paediatric studies. Pitfalls often occur from the 
misunderstanding of normal conditions that are perceived as abnormal based on 
a comparison with the appearance of the normal brain in adults. This includes, for 
instance, the evaluation of the brain in the first 2-3 years of life during the course 
of the process of myelination. A summary of the most frequent conditions that may 
lead to misinterpretation of findings will be provided here. 
Learning Objectives:
1. To understand a different approach to neuroimaging in the developing 
paediatric brain and spine.
2. To appreciate that, despite the wide and potentially complex spectrum 
of diseases seen in neuropaediatrics, most interpretations can be made 
through the thoughtful application of basic neuroradiological analytical 
techniques.
3. To be aware of certain areas where common pitfalls, myths and 
misunderstandings occur.
A‑278	 17:00 
C. Neuroimaging in the acutely ill child 
E. Vázquez; Barcelona/ES (evazquez@vhebron.net) 
The ability to develop more aggressive treatments of acute neurological disorders 
in children is nowadays improving; however, infants and children are often unco-
operative, clinical signs are not always easily localised, and diagnosis and therapy 
may be both delayed. Effective imaging of the central nervous system assumes 
an increasingly important role in the evaluation of these critically ill children. This 
lecture will review the main indications to perform a neuroimaging procedure in 
children with a neurological emergency. With didactic purposes, acute conditions 
will be classified in traumatic and non-traumatic (ischaemic and haemorrhagic 
stroke, infection and acute metabolic disorders). Differential diagnosis will be 
discussed based on representative cases selected from the daily routine in a 
paediatric tertiary hospital. The varied neurological complications that can occur 
in the child admitted at the intensive care unit will also be presented in a didactic 
manner, including PRES (posterior reversible encephalopathy syndrome), acute 
liver failure, osmotic demyelination syndrome, hypoglycaemic encephalopathy or 
induced neurotoxicity. Eventually, some peculiarities in oncologic and immunosu-
pressed children, particularly opportunistic infections, will be highlighted. Practical 
algorithms with the preferential use of either CT or MRI will be developed for each 
section. CT continues being the primary modality for trauma, although it should 
be better used in cases of non-available MRI in the other acute conditions to save 
radiation in children. MR imaging is nowadays better for imaging these children 
owing to the new techniques that can be used, such as diffusion imaging (DI), 
spectroscopy, arterial spin labelling (ASL) or susceptibility-weighted imaging (SWI). 
Learning Objectives:
1. To learn the characteristic neuroimaging findings that may be useful in 
establishing differential diagnoses.
2. To understand the various neurological complications that can occur in the 
intensive care unit and to become familiar with their most typical imaging 
patterns.
3. To consolidate knowledge of the best neuroimaging protocols for the acutely 
ill child and establish the main indications for the use of MR imaging, 
particularly diffusion and spectroscopy.
Learning Objectives:
1. To prove that modern imaging techniques, such as perfusion MRI, can be 
used to measure tumour angiogenesis and vascular permeability.
2. To show that imaging parameters can be directly correlated with molecular 
markers such as vascular endothelial growth factor (VEGF).
3. To correlate tumour perfusion with histopathologic changes (e.g. 
hypercellularity, pleomorphism, vascular endothelial proliferation, mitotic 
activity, and necrosis).
A‑275	 17:00 
Challenges for morphologic imaging in oncology trials: reproducibility and 
reading 
F.E. Lecouvet; Brussels/BE (frederic.lecouvet@uclouvain.be) 
Beside clinical endpoints and biological or molecular parameters, beside emerg-
ing perfusion or diffusion imaging techniques, morphologic imaging remains the 
cornerstone of the evaluation of treatment response in the majority of primary or 
metastatic tumours. The large variety in cancers and imaging methods, as well 
as the large variety and permanent evolution in imaging equipments, raises the 
need for a concerted design of imaging protocols to guarantee transposability of 
these protocols to multiple centers. The reliable evaluation of imaging studies 
obtained in trials requires readers experienced in the area of the definite cancer 
targeted in this trial, and in the use of imaging tools for lesion quantification. The 
imaging group of the EORTC targets this optimisation of imaging protocols. First, 
the different “organ groups” of the EORTC will benefit from the availability of expert 
radiologists in the different fields of oncology, involved in the choice and tuning of 
adequate and generalisable imaging tools from the beginning of trials design. The 
design of CT or MRI studies should target acquisition parameters transposable in a 
large number of centers; there is no need for “cutting edge” protocols for a reliable 
assessment of response in a majority of cancer patients. Second, the central review 
of imaging studies will be possible based on the involvement of expert radiologists, 
and on a robust imaging platform that guarantees availability, quality control, and 
“side by side” evaluation of baseline and follow-up examinations. Principles and 
limits of response evaluation by morphologic imaging in oncology will be illustrated. 
Learning Objectives:
1. To illustrate the setting up of an independent image analysis platform in the 
EORTC Imaging Group.
2. To underline the need for defining imaging protocols reproducible and 
transposable to multiple centre trials, facing technical and manufacturer 
dependent variability.
3. To illustrate how “simple” protocols may guarantee robust imaging 
monitoring of cancer (compared to some advanced and multiparametric 
protocols).
Panel discussion: 
Can we use imaging parameters as biomarkers in multicentre trials and 
predict tumour response? 17:18
16:00 - 17:30 Room G/H 
Neuro 
RC 1011 
Common disorders of the paediatric brain 
Moderator: 
O. Flodmark; Stockholm/SE 
A‑276	 16:00 
A. Foetal MR imaging: more than just T2-weighted images 
C. Hoffmann; Tel Hashomer/IL (chen.hoffmann@sheba.health.gov.il) 
The objective of this talk is to introduce other techniques than SS FSE T2 in use 
when scanning the foetal brain. The most frequent indications for MRI are ven-
triculomegaly, asymmetry of the ventricular system, brain malformations, infection 
and others. Most of the MR scan is done with Single Shot FSE T2 (SSFSET2), 
this is a sequence allowing the acquisition of slice by slice of the brain, and thus 
minimising the effect of foetal movement on the scan. Today, fast FRFSET2 are 
available, this is a very short T2 sequence in which the white and gray matter junc-
tion is visualised very well. T1 or FSPGR is used with limitations due to the foetal 
movements. It is necessary to perform T1 to demonstrate the myelination. DWI is 
a very important tool in understanding the ischaemic changes in the adult brain, 
allowing the diagnosis of acute infarcts. Ischaemic insult can occur in foetuses with 
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A‑281	 16:28 
B. From pattern recognition to disease diagnosis: a practical approach 
(part 1) 
M.-L. Storto; Chieti/IT (ml.storto@radiol.unich.it) 
A practical approach to HRCT of the chest for diagnosis of diffuse lung diseases 
includes: recognition of the abnormalities, definition of their distribution within the 
secondary lobule or the lung, identification of associated findings. When combined 
with the patient clinical history, these 3 steps allow to shorten the list of differential 
diagnoses and may sometimes lead to a specific diagnosis. A reticular pattern 
consists of multiple lines as the result of interlobular septal thickening, intralobular 
lines or cystic walls of honeycombing. When present as a predominant abnormality, 
thickening of interlobular septa has a limited differential diagnosis which includes 
pulmonary oedema/haemorrhage, lymphangitic spread of cancer, sarcoidosis and 
alveolar proteinosis. Honeycombing represents destroyed and fibrotic lung tissue 
containing numerous cystic airspaces with fibrous walls and is considered a CT 
feature of established pulmonary fibrosis. When honeycombing is present, UIP is 
likely the histologic pattern and IPF is the most likely diagnosis, in the absence of 
a known disease. A nodular pattern consists of multiple rounded opacities 2-10 mm 
in size. The distribution of nodules is the most important factor in making an ac-
curate diagnosis. A centrilobular predominance of nodules that typically spare 
pleural surfaces is a frequent sign of bronchiolitis and airway disease. A perilym-
phatic distribution is most frequently seen in patients with sarcoidosis, silicosis and 
lymphangitic spread of cancer. A random distribution with nodules diffusely and 
uniformly distributed can be the result of infection, haematogenous metastases 
and other rare diseases such as Langerhans cell histiocytosis. 
Learning Objectives:
1. To understand the different patterns on HRCT scans of the chest.
2. To learn about a systematic approach to differential diagnosis of diffuse lung 
diseases.
3. To review key imaging findings.
A‑282	 16:51 
C. From pattern recognition to disease diagnosis: a practical approach 
(part 2) 
T. Franquet; Barcelona/ES (tfranquet@santpau.es) 
The diffuse interstitial lung diseases (DILDs) are a heterogeneous group of disorders 
which principally affect the lung parenchyma. Basic HRCT patterns are common to 
many disease processes and are usually non-specific. However, their distribution 
and their temporal evolution are often characteristic enough for diagnostic purposes. 
Increased lung opacity: air-space consolidation, by definition, occurs when alveolar 
air is replaced by fluid, cells, or other material. On HRCT, consolidation results in 
an increase in lung opacity associated with obscuration of underlying vessels. 
Conversely, ground-glass opacity is defined as: “... hazy increased attenuation 
of lung with preservation of bronchial and vascular margins". The significance 
of ground-glass opacity depends on the clinical scenario. Cysts and decreased 
lung opacity: a cyst appears as a round parenchymal lucency or low-attenuating 
area with a well-defined interface with normal lung. Lung diseases characterised 
by cysts include Langerhan´s cell histiocytosis, lymphangioleiomyomatosis, LIP, 
postinfectious pneumatoceles, and amyloidosis. Recently, lung cysts have been 
reported in association with extrinsic allergic alveolitis. Honeycombing is a process 
characterised by the presence of cystic spaces.The determination of the presence or 
absence of honeycombing on HRCT in patients with idiopathic interstitial pneumonia 
is of great importance. Honeycombing may have an atypical distribution particularly 
in asbestosis, sarcoidosis, non-specific interstitial pneumonia (NSIP), drug-related 
fibrosis and hypersensitivity pneumonitis. HRCT is now an integral component of 
the clinical investigation of patients with suspected and established interstitial lung 
disease. A knowledge of the close relationship between histopathological changes 
and CT appearances. 
Learning Objectives:
1. To understand the different patterns on HRCT scans of the chest.
2. To learn about a systematic approach to differential diagnosis of diffuse lung 
diseases.
3. To review key imaging findings.
Panel discussion: 
How do we report CT of the chest? 17:14
The radiology report is often the primary method of communicating imaging findings 
to the referring physician. Practical guidelines on how to report CT scans of the 
chest for diffuse infiltrative lung diseases will be provided by the panel. Emphasis 
will be placed on both report content and style in order to provide the clinician a 
tool for good patient care. 
16:00 - 17:30 Room I/K 
Chest 
RC 1004 
Diffuse lung diseases: what the radiologist should 
know 
Moderator: 
C. Schaefer‑Prokop; Amersfoort/NL 
A‑279	 16:00 
Chairman’s introduction 
C. Schaefer-Prokop; Amersfoort/NL (cornelia.schaeferprokop@gmail.com) 
With the advent of volumetric data acquisition and with increasing knowledge of 
patho-radiological correlations, HRCT has further matured over the last decade 
and provides the radiologist with an excellent tool for accurately demonstrating 
gross lung anatomy and precisely analysing abnormal findings. The radiologic 
diagnosis of many pulmonary abnormalities is based on an assessment of their 
pattern and distribution. While the pathologist has the advantage of being able to 
evaluate specimens microscopically, the radiologist is confined to the assessment 
of more gross disease. However, the radiologist is able to examine the entire lung 
providing him with information about the distribution of disease and about additional 
diagnostic clues in mediastinum and pleura. Both together, characterisation of the 
gross findings and knowledge of their distribution represent the key features for 
arriving at a confident diagnosis. 
Session Objectives:
1. To become familiar with the standardized and internationally accepted 
terminology for describing and analysing HRCT findings.
2. To learn how a structured analysis of the predominant pattern and its 
distribution represent the key for making a specific diagnosis in the best 
case scenario or to understand how it helps to narrow the differential 
diagnosis.
3. To promote the understanding how the variability of manifestations of some 
diseases can cause an overlap of findings being responsible for difficulties 
the radiologist encounters when categorizing diffuse diseases of the lung 
parenchyma.
A‑280	 16:05 
A. The glossary of terms for thoracic imaging: old and new definitions 
J.A. Verschakelen, W. De Wever, J. Coolen; Leuven/BE 
(johny.verschakelen@uz.kuleuven.ac.be) 
Most radiological reports consist of a ‚descriptive part‘ in which the radiologist 
describes the findings and a short ‚conclusion part‘ containing the interpretation 
of what is seen. Both parts are filled with ‚jargon‘. Some terms are typical radio-
logical ‚language‘ while others refer to terminology also used by clinicians and 
pathologists. Some terms are purely descriptive but others may contain already 
some interpretation of what is seen and hence narrow the differential diagnosis. 
The meaning of a term may also change over time. It is very important that both 
radiologists and the readers of their reports speak the same language and know and 
understand the meaning and full content of each term. This is especially important 
when radiological findings in patients with diffuse lung diseases are described 
and interpreted. Diagnosis of diffuse lung disease is indeed largely based on the 
recognition and description of the appearance pattern of the disease because this 
often allows developing an appropriate list of differential diagnosis. Members of 
the Fleischner Society have introduced a glossary of terms for thoracic imaging. 
This presentation will emphasise on the importance of such a glossary for both 
describing and interpreting chest images. Special attention will be given to the 
terms used to describe the different patterns in diffuse lung diseases: (1) reticular 
and short linear opacities, (2) nodular opacities, (3) increased lung opacity and (4) 
cysts and decreased lung opacity. 
Learning Objectives:
1. To understand the importance of a glossary of terms for thoracic imaging.
2. To become familiar with the new definitions introduced in the last glossary of 
terms proposed by members of the Fleischner Society.
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A‑285	 17:00 
C. Ethical problems in diagnostic radiology in terms of radiation protection 
K. Paalimäki-Paakki; Oulu/FI (karoliina.paalimaki‑paakki@oamk.fi) 
The purpose is to describe ethical dilemmas related to the use of radiation in Finn-
ish radiographer’s work in diagnostic imaging. The data were collected during the 
spring and summer of 2008, and it consisted of thematic interviews of diagnostic 
radiographers (N=8) whose working experience varied from 4 to 31 years. The data 
were analysed by the method of data-oriented qualitative inductive content analysis. 
Ethical dilemmas related to the use of radiation were found to concern justification 
and optimisation principles, which were found to be inadequately implemented by 
radiographers. The background factors of these dilemmas were found to be both 
dependent on and independent of the employee, resulting in worsened well-being at 
work and in seeking for change. The current processing methods of dilemmas were 
found to be insufficient, and suggestions for better processing methods were made. 
The results suggest that there may be shortcomings in radiographers’ knowledge of 
radiation usage. Attitudinal problems within the work community seem to maintain 
ethical shortcomings. Instead of ethically inadequate routines and passing the 
baton to other professionals, radiographers should be encouraged in committing 
themselves into responsibility and safety culture. Respondents repeatedly described 
powerlessness and inability to intervene in ethical problems. 
Learning Objectives:
1. To consolidate knowledge of basic radiation protection principles.
2. To become familiar with ethical dilemmas in radiographers work.
3. To gain knowledge about ethical dilemmas in the implementation of 
justification and optimisation principles in diagnostic radiographer’s work.
4. To consider and learn to recognise ethical dilemmas in the use of radiation.
16:00 - 17:30 Room N/O 
Head and Neck 
RC 1008 
Runny and stuffy noses: paranasal sinus imaging 
Moderator: 
M.G. Mack; Frankfurt a. Main/DE 
A‑286	 16:00 
Chairman’s introduction 
M.G. Mack; Frankfurt a. Main/DE (m.mack@em.uni‑frankfurt.de) 
The common cold is one of the most frequent illnesses in Europe and the United 
States. Although most cold are mild and resolve within a short time period, colds 
cost billions of dollars per year, mostly due to lost time at work and school. The 
common cold is a group of symptoms caused by one of a large number of viruses. 
Rhinoviruses cause the greatest number of colds; there are more than 100 dif-
ferent varieties of rhinovirus. The average adult experiences two to three colds 
per year, while children average 8-12 colds per year. In most cases, colds do not 
cause serious illness. Most colds last for 3-7 days, although many people continue 
to have symptoms (coughing, sneezing and congestion) for up to 2 weeks. Some 
viruses that cause the common cold can also depress the immune system or cause 
swelling in the lining of the nose or airways; this can lead to bacterial infection. 
One of the more common complications is sinusitis, which is usually caused by 
viruses and rarely (about 2% of the time) by bacteria. However, it can be difficult 
to distinguish bacterial sinusitis from sinusitis caused by a cold because the signs 
and symptoms can be similar. However, due to the fact that a runny nose can also 
result from inflammation, trauma, foreign body and other abnormal processes, 
including tumours, an excellent diagnostic workup is necessary. 
Session Objectives:
1. To discuss the epidemiology of runny and stuffy noses.
2. To discuss the pathophysiology of runny and stuffy noses.
3. To become familiar with facts concerning the economic aspects of runny and 
stuffy noses.
A‑287	 16:05 
A. Functional anatomy and anatomic variants 
S. Robinson; Vienna/AT (s.robinson@dzu.at) 
The paranasal sinuses develop in pairs from the nasal cavity and grow from early 
pregnancy to late puberty. They humidify and warm inspired air, increase the 
surface area for olfaction, are thought to regulate intranasal pressure, lighten the 
skull, provide resonance and absorb shock. They are all lined by ciliated columnar 
16:00 - 17:30 Room L/M 
Radiographers 
RC 1014 
Radiography as an ethical practice 
Moderators: 
B.T. Andersson; Lund/SE 
A.L. Baert; Kessel‑Lo/BE 
A‑283	 16:00 
A. The relationship between man and technology in radiographic practice: 
a narrative approach 
B.R. Mussmann; Odense/DK (borm@ucl.dk) 
The purpose is to examine the relationship between man and technology within 
radiography without considering man and technology as separate entities. The 
study is designed as an observational study which took place in a Danish radiologi-
cal department. It involved 20 examinations followed up by three semi-structured 
interviews. Through emergent narratives radiographers construct a practice in which 
the relationship between man and technology is marked by a struggle of domina-
tion of one over the other. The struggle expresses itself through two competing 
plots: a diagnostic plot with a prevailing, but not merely chronological structure 
mostly composed of events tied to pathology. The life story, in opposition, plots 
the examination as a significant experience in the patient‘s life, transforming it 
into events stretching towards a future yet unknown. Most often the radiographers 
contributed to the domination of man over technology through active engagement 
of their narrative alertness. Errors and failure to keep the time schedule can, how-
ever, lead the radiographers to a change of perspective that makes them displace 
man from the scene of radiography by playing on the premises of technology. In 
several stories technology can be labelled ‚setting‘ while the patient plays the main 
role. The radiographers act with the patient as point of origin, but they reason with 
technological arguments. Hence, the human aspects of radiography constitutes 
an underground practice, which is not explicitly articulated valuable. This creates a 
field of tension between man and technology, with risk of technological dominance. 
Learning Objectives:
1. To gain knowledge about narrative analysis in a radiographic context.
2. To appreciate humanistic aspects of radiography.
3. To consolidate knowledge of ethics in radiographic practice.
4. To understand how perspectives of illness and disease influences the 
patients experience.
A‑284	 16:30 
B. Ethical codes across Europe 
D.S. Oreti; Monfalcone/IT (graig@virgilio.it) 
The private life of everyone of us as well as the everyday practice of our profession 
is deeply embedded in ethical/deontological aspects which play a critical role into: 
our profession, the relationship with our patients, with our colleagues, with the 
health care team we work with, and with ourselves. The radiographer’s everyday 
practice has to take this aspects into account. Ethics finds its origins in the fusion 
of three different sources, as if it were a compromise between: the species we 
belong to, the society we live in, and ourselves. Yet, we are not obliged to abide 
to these three elements. It is through our actions that we decide how to behave in 
certain situations. And this is the reason why every single action towards the others 
gathers importance, the simple rites when individuals meet play a pivotal role in 
the creation of a relationship with the others. Shaking hands, greeting and using 
polite forms of speech, all these actions are ethically important, they allow us to 
catch the benevolence of our interlocutor and to discourage any possible hostility. 
What would happen if our professional identity were perceived and acknowledged 
through the way we can interact and relate to others? In this case, the work no 
longer ennobles the man, but it is the man, through his actions, who ennobles his 
profession. Behaving ethically towards one’s own profession, towards the others 
and towards ourselves, is it, or could this be the common ground of European 
professional ethics? 
Learning Objectives:
1. To gain knowledge about the border between philosophical, ethical and 
personal application in the professional field.
2. To understand the ethical aspect of daily practice, starting from simple actions.
3. To appreciate how the ethic can exploit the profession of the radiographer.
4. To consolidate knowledge of the role of the ethic within the profession of the 
radiographer in Europe.
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cystic carcinoma, mucoepidermoid carcinoma, haemangiopericytoma, melanoma, 
olfactory neuroblastoma, osteogenic sarcoma, chondrosarcoma, rhabdomyosar-
coma, lymphoma, extramedullary plasmacytoma, and metastatic tumours. Benign 
tumours are: papillomas, osteomas, fibrous dysplasia, juvenile angiofibroma, 
schwannomas and neurofibromas. Till date, the TNM classification is used only 
for maxillary sinus carcinoma. 
Learning Objectives:
1. To understand the value of different imaging techniques.
2. To review imaging findings in benign and malignant disease.
3. To become familiar with TNM staging of sinonasal neoplasms.
4. To learn about a template for a “structured report”.
Panel discussion: 
Diagnostic considerations in runny and stuffy noses 17:14
A runny or stuffy nose can be due to colds, allergies, sinus infections or the flu and 
sometimes the nose is stuffed by a tumour. Do we need imaging at all in runny 
and stuffy noses? When should imaging be performed? Which type of imaging 
is indicated? 
16:00 - 17:30 Room P 
Physics in Radiology 
RC 1013 
Diagnostic radiology and pregnancy 
Moderators: 
R. Padovani; Udine/IT 
H. Ringertz; Linköping/SE 
A‑290	 16:00 
A. Conceptus doses and risks from maternal diagnostic x-ray 
examinations 
J. Damilakis; Iraklion/GR (damilaki@med.uoc.gr) 
Whenever a diagnostic x-ray examination of a pregnant patient is considered to be 
necessary, conceptus dose estimation is an important step in assessing the risks 
to the unborn child. Accurate estimation of conceptus dose is also needed after 
inadvertent irradiation of a pregnant patient from a diagnostic x-ray procedure. 
Several methods have been developed to estimate conceptus dose from radiologic 
examinations. When the uterus is remote from the directly exposed tissues, the 
conceptus is exposed to scattered radiation and its dose is negligible (< 1 mGy). 
Examinations involving the abdomen-pelvis may deliver higher dose to the child. 
Variations in maternal body size and uterus position should be taken into account 
to obtain accurate conceptus dose estimation. Multidetector CT (MDCT) scanners 
have replaced conventional CT technology. Conceptus doses from abdominal 
MDCT range from about 13 to about 31 mGy during the first post-conception 
weeks for a scan acquired at 120 kVp, 200 mAs with a pitch of 1.0, depending on 
maternal body size and uterine position. Multi-phase abdominal CT examinations 
may deliver relatively high doses to the unborn child. Doses to the conceptus below 
100 mGy should not be considered a reason for termination of pregnancy. The risk 
to the embryo/foetus for stochastic effects is assessed on the basis of dose using 
appropriate risk factors. Although these risks from a single diagnostic procedure 
are low for the majority of diagnostic x-ray examinations, it is important to ensure 
that doses are kept as low as reasonably achievable. 
Learning Objectives:
1. To learn how to manage and counsel pregnant patients in case of (a) 
intentional and (b) accidental exposure.
2. To learn how to estimate conceptus radiation dose from diagnostic x-ray 
examinations.
3. To learn how to assess the radiogenic risks to the embryo/foetus from 
diagnostic x-ray examinations.
epithelial cells. The mucociliary transport drains each sinus in a specific pattern 
through its ostium to the nasal cavity and ensures a constant flow of mucus contain-
ing bacteria and particulate matter. Functional endoscopic sinus surgery (FESS) 
aims to enlarge the preformed ostia to allow physiologic drainage. Preoperatively, 
anatomic variants have to be ruled out or shown by CT to avoid injury. Special 
emphasis lies on the ostiomeatal unit, a complex anatomic region at crossroads of 
mucociliary drainage from frontal, anterior ethmoid and maxillary sinuses (uncinate 
process, Haller, Agger and frontoethmoidal cells, inverse turbinate). Description 
of the level of the cribriforme plate in relation to the roof of the ethmoid is another 
key element in a report to avoid skull base injury (Keros I-III). Preoperative iden-
tification of variations in the location of the optic nerve and the cavernous portion 
of the internal carotid artery is also mandatory. Furthermore, the close proximity 
of the sinuses to neighbouring structures and their thin bony walls predispose to 
certain pathways of spread. 
Learning Objectives:
1. To become familiar with the normal anatomy and surgically relevant 
anatomic variants.
2. To learn about the functional anatomy and patterns of disease.
A‑288	 16:28 
B. Sinusitis: imaging findings before and after treatment 
D. Farina; Brescia/IT (nappaje@yahoo.it) 
Runny and stuffy noses may be due to a long list of pathologic conditions, which 
require distinct imaging strategies and treatment options. Acute rhinosinusitis, for 
example, is normally managed by GPs without any imaging study. Occasionally, 
signs and symptoms suggest orbital or intracranial complications: in such cases 
MSCT allows a prompt diagnosis and is preferred to MRI for wider availability and 
faster acquisition. Persistence of signs/symptoms for longer than 12 weeks clas-
sifies rhinosinusitis as chronic (CRS); the condition may or may not be associated 
with the presence of nasal polyps. In patients affected by CRS cross-sectional 
imaging aims at precisely depicting bone structures and air conduits. In detail, 
imaging shows the anatomic arrangement of sinus drainage pathways and their 
patency, maps anatomic variants that may facilitate CRS or increase surgical risk, 
depicts bone changes induced by CRS or by the mechanical pressure exerted 
by polyps. These tasks are better accomplished by CT, even more so after the 
advent of multislice technology allowed multiplanar reconstructions along oblique 
planes. After surgery, imaging is required when signs/symptoms recur - to asses 
presence and extension of CRS or nasal polyps - or when late complications are 
suspected - such as mucosal synechiae impairing mucus drainage or mucocele. 
MRI plays a limited role in sinusitis because it fails to demonstrate thin bone 
structures; nonetheless, its use is advocated in aggressive inflammatory diseases 
(such as invasive mycoses and Wegener’s granulomatosis) to demonstrate the 
involvement of deep spaces of the face and of the skull base. 
Learning Objectives:
1. To understand the value of different imaging techniques.
2. To review imaging findings in acute infections and chronic inflammatory 
disease.
3. To become familiar with postoperative changes.
4. To learn about a template for a structured report.
A‑289	 16:51 
C. Sinonasal tumours 
H.B. Eggesbø; Oslo/NO (h.b.eggesbo@medisin.uio.no) 
Sinonasal tumours are rare and comprise only 1% of all malignancies. The clinical 
and radiological challenge is to differentiate malignancy from benign or inflamma-
tory changes. Most malignant tumours present at advanced stages. Malignant 
tumours are most common in the 5th-7th decades and have a male preponderance. 
Squamous cell carcinomas are the most prevalent (80%) followed by adenocarci-
nomas. Squamous cell carcinomas are most common in the maxillary sinus, next 
the nasal cavity and ethmoid sinuses, while adenocarcinomas are most often 
seen in the ethmoid sinuses, and commonly caused by occupational exposures, 
e.g. nickel and hardwood workers. Inverting papilloma is one of the most common 
benign tumours and have been associated with human papillomavirus. CT should 
be the first modality in paranasal sinus imaging, while complementary MRI before 
and after gadolinium i.v. is mandatory to differentiate tumour from inflammatory 
disease. A general rule is that tumours more often have unilateral extension and 
that malignant tumours usually erode the bone. However, malignancy may mimic 
benign tumours with thickening or remodelling of the adjacent bone. While CT is 
superior to demonstrate changes in the bone, MRI can differentiate tumour from 
inflammatory changes and demonstrate tumour invasion and perineural spread. 
Malignant tumours are: squamous cell carcinoma, adenocarcinoma, adenoid 
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B. X-ray imaging and pregnancy: justification and optimisation of 
exposure 
P. Vock; Berne/CH (peter.vock@insel.ch) 
As outside pregnancy, justification and optimisation are the main steps to be 
done when an imaging examination using ionising radiation is considered during 
pregnancy. However, the risk concerns the embryo/foetus in addition to the mother 
which means that justification has to be more critical whenever the uterine dose 
is not neglectable. The practical approach to an examination in any woman of 
child-bearing age starts by ruling out pregnancy, whether by taking history or by 
a laboratory test. When pregnancy cannot be ruled out, further steps will depend 
on the type of examination needed and the urgency of diagnostic clarification. 
Ultrasound is the alternative to be preferred when it can answer the clinical ques-
tion. But even among x-ray examinations, the uterine dose is varying widely which 
asks for a careful selection, optimisation and, maybe, for postponing the test. Once 
pregnancy is confirmed, the major question is whether the specific type of diagnostic 
examination will include the uterus in the primary radiation field. Examinations not 
involving the uterus by direct radiation - despite a potentially significant exposure by 
scattered radiation - can usually be performed without a relevant risk to the embryo/
foetus. The situation is more critical when the uterus is within the examination field 
and when therapeutic interventions are considered. The presentation will discuss 
the practical approach to these different situations, the influence of the stage of 
pregnancy, optimisation methods and the choice between alternative methods in 
some frequent clinical situations. 
Learning Objectives:
1. To become familiar with the radiologist’s practical approach to justification 
during pregnancy.
2. To learn how to optimise imaging protocols for x-ray examinations performed 
on pregnant patients.
3. To present the role of imaging modalities in the evaluation of pregnant 
patients.
A‑292	 17:00 
C. Pregnancy and MRI: risks to the unborn child 
J. De Wilde; Edinburgh/UK (jdewilde@staffmail.ed.ac.uk) 
This paper explores the risks to the foetus when magnetic resonance imaging 
(MRI) is used. MRI uses three main components to produce images from inside the 
body: a static magnetic field; a pulsed radio-frequency (RF) fields and time-varying 
gradient electromagnetic fields. The exact frequencies of these fields depend on 
the MRI system purchased, for example; a 0.5T scanner uses 21 MHz RF, a 1.5 
T system uses 63 MHz and a 3 T system uses 127 MHz RF. There is also a wide 
range of options for gradient strengths and slew rates to be considered as well. 
The overall exposure for the foetus depends ultimately on the imaging sequence 
used and the area being scanned. This paper will discuss particular hazards that 
need to be addressed for pregnant women including biological effects of the static 
and time-varying magnetic fields, heating effects of the RF pulses and acoustic 
noise generated by the spatial encoding gradients. The circumstances for foetal 
exposure in MRI will also be discussed including the following situations: the pa-
tient may not be aware that she is pregnant, likely to be in the first trimester; the 
mother is referred for direct foetal imaging after ultrasound (normally second or 
third trimester); the expectant mother may need diagnosis; research on pregnant 
volunteers. The exposure for pregnant staff working in MRI is also an essential 
consideration. Finally, how to minimise the exposure for the foetus during MR 
imaging will be discussed. 
Learning Objectives:
1. To understand the risks to the foetus in MRI from static and time-varying 
magnetic fields, with particular reference to the radiofrequency field.
2. To consider the exposure of the foetus to noise during MRI.
3. To understand how to minimise the exposure of the foetus during MR 
imaging.
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in terms of cerebral perfusion (rCBF, rCBV, MTT and TTP) and cell metabolism 
(cytotoxic versus vasogenic oedema, diffusion restriction). The fundamental goals 
of stroke imaging in the acute phase are: 1. to rule out intracranial haemorrhage, 
and other non-stroke causes of the patient‘s symptoms; 2. to show occlusion of a 
major blood vessel, e.g. by CT or MR angiography; 3. to demonstrate ischaemic 
brain tissue (cytotoxic oedema), e.g. by diffusion-weighted MRI; 4. to reveal tissue 
blood flow and to identify areas of salvageable brain tissue („penumbra“), e.g. by 
perfusion CT or MRI; 5. to select candidates for thrombolytic therapy within the 
critical 3 to 6 hour time window. The purpose of this presentation is to review how 
new developments in neuroimaging improve our understanding of the pathophysiol-
ogy of acute stroke and to demonstrate that multiparametric techniques now play 
a crucial role in the rapid diagnosis, clinical management, therapy and outcome 
prediction of patients with an acute stroke. 
Learning Objectives:
1. To illustrate the objectives of neuroimaging in patients admitted with an 
acute neurologic deficit.
2. To show that perfusion imaging is useful to differentiate the infarct core from 
the penumbra.
3. To discuss the role of CT versus MRI in the management of acute stroke 
patients.
A‑296	 09:21 
C. Intervention in stroke 
M. Leonardi; Bologna/IT (marco.leonardi@centauro.it) 
Organisation is crucial to the practice of dethrombosis. The first step is to grasp 
the fact that ischaemic stroke is an emergency. Stroke victims require an organi-
sation similar to that provided for heart attack patients. Patients must be taken to 
hospital in an ambulance manned by a specifically trained crew. Ideally equipped 
with a mini CT scanner recently made available. This device provides an immedi-
ate morphological scan and CT angiogram to be sent by satellite to the reference 
hospital so that the problem will be clear and the medical team ready on the patient’s 
arrival. Clinical and neurological assessment of the patient must be undertaken 
immediately along the lines of UK practice implementing a simple, clear and rapid 
procedure. If the clinical, CT and CT angiography findings indicate intra-arterial 
treatment, responsibility shifts to the neuroradiology team, organised to work a 24 
hour shift, at the hospital or at least on call. Dedicated imaging systems must be 
available: a multi-layer CT device (CT angiography and perfusion studies). Dedi-
cated angiography suite is essential. A flat panel system would be ideal. There is 
growing evidence supporting the availability of an MR system. This device would 
certainly enhance the possibilities of a stroke unit but it is not essential in the initial 
stages. A stroke unit should be based on a dedicated facility, with emergency ac-
cess separate from the general emergency room, dedicated equipment, dedicated 
ambulances and appropriate links including a dedicated ward and a rehabilitation 
unit essential to the success of the project. 
Learning Objectives:
1. To learn about the benefits and risks in stroke intervention.
2. To consolidate knowledge of different methods of intervention in stroke 
therapy.
3. To learn about the different imaging methods used to decide on and perform 
stroke intervention.
Panel discussion: 
Where do we stand in stroke therapy today? 09:44
Stroke is a common health problem with high socio-economic costs. In recent 
years much effort has been focused on finding ways to ensure early intervention 
as well as new methods not only for early detection but for early treatment. The 
discussion will focus on where we stand today and whether we think stroke imaging 
and treatment will advance further. 
08:30 - 10:00 Room A 
Neuro 
RC 1111 
Imaging stroke 
Moderator: 
R. Siemund; Lund/SE  
A‑293	 08:30 
Chairman’s introduction 
R. Siemund; Lund/SE (roger.siemund@skane.se) 
During the last decade imaging of stroke has developed from a minor field dealing 
with a barely treatable disease to one of the most dynamic parts of neuroradiology. 
The routinely treatment with intra-venous thrombolysis within the 4.5 hour time win-
dow and the continuously expanding treatment of severe strokes with intra-arterial 
thrombectomy have lead to increasing requests from clinicians and interventional 
neuroradiologists to provide imaging information for treatment guidance. All radi-
ologists involved in the management of stroke are facing mainly three demands: 
first, to have good knowledge of the causes and the pathophysiology of ischaemic 
stroke and a proper understanding of the current models for infarct development, 
as a prerequisite for rational decision making and efficient communication with the 
clinicians. Second, to be able to choose and to use appropriate imaging modalities 
for the acute work up of patients with stroke and to be aware of the benefits and 
drawbacks of CT and MRI. Finally, is good knowledge about the therapy options 
mandatory in order to be able to support the clinicians in the time critical treatment 
decision. This session will try to cover these three demands in order to give an 
overview on the current status and the opportunity to discus future perspectives. 
A‑294	 08:35 
A. Aetiology and pathophysiology of stroke 
R. von Kummer; Dresden/DE (ruediger.vonkummer@uniklinikum‑dresden.de) 
„Stroke“ is the commonly used diagnosis for disturbances of brain blood supply due 
to ischaemia, haemorrhage, or venous obstruction. It is evident that „disturbances 
of blood supply“ in stroke patients do not represent a useful concept in order to 
develop effective treatment. It is the radiologist‘s task to describe the acute brain 
pathology, its conditions (pathophysiology), and its aetiology to give directions 
for specific treatment and prophylaxis. The approach is vascular and brain tissue 
imaging. Brain ischaemia is the cause of stroke in about 85% of patients, intracra-
nial haemorrhage in 15% of patients. Arterial obstruction causing brain ischaemia 
is thrombotic or embolic. It can as well be caused by arterial wall dissection or 
inflammation. Arterial wall diseases and heart diseases including a patent foramen 
ovale are sources for brain embolism. The obstruction of a brain supplying artery 
causes brain tissue ischaemia of various degrees depending on the capacity of 
collaterals supplying the same arterial territory. The chances for collateral compen-
sation depend on the site of obstruction and the development of collateral vessels. 
Neurons cannot tolerate low cerebral blood flow (CBF) below 10 ml/100 g x min 
for more than 20 minutes and develop first cellular then irreversible ionic oedema. 
They survive, but do not function with low CBF between 10 and 20 ml/100 g x min. 
Enhancement of CBF in such regions, e.g. by arterial recanalisation can mean 
functional recovery. The imaging diagnosis of damaged brain is therefore the first 
aim in acute ischaemic stroke patients. 
Learning Objectives:
1. To comprehend the etiology and pathophysiology of stroke.
2. To learn to differentiate between different types of stroke.
3. To consolidate knowledge of the key imaging findings in different types of 
stroke.
A‑295	 08:58 
B. Stroke imaging in the acute phase or in critically ill patients 
P.M. Parizel, C. Venstermans, F. De Belder, J.W. Van Goethem, 
L. Van den Hauwe, T. Van der Zijden, M. Voormolen; Antwerp/BE 
Acute stroke is the most common non-traumatic neurological emergency. Clinical 
history and physical examination do not provide reliable information regarding the 
extent and localisation, vascular distribution territory, and aetiology of the stroke. The 
role of stroke imaging has changed dramatically in recent years, thanks to the arrival 
of aggressive new therapies aimed at re-establishing blood flow, reducing infarct 
size and protecting the brain at risk. Multiparametric neuroimaging, involving CT, 
MRI or both, has opened new insights to determine the pathophysiology of stroke, 
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08:30 - 10:00 Room C 
CLICK (Clinical Lessons for Imaging Core Knowledge): Common 
Clinical Cases 
CC 1118 
Surprise in the liver 
Moderator: 
C. Bartolozzi; Pisa/IT 
A‑299	 08:30 
A. Clinical considerations 
A. Palkó; Szeged/HU (palkoand@gmail.com) 
Focal liver lesions are part of our everyday practice because radiologists perform-
ing various types of examinations may encounter them without being aware of 
any clinical condition rising the suspicion of these changes. In a situation like this 
several important decisions are to be made by the radiologists, like: is the lesion 
clinically significant, is the lesion benign or malignant, are additional imaging ex-
aminations necessary, does it require medical, surgical or interventional radiologi-
cal action, should it be, and if yes, how frequently followed up, etc. For providing 
a well-established answer to these questions the reporting radiologist has to be 
familiar with medical history and results of former examinations (physical, laboratory, 
imaging, etc.); consider the age, gender, physical condition, eating and drinking 
habits, potential drug abuse of the patient; bearing in mind the prevalence and 
statistical probabilities of different pathologic conditions. With all this information 
at hand the thorough analysis of images obtained by different modalities will allow 
a rather reliable differential diagnosis and a well-established planning of therapy 
of the incidentally detected lesions. 
Learning Objectives:
1. To learn more about the clinical conditions that may result in the appearance 
of focal liver lesions.
2. To be informed about the clinician’s way of thinking in the process of 
differential diagnosis.
3. To become familiar with the potential role of imaging in the establishment of 
the final diagnosis and planning of therapy.
A‑300	 09:00 
B. Imaging techniques and typical findings 
C.J. Zech; Munich/DE (Christoph.Zech@med.uni‑muenchen.de) 
The spectrum of differential diagnoses is broad in the liver. Therefore, incidentally 
discovered liver lesions represent a challenging clinical situation. Fortunately, there 
are specific imaging features for the most common benign and malignant liver le-
sions (such as, e.g. hemangioma, FNH, cysts, vascular pseudolesions, HCC and 
metastases) so that a minimal-invasive diagnosis with a biopsy is not needed in 
a lot of cases. In ultrasound, the echogenity and recently also the contrast agent 
behaviour are used for liver lesions characterisation. In CT, attenuation and also 
contrast agent behaviour are used for characterisation. MR imaging offers several 
options including T1- and T2-weighted images, use of chemical shift imaging, 
GRE sequences with long echos and diffusion weighted images, so that tissue 
components such as fat, water, glycogen, iron, etc. can be evaluated already in the 
pre-contrast examination. Beside the evaluation of dynamic signal characteristics 
in the early dynamic phase after contrast agent application, MR can utilize also 
tissue-specific contrast agents dedicated to the RES or to the hepatocytes. Other 
modalities such as angiography, PET or other nuclear medicine methods usually 
only play a minor role nowadays in the evaluation of incidental liver lesions in non-
oncological patients. In oncological patients the clinical consequences and also the 
range of diagnoses and pre-test probabilities are different from the non-oncological 
group; therefore, the demands to imaging are even higher. In case of atypical pre-
sentation of otherwise benign liver lesions such as sclerosed hemangioma close 
follow-up or even biopsy can be necessary in such a setting. 
Learning Objectives:
1. To learn about the available imaging modalities to be used for the evaluation 
of patients with incidentally detected focal liver lesions.
2. To become familiar with the technical imaging considerations and the proper 
diagnostic algorithm.
3. To know more about the typical imaging findings.
08:30 - 10:00 Room B 
Interactive Teaching Session 
E³ 1120 
Common radiological problems: palpable lower 
neck mass - thyroid or not? 
A‑297	 08:30 
A. Thyroid nodule 
H. van Overhagen; Den Haag/NL (h.voverhagen@hagaziekenhuis.nl) 
Thyroid nodules are common. In 4-8% of adults nodules can be palpated and 
at ultrasonographic examination nodules are seen in 10-41%. Most nodules are 
benign, the eventual diagnosis in patients with a palpable nodule is carcinoma in 
only 5% of cases. The incidence of thyroid carcinoma is low. Papillary carcinoma 
is the most common type and is found in 75-80% of thyroid cancer. Lymph node 
metastases in thyroid carcinoma are primary to the paratracheal and prelaryngeal 
nodes (Level VI), and the upper (Level III) and lower (Level IV) jugular nodes. 
Malignancy should be suspected when there is rapid growth, a firm or fixated 
mass, when enlarged lymph nodes are present or in case of vocal cord paralysis. 
In patients with multiple thyroid nodules the cancer risk per patient is not altered. 
Ultrasound is the primary imaging technique in patients with a palpable thyroid 
nodule. It is best performed with the patient supine, the neck slightly extended and 
using a high frequency linear-array transducer. Several ultrasonographic features 
are more often associated with benign or malignant nodules. However, while some 
ultrasonographic features may strongly suggest malignancy it may be very difficult 
to rule out malignancy by means of these features alone. Ultrasound-guided fine 
needle biopsy can be performed in an attempt to differentiate between benign and 
malignant nodules. Unfortunately, even with ultrasound guidance, an important 
number of cytological examinations will be non-diagnostic. In addition, in follicular 
lesions it is usually impossible to differentiate cytologically between benign and 
malignant follicular nodules. 
Learning Objectives:
1. To learn about the optimal settings for US examination of the thyroid.
2. To identify morphologic characteristics of benign and malignant thyroid 
nodules.
3. To identify the most common pathways of lymph node metastases in the thyroid.
4. To learn about the role of US-guided fine needle aspiration cytology in the 
thyroid.
A‑298	 09:15 
B. Outside the thyroid 
N.J.M. Freling; Amsterdam/NL (n.j.freling@amc.uva.nl) 
The neck is host to a large variety of benign and malignant diseases ranging from 
simple cysts to acute inflammation with complications to highly malignant sarcomas 
and imaging plays an important role to assess the nature and the extention of 
disease. Patient history and clinical findings will decide which imaging technique 
is best suited to resolve the diagnostic dilemma. Ultrasound is recommended to 
differentiate between a cystic or solid lesion, to guide FNA, being quick and ac-
curate. Pathologic flow within or around a lesion can be assessed adding Doppler 
technique. In acute illnesses with anticipated complications, such as a deep neck 
abscess, contrast-enhanced CT is required to evaluate local extention and demon-
strate spread from the neck deep to the mediastinum. MRI is indicated to assess 
non-inflammatory, subacute or chronic diseases, such as vascular malformations, 
branchial cleft cysts, benign and malignant soft tissue tumours, brachial plexus 
pathology and neurologic diseases. Vascular malformations are easily depicted 
with MRI using T2 sequences in different image planes. Persistent fistulas of the 
branchial system can also be depicted by MRI running from the anterior border of 
the sternocleidomastoid muscle to the lateral pharyngeal wall. Assessing the origin 
of a soft tissue tumour has major implications for surgery. Staging a malignant soft 
tissue tumour must comprise the skull base and upper mediastinum including local 
extention, pathologic neck nodes and perineural spread. Follow-up during chemo-
therapy and postoperative monitoring of malignant disease are important indications 
for (MR) imaging, the more so in young patients, diminishing ionising radiation. 
Learning Objectives:
1. To identify different compartments in the neck.
2. To be able to choose the optimal imaging technique relating to request.
3. To become familiar with the most common pathology in adults and children.
4. To be able to address a short list of differential diagnoses.
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patients (92%) and by ultrasound in 95 patients (93%). The activity of the disease 
was assessed correctly in 91% patients by ultrasound, compared to 74% patients 
by enteroclysis. There was no statistically significant difference. Bowel US is a use-
ful investigation for the diagnosis and follow-up of patients with Crohn´s disease. 
Learning Objectives:
1. To learn about US techniques used in the assessment of patients with 
inflammatory bowel disease.
2. To learn tips for interpretation of US in the diagnosis and follow-up of 
patients with inflammatory bowel disease.
3. To understand the pros and cons of using US, including CEUS, in the 
diagnosis and follow-up of patients with inflammatory bowel disease, 
including assessment of disease activity.
4. To appreciate the accuracy, reproducibility and usefulness of US compared 
with other imaging techniques in assessing patients with inflammatory bowel 
disease.
A‑304	 08:58 
B. Role of CT in diagnosis and follow-up 
S. Romano; Naples/IT (stefromano@libero.it) 
The use of computed tomography (CT) in the diagnostic imaging of patients affected 
by inflammatory bowel disease (IBD) has a long standing history. CT techniques 
such as CT-enteroclysis and CT-enterography have been reported as efficient 
tools for a radiological assessment of disease. The state-of-the art methods will 
be reported and their potentialities in diagnostic accuracy discussed in different 
clinical type of IBD. The acute setting of unknown IBD could be demanded as well 
to CT examination performed in emergency without endoluminal contrast medium 
administration. The CT appearance of the intestinal wall of the segments involved 
by an active disease could be not correctly interpreted if the knowledge of basic 
and classic typical findings of IBD is not combined to consider different pathologic 
entities that could affect the intestine, offering similar but not even equal signs. 
The entire abdominal background needs to be evaluated according to the clinical 
symptoms, signs, laboratory parameters and history of the patient. CT examination 
could be an efficient tool to determine the degree of disease activity in patient with 
known IBD as well as to assess the presence of an acute inflammatory disease of 
the intestine in patients with unknown IBD affection. The actual role of CT in the 
early diagnosis of IBD, in disease staging and detection of complications as well 
as monitoring therapy in follow-up will also be considered and discussed. 
Learning Objectives:
1. To learn about state-of-the-art CT techniques for the assessment of patients 
with inflammatory bowel disease.
2. To learn tips for interpretation in terms of diagnosis and differential diagnosis 
of inflammatory bowel disease.
3. To discuss the value of CT in determining disease activity and monitoring 
therapy.
A‑305	 09:21 
C. CT versus MRI 
M.A. Patak; Zurich/CH (michael.patak@usz.ch) 
The aim of this lecture is to give an overview of the techniques and typical find-
ings for imaging Crohn’s disease (CD) with either multidetector row computed 
tomography (MDCT) or with magnetic resonance imaging (MRI) and compare 
the two different modalities. Optimal imaging of CD begins with the preparation 
phase. The small bowel has to be distended for a concise examination. This can 
be done either invasively, i.e. enteroclysis or orally, which is named enterography. 
There is much debate on which of these two preparation methods is better. For 
the administered intraluminal contrast, best is water with some additives, which 
are neutral in CT and biphasic in MR. Imaging in MDCT is done 40 sec and 70 
sec after IV administration of iodinated contrast with a thin collimation. All image 
data are reconstructed in axial, coronal and sagittal planes. The aim of imaging 
in CD should be to establish the following: (1) presence, severity, and extent of 
the disease; (2) its activity; and 3) extra-intestinal complications. Both modalities 
have proven to be a good tool to evaluate the extent, the activity of the disease 
and the presence of extraluminal complications. Both are also able to identify the 
type of the disease, being either the active/inflammatory, the fistulising/perforating, 
the fibrostenosing or the reparative/regenerative type. The challenge for MRI is 
mostly the in-plane resolution of the image data whereas radiation dose is for CT. 
Learning Objectives:
1. To consolidate knowledge of MR techniques and results in the assessment 
of inflammatory bowel disease.
2. To consider the pros and cons of CT and MRI in inflammatory bowel 
disease.
A‑301	 09:30 
C. Interactive case discussion 
G. Brancatelli; Palermo/IT (gbranca@yahoo.com) 
Incidental lesions are frequently discovered during routine radiographic evaluations. 
Correlation with clinical history and additional confirmatory imaging is essential to 
the development of an accurate, focused differential diagnosis and for appropriate 
management. The objective of this presentation is to describe the imaging findings 
associated with incidentally found liver lesions and to review those clinical and 
radiologic features, which should be considered in development of an ordered and 
accurate differential diagnosis. 
Learning Objectives:
1. To introduce typical cases illustrating the role of imaging modalities in the 
differential diagnosis of unexpected liver lesion cases.
2. To motivate the audience by the use of voting pads to be involved in the 
diagnostic process.
3. To highlight the conclusion that may be drawn on the basis of the discussed 
cases.
08:30 - 10:00 Room D1 
Abdominal and Gastrointestinal 
RC 1101 
Inflammatory bowel disease: which test and when? 
Moderator: 
Z. Tarján; Budapest/HU 
A‑302	 08:30 
Chairman’s introduction 
Z. Tarján; Budapest/HU (ztarjan@gmail.com) 
The diagnosis of IBD is based on complex evaluation of clinical signs, endoscopic 
appearance, radiological imaging, laboratory tests and histology. Besides Crohn's 
disease (CD) and ulcerative colitis (UC) the modern classification advises to use 
the term IBDU (IBD unclassified) colitis to those 10% of cases, where the distinction 
between CD and UC is impossible based on the results of multiple exams. These 
cases are usually clinically more severe, with humbler therapeutic results. The 
new classification of CD types includes besides the phenotype (B1: inflammatory 
non stenosing non penetrating, B2: stenosing, B3: penetrating) the age (A1: ≤16 y, 
A2: 17-40 y, A3: > 40 y) the location (L1: ileum, L2: colon, L3: ileocolic, L4: upper 
GI tract) and P perianal involvement. In UC the most important clinical factors are 
extent, type and severity. The classification includes length and clinical types as 
acute, relapse-remission and chronic continuum. The radiological imaging in CD is 
needed for lesions not reachable by the endoscope, for categorising, for follow-up 
and detecting complications. Different modalities fit best for these different tasks. 
The goal of imaging in UC is rather to help differential diagnosis and detection of 
complications. While in UC there are good correlation between laboratory and 
endoscopic signs of activity and severity so there is not much need for radiological 
activity indices, in CD the clinical activity does not correlate with the histological 
changes. Although CDAI is widely used for clinical studies, it includes several 
subjective factors, thus radiological activity indices may be of help. 
A‑303	 08:35 
A. Role of US in diagnosis and follow-up 
V. Válek; Brno/CZ (vlvalek@med.muni.cz) 
Crohn’s disease is more likely a systemic disease governed by a shift in the immune 
response, thus affecting the whole MALT system. Bowel ultrasound is a quick, 
simple and effective investigation. The method is simple and requires no bowel 
preparation. We use both - convex (C 5-1 - overview, anatomical orientation) as well 
as linear transducer (L 12-5 - preferred, incl. CEUS, L 17-5 -children and very slim 
patients, L 9-3 - TDPs, deep structures). We examine patients in supine position, 
first small bowel, than mesentery and large bowel. Finally, we examine the terminal 
ileum and cecum or the areas of anastomoses. We assess folds, hastrum, wall 
thickness, vascularity, echogenity of the surrounding fat, the presence of nodes 
and peristalsis. In some cases we use intravenous contrast (CEUS). At least four 
studies have prospectively compared the diagnostic accuracy of US with radiological 
studies, endoscopy or surgery in those with suspected Crohn’s disease. In these 
studies, the sensitivity of US ranged between 84% and 90% and its specificity 
reached 98% and 100%. In our prospective study we investigated patients by 
ultrasound and enteroclysis. We established the diagnosis by enteroclysis in 94 
S
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A‑308	 09:30 
C. Central venous occlusions 
P. Haage1, C. Hohl2; 1Wuppertal/DE, 2Siegburg/DE 
The central venous vasculature and particularly the upper venous system may 
be obstructed by either benign or malignant lesions. Malignant central venous 
obstructions are mainly due to bronchial carcinoma, mediastinal metastasis, 
mesothelioma or lymphoma. The most common cause for benign central venous 
obstruction is haemodialysis related; other benign reasons are rather uncommon 
but increasing due to the omnipresent use of permanent central venous access 
catheters as well as implantable cardiac rhythm management devices. The inci-
dence of haemodialysis-related central venous obstruction resulting in angioplasty is 
described to be more than 10 times higher compared to, for example, pace-maker-
induced stenosis. In any case, early detection and treatment of complications are 
essential to provide adequate care. Contrast venography for many years has been 
the standard of reference; yet this procedure has its shortcomings. Sonography is 
not consistently reliable for detection of central pathologies, owing to difficult access 
to these vessels. Today contrast enhanced CT is employed to define the site of the 
obstruction and the presence of possible thrombosis and reveal surrounding soft 
tissue alterations. MRI is of comparative or even higher sensitivity and specificity in 
evaluating the patency of the central veins. The efficacy and safety of stent place-
ment in central venous occlusion of benign and malignant origin lead to rapid relief. 
Stenting provides fast symptomatic help. Repetitive percutaneous intervention can 
prolong the cumulative patency. Thrombolysis may be required to improve the final 
result, should, however, not be employed as a sole means for revascularisation. 
Learning Objectives:
1. To review imaging modalities for SVC, IVC, hepatic and portal venous 
occlusions.
2. To learn about interventional radiological treatment options.
3. To learn about different indications and routes of treatment.
08:30 - 10:00 Room E1 
Musculoskeletal 
RC 1110 
Sports injuries: US or MRI? 
Moderator: 
G.M. Allen; Oxford/UK 
A‑309	 08:30 
Chairman’s introduction 
G.M. Allen; Oxford/UK (georgina.allen@gtc.ox.ac.uk) 
US and MR are excellent imaging techniques for studying tendons and muscles. 
During this integrated session we will review the advantages and disadvantages 
of US and MR for the diagnosis and follow-up of sports injuries. Tricks of both 
techniques will be addressed, together with some useful guidelines for specific 
sports injuries. Ultrasound is being used at the pitch side and in sports medicine 
practice as an adjunct to clinical practice. With this in mind there are a number of 
questions that will be answered in these talks. 1. When US and MRI are the primary 
imaging and when they are complimentary. 2. What advances have there been 
in US and MRI imaging to help advance our use of these techniques in tendon 
and muscle injury. 3. Should we be aspirating haematomas and using autologous 
blood injections or PRP to treat tendon or muscle disease. 4. Can we predict the 
athletes return to sport? 
A‑310	 08:35 
A. Muscle and US 
C. Martinoli; Genoa/IT (carlo.martinoli@libero.it) 
Muscle imaging is inherently complex and presents unique morphologic challenges 
and continuing integration of dynamic, physiologic and functional capabilities. In 
sports medicine, ultrasound (US) has proved to be an excellent tool to evaluate 
muscle strain and contusion injuries in athletes providing good correlation with 
clinical findings. In the acute phase, US has nearly equal sensitivity to MR imaging 
to diagnose muscle strains, except in the first few hours after the injury, when fresh 
haemorrhage and oedema have similar echogenicity to normal muscle and strains 
may go unnoticed. Later in the process, US has been shown to be a useful tool in 
assessing the sequential stages of muscle repair, showing progressive resolution 
of blood fluid products, decrease in oedema and formation of scar tissue, thus 
aiding rehabilitation planning. Dynamic US during muscle contraction can be valu-
3. To compare the diagnostic accuracy of CT versus MRI in Crohn’s disease.
4. To learn about a strategy for the use of CT and MRI in the radiological work-
up of patients with inflammatory bowel disease.
Panel discussion: 
Five good reasons for the radiologist to be at the forefront 09:44
The chairman and speakers will debate the optimum imaging paradigms according 
to (1) the clinical indication, (2) assessment of those with suspected but as-yet-
undiagnosed disease, (3) staging of the small bowel in those with newly diagnosed 
Crohn disease, (4) evaluation of response to therapy and (5) assessment of those 
with long standing disease. The optimum approach to assessing and monitoring 
disease activity will be discussed. 
08:30 - 10:00 Room D2 
Interventional Radiology 
RC 1109 
Venous intervention 
Moderator: 
L. Lonn; Copenhagen/DK 
A‑306	 08:30 
A. DVT and prevention of pulmonary emboli 
C. Binkert; Winterthur/CH (christoph.binkert@ksw.ch) 
Deep vein thrombosis (DVT) is a common condition which can lead to possible life-
threatening pulmonary embolism (PE). The primary imaging modality nowadays is 
Duplex ultrasound. In cases where the pelvic veins and/or the vena cava is involved, 
a venous-phase CT is helpful to determine the exact extend of the clot burden. 
Standard therapy for DVT is anticoagulation. However, if there is a contraindication 
or a complication (bleeding) to anticoagulation a vena cava filter is a good option 
to prevent PE. A filter should also be considered if a catheter directed thrombolysis 
is performed. With the new optional filters the filtration can be terminated either 
by removing the filter or by converting the filter into a stent. One problem which 
was observed with these optional filters is that (too) many of them are left in place. 
Despite a low complication rate of filters, a filter may cause an increased risk of 
further DVT, or a caval occlusion and in rare cases even a migration or penetration 
is possible. Therefore, patients with optional filters should be followed and filters 
should be retrieved when clinically no longer needed. 
Learning Objectives:
1. To learn about optimal examination and imaging.
2. To understand the role of IVC filters in the management of DVT.
3. To learn about filter concepts.
A‑307	 09:00 
B. Endovascular treatment of varicose veins 
D.J. West; Stoke‑on‑Trent/UK (david.west@uhns.nhs.uk) 
Varicose veins are an early manifestation of venous insufficiency of the lower limbs 
which can also lead to skin changes including extensive ulceration. It is a very com-
mon problem affecting up to 30% of adults in Europe. Patients presenting with venous 
insufficiency must first be assessed by a history and clinical examination to determine 
the presence and extent of the disease. A duplex ultrasound examination is essential 
to determine the cause from which an appropriate treatment plan can be decided. 
Depending on the patients wishes and their funding options it is perfectly reasonable 
to treat all stages of the disease even if just cosmetic. Treatment aims to eliminate the 
reflux in all contributing veins starting proximally and moving distally. Surgery used to 
be the commonest treatment offered to patients but this has been largely superceded 
by endovenous methods which have significant advantages including: no general 
anaesthesia, outpatient based, no cuts, no scars, low recurrence, rapid convalesence. 
There are several endovenous methods using laser, RF, foam sclerotherapy and most 
recently steam heating and a combined mechanical/sclerosant system (ClariVein (R)). 
Laser and RF give almost identical results and 95% permanent truncal vein closure is 
to be expected. Foam sclerotherapy is cheaper and quicker but long-term results are 
poorer and patients often have to return for repeat procedures. Having ablated the main 
truncal veins using laser or RF at least 50% of patients require additional treatments 
for residual varicosities, e.g. microavulsions or foam sclerotherapy. 
Learning Objectives:
1. To learn about diagnostic strategies and options.
2. To know the principles of treatment and discuss the indications.
3. To review the short term and long term results.
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Panel discussion: 
What is the best imaging modality for diagnosing sports injuries? 09:44
US and MR are excellent imaging techniques to study tendons and muscles. During 
this integrated session we will review advantages and disadvantages of US and 
MR for the diagnosis and follow-up of sports injuries. Tricks of both techniques 
will be addressed, together with some useful guidelines for specific sports injuries. 
08:30 - 10:00 Room E2 
Organs from A to Z: Pancreas 
MC 1119 
Imaging adenocarcinoma 
Moderator: 
T.K. Helmberger; Munich/DE 
A‑313	 08:30 
A. MDCT: how to diagnose, how to stage 
W. Schima; Vienna/AT (Wolfgang.Schima@khgh.at) 
Adenocarcinoma is the most common pancreatic malignancy, affecting the head in 
60-70%. MDCT is very effective in detection and staging of adenocarcinoma, with a 
sensitivity of up to 90% for detection and accuracy of 80-90% for staging, but it has 
limitations (detection of small cancers, characterisation). MRI is a problem-solving 
tool in equivocal CT to depict small cancers. MRI with MRCP helps to differentiate 
between adenocarcinoma and focal pancreatitis. The “duct penetrating sign” at 
MRCP is indicative of an inflammatory mass. Examination protocols for MDCT 
include oral administration of 1-1.5 l of water (“hydro-CT”), IV contrast administration 
of 2 ml/kg b.w. (app. 140-150 ml), a flow rate of 4-5 ml/s, and a biphasic scan in 
parenchyma and venous phases. MRI protocol should include non-fatsat and fat-sat 
T1w GRE, T2w TSE, DWI, MRCP, and contrast-enhanced sequences. Gadolinium-
enhanced T1w 3D-GRE are helpful for assessment of vessel infiltration and cystic 
tumours, whereas mangafodipir-enhanced sequences improve delineation of small 
tumours. In patients with locally advanced tumours, neoadjuvant chemoradiation 
may be used for tumour downsizing to make it amenable to radical surgery. How-
ever, pancreatic cancer often does not shrink after tumour response, which renders 
MDCT or MRI unreliable for tumour assessment in this setting. PET/CT may play 
a role in this indication. In conclusion, CE hydro-MDCT is an excellent and robust 
tool for pancreatic cancer detection and staging. MDCT in combination with MRI or 
EUS provides high accuracy for characterisation of tumours. Further improvement 
is needed to assess tumour response after neoadjuvant chemoradiation. 
Learning Objectives:
1. To understand the main pathologic features of pancreatic adenocarcinoma 
and how it governs imaging findings.
2. To learn how to set up imaging protocols for detection and staging purposes 
including contrast media considerations.
3. To learn about the current role of endosonography and PET/CT.
4. To understand the role of image-guided biopsy.
5. To review current trends in tumour management, including the role of 
preoperative neoadjuvant therapy.
A‑314	 08:55 
B. MR imaging: a main course or just a side dish? 
M. Zins; Paris/FR (mzins@hpsj.fr) 
CT is the established imaging technique for evaluation of pancreatic adenocarcinoma. 
MRI, however, can play a major role in this disease. Technical advances of MRI includ-
ing parallel imaging techniques, multichannel receive coils of the abdomen, dynamic 
gadolinium-enhanced T1-weighted fat sat 3D GRE sequences, 3D MRCP sequences, 
mangafodipir-enhanced MRI and diffusion weighted imaging (DWI) have greatly im-
proved the results of MRI in the assessment of pancreatic tumours. Standard imaging 
sequences include T1-weighted GRE with fat saturation, in-phase and opposed phased 
T1-weighted, axial single-shot turbo spin-echo (TSE) and coronal/oblique 2D and/or 3D 
MR cholangio-pancreatography (MRCP) pulse sequences, post-gadolinium-enhanced 
3D T1-weighted fat sat sequence and DWI with multiple b values. MR imaging may be 
useful as subsequent examination for: (1) detection of small non-contour-deforming 
tumours with isoattenuated appearance at CT, (2) evaluation of local extension and 
vascular encasement, (3) detection of the presence of lymph node and peritoneal 
metastases, and (4) detection and characterisation of associated liver lesions and liver 
metastases. Diffusion-weighted imaging may be helpful as a complementary imaging 
method in the differentiation between mass-forming focal pancreatitis and pancreatic 
adenocarcinoma. Due to its superior soft-tissue contrast compared with CT, MRI ap-
able to monitor the healing process. Local complications, such as vein thrombosis, 
irritation of adjacent neurovascular bundles, chronic haematoma and myositic 
ossificans can be demonstrated with this technique as well. However, US tends 
to underestimate the extent of injury and the abnormalities seen disappear more 
quickly when compared with MR imaging. At least in elite athletes, MR imaging 
seems, therefore, to play a more significant role in management of muscle injury, 
particularly when decisions regarding the time at which the patient can return to play 
are needed. By contrast, US is more accessible, and cheaper than MR imaging. 
In most clinical settings, US should be regarded as the first-line imaging choice 
for assessing skeletal muscle injury. 
Learning Objectives:
1. To understand the mechanism of injury of muscles in athletes.
2. To understand the role of US in the diagnosis of muscles injuries.
3. To recognise the imaging pattern of abnormalities in athletes.
4. To understand how US might be used in the management of sports muscle 
for diagnosis and follow-up.
A‑311	 08:58 
B. Tendon and US 
A. Klauser; Innsbruck/AT (andrea.klauser@i‑med.ac.at) 
Sports activity can affect tendons due to chronic overuse or acute injury. Both can 
result in complete tendon rupture. US is helpful in precise assessment of rupture 
severity and extend, but enables alsofor assessment of tendon degeneration, where 
rupture of individual collagen fibres stimulates a chronic cycle of reparative response 
caused due to repetitive microtrauma. In chronic tendinopathy histopathological 
changes, such as hypoxic, mucoid, calcifying, or lipoid degenerations are present. US 
enables for differentiation of partial tears, tendinosis, tenosynovitis or paratendinosis, 
because of active and passive dynamic examination possibilities, and high-resolution 
capability when using high frequency probes. US developments as power Doppler 
US, sonoelastography and contrast enhanced US allow further for new insights into 
tendinopathy. With the use of US, tendon changes can be diagnosed before they 
become symptomatic and a reduction of tendon load and initiation of treatment before 
the condition becomes chronic seem to gain important place in therapeutic regimes. 
Furthermore, US-guided therapies are advisable over blinded-guided injections to 
minimise side effects and to allow an accurate targeted therapeutic approach. 
Learning Objectives:
1. To understand the mechanism of injury of tendons in athletes.
2. To understand the role of US in the diagnosis of tendon injuries.
3. To recognise imaging patterns abnormality in athletes.
4. To discuss how US might be useful in the management of tendon injuries for 
diagnosis and follow-up.
A‑312	 09:21 
C. Muscle and tendon by MRI 
U. Aydingoz; Ankara/TR (uaydingo@hacettepe.edu.tr) 
Although diagnosis of acute muscle injuries in athletes is usually clinical, magnetic 
resonance imaging (MRI) is a very helpful adjunct tool in this setting, showing the 
location, extent and severity of the injury and thereby streamlining the manage-
ment of the patient. Portability of ultrasonography (US) on the playfield in the acute 
setting is not matched by MRI, which nevertheless has distinct patterns of grade 
1-3 muscle strains; however, it is usually with nonacute and deeper injuries of the 
muscles that MRI is especially helpful. Presence of bone contusion, stress reac-
tion, or stress fracture is readily displayed by MRI and this is practically beyond 
the limits of US. Evolving haematomas, fibrosis, scarring, and myositis ossificans 
are sequelae of direct or indirect muscle injury which are usually outlined in a 
single field of view by MRI. Delayed onset muscle soreness and chronic exertional 
compartment syndrome, as well as acute and chronic stages of muscle denerva-
tion changes, are readily diagnosed with MRI. By providing an understanding of 
distinct muscular denervation changes, MRI may actually noninvasively point to 
the entrapped or involved nerve and guide medical or surgical intervention. Foci 
of mucoid degeneration within the muscle, myotendinous junction, or tendon itself 
are readily shown by MRI, which thereby displays potential sites of failure during 
sport activities. Diffusion tensor imaging may have a role in displaying the subtle 
architectural disruptions of directly or indirectly injured muscles. 
Learning Objectives:
1. To understand the specific role of MRI in the evaluation of muscle and 
tendon injuries in athletes.
2. To recognise imaging patterns of tendon abnormalities in athletes: acute and 
over-use injuries.
3. To review different mechanisms of muscle injuries: direct and indirect.
4. To understand how MRI might be used in the management of athletes.
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be as much familiar as the referring physician with plain film appearances of many 
types of abdominal pathology and established roentgen signs. The purpose of the 
presentation is to review remaining indications for abdominal plain films and to 
revisit common imaging findings. 
Learning Objectives:
1. To review the most common causes of hollow organ perforation.
2. To know the optimal technique for plain film of the abdomen in the 
emergency setting, signs of perforation.
3. To know if there are still indications for plain film of the abdomen in the era 
of US and CT.
A‑317	 09:00 
B. Defining the role of US 
J.B.C.M. Puylaert; The Hague/NL (dr.jbcmpuylaert@wxs.nl) 
When a defect occurs in the bowel wall, air will appear within the peritoneal cavity, 
most frequently due to perforated peptic ulcer and perforated sigmoid diverticulitis. 
In most perforating gastrointestinal conditions however, the -imminent- perforation is 
walled-off by neighbouring bowel loops, mesentery and especially by the omentum, 
nick-named “policeman of the belly”. If this walling-off process occurs timely and 
effectively, no or only minimal free air will appear. The most important causes of 
walled-off gastrointestinal perforation are appendicitis, peptic ulcer disease, sigmoid 
diverticulitis, bowel malignancy, Crohn disease and -often underdiagnosed- acci-
dently ingested sharp foreign bodies, as toothpicks, fish bones, chicken bones, etc. 
The extent to which the perforation is walled-off, determines the eventual course of 
the disease. The US hallmark of -imminent- perforation is inflamed fat around the 
involved bowel structure. Inflamed fat on US corresponds to what is often called 
“dirty fat” on CT scan: hypodense fat is interspersed with hyperdense streaks. This 
represents oedema or cellular infiltration of the fatty mesentery and omentum, which 
have migrated towards the site of the imminent perforation in an attempt to seal 
it off. On US inflamed fat is recognised as hyperechoic, non-compressible fatty 
tissue often interspersed with hypoechoic streaks. If fluid collections occur within 
the inflamed fat, this implies abscess formation. Inflamed fat is an important and 
valuable sign in perforating gastrointestinal conditions. If found in the absence of 
bowel pathology, the diagnosis is usually epiploic appendagitis or omental infarction. 
Learning Objectives:
1. To understand the strength of US as the primary imaging modality.
2. To know typical signs of bowel perforation.
3. To be aware of the limitations and pitfalls of US.
A‑318	 09:30 
C. In search of the hole: CT 
A. Laghi; Latina/IT (andrea.laghi@uniroma1.it) 
MDCT is an extremely powerful tool when the search for a GI perforation is required. 
The high spatial and contrast resolutions make MDCT the most accurate imaging 
method to identify even small amount of free intraperitoneal air. There is general 
consensus about the acquisition of a contrast-enhanced scan acquired during the 
portal venous phase of enhancement (delay of around 60-70 sec). Controversies 
are still present in the literature about the utility of a pre-contrast scan as well as 
the need for a preliminary administration of an oral soluble iodinated CM or for 
an enema or gaseous distention of the distal GI tract. Image reviewing needs the 
use of a workstation because multiplanar reformations have been demonstrated 
to improve the detection of small amount of free air. An appropriate window setting 
is mandatory and it makes MDCT 100% accurate for identification of free air and 
almost 90% accurate in the identification of the precise site of perforation. The aim 
of the examination is not only to assess the presence of free air but also to detect 
the site of perforation: this is an extremely useful clinical information especially if 
surgeons decide to perform a laparoscopic repair. Several CT signs have been 
described, able to guide the diagnosis and to differentiate between a perforation 
originating in the upper GI tract (stomach and duodenum), in the small bowel or 
in the colon. 
Learning Objectives:
1. To learn the appropriate imaging protocols in patients with suspected bowel 
perforation.
2. To learn useful signs for the detection and localisation of perforation.
3. To become familiar with imaging strategies in case of clinical suspicion of 
bowel perforation.
pears to be particularly useful for characterisation of small liver metastases and for 
direct visualisation of small pancreatic tumours. 
Learning Objectives:
1. To learn how to set up a useful protocol for pancreatic evaluation for different 
high field equipments.
2. To understand the current role of diffusion-weighted imaging and ADC values.
3. To review the role of organ-oriented contrast media.
4. To understand the technique and role of diffusion-weighted imaging of the pancreas.
A‑315	 09:20 
C. Detection and staging: multimodality comparison 
D.E. Malone; Dublin/IE (dmalone@ucd.ie) 
Evidence-based radiology’ (EBR) is based on best current evidence, traditionally 
acquired radiological expertise, the ALARA principle and the values of referring 
doctors and patients. Any appropriately trained radiologist can formulate an answer-
able question, search the literature, appraise the retrieved evidence, apply their 
findings to local practice and evaluate the results. This presentation will describe 
and illustrate the ‘EBR’ process. Patients with chronic pancreatitis (CP) may pres-
ent with features resembling pancreatic carcinoma, for which CP is a risk factor 
with an incidence of 5.9% after 20 yrs. EBR methods were applied to the problem 
of differentiating mass-forming CP from pancreatic adenocarcinoma. A focused 
question and literature search found no secondary literature or imaging guidelines. 
Primary literature searching found 53 relevant papers, 9 comprised current best 
evidence. For CT, time-attenuation curve characteristics had a sensitivity of 94% 
and a specificity of 83% for carcinoma. For MR, dynamic time intensity curve 
characteristics were only reported in a descriptive study but the Duct Penetrat-
ing Sign (MRCP) had a sensitivity of 85% and a specificity of 96%. For PET/CT, 
18F-FDG had a sensitivity for carcinoma between 86% and 96% with specificity 
of 87%-100%. For EUS/FNA, the sensitivity for carcinoma in pre-existing CP was 
consistently low (54-74%), but the specificity was 100%. Simple Bayesian analysis 
was used to establish the best order in which to apply these studies in practice. An 
algorithmic approach will be presented. The presentation will also consider other 
‘grey areas’ in the field of pancreatic adenocarcinoma imaging using EBR methods. 
Learning Objectives:
1. To learn about evidence-based methods of literature searching and 
appraisal.
2. To understand how these methods can be used to produce diagnostic 
algorithms using the differentiation of pancreatic adenocarcinoma from 
mass-forming chronic pancreatitis as an example.
3. To learn about diagnostic algorithms based on different clinical scenarios 
(local and distant staging, advance versus early disease) involving multiple 
imaging techniques.
Discussion 09:45
08:30 - 10:00 Room F1 
Radiology in Abdominal Emergencies 
CC 1117 
The hole in the guts 
Moderator: 
G. Mathis; Rankweil/DE 
A‑316	 08:30 
A. Wasting time with plain radiography? 
M. Laniado; Dresden/DE (michael.laniado@uniklinikum‑dresden.de) 
In recent years, continuing trends in radiology have diminished the importance of 
plain films of the abdomen significantly. Ultrasonography and MDCT are applied 
with enormous success to the investigation of many abdominal conditions in the 
emergency setting. In the eyes of the radiologist, plain films, therefore, seem irrel-
evant in the presence of such powerful imaging procedures. Surprisingly, referring 
physicians, mostly surgeons, gastroenterologists and urologists, still request plain 
films although the potential of MDCT is obvious to them as well. In their perception, 
the plain film is either a definitive examination before initiation of treatment (e.g. 
stone at the ureteropelvic junction in US proven hydronephrosis) or a preliminary 
study prior to MDCT or surgery (exclusion of pneumoperitoneum or ileus). In the 
present climate of cost and radiation consciousness this trend may continue. 
Moreover, many surgeons, gastroenterologists, urologists, etc. have greater skills 
in reading plain films than in understanding MDCT. Therefore, the radiologist should 
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poration. All these techniques remain investigational at this time for the treatment 
of breast cancer. The limitations of and challenges associated with each ablation 
technique and the issues raised by early pilot studies, which have so far prevented 
these techniques from replacing standard surgical techniques, will be discussed. 
Learning Objectives:
1. To learn about current therapeutic interventional procedures for malignant 
lesions.
2. To learn about current therapeutic interventional procedures for benign 
lesions.
3. To learn about the possible role of therapeutic interventions in the future.
08:30 - 10:00 Room G/H 
Special Focus Session 
SF 11 
Can we predict premature ageing? 
Moderator: 
G. Guglielmi; Foggia/IT 
A‑322	 08:30 
Chairman’s introduction 
G. Guglielmi; Foggia/IT (g.guglielmi@unifg.it) 
In the elderly the co-existence of several diseases, the prevalence of involutional 
and degenerative aspects, together with physical and cognitive problems represent 
‘the norm’. It is therefore important to know how to distinguish the healthy elderly 
from those in need of treatment to avoid overdiagnosis and overtreatment. So the 
question is how to be aware of the potential and limits of diagnostic imaging and 
its applications in geriatric patients. 
Session Objectives:
1. To recognise the coexistence of several diseases in the elderly.
2. To distinguish the healthy elderly from those in need of treatment.
3. To be aware of the potential and limits of imaging in geriatric patients.
A‑323	 08:35 
Brain ageing/dementia 
F. Barkhof; Amsterdam/NL (f.barkhof@vumc.nl) 
Brain development occurs rapidly during the last trimester of pregnancy and 
continues at a rapid pace in the first two years of life. More subtle maturation, for 
example in the white mater, occurs well into the third decade of life, as evidenced 
by diffusion tensor imaging (DTI). Evidence of brain degeneration is occurring soon 
afterwards and includes mild brain volume los, reductions in white mater integrity 
on DTI, widening of Virchow-Robin spaces and accumulation of incidental white 
matter lesions (WML). Severe WML and incidental cerebral microbleeds (MBs) are 
associated with know cardiovascular risk factors and while the concurrent impact 
may be subtle in terms of cognition, they carry a poor prognosis in the long run. The 
same is true for silent cerebral infarcts, which increase the risk of dementia. Neu-
rodegenerative (general brain volume loss, ventricular dilatation and hippocampal 
atrophy) changes also occur well before the onset of clinical signs of dementia. In 
genetically predisposed subjects (e.g. APOE4 carriers) abnormal (compensatory) 
brain activity on functional MRI and increased (compensatory) cerebral metabolism 
on FDG-PET have been observed that predict subsequent cognitive decline. More 
recently, PET studies employing amyloid tracers have shown abnormal binding in 
a significant proportion of cognitively elderly, suggesting that these subjects are at 
risk to develop Alzheimer’s disease - the pace of which is currently undetermined. 
Learning Objectives:
1. To learn which structural brain changes occur with normal ageing.
2. To understand imaging biomarkers that predict premature ageing.
3. To learn how to diagnose dementia as early as possible using MRI and PET.
A‑324	 08:58 
Bone and joint ageing 
A. Cotten; Lille/FR (anne.cotten@chru‑lille.fr) 
Musculoskeletal disorders are frequent in the elderly population. The loss of mobility 
and physical independence resulting from fractures, osteoarthritis, and osteopo-
rosis can be devastating, both physically and psychologically. A current increase 
in geriatric imaging is likely to persist into the near future and requires radiologists 
to be more aware of musculoskeletal complaints and conditions pertaining to the 
geriatric population. The aim of the lecture is to review the main musculoskeletal 
08:30 - 10:00 Room F2 
Breast 
RC 1102 
Interventional: from diagnosis to treatment 
Moderator: 
G. Acunas; Istanbul/TR 
A‑319	 08:30 
A. Practical tips for a successful needle biopsy procedure 
M.T.G. Gaskarth; Cambridge/UK (matthew.gaskarth@addenbrookes.nhs.uk) 
The objective of percutaneous needle biopsy of the breast is to obtain an accurate 
preoperative diagnosis with a low upgrade rate post-surgery. Indications arise in both 
symptomatic and screen-detected lesions. A range of biopsy needle designs are 
available and their selection depends on being aware of the range of needle design 
types, their advantages and limitations. Cutting needles, guns, vacuum systems and 
MR compatible devices will be discussed. Guidance technique for ultrasound, x-ray 
stereotaxis and MR-guided procedures is extremely important, beginning with patient 
positioning and anaesthesia prior to commencing the procedure. Accurate needle 
placement under direct vision using high frequency ultrasound probes, x-ray stereo-
taxis with digital systems and MR guided - with the option of using a CAD system for 
distance calculation - will be presented. Typical imaging signs and potential pitfalls of 
each technique, both anatomical and technical, will be highlighted. Methods to increase 
accuracy including the use of meticulous technique, adequate sampling and correlation 
of specimen pathology with imaging findings at multidisciplinary meetings are essential. 
Learning Objectives:
1. To consolidate knowledge of needle selection for successful biopsy.
2. To consolidate knowledge of guidance technique for successful biopsy.
3. To learn about possible solutions to increase accuracy in needle biopsies.
A‑320	 09:00 
B. Underestimation of disease in needle biopsies 
I. Schreer; Kiel/DE (ischreer@email.uni‑kiel.de) 
There is always the possibility of a false negative biopsy results in any type of 
percutaneous image-guided needle biopsy (FNAC, core biopsy, vacuum-assisted 
biopsy). The risk depends upon the quality of the harvested cytologic or histologic 
material. The quality is closely related to the amount of material collected and the 
accurate targeting of a lesion. Some lesions are at a higher risk of underestima-
tion (sizes < 5 mm, architectural distortions, microcalcifications, stellate lesions) 
than others (i.e. focal lesions). The false-negative rates for microcalfications using 
vacuum-assisted biopsy were reported to be 1.2%, for mass lesions 0.8%. Using 
ultrasound-guided 14 g-core needle biopsy the false-negative rates were reported 
to be in the range of 2.5%. Radiologic-histologic correlation plays a key role in the 
definite and correct judgement of the diagnostic result. In case of imaging-histologic 
discordance re-biopsy, possibly using larger needle diameters, or even open biopsy 
should be considered. The European Guidelines for Quality Assurance of Breast 
Cancer Screening and Diagnosis define outcome parameter for breast biopsies. 
Guidelines from the European Society of Breast Imaging published in 2007 define 
the standards and skills necessary to perform these procedures. Documentation 
standards should be used (B1-B5) to allow continuous yearly evaluation of the 
individual institution results and quality improvement. The aim of any needle biopsy 
is to get as much, i.e. representative material as possible. Nevertheless, a certain 
amount of underestimation, caused by lesion type (ADH, DCIS, LIN, papilloma, 
for example) will remain and has to be reflected. 
Learning Objectives:
1. To realise the risk of a false negative result in needle biopsies.
2. To understand the performance standards needed to minimise the risk of 
underestimation.
3. To evaluate the importance of radiologic-pathologic correlation before 
definite diagnosis.
A‑321	 09:30 
C. New developments: therapeutic interventional procedures 
B.D. Fornage; Houston, TX/US 
The various modalities currently available to ablate breast masses include ther-
motherapy using radiofrequency current, laser irradiation, microwave irradiation, 
or insonation with high-intensity focused ultrasound (HIFU) waves, cryotherapy, 
which freezes tissues through the use of refrigerant gases, and irreversible electro-
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specific, reliable diagnostic tests are needed. CT angiography (CTA) is reported to 
have more frequent inconclusive results (up to 20%) in pregnant and postpartum 
patients, mainly because of poor opacification. Suboptimal opacification is explained 
by physiological changes during pregnancy and persisting in postpartum such 
as the increase in blood volume, which reaches 50% by the 36th week. Shallow 
breathing during CTA acquisition is better than suspended full inspiration to avoid 
massive return of non-opacified blood from the inferior vena cava. The amount 
of contrast medium must also be adapted to the weight. Using standard CTA pro-
tocols, mean maternal radiation dose is roughly 8 times that of lung scintigraphy. 
Reduced kilovoltage or bismuth shielding are different options to reduce skin entry 
dose to the breast, the main radiosensitive organ. Dedicated studies using Monte 
Carlo simulations have shown foetal dose is less for CTA than for V-Q scan, both 
being negligible. CTA allows identifying an alternate diagnosis in 12% to 27% of 
the pregnant and postpartum patients with negative results for VTE. In postpartum 
patients, CT venography following CTA leads to an absolute increase in the VTE 
detection rate of 12%, by allowing detection of iliac or ovarian vein thrombosis. 
Learning Objectives:
1. To understand the role of CTA in the diagnosis of acute PE during pregnancy 
and post-partum.
2. To learn how to optimise CTA protocols for PE during pregnancy and post-
partum.
3. To review key imaging findings.
A‑327	 09:00 
B. CT angiography of large vessel vasculitis 
A.A. Bankier; Boston, MA/US (abankier@bidmc.harvard.edu) 
The presentation will discuss the role of large vessel arteritis within the spectrum 
of thoracic vascular diseases. It will detail the pathological entities and their mor-
phological, functional, and clinical characteristics. It will present typical CT and 
MRI findings and discuss key elements to the differential diagnosis. It will finally 
discuss the clinical relevance of this diseases, with a special emphasis on overall 
evolving importance of thoracic vascular disorders. 
Learning Objectives:
1. To understand the role of CTA in the diagnosis of large vessel vasculitis.
2. To learn how to optimise CTA protocols in patients with known or suspected 
large vessel vasculitis.
3. To consolidate knowledge of typical imaging findings in patients with large 
vessel vasculitis.
A‑328	 09:30 
C. CT angiography for severe haemoptysis 
A.R. Larici; Rome/IT (anna.larici@rm.unicatt.it) 
Severe haemoptysis can occur in about 5% of patients. It is associated with high 
mortality due to asphyxiation, if not treated, and needs urgent and comprehensive 
evaluation of the lung parenchyma, airways, and thoracic vasculature. Multi-
detector row CT angiography is a very useful noninvasive imaging modality for 
initial assessment of haemoptysis in stable patients. It can accurately identify the 
source and the most common predisposing causes of haemoptysis (bronchiec-
tasis, chronic bronchitis, lung malignancy, tuberculosis and fungal infection) and 
the effects of haemorrhage on the lungs and airways. Moreover, the combined 
use of thin-section axial and complex reformatted images allows clear depiction 
of the origins and trajectories of abnormally dilated systemic arteries that may be 
responsible for the bleeding in over 90% of cases requiring intervention with arterial 
embolisation or surgery. Nonbronchial arteries may also represent an important 
cause of haemoptysis. The road maps of dilated bronchial and nonbronchial arteries 
provided by CT angiography represent a useful guide for endovascular treatment. 
CT angiography is a quick and noninvasive tool that is helpful in the diagnosis and 
management of haemoptysis. 
Learning Objectives:
1. To understand the role of CTA in the clinical management of patients with 
hemoptysis.
2. To learn how to optimise CTA protocols for evaluating patients with 
hemoptysis.
3. To consolidate knowledge of typical imaging findings in patients with 
hemoptysis from different etiologies.
disorders that affect the elderly population. Some misleading radiological presenta-
tions typically occurring in this population will be also presented. 
Learning Objectives:
1. To recognise the increased incidence of trauma, degeneration and 
malignancy in ageing.
2. To understand that the loss of mobility and physical independence resulting 
from fracture, arthritis and osteoporosis affect both the physical and 
psychological quality of life.
3. To be more aware of musculoskeletal complaints and conditions pertaining 
to the geriatric population.
A‑325	 09:21 
Cardiovascular ageing 
T. Saam; Munich/DE (Tobias.Saam@med.uni‑muenchen.de) 
Cardiovascular ageing is a universal phenomenon associated with an increased 
likelihood of the development of cardiovascular diseases and of adverse outcomes 
once disease does develop. In fact, most complications of cardiovascular disease, 
including myocardial infarction, stroke, congestive heart failure, atrial fibrillation, and 
cardiovascular death, occur in the increasing number and proportion of our popula-
tion that is 65 years of age and older. Traditionally, imaging techniques that have 
been used to assess the vasculature have focused on depicting the arterial lumen. 
However, luminal narrowing occurs late in the atherosclerotic disease process and it 
is commonly accepted that knowing the degree of luminal stenosis alone is insufficient 
to determine the vulnerability of atherosclerotic lesions. Thus, a number of imaging 
methods, such as ultrasound, PET/CT and high-resolution black-blood MRI have 
emerged that are able to assess the composition and morphology of atherosclerotic 
plaques. IMT measurements of the carotid arteries and calcification in the coronary 
arteries are well validated imaging markers that are associated with adverse outcomes 
independent of other traditional cardiovascular risk factors. Recent studies suggest 
that several other imaging markers, such as arterial FDG-uptake as assessed by 
PET/CT or intraplaque haemorrhage and fibrous cap thickness as assessed by MRI 
are associated with an increased risk of future cardio- or cerebrovascular events. 
It still remains a hotly debated topic whether atherosclerosis is reversible. This talk 
will also provide an update of the latest imaging studies which examined the effects 
of anti-atherosclerotic drugs on plaque regression and progression. 
Learning Objectives:
1. To consolidate knowledge of the underlying pathophysiology of 
cardiovascular ageing.
2. To learn about different imaging strategies to assess cardiovascular ageing.
3. To become familiar with imaging features that might be able to predict 
premature ageing.
4. To learn about imaging studies that examine the effects of drugs on the 
regression/progression of the ‘cardiovascular age’.
Panel discussion: 
What specific knowledge do you need to be able to interpret and 
understand the radiological scenarios in geriatric patients? 09:44
In the elderly the coexistence of several diseases, the prevalence of involutional 
and degenerative aspects, together with physical and cognitive problems represent 
‘the norm’. It is therefore important to know how to distinguish the healthy elderly 
from those in need of treatment to avoid overdiagnosis and overtreatment. So the 
question is how to be aware of the potential and limits of diagnostic imaging and 
its applications in geriatric patients. 
08:30 - 10:00 Room I/K 
Chest 
RC 1104 
CT angiography of the chest beyond aorta 
Moderator: 
C. Engelke; Göttingen/DE 
A‑326	 08:30 
A. CT angiography for PE diagnosis during pregnancy and post-partum 
M.-P. Revel; Paris/FR (marie‑pierre.revel@egp.aphp.fr) 
The risk of venous thromboembolism (VTE) is increased by a factor of four to five 
during pregnancy and in the postpartum period owing to factors such as the higher 
concentration of procoagulant factors and venous stasis. In developed countries, 
PE is the leading cause of maternal death. Because clinical symptoms are non-
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A‑331	 09:30 
C. Radiation dose optimisation and the radiographer’s role 
A. Henner; Oulu/FI (anja.henner@oamk.fi) 
Fast development in the area of imagining modalities demands a lot of work in dose 
and image quality optimisation and management. Deterministic harms have been 
reported both in interventional and diagnostic radiology. There are also some special 
groups (e.g. children) which need a lot of attention and especially tight indications for 
x-ray examinations. Radiation dose and image quality optimisation can be applied 
with small steps in everyday clinical work as a part of self assessment, if the safety 
culture is agreed by all professionals. The vendors put the settings high in order to 
reach the best image quality. After installation the settings must be re-evaluated 
before starting clinical use of the equipment. Also, the sensitivity of AEC (automatic 
exposure control) must be turned according the detector. Using the air gap (30 cm) 
instead of grid, e.g. in hip axio-lateral project or scoliosis, dose decrease can be 
even two thirds. The role of radiographer is expanding to new areas. Quality assur-
ance and dose and image optimisation could be parts of the expanded role. The 
new technical solutions in imaging offer a lot of possibilities for dose reduction, if 
we want, but there is also danger of dose creeping if the doses are not followed up 
frequently. The management and legislation offer the basics but the work must be 
done among those who are working in radiological departments. Commitment to the 
safety culture on all levels in medical radiation offers better care and procedures with 
lower doses to the patients. 
Learning Objectives:
1. To understand the importance of radiation dose optimisation.
2. To become familiar with procedures to optimise the radiation dose.
3. To consolidate knowledge of the radiographer’s role in radiation dose 
optimisation.
08:30 - 10:00 Room N/O 
Joint Course of ESR and RSNA  
(Radiological Society of North America) 
MC 1125 
Essentials in oncologic imaging:  
what radiologists need to know (part 1) 
Moderator: 
D.M. Panicek; New York, NY/US
A‑332	 08:30 
A. Principles of oncologic imaging and reporting 
D.M. Panicek; New York, NY/US 
Learning Objectives:
1. To review general principles of oncologic imaging.
2. To understand the critical importance of clinical context during interpretation 
of oncologic exams.
3. To evaluate ways to ensure that our reports provide added value and reflect 
the radiologist’s role as consultant.
A‑333	 08:50 
B. Lung cancers (primary, metastases) 
C.J. Herold; Vienna/AT 
Learning Objectives:
1. To review the strengths and limitations of radiologic techniques suitable for 
detecting and characterising primary and metastatic lesions in the lungs.
2. To understand the imaging findings relevant for lung cancer T, N and M 
staging, and appraise the implications of the new IASLC lung cancer staging 
system.
3. To evaluate the imaging findings used to assess response to conventional 
and new therapies for lung cancers.
08:30 - 10:00 Room L/M 
Radiographers 
RC 1114 
Radiation protection and optimisation of 
radiological procedures 
Moderators: 
K. Åhlström Riklund; Umeå/SE 
D. Katsifarakis; Athens/GR 
A‑329	 08:30 
A. Diagnostic quality and patient dose management in digital radiography 
systems 
L.J.O.C. Lanca; Lisbon/PT (luis.lanca@estesl.ipl.pt) 
Several digital systems are currently available for projection radiography. Digital 
systems are traditionally split into two broadly defined categories: computed radiog-
raphy (CR) and digital radiography (DR). CR systems use storage-phosphor image 
plates with a separate image readout process and DR technology converts x-rays 
into electrical charges by means of a direct readout process using TFT arrays. DR 
systems can be further divided into direct and indirect x-ray conversion systems. 
Digital detectors offer several advantages when compared to analogue detectors 
such as wide dynamic range, adjustable image processing, better image quality, 
rapid image acquisition and image access at remote locations. The management 
of diagnostic quality and patient dose is a very important issue to be considered 
by radiographers when working with digital systems. Exposure has a direct influ-
ence in image quality representation and dose delivered to the patient could be 
inappropriate for diagnostic purpose. Diagnostic accuracy could be affected by 
inadequate exposure and thus an appropriate exposure level should be achieved. 
Digital detector technologies have the potential to reduce patient exposure while 
maintaining diagnostic quality using appropriate methods of process optimisation. 
Learning Objectives:
1. To get a global overview of digital radiography systems (both CR and DR).
2. To gain knowledge about advantages when using digital radiography 
technologies.
3. To learn about strategies for the management of diagnostic quality and 
patient dose.
A‑330	 09:00 
B. The radiographer’s position in the initial optimisation procedure 
D. Pekarovic; Ljubljana/SI (dean.pekarovic@kclj.si) 
Radiological procedures are performed because of medical benefits to patients, 
but they also cause some harm because of the dose. If medical benefit overweighs 
detriment the procedure is justified. The purpose of the optimisation is then to adjust 
the procedure in a way to maximise the ratio of benefit over harm. Question is who 
is responsible to do it and how it can be done. Who should participate: we believe 
there is a major role of radiographer as she/he is present at each and every radio-
logical procedure performed. But it is absolutely mandatory for them to understand 
benefits of the procedure and understand harm (dose). Radiographer’s position 
is the connection between radiologist, medical physicist and vendor’s engineers. 
Radiologists usually do not have in depth knowledge of technology and dose 
and physicists and engineers on the other hand do not understand in depth the 
medical aspects of procedure. Radiographers must also understand operational 
possibilities of every x-ray machine. To get to know them they should be there at 
the acceptance of the x-ray machine and talk to service engineers and applicators. 
They should also talk to physicist when he/she is doing tests. And finally simula-
tion of procedure(s) using different phantoms is the best way to understand how 
machine parameters are affecting image quality and dose. In presentation, some 
examples for different modalities will be given. 
Learning Objectives:
1. To gain knowledge about how to start with optimisation of radiological 
procedures.
2. To understand the basics of quality control (QA) for radiographic modalities 
and how to use experience acquired from QA in daily work.
3. To become familiar with guidelines and applications for good radiological 
practice and how to implement them in the optimisation process.
4. To consolidate knowledge of technology of radiographic modalities and the 
use of materials in daily practice according to guidelines, and to be familiar 
with the radiographers responsibility in the field of radiation protection.
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mentations the phase and magnitude relations are even varied during RF pulses. 
In combination with equally dynamic gradient waveforms such fully individual 
control permits particularly fast spatially tailored RF pulses (Transmit SENSE). 
Array transmission entails a generalisation of RF pulse design, for which a range 
of efficient mathematical methods have been developed. One important challenge 
that remains, however, is the need to calibrate array transmitters in terms of the 
individual channels‘ RF field contributions, both magnetic and electric. The latter, 
in particular, underlie power deposition in the tissue and hence need to be closely 
controlled to enforce strict SAR limits. 
Learning Objectives:
1. To learn about the need to control radio-frequency fields, particularly at high 
B0.
2. To understand the principles of doing so by multiple-channel transmission.
3. To become acquainted with the methods of obtaining uniform and tailored 
excitation within SAR limits.
A‑337	 09:30 
C. Is 7T ready for clinical use? 
R.W. Bowtell; Nottingham/UK (richard.bowtell@nottingham.ac.uk) 
The availability of magnetic resonance (MR) scanners operating at 7 T and above 
has already proved beneficial for MR imaging and spectroscopy of the human brain 
and promises similar benefits in the human body. These advantages result from 
the increases with the magnetic field of the intrinsic signal-to-noise ratio, blood 
oxygenation level dependent (BOLD) contrast, which forms the basis of the vast 
majority of functional MR imaging (MRI) experiments, and chemical shift dispersion. 
These gains can be exploited in improving the spatial and/or temporal resolution of 
anatomical and functional MRI experiments and in increasing the spectral resolu-
tion in volume selective spectroscopy or chemical shift imaging. Operation at the 
increased magnetic field also offers easier access to T2
*-contrast and improved 
implementation of susceptibility-weighted imaging (SWI) in which the phase of 
gradient echo images provides information about local variation of magnetic sus-
ceptibility. In the brain, such variation appears to be dominated by differences in 
iron concentration and myelin content, so that high-field SWI may provide useful 
information about the progression of neurodegenerative disease. The elevated T1 
relaxation times at 7 T also offer benefits for arterial spin labelling and time of flight 
angiography. Current and potential future applications of high-field MRI in clinical 
and pre-clinical studies in a number of areas and will be discussed in this presen-
tation, along with the barriers to wider usage of 7 T systems for clinical studies. 
Learning Objectives:
1. To become familiar with the advantages that 7T provides for magnetic 
resonance imaging and spectroscopy.
2. To recognise the areas of clinical application where 7T already offers 
significant benefits over lower fields.
3. To understand the barriers to clinical usage of 7T.
4. To recognise the technical developments that will help to overcome these 
barriers and allow wider clinical usage of 7T.
08:30 - 10:00 Room Q 
Paediatric 
RC 1112 
Abdominal emergencies in children 
Moderator: 
M. Haliloglu; Ankara/TR 
A‑338	 08:30 
A. Non-traumatic acute abdomen 
C. Veyrac; Montpellier/FR (c‑veyrac@chu‑montpellier.fr) 
The purpose is to present and discuss the role of imaging in non-traumatic acute 
abdomen, with particular focus on ultrasound (US). The neonatal GI tract emer-
gencies, associated with specific disorders and imaging strategies, are excluded. 
Acute abdomen in children refers to a wide variety of conditions ranging from benign 
disorders, such as gastroenteritis, to threatening disease, such as midgut volvulus 
or intussusception. The recognition of a surgical emergency requires usually, after 
a competent clinical evaluation, an imaging investigation in order to avoid nega-
tive or unnecessary surgery. Abdominal plain film is known as poorly sensitive in 
most situations, except bowel occlusion. Ultrasound requires experience and a 
thorough examination but has demonstrated a high sensitivity and specificity for 
diagnosing bowel obstruction, midgut volvulus, intussusception, acute appendicitis, 
A‑334	 09:25 
C. Colon cancer 
R.M. Gore; Highland Park, IL/US 
Learning Objectives:
1. To get an overview of current recommendations for the diagnosis of 
colorectal cancer.
2. To understand the specific role of MDCT, MR imaging, endoscopic 
ultrasound, and PET/CT in the staging of colorectal cancer in optimising 
patient management.
3. To learn the utility of imaging in assessing tumour response to therapy and 
in the general follow-up of patients with colorectal cancer.
Questions 09:50
08:30 - 10:00 Room P 
Physics in Radiology 
RC 1113 
High field MRI: Beyond 3 T 
Moderators: 
M. Tosetti; Pisa/IT 
A.J. van der Molen; Leiden/NL 
A‑335	 08:30 
A. Challenges of high field MR 
M. Bock; Heidelberg/DE 
Over the recent years the clinical MRI field strengths have gradually been increased 
to 3 Tesla; however, whole body MRI systems with higher fields of up to 9.4 Tesla 
have become available in experimental settings. Compared to clinical field strengths, 
MRI at very high magnetic fields has several advantages but also some unique 
challenges. With increasing field strength the signal-to-noise ratio increases, which 
can be used to either increase the spatial resolution in the images, or to acquire 
the images more rapidly. Unfortunately, the energy deposited in the human body 
via the RF excitation scales quadratically with the field strength. Thus, the specific 
absorption rate (SAR) is a critical factor in all rapid imaging protocols, and requires 
the design of RF pulses with low SAR, (e.g. VERSE pulses). Inhomogeneities of the 
RF field which are induced by standing wave phenomena have to be compensated, 
and make the design of efficient spin echo pulse sequences very difficult. At higher 
field also the field inhomogeneities become larger and stronger imaging gradients 
are required to overcome the susceptibility-induced image distortion. Stronger 
gradient systems are difficult to manufacture, and the usable gradient slew rate 
is limited by peripheral nerve stimulation thresholds. Furthermore, stronger and 
faster gradients become very loud at high fields, and special measures for sound 
protection are required. Despite these limitations, high-field MRI offers image with 
very high resolution, it provides unique contrasts, a better spectral separation of 
the resonance lines and high signal for non-proton applications. 
Learning Objectives:
1. To understand how the increased field strength affects exposure and image 
quality characteristics.
2. To learn about MR imaging protocols developed for ultra-high field MRI.
3. To become familiar with technology for specific absorption rate reduction.
A‑336	 09:00 
B. A complicated solution to a complicated problem: transmit array 
K.P. Pruessmann; Zurich/CH (pruessmann@biomed.ee.ethz.ch) 
Clinical MRI usually aims to depict anatomic regions of interest with uniform 
coverage and contrast behaviour. To this end it is essential to use suitably homo-
geneous radiofrequency (RF) magnetic fields for spin excitation, refocusing, and 
saturation. Traditionally, such uniform transmit fields are generated by volume 
resonators based on quasi-stationary electrodynamics, which, however, gradually 
cease to apply as clinical MRI explores high field strengths of 3 T and beyond. The 
concomitant increase in operating frequency entails shorter RF wavelength and 
increasing tissue interactions, which render the tailoring of RF fields substantially 
more complex and patient-dependent. One promising response to this challenge 
is to depart from volume resonators and perform RF transmission by multiple, 
individually fed transmitter elements. With such transmit arrays the effective RF 
field can be tailored on a per-patient and per-scan basis by adjusting the relative 
magnitude and phase of driving the elements (RF shimming). In advanced imple-
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08:30 - 10:00 Room Z 
ENCITE Session
Visualisation of cell therapy meets clinical 
application 
Moderator: 
G.P. Krestin; Rotterdam/NL 
A‑341	 08:30 
ENCITE - a translational approach for novel cell therapy applications 
S. Aime; Turin/IT 
ENCITE (European Network for Cell Imaging and Tracking Expertise) is an EU 
integrated project aiming at developing tools and procedures for an efficient in vivo 
image-guidance for cell therapy. It relies on a large interdisciplinary consortium 
that includes chemists, biologists, physicians and imaging scientists. It consists 
of six sub-projects devoted to: 1. Novel imaging technologies; 2. Novel imaging 
reporter probes; 3. Novel tools for cell labelling; 4. Pre-clinical validation; 5. Trans-
laction towards clinical applications; 6. Dissemination and training. The research 
work carried out in the project is providing important contributions to get a better 
understanding of the mechanisms by which cell therapy works. The availability of 
dedicated methods and probes will allow an improved in vivo spatio-temporal track-
ing of labelled cells thus providing the clinicians with the possibility of monitoring 
innovative cell therapies to cure major diseases. 
A‑342	 08:50 
Visualising transplanted neural stem cells and tissue regeneration by MRI 
M. Modo; London/UK 
Neural stem cells are in the process of finding their translation into the clinic. However, it 
is well-known that the cells by themselves do not regrow lost tissue. To this end, neural 
stem cells need further support and guidance. Tissue engineering is using biomaterials 
to provide a structural support for cells, but can also incorporate the release of factors 
that guide the fate of transplanted cells. Ideally, an in vivo imaging approach would 
encompass all these processes. We here demonstratethe use of a 19 F MRI contrast 
agent to detect clinical-grade human neural stem cells non-invasively over 7 days within 
a tissue cavity formed by stroke. To provide structural support for these transplanted cells 
within the tissue cavity, cells were mixed with an engineered de-cellularisedextracellular 
matrix (ECM). Using diffusion MRI, we were able to detect the presence of the ECM 
within the stroke cavity. This approach hence provides a novel approach as to how we 
can study transplanted cells and tissue regeneration in vivo by MRI. 
A‑343	 09:10 
Imaging dendritic cell vaccinations in melanoma patients 
M. Srinivas, E.H.J.G. Aarntzen, F. Bonetto, A. Heerschap, W.J. Oyen, 
O.C. Boerman, C.J.A. Punt, C.G. Figdor, I.J.M. de Vries; Nijmegen/NL 
Our lab has been among the first to exploit dendritic cell (DC) therapy to treat 
melanoma patients. Over the past years, immunological responses are increasingly 
reported and clinical responses have consistently been observed. Moreover, DC 
therapy often has much milder side effects than standard chemotherapy. A key 
hurdle in the development of the DC therapy is accurate delivery of the cells to 
lymph nodes (LNs), or their successful migration from the site of injection to LNs. 
In particular, tools for measuring cell migration in vivo are necessary. Ideally, we 
would be able to quantify the number of DCs at the relevant site, with high resolution 
anatomical context to allow differentiation of LNs and the possibility of longitudinal 
data acquisition. Furthermore, functional data on the ensuing immune response is 
also required. Towards these ends, we have been working on developing imaging 
techniques to study DCs in vivo, for example with scintigraphy on 111In-labeled 
DCs, and magnetic resonance imaging (MRI) on iron-labelled DCs. Scintigraphy is 
quantitative, but it is restricted to the relatively short half-life of the radioisotope and 
is unable to resolve individual LNs. MRI allows high resolution anatomic localisation, 
but the use of contrast agents such as iron oxide is not quantitative. Our recent 
work has focused on imaging the functionality of these DCs using positron emis-
sion tomography (PET) to study LN activation. Finally, we have also developed in 
vitro assays that closely mimic in vivo DC migration in 3D scaffolds imaged using 
quantitative 19F MRI, as a substitute for in vivo optimization. We plan on applying 
19F MRI to the tracking of DCs in vivo, as the technique allows both quantification 
and high-resolution anatomic detail. 
hypertrophic pyloric stenosis, etc. It enables some differential diagnosis such as 
infectious ileocolitis, ischaemic colitis, Henoch Schonlein purpura, complicated 
Meckel diverticulum or duplication, etc. or even pyelonephritis. It can provide 
some findings suggesting mesenteric adenolymphitis, viral gastroenteritis, etc. The 
US findings will be described as well as the potentialities and limitations of US in 
each of these conditions. The accurate knowledge of the clinical findings together 
with the results of US will guide the need for another imaging modality: enhanced 
CT in case of suspected appendicitis with inconclusive US, upper GI series in an 
infant with bilious vomiting and impossibility to display the mesenteric vessels, etc. 
At last, some aspects of pancreatic and biliary tract emergencies will be shown. 
Learning Objectives:
1. To understand the role of sonography in acute digestive disease.
2. To become familiar with the specific imaging findings of intussusception and 
appendicitis.
3. To learn about the acute pathology of the liver, biliary tract and pancreas.
A‑339	 09:00 
B. GU emergencies in children: kidney, ovary, testis 
M. Riccabona; Graz/AT (michael.riccabona@medunigraz.at) 
The purpose is to discuss the role of emergency imaging in acute paediatric GU 
conditions, with particular focus on the potential of ultrasound (US). Besides GU 
tract trauma conditions such as urosepsis, renal failure, renal colics, ovarian or 
testicular torsion with all the respective relevant differential diagnoses have to be 
considered and urgently addressed adequately. Particularly with respect to radia-
tion protection (ALARA-principle) and due to the superb US potential in childhood, 
US is often used as the primary imaging tool. In many conditions US will reveal 
all treatment relevant information and no additional imaging is necessary in the 
acute setting. However, in other conditions such as severe (multiple) trauma CT 
remains the best primary imaging tool, however, only by using age-adapted CT 
protocols. The work-up and follow-up may also require imaging, usually achiev-
able by US and partially by MRI, scintigraphy and/or cystography. All these lead 
to imaging algorithms that differ from adults. The most important conditions, their 
imaging appearance, the potential pitfalls and some important methodical details 
will be presented, also discussing the recommended dedicated paediatric imaging 
algorithms. In most paediatric acute GU conditions US is adequate as the first and 
often sufficient imaging modality. Rarely other imaging is necessary particularly in 
the acute setting - except for CT in severe (multiple) trauma. All imaging should 
be indicated with respect to therapeutic consequences and the ALARA principle, 
and proper paediatric protocols as well as methododical skills (e.g., dedicated 
paediatric US) should be provided 24 hours throughout the year. 
Learning Objectives:
1. To learn about the diagnostic imaging approach in acute urinary tract disease.
2. To recognise the sonographic aspects of ovarian emergencies.
3. To understand the role of sonography in acute scrotum diseases.
A‑340	 09:30 
C. Abdominal trauma in children 
M.P. García-Peña; Barcelona/ES (pilagarcia@vhebron.net) 
Trauma is a leading cause of morbidity and mortality in children. The clinical 
evaluation of children with potential blunt abdominal injury presents a difficult and 
challenging task. Therefore, diagnostic imaging plays an important role in the 
evaluation of injured children. The most common indication for abdominal imaging 
following trauma in children is haematuria. The majority of children with haematuria 
do not have urinary tract injury. Certain clinical variables have been associated 
with a higher risk of abdominal injury. These include gross haematuria, abdominal 
tenderness, ecchymoses, and a low trauma score. Lap belt ecchymoses represent 
an important high-risk marker for injury. They are associated with complex of injury. 
Sonography has limited utility in the assessment of paediatric abdominal trauma. 
Computed tomography (CT) is the imaging method of choice in the evaluation of 
abdominal injury after blunt trauma in haemodynamically stable children. An un-
stable patient needs to be stabilised prior to CT or to proceed directly to surgery. 
Evaluation with CT allows for accurate detection and quantification of injury to solid 
and hollow viscera, and can also identifies an active haemorrhage. CT can help 
prioritise optimal management by diagnosing the major or most life-threatening 
site of haemorrhage or injury. CT can also demonstrate associated bony injury 
to ribs, spine, and pelvis. A normal CT examination may prevent other unneces-
sary explorations. The decision for operative intervention in the small percentage 
of children who require surgical haemostasis is primary made based on clinical 
criteria and not on CT findings. 
Learning Objectives:
1. To learn about traumatic lesions of the abdomen in children.
2. To learn the diagnostic strategy after abdominal trauma.
3. To discuss the diagnosis improvement with the new technology.
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A‑346	 10:40 
How to start interventional radiology 
H. Ghanaati; Teheran/IR (ghanaati@yahoo.com) 
Interventional techniques deeply changed approach to treatment of diseases. In each 
country, interventional radiology practice establishment varies according to local fac-
tors, but following a standard strategy seems better to set up this facility. According 
to above-mentioned points, I decided to establish this specialty in our hospital since 
1996 as the pioneer center in interventional radiology Iran. At first the procedures 
included percutaneous laser disc decompensation (PLDD), and vertebroplasty fol-
lowed by vascular procedures such as UAE in later years. Now, we are performing all 
interventional procedures in our country including aortic stent and all neurointervention 
procedures. The following items will be discussed: 1. Prepare step by step strategies 
for establishing intervention. 2. Solving issues regarding interventions procedures. 3. 
Modified techniques for lowering costs to cover interventions in poor people. 4. Setting 
of fellowship courses. 5. Co-operation with dedicated and pioneer international centers 
such as using neocrylate for treatment of brain aneurysms in conjunction with UCSD 
for the first time on human. When presenting our experience we want to review how 
we should start interventional radiology in developing countries. 
Learning Objectives:
1. To understand why interventional radiology is a mandatory resource.
2. To learn about the milestones of a strategy for building an interventional suite.
3. To understand what the priorities are.
A‑347	 10:55 
Uterine artery embolisation for treatment of symptomatic fibroids 
K. Firouznia; Tehran/IR (k_firouznia@yahoo.com) 
Fibroids are the most common benign tumours of the uterus during female re-
productive age. Uterine artery embolisation (UAE) is a procedure in which using 
embolic particles (PVA, Gelfoam, etc.) we block blood supply to uterine fibroids. It 
has been reported as a relatively safe, effective, and durable nonsurgical alternative 
method diminishing fibroid-related symptoms. UAE is typically performed in both 
uterine arteries by an experienced interventional radiologist. After UAE, reduction 
in menorrhagia has been reported as 80-93% and the mean decrease in fibroid 
size varies from 50% to 78% in the literature. Complications including amenorrhoea 
are frequency ranging from 1% to 7% in the literature. UAE may be followed by 
menopause in 1% of the cases. Nevertheless, it is usually encountered in women 
in their late 40s. It seems that the future of UAE depends on optimal selection of 
patients based on the prediction of volume-shrinkage, the outcome of fertility, and 
the long-term efficacy. Although pregnancy is possible after embolisation, neither 
fertility preservation nor its improvement can be definitely guaranteed. Women 
who desire to become pregnant should definitely be cautioned about potential 
complications during pregnancy. In this presentation we are going to review the 
position of UAE in Iran and to present our experience about the efficacy, and safety 
of UAE. Besides, we will discuss some methods of dose reduction during UAE and 
the effects of UAE on fertility and pregnancy outcome. 
Learning Objectives:
1. To understand the technique of uterine artery embolisation.
2. To learn about the results and complications through literature and 
experience.
3. To learn about the future of this technique, including clinical benefit and 
comparison with other strategies.
A‑348	 11:10 
Interlude (I): Persian physicians' contribution to the evolution of medicine 
K. Vessal; Shiraz/IR 
A‑349	 11:15 
Interventional procedures in liver transplantation 
A. Rasekhi; Shiraz/IR (DrRasekhi@yahoo.com) 
Advances in immunosuppressive therapy, the early diagnosis of complications 
and treatment by interventional methods have all led to prolonged survival of liver 
transplantation. Interventional radiologist is always a part of transplantation team 
and has a very important role to face with complications. During 2001 to 2010, 
846 patients with end stage liver disease underwent liver transplantation in Shiraz 
University of medical science. Among the complications 13 HA, 6 HO and 39 
biliary structures treated by interventional endovascular methods. HA thrombosis 
was treated mostly by direct thrombolytic injection in the clot. The patients treated 
by ballooning the site of strictures and putting an internal-external drainage. 8 HV 
strictures treated by endovascular stenting and ballooning. 11 of 13 patients with 
A‑344	 09:30 
Monitoring of transplanted pancreatic islets in humans by MRI 
M. Hájek, D. Jirák, M. Dezortová, V. Herynek, P. Girman, J. Kříž, F. Saudek; 
Prague/CZ 
Purpose: Labelling pancreatic islets (PI) with superparamagnetic mark-
ers enables their detection as hypointense spots on magnetic resonance 
(MR) images. We tracked PI transplanted into the liver and quantified 
their signal loss in liver tissue using MR imaging over a six-month period. 
Methods and Materials: PI were labelled with ferucarbotran 5 μl/ml for 6-44 
hours and transplanted into the portal vein in 8 C-peptide negative recipients 
(12 infusions). The liver was examined prior to transplantation and subsequently 
1 day and 1, 2, 4 and 24 weeks after transplantation using a 3 T MR scanner. 
Results: In all recipients significant C-peptide levels and near-normal HbA1c values 
were achieved with 50-80% insulin dose reduction. No side-effects related to the 
labelling procedure were documented. A significant decrease in the number of islet 
spots was detected at 1 week post-transplantation (on average 60%) with a subse-
quent only slight decrease for up to 24 weeks. In two subjects with a labelling period 
of less than 6 and 10 hours respectively only a few islet spots were detected corre-
sponding to poor islet visualization in phantoms labelled for the same period of time. 
Conclusion: PI visualization was successful in all recipients but was less efficient 
if the labelling period was less than 16 hours. A significant decrease in islet spots 
occurred at 1 week post-transplantation suggesting early islet destruction or im-
paired engraftment. Then, the decrease in islet spot numbers slowed and islets 
were still detected at 24 weeks post-transplantation. Data shows that MR detection 
of ferucarbotran-labelled islets correlates with sustained C-peptide production. 
Discussion and exchange 09:50
10:30 - 12:00 Room B 
ESR meets Iran 
EM 4 
Interventional radiology: from scratch to innovation 
Presiding: 
Y. Menu; Paris/FR 
A. Sedaghat; Tehran/IR 
A‑345	 10:30 
Welcome and introduction 
A. Sedaghat; Tehran/IR (radiologysociety@gmail.com) 
Iran, is one of the largest countries in the Middle East, with the population of over 75 
million people. Iran has always had special geographic, social, cultural, and economic 
situations. Iran is the cradle of civilisation and home to great people like Cyrus the 
Great, who mentioned the human rights as Cyrus Cylinder and Ibn Sina the author of 
Qanun, one of the most reliable text books in past medicine. At the present time, there 
are 17 medical schools that are training more than 300 radiologist assistants, and over 
1600 radiology practitioners are working in IRAN. The Iranian Journal of Radiology, 
the scientific organ of the Iranian Society of Radiology is published in English and 
has passed seven years of publication. During the past decade, the Iranian Society 
of Radiology has expanded its overseas-activities. Besides local societies and their 
congresses, ISR has established a close and appropriate connection to the European 
Society of Radiology (ESR) justified as the large attendance of Iranian radiologists in 
ECR, the submission of numerous articles to ESR, the membership of Iranian radiolo-
gists in ESR as corresponding members, the significant presence of European radiolo-
gists in the Iranian annual congress of radiology (ICR). Interventional radiology has 
developed in Iran at the same place as in other countries, so that we can offer most of 
the interventional services, such as vertebroplasty, chemoembolisation, various stent 
placements, aneurysm treatment and uterine fibroid embolisation in Iranian radiology 
centers by Iranian radiologists. 
Session Objectives:
1. To learn about prominent clinical situations in which interventional radiology 
plays an important role in the treatment of patients.
2. To understand how interventional radiology can be created and organised 
from the beginning.
3. To learn about the Iranian strategy for the development of interventional 
radiology.
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areolar complex), the presence of other imaging findings (extension to the skin, 
inflammatory cancers) and the status of regional lymph nodes. This information 
influences the type of treatment given to the patient and it is very important to 
gather as much information as possible in order to obtain a one-step surgical 
excision with free margins at pathology. On the basis of this information and on 
discussions held in multidisciplinary meetings, markers will be placed wherever 
needed in order to locate the exact distribution of the tumour(s). The different parts 
of a structured report (clinical data relevant to the report, technical description of 
the diagnostic or the interventional modality, pitfalls during the exam, description 
of breast composition, description of lesions, categories and overall assessment) 
should always be included in order to guarantee that all the important information 
is there. Breast imaging, like other subspecialties in radiology, is a multimodality 
area of knowledge where it is vital to integrate the information obtained through 
diagnostic and interventional procedures in order to supply the clinician with a body 
of data that is useful and straightforward. 
Learning Objectives:
1. To know the pertinent information the clinicians need in a breast cancer patient.
2. To learn the different parts of a structured report using the BI-RADS system.
3. To learn how to integrate the information from various modalities in a report.
10:30 - 12:00 Room N/O 
Joint Course of ESR and RSNA 
(Radiological Society of North America)
MC 1225 
Essentials in oncologic imaging: 
what radiologists need to know (part 2) 
Moderator: 
D.M. Panicek; New York, NY/US
A‑353	 10:30 
A. Pancreatic cancer 
F. Caseiro-Alves; Coimbra/PT 
Learning Objectives:
1. To understand current pathologic concepts for the classification of pancreatic 
tumours.
2. To learn about imaging findings used for tumour detection, staging, and 
restaging after adjuvant therapy.
3. To understand the role of functional and molecular information provided by 
PET/CT, DWI and perfusion imaging when assessing pancreatic tumours.
A‑354	 10:55 
B. Kidney cancer 
E.K. Fishman; Baltimore, MD/US 
Learning Objectives:
1. To understand the diagnostic implications of minimally invasive treatments 
of renal cancer.
2. To review the genetic causes of renal cancer and the radiologic appearances 
of specific histologic subtypes.
3. To review the potential role of molecular imaging in the management of 
advanced renal cancer.
A‑355	 11:20 
C. Ovarian cancer 
H. Hricak; New York, NY/US 
Learning Objectives:
1. To get an overview of the essential imaging findings in characterisation and 
staging of ovarian cancer.
2. To learn the key imaging findings that affect management of ovarian cancer.
3. To understand the changes in imaging armamentarium in ovarian cancer, 
and learn the best practice in proper image utilisation. 
Questions 11:50
hepatic artery thrombosis treated by direct intra-vascular injection of streptokinase, 
flow is again restarted. 2 patients underwent surgery because of right stenosis and 
organised clot. Among 39 biliary strictures 32 strictures were at the site of anasto-
mosis, and 3 patients had changes infavour of sclerosing cholangitis and 4 patients 
had multiple stones and casts. All 8 patients with hepatic vein stricture stended 
successfully. In conclusion, a close working relationship between radiologist and 
liver transplantation team has always been and continues to remain an essential 
component of a successful liver transplantation program. 
Learning Objectives:
1. To understand the main clinical situations in which intervention is necessary 
in patients with a transplanted liver.
2. To become familiar with illustrative cases of the most important procedure.
3. To learn about the role of imaging work-up in the planning of intervention.
A‑350	 11:30 
Interlude (II): Persian physicians' contribution to the evolution of medicine 
K. Vessal; Shiraz/IR (k_vessal@yahoo.com) 
A‑351	 11:35 
Radiochemoembolisation of hepatic metastases 
S. Akhlaghpoor, M. Fatehi, A. Aziz Ahari, M. Amoui, S. Tolooee, H. Poorbeigi, 
S. Sheibani; Tehran/IR 
Liver metastases are of the most difficult therapeutic challenges in oncologic man-
agements. Surgery is frequently impossible due to disease extent and systemic 
chemotherapy usually fails. In other body parts, the combination of radiotherapy and 
systemic chemotherapy is used for several types of malignancies. We successfully 
adopted a novel image-guided form of this combination for such masses referred 
to as radiochemoembolisation, which substantially intensifies the treatment locally. 
Patients underwent transarterial radiochemoembolisation with chemotherapy 
protocol of mitomycin, doxorubicin, and cisplatin and embolisation with radioiso-
tope particles of 32P. The effectiveness of method was determined by comparing 
contrast-enhanced CT images, pre- and post-intervention. Treatment response 
was evaluated using RECIST criteria. We also used some arbitrary criteria such as 
tumoural mean density and enhancement pattern. For stable and partial-response 
cases, the procedure was repeated. We did not repeat the treatment for progressive 
diseases. Complete-response cases were only followed. After completing treatment 
sessions, regardless of the tumour source, considerable amount of patients showed 
substantial response. In terms of RECIST criteria, a significant portion of patients 
gained at least a “Partial Response”. But the decrease in tumour density and the 
appearance of non-enhancing tissues were more promising. Radiochemoembolisa-
tion is an effective method for the treatment of patients with unresectable hepatic 
metastases. Although this study lacks a control group, it shows the effectiveness 
of the treatment. Literature review showed the response to treatment with regard 
to RECIST criteria had been better in our study comparing with studies only used 
chemoembolisation or radioembolisation. 
Learning Objectives:
1. To understand the technique of radiochemoembolisation and the necessity 
of multidisciplinary cooperation.
2. To learn about the possibilities and limits of radiochemoembolisation.
3. To understand the potential role of radiochemoembolisation in the treatment 
strategy of hepatic metastases.
Panel discussion 11:50
10:30 - 12:00 Room C 
Interactive Teaching Session 
E³ 1220 
Breast cancer: what the radiologist must report 
A‑352	 10:30 
Breast cancer: what the radiologist must report 
A. Tardivon1, J. Camps Herrero2; 1Paris/FR, 2Valencia/ES 
(anne.tardivon@curie.net) 
In a patient with a recently diagnosed breast cancer, the clinicians (oncologist, 
surgeon and radiotherapist) need information relative to the location of the can-
cer, its size, the relationship with adjacent structures, its distribution (multifocal, 
extensive intraductal component, multicentric, bilateral, extension to the nipple-
S
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A‑358	 11:10 
Secondary evidence for interventional radiology 
D. Vorwerk; Ingolstadt/DE 
A search on PubMed/EMBASE using 12 terms identifying imaging modalities and 
their explosions was performed to retrieve secondary studies (systematic reviews/
meta-analyses, cost-effective analyses, guidelines, and position papers) on imag-
ing-guided interventional therapeutic procedures (ITPs) published from January 
2000 to May 2010. A total of 1,902 abstracts were initially found and evaluated. 
Excluding congress abstracts, non-secondary studies, and those not imaging-
related, secondary studies concerning diagnostic imaging procedures as well as 
those concerning imaging-guided needle biopsy procedures, 203 papers concerning 
ITPs were found, published with a rate of 19.6/year. Of these 203 studies, 45 (22%) 
were studies concerning ITPs performed by radiologists (R-ITPs=4.4/year), while 
158 (78%) were studies concerning ITPs also performed by non-radiologists (NR-
ITPs=15.3/year). The overall R-ITPs/NR-ITPs resulted 0.29. The mean number of 
studies/year per body district was as follows: neuro/head-neck, 1.8 (R-ITPs) and 
0.4 (NR-ITPs); gastrointestinal/abdominal, 1.3 and 5.9; cardiovascular, 0.5 and 
7.2; musculoskeletal 0.5 and 0.5; thoracic, 0.0 and 0.3; pediatric, 0.0, and 0.1; 
urogenital, 0.3 and 0.6; maternal/fetal, 0.0 and 0.2, respectively. For seven out 
of eight body districts (neuro/head-neck being the only exception), the number 
of studies for NR-ITPs is equal or greater than the number of studies for R-ITPs. 
These data show the under-representation of interventional radiology in terms of 
secondary evidence. To analyze whether this is due to the lack of primary studies 
or to the lack of systematic reviews and meta-analyses of existing primary studies 
is one of the aims of the EBR working group promoted by EuroAIM. 
A‑359	 11:30 
The American College of Radiology Imaging Network (ACRIN): twelve 
years of conducting trials of medical imaging 
B.J. Hillman; Charlottesville, VA/US 
The American College of Radiology Imaging Network (ACRIN) is a U.S.-based, 
National Cancer Institute (NCI)-funded network of institutions and individuals 
collaborating in the design, conduct, and analysis of scientifically rigorous clini-
cal trials of diagnostic imaging and image-guided therapy. Since its inception in 
1999, ACRIN has conducted over 40 trials focused on all applications of imaging: 
screening and early detection, diagnosis and staging, image-guided treatment, and 
response to treatment. An important early focus was the design of large screen-
ing trials that have had an important impact on medical practice. These include: 
the Digital Mammographic Imaging Screening Trial (DMIST), which showed the 
superiority of digital mammography for younger and perimenopausal women, as 
well as those with dense breasts; the National CT Colonography Trial (NCTCT), 
demonstrating the equivalence of CTC with colonoscopy; and the National Lung 
Screening Trial (NLST) which has preliminarily reported a 20% decrease in lung 
cancer- specific mortality associated with annual CT screening. ACRIN’s current 
focuses include the assessment of emerging imaging biomarkers for the prediction 
of and monitoring of response to treatment and the extension of its activities to 
disease processes beyond cancer. 
Discussion 11:50
12:15 - 12:45 Room A 
Plenary Session 
HL 3 
Wilhelm Conrad Röntgen - Honorary Lecture 
Presiding: 
Y. Menu ; Paris/FR 
A‑360	 12:15 
Detecting liver tumours: the search for the Holy Grail 
R.L. Baron; Chicago, IL/US (rbaron@uchicago.edu) 
For decades, abdominal imagers have focused on liver tumour detection and 
characterisation as their holy grail. Most general abdominal CT techniques aim to 
optimise liver mass lesion detection/characterisation, recognising it as (1) prevalent 
disease yet difficult to optimise and (2) one of few areas in abdomen where contrast 
material volumes and timing of scanning is critical. Despite being one of the most 
common topics of publication over the last 30 years in radiology, there is not con-
currence among the radiology community or with clinical colleagues as to the best 
10:30 - 12:00 Room Z 
EuroAIM Session 
Evidence-based radiology: why is evidence-based 
radiology crucial? 
Moderators: 
G.P. Krestin; Rotterdam/NL 
F. Sardanelli; Milan/IT 
A‑356	 10:30 
Applying EBM to radiology - the EuroAIM project 
F. Sardanelli; Milan/IT 
During ECR 2010, the EuroAIM initiative promoted a European working group for 
Evidence-Based Radiology. A search on PubMed and EMBASE database using 
12 terms identifying imaging modalities and their explosions was performed to 
retrieve secondary studies (systematic reviews/meta-analyses, cost-effective 
analyses, guidelines, and position papers) on both diagnostic imaging proce-
dures (DIPs) and interventional therapeutic procedures (ITPs) published from 
January 2000 to May 2010. Imaging-guided needle biopsy procedures were 
included in DIPs. A total of 3,147 abstracts were initially found and evaluated. 
Primary studies, papers not concerning imaging procedures, and congress ab-
stracts were discarded (n=1,699). The remaining 1,448 papers were classified as 
secondary studies on: DIPs performed by radiology/nuclear medicine specialists 
(R-DIPS=807; 56%); ITPs performed by radiologists (R-ITPs=45; 3%); the effect 
of a treatment using a DIP as an end-point (Treat-DIPs=195, 13%); DIPs also 
performed by non-radiology/nuclear medicine specialists (NR-DIPs=243; 17%); 
ITPs also performed by non-radiologists (NR-ITPs=158; 11%). The following ratios 
were calculated: (R-DIPs+R-ITPs)/(NR-DIPs+NR-ITPs)=852/401=2.12; R-DIPs/
NR-DIPs=807/243=3.32; R-ITPs/NR-ITPs=45/158=0.28. From 2000 to 2005, the 
mean number of published secondary studies per year was 28.5 R-DIPs, 1.5 R-
ITPs, 7.7 Treat-DIPs, 10.4 NR-DIPs, and 5.1 NR-ITPs; from 2006 to 2010, 41.7, 
2.0, 10.5, 12.4, and 9.8, respectively. Secondary studies on R-DIPs and R-ITPs 
are relatively underrepresented in comparison with those concerning NR-DIPs 
and especially NR-ITPs. A delay of production of radiological secondary evidence 
negatively impacts on the challenge of an evidence-based demonstration of the 
clinical role of our discipline. The EuroAIM and the European EBR working group 
should make radiologists fully aware of this gap. 
A‑357	 10:50 
Secondary evidence for diagnostic imaging 
L.M. Sconfienza; Milan/IT 
A search on PubMed/EMBASE using 12 terms identifying imaging modalities and 
their explosions was performed to retrieve secondary studies (systematic reviews/
meta-analyses, cost-effective analyses, guidelines, and position papers) pub-
lished from January 2000 to May 2010 on diagnostic imaging procedures (DIPs), 
including imaging-guided needle biopsy procedures. A total of 2,944 abstracts 
were initially found and evaluated. Excluding congress abstracts, non-secondary 
studies and those not imaging-related, 1,245 papers, published with a rate of 
120.5/year, were classified as studies on: DIPs performed by radiology/nuclear 
medicine specialists (R-DIPs=78.1/year), evaluation of a treatment using a DIP 
as an end-point (Treat-DIPs=18.9/year), DIPs also performed by non-radiology/
nuclear medicine specialists (NR-DIPs=23.5/year). For the R-DIPs group, the 
mean number of studies/year according the subspecialty was as follows: neuro/
head-neck 19.5; gastrointestinal/abdominal 11.7; cardiovascular 10.9; breast 9.8; 
musculoskeletal 6.9; thoracic 5.7; pediatric 4.8; oncology (general) 4.2; urogenital 
2.3; maternal/fetal 0.7; other 1.5; for Treat-DIPs, 5.3, 2.2, 1.5, 0.8, 3.1, 1.6, 0.9, 0.7, 
0.2, 0.2, 2.4; for the NR-DIPs group, 9.1, 0.9, 6.7, 0.0, 0.1, 0.2, 0.7, 0.2, 1.1, 4.4, 
0.3, respectively. One subspecialty (neuro/head-neck) has more than 20 studies/
year, five have more than 10. About 20% of all studies concerns NR-DIPs, 23% 
excluding Treat-DIPs. Moreover, the role/number of radiologists in the authorship of 
radiological secondary studies as well as the publishing journal (general medicine, 
clinical specialty, imaging) should be considered. The EuroAIM EBR working group 
should encourage the diffusion of EBR culture and practice in order to fill the gap 
identified with this preliminary analysis. 
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pulse sequences with low and high b-values improves lesion detection. Administra-
tion of a contrast agent is mandatory in liver MRI, because many focal lesion are 
only highlighted by enhanced pulse sequences. Dynamic gadolinium-enhanced 
T1-w GRE pulse (preferably 3D interpolated) sequences are versatile and useful 
for lesion detection and characterisation as well assessment of the vasculature 
(i.e., hepatic artery aneurysms, Budd-Chiari-S., portal vein thrombosis, etc). Liver-
specific contrast agents render excellent results for detection and differentiation 
between metastasis and haemangioma or FNH. Manganese- or superparamagnetic 
iron oxide liver-specific contrast agents can be administered in patients with renal 
insufficiency. The choice of contrast material should be based on availability, the 
specific clinical question, and renal function of the patient. 
Learning Objectives:
1. To learn about the standard basic pulse sequences for liver imaging and the 
critical technical parameters.
2. To appreciate the diagnostic value of non-specific gadolinium chelates 
and different liver-specific contrast agents as well as optional sequences, 
depending on the clinical question.
3. To learn how to optimise pulse sequences and use advanced protocols 
including ‘knife-edge’ sequences and functional/structural imaging.
A‑363	 14:30 
B. Small bowel and colon 
N. Papanikolaou; Iraklion/GR (nickolas.papanikolaou@gmail.com) 
The advent of powerful gradient systems resulted in substantial improvement of 
image quality in ultrafast magnetic resonance (MR) imaging and therefore novel 
clinical applications emerged including gastrointestinal tract imaging. Within this 
context, MR enteroclysis and MR colonography were developed, providing luminal, 
transmural and extramural diagnostic information at the same imaging session. Two 
different protocols have been developed for imaging the small bowel with MR. These 
include MR follow-through and MR enteroclysis. MR follow-through is based on the 
oral ingestion of an adequate amount of contrast agent and acquisition of consecu-
tive sequences. In a clinical setting, sufficient luminal distention that guarantees 
accurate individual lesion detection can be achieved by MR enteroclysis. Two MR 
colonography protocols have been proposed. According to the first, termed as ‚bright 
lumen MRC‘, a gadolinium-spiked water solution is administered endorectally to 
the patient who has previously undergone colonic cleansing to distend the colon, 
resulting in a homogeneous high-signal intensity on heavily T1-weighted 3D gradient 
echo images. Polyps are demonstrated as filling defects while air bubbles can be 
differentiated by performing the examination in both supine and prone positions. 
According to the second approach, termed as ‚dark lumen MRC‘, dense barium or 
tapped water is used to distend the colon in conjunction with post-gadolinium 3D 
gradient echo with fat-saturation sequences. The colonic wall and the correspond-
ing polyps exhibit high signal intensity as a result of gadolinium uptake while the 
colonic lumen presents with low signal intensity. 
Learning Objectives:
1. To review the basic technical aspects of MR enteroclysis and MR 
colonography.
2. To review MR enteroclysis imaging features of Crohn’s disease.
3. To understand the use of optional sequences depending on the clinical 
question in patients with Crohn’s disease.
4. To recognise the potential of MR colonography in the era of CT 
colonography and propose advanced imaging protocols.
A‑364	 15:00 
C. Pancreas and bile ducts 
C. Matos; Brussels/BE (cmatos@ulb.ac.be) 
MR imaging of the pancreas and bile ducts relies upon a combination of T2-w and T1-w 
strategies in order to safely acquire anatomic, cross-sectional and functional information.
Tissue-imaging strategies include free breathing T2-w imaging (obtained with echo-train 
spin-echo sequences with or without fat saturation) and breath-hold 3D-gradient echo 
T1-w imaging (obtained with fat saturation) without gadolinium and in the capillary phase 
and in the interstitial phase post-gadolinium. This combination is valuable in the assess-
ment of the full spectrum of pancreatic diseases and malignant bile duct obstruction. 
Hardware improvements (gradients) and the advent of more sophisticated phased-array 
coils and parallel imaging capabilities in modern MR scanners allowed to increase the 
spatial and temporal resolution of “conventional” T2-w and T1-w sequences. Furthermore, 
it provided the possibility of adding high-b-value diffusion weighted imaging (DWI) to our 
routine protocol in order to increase the sensitivity of MRI in detecting malignant and 
inflammatory diseases. To obtain conventional MRCP imaging thick-slab heavily T2-w 
TSE sequences or 3D heavily T2-w TSE sequences may be used. Advantages and 
limitations of both sequences will be underlined. Functional bile duct imaging is obtained 
imaging modality or technique for this problem. Increasing technological capabilities 
and knowledge of how to optimise CT/MR contrast utilisation provides better ways 
to characterise tumours than ever before such that key clinical specialties outside 
of radiology now recommend nonbiopsy imaging diagnosis of HCC to triage patient 
treatment. Radiologists must work extra diligently to learn the clinical issues, triage 
points and implications that are associated with specific clinical presentations and 
imaging findings. The perfect test that does not require cognitive interpretation of 
the constellation of imaging findings with integration of the patient clinical presen-
tation to optimise patient care is not in our near future. This lecture emphasises 
historical advances in liver imaging and how data in the literature impacted patient 
care decisions in ways that may be different than expected from radiologists. An 
emphasis on pathologic-imaging correlation will be used to put apparent disparate 
published results in proper perspective to allow radiologists to meaningfully interact 
with clinical colleagues in determining optimal patient treatment. 
Learning Objectives:
1. To understand the pathologic changes and imaging correlates in cirrhosis 
that lead to neoplastic development.
2. To gain an awareness of the key role of diagnostic imaging in triaging 
patients with cirrhosis and hepatocellular carcinoma among treatment 
options.
3. To better understand apparent disparate published results to allow 
radiologists to meaningfully interact with clinical colleagues in determining 
optimal patient treatment.
12:30 - 13:30 Room Z 
The Beauty of Basic Knowledge: Interpretation of the Chest 
Radiograph 
MC 21D 
Rounded lesion(s) 
A‑361	 12:30 
Rounded lesion(s) 
J. Cáceres; Barcelona/ES (josecac@gmail.com) 
Rounded lesions of the lung may be solitary or multiple. It is important to separate 
pulmonary from extra-pulmonary nodules, because the significance is different. 
Multiple pulmonary nodules are usually due to metastatic disease. In managing 
the solitary pulmonary nodule it is imperative to exclude pseudonodules due to skin 
or rib lesions and it is of the utmost importance comparing with previous studies. 
Learning Objectives:
1. To understand the importance of rounded opacities.
2. To review the most frequent causes of rounded lesions.
3. To learn current imaging management of the solitary nodule.
14:00 - 15:30 Room A 
Abdominal and Gastrointestinal 
RC 1301 
Abdominal MRI: protocols that work 
Moderator: 
S. Yarmenitis; Iraklion/GR 
A‑362	 14:00 
A. Liver 
W. Schima; Vienna/AT (Wolfgang.Schima@khgh.at) 
Liver MRI is undertaken to assess the liver parenchyma, vasculature, and biliary 
system. It is necessary to use a variety of unenhanced and contrast-enhanced MR 
pulse sequences to achieve lesion detection and characterisation. A set of T1-, T2-w 
and DWI sequences is now standard for lesion delineation and assessment of liver 
fat and iron content. In-phase and opposed-phase T1-w GRE images show focal or 
diffuse fatty infiltration and focal sparing. A fat-suppressed T2-w TSE sequence is 
robust and provides high tumour contrast, with 3.0 T units now allowing acquisition 
of isotropic 3D-TSE sequences. The quite popular T2-w half-Fourier single-shot 
TSE (e.g., HASTE) pulse sequences show anatomic detail (including bile ducts), but 
lack lesion contrast. In case of suspected iron overload (i.e., haemosiderosis and 
haemochromatosis) an additional T2*-w GRE is recommended. Acquisition of DWI 
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14:00 - 15:30 Room C 
CLICK (Clinical Lessons for Imaging Core Knowledge): Common 
Clinical Cases 
CC 1318 
Fever of unknown origin 
Moderator: 
P.A. Grenier; Paris/FR 
A‑367	 14:00 
A. Clinical considerations 
C.P. Heussel; Heidelberg/DE (heussel@uni‑heidelberg.de) 
Patient transport into the radiology department, contact to other potentially infec-
tious persons, and things such as breath-holding are reasonable burdens and 
dangers to immunocompromised patients. When searching the focus of fever, 
imaging should help to identify an affected organ system in order to eventually 
guide invasive procedures to identify underlying micro-organism or non-infectious 
disease. Equally relevant is the exclusion of its involvement with a reasonable 
specificity. Depending on local epidemiology, organ system, and the clinical signs 
and symptoms, suspected differential diagnosis can be derived from image pat-
terns. Some of these diagnoses might be exclusion diagnosis, others might require 
invasive procedures including time consuming and costly analysis to be verified. 
Invasive procedures, however, require adequate hemostasis, which is usually not 
available for a substantial duration due to pancytopenia in patients who underwent 
chemotherapy. If imaging fails to derive the underlying disease confident and 
conclusively in a fast way, clinicians might need to treat on an empirical basis. 
Empirical treatment plays a major role in immunocompromised or severely ill 
patients at risk, because mortality rises within hours of untreated disease. On the 
other hand, empiric treatment causes relevant toxicity and substantial costs, while 
imaging might become cost-effective. 
Learning Objectives:
1. To learn more about the clinical conditions causing fever without an apparent 
origin.
2. To be informed about the clinician’s way of thinking in the process of 
differential diagnosis.
3. To become familiar with the potential role of imaging in the establishment of 
the final diagnosis and planning of therapy.
A‑368	 14:30 
B. Imaging techniques and typical findings 
G.R. Ferretti; Grenoble/FR (GFerretti@chu‑grenoble.fr) 
Diagnosis of fever of unknown origin (FUO) is a major challenge for internists. 
The spectrum of disease includes infections (28%), inflammatory diseases (21%), 
malignancies (17%), and “no diagnosis” (19%). Deep vein thrombosis (3%) and 
temporal arteritis in the elderly (16%-17%) are important considerations. Investi-
gation of patients with FUO usually includes clinical and standard biological tests 
which give numerous clues. Imaging procedures depend on objectives and various 
imaging investigations should be organised in strategies. Early identification of the 
best tissue to be the site of biopsy is one of the most decisive procedures. First 
line imaging studies usually include chest radiography, abdomen ultrasonography 
and contrast enhanced CT of the thorax abdomen pelvis in order to disclose com-
mon etiologies such as infections (tuberculosis, Pneumocystis carinii pneumonia, 
abdomen abscesses and pelvic abscesses), malignancies (lymphoma, metastatic 
cancers, renal cell carcinoma and pancreatic carcinoma), autoimmune conditions 
(Behçet’s disease) and miscellaneous (sarcoidosis). Vein sonography is useful for 
detecting deep venous thrombosis. Nevertheless, there is a need for more complex 
techniques if this strategy fails. Second line techniques include MRI and 18-FDG 
PET scan as (18)F-FDG accumulates in malignant tissues, at the sites of infection 
and inflammation and in autoimmune and granulomatous diseases. In some stud-
ies, the PET scan contributed to the final diagnosis in 25%-69% of the patients. 
Learning Objectives:
1. To learn about the available imaging modalities to be used for the evaluation 
of patients with fever of unknown origin.
2. To become familiar with the technical imaging considerations and the proper 
diagnostic algorithm.
3. To know more about the typical imaging findings.
using contrast agents that are taken up by hepatocytes and excreted through the biliary 
system in combination with volumetric T1-w sequences. We use this technique in post-
operative complications and to elucidate complex biliary anatomy. Functional imaging 
of the pancreas is obtained by combining MRCP along with hormonal stimulation with 
secretin. In addition, secretin improves anatomic delineation and allows MRI quantifica-
tion of fluid production by the exocrine pancreas. 
Learning Objectives:
1. To understand the basic sequences (with technical details) for MRI/MRCP of 
the pancreas and bile ducts.
2. To learn about the use of optional sequences related to special clinical 
situations.
3. To learn about advanced imaging protocols for MRI/MRCP of the pancreas 
and bile ducts concerning functional/structural imaging.
14:00 - 15:30 Room B 
Interactive Teaching Session 
E³ 1320 
Common radiological problems: cardiovascular 
A‑365	 14:00 
A. Looking at the heart in chest x-rays 
J. Andreu; Barcelona/ES (jandreus@gmail.com) 
Despite the advance of cross-sectional techniques, the chest radiograph remains 
a basic tool for the initial approach to heart diseases. In this lecture we will present 
our current approach to evaluate cardiac pathology in conventional radiography 
illustrating it with selected cases. The basic approach consists of seven steps, 
evaluating the size and shape of the cardiac silhouette, cardiac calcifications, 
pulmonary circulation and lung changes, great vessels and implanted devices, all 
of them correlated with the clinical findings. 
Learning Objectives:
1. To learn how to detect and characterise cardiac abnormalities in the chest 
radiograph.
2. To learn how to detect and characterise cardiac abnormalities on chest CT.
3. To learn the limitations of the interpretation of cardiac abnormalities on un-
gated chest CT.
4. To learn when further evaluation is required.
A‑366	 14:45 
B. Looking at the heart in chest CT 
F. Laurent; Pessac/FR (francois.laurent@chu‑bordeaux.fr) 
Looking at the heart on a chest film may be considered at a first glance as wasting 
time since, today, many other techniques are available today to offer an impressive 
luxury details of the morphological and functional evaluation of heart. Neverthe-
less, the chest film remains often the first modality performed in many situations 
in which symptoms can be both from pulmonary or cardiac origin and then, careful 
analysis of heart may avoid rough mistakes in patient management. Acquired and 
congenital pericardial or cardiac abnormalities may be responsible for a deformity 
of the cardiac silhouette and lead to explore the patient by a chest CT. CT with 
fast scanning capabilities can acquire images of the thorax with reduced cardiac 
motion artefacts, improving the evaluation of the heart in the course of a thoracic 
CT. Unexpected findings of cardiac structures on both unenhanced and enhanced 
acquisition can dramatically influence the patient’s clinical management. In many 
situations, a chest CT is performed without cardiac gating and it may be necessary 
to complement the initial examination by a gated acquisition to provide a more dedi-
cated analysis. The normal appearance of cardiac structures and the most common 
cardiac abnormalities should be known by all the radiologists. Various conditions 
such as idiopathic and acquired cardiomyopathy, ischaemic heart disease, valvular 
dysfunction can be identified even on non-gated scans. Pulmonary diseases may 
also involve pericardium and cardiac structures and this should be clearly identified. 
Learning Objectives:
1. To learn how to detect and characterise cardiac abnormalities in the chest 
radiograph.
2. To learn how to detect and characterise cardiac abnormalities on chest CT.
3. To learn the limitations of the interpretation of cardiac abnormalities on un-
gated chest CT.
4. To learn when further evaluation is required.
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nal in discs and vertebrae to the adult shape and signal pattern will be reviewed. 
The normal pattern of unfused bony segments and apophyses in the child and 
fusion to the mature adult form will be reviewed. Normal variants such as persis-
tent segmentation/non-union leading to limbus vertebrae and dysraphism will be 
reviewed. Intervertebral discs, vertebral body endplates, posterior elements and 
bone marrow show a wide degree of variation and the borderland of normal variant 
versus pathological abnormality is often difficult to navigate. Common borderland 
findings such as Schmorl’s nodes versus Scheuermann’s disease will be discussed. 
Transitional vertebrae as such are normal but incomplete transitional changes are 
associated with clinical symptoms. Even without associated pathological changes 
the terminology of transitional vertebrae is a common pitfall. Simple coping strate-
gies will be reviewed. Various imaging artefacts can have an influence on image 
interpretation though lumbar spine MR imaging is more resistant to these than 
imaging of the cervical and thoracic spine. 
Learning Objectives:
1. To become familiar with the normal anatomy.
2. To be able to identify normal variants.
3. To appreciate the range of pitfalls that may simulate pathology.
A‑372	 14:50 
C. Identifying and reporting abnormal findings 
A. Stäbler; Munich/DE (info@radiologie‑muenchen‑harlaching.de) 
Most frequent pathologies encountered on lumbar spine examinations are 
caused by degenerative disc disease and include: Disc herniation with nerve root 
entrappement, activated erosive intervertebral osteochondrosis from instability, 
spinal canal stenosis, recess stenosis and neuroforamen stenosis. Disc hernia-
tion is defined as dislocation of nucleus pulposus material through a defect of the 
annulus fibrous (annular tear) beyond the outer part of the annulus fibrosus. The 
concept of contained disc versus non-contained disc describes whether there is 
disc material dislocated into the epidural space or not. The terms intradiscal disc 
hernia, bulging or protrusion of disc material have to be differentiated. Segmental 
instability plays a causative role in the development of activated erosive interver-
tebral osteochondrosis, which is accompanied by band-like/hemispherical bone 
edema in the adjacent vertebrae and/or band-like vascularity in the disc space at 
the disco-vertebral junction. Bony changes and spurs at the endplates are absent 
or only moderately developed. Spinal stenosis may be congenital or acquired by 
degenerative constriction of the spinal canal leading to spinal cord, nerve root or 
cauda equina compression. Measurement of the bony spinal does not help in the 
determination of clinical significance of spinal stenosis. The required space of the 
nerve roots to pass unaffected through the spinal canal increases when ascending 
the lumbar spine levels. Severity of spinal canal stenosis is related to the residual 
subarachnoid space, which is present on axial T2w images. Imaging findings that 
correlate with the severity and clinical relevance of spinal canal stenosis are cauda 
redundancy and swelling/edema of nerve roots. 
Learning Objectives:
1. To review the imaging appearances of common abnormalities.
2. To understand the use of terminology to describe pathological findings.
3. To learn how to structure a radiological report to ensure clarity and brevity.
14:00 - 15:30 Room D2 
Interventional Radiology 
RC 1309 
Infection and percutaneous drainage 
Moderator: 
M. Bezzi; Rome/IT 
A‑373	 14:00 
A. Empyema 
A. Keeling; Dublin/IE (aoifekeeling@hotmail.com) 
At the end of this presentation one should be familiar with the: (1) appearances 
of empyema on each imaging modality, (2) clinical indications for percutaneous 
drainage, (3) technique and image guidance methods employed for percutaneous 
chest catheter insertion, (4) potential procedure-related complications and their 
management, (5) role of urokinase/TPA and (6) existing literature on image-guided 
chest drainage success rates. Empyema represents a common medical problem 
with a mortality of up to 20%. Difficulty in differentiating empyema from simple pleural 
effusion with imaging alone often occurs. Needle aspiration with or without formal 
chest drainage may be necessary in many circumstances. Traditionally, large bore 
A‑369	 15:00 
C. Interactive case discussion 
W. Curati-Alasonatti1, G.H. Mostbeck2; 1Stanmore/UK, 2Vienna/AT 
The cases presented during this part of the session illustrate the three principles the 
clinician and the radiologist should be guided by: 1. Starting with a clinical problem, 
choose the best imaging modality as part of the investigative process to establish 
a differential diagnosis. 2. Study the imaging documents acquired and identify the 
relevant findings leading to the diagnosis or further investigations. 3. Avoid perform-
ing multiple imaging modalities, comply with ALARA directives and keep the cost 
to a minimum: a variation of ALARA. We will illustrate the compliance with these 
principles as, in the clinical context of a FUO, strategy, individual knowledge and 
multidisciplinary team-work are critical to the success of the algorithmic approach. 
Thirty years ago a seminal textbook appeared in the radiological literature: “Critical 
Diagnostic Pathways in Radiology - An Algorithmic Approach”, edited by Ronald 
Eisenberg and John Amberg and published by J.B. Lippincott (1981). This textbook 
was published at a time when a spectrum of imaging modalities was becoming well 
established and critical guidance for their use - and not abuse - was desperately 
needed by the radiologists of my generation. 
Learning Objectives:
1. To introduce typical cases illustrating the role of imaging modalities in the 
differential diagnosis of patients with fever of unknown origin.
2. To motivate the audience by the use of voting pads to be involved in the 
diagnostic process.
3. To highlight the conclusion that may be drawn on the basis of the discussed 
cases.
14:00 - 15:30 Room D1 
KISS (Keep It Simple and Straightforward): Musculoskeletal MRI 
CC 1316 
The lumbar spine 
Moderator: 
M. Epermane; Riga/LV 
A‑370	 14:00 
A. How I do it 
P. Richards; Stoke‑on‑Trent/UK (paula.richards@uhns.nhs.uk) 
1. Always report in the same logical manner for each examination, which imprints 
normal pathology ‘jumps out at one’. 2. Evaluate all images before looking at the 
clinical information to prevent bias and satisfaction of search. 3. Review every scout 
image. Scoliosis transitional vertebrae and pseudoarthrosis become more obvious 
on coronals. Single kidneys, hydronephrosis and renal tumours may explain ‘back 
pain’, especially if there are mets. 4. Review any x-rays or old IVUs, remembering 
that abdominal x-rays show the spine. 5. Indications; summarise the reason for the 
scan. Think of the differential diagnosis to exclude. 6. Technique; allows one to check 
the levels scanned. Be sure there has been no area missed between 2 studies. 7. 
Report vertebral alignment and disc height. 8. MRI just like an x-ray, i.e. there is 
normal alignment from D10 to S3. 9. Start at the far sagittals and look at the nerve 
roots in the ‘key hole’, the pars and facets. 10. Determine the worst abnormality 
on the axials and report the most significant findings first. Check the facets at each 
level. 11. Have a checklist of normals at the end; ‘the bone marrow, cord and CSF 
return normal signal. The conus ends normally with no pars or metastasis’. 12. 
Opinion: explain what you think is causing the patient’s symptoms. Assume this 
is the only part read, so if there is only one kidney reiterate here. The lecture will 
illustrate additional information on scout images and benefits of coronal images. 
Learning Objectives:
1. To understand the influences of patient positioning, scan parameters and 
magnet/coil technology on image quality.
2. To learn how to optimise scan protocols to maximise patient throughput 
without compromising diagnostic quality.
3. To recognise how and when to modify scan protocols to answer specific 
clinical questions.
A‑371	 14:25 
B. Normal variants and pitfalls 
B. Tins; Oswestry/UK (Bernhard.Tins@rjah.nhs.uk) 
The lumbar spine undergoes morphological changes with age. Normal appearances 
and relevant normal variants will be discussed. In particular, the morphological 
change from an almost round intervertebral disc in newborns with high water sig-
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14:00 - 15:30 Room E1 
Musculoskeletal 
RC 1310 
Postoperative imaging of the lower extremity 
Moderator: 
F. Aparisi; Valencia/ES 
A‑376	 14:00 
A. Hip 
S.J. Eustace; Dublin/IE (seustace@iol.ie) 
This talk will review an approach to imaging complications of total hip replacements. 
The talk will briefly review surgical techniques and types of prostheses. The talk 
will subsequently review early and late complications of prostheses and focus on 
the integrated use of all modalities including radiographs, aspiration arthrography, 
scintigraphy and MRI in achieving a diagnosis. 
Learning Objectives:
1. To understand the principles of basic surgical techniques.
2. To review technical aspects of different modalities for imaging post-surgical 
patients.
3. To recognise normal imaging findings after surgery and how to differentiate 
them from pathological ones.
4. To become familiar with the main complications after hip surgery.
A‑377	 14:30 
B. Knee 
K. Verstraete; Gent/BE (koenraad.verstraete@ugent.be) 
There are many surgical techniques to repair meniscal tear, focal cartilage defect, 
cruciate ligament tear, malalignment, fracture, osteoarthrosis, etc. Conventional 
radiography, CT-scan, CT-arthrography and MRI play an important role in evalua-
tion of the knee after surgery or arthroscopy. Indications for postoperative imaging 
are infection, persistent pain and dysfunction. Every radiologist should be familiar 
with “normal” imaging findings after arthroscopy, osteosynthesis, ligament recon-
struction, osteotomy, knee prosthesis and meniscal or (osteo)chondral repair, 
but also recognise the main complications after knee surgery or arthroscopy. 
Orthopaedic hardware is usually evaluated on plain radiography or CT, and only 
a relative contraindication for MRI. Microscopic metal artefacts and fibrotic scar-
ring are frequently seen along the course of the instrumentation tract. After partial 
meniscectomy, an obtuse angle at the apex of the meniscus and increased signal 
intensity of the remnant part of the meniscus are normal findings, whereas fibrilla-
tion and recurrent tear may explain the complaints of the patient. Various intra- and 
extra-articular reconstructive procedures exist for anterior and posterior cruciate 
ligament reconstruction. Besides the neoligament, an osseous tunnel, screws and 
metal artefacts are also visible. Postoperative findings of the extensor apparatus 
include a thickened patellar tendon, focal myxoid degeneration, fibrosis and focal 
defects, e.g. after harvesting tendon tissue for ACL reconstruction or after release of 
the lateral patellar retinaculum for ‘unstable’ patella. Accelerated osteoarthritis may 
be a late postoperative finding. MRI very well depicts incorporation and alignment 
of osteochondral auto- or allografts, and the position, morphology and integrity of 
the meniscus after repair or transplantation. 
Learning Objectives:
1. To understand the principles of basic surgical techniques.
2. To review technical aspects of different modalities for imaging post-surgical 
patients.
3. To recognise normal imaging findings after surgery and how to differentiate 
them from pathological ones.
4. To become familiar with the main complications after knee surgery.
A‑378	 15:00 
C. Ankle 
C. Masciocchi; L’Aquila/IT (carlo.masciocchi@cc.univaq.it) 
To evaluate postsurgical patients it is important to know the primary clinical diagno-
sis, the surgical treatment, the interval since surgery, and patients’ current clinical 
symptoms. Radiography is the most common imaging modality to evaluate the 
postoperative ankle, particularly in traumatic cases; after reduction and fixation of 
a fracture or dislocation it is generally carried out as routine. Ultrasonography is 
highly sensitive and specific in postoperative tendon assessment, thanks to the 
superb resolution, and the opportunity for dynamic evaluation of tendon integrity. 
chest drains (28-30 Fr) with underwater seals achieved decompression of pleural 
fluid collections. Recent literature suggests small bore drains may be adequate, with 
image guidance playing an important role. Pleural space anatomy, including fissural 
locations will be revised. Aetiology of transudates, exudates and empyemas, along 
with typical clinical presenting features are outlined. Various examples of plain film, 
ultrasound, multi-detector computed tomography and MRI appearances of pleural 
collections and their aetiologies are presented. Selection of patients, image guidance 
methods, catheter size, insertion technique, pitfalls and procedure complications 
are discussed. Importance of physician-radiologist liaison with respect to catheter 
management and catheter dwell times is emphasised. Pleural space fluid collections 
are common clinical entities that radiologists can accurately diagnose as well as 
successfully treat. Overview of aetiology, radiological appearances and method of 
image-guided drainage of infected pleural fluid collections is provided. 
Learning Objectives:
1. To learn about imaging strategies and indications for drainage.
2. To review technical aspects of catheter drainage.
3. To understand the use of urokinase.
4. To appreciate the results of percutaneous drainage.
A‑374	 14:30 
B. Abdominal abscess 
V. Válek; Brno/CZ (vlvalek@med.muni.cz) 
With new antimicrobial agents, advances in diagnostic imaging and imaging-guided 
percutaneous procedures, the management of pyogenic liver abscess has significantly 
improved. The advantages of the percutaneous approach include a marked decrease 
in the invasiveness and cost of abscess drainage. The classic triad of fever, upper right 
quadrant pain or fullness, and jaundice is rarely seen nowadays. Possible image-based 
exclusionary criteria for drainage include abscess size of less than 3 cm in diameter, 
fluid attenuation of more than 40 HU, absence of contrast material-enhanced margins, 
absence of trapped air in a fluid collection, absence of free intraperitoneal air, and 
presence of air without fluid in the abscess cavity. The most important is the size of 
less than 3 cm. Possible clinical exclusionary criteria include normal white blood cell 
count, normal temperature, normal blood pressure, absence of peritoneal signs, lack of 
relevant medical history and a do-not-resuscitate code status. Indications for tacking a 
percutaneous approach to abdominal abscess drainage are the signs of inflammation 
and fluid collection (abscess) larger than 3 cm. Contraindications are today only relative. 
Percutaneous needle aspiration or catheter drainage guided by CT or sonography has 
become the first line treatment for abdominal abscess. 
Learning Objectives:
1. To understand imaging strategies and indications for drainage.
2. To learn about image guidance, route planning and catheter placement.
3. To review follow-up strategies and results.
A‑375	 15:00 
C. Pelvic abscess 
M.A. Funovics; Vienna/AT (martin.funovics@meduniwien.ac.at) 
Pelvic abscess drainage may employ more difficult access routes due to anatomic 
restrictions. The procedure may carry a higher risk of complications compared to 
simple abdominal drainage. To optimise patient preparation, correction of coagula-
tion deficits, optimisation of antibiotic treatment, and sedation or anesthesia may 
be needed. The usual access routes for deep pelvic abscesses are the anterolat-
eral and the posterior transgluteal approach. In selected cases, a transvaginal or 
transrectal approach may be the safer and more efficient option. Depending on 
the viscosity of the drained fluid, the presence of necrotic solid tissue and gas, dif-
ferent sizes of drainage material may be needed. Do not hesitate to employ large 
drainage catheters if indicated. An overview of the available material will be given. 
Intestinal laceration is a major complication which can be managed percutaneously 
in selected circumstances. Often, the weakest part of percutaneous drainage is the 
postinterventional management. It is advocated that the management is actively 
guided by the interventionalist who ensures that the drainage is properly handled, 
rinsed, and cleaned, that follow-up imaging is performed at the right intervals, and 
who is also responsible for indicating drain removal. 
Learning Objectives:
1. To understand imaging strategies and indications for drainage.
2. To learn about transgluteal, endocavitary and other routes of drainage.
3. To review results and follow-up strategies.
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Learning Objectives:
1. To appreciate the importance of looking at the heart on CT scans of the chest.
2. To review the normal appearance of cardiac structures that can be easily 
identified on CT scans of the chest.
3. To understand key imaging findings.
A‑381	 14:28 
B. Incidental findings and their clinical relevance 
A. de Roos; Leiden/NL (A.de_Roos@lumc.nl) 
Chest CT and MRI are commonly performed to evaluate patients with acute chest 
pain. A number of imaging techniques are available that may cover the entire 
chest, including the cardiovascular system. The radiologist will encounter more 
and more cardiovascular disease that was not visible with ungated CT and MRI 
techniques. The differential diagnosis of acute chest pain may include over 30 
possible diagnoses, a substantial number related to cardiovascular disease. It is 
important to recognise chronic and acute coronary disease, myocardial infarction 
and its complications, left ventricular function, pericardial disease, atrial disease 
and large vessel disease. Case material will be presented and discussed using 
both CT and MRI techniques to illustrate the spectrum of usual and more unusual 
cardiovascular pathology that should be considered in the differential diagnosis 
of unexplained chest pain. 
Learning Objectives:
1. To become familiar with cardiac anomalies that can be identified on CT 
scans of the chest.
2. To understand the clinical value of cardiac anomalies incidentally detected 
on CT scans of the chest.
3. To learn how to manage and report incidental cardiac findings to the 
referring clinician.
A‑382	 14:51 
C. Pulmonary hypertension and right ventricle function 
M. Rémy-Jardin, F. Pontana, A.-L. Hachulla, J. Rémy; Lille/FR 
(martine.remy@chru‑lille.fr) 
Pulmonary hypertension (PHT) remains a disease difficult to diagnose because 
the clinical findings are nonspecific, often leading to a delayed diagnosis. Once 
recognised, it is necessary to determine the underlying cause and to estimate the 
severity of pulmonary hypertension. Among the noninvasive methods of assessment 
of PHT, CT angiography (CTA) now plays an important role in the diagnosis and 
post-therapeutic management of PHT. Numerous recent technological advances 
of multidetector-row CT technology (MDCT) have reinforced the clinical impact 
of this technology by introducing new tools for the morphological evaluation of 
small-sized pulmonary arteries and pulmonary capillaries, the latter being acces-
sible with dual energy CT and often referred to as pulmonary “perfusion”. The role 
of CT now also includes the possibility to investigate the presence of PHT on the 
basis of functional parameters, such as the distensibility of the pulmonary arterial 
wall, and to integrate cardiac functional information, with great interest towards 
right ventricular function. The major clinical impact of these new scanning modes 
is that morphology and function can be obtained from the same data set, with 
no restriction on the diagnostic performance of high-resolution CT angiographic 
images. The purpose of this lecture is to review these new trends in imaging of 
PHT and estimating right ventricular function through practical clinical situations, 
including the most common causes of PHT. 
Learning Objectives:
1. To review the normal appearance of pulmonary vessels and right ventricle 
on CT scans of the chest.
2. To learn about CT findings indicative of pulmonary hypertension in 
comparison with other imaging modalities.
3. To understand how to evaluate the right ventricle function.
Panel discussion: 
Ready for routine reporting of cardiovascular findings on CT scans of the 
chest? 15:14
CT scans of the chest are usually performed and reported as if the lungs were the 
only organs in the thoracic cage. However, the heart and pulmonary arteries can 
show significant abnormalities either as associated findings of the parenchymal 
disease or as incidental findings. So the recommendation is: do not forget the heart 
and pulmonary vessels when reporting a CT scan of the chest. 
MRI has rapidly become important in post-operative assessment of the ankle, 
because it provides high soft-tissue contrast, multiplanar capability and osseous 
structures visualisation. It shows signal changes of ligaments and tendons, hypoin-
tense subchondral sclerosis, subchondral bone marrow oedema, joint effusion, 
capsular thickening, fibrosis, and synovitis. MRI has also an important role in the 
evaluation of post-surgery ankle pain due to impingement syndrome and in the 
hindfoot chronic instability related to postoperated sinus tarsi syndrome; it demon-
strates the anatomy of sinus tarsi, chronic synovitis and nonspecific inflammatory 
changes, synovial cysts, fibrosis and subtalar joint effusion. It is important also in 
the follow-up of tumours and tumour-like conditions of bone and soft tissues after 
surgery. Computed tomography is the most valuable method to define the osseous 
anatomy of the postoperative ankle, so it is important in the follow-up of the oper-
ated osteochondral lesions of the talus. CT allows the evaluation of irregularities 
or degenerative changes, and progressive degenerative arthritis; however, CT 
usually fails to evaluate soft tissue’s ankle lesion. 
Learning Objectives:
1. To understand the principles of basic surgical techniques.
2. To review technical aspects of different modalities for imaging post-surgical 
patients.
3. To recognise normal imaging findings after surgery and how to differentiate 
them from pathological ones.
4. To become familiar with the main complications after ankle surgery.
14:00 - 15:30 Room E2 
Chest 
RC 1304 
When CT sees both the heart and the lungs 
Moderator: 
L. Bonomo; Rome/IT  
A‑379	 14:00 
Chairman’s introduction 
L. Bonomo; Rome/IT (lbonomo@rm.unicatt.it) 
The development of subsecond MDCT scanners with high temporal and spatial 
resolution has significantly reduced scanning times and now it is possible to have 
very good quality images of the heart during routine chest CT examinations. There-
fore, the importance of looking at the heart and pulmonary vessels on a CT scan 
performed for non-cardiac reasons will be emphasised. Anatomic cardiac details that 
every radiologist should know will be discussed in the first talk; the presentation is 
aimed mainly at the non-cardiac radiologist. It will review normal cardiac anatomic 
details, as routinely encountered on modern multi-detector CT studies. It is now 
possible to delineate much of the intracardiac anatomy on a contrast enhanced 
study and significant pathology may also be evident on non-enhanced CT exami-
nations. Important incidental findings and their clinical relevance will be discussed 
in the second talk. Unexpectedly, cardiac abnormalities may be diagnosed when 
lung disease is clinically suspected and vice versa; the focus of this presentation 
will be the comprehensive evaluation of lung and heart/large vessels diseases.The 
strong correlation existing between pressure in the pulmonary artery system and 
dilatation of the pulmonary trunk and central branches will be discussed in the last 
talk. CT is considered more useful than echocardiography because it can depict 
the cardiac structures in all patients including those with extensive parenchymal 
abnormalities. At the end of the presentations we should try to answer the question 
about the routine reporting of cardiovascular findings on CT scan of the chest. 
A‑380	 14:05 
A. Anatomic cardiac details that every radiologist should know 
S.P.G. Padley; London/UK (s.padley@ic.ac.uk) 
This presentation is aimed at the non-cardiac radiologist. It will review normal cardiac 
anatomic detail, as routinely encountered on modern multi-detector CT studies. 
It is now possible to delineate much of the intracardiac anatomy on a contrast 
enhanced study, and significant pathology may also be evident on non-enhanced 
CT examinations. This study will primarily review normal cardiac anatomy, including 
cardiac chambers, valves and coronary vessels. The typical radiological appear-
ances of innocent incidental intra-pericardial abnormalities will then be reviewed. 
Important incidental pathology will be discussed in the next talk. 
S
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A‑385	 14:32 
Quantification of liver inflammation 
J.F.L. Cobbold; London/UK (j.cobbold@imperial.ac.uk) 
Liver inflammation, or hepatitis, may be acute or chronic and occurs as a result 
of one or more hepatocellular insults (including viral, metabolic and toxic causes) 
leading to a pro-inflammatory cytokine response, oxidative stress, hepatocellular 
damage, necrosis, apoptosis and inflammatory cell infiltration. Hepatic stellate cell 
activation and net deposition of disordered extracellular matrix (fibrosis) may occur 
in chronic liver disease. Histological scoring systems for the assessment of chronic 
liver disease include the assessment of inflammation, while in acute hepatitis, liver 
biopsy is rarely indicated. Histological scoring systems rely on identification of 
features producing scores which are categorical in nature and cannot be consid-
ered truly quantitative. Serum aminotransferase values are conventionally used 
for the routine assessment of hepatic inflammation with limitations. Conventional 
ultrasound demonstrates characteristic appearances in acute and chronic hepa-
titis, but is unable to quantify inflammation. When considering the non-invasive 
assessment of chronic liver disease, interpretation of aminotransferase values 
is less clear and conventional imaging techniques (MRI, CT and ultrasound) are 
poor discriminators of hepatic inflammation. Liver stiffness, measured by transient 
elastography, is predominantly influenced by fibrosis, but the effect of inflammation 
may substantially affect values, with implications for clinical practice. Predominantly 
research-based techniques show promise, including contrast-enhanced ultrasound, 
proton and phosphorus-31 MR spectroscopy and diffusion-weighted imaging. Serum 
aminotransferase values are a useful and sensitive tool in clinical practice with well-
described limitations. Radiological-pathological correlations have demonstrated that 
inflammatory processes affect the output from a number of techniques, yet the chal-
lenge remains to find clinically relevant and specific markers of liver inflammation. 
Learning Objectives:
1. To review clinical, histological, and pathogenic features of liver inflammation.
2. To review conventional techniques for detecting and qualitatively assessing 
liver inflammation.
3. To consolidate knowledge of advanced techniques for quantifying liver 
inflammation.
4. To be aware of current gaps in knowledge about non-invasive quantification 
of liver inflammation and learn about future directions.
A‑386	 14:54 
Quantification of liver fibrosis 
B. Van Beers; Clichy/FR (bernard.van‑beers@bjn.aphp.fr) 
Fibrosis is a non-specific healing process that occurs in all chronic insults of the liver. 
Fibrosis staging is based on semi-quantitative histopathological scores obtained at 
liver biopsy. However, biopsy is invasive and the results are limited by sampling. 
Non-invasive assessment of liver fibrosis can be based on serum biomarkers or 
liver imaging. Composite scores of biomarkers, such as the fibrotest, have a reason-
able accuracy for detecting liver cirrhosis but are unable to discriminate between 
intermediate stages of fibrosis. Dynamic elastography is a quantitative functional 
imaging method that measures the visco-elastic parameters of tissues by analysing 
the propagation of transmitted mechanical waves elasticity of the liver is observed 
in liver fibrosis. Transient ultrasound elastography is increasingly used as first-line 
examination to stage liver fibrosis. However, this method remains limited for staging 
intermediate fibrosis, and often fails in obese patients and patients with ascites. It 
has been shown that more robust, reproducible and accurate assessment of liver 
fibrosis can be obtained with MR elastography. MR elastography holds the promise 
of complementing ultrasound elastography and serum biomarkers for quantifying 
liver fibrosis and monitoring the response to treatment. However, elastography is not 
a specific method for assessing liver fibrosis because it measures liver stiffness that 
is influenced by other abnormalities including oedema, inflammation, cholestasis, 
congestion and activation of the stellate cells. The precise role of other functional 
imaging methods, including perfusion imaging in cirrhosis and diffusion MRI in liver 
fibrosis remains to be determined. 
Learning Objectives:
1. To review clinical, histological, and pathogenic features of liver fibrosis.
2. To review conventional techniques for detecting and qualitatively assessing 
liver fibrosis.
3. To consolidate knowledge of advanced techniques for quantifying liver 
fibrosis.
4. To be aware of current gaps in knowledge about non-invasive quantification 
of liver fibrosis and learn about future directions.
14:00 - 15:30 Room F1 
Special Focus Session 
SF 13 
Quantifying liver fat, inflammation and fibrosis: 
routine or research? 
Moderator: 
C.B. Sirlin; San Diego, CA/US 
A‑383	 14:00 
Chairman’s introduction 
C.B. Sirlin; San Diego, CA/US (csirlin@ucsd.edu) 
Liver fat, inflammation, and fibrosis are important pathological features in patients 
with diffuse liver disease. The clinical gold standard for assessing these features is 
liver biopsy. Due to its invasiveness and sampling variability, however, liver biopsy 
is suboptimal for screening, monitoring, and clinical research. There is, therefore, a 
need to develop biomarkers to assess liver fat, inflammation, and fibrosis non-inva-
sively. In recent years, many quantitative imaging techniques have been developed, 
refined, tested, and made available. The question becomes: are these techniques 
ready for routine clinical use or are they most appropriate for research? In this 
special focus question, we will begin with a brief overview of diffuse liver disease 
and discuss basic concepts of biomarker validation and qualification. Dr. Reeder 
then will discuss conventional and state-of-the-art imaging-based biomarkers of liver 
fat. Dr. Cobbold will discuss the current status of non-invasive biomarkers for liver 
inflammation. Dr. Van Beers will discuss ultrasound- and MR-based biomarkers of 
liver fibrosis, with emphasis on techniques such as transient elastography and MR 
elastography that measure visco-elastic properties of liver tissue. We will conclude 
with a panel discussion asking the question: are the repeatability, reproducibility, 
and robustness of the non-invasive biomarkers presented in this session adequate 
for routine clinical implementation? 
Session Objectives:
1. To review the clinical importance of diffuse liver disease.
2. To understand that key features of diffuse liver disease include fat 
accumulation, inflammation, and fibrosis.
3. To understand the need for non-invasive biomarkers to assess fat, 
inflammation, and fibrosis.
4. To review basic concepts in biomarker validation and qualification.
A‑384	 14:10 
Quantification of liver fat 
S.B. Reeder; Madison, WI/US (sreeder@wisc.edu) 
Intracellular deposition of fat within hepatocytes (steatosis) is a common condi-
tion of the liver. Fat is the histological hallmark of non-alcoholic fatty liver disease 
(NAFLD) but also may occur with alcohol abuse, viral hepatitis, HIV and genetic 
lipodystrophies, and chemotherapy. NAFLD alone afflicts an estimated 20-80 million 
in the US and is a rapidly growing condition in other Western societies, paralleling 
the expanding epidemics of obesity and diabetes type II. This talk will review the 
clinical, pathogenic and histological features of liver fat, including an overview of 
fatty liver disease and diseases where fat is an important disease feature. Next, 
it will review the current use and limitations of non-targeted biopsy in diffuse liver 
disease, and why quantitative non-invasive biomarkers of liver fat and iron would 
be beneficial. Currently available conventional magnetic resonance imaging tech-
niques that attempt to detect and quantify liver fat will then be discussed, as well 
as known confounding factors that corrupt the ability of conventional methods to 
quantify fat. This lecture will then describe emerging quantitative imaging methods 
for accurate and precise quantification of liver fat, and the advantages offered by 
these methods address in comparison with conventional methods. Finally, remain-
ing challenges and unsolved problems for quantifying liver fat will be discussed. 
Learning Objectives:
1. To review clinical, histological, and pathogenic features of liver fat.
2. To review conventional techniques for detecting and qualitatively assessing 
liver fat.
3. To consolidate knowledge of advanced techniques for quantifying liver fat.
4. To be aware of current gaps in knowledge about quantification of liver fat 
and learn about future directions.
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Learning Objectives:
1. To understand the advantages and limitations of BI-RADS in clinical practice.
2. To appreciate the potential of an automated analysis of the descriptors.
3. To trace continuous modifications required by technological advancements.
4. To review BI-RADS categorisation with case illustrations.
A‑389	 15:00 
C. MRI 
C.K. Kuhl; Aachen/DE (ckuhl@ukaachen.de) 
The breast imaging reporting and data system (BI-RADS) for MRI has been the 
first effort to standardise terminology in breast MRI. The system lists a number 
of descriptors for all sorts of breast MR imaging findings. Its main feature is that 
it distinguishes between “type of enhancement”: mass-like and non-mass-like 
enhancement. This distinction is important because it marks a crossroad of dif-
ferential diagnosis: whereas the descriptors for mass-like enhancement serve to 
help distinguish benign and malignant solid tumours, e.g. fibroadenomas from 
breast cancer, the descriptors for non-mass-like enhancement can be used to 
distinguish DCIS or diffusely infiltration cancer from benign changes such as 
adenosis, hormonal stimulation, mastitis. So far, the PPV and NPV of the different 
descriptors are not yet established, such that the current BI-RADS lexicon helps 
describe, but not necessarily interpret breast MR images. The lecture is meant to 
help fill this gap by presenting the newest revisions and amendments of the BI-
RADS MRI lexicon, and by a systematic review of BI-RADS descriptors in benign 
and malignant breast lesions. 
Learning Objectives:
1. To review BI-RADS descriptors for MRI.
2. To understand the differences in the final version of BI-RADS.
3. To review BI-RADS categorisation with case illustrations.
14:00 - 15:30 Room G/H 
Neuro 
RC 1311 
Focal brain lesions 
Moderator: 
M. Golebiowski; Warsaw/PL 
A‑390	 14:00 
A. Differential diagnosis of T2 hyperintense lesions 
A. Rovira-Cañellas; Barcelona/ES (alex.rovira@idi‑cat.org) 
Conventional MRI techniques, such as T2W and gadolinium-enhanced T1W 
sequences, which are highly sensitive for detecting demyelinating plaques, are 
recognised as the most important paraclinical tool for diagnosing multiple sclerosis 
(MS). However, the changes seen on MRI in patients with MS are not disease-
specific, as focal white matter T2 hyperintense lesions (THL) are also commonly 
observed not only in the elderly but also in middle age and young patients, and in 
a large list of different disorders such as hypoxic-ischaemic vasculopathies (ath-
erosclerotic and hypertensive small vessel disease, CADASIL, Fabry’s disease 
and Susac’s syndrome), CNS vasculitis, sarcoidosis, adult forms of leucoencepha-
lopathies, trauma and radio chemotherapy, and acquired metabolic conditions 
(hepatic encephalopathy, alcoholism), among others. While it is recognised that 
a combination of findings from clinical history, physical examination and labora-
tory tests is commonly required to correctly establish a firm and clear aetiological 
diagnosis of THLs, a detailed analysis of different MRI features should also be 
considered essential, e.g. lesions shape, size, and distribution; contrast-uptake; 
and associated structural lesions (microbleeds, infarcts, spinal cord, brainstem and 
cerebellar involvement, …). In addition to these conventional MRI-based features, 
non-conventional MR techniques (diffusion, MRS and perfusion) may also provide 
in some cases useful diagnostic information. Knowledge of these features will assist 
the diagnostic work-up of patients presenting with THLs, and should be considered 
a first step to take full advantage of the potential of MRI, and in doing so should 
result in a reduced chance of misdiagnoses and facilitate the correct diagnosis of 
sometimes treatable disorders. 
Learning Objectives:
1. To be aware of the limited specificity of brain multifocal T2 abnormalities.
2. To learn about recognition patterns that might be helpful in suggesting the 
most likely etiology of brain multifocal T2 lesions.
3. To learn about the role of spinal cord imaging and advanced neuroimaging 
techniques for the differential diagnosis of brain T2 hyperintense lesions.
4. To be able to establish a neuroimaging diagnostic strategy in patients with 
multiple brain T2 lesions of unknown origin.
Summary of presentations 15:16
C.B. Sirlin; San Diego, CA/US 
Panel discussion: 
Routine or research? 15:21
Is non-invasive image-based quantification of liver fat, inflammation, and fibrosis 
ready for routine clinical use? Validation of biomarkers requires demonstration 
not only of accuracy but also of repeatability, reproducibility, and robustness. For 
emerging technology, initial research usually focuses on accuracy but not on the 
other parameters. So the question is: are the repeatability, reproducibility, and 
robustness of the non-invasive biomarkers presented in this session adequate for 
routine clinical implementation? 
14:00 - 15:30 Room F2 
Breast 
RC 1302 
Update in BI-RADS 
Moderator: 
G. Forrai; Budapest/HU 
A‑387	 14:00 
A. Mammography 
E. Aribal; Istanbul/TR (earibal@marmara.edu.tr) 
Breast imaging reporting and data system (BI-RADS) was developed by American 
College of Radiology in order to set standards for mammography reporting, common 
terminology and data collection. BI-RADS is being used widely for over a decade 
and many studies have assessed the validity of the system. An important compo-
nent of BI-RADS is the lexicon which gives descriptors of specific imaging features 
that facilitate image interpretation and unify the reports. Two main titles for these 
descriptors are about masses and calcifications. An asymmetry is called a mass 
when it is seen in two projections. A mass is defined with its shape, margin and 
density. Definition of a mass with these three modifiers would help the radiologist to 
determine the type of the mass and probability of its malignancy. Calcifications are 
divided into three categories by their shapes and another descriptor is defined for 
their distribution. The first category is for typically benign calcifications. The other 
two are for probably malign calcifications where biopsy should be suggested. The 
distribution modifiers for calcifications can also play an important role in assessing 
the probability of malignancy. BI-RADS defines 7 assessment categories from 0 to 
6 for the final report that facilitate data management for yearly audits. Category 3 
is the transition zone between malignant and benign lesions where the suspicion 
for malignancy should be less than 2% and requires short-term follow-up. BI-
RADS morphology and distribution descriptors are effective in assessing the risk 
of malignancy with a reasonable positive predictive value. 
Learning Objectives:
1. To review the outline of BI-RADS mammography and its updates.
2. To review literature on the applicability of BI-RADS.
3. To review BI-RADS categorisation with case illustrations.
A‑388	 14:30 
B. US 
G. Rizzatto; Udine/IT (grizzatto@libero.it) 
The breast imaging reporting and data system (BI-RADS®) for ultrasound (US) was 
developed by the American College of Radiology (ACR) and published in 2003. 
Although this lexicon was created to achieve a consensus among radiologists when 
describing breast abnormalities, clinical practice shows substantial intraobserver 
agreement but only moderate interobserver agreement. Most problems are reported 
for descriptors related to shape (when trying to classify abnormalities containing 
lobulations and/or elliptical with not-parallel orientation), echo pattern and margin. 
Especially mass margin is a critical feature for determining whether a lesion should 
be biopsied or not. Other problems are related to the final assessment, including 
difficulties in applying the subcategories and the relatively high percentage of 
false negative cases for lesions interpreted as category 3. Many computer-aided 
diagnosis software have shown the potential to improve performance amongst less 
experienced readers and decrease interobserver variability; still they do not solve 
all the problems. The BI-RADS® lexicon is actually under advanced revision by an 
international panel and Ellen B. Mendelson chairs the US subcommittee. Revision 
is reviewing both descriptors and categories; it will include also new parameters 
linked to the evolution of US technology as colour flow mapping and elastography. 
S
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troubles. Characterisation of AML is possible, based on identification of its fatty 
content mainly using CT. When microscopic, this component may be missed and 
biopsy is required with immunostaining. MR imaging may be helpful using chemical-
shift sequences but thresholds, to rule-out clear cell carcinoma, have to be better 
defined. Presence of necrosis or calcifications rules-out diagnosis of AML. AMLs 
must be treated if haemorrhagic, painful or if diameter exceeds 4cm. Embolisa-
tion is the main nonsurgical method, using microparticles, alcohol and/or coils but 
postembolisation syndrome must be prevented. Volume regression may require 
all agents whereas aneurysm occlusion requires coiling. The effect on volume 
and on haemorrhagic risk is substantial making surgery as an alternative method 
for nephron sparing purposes. Secondary surgery is required in less than 10% of 
embolisation. RF ablation is also possible but its efficacy is still under evaluation. 
Learning Objectives:
1. To learn the high frequency of angiomyolipoma, and the possibility of 
complication.
2. To review the imaging appearance of typical and atypical angiomyolipoma.
3. To understand the higher incidence of angiomyolipoma in certain 
phakomatoses.
4. To learn about the possibilities of intervention and to discuss the indications 
and results.
A‑394	 14:30 
B. The (not so) rare malignant tumours of the kidney 
P. Hallscheidt; Heidelberg/DE (Peter.Hallscheidt@med.uni‑heidelberg.de) 
Today, an increasing number of renal cell carcinomas is detected in a very early 
stage. These incidentally detected carcinomas must be differentiated from benign 
tumour. The role of the radiologist is to differentiate renal lesions and to diagnose 
malign tumours in adults and children. With the individual therapy for each tumour 
and patient, a better knowledge of different gradings and entities is demanded. 
Modern imaging modalities such as CT and MRI have the capability to differenti-
ate renal tumours because of different attributes. Besides the benign tumours, the 
malign tumours such as renal cell carcinoma, complex cysts, metastasis of other 
malignomas and lymphomas of the kidneys have to be differentiated. Whereas CT 
remains the standard tool for staging RCC, the differentiation of different tumours 
is a field increasingly pre-operatively worked up by MRI with dynamic and diffusion 
imaging. The most common and not so common renal tumours are demonstrated 
and typical findings are discussed. 
Learning Objectives:
1. To know the rare malignant tumours of the kidney: Bellini duct carcinoma, 
chromophobe renal cell carcinoma, lymphoma, sarcoma, renal medullary 
carcinoma and metastases.
2. To learn capabilities and limitations of MRI and CT.
A‑395	 15:00 
C. Radiofrequency and cryotherapy of renal tumours: techniques, results 
and complications 
J.-M. Correas; Paris/FR (jean‑michel.correas@nck.aphp.fr) 
The number of small renal tumours is increasing due to the large amount of imag-
ing examinations of the kidneys performed with various modalities and the true 
increasing incidence of renal cancer. Conservative therapy of small renal tumours 
is now widely recognised as the reference technique for the treatment of these 
small lesions. The increasing rate of chronic renal failure in the elderly and the 
efficacy of conservative therapy to treat cancer as demonstrated by the urolo-
gists performing partial nephrectomy and tumourectomy emphasise the role of 
percutanaeous minimally invasive ablative procedures, particularly in patients with 
surgical contraindications. Radiofrequency ablation and cryotherapy are the two 
most developed techniques, but new technical approaches are under development 
such as microwave ablation, electroporation, etc. The evaluation of the success 
of the procedure relies on imaging techniques showing the lack of enhancement 
within the lesion and the size and shape of the necrotic covering the entire tumour 
area. The techniques, indications, results, and complications of both radiofrequency 
ablation and cryotherapy will be discussed. 
Learning Objectives:
1. To learn the technique and results of radiofrequency ablation of renal 
tumours.
2. To learn principles, indications and results of cryotherapy, microwave 
ablation and high-intensity focused US (HIFU).
A‑391	 14:30 
B. Neoplasm or non-neoplasm 
Z. Rumboldt; Charleston, SC/US (rumbolz@musc.edu) 
A variety of diseases including neoplasms, but also infectious, inflammatory, 
vascular and traumatic processes, may present as focal intracranial mass le-
sions. Modern neuroimaging, primarily with MRI, enables differentiation of these 
entities allowing for accurate diagnosis in almost all cases. The requirements are 
appropriate image acquisition and detailed analysis of imaging findings, while 
pertinent clinical information may be very helpful in certain cases. The distinction 
is frequently broad, between different disease processes, such as with tumefac-
tive demyelination versus neoplasm, which is often sufficient for clinical decision 
making and patient management; at times this may be more specific, approaching 
histological diagnosis, such as with pilocytic astrocytoma versus medulloblastoma. 
This presentation will go briefly over the imaging techniques and various disease 
processes, while heavily concentrating on the differentiating features of intra-
axial primarily non-haemorrhagic mass lesions. The emphasis will be on the key 
distinguishing imaging features, such as presence or absence of mass effect or 
vasogenic oedema, signal intensity characteristics, presence and pattern of con-
trast enhancement, as well as diffusion and perfusion features. Decision making 
process will be discussed. A number of cases with intracranial masses will then 
be reviewed and analysed, using a step by step approach, accentuating the most 
reliable distinguishing findings. 
Learning Objectives:
1. To list various pathologic processes that present as focal brain masses.
2. To define the differentiating imaging and clinical features of those processes.
3. To recapitulate the role of imaging techniques for differentiation of brain 
mass lesions.
A‑392	 15:00 
C. Adult glioma: advanced neuroimaging for treatment planning 
C. Calli; Izmir/TR (cem.calli@gmail.com) 
The role of MR imaging in adult gliomas consists of many steps. (1) Is there a 
lesion in the brain? (2) Is the lesion a tumour? (3) Is the tumour a glioma? (4) Is 
it a high- or low-grade glioma? (5) If there is a suspicion and a biopsy is planned, 
which part of the tumour should be targeted at biopsy. (6) How the surgery should 
be performed to avoid injury to functional areas of the brain (e.g. motor cortex). (7) 
If there is need for adjunctive radiotherapy, how the extent of the tumour should 
be defined? (8) After radiotherapy, if a new enhancing lesion occurs, is it a recur-
rent neoplasm or radiation necrosis? Conventional anatomical MR imaging is not 
always powerful enough to answer these questions. However, with advanced MR 
imaging techniques such as diffusion MR (including tractography), perfusion MR, 
MR spectroscopy and functional MRI (fMRI) we can answer the above questions 
reliably in most cases. 
Learning Objectives:
1. To recognise different treatment protocols for different types of adult gliomas.
2. To get an overview of the advanced neuroimaging techniques that may aid 
in the pre-operative characterisation of adult gliomas.
3. To discuss the roles of various advanced neuroimaging techniques for 
glioma treatment planning.
14:00 - 15:30 Room I/K 
Genitourinary 
RC 1307 
Kidney: imaging and intervention 
Moderator: 
M.N. Özmen; Ankara/TR 
A‑393	 14:00 
A. Angiomyolipoma: a review 
N. Grenier; Bordeaux/FR (nicolas.grenier@chu‑bordeaux.fr) 
Angiomyolipomas (AML) are benign tumours derived from the perivascular epi-
thelioid cell (PEC) characterised at pathological examination by the expression 
the of melanocytic marker HBM-45. They contain various proportions of the three 
components: vascular, fatty and muscular. An epithelioid variant with a malignant 
potential is exceptional. 80% are sporadic and 20% integrated to tuberous sclerosis. 
The association with a lymphangioleiomyomatosis is always possible: chest CT 
will be performed in TS and sporadic AML if large or associated with respiratory 
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Learning Objectives:
1. To understand the necessity of imaging in the delivery of external 
radiotherapy.
2. To be familiar with the technology of image-guided radiation therapy (IGRT).
3. To gain knowledge about the implementation of 3D IGRT.
A‑398	 15:00 
C. Bridges between radiotherapy and radiography from a European 
perspective 
K. Sjövall; Lund/SE (Katarina.sjovall@skane.se) 
Radiotherapy is an area with a rapidly improving development of new techniques 
and improved possibilities for accuracy. This lecture aims to illustrate and discuss 
points of contact and the need for collaboration between radiotherapy and radi-
ography. European educational programmes and working fields for radiotherapy 
nurses and radiotherapy technicians are compared. Radiotherapy nurses and 
radiotherapy technicians are responsible for the administration of radiotherapy 
to cancer patients and for the clinical care related to the treatment. Apart from 
prevention and treatment of side effects and psychosocial support during the treat-
ment, it encompasses preparations, delivery and verification of the radiation dose. 
Educational programmes differ in terms of academical level and target groups, 
whether it is nurses or technicians in radiology or radiotherapy exclusively. Areas 
in the radiotherapy process where competences from radiography are needed 
are discussed, considering both technical development and research progresses. 
Learning Objectives:
1. To gain knowledge about the differences and similarities between the 
areas of education and profession in radiography and radiotherapy from a 
historical perspective.
2. To gain knowledge about national differences and similarities from a 
European perspective.
3. To consolidate knowledge about what competences are needed in the area 
of radiotherapy, and to define common ground with radiography.
4. To consolidate knowledge about present and future needs of research and 
development in radiotherapy, how radiotherapy can apply competences from 
radiography.
14:00 - 15:30 Room N/O 
Joint Course of ESR and RSNA 
(Radiological Society of North America) 
MC 1325 
Essentials in oncologic imaging: 
what radiologists need to know (part 3)
Moderator:
H.‑U. Kauczor; Heidelberg/DE 
A‑399	 14:00 
A. Oncologic imaging: terminology, definitions and buzzwords 
Y. Menu; Paris/FR 
Learning Objectives:
1. To get an overview and precise explanation of current cancer-related 
terminology, definitions and "buzz" words used in everyday practice.
2. To understand why and how this terminology should ensure and simplify 
communication with all specialists involved in cancer management, including 
clinicians, researchers as well as other radiologists.
3. To learn common tricks and traps in providing a radiology report, illustrated 
with clinical cases.
A‑400	 14:20 
B. Liver cancers (primary, metastases) 
R.L. Baron; Chicago, IL/US 
Learning Objectives:
1. To get an overview of the AASLD/EASL imaging criteria for noninvasive 
diagnosis of hepatocellular carcinoma.
2. To learn about best practice CT/MR/US imaging techniques that optimise 
characterisation, detection and staging of primary and metastatic liver 
tumours.
3. To understand the key role specific findings reported by radiologists have in 
determining patient treatment options for hepatocellular carcinoma.
14:00 - 15:30 Room L/M 
Radiographers 
RC 1314 
Radiotherapy and integration with a diagnostic-
therapeutic path 
Moderators: 
S. Geers‑van Gemeren; Utrecht/NL 
C. Hohl; Siegburg/DE 
A‑396	 14:00 
A. Electronic portal imaging used for the development and improvements 
in radiation therapy for prostate cancer 
A. Thorolfsdottir, A. Einarsdóttir, G. Mýrdal; Reykjavik/IS (agnest@landspitali.is) 
The purpose is to gain numerical information of accuracy in the treatment of localised 
prostate cancer and calculate the necessary size of the safety margin around the clini-
cal target volume (CTV-PTV). In addition, the purpose was to evaluate the accuracy 
in treatment set up with patients with high BMI to find out whether patients with high 
BMI need a larger safety margin. Portal imaging was used to measure off-line random 
set-up error from bony structure. The sample size was 40, i.e. all the patients who 
received radiation treatment for localised prostate cancer in Landspítali - University 
Hospital (LSH) 2006. A total of 3032 portal images were acquired. In 2010, the task 
was repeated for 38 patients having gold fiducial markers in the prostate. The calcu-
lated 3-D IMRT safety margins in LSH 2006 was to be 15.8 mm. Correlation is with 
high BMI and set-up errors in medio lateralis (M-L) direction (r=0.21). This indicates 
that a patient with an increased pelvic circumference has a tendency to have more 
set-up errors. Reformed procedural workflow resulted in more acceptable calculated 
margins in 2010. When corrected on line 3 times per week the margin is to be 7.2 mm 
and 3.0 mm if corrected 5 times per week. In conclusion, for delivery of 76-78 Gy 
to the prostate with IMRT and spare surrounding healthy tissue effort is needed to 
secure the accuracy in the overall procedure of treatment planning and delivery. 
Learning Objectives:
1. To gain knowledge on how to improve the target accuracy in treating 
prostate cancer with radiation therapy using Electronic Portal Imaging.
2. To understand the importance of gaining numerical information of accuracy 
in the treatment of clinically localised prostate cancer and how to use the 
information to calculate the necessary size of the safety margin around the 
clinical target volume.
3. To become familiar with the preparation needed before starting treatment 
with IMRT and be aware that there is a need to look at all the treatment 
elements including the technical side, quality, education, staff and patients.
4. To consolidate knowledge of radiation therapy for prostate cancer and the 
meaning of giving high dose to the target while minimising radiation dose to 
healthy tissue.
A‑397	 14:30 
B. Image-guided radiation therapy: when imaging meets therapy 
A. Sarchosoglou; Athens/GR (anastasia71@hotmail.com) 
The aim of this presentation is: to understand the necessity of imaging in the delivery 
of external radiotherapy; to be familiar with the technology of image-guided radiation 
therapy and to to gain knowledge about the implementation of 3D IGRT. The aim of 
radiotherapy is to deliver high dose to target volume while minimising the dose to 
surrounding healthy tissues. However, during treatment delivery many uncertainties 
may arise that can result in higher toxicity and poor local control. Thus, it is crucial to 
monitor and adjust if necessary, the actual treatment. Image-guided radiation therapy 
is the process where images are taken immediately prior or during a course of radia-
tion treatment, to assess and improve the accuracy of therapy. Manufactures have 
developed a number of systems to perform IGRT providing the options of ionising 
radiation images/non-ionising imaging technology and gantry mounted/room mounted 
equipment. 3D IGRT can be performed by acquiring computed tomography images on 
the treatment unit. These images are matched with reference images from planning 
CT and potential discrepancies are recognised, calculated and corrected by couch 
shifts giving optimal results. Such advanced technologies require quality assurance 
systems to be in place and high trained personnel. When properly implemented, 
IGRT meets the aim of radiation therapy. Imaging provides confidence to radiation 
therapy to be aggressive, to fight cancer. Imaging promises radiation therapy a great 
future with improvements in clinical outcomes and patient survival! 
S
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A‑404	 15:00 
C. Hospital perspective on clinical audit 
P. Gilligan; Dublin/IE (PGilligan@materprivate.ie) 
The demand from the public for greater accountability and standards has increased 
the importance of audit and accreditation in modern healthcare delivery. Specifically 
radiology departments participate in audit and accreditation by a number of enti-
ties. These include: 1. National bodies concerned with improving radiation safety 
particularly originating from EU 97/43 directives. 2. Hospital wide accreditation 
surveys from state and private accrediting organisations. 3. Auditing of standards 
from within professional bodies. 4. Following from investigation of specific inci-
dents such as misdiagnosis or radiation concerns. 5. Modality-specific standards. 
Although the specific requirements of the accrediting or auditing body may differ, 
the processes and practical aspects in demonstrating compliance with standards 
and quality improvement are generally similar. Mechanisms such as outcomes, 
quality cycles, and performance indicators are critical in the success of any ac-
creditation or audit program. In addition to fulfilling basic regulatory requirements, 
the medical physicist is playing an increasing role in developing performance indices 
particularly in radiation safety, clinical image quality and equipment management. 
The increasing role of the medical physicist in audit underpins the requirement for 
inclusion of audit and accreditation as part of their education. Recent experience 
of setting up and participating in EU 97/43 directive-based clinical audit in Ireland 
highlighted the critical need for clarity of roles and ownerships of processes to be 
communicated to those who are carrying out audit and those who are being audited 
in hospitals and dental practices. 
Learning Objectives:
1. To understand practical aspects of complying with standards and undergoing 
audit.
2. To understand the outcomes of the audit.
3. To understand how to implement the results of the clinical audit.
14:00 - 15:30 Room Q 
Paediatric 
RC 1312 
Safety first 
Moderator: 
R. Fotter; Graz/AT 
A‑405	 14:00 
A. Security and dose with conventional radiology 
J.-F. Chateil; Bordeaux/FR (jean‑francois.chateil@chu‑bordeaux.fr) 
Performing imaging studies in a child requires basic knowledge. The first point is 
to reassure and to avoid stressful/painful procedure. Training of radiographer and 
radiologist is fundamental. Explanations, presence of a parent (if not pregnant…), 
are preferable. Specific devices may be useful for immobilisation and to avoid 
repeated exposures. Antalgic drugs (traumatic circumstances) or sedative nitrous 
oxide inhalation (MCUG) may be useful. X-rays exposition in relation with conven-
tional radiology is lower than the one encountered with CT. But dose depends on 
type of examination and also on imaging equipment. New devices, such digital 
fluoroscopy with x-rays pulsed emission, flat-panel detector, slot-scanning x-ray 
imager need less ionising radiation than conventional screen-films devices or even 
photostimulable phosphor imaging plates. The scale between the higher and the 
lower dose for the same examination can be from ten to one. Common principles 
of protection that apply to all x-ray imaging procedures, known as ALARA concept 
(as low as reasonably achievable), have to be used daily. Act in accordance of the 
medical justification of the examination, without any non-ionising alternative method, 
remains the first step. The second one is the optimisation of each procedure, the 
limitation of expositions, with control of the x-ray beam adjusted to optimise the 
critical balance between image quality and exposure to the child. Measure of the 
dose is mandatory to demonstrate appropriate levels on child exposure and to 
be sure in the future that very low radiation doses received during conventional 
imaging procedures will not produce adverse effects. 
Learning Objectives:
1. To learn about management of children in the radiology unit.
2. To understand how technology affects dose delivery.
3. To recognise the necessity for the application of the ALARA principles in 
paediatric radiology.
A‑401	 14:55 
C. Prostate cancer 
J.O. Barentsz; Nijmegen/NL 
Learning Objectives:
1. To learn the key clinical indications for MR imaging in prostate cancer.
2. To get an overview of essential MR imaging techniques in detection, 
characterisation, localisation and staging of prostate cancer.
3. To understand how MR imaging influences therapeutic decisions and how 
best to provide a value added MR report.
Questions 15:20 
14:00 - 15:30 Room P 
Physics in Radiology 
RC 1313 
Clinical audit, accreditation and the role of the 
medical physicist 
Moderators: 
W.J.M. van der Putten; Galway/IE 
M. Wucherer; Nürnberg/DE 
A‑402	 14:00 
A. European-wide perspective on clinical audit 
H. Jarvinen; Helsinki/FI (hannu.jarvinen@stuk.fi) 
The Council Directive 97/43/EURATOM introduced the concept of clinical audit 
to medical radiological (diagnostic radiology, nuclear medicine and radiotherapy) 
procedures. Clinical audit is a systematic review of the procedures in order to 
improve the quality and the outcome of patient care. According to the directive, 
clinical audits shall be implemented in accordance with national procedures. The 
review of its implementation in Europe has revealed a high variation of approaches 
and many practical problems. Therefore, the European Commission has published 
further guidelines on clinical audits in its report Radiation Protection No. 159 (2009). 
The purpose is to improve the implementation of clinical audits and to enable the 
Member States to adopt the model of clinical audit with respect to their national 
legislation and administrative provisions. The guideline points out the importance 
of both internal and external assessments for clinical audit. It deals with all types 
and levels of clinical audit and gives practical guidance for application. It defines 
the list of topics which should be covered, while the actual criteria of good practice 
are discussed on generic levels only. The borderline between clinical audit and 
other quality assessments (accreditations, certifications, peer reviews) and regula-
tory inspections is also discussed. The guideline is addressed to all professional 
groups, hospital management, auditing organisations and regulatory bodies. It is 
important to recognise that the guideline is not a legal requirement. This refresher 
course lecture will give a summary of the EC guidelines and discuss briefly the 
implementation of clinical audits in Europe. 
Learning Objectives:
1. To understand the purpose and essential contents of the European 
commission guideline on clinical audit.
2. To learn about a review of clinical audits in Europe.
A‑403	 14:30 
B. National perspective: clinical audit inspections 
S. Ebdon-Jackson; Didcot/UK (steve.ebdon‑jackson@hpa.org.uk) 
European Council Directive 97/43/Euratom requires under Article 6 (4) that “clinical 
audits are carried out in accordance with national procedures”. Implementation 
of this requirement across Europe has been varied. This paper will reflect on the 
experience in the UK and will consider examples of the various initiatives under-
taken in the UK by professional bodies and organisations. This will be contrasted 
with the role of the regulator and the aims of the inspection process with regard to 
compliance with the specific regulation addressing clinical audit and the remaining 
regulations addressing justification, optimisation, etc. Examples will be provided 
of the type of audits undertaken within UK hospitals. A UK perspective of EC and 
IAEA initiatives in clinical audit will be provided. 
Learning Objectives:
1. To understand the approach taken by a national body towards performing 
clinical audit.
2. To understand practical aspects of clinical audit inspections.
3. To understand the lessons learned from inspection and suggestions for 
improvement.
Postgraduate.Educational.Programme
S104 A B C D E F G H
16:00 - 17:30 Room A 
Abdominal and Gastrointestinal 
RC 1401 
CT colonography: the big picture 
Moderator: 
S.A. Taylor; London/UK 
A‑408	 16:00 
A. Optimised techniques for best results 
D. Regge; Turin/IT (daniele.regge@ircc.it) 
Multicentre trials have shown that CT colonography is ready for widespread clinical 
use. However, these studies have also highlighted the inconsistent performances 
of CT colonography, with divergent results being recorded in different centres and 
between readers. Inter-observer and inter-centre variability may be related to reader 
experience but it is also affected by how CT colonography is performed. While faecal 
tagging has been accepted universally as the proper way to prepare patients for CT 
colonography, there is no consensus on which tagging agent is better, on the timing 
of contrast agent administration and on whether laxatives should be administered 
and in what dosage. In a similar way it is not yet clear which is the best way to 
obtain colon distension, whether by administering spasmolytic agents routinely or 
by changing patient’s decubitus. Standardising bowel preparation and technique 
is one of the most important goals that need to be achieved for CT colonography 
to be universally accepted and this presentation will attempt to deal with the issue 
using an evidence-based approach. 
Learning Objectives:
1. To review bowel preparation techniques for CT colonography.
2. To learn about the possible options in terms of technique used (method of 
colonic distention, use of spasmolytic agents, use of IV contrast material, 
dual positioning etc).
3. To learn about optimal data acquisition parameters for CT colonography.
4. To become familiar with published results with emphasis on techniques 
used.
A‑409	 16:30 
B. Guide to interpretation and generating a useful report 
T. Mang; Vienna/AT (thomas.mang@meduniwien.ac.at) 
The evaluation of CT colonography (CTC) studies is based on detection, interpre-
tation and reporting of colonic findings. It is performed on a computer workstation 
equipped with dedicated CTC software by a primary 2D or a primary 3D approach. 
In either case, the alternative viewing technique must be available for rapid correla-
tion and characterisation of suspicious findings. Primary 2D evaluation is based on 
“lumen tracking” by interactively scrolling through the axial slices and multiplanar 
reformatted images, focusing only on the air-distended colonic lumen from one end 
to the other one. Primary 2D evaluation provides information about the attenuation 
of findings during the search process and is time-efficient. Primary 3D evaluation 
is based on 3D virtual endoscopy in an antegrade and retrograde fashion and in-
creases both, the conspicuity, especially of small and medium-sized polyps, and the 
duration of visualisation. The use of advanced 3D displays like virtual dissection or 
unfolding techniques may reduce the interpretation time for primary 3D evaluation. 
Computer-aided detection (CAD) algorithms used as a 2nd reader were shown to 
reduce the number of perceptual errors by pointing out possible abnormalities that 
might otherwise be missed. Colonic findings are characterised by their morphology, 
their attenuation characteristics, and by their mobility. Knowledge of CTC imaging 
features of common colonic lesions and artefacts is necessary for characterisation 
of findings and differentiation between definite colonic lesions and pseudo-lesions. 
Standardisation of CTC reporting facilitates classification and communication of 
findings and the comparison with previous studies, thereby better assisting physi-
cians in making appropriate management decisions. 
Learning Objectives:
1. To understand what the radiologist needs to know to accurately interpret CT 
colonography examinations.
2. To recognise the relative merits of different interpretation techniques.
3. To learn about a standardised method for generating a CT colonography 
report.
4. To briefly summarise the current status of CAD and its potential use in CT 
colonography.
A‑406	 14:30 
B. CT in children: dose reduction strategies 
R.A.J. Nievelstein; Utrecht/NL (R.A.J.Nievelstein@umcutrecht.nl) 
The revolutionary development in multidetector CT (MDCT) technology during the 
past decade has contributed to a substantial increase in its diagnostic applications 
and accuracy in children. A major drawback of MDCT is the use of ionising radiation 
with the risks of radiation-induced side effects, of which the induction of secondary 
cancer is the most important. Therefore, justification and optimisation of paediatric 
MDCT is of great importance in order to reduce these risks as much as possible 
(‚as low as reasonably achievable‘ principle). Optimisation of paediatric MDCT 
starts with a solid understanding of all technical aspects of CT, including the most 
relevant scan parameters, dose reduction techniques and technique of IV contrast 
material administration. Furthermore, due to the smaller size and lack of visceral fat 
in young children the interaction and absorption of radiation will be different which 
will influence the choice of the various technique and scan parameters. Although all 
these issues are pivotal for a successful CT examination, it may become worthless 
if the importance of pre-scan issues such as justification and patient preparation 
are ignored. After a short overview concerning the current knowledge on radiation-
related risks in children, this lecture will focus on several aspects relevant for MDCT 
optimisation in children. Issues such as justification, patient preparation, technique 
and scan parameters will be addressed. Finally, some guidelines for radiation dose 
level-based CT protocols will be given. 
Learning Objectives:
1. To get an overview of current knowledge on radiation risks in children.
2. To understand the CT scan and technique parameters that influence 
radiation dose.
3. To learn about dose reduction strategies in order to optimise CT in children.
A‑407	 15:00 
C. Ensuring safety for infants undergoing MRI 
T.G. Maris; Iraklion/GR (tmaris@med.uoc.gr) 
The purpose is to present an overview of the safety hazards and safety protocols 
related to infants undergoing MRI examinations. MRI infrastructure-dependent 
safety hazards originating from: (a) static and fringe magnetic fields, (b) gradient 
subsystems, (c) radiofrequency subsystems and (d) acoustic noise sound pressure 
will be reviewed and discussed. Safety hazards related to upcoming technological 
issues and future trends concerning MRI will be presented. The current status of 
the organisations responsible to the problems of MR safety will be reviewed. Which 
authority is responsible and where the responsibility is addressed to (Directives, 
Legislation policies, etc). An optimised protocol related to a variety of clinical MR 
sequences in reference to temperature measurements, EMF measurements, SAR 
and acoustic noise figures using basic commercially available infrastructure will be 
presented. 2D/3D TSE sequences with different ETL’s, 2D/3D GRE, 2D/3D SSFP 
and SE/GRE EPI sequences with multi-(b) diffusion gradients and 3D TOF MR 
angiography sequences will be examined. In vitro measurements of SNR, spatial 
resolution and scan times will be performed for each clinical MR sequence. A com-
prehensive MRI equipment operational policy (optima: (ETL, TR, TE, b-value, EPI 
factor etc).) for a safety protocol for infants undergoing MRI is proposed. Recom-
mendations for safe infant MRI examinations will be summarised and presented. 
Conclusion: MRI equipment can operate safely for infant imaging but require policies 
and procedures beyond those required for standard diagnostic MRI examinations. 
Learning Objectives:
1. To get an overview of the three basic safety hazards related to infants 
undergoing MRI examinations.
2. To become familiar with safety hazards related to upcoming technological 
issues and future trends.
3. To learn about a safety protocol that could be applied in MRI examinations 
for infants.
S
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perfusion imaging. New possibilities arise in MRI almost every day. Imaging algorithms 
are to provide the correct diagnosis in the shortest time with the lowest expenses and 
harm to the patient. MRI is the first method of choice in neurological diseases with two 
exceptions: acute stroke and acute trauma, CT providing the necessary information, 
more available and with easier patient care. Adequate imaging protocols optimally 
visualise the anatomical region of interest and pathological processes, optimise the 
comparison between serial examinations and provide the information in reasonable 
examination time. Appropriate and well understood clinical information is indispensable 
(neuroradiology means good clinical knowledge combined with expertise in imaging 
methods and their evaluation). Complicated protocols are superfluous without com-
petent clinical background but adequate information must be provided to experienced 
clinicians. Basic protocols help to gather important information but do not exclude 
additional necessary methods. Examples to be demonstrated are MRI protocol for the 
pituitary, epilepsy, multiple sclerosis and spine. The up-to-date concepts of image evalu-
ation and interpretation will be demonstrated for brain CT, brain MRI and spinal MRI, 
including the importance of follow-up. The body and conclusion part of the structured 
neuroradiological report will be discussed. Consultation with other neuroradiologists and 
with clinicians is the final tool to reach the goal: to help in recovering the patients’ health. 
Learning Objectives:
1. To learn about the available imaging modalities to be used for the evaluation 
of patients with a focal neurological disorders.
2. To become familiar with the technical imaging considerations and the proper 
diagnostic algorithm.
3. To know more about the typical imaging findings.
A‑413	 17:00 
C. Interactive case discussion 
G. Krumina; Riga/LV (gaida.krumina@apollo.lv) 
Ten authentic and original typical clinical cases illustrating the importance of im-
aging modalities in the differential diagnosis of focal neurological symptoms from 
headache to epilepsy will be presented while respecting the privacy of the patient. 
The spectrum of pathologies includes vascular, inflammation, metabolic, degen-
erative diseases, congenital malformations and neoplasms of the central nervous 
system. Each case story will be described shortly in a standard form followed by 
demonstration of typical CT and/or MRI images. In some cases, conventional 
MRI will be supplemented by multi-voxel MR spectroscopy, DTI, MR tractography 
images, and morphological pictures. Follow-up images will be presented where 
appropriate. Several diagnostic options will be offered for attendants. The audience 
will be asked to participate in the diagnostic process by the use of voting pads. 
After highlighting of final diagnosis the basic differential diagnostic considerations 
will be briefly summarised and emphasised from the clinical and imaging point of 
view for each presented case. 
Learning Objectives:
1. To introduce typical cases illustrating the role of imaging modalities in the 
differential diagnosis of focal neurological symptoms.
2. To motivate the audience by the use of voting pads to be involved in the 
diagnostic process.
3. To highlight the conclusion that may be drawn on the basis of the discussed 
cases.
16:00 - 17:30 Room D1 
KISS (Keep It Simple and Straightforward): Musculoskeletal MRI 
CC 1416 
Soft tissue extremity masses 
Moderator: 
A.R. Mester; Budapest/HU 
A‑414	 16:00 
A. How I do it 
J.C. Vilanova; Girona/ES (kvilanova@comg.cat) 
Diagnostic quality MRI of soft tissue masses can be performed using a variety of 
magnetic equipments and a variety of field strengths. Regardless of system design, 
efforts should be made to maximise signal-to-noise ratios (SNR) using the most 
appropriate coil to include the lesion and associated oedema. FOV should be 
tailored to the size of the patient and the size of the mass. It is important to obtain 
images in at least two planes through the lesion. Slice thickness vary depending 
on the size of the lesion and interslice should be not more than one-half of the slice 
width. Imaging matrix should be balanced to in-plane spatial resolution. Parallel 
A‑410	 17:00 
C. Dose, risk and relevance in a screening population 
A. Graser; Munich/DE (Anno.Graser@med.uni‑muenchen.de) 
While CTC has achieved excellent results in average risk individuals with regard to 
detection of clinically relevant polyps, it has not yet been implemented on a large 
scale in colorectal cancer (CRC) screening programmes. This is mainly due to the 
fact that it uses ionising radiation. There is uncertainty about adequate screening 
strategies and the risk of radiation-induced malignancy. This presentation will sum-
marise recent results of CTC in a screening setting, will look at the dose associated 
with CTC, and summarise calculations of radiation-associated risk of malignancy. 
The key question is whether low doses from CTC will cause relevant negative 
effects in the screening population. The lecture will also feature a comparison 
between CT and MR colonography, an imaging test that might be able to provide 
high sensitivity CRC screening without ionising radiation. 
Learning Objectives:
1. To understand the radiation dose imparted to patients undergoing CT 
colonography.
2. To understand the use of dose reducing techniques and their effect on 
diagnostic performance.
3. To consider the risk of radiation-induced malignancy versus potential benefits of 
CT colonography in the context of population screening for colorectal cancer.
16:00 - 17:30 Room C 
CLICK (Clinical Lessons for Imaging Core Knowledge): Common 
Clinical Cases 
CC 1418 
Focal neurological disorders 
Moderator: 
M. Sasiadek; Wroclaw/PL 
A‑411	 16:00 
A. Clinical considerations 
D. Balériaux; Brussels/BE (dbaleri@ulb.ac.be) 
From headache to epilepsy… or from “normal”, physiological “headache” to life 
threatening pathological conditions. When do we need “neuroimaging” and what 
is the optimal diagnostic work-up? The radiologist must and should remain first of 
all a Medical Doctor: he/she should keep close contact with the clinical world and 
always keep an active dialogue with the referring clinician. Indeed, medical Imaging 
has become more and more sophisticated but also more expensive. Imaging is 
not a “screening procedure” in brain pathology but should be performed in order to 
confirm a clinical, suspected diagnosis keeping still in mind that differential diagnosis 
must be considered as well. Imaging plays also a unique role in lesion evaluation 
and treatment monitoring. The radiologist must answer precise questions about the 
patient’s suspected pathological condition and if necessary, discuss the Imaging 
findings with the clinician in order to narrow the differential diagnosis. Each MRI 
or CT must be performed with a clear knowledge of the clinical question and the 
suspected pathology. Therefore, the radiologist will make the proper choices of 
imaging techniques especially with MRI where imaging sequences have become 
numerous. Headaches and seizures are symptoms only and may be present 
in multiple and very diverse pathological conditions as infectious, neoplastic, 
haemorrhagic, vascular diseases: by knowing the clinical history a good “clinically 
conscious” radiologist will undoubtedly be of greater “added value”! 
Learning Objectives:
1. To learn more about the clinical conditions causing focal neurological 
symptoms.
2. To be informed about the clinician’s way of thinking in the process of 
differential diagnosis.
3. To become familiar with the potential role of imaging in the establishment of 
the final diagnosis and planning of therapy.
A‑412	 16:30 
B. Imaging techniques and typical findings 
P. Barsi; Budapest/HU (barsipeterdr@gmail.com) 
Neuroradiology has a continuously changing and developing array of modalities. Con-
ventional radiography has lost its importance. Angiographic practice has shifted from 
diagnostics to therapy. MS-MD CT scanners provide high-quality CT angiography and 
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16:00 - 17:30 Room D2 
Interventional Radiology 
RC 1409 
Oncologic interventions in the liver 
Moderator: 
M. Glynos; Athens/GR 
A‑417	 16:00 
A. RF ablation 
F. Deschamps; Villejuif/FR (Frederic.Deschamps@igr.fr) 
Percutaneous radiofrequency ablation (RFA) is a safe and effective treatment 
for well selected patient with hepatic tumours such as hepatocellular carcinoma 
(HCC) and liver colorectal metastases (LCM). An appropriate selection is crucial. 
It is based on clinical and technical arguments. Clinically, surgical resection of the 
haepatic tumours remains the gold standard. Indeed, survival data following RFA 
are not as good as surgical resection. The only exception seems to be the RFA of 
the very early HCC (≤3.0 cm) in cirrhosis that is not candidate for liver transplanta-
tion. Most often, the RFA offers an alternative for patients with medical comorbidi-
ties, poor liver function or prior hepatectomy. Technically, there are three decisive 
points for complete ablation. The first point is the good visualisation of the tumour 
either under ultrasound or un-enhanced computed-tomography (CT) examination. 
Metallic coil placement, lipiodol tattoo and virtual CT sonography with magnetic 
navigation are technical tricks that allow the RF ablation of "invisible" tumour. The 
second point is the tumour size: in most series, a diameter less than 25-35 mm is 
commonly admitted as a prognostic factor. This is probably because the maximal 
ablation diameter is slightly larger than 40 mm with the electrode needles avail-
able now. Micro-waves ablation might improve the local control by increasing the 
ablation diameter. The last point is the "heat-sink effect" that requires a temporary 
occlusion of a large vessel close to the tumour. The quality of follow-up imaging is 
a key factor for evaluation of tumour destruction. 
Learning Objectives:
1. To understand indications for RF ablation.
2. To learn about the technique and devices for RF ablation.
3. To understand results and follow-up strategies.
A‑418	 16:30 
B. Portal embolisation 
O.M. van Delden; Amsterdam/NL (o.m.vandelden@amc.uva.nl) 
Partial hepatectomy for liver metastases or primary liver tumours can only be 
performed when the future remnant liver volume (FRLV) is considered large 
enough to avoid the risk of post-operative liver failure. In normal livers a FRLV of 
25-30% is considered safe whereas in compromised livers a FRLV of at least 40% 
is required. In patients whom the FLRV is considered to small, PVE may be per-
formed pre-operatively to increase the FRLV. PVE involves percutaneous selective 
embolisation of the portal venous (PV) system, usually of the right liver lobe, which 
leads to atrophy of the embolised lobe. This, in turn, leads to hypertrophy of the 
FRLV. Because of the dual vascular supply to the liver (arterial and portal venous), 
necrosis of the embolised lobe does not occur. This compensatory hypertrophy 
of the left lobe facilitates resection in patients in whom the FRLV would otherwise 
have been to small to allow resection. PVE is most often performed percutaneously 
under conscious sedation and local anaesthesia through an ipsilateral approach, 
using a combination of particles, such as polyvinyl-alcohol (PVA) and embolisation 
coils. Potential complications of PVE include thrombosis of the contralateral PV, 
liver abscess formation or cholangitis and are rare. Most of the hypertrophy occurs 
in the first 3-4 weeks after PVE and increase in volume of the FRLV averages 12% 
after this time period. CT-volumetry should be performed both before PVE and after 
3-4 weeks to measure increase in FRLV. 
Learning Objectives:
1. To learn about imaging strategies and indications for embolisation.
2. To learn about embolisation methods.
3. To learn about complications, results and follow-up strategies.
imaging techniques allow to reduce scan time or improve SNR. Fat suppression 
techniques are mandatory, and Dixon or STIR techniques should be used for 
low-field systems. Spin and gradient echo sequences should be used including 
at least T1 and T2 WI. Intravenous gadolinium may be helpful especially using 
multiphase dynamic contrast on fast gradient echo sequence depending on medi-
cal appropriateness. Emerging MR imaging techniques may be useful, including 
diffusion-WI and spectroscopy. 
Learning Objectives:
1. To understand the influences of patient positioning, scan parameters and 
magnet/coil technology on image quality.
2. To learn how to optimise scan protocols to maximise patient throughput 
without compromising diagnostic quality.
3. To recognise how and when to modify scan protocols to answer specific 
clinical questions.
A‑415	 16:25 
B. Normal variants and pitfalls 
F.M.H.M. Vanhoenacker; Antwerp/BE (filip.vanhoenacker@pandora.be) 
Mimickers of the soft tissue tumours belong to a large and heterogeneous group of 
disorders, varying from normal anatomic variants, and other pitfalls such as inflam-
matory and infectious lesions, post-traumatic lesions, skin lesions, nonneoplastic 
vascular lesions, metabolic disorders (crystal deposition disease, amyloidosis) 
and miscellaneous disorders (Geyser phenomenon in longstanding rotator cuff 
disease, Baker’s cyst, elastofibroma dorsi, pseudohypetrophy of the lower leg due 
to neurogenic compression…). Classification of these pseudotumours remains still 
a matter of debate. Many of these lesions are reactive or self-limiting without the 
need for further investigation or significant intervention. The imaging approach 
is often very similar to the approach of “true” soft tissue tumoural counterparts. 
Knowledge of the normal anatomy and existence and common presentation of 
these diseases, in combination with the relevant clinical findings (clinical history, 
location, skin changes), enables the correct diagnosis in most cases, thereby limiting 
the need for invasive procedures. Biopsy should be performed in doubtful cases. 
Learning Objectives:
1. To become familiar with the normal anatomy.
2. To be able to identify normal variants.
3. To appreciate the range of pitfalls that may simulate pathology.
A‑416	 16:50 
C. Identifying and reporting abnormal findings 
J.L.M.A. Gielen; Edegem/BE (jan.gielen@uza.be) 
Accurate identification and reporting on soft tissue extremity masses is essential 
for correct diagnosis and optimal treatment planning. This lecture focuses on 
the MRI signs to stage and grade-characterise soft tissue mass lesions. These 
two objectives are the major structural components of the MRI report and fit the 
request of the referring clinician. This implies an accurate description of these 
signs with appropriate terminology in the report. Local staging is essential for the 
preoperative work up. Important staging parameters are size, compartmental loca-
tion, skip lesions and relationship to neurovascular structures and joints, as well as 
distance to the nearest joint space. Grading and characterisation is complex and 
multifactorial and classifies the lesions as „certainly benign“ (no biopsy needed) 
and „possibly „ or „certainly malignant“ (biopsy needed). Grading parameters are 
homogeneity, (changing) signal intensities in multiple acquisition techniques and 
static and dynamic gadolinium enhancement pattern. These are used to define the 
composition of the lesion, i.e. fat, met-Hb, hemosiderin, myxoid tissue, collagen, 
viable, cystic or necrotic components. Other important grading and parameters 
are lesion margin, shape, perilesional invasion or destruction, multiplicity, specific 
location and associated findings but also age and gender of the patient. Benign 
lesions often have characteristic presentations. This is the case in arthrosynovial 
cysts, myxomas, lipomas, giant cell tumour of tendon sheat, hamartoma of nerve, 
elastofibroma dorsi, fibromatosis, neurinoma, etc. In the suspicion of tumour recur-
rence, a comparison of these grading parameters with the primary tumour result in 
a high specificity. Typical examples are used to illustrate „state-of-the-art“ reporting. 
Learning Objectives:
1. To review the imaging appearances of common abnormalities.
2. To understand the use of terminology to describe pathological findings.
3. To learn how to structure a radiological report to ensure clarity and brevity.
S
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T2W-MRI to localise PZ-Zone PCa. In the T-Zone, stromal nodules commonly have a 
low ADC value simulating PCa. Significant differences in tumour ADC values existed 
between patients with low-risk, and those with higher risk localised P-Zone PCa. With 
S-MRI, the best accuracy for diagnosing PCa is obtained by combining a positive 
T2W-MRI and a choline+creatine/citrate ratio > 0.75. In the T-Zone, S-MRI has the 
same limitations than DCE and DW-MRI. Multiparametric functional MRI accuracy of 
MRI to detect PCa can be improved by combining different functional sequences. At 
the moment, it seems that the most widespread used protocol is a combination of DW 
and DCE-MRI for detection of P-Zone tumours. Performance of functional MRI to detect 
T-Zone PCa is less well established. Multiparametric MRI can now be used to perform 
stereotaxic TRUS-guided biopsies after TRUS-MRI image fusion. 
Learning Objectives:
1. To understand the role of MRI in diagnosis of prostatic cancer.
2. To understand the key MRI findings in prostatic cancer.
3. To learn about the role of MR spectroscopy in diagnosis of prostatic cancer.
A‑422	 16:28 
B. MRI in the post-treatment follow-up 
A.T. Turgut; Ankara/TR (ahmettuncayturgut@yahoo.com) 
The role of imaging in patients with increased PSA level after radical prostatectomy 
or radiation therapy is to aid in differentiating locally recurrent disease which can 
be managed with local therapy from distant metastatic disease requiring systemic 
therapy. Although the majority of local recurrences in post-surgical patients can be 
detected by MRI in the perianastomotic region which can also be evaluated with 
TRUS and TRUS-guided biopsy, some recurrences can occur at pelvic sites that 
are beyond the range of TRUS; MRI has a role of labelling these sites for TRUS-
guided biopsy. The combination of an external phased-array coil and endorectal 
coil is recommended for detecting local recurrent cancer. Current protocols involve 
T2-weighted MRI combined with functional techniques such as dynamic contrast-
enhanced MRI (DCE-MRI), magnetic resonance spectroscopy and diffusion-
weighted MRI. In the post-prostatectomy bed, recurrences present as lobulated 
masses having low to intermediate signal intensity on T2-weighted images and 
showing early, nodular enhancement with early washout of gadolinium on DCE-MRI. 
The predominant finding after radiotherapy is a diffusely low signal intensity with 
an indistinct zonal anatomy where the contrast between a hypointense recurrence 
and benign irradiated tissue decreases. On DCE-MRI, peripheral zone enhance-
ment is lower after radiotherapy and any focal enhancement should be regarded 
as suspicious. The overall diagnostic efficacy of DCE-MRI for detecting recurrent 
prostate cancer is better than T2-weighted MRI alone. On MRI, bone metastases 
have low and high signal intensity on T1- and T2-weighted images, respectively, 
and enhance after intravenous gadolinium administration. 
Learning Objectives:
1. To understand the role of MRI in the follow-up of the patients with prostate 
cancer after radical prostatectomy or radiotherapy.
2. To learn about the MRI findings for local or distant metastasis in the post-
treatment follow-up of prostate cancer.
3. To learn about the post-radiotherapy signal intensity changes on the 
detectability of recurrent prostate cancer after radiotherapy.
A‑423	 16:51 
C. New frontiers in imaging of the prostate 
J.O. Barentsz; Nijmegen/NL (J.Barentsz@rad.umcn.nl) 
In this presentation new techniques with potential clinical value will be described 
with a focus on prostate cancer multi-modality MR imaging. Techniques such as 
T2W, DWI, DCE and MRSI will be addressed, and their role in screening, deter-
mination of tumour aggression and localisation, MR-guided biopsy, MR-guided 
minimal invasive focal therapy (laser, cryo, HiFu), and MR-guided radiotherapy 
will be discussed. Examples will be shown. 
Learning Objectives:
1. To become familiar with new developments in MRI of prostate cancer.
2. To understand the future clinical needs, and how MRI can solve them.
Panel discussion: 
What is the most appropriate radiological approach in patients with rising 
PSA levels, and when? 17:14
The major area of debate is how to approach patients with increased PSA levels. 
The discussion has two parts: one is the patient who has not had a prior cancer 
diagnosis and the other one is the patient who has already been treated for pros-
tate cancer. What is the role of MR (as well as MRS, DW MR and dynamic MR) 
in precluding the need for multiple biopsies? When should we stop in cases with 
high or increasing levels of PSA despite consecutive negative biopsy outcomes? 
A‑419	 17:00 
C. Future directions 
J. Kettenbach; Berne/CH (joachim.kettenbach@insel.ch) 
Image guidance and imaging fusion techniques represent an integral element in 
oncologic interventions and liver surgery. In addition, several liver planning tech-
niques such as the virtual liver surgery planer enhance simulation of a proposed 
liver resection. Using roboter-assistance or navigational guidance combined 
with thermal ablation techniques such as radiofrequency ablation, significantly 
enhances accuracy of ablation probe placement and efficacy of ablation necrosis. 
Furthermore, the local recurrence rate can be considerably reduced, and the 
amount of complete tumour ablation is significantly more likely. Integrating magnetic 
resonance imaging, and focused ultrasound to deliver and activate nano-capsules 
carrying anti-cancer drugs to effectively target tumours will be another task. This 
will involve drugs being injected into the body in the form of tiny capsules, which 
are harmless until they are activated by a concentrated focused ultrasound ` blast’. 
The MRI scanner will then be used to track the passage of the drugs, visualise the 
target and monitor the delivery of the drug treatment. 
Learning Objectives:
1. To review new ablation modalities.
2. To review research on targeted embolotherapy.
3. To understand the use of combined therapies.
16:00 - 17:30 Room E1 
Genitourinary 
RC 1407 
MRI in prostate cancer 
Moderator: 
J. Venancio; Lisbon/PT 
A‑420	 16:00 
Chairman’s introduction 
J. Venancio; Lisbon/PT (josevenancio@netcabo.pt) 
MRI is used in the detection of prostate cancer (PCa) in several circunstances highlight-
ing: A. Patients with previous series of negative ultrasound-guided biopsies and clinical 
or biochemical suspicion of PCa. B. Patients already treated for PCa, with rising PSA. 
Functional multiparametric MRI including: dynamic contrast enhanced MRI (DCE-
MRI), diffusion-weighted MRI (DW-MRI), and spectroscopic MRI (S-MRI) is useful 
to detect suspect areas, mainly in peripheral zone and direct TRUS or MRI-guided 
biopsies. Nowadays 3 T MRI can improve PCa detection due to higher multiparamet-
ric capabilities and more precise staging. It is very important precise localisation of 
tumour in some kind of patients indicated for focal treatment: HIFU, brachytherapy, 
cryotherapy… In the follow-up after treatment, with a biological or clinical suspiction of 
relapsing, it is very important to detect peri-anastomotic or pelvic recurrences, and MRI 
(combining the use of endorectal and pelvic phased array coils) is better than US or 
CT. Particular conditions concerning this matter will be discussed. Present and future 
clinical needs on imaging PCa. New developments in MRI of PCa will be presented, 
emphasising local staging, recurrences perianastomotic and the evaluation of lymph 
nodes (Fe-nanoparticles?). 
Session Objectives:
1. To review and compare the most important MRI developments.
2. To evaluate prostate after treatment for cancer, and signal intensity changes 
to detect local recurrences.
3. To learn about future trends of MRI in prostate cancer, answering future 
clinical needs, namely in the evaluation of lymph nodes.
A‑421	 16:05 
A. MRI in detection of prostatic cancer 
F. Cornud; Paris/FR (francois.cornud@imagerie‑tourville.com) 
MRI is more and more used for PCa detection in patients with a negative series of 
TRUS-guided biopsies and a persistent biological suspicion of PCa. Functional MRI 
increases the accuracy of T2W-Imaging to localise PCa. It includes dynamic contrast 
enhanced MRI (DCE-MRI), diffusion-weighted MRI (DW-MRI) and spectroscopic MRI 
(S-MRI). Sensitivity and specificity of DCE-MRI are significantly higher than that of 
T2W-MRI to detect P-Zone cancers with a tumour volume > 0.2-0.5 cc. Limitations of 
DCE-MRI include the frequent enhancement of benign P-Zone sextants and T-Zone 
BPH nodules. With DW-MRI, PCa shows a significantly lower apparent diffusion coef-
ficient (ADC) value than that of benign prostate tissue which increases the accuracy of 
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occult injuries of the large vessels, heart, tracheobronchial tree, diaphragm or spine. 
Despite significant merits of MDCT the chest x-ray together with ultrasound still 
serves as a tool for fast orientation and detection of traumatic changes requiring 
urgent intervention (e.g. tension pneumothorax, large haemothorax and pericardial 
tamponade). MDCT is currently accessible in practically all trauma centers and it 
is considered to be the gold standard of the imaging of trauma. This fact results 
in a tendency to perform MDCT in patients with high-energy injury as a routine 
examination without selection according to the clinical and x-ray finding. The dis-
advantages of this approach are increased costs and higher radiation exposure, 
but on the other hand it increases the number of relevant additional findings (in 
7-40%) leading to the modification of the therapeutic strategy. 
Learning Objectives:
1. To learn about imaging algorithm in chest trauma: the value of CT.
2. To understand the benefits of MDCT.
3. To learn about examination protocols.
4. To learn about post-processing methods.
5. To learn about imaging findings focused on merits of MDCT.
A‑427	 16:51 
Radiation in emergency thoracic CT: can it be reduced? 
S. Leschka; St. Gallen/CH (sebastian.leschka@kssg.ch) 
The risks associated with radiation exposure in CT is of concern to radiologists, 
medical physicists, government regulators, and the media. Thoracic CT is a techni-
cally robust, non-invasive imaging technique for the evaluation of several traumatic 
and non-traumatic thoracic emergencies. Technical advances in the past years 
have resulted in improvements in image acquisition speed, spatial resolution, and 
the temporal resolution. Consequently, thoracic CT can now be performed rapidly 
in emergency conditions without substantial delay in treatment. State-of-the-art 
CT systems are now capable of imaging the entire thorax within a few seconds. 
However, radiation exposure associated with thoracic CT have been increased 
with the advantages of modern CT systems particularly in the evaluation of chest 
pain syndrome. Thoracic aortic CT angiography with cardiac gating may now be 
considered the preferred technique for the evaluation of chest pain syndrome in 
selected patients but is associated with a substantial higher radiation dose than 
routine non-gated thoracic CT. Several effective strategies have been developed to 
limit the radiation exposure in cardiac gated thoracic CT including prospective ECG 
gating techniques, anatomy and ECG-based tube current modulation, high pitch 
acquisition, and adaptation of the CT scanning parameters to the body habitus. In 
addition, several techniques are available to reduce the radiation exposure in non-
gated thoracic CT depending on the patient’s body habitus and the clinical indication. 
Learning Objectives:
1. To become familiar with radiation dose values associated with current CT 
protocols used in thoracic emergencies.
2. To learn which factors influence the radiation dose in thoracic CT.
3. To learn how radiation dose can be reduced in clinical practice.
Panel discussion: 
Increasing use of MDCT in emergency radiology of the chest: is it 
appropriate? Can we stop it? Do we want to? 17:14
In many countries imaging in the emergency department is only partly based on 
appropriateness but also on defensive medicine, finances or politics. The number of 
procedures increases with decreasing positive rates. Furthermore, especially with 
the use of MDCT, radiation exposure is increasing. If radiologists want to reduce 
inappropriate use of MDCT, the questions arise of whether we are able to do it and 
how it can be achieved. Are there alternative diagnostic strategies? 
16:00 - 17:30 Room F1 
Radiology in Abdominal Emergencies 
CC 1417 
Inflammation and oedema 
Moderator: 
N. Elmas; Izmir/TR 
A‑428	 16:00 
A. The three musketeers: appendicitis, diverticulitis, colitis 
J. Stoker; Amsterdam/NL (j.stoker@amc.uva.nl) 
Appendicitis, diverticulitis and colitis are frequent causes of acute inflammatory 
bowel emergencies. In many patients, suspected for these conditions the diagnosis 
is not clear upfront. Imaging plays an important role in identifying the underlying 
16:00 - 17:30 Room E2 
Special Focus Session 
SF 14 
Thoracic emergencies: triage with MDCT 
Moderator: 
D.R. Kool; Nijmegen/NL 
A‑424	 16:00 
Chairman‘s introduction 
D.R. Kool; Nijmegen/NL (dignakool@gmail.com) 
Because of advancing technical developments and increasing diagnostic utility of 
MDCT in emergency care, its use has expanded significantly and has changed 
patient care, especially in chest emergencies. However, MDCT has important 
drawbacks in cost and radiation exposure. The first presentation will discuss MDCT 
in acute chest pain (ACP). Scan techniques in different scanners will be addressed. 
The reasons why CTA/CTCA can be a viable application for ACP and the current 
evidence for CTA in ACP will be discussed followed by an update on indications. 
The next presentation will address MDCT in chest trauma. Its significance, the 
utility of this imaging method and its advantage compared to other modalities will 
be discussed. The examination protocol and the role of post-processing methods 
will be addressed. The interpretation of MDCT, findings, benefits, limitations and 
pitfalls will be shown. The utility of chest x-ray and ultrasound as primary examina-
tions and the indication for MDCT, routine or selective, will be discussed. Our last 
speaker will familiarise us with procedures to measure radiation dose in thoracic 
MDCT, followed by an update of radiation exposure associated with the protocols 
for the different clinical indications. Finally, available techniques for radiation dose 
reduction in ECG-gated and non-gated MDCT and their effectiveness in radiation 
dose reduction will be demonstrated. However, the best way to reduce radiation 
is to perform MDCT only when there is an appropriate indication and this will be 
the focus of the concluding panel discussion of this session. 
Session Objectives:
1. To learn about the benefits of MDCT in traumatic and non-traumatic 
emergencies of the chest.
2. To learn about the disadvantages of MDCT in emergency care.
3. To learn about ways to reduce the disadvantages of MDCT and improve 
appropriate use of MDCT.
A‑425	 16:05 
MDCT in acute chest pain 
F. Cademartiri, E. Maffei; Parma/IT (filippocademartiri@hotmail.com) 
MDCT in acute chest pain has been performed for several years. However, one of the 
major missing pieces of the puzzle in this field was the heart and the coronary arteries. 
Major life-threatening causes of chest pain such as acute aortic dissection and pulmo-
nary embolism are part of our daily practice in emergency radiology care. Coronary 
arteries and cardiac assessment are, instead, a new and challenging application. CT 
scan technique has several and demanding requirements as well as training for proper 
reporting. Current state-of-the-art CT scanner can perform a complete chest CT with 
ECG synchronisation in few seconds with a reasonable, if not low, radiation dose. 
Technique has to be optimised depending on patients’ features, and clinical indications. 
Learning Objectives:
1. To become familiar with the CT scan technique for non-traumatic thoracic 
emergencies.
2. To learn about the rationale of triple rule-out with CT.
3. To learn about the indications of CT in settings of acute chest pain.
A‑426	 16:28 
MDCT in chest trauma: indications, technique and interpretation 
H. Mirka; Plzen/CZ (mirka@fnplzen.cz) 
Chest trauma is, particularly in younger population, a significant cause of morbidity 
and mortality. It is directly responsible for 20-25% of trauma-related deaths and in 
other 50% of deaths it is an important contributing factor. Imaging methods play 
the key role in management of this group of patients. Introduction of MDCT in the 
last decade of the 20th century markedly changed the diagnostic approach to the 
thoracic trauma. Fast data acquisition and increased resolution in the z-axis enabled 
reliable assessment of all chest anatomical components (often together with other 
parts of the body) in one examination. Compared to x-ray MDCT defines more 
accurately the extent and severity of traumatic changes and may detect serious 
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Learning Objectives:
1. To learn epidemiology and clinical outcome of patients with pancreatitis.
2. To understand typical findings and diagnostic pitfalls.
3. To know the role of radiology in patients with acute and chronic pancreatitis.
16:00 - 17:30 Room F2 
Breast 
RC 1402 
Evaluation of the treated breast and follow-up 
Moderator: 
A. Tardivon; Paris/FR 
A‑431	 16:00 
Chairman’s introduction 
A. Tardivon; Paris/FR (anne.tardivon@curie.net) 
The topics of this refresher course cover very interesting fields in patients with 
a breast cancer. How to evaluate residual disease after surgical biopsy? How to 
evaluate tumour response to neoadjuvant therapies and what about surveillance 
after treatment? In all these fields, many questions remain without clear answers 
and univocal recommendations especially about the timing of imaging after surgery, 
under treatment and during follow-up. If MRI is the most sensitive imaging technique 
for detecting cancer (residual disease, new cancer event and local relapse), we 
have to keep in mind that it is not perfect (calcifications, low grade DCIS detection) 
and that radiation therapy and systemic treatments play a major role for curing 
minimal residual disease. For evaluating and predicting response to neo-adjuvant 
treatments, the major question is the debate between morphology (size and volume) 
and function (perfusion, spectroscopy and diffusion). For follow-up after treatment, 
considering the number of women concerned, cost benefit analyses are mandatory 
to offer the most efficient imaging strategies based not only on defined subgroups 
(risk factors of local relapse) but also over time. One of the first take home mes-
sages of this course is the multidisciplinary approach of this disease or in another 
way: we do not treat images but patients! 
A‑432	 16:05 
A. Evaluation of residual disease after excisional biopsy 
C. Boetes; Maastricht/NL (c.boetes@mumc.nl) 
Mammography can have an additional value in evaluating if microcalcifications are left 
behind in the case of DCIS and irradical operation. Ultrasonography has proven to have 
no additional value in evaluating the postoperative breast, because of haematoma and 
scar tissue. MR imaging of the breast can of all imaging techniques predict residual 
disease in the most accurate way. However, false positive results can exist because 
of enhancing scar tissue. Also, false-negative results exist, especially owing to residual 
low and intermediate grade DCIS. It is recommended to perform postoperative breast 
MRI in premenopausal women in the right time of the menstrual cycle, that means 
between the 5th and 12th day after the start of the menstrual cycle. Unclear is how soon 
after the operation one should perform breast MRI. If a large mass of residual disease 
is suspected, MRI is an excellent tool to confirm this fact. But, if a mastectomy is con-
sidered, pathological confirmation before the re-operation is recommended. Another 
imaging technique is TC-99m-MIBI scintimammography. This seems a promising 
technique with a high sensitivity and specificity. 
Learning Objectives:
1. To review indications for imaging after excisional biopsy.
2. To understand imaging findings in the treated breast.
3. To understand the role of MRI in detection of residual disease.
A‑433	 16:28 
B. Evaluation of response to neoadjuvant chemotherapy 
P.A.T. Baltzer, M. Dietzel, W.A. Kaiser; 
Jena/DE (pascal.baltzer@med.uni‑jena.de) 
Neoadjuvant chemotherapy is regularly used for downstaging of locally advanced 
breast cancer. While it is equivalent to adjuvant therapy regarding overall survival and 
occurrence of distant metastasis, more patients are eligible for surgical treatment by 
less aggressive breast conservative therapy. Neoplastic growth depends on blood 
supply with nutrients and oxygen. Hypoxia-induced angiogenesis is an early step in 
tumour progression. MRI is the imaging modality providing highest sensitivity for detec-
tion of breast cancer, highlighting tumour vascularisation by injection of T1-shortening 
contrast agents. Characteristic differences between benign and malignant lesions are 
cause. Ultrasound (US) and computed tomography (CT) are readily available and 
widely used imaging techniques for this work up. US comprises an examination of 
the abdomen with the graded compression technique. A transducer should be used 
optimised for the visualisation of the bowel. The CT protocol includes the use of 
intravenous contrast medium, while oral contrast medium will not be routine in many 
institutions. Findings are bowel wall thickening (or enlarged appendiceal diameter), 
fat infiltration, free air and fluid collections. The present evidence on the role of 
imaging in appendicitis and diverticulitis is substantial and has been summarised 
in systematic reviews. Although US is accurate in diagnosing appendicitis and 
diverticulitis, CT is more accurate than US. Further advantages of CT are better 
identification of alternative diagnoses and better comparison between consecutive 
examinations. Thereby, CT is more helpful in communicating the diagnosis to the 
referring physician. Cost effectiveness of CT in acute appendicitis has been dem-
onstrated as well as the positive impact on management. For colitis, the evidence 
is more limited and imaging has more limitations here. Drawback of CT is ionising 
radiation exposure. An imaging strategy with initial US and CT only in inconclusive 
of negative US cases results in the highest sensitivity, reduces ionising radiation 
exposure and is cost effective. 
Learning Objectives:
1. To know the pros and cons of ultrasound and computer tomography in 
appendicitis, diverticulitis and colitis.
2. To understand the imaging findings and results in appendicitis, diverticulitis 
and colitis.
3. To learn the role of imaging in acute inflammatory bowel emergencies.
A‑429	 16:30 
B. Liver and biliary tree 
J.A. Soto; Boston, MA/US (jorgeasoto@aol.com) 
Accurate and rapid diagnostic imaging is essential for the appropriate manage-
ment of acute biliary tract disorders. Ultrasonography (US) continues to be the 
first and often the only test needed to confirm suspected diagnoses affecting the 
ducts and gallbladder. However, there has been an increase in the overall use of 
computed tomography (CT) in the emergency room setting, mostly because for 
its widespread availability and the relative speed, ease and uniformity with which 
evaluations can be performed. Thus, CT may be the first imaging examination 
performed on patients presenting with signs and symptoms that are less specific 
for biliary diseases. Magnetic resonance (MR) imaging has similarly robust potential 
as CT, although its integration into the acute care setting requires greater technical 
and logistical effort. Improved MR imaging sequences, advances in coil technol-
ogy, streamlined imaging protocols, and increased technical and professional 
familiarity with the modality make it an increasingly attractive option when there is 
concern about patient radiation exposure or allergy to iodinated contrast material, 
as in pregnant patients with acute abdominal symptoms. MR can also be used 
as a problem-solving modality. In this presentation, the common and uncommon 
imaging appearances on US, CT and MR of acute diseases of the biliary tract and 
gallbladder will be reviewed. Potential pitfalls to be avoided with the three modali-
ties are also illustrated. 
Learning Objectives:
1. To learn the etiology and clinical presentation of acute inflammatory liver 
diseases.
2. To understand imaging strategies using US, CT and MRI.
3. To know typical findings and the spectrum of differential diagnoses.
A‑430	 17:00 
C. Pancreatitis: common and critical 
P.R. Ros; Cleveland, OH/US (Pablo.Ros@UHhospitals.org) 
Pancreatitis is an abdominal condition potentially life threatening. Imaging plays a 
key role not only in the diagnosis but also in the staging and patient management 
of acute and chronic pancreatitis. Pancreatic inflammation and necrosis can be 
easily identified by imaging methods and has prognostic implications. The clinical 
prognostic criteria in acute pancreatitis are currently coupled with imaging crite-
ria. CT plays a central role in the evaluation of patients with known or suspected 
pancreatitis. A CT-based severity index is the main prognostic method to predict 
outcomes. In addition, MRI and MRCP play increasingly important roles in pancre-
atitis evaluation. Integrity of the pancreatic duct can be easily evaluated by this last 
method, particularly if enhanced with the use of secretin. Imaging appropriateness 
criteria determine the value of distinct imaging modalities with regard to the stage 
of disease. We review the modern imaging criteria for the diagnoses, staging and 
patient management in acute and chronic pancreatitis. We also discuss current 
severity indices and imaging appropriateness criteria. 
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16:00 - 17:30 Room G/H 
Neuro 
RC 1411 
Update on brain aneurysms 
Moderator: 
S. Bracard; Nancy/FR 
A‑435	 16:00 
Introduction to brain aneurysms 
S. Bracard; Nancy/FR (s.bracard@chu‑nancy.fr) 
Cerebral aneurysm is a challenging problem. Subarachnoid haemorrhage (SAH) remains 
a devastating accident. The incidence of SAH is around 6 per 100000 patient-years, higher 
in Finland and account for around 5% of all strokes. The diagnosis may be difficult on 
CT or MR but is essential. Complications are frequent and precocious: hydrocephalus, 
vasospasm and the most important, rebleeding. In the first day, up to 15% of patients 
have a rebleeding and after the first day, the risk of rebleeding is more-or-less constant 
at a rate of 1 to 2% per day during the next 4 weeks with a poor prognosis. After rebleed-
ing, 80% of patients died or remain disabled. Ruptured aneurysms are the cause of 
SAH in 85% of patients, whereas 5-10% fit into the pattern of so-called non-aneurysmal 
perimesencephalic haemorrhage. The remaining are caused by various causes. Both 
CTA and MRA may be proposed as a first-choice, non-invasive examination, The aver-
age sensitivity of CTA for the detection of intracranial aneurysms reaches 90%, but the 
negative predictive value is poor, and therefore digital subtraction angiography (DSA) 
is mandatory for all SAH cases with negative CTA or MRA. During the past decade, 
endovascular occlusion by means of detachable coils (coiling) of aneurysms has largely 
replaced surgical occlusion as the intervention of choice for the prevention of rebleeding. 
On the other hand, more and more unruptured aneurysms are fortuitously discovered 
and the question to treat or not to treat is also a challenging issue. 
A‑436	 16:05 
A. Subarachnoid haemorrhage 
L. van den Hauwe1, C. Venstermans2, M. Voormolen2, T. van der Zijden2, 
F. De Belder2, J.W. Van Goethem2, P.M. Parizel2; 1Brasschaat/BE, 2Antwerp/BE 
(lucvdhauwe@mac.com) 
In 85% of nontraumatic cases, subarachnoid haemorrhage (SAH) is the result of 
aneurysmal rupture. Other causes of SAH include perimesencephalic SAH (10%) 
and other disorders (5%) such as arteriovenous malformation (AVM), vertebrobasilar 
artery dissection, dural AV-fistula, cortical vein thrombosis, amyloid angiopathy, … 
SAH represents an emergency situation and diagnosis should be established ASAP. 
Plane computed tomography (CT) is the initial diagnostic test of choice (wide avail-
ability, easy accessibility, high sensitivity and specificity). If CT is negative, lumbar 
puncture and/or MRI of the brain (including FLAIR images) and spine should be 
performed. 3D TOF MR angiography (MRA) sequences have high sensitivity and 
specificity in detecting cerebral aneurysms; but because of their lower spatial reso-
lution are insufficient to analyse in detail aneurysm morphology. This in contrast 
with CTA. Both CTA and MRA may be proposed as a first-choice, noninvasive 
examination, but the negative predictive value is poor, and therefore digital subtrac-
tion angiography (DSA) is mandatory for all SAH cases with negative CTA or MRA. 
Catheter angiography remains the golden standard in the detection and evaluation 
of cerebral aneurysms (size, relationship between neck and adjacent vessels, etc). 
Increased attenuation (CT) and hyperintense signal (FLAIR) within the basal cisterns 
and sulci are a characteristic finding of SAH; however, it is aspecific. Pattern and 
location of the blood may help to locate the ruptured aneurysm; sometimes helpful 
when multiple aneurysms are found. Pseudo-SAH may be a potential imaging pitfall 
because it may be observed in other acute neurological conditions (cerebral edema, 
bacterial meningitis, etc). 
Learning Objectives:
1. To review the different causes of subarachnoid haemorrhage.
2. To learn about the basic imaging strategies in the diagnostic work-up of 
subarachnoid haemorrhage.
3. To learn how to recognise the early CT and MR signs of subarachnoid 
haemorrhage.
best identified by dynamic repetitive T1w imaging which is referred to as DCE-MRI. 
Chemotherapeutic treatment leads to characteristic tissue changes affecting both 
vascularisation, tumour microstructure, i.e. extracellular space and chemistry, e.g. 
choline metabolites. While the first is assessed by DCE-MRI, further MRI techniques 
such as diffusion weighted imaging (DWI) and MR-spectroscopy (MRS) provide means 
to measure changes in tumour microstructure and chemistry due to neoadjuvant che-
motherapy. This talk will introduce and discuss different MRI concepts for monitoring 
of neoadjuvant chemotherapy using MRI. Furthermore, accuracy and limitations of 
MRI for prediction of response will be discussed. 
Learning Objectives:
1. To understand principal mechanisms of tumour vascularisation and 
microstructure.
2. To understand changes in tumour vascularisation and microstructure due to 
neoadjuvant chemotherapy.
3. To understand the accuracy and limitations of response monitoring using 
breast MRI.
A‑434	 16:51 
C. Surveillance for and detection of recurrent disease after therapy 
F.J. Gilbert; Aberdeen/UK (f.j.gilbert@abdn.ac.uk) 
Recurrent disease following treatment for primary breast cancer can occur in the same 
breast following conservation surgery, ipsilateral breast tumour recurrence (IBTR) or in 
the contralateral breast, metachronous contralateral breast cancer (MCBC). Estimations 
for the rate of recurrence are between 04 and 0.8% each year. The rate of recurrence 
is higher than breast cancer incidence in the general population. Risk factors for recur-
rence are young age (< 50), high grade disease, incomplete tumour excision and no 
radiotherapy. Due to the large numbers of women who develop and survive breast cancer 
the cost and resource required to follow-up these women is considerable. There are vari-
able guidelines in Europe for the surveillance of women but most regimes include clinical 
follow-up and mammography. Variations concern the frequency of mammography, the 
length of follow-up required, and whether clinical examination is required. The clinical 
effectiveness and cost-effectiveness of different surveillance mammography regimens 
after the treatment of primary breast cancer will be reviewed together with the results 
of systematic reviews. Modelling of two data registries was undertaken to ascertain the 
survival benefit. Alternative methods of surveillance will be considered such as MRI with 
the diagnostic accuracy of the various imaging techniques considered. A summary of 
the economic evaluation will be presented to demonstrate the assumptions that require 
to be made in this complex area where there is a paucity of evidence. 
Learning Objectives:
1. To understand the risk of recurrent disease and second primary following the 
treatment of breast cancer.
2. To review literature on surveillance mammography and other imaging 
methods for detection.
3. To appreciate the range of recommendations for surveillance mammography 
and clinical follow-up with cost benefit analysis.
Panel discussion: 
The new challenge in breast cancer: evaluation of response 17:14
Evaluation of the treated breast is one of the major challenges in breast imaging. 
There is especially much debate on the evaluation of response to therapy. The 
best imaging modality, the best imaging criteria, timing, accuracy and limitations of 
imaging are currently being investigated. Whether it is time to reach conclusions 
regarding these aspects is the issue of this panel discussion. 
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MRI and CT before cardiac interventions or surgery 
Moderator: 
G.P. Krestin; Rotterdam/NL 
A‑439	 16:00 
Chairman’s introduction 
G.P. Krestin; Rotterdam/NL (g.p.krestin@erasmusmc.nl) 
Advancements in CT and MRI technology have lead to an increasing use of these 
modalities in the non-invasive assessment of coronary arteries, myocardial perfu-
sion, and cardiac function. While their role in detecting coronary artery disease and 
functional disorders has been widely accepted, it is still unclear whether they could 
be adopted in triaging patients for the best therapeutic approach. Large studies 
have already suggested that indication for surgery and percutaneous interventions 
cannot be solely based on the demonstration of morphologic alterations and that 
such “cosmetic” interventions are not always leading to the expected outcomes. 
Therefore, non-invasive imaging techniques have to offer more then just the detec-
tion of grades of coronary artery stenosis, of areas of infarcted myocardium, or of 
valvular alterations. Adjustment of imaging protocols for additional evaluation of 
coronary flow reserve, of myocardial perfusion and contractility and of valve size, 
position and damage with subsequent quantification of degree of stenosis and/
or regurgitation are necessary in order to allow to choose the most appropriate 
therapeutic approach and thus become the “gold standard” for prognosis and 
pretherapeutic diagnosis of cardiac diseases. 
A‑440	 16:05 
A. Can CT predict the outcome of percutaneous intervention? 
C. Loewe; Vienna/AT (christian.loewe@meduniwien.ac.at) 
The outcome of coronary revascularisation is not only defined by primary technical 
success but also by improvement of symptoms and quality of life. Thus, despite 
the individual comorbidities, the outcome and thus the potential benefit of coronary 
revascularisation depends on many different factors, including morphology, distribu-
tion and severity of coronary lesions, myocardial viability, and ventricular function. 
Consequently, the detection of coronary stenosis is not sufficient for planning an 
optimised treatment. It should be evaluated if the myocardial territory supported by 
the diseased artery is still vital. In addition, lesions at risk for plaque rupture (culprit 
lesions) should be identified and treated to avoid major coronary events. Cardiac 
CT allows for the exact assessment of coronary morphology including length, 
calcification and severity of lesions. Based on this morphological information, suc-
cess of a percutaneous revascularisation procedure can be anticipated with high 
prognostic accuracy. In addition, the possibility of identification of culprit lesion by 
means of coronary CT has been described recently. By this, dedicated treatment 
of only the relevant stenosis should become possible avoiding multiple, potentially 
unneeded, stents. Finally, even the assessment of myocardial viability by means 
of CT becomes possible. Using all the possibilities of cardiac CT optimised treat-
ment plan can be established, and outcome can be estimated. This presentation 
should give an overview about potential applications of cardiac CT for optimised 
treatment decisions and planning. Recent literature should be introduced based on 
clinical examples. Potentially useful algorithms for appropriate treatment selection 
should be provided allowing for improving the outcome of coronary interventions. 
Learning Objectives:
1. To understand the role of CT coronary angiography in the assessment of 
patients prior to percutaneous intervention.
2. To appreciate the role of CT findings regarding the myocardium in patients 
prior to cardiac interventions.
3. To understand the positive and negative predictive value of CT in the 
assessment of potential candidates for cardiac interventions.
A‑437	 16:28 
B. CTA/MRA in aneurysm diagnosis 
Z. Merhemic; Sarajevo/BA (merhemic.zulejha@gmail.com) 
Intracranial aneurysms are abnormal dilatations of the arteries, and will be found 
in 1% to 14% in general population. In 90% cerebral aneurysms are saccular and 
develop from the arteries of the circle of Willis or its major branches. Aneurysms typi-
cally become symptomatic between the age of 40 and 60 years, with subarachnoid 
haemorrhage (SAH) or intracerebral haematomas. Less common are giant aneu-
rysms usually found in middle-aged women presenting with signs more indicative 
of a mass lesion. CT angiography (CTA) has been proven to be an excellent tool 
to visualise intracranial arteries. The average sensitivity of CTA for the detection 
of intracranial aneurysms reaches 90%. Post-processing allows assessment of 
the aneurysm with maximum intensity projections (MIP) and surface-rendered 3D 
projections in multiple plains. MR angiography (MRA) is a practical and noninva-
sive tool for screening of high-risk individuals for aneurysms. DSA is diagnostic 
method of choice for assessment of intracranial aneurysms and was considered to 
be a ‘gold standard’ for evaluation of cerebral vessels. A clear shift from invasive 
to noninvasive imaging of cerebral vessels has been noticed in the last decade. 
This lecture will discuss advantages and disadvantages of CTA, MRA and DSA in 
detection, assessment, and post-treatment evaluation of intracranial aneurysms. 
Learning Objectives:
1. To understand the imaging findings on CTA and MRA of brain aneurysm.
2. To recognise the key features of an imaging protocol for patients with 
suspected aneurysm.
3. To understand the optimal CTA and MRA protocol for diagnosing brain 
aneurysm.
A‑438	 16:51 
C. Treatment of aneurysms 2011 
P. Vilela; Almada/PT (ferrovilela@sapo.pt) 
Intracranial aneurysms have a multifactorial origin. A heterogeneous and complex 
group of pathogenic mechanisms including luminal, mural and extramural factors 
interact for the development and growth of aneurysms. There are several types of 
intracranial aneurysms, being the saccular the most common type. The aneurismal 
treatment is dependent on its type and needs a multidisciplinary approach including 
endovascular and microsurgical teams. Endovascular treatment is recognised as 
the first-line treatment for most of the ruptured saccular intracranial aneurysms. 
There has been an enormous improvement in the endovascular technology and 
techniques offering a wide spectrum of treatment possibilities that broadened the 
variety of aneurysms that can be treated. The treatment options include the use 
of coils with/without the help of balloon-remodelling and/or stenting. Other options 
include the use of covered stents, of “flow-diverter” stents, of liquid embolics, or the 
parent vessel occlusion. The multislice computer tomography angiography (MSCTA) 
is a reliable method for pretreatment evaluation of intracranial aneurysms. For the 
posttreatment evaluation, magnetic resonance angiography (MRA) can be used for 
the follow-up of embolised aneurysms; and MSCTA may be used for the follow-up of 
surgically treated aneurysms. There are several challenges remaining in aneurysm 
management. In the diagnostic field, improvement of the non-invasive techniques 
for the diagnosis, for the morphological and haemodynamic characterisation and 
for the posttreatment follow-up of aneurysms is expected. In the endovascular field, 
technological breakthroughs to improve the occlusion rate, to increase the treatment 
durability, and to promote the vessel wall healing are desired. 
Learning Objectives:
1. To learn about present treatment of brain aneurysms.
2. To understand the strategies for multimodal CT and MR aneurysm imaging 
pre and post-treatment.
3. To present the challenges for neuroimaging in the field in the near future.
Panel discussion: 
Where do we stand in brain aneurysm treatment today? 17:14
There is a significant difference in the management of patients with ruptured versus 
un-ruptured brain aneurysms. This panel discussion will focus on the management 
of patients with brain aneurysms and will with simple case presentations show the 
management in ruptured and un-ruptured aneurysms and discuss the involvement 
of the neurosurgeon in more complex cases. 
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RC 1414 
Radiography in the operating theatre 
Moderators: 
R. Passariello; Rome/IT 
A. Yule; Cardiff/UK 
A‑443	 16:00 
A. Cone-beam CT imaging in the operating room during endovascular 
aortic repair (EVAR) 
K.R. Eide, A. Ødegård, H.O. Myhre, S. Hatlinghus, O. Haraldseth; 
Trondheim/NO (kari.eide@hist.no) 
Cone beam CT (CBCT) is a method for obtaining CT-like images using a C-arm 
system. Our aim was to investigate the accuracy of these images compared with 
multi-detector CT (MDCT) as a gold standard in radiological imaging of abdominal 
aortic aneurysms (AAA). 40 patients with AAA referred for elective EVAR were 
included in a pre-therapy protocol (20 patients) and in a post-therapy protocol (20 
patients). All were exposed to standard MDCT and one additional CBCT. Image data 
were evaluated by two radiologists and statistically compared using a linear mixed 
model. First, 6 predefined arterial measurements were performed, then 9 predefined 
anatomical areas were assessed and scored for visibility on a scale from 1 to 4. All 
measurements were chosen to be relevant for evaluating of AAA before and after 
EVAR. For the arterial measurements no significant differences were found between 
MDCT and CBCT. Visibility for the anatomical areas was significantly better for 
MDCT; however, most of the CBCT readings were above lowest acceptable level. 
Visualisation of the iliac arteries was suboptimal. We think that our results support 
the start of clinical trials that scientifically can test the outcome without the use of 
MDCT immediately before and after EVAR. The problem with poor visualisation 
of the distal iliac arteries might be solved with newer technology. In conclusion, 
the result indicates that CBCT in the operation room gives sufficient image-based 
information to support EVAR in a pre- and post-therapy setting. 
Learning Objectives:
1. To gain knowledge about visualisation of high- and low contrast structures 
using cone-beam CT.
2. To appreciate some strengths and limitations using intraoperative cone-
beam CT.
3. To become familiar with doses of radiation needed to plan and carry out 
EVAR.
A‑444	 16:45 
B. Key radiographic skills in the operating theatre 
K.G. Holmes; Lancaster/UK (ken.holmes@cumbria.ac.uk) 
Undertaking theatre radiography can appear a daunting task for the radiographers 
lacking in confidence in their ability but others (like all expert practitioners) make 
it look easy and uncomplicated. Theatre radiography requires all the knowledge, 
skills and abilities of a competent radiographer together with assertiveness, re-
flection and the ability to modify your technique at a moment’s notice. There are 
a multitude of ‘traits’ which distinguish the expert from the novice. These include 
production of optimum images, effective use of the equipment, radiation protection, 
infection control, effective communication and teamworking. There is also a clear 
depth of knowledge together with a multitude of skills and abilities. The key to a 
stress-free experience is preparation. It is essential that there is a mechanism for 
theatre staff and the radiology department to communicate effectively and give the 
radiographer prior notice of all cases requiring their attendance. It is also desirable 
to be in the theatre when the patient arrives for their examination to enable you to 
check the patient’s identity, pregnancy status and ensure the patient is positioned 
correctly to facilitate screening. There are few excuses to give the surgeon if you 
cannot screen the area of interest because of poor positioning of the patient and 
equipment. This paper will discuss the knowledge, skills and abilities required to 
undertake theatre radiography in a safe and proficient manner without feeling 
threatened by the experience. 
Learning Objectives:
1. To understand the key skills required to undertake radiographic procedures 
in the operating theatre.
2. To gain an insight into the interpersonal skill required for effective 
radiographic practice in the operating theatre.
A‑441	 16:28 
B. Can MRI predict the outcome of coronary revascularisation? 
M. Francone; Rome/IT (marco.francone@uniroma1.it) 
Prediction of coronary revascularisation outcome represents a major clinical question 
because a large number of medical and surgical options have become available for 
ischaemic cardiomyopathy with need to identify more rigorous criteria for patient’s 
selection. The combination in a single examination of function, stress-perfusion and 
tissue characterisation with T2-weighted ‘oedema-sensitive’ and late-gadolinium en-
hancement (LGE) techniques supported the role of cardiac MR (CMR) as an important 
technique for the evaluation of patients candidates to revascularisation. Besides more 
“traditional” indicators such as ejection fraction, end-diastolic wall thickness or end-
systolic volumes, extent and distribution of myocardial scar depicted with LGE has been 
identified as one of the most important predictors of post-revascularisation outcome 
with direct influence on functional recovery and on major adverse cardiovascular events 
(MACE) due to the potential induction of arrhythmias from the scar. LGE technique 
has been shown to be superior to nuclear medicine for the assessment of myocardial 
viability due to the higher spatial resolution (up to 60-fold greater than SPECT) and 
an intrinsic high contrast resolution. A further technique that could be adopted before 
revascularisation is stress imaging. Myocardial ischaemia detected by either CMR ad-
enosine first-pass perfusion or dobutamine-induced wall motion abnormalities has been 
shown to predict subsequent cardiac death whereas normal stress perfusion showed 
a high negative predictive value for MACE. In conclusions, although as a relatively 
new diagnostic modality prognostic evidence is predominantly derived from single-
center studies, CMR is increasingly becoming an important tool for risk stratification 
of patients before revascularisation, offering indications about outcome and mortality. 
Learning Objectives:
1. To review the scientific evidence of MRI in CAD.
2. To understand the important prognostic factors that MR is able to provide.
3. To learn about the advantages of performing cardiac MR prior to coronary 
revascularisation.
A‑442	 16:51 
C. The value of CT before percutaneous aortic valve replacement 
R. Salgado; Antwerp/BE (rodrigo.salgado@uza.be) 
Cardiac valve diseases are an important public health problem, strongly linked to 
the general increasing age of the Western population. The most frequent valve 
disease is aortic stenosis, for which percutaneous aortic valve replacement (PAVR) 
is currently evolving to a feasible alternative therapy for the classical surgical ap-
proach in high-risk patients. Nevertheless, careful evaluation of all aspects of this 
new approach is still required to avoid uncontrolled diffusion. Imaging plays a key 
role in selecting patients who may be eligible for PAVR, focusing on the evaluation 
of leaflet anatomy, severity of valve dysfunction, haemodynamic consequences 
and potential problems in the access route. While echocardiography is commonly 
used for both the anatomical and functional evaluation, multidetector CT (MDCT) 
has important intrinsic advantages providing state-of-the-art 3D imaging with a 
high spatial resolution over a large anatomic coverage. During this course, we will 
discuss the advantages and disadvantages of MDCT compared to other imaging 
modalities. The relevant anatomy of the aortic valve and annulus will be reviewed, 
with emphasis on correct alignment of the imaging planes, and its implications for 
correct reporting of the necessary measurements targeted at the clinicians need. 
Furthermore, MDCT scan protocol design will be reviewed, focusing not only on 
optimal implementation of common scan parameters but also on the need of 
ECG-triggering and its consequences. Finally, we will present the current status 
of evidence on using MDCT in PAVR procedures, and discuss future challenges 
and perspectives. 
Learning Objectives:
1. To understand how to optimise the imaging protocol for aortic valve imaging.
2. To learn how to report the findings and what to include in the report.
3. To understand the impact of this approach on patient management.
Panel discussion: 
Improve your interaction with your colleagues 17:14
MR and CT are increasingly being used as the modalities of choice in the evalu-
ation of patients prior to cardiac interventions or surgery. It is very important to 
understand the specific clinical question that prompted the clinician to order the 
exam and to answer it in the best possible way. The radiologist has to make clear 
statements and should know the therapeutic implications of his report and findings. 
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Visualisation, perception and image processing 
Moderators: 
A.A. Lammertsma; Amsterdam/NL 
B. Wein; Aachen/DE 
A‑448	 16:00 
A. Visualisation and perception 
A.G. Gale; Loughborough/UK (a.g.gale@lboro.ac.uk) 
Radiological interpretation always incurs some degree of error due to the nature of 
disease presentation coupled with the difficulty in diagnosis, especially where early 
signs of disease need to be identified such as in medical screening. Early research 
studies of radiologists’ performance concentrated upon the chest radiograph but 
more recent work has studied breast screening extensively, as well as MRI and CT. 
As radiology is now almost fully digital then research has also examined observer 
behaviour with a range of digital images, viewing conditions, and image display 
presentations. It is possible that radiological interpretation will never be accom-
plished without some errors occurring; however, it is important that steps are taken 
to minimise any causes of errors as far as possible. The reported error rates found 
in numerous investigations across different radiological domains will be reviewed 
and the reasons for these will be elucidated. Appropriate reporting conditions will 
be highlighted for different image viewing scenarios. A theoretical framework for 
understanding error causation, especially where abnormalities are missed will be 
detailed. Furthermore, the underlying visual, perceptual and cognitive processes 
which lead to errors will be detailed and approaches to minimise error occurrence 
will then be proposed. The relationship between human perceptual and cognitive 
skills and computer imaging processing will be discussed and the usefulness of 
CAD systems outlined as how they can best aid the radiologist from the human 
performance viewpoint. 
Learning Objectives:
1. To review the basic principles of perception, detection and detectability.
2. To learn about specifics of perception in medical imaging.
3. To learn how image processing can help us with the perception process.
A‑449	 16:30 
B. Image processing and perception 
B.M. ter Haar Romeny; Eindhoven/NL (B.M.terHaarRomeny@tue.nl) 
The need for quantitative image analysis in radiology is universal: computer-aided 
detection, segmentation for 3D volume visualisation, image enhancement, pattern 
recognition, etc. All need effective, robust and preferably generic (not ‘ad hoc’) 
algorithms for the computer. How to design such algorithms? A good inspiration 
source is the functionality of the visual system, the best investigated brain struc-
ture today. In this talk we will explain how we think the brain calculates features in 
images, why the retina measures at a wide range of resolutions and how we can 
exploit this. The visual system is strongly adaptive and self-learning. New optical 
recording techniques have given new insight in how the cells in the visual cortex are 
functioning. We will go through these functionalities step-by-step. What we discover 
is quite amazing. We recognise huge amounts of filter banks in the first stages of 
vision: many filters analyse each pixel of the incoming image at a range of scales, 
orientations, derivative order, for each colour, and also as a function of time. Ex-
tensive feedback loops take care of optimal settings locally. We programmed these 
filters into the computer, and were able to build many interesting applications for 
computer-aided diagnosis: detection of catheters at seriously reduced levels of x-ray 
radiation dose, automatic polyp detection, quantitative analysis of ischaemic heart 
ventricle deformation, breast cancer CAD, pulmonary emboli CAD and analysis 
of in vivo microscopy images now so abundant in modern life-sciences research. 
Learning Objectives:
1. To gain insight into modern computer vision techniques for computer-aided 
diagnosis.
2. To learn how the first stages of human visual perception process information.
3. To learn a range of application areas of image processing techniques for 
medical imaging.
3. To appreciate effective methods for reducing radiation dose to patients and 
staff during radiographic procedures in operating theatres.
4. To learn how to improve radiographic techniques in theatre to ensure 
optimum images are produced during procedures.
16:00 - 17:30 Room N/O 
Joint Course of ESR and RSNA 
(Radiological Society of North America)
MC 1425 
Essentials in oncologic imaging: 
what radiologists need to know (part 4)
Moderator:
H.‑U. Kauczor; Heidelberg/DE
A‑445	 16:00 
A. Lymphoma 
M.P. Federle; Stanford, CA/US 
Learning Objectives:
1. To get a practical, clinically relevant summary of key imaging issues in 
Hodgkin and non-Hodgkin lymphoma.
2. To learn how imaging, especially PET and PET-CT can optimally assess 
and measure tumour treatment response, providing a value-added radiology 
report.
A‑446	 16:30 
B. Musculoskeletal neoplasms 
M.F. Reiser; Munich/DE 
Learning Objectives:
1. To review imaging features of common malignant musculoskeletal 
neoplasms.
2. To learn about key imaging findings required for staging of bone and soft 
tissue tumours, as well as associated imaging pitfalls.
3. To learn about criteria for conventional imaging, perfusion MR imaging 
and diffusion-weighted MR imaging and PET/CT in assessing response to 
treatment in musculoskeletal neoplasms.
A‑447	 16:55 
C. Chemo- and radiation therapy-induced toxicity 
H.-U. Kauczor; Heidelberg/DE 
Learning Objectives:
1. To get an overview of organ-specific toxicity and other adverse effects of 
chemo- and radiotherapy.
2. To review the key imaging findings of therapy-induced organ toxicity and 
adverse effects.
3. To understand how to differentiate inflammatory, infectious, fibrotic, and 
necrotic changes from tumour recurrence.
Questions 17:20
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ing using Graf’s method led to higher treatment and follow-up rates than that based 
on NHI alone, i.e. 3-5% vs. 0.4-1.5% and 10-20% vs. 6-7%, respectively. However, 
improved examination techniques and a better understanding of the findings have 
led to a more tailored approach, and an extensive meta-analysis performed in 2000, 
including 534 papers, could not find any differences in treatment rates due to different 
ultrasound techniques. In this lecture I will present a crude status for US techniques 
used and also give recommendations for a worth while screening strategy based on 
present knowledge, and on work performed within the ESPR’s DDH Task Force group. 
Learning Objectives:
1. To learn about the different approaches of hip sonography in neonates.
2. To understand the need for a systematic study.
3. To learn about proposed standardisation for examination and reporting.
A‑453	 17:00 
C. Whole body imaging: PET/CT vs MRI 
P.D. Humphries; London/UK 
With technological advances in recent years, paediatric whole body imaging is now 
a clinically feasible and increasingly accessible technique. The two principle modali-
ties available are PET, with or without co-registered CT images, and whole body 
MRI (WB-MRI), both of which can be utilised to evaluate widespread disease states 
efficiently. The main application of these techniques has hitherto been oncological; 
however, as these techniques become more accepted, their use is becoming more 
varied. PET provides functional assessment, utilising a radiotracer, most commonly 
FDG-18, to assess metabolic activity within tissues, with areas of greater metabolic 
activity depicted as increased tracer uptake. The use of combined CT-PET enables 
accurate specific uptake values (SUV) to be determined, via attenuation correction, 
and anatomical co-registration which reduces perceptual errors. WB-MRI primarily 
provides an anatomical assessment, using tissue contrast to identify pathology. 
This typically uses water sensitive sequences to provide high sensitivity. “Physi-
ologic” MRI sequences, such as diffusion weighted imaging (DWI) can also be 
employed to obtain functional MRI data, either qualitatively or quantitatively. There 
are advantages and disadvantages to both techniques, including ionising radiation 
exposure, acquisition times, movement and other artefacts, and reproducibility, 
which all need to be considered when choosing a particular technique for whole 
body assessment in any given paediatric patient, with the disease process being 
investigated also influencing the technique used. The relative merits, clinical ap-
plications and evidence base for the use of PET/CT and WB-MRI in paediatrics will 
be discussed. Near future developments, such as PET-MRI will be touched upon. 
Learning Objectives:
1. To get an overview of PET/CT and whole body MRI.
2. To learn about advantages and limitations of each technique.
3. To learn about examples of benign and malignant diseases.
A‑450	 17:00 
C. Clinical application of image processing 
A. Persson; Linköping/SE (anders.persson@cmiv.liu.se) 
The practice of medical image diagnosis is currently undergoing a fast transforma-
tion. Vast amounts of data can be generated in standard examinations and focus 
is shifting from improving the collection of relevant data for diagnosis to develop-
ment of effective methods to analyse, visualise, navigate and interact with medical 
information. It is now becoming generally accepted in the medical community that 
one of the most important keys to manage the increasing information work load is 
the use of 3D and 4D applications. This talk will take its starting point in state-of-
the-art medical visualisation and then discuss the need for a research agenda that 
focuses on the development of the next generation of medical visualisation tools, 
emphasising the fact that these tools must be based on medical user requirement 
and work flow studies as well as on new technical developments. 
Learning Objectives:
1. To learn how to use adequate reconstructions/image sequences in CT/MR.
2. To learn when to use transverse, sagittal and coronal displays.
3. To learn when to use 3D displays.
16:00 - 17:30 Room Q 
Paediatric 
RC 1412 
Children’s bones and joints 
Moderator: 
M. Rasero; Madrid/ES 
A‑451	 16:00 
A. Imaging findings in childhood osteomyelitis 
R.R. van Rijn; Amsterdam/NL (r.r.vanrijn@amc.uva.nl) 
Childhood osteomyelitis is a relatively rare finding in childhood with an estimated annual 
incidence of 1 per 5000 and is predominantly seen in young children (< 5 years). It can 
be caused by via haematogenous spread, contiguously from local areas of infection 
or from penetrating trauma or surgery. Usually it is caused by bacterial infections, but 
occasionally fungi, viruses or parasites are causative agents. Clinical findings can 
range from mild to severe and depends on many factors such as age, site of infection, 
acute versus chronic osteomyelitis, and causative agent. The CRP and sedimentation 
rate are usually elevated; however, this is not always the case. Given the variability 
in clinical presentation radiology plays a crucial role in the detection of osteomyelitis. 
Although conventional radiography (CR) has a limited sensitivity and specificity for the 
diagnosis of osteomyelitis, its wide availability makes it the first diagnostic technique 
of choice in children. For further analysis both MRI and radionuclide bone scintigraphy 
(RBS) have shown to have a high sensitivity for the detection of osteomyelitis. The 
advantages and disadvantages of both the techniques will be addressed. CT mostly 
plays a role in the diagnosis of chronic osteomyelitis or in the pre-surgical work-up. 
The use of radiology also allows for a differential diagnosis of osteomyelitis, based on 
clinical cases, an overview of this differential diagnosis will be given. The aim of this 
lecture is to present an evidence-based diagnostic strategy for childhood osteomyelitis. 
Learning Objectives:
1. To get an overview of current imaging practices in the evaluation of osteomyelitis.
2. To learn about patterns of skeletal lesions found in osteomyelitis.
3. To understand findings that point to alternative diagnoses.
A‑452	 16:30 
B. Hip dysplasia: US techniques and recommendations 
K. Rosendahl; Bergen/NO (karen.rosendahl@helse‑bergen.no) 
Developmental dysplasia of the hip (DDH) is the most common musculoskeletal 
disorder in childhood, with a reported prevalence of 1-4% according to method 
of ascertainment and definitions used. Ultrasound has enabled a detailed view of 
both neonatal hip stability (NHI) and morphology, and two different schools have 
developed; one arguing that NHI alone is the major pathology warranting splinting, 
the other including acetabular dysplasia as an important feature. Both static (Graf, 
Morin) and dynamic (Harcke) ultrasound techniques, as well as a combination of 
the two (modified Graf (Rosendahl)), have been described and are currently used. 
In Europe, Graf’s ultrasound technique or a modification of this is commonly used 
within the German speaking countries and areas, in parts of Scandinavia, the UK, 
Italy, France, Hungary and the Netherlands. Others use a modified Morin’s method 
while Harcke’s method is used only occasionally. Initially, universal ultrasound screen-
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the GI tract are leading causes but any tumour involving the abdominal cavity or 
haematological malignancy may be implicated. During treatment with chemotherapy 
or radiotherapy acute abdominal symptoms are common as a consequence of 
direct toxicity. Imaging must be used as an adjunct to clinical assessment. Pat-
terns of abdominal involvement are often modified in the later phases of disease. 
GI tract obstruction may be due to progression or the mechanical consequences 
of prior surgery and is more commonly at multiple levels. Perforation or fistulation 
may occur with either progressive disease or tumour lysis in response to therapy. 
Cancer does not protect against the common inflammatory conditions but poor host 
response and the use of steroids may mask signs leading to extensive abnormal-
ity at diagnosis. Bone marrow suppression increases susceptibility to infection 
including neutropenic enterocolitis and haemorrhage. Bone marrow transplantation 
and consequent graft versus host disease is a potent cause of acute abdominal 
symptoms. CT is the major imaging technique although MR has an increasing 
role particularly in the assessment of the female pelvis. Major determinants when 
considering the differential diagnosis include; the nature and initial stage of the 
primary, any prior anatomical modification (surgery), the nature and relationship 
to current treatment and the bone marrow status. 
Learning Objectives:
1. To be able to list neoplastic diseases that may potentially lead to acute 
abdominal symptoms.
2. To appreciate the differences in causes and findings of the acute abdomen 
between the initial presentation with neoplasia and when undergoing 
treatment.
3. To understand typical CT findings and pitfalls, and the potential role of MRI.
08:30 - 10:00 Room B 
Interactive Teaching Session 
E³ 1520 
Prostate cancer: what the radiologist must report 
A‑457	 08:30 
Prostate cancer: what the radiologist must report 
A.R. Padhani1, H.-P. Schlemmer2; 1Northwood/UK, 
2Heidelberg/DE (anwar.padhani@stricklandscanner.org.uk) 
This workshop will begin by describing the current limitations of MRI in evaluating 
prostate cancer patients and will show how to overcome these with advanced 
imaging techniques including diffusion weighted MRI (DW-MRI), MR spectroscopic 
imaging (1H-MRSI) and dynamic contrast enhanced MRI (DCE-MRI). The emphasis 
will be on the use of processing tools that are readily available for clinical practice. 
We will describe how to analyse images and provide a scheme for reporting findings 
back to surgeons/oncologists. We will show that using more than one MRI tool 
improves imaging performance and that the relative importance of each technique 
remains unresolved. We will demonstrate new indications for advanced MRI in 
prostate cancer patients. 
Learning Objectives:
1. To understand the current crisis in prostate cancer diagnosis and patient care.
2. To appreciate that limitations of morphological imaging methods can be 
overcome by functional techniques such as diffusion MRI, dynamic contrast 
enhancement and spectroscopy.
3. To get to know the biological basis for observations, data acquisition and 
analysis methods, validation, interpretation of data of these technique.
4. To learn methods for reporting findings back to surgeons/oncologists.
5. To appreciate that advanced MRI tools will enable us to tackle new 
indications in prostate cancer diagnosis.
08:30 - 10:00 Room A 
Radiology in Abdominal Emergencies 
CC 1517 
The acute abdomen 
Moderator: 
J.‑M. Bruel; Montpellier/FR 
A‑454	 08:30 
A. Abdominal hernias 
G. Brancatelli; Palermo/IT (gbranca@yahoo.com) 
Abdominal hernias are common in daily practice and can be divided into: external 
or abdominal wall hernias, internal hernias and diaphragmatic hernias. External 
hernias typically involve protrusion of abdominal contents through a defect in the 
abdominal wall. Internal hernias involve protrusion of viscera through congenital 
or acquired defects in the mesentery or the peritoneum. Diaphragmatic hernias 
involve protrusion of abdominal contents into the chest. Among these conditions, 
the diagnosis of internal hernia is the most challenging. Bariatric surgery and liver 
transplantation with biliary-enteric anastomosis, with the Roux-en-Y loop placed 
in a retrocolic position, are recognised predisposing factors for internal hernia 
development. Symptoms of hernia are nonspecific and vague, and clinical and 
radiologic diagnosis can sometimes be challenging. Immediate diagnosis is man-
datory because misdiagnosis can be complicated by bowel obstruction, volvulus, 
strangulation, incarceration, or trauma. MDCT with its multiplanar capabilities is 
widely believed to facilitate this diagnosis, because it is able to delineate hernia 
type, location, size, and shape and is particularly useful to diagnose unsuspected 
hernias. It also allows distinguishing hernias from masses of the abdominal wall, 
such as tumours, haematomas and abscesses. As a result, knowledge of the CT 
findings of abdominal hernias may allow early and more accurate diagnosis, with 
a resultant decrease in the mortality rate. 
Learning Objectives:
1. To understand the predisposing factors, clinical presentation and 
complications of abdominal hernias.
2. To be able to recognise abdominal hernias on imaging through multiple 
examples with an emphasis on MDCT.
3. To illustrate the postsurgical anatomy underlying internal hernias.
A‑455	 09:00 
B. The wrong twist: mesenteric and omental torsion 
S.C. Efremidis; Ioannina/GR (sefremid@cc.uoi.gr) 
The title of this talk limits the discussion of torsion to the mesentery and omentum. 
It has to be mentioned, however, that an abnormal twist (torsion) can involve any 
peritoneal reflection of those suspending and fixating hollow viscera, (e.g. stomach, 
small bowel, cecum, sigmoid and gallbladder), solid organs, (e.g. spleen, ovaries), 
or even extraperitonel (extraabdominal) organs such as the testicles, leading to the 
pathologic entity of volvulus or torsion of the corresponding viscous with its associ-
ated (different) imaging findings, prognosis and treatment. Moreover, twisting of the 
mesentery and volvulus can occur secondary to a variety of conditions including 
congenital anomalies of intestinal rotation with variable prognosis. Finally, torsion 
of the omentum can be either primary or secondary, also associated with different 
pathology, imaging findings and treatment. Consequently, a broad spectrum of 
abnormalities ensues related to the pathophysiology of torsion which requires a 
detailed classification, an accurate description and the use of correct terminology 
making it impossible to be covered within the time limits of a presentation. There-
fore, focusing the discussion on to abnormal twist of small bowel mesentery and 
omentum will simplify the approach to avoid overlaps and confusion. 
Learning Objectives:
1. To understand the pathophysiology of mesenteric and omental torsion.
2. To know the typical presentation on cross-sectional imaging modalities.
3. To learn imaging strategies with focus on MDCT.
A‑456	 09:30 
C. Acute stages in neoplastic diseases 
J.A. Guthrie; Leeds/UK (Ashley.Guthrie@leedsth.nhs.uk) 
After the initial presentation, a patient with cancer enters a phase of active treat-
ment (surgery, chemotherapy or radiotherapy), and then remission/cure or palliative 
phases. An „acute abdomen“ may complicate any phase. The principle causes are 
obstruction, perforation, haemorrhage, ischaemia and sepsis. Tumours arising from 
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2. To become familiar with the technical imaging considerations and the proper 
diagnostic algorithm.
3. To know more about the typical imaging findings.
A‑460	 09:30 
C. Interactive case discussion 
A.G. Rockall; London/UK (andrea.rockall@bartsandthelondon.nhs.uk) 
This case-based lecture will present typical clinical cases of pelvic pain as well as 
some unusual but important causes. Cases of acute and of chronic pelvic pain, and 
benign as well as malignant disease will be included. The audience will have the 
opportunity to participate in case discussion by the use of interactive voting pads. 
The selection of imaging modality for each clinical presentation and the importance 
of knowing the clinical findings at the time of the radiological interpretation will be dis-
cussed. For each case, the key radiological features will be illustrated. The essential 
elements of the radiology report and the key information required by the clinician will 
be discussed. In each case, the differential diagnosis and the need for follow-up imag-
ing will be considered. The key teaching points for each diagnosis will be reviewed. 
Learning Objectives:
1. To introduce typical cases illustrating the role of imaging modalities in the 
differential diagnosis of pelvic pain in female patients.
2. To motivate the audience by the use of voting pads to be involved in the 
diagnostic process.
3. To highlight the conclusion that may be drawn on the basis of the discussed 
cases.
08:30 - 10:00 Room D1 
KISS (Keep It Simple and Straightforward): Musculoskeletal MRI 
CC 1516 
The hip 
Moderator: 
C.W.A. Pfirrmann; Zurich/CH 
A‑461	 08:30 
A. How I do it 
A. Kassarjian; Majadahonda/ES 
MR imaging of the hip and pelvis can be challenging given the complex anatomy, 
multiple potential sites of injury, lack of dedicated hip coils, the deep location of the hip 
joint, and the tightly opposed intra-articular structures. Optimisation of patient position-
ing, scan parameters, and use of contrast can vastly improve diagnostic accuracy in 
assessing both intra- and extra-articular lesions that may result in hip and groin pain. 
Learning Objectives:
1. To understand the influences of patient positioning, scan parameters and 
magnet/coil technology on image quality.
2. To learn how to optimise scan protocols to maximise patient throughput 
without compromising diagnostic quality.
3. To recognise how and when to modify scan protocols to answer specific 
clinical questions.
A‑462	 08:55 
B. Normal variants and pitfalls 
U. Studler; Basle/CH (studleru@uhbs.ch) 
This lecture provides a practical approach to the fundamentals of normal cross-sectional 
anatomy of the hip. Basic knowledge necessary to identify the different portions and 
contents of the joint anatomy is provided. A special emphasis is on cartilaginous struc-
tures, the acetabular fossa, and capsular fibers and ligaments. Functional anatomy 
of muscles and tendons about the hip is reviewed. The location of bursae and their 
association with adjacent structures is discussed. In the second part of the lecture 
attendees will learn how to avoid commonly seen pitfalls about the hip. A special 
focus on anatomic variants of the acetabular labrum simulating disease is given. 
Osseous variants including acetabular ossicles and the superior acetabular notch will 
be explained and explored. Debates about the role of herniation pits referred to as a 
normal variant are reviewed. The lecture offers an overview of muscular and tendinous 
variations around the hip joint. 
Learning Objectives:
1. To become familiar with the normal anatomy.
2. To be able to identify normal variants.
3. To appreciate the range of pitfalls that may simulate pathology.
08:30 - 10:00 Room C 
CLICK (Clinical Lessons for Imaging Core Knowledge): Common 
Clinical Cases 
CC 1518 
Female pelvic pain 
Moderator: 
A.J.M. Maubon; Limoges/FR 
A‑458	 08:30 
A. Clinical considerations 
G. Restaino, V. Chiantera; Campobasso/IT (gennares@hotmail.com) 
Pelvic pain is an important part of clinical practice for any clinician who provides health 
care for women. Pelvic pain may be acute, recurrent or chronic. Acute pelvic pain (APP) 
rarely lasts more than one month without crisis, resolution, or cure. Pain of more than 
1 or 3 or 6 months of duration is considered as chronic pelvic pain (CPP) and in many 
settings may be considered and treated as an illness itself. Women who present with 
APP frequently exhibit nonspecific signs and symptoms. Diagnostic considerations 
encompass multiple organ systems, including obstetric, gynaecologic, urologic, gastro-
intestinal, and vascular aetiologies. As the first priority, urgent life-threatening conditions 
(e.g. ectopic pregnancy, appendicitis and ruptured ovarian cyst) and fertility-threatening 
conditions (e.g. pelvic inflammatory disease and ovarian torsion) must be considered. 
Adolescents and pregnant and postpartum women require unique considerations. 
CCP is a common and significant disorder of women, with a prevalence of 3.8-12%. 
Many disorders of the reproductive tract, gastrointestinal system, urological organs, 
musculoskeletal system, and psychoneurological system may be associated with 
CCP, the most common being endometriosis, adhesions, irritable bowel syndrome 
and interstitial cystitis. Ultrasonography should be the initial imaging test because of 
its sensitivities across most aetiologies and its lack of radiation exposure. Computed 
tomography (CT) serves an important role in patients with nonlocalizing symptoms, 
an indeterminate US evaluation, or in patients who require a wider search beyond the 
field of view available with US. Magnetic resonance imaging is an extremely useful 
second-line modality for problem solving after US or CT. 
Learning Objectives:
1. To learn more about the clinical conditions causing pain in the female pelvis 
without an apparent origin.
2. To be informed about the clinician’s way of thinking in the process of 
differential diagnosis.
3. To become familiar with the potential role of imaging in the establishment of 
the final diagnosis and planning of therapy.
A‑459	 09:00 
B. Imaging techniques and typical findings 
B. Brkljacic; Zagreb/HR (boris.brkljacic@zg.htnet.hr) 
Many gynaecologic and nongynaecologic conditions causing pelvic pain are grouped 
according to the anatomic origin; after determining whether the patient is pregnant 
imaging work-up is tailored to establish potential causes within and outside of pelvis. 
Transabdominal and transvaginal ultrasound (TVUS) with color duplex-Doppler are 
first imaging modalities. Examination technique will be discussed. Most patients 
with pelvic pain and normal US findings have improvement or resolution of symp-
toms; normal TVUS has negative predictive value of 92%. US findings are often 
inconclusive, some diseases are hard to diagnose, and appearance of benign and 
malignant conditions may overlap. CT is performed when US and/or clinical findings 
are equivocal or indicate pelvic abscess, haematoma, postpartum complications, 
complications of pelvic inflammatory disease, and when GI or urinary diseases need 
to be excluded. Advantage is availability in emergency, but CT lacks precise defini-
tion of pelvic structures and includes exposure to ionising radiation, problematic in 
young or pregnant women. Examination technique and protocols will be presented. 
MRI has the highest accuracy. Fast MRI considerably shortened imaging time. 
Fat-suppression sequences help to establish fat-containing lesions and increase 
the conspicuity of inflammatory lesions. Different sequences will be discussed. MR 
is rated below US and CT for evaluation of acute pelvic conditions, but is excellent 
alternative when administration of iodinated contrast media or radiation exposure is 
undesirable, especially in young or pregnant patients. Long imaging times, limited 
access and cost are major drawbacks of MRI. Imaging findings of various gynaeco-
logic and nongynaecologic conditions causing female pelvic pain will be presented. 
Learning Objectives:
1. To learn about the available imaging modalities to be used for the evaluation 
of female patients with pelvic pain.
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A‑466	 08:58 
B. Vertebroplasty and kyphoplasty 
T. Sabharwal; London/UK (Tarun.Sabharwal@gstt.sthames.nhs.uk) 
Bone filling with cement aims to treat and prevent pathological fractures and relieve 
pain in patients with osteoporosis and bone metastases. Several advances have 
occurred with new mechanical devices for effective restoration of vertebral height, 
as well as the introduction of osteoconductive and osteoinductive cements that will 
promote more physiological bone healing. 
Learning Objectives:
1. To learn about indications to treat.
2. To learn about how to treat non-surgically.
3. To review the results. Is there evidence that it works on a long term or 
placebo treatment?
A‑467	 09:21 
C. Interventional management of painful osseous metastases 
A.G. Ryan; Waterford City/IE (jackoriain@yahoo.ca) 
An overview of the interventional radiology management of painful osseus metas-
tases will be presented. Consideration will be given to patient, lesion and treatment 
modality selection (including radiofrequency ablation, cryoablation, microwave 
ablation, laser ablation, ethanol ablation, MR focused ultrasound ablation, cement 
osteoplasty, transarterial embolisation and combinations therein, e.g. combined 
radiofrequency ablation and cement osteoplasty). The evidence supporting these 
techniques and patient outcomes will be reviewed. 
Learning Objectives:
1. To review the typical hierarchy of pain relief methods used in the treatment 
of painful osseous lesions.
2. To review the technical and anatomic appropriateness of individual 
treatments and their combinations.
3. To review the evidence supporting the use of these techniques and their 
impact on patients’ pain outcome.
Panel discussion: 
Experience-based vs evidence-based practice in spinal 
intervention 09:44
Experience/sense/empirical/economic vs evidence-based practice in spinal and 
extremity intervention. Who needs treatment and which modality (RFA, Cryo, os-
teoplasty, embolisation, coblation) is best, alone or in combination? Which modality 
should be recommended for management of painful osseous lytic or sclerotic le-
sions in the spine or extremities? What are the interventional limitations and which 
patients should not be offered treatment by IR? 
08:30 - 10:00 Room E1 
Special Focus Session 
SF 15a 
Molecular imaging made easy 
Moderator: 
F.M.A. Kiessling; Aachen/DE 
A‑468	 08:30 
Chairman’s introduction 
F.M.A. Kiessling; Aachen/DE (fkiessling@ukaachen.de) 
Molecular imaging - defined as the non-invasive assessment of biological mecha-
nisms at molecular and cellular level - will play a major role in future disease 
diagnosis and treatment planning. In this context, the aim of this session is to 
introduce in simple terms several major research areas in molecular imaging and 
to discuss their future potential for clinical radiology. 
Session Objectives:
1. To learn about important applications for molecular imaging in drug 
development and in the clinics.
2. To understand the main challenges and research tasks for molecular 
imaging.
3. To become familiar with the areas where the profound knowledge of a 
radiologist is required.
4. To identify areas in which radiologist’s interested in molecular imaging 
should be trained.
A‑463	 09:20 
C. Identifying and reporting abnormal findings 
P.M. Cunningham; Navan/IE 
The differential diagnosis of hip pain is broad and includes intra-articular pathology, 
extra-articular pathology including referred pain from the spine, and mimickers 
including groin pain and pain from the joints of the pelvic ring. The diagnosis of all 
causes of hip pain/pathology has improved with greater use of magnetic resonance 
imaging (MRI) to complement traditional investigations. In this session pathology 
involving the hip and groin will be reviewed in a systematic way which will outline an 
approach to the hip that will allow the reader to maximise their diagnostic ability. The 
review will include evaluation of bone marrow disorders such as avascular necrosis 
and transient osteoporosis and intra-articular pathology including labral tears and 
femoroacetabular impingement (arthritis and traumatic fractures will not be reviewed). 
Extra-articular diagnoses such as bursitis, groin pain (osteitis pubis and adductor/
gracilis dysfunction) and common muscle and tendon injuries will then be reviewed. 
Learning Objectives:
1. To review the imaging appearances of common abnormalities.
2. To understand the use of terminology to describe pathological findings.
3. To learn how to structure a radiological report to ensure clarity and brevity.
08:30 - 10:00 Room D2 
Interventional Radiology 
RC 1509 
Musculoskeletal interventions 
Moderator:
A. Gangi; Strasbourg/FR 
A‑464	 08:30 
Chairman’s introduction 
A. Gangi; Strasbourg/FR (gangi@rad6.u‑strasbg.fr) 
Today, many procedures of bone and joint are performed under imaging control. 
Minimally invasive procedures require less resources, time, recovery, and cost, and 
often offer reduced morbidity and mortality, compared to other modalities. Many 
percutaneous techniques are available. Some aim to treat pain and consolidate 
bone (cementoplasty). Others ablate or reduce the tumour (chemical and thermal 
ablation techniques). The interventional radiologist with an efficient imaging-guided 
technique (flat panel fluoroscopy, CT, and MRI) can increase the precision of the 
above-described procedures allowing an improvement of the results and reduc-
tion of the complications. Furthermore, the presented interventions are carried out 
either on an outpatient basis or with 24 hours hospitalisation which contributes 
to the reduction of overall costs and presents a major advantage for patients of 
working age. Some of these minimally invasive procedures can be considered 
as alternatives to surgery without excluding further surgical options if necessary. 
A‑465	 08:35 
A. Guidelines for spinal infiltrations and nerve blocks 
S. Masala; Rome/IT (salva.masala@tiscali.it) 
Back pain is one of the most common complaints, it is estimated that almost 50% of 
working adults will experience it in any given year. Diseases of peripheral skeleton 
may produce painful symptomatology as well. Some of the algogenic structures 
of the spine and peripheral skeleton are lumbar intervertebral discs, facet joints 
and atlanto-axial/occipital joints, sacroiliac joints, nerve root dura, periosteum, 
ligaments, fascia. Among several aetiologies which can involve these structures, 
spine degenerative pathology plays the leading role. Nowadays, several different 
interventional techniques are available, each one with its specific target of action. 
With the right indication each of them has been proved to be effective as painkill-
ing modality. Herein, we present an up to date comprehensive overview on the 
interventional techniques available with their own indications. 
Learning Objectives:
1. To learn about examination methods and indications to treat.
2. To learn about treatment modalities.
3. To review results.
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are explained. Principle requirements for clinical translations of MR-based molecular 
imaging strategies are discussed. 
Learning Objectives:
1. To get an overview on clinical studies on USPIO-based lymph node imaging 
and cell tracking.
2. To learn about different designs for molecular MR-probes.
3. To understand the principle of activatable MR-contrast agents.
4. To identify areas for clinical translation.
Panel discussion: 
Which role can radiologists easily play in molecular imaging? 09:44
A.K. Dixon; Cambridge/UK 
Disease stage, aggressiveness, and therapy response are not sufficiently charac-
terised by morphologic features. Therefore, imaging should assess disease-specific 
pathophysiology down to the cellular and molecular level. Multimodal imaging and 
experts with profound knowledge about imaging modalities and diagnostic agents 
are required. However, knowledge about the molecular biology of pathologies is 
also needed. Mostly interdisciplinary teams will drive this innovative field forward, 
in which the role of radiologist will be discussed. 
08:30 - 10:00 Room E2 
Special Focus Session 
SF 15b 
CT of small airways: elementary images for disease 
classification 
Moderator: 
J.A. Verschakelen; Leuven/BE 
A‑472	 08:30 
Chairman’s introduction 
J.A. Verschakelen; Leuven/BE (johny.verschakelen@uz.kuleuven.ac.be) 
Small airways and small airways diseases (SAD) have attracted a lot of interest that 
has resulted in a large number of publications since the early 1970s. Despite the 
several histopathological and clinical subtypes that have been described diagnosis 
is not always obvious. The introduction of thin section CT and the fact that this CT 
technique is able to depict signs of SAD has not only renewed interest but has 
also improved insights in these disorders. In this session the direct and indirect 
CT signs of SAD will be presented and the CT techniques that can improve their 
detection will be explained. Correlations between pathological findings and the 
presence of these CT signs will be made and diseases that can mimic these CT 
findings will be discussed. Schemes of classification of SAD based on clinical and 
pathological findings will be discussed briefly, but most attention will be given to the 
radiological classification, which is based on the recognition of the direct and indirect 
signs of SAD. Algorithms that help to identify the cause of SAD will be presented. 
Finally, the use of CT and also of MR as a tool to examine the structure-function 
relationship in SAD will be discussed. It will be shown how careful interpretation 
and software tools can help to generate data about disease extent and global and 
regional lung function. 
Session Objectives:
1. To become familiar with the direct and indirect CT signs that indicate the 
presence of small airway disease (SAD).
2. To understand how these signs can be helpful in classifying and diagnosing 
the different types of SAD.
3. To learn about the use of CT and other imaging methods to determine 
disease extent and disease activity, and to predict pulmonary function 
deterioration.
A‑473	 08:35 
Basic signs in small airways disease 
D.M. Hansell; London/UK (davidhansell@rbht.nhs.uk) 
The ability to recognise direct and indirect signs of small airways disease on 
HRCT has led to renewed interest in these elusive disorders. The “purest” of these 
diseases is constrictive obliterative bronchiolitis which is manifested on HRCT by 
the indirect sign of a mosaic attenuation pattern; the differential diagnosis for mo-
saicism and an algorithm that helps to identify the correct cause of small airways 
disease will be presented. The necessity for routine expiratory HRCT to make the 
diagnosis of obliterative bronchiolitis is controversial and will be discussed jointly 
A‑469	 08:35 
Probes and targets in optical imaging 
C.W.G.M. Löwik; Leiden/NL (c.w.g.m.lowik@lumc.nl) 
Whole body fluorescent imaging and bioluminescent imaging are now widely ap-
plied in small animals to study all kinds of biological and molecular processes like 
i.e. gene expression, tumour progression and metastasis, apoptosis, inflammation, 
angiogenesis, proteolysis and to follow trafficking, differentiation and fate of cells 
(i.e. stem-, immune- and tumour cells). This has been done mainly by using gene 
reporters expressing fluorescent proteins or luciferases. Recently new mutated 
red shifted fluorescent proteins (with better light penetration and less absorption 
and autofluorescence) and codon optimized and mutated luciferases have been 
developed making optical imaging more sensitive and offering the possibility to 
use dual gene reporters. Apart from new „smart gene reporters“ there has also 
been a great development in injectable near infrared fluorescent (NIRF) probes, 
especially for tumour detection. These NIRF probes can either be targeted or 
enzyme-cleavable. These new developments has opened up the possibility to 
apply NIRF imaging in the clinic especially to image tumour tissue and to identify 
sentinel lymph nodes during operation. The assessment of the tumour-free margin 
during cancer surgery is critical to completely remove the tumour and improve 
the prognosis of the patient. By injecting a tumour specific NIRF probe, tumour 
tissue and local metastases can be visualised in real-time during operation using 
a dedicated NIRF camera system. We now already use NIRF imaging in the clinic 
to detect the sentinel lymph node (SLN) in several types of cancers. In the current 
presentation preclinical and clinical applications of NIRF imaging in image-guided 
surgery will be discussed. 
Learning Objectives:
1. To understand the principle of near infrared optical imaging.
2. To learn about the strengths and limitations of optical imaging.
3. To understand the principle of activatable probes.
4. To identify indications for its use in preclinical and clinical research as well 
as in clinical routine.
A‑470	 08:58 
Ultrasound providing molecular imaging 
M. Palmowski; Aachen/DE (mpalmowski@ukaachen.de) 
Targeted ultrasound contrast agents have opened up the door for molecular 
imaging with sonography. These contrast agents, which consist of encapsulated 
gas microbubbles, are coated with antibodies or specific ligands. Injected into 
the circulation, microbubbles are retained in diseased tissue where they can be 
detected and quantified by different approaches such as “semiquantitative 2-D” 
or “quantitative 3-D” imaging techniques. Due to their size, microbubbles behave 
similar to red blood cells and remain within the intravascular space. Therefore, 
the disease process must be characterised by specific molecular changes on the 
surface of the endothelial cells to be assessable by ultrasound. Several angio-
genic markers such as VEGFR2, αvβ3-integrins, ICAM-1 and VCAM are known 
to be overexpressed by the endothelium in neoplastic, inflammatory and vascular 
diseases. Thus, molecular ultrasound imaging seems perfectly suited to detect 
these markers and monitor changes which might occur during treatment response 
or disease progression. Today, targeted ultrasound contrast agents are becoming 
a routinely used preclinical tool and the first application of specific microbubbles in 
a clinical scenario is expected for the near future. This talk will introduce into the 
principles of molecular imaging with ultrasound. Based on recent studies, basics of 
tumour biology, potential endovascular targets, synthesis of molecular probes and 
different imaging approaches for a preclinical and clinical application of molecular 
ultrasound will be discussed. 
Learning Objectives:
1. To learn about potential targets and indications for molecular ultrasound 
imaging of tumour angiogenesis.
2. To understand the principle of target-specific ultrasound contrast agents.
3. To learn about different MB detection techniques and about the requirements 
on ultrasound hardware.
A‑471	 09:21 
MR in molecular imaging 
E.A. Schellenberger; Berlin/DE (eyk.schellenberger@charite.de) 
A summary about the advantages, problems and challenges of USPIO-based lymph 
node diagnostics are given. Examples of clinical cell tracking are demonstrated. 
The contrast mechanisms of paramagnetic and superparamagnetic contrast agents 
and their use for the design of non-targeted, targeted and activatable MR imaging 
probes are explained. The function of different designs of activatable MR-probes 
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(helium or xenon), oxygen-enhancement or other technologies. All of these might 
also provide quantitative read-outs for disease and/or therapy monitoring. 
Learning Objectives:
1. To learn how CT and other imaging methods can be used to examine the 
structure-function relationship in SAD.
2. To review the state-of-the-art imaging methods that can provide information 
about disease extent, disease activity and global and regional lung function 
in patients with SAD.
3. To become familiar with the current use and the future developments of 
these techniques.
Panel discussion: 
Signs of small airways disease can be seen on CT but when and why do 
they really matter? 09:44
Signs of small airways disease are a frequent finding on CT especially when 
expiratory scans are performed in addition to inspiratory scans. When should we 
report these changes? Are they always important, do they perhaps predict the 
development of more severe disease, or are there cases where they have little 
influence on diagnosis and therapy? When should an expiratory scan be performed? 
08:30 - 10:00 Room F1 
Abdominal and Gastrointestinal 
RC 1501 
Rectal cancer imaging: all you need to know 
Moderator:
G. Brown; Sutton/UK 
A‑476	 08:30 
Chairman’s introduction 
G. Brown; Sutton/UK (gina.brown@rmh.nhs.uk) 
Careful preoperative staging and preoperative using high-resolution MRI together 
with preoperative multidisciplinary team discussion has been shown to reduce 
margin involvement by tumour from 30% to < 5% by identification of patients that 
require more radical preoperative therapy and surgery. The detailed demonstra-
tion of preoperative prognostic factors also recognises patients on imaging that 
are not at risk of local recurrence and therefore the avoidance of unnecessary 
preoperative therapy in a proportion of patients. The use of EUS can help in the 
assessment of early stage flat lesions suitable for local excision and is a powerful 
complementary tool. PET-CT is crucial for the preoperative work up of patients 
undergoing radical procedures such as metastatectomy. Follow-up for colorectal 
cancer patients at high risk for developing recurrent disease is now well established, 
and the emergence of specialised multidisciplinary teams, combined with a range 
of treatment options for recurrent disease has improved curative resection rates 
following metastatectomy and pelvic recurrence surgery. Radiologists with a solid 
understanding of not only the pathological manifestations of primary and recurrent 
rectal cancer but also the treatment options available play a key role in enabling 
the appropriate selection of patients - increasing overall cure rates and reducing 
treatment-related morbidity. This refresher course aims to provide radiologists 
with an understanding of local staging of rectal cancer, the assessment of recur-
rent disease, and assessing response to treatment. The course will highlight how 
imaging underpins the key preoperative decisions for surgical and oncological 
treatment planning in rectal cancer. 
A‑477	 08:38 
A. Staging with US and CT 
A. Maier; Vienna/AT (andrea.maier@meduniwien.ac.at) 
For rectal cancer surgery a variety of alternative operations are currently pos-
sible. Furthermore, there is an increasing trend towards treating patients with 
radiotherapy before surgery. The choice of operation and the decision whether 
to employ radiotherapy is based on preoperative staging. In patients with primary 
rectal cancer accurate assessment of tumour extent and the presence or absence 
of lymph node invasion are factors for determining prognosis and risk of tumour 
recurrence. Endorectal ultrasound (EUS) is effective for T-staging. It has been 
recommended as the investigation of choice in the selection of potentially curative 
local excision. Lymph node staging by this method is less precise than tumour 
staging. Initial reports of the use of CT for tumour staging were encouraging. 
Studies which compare CT with EUS staging consistently show the latter to be 
more accurate for both tumour stage and lymph node stage. Thus, the usefulness 
by the speakers at the end of the session. At the other end of the clinical and 
imaging spectrum to obliterative bronchiolitis is exudative small airways disease, 
typified by (Japanese) diffuse panbronchiolitis. The exudative bronchiolitides are 
characterised by direct signs on HRCT, notably a tree-in-bud pattern. While this 
is a readily appreciated and specific sign, other diseases that mimic this HRCT 
finding will be discussed. Bronchiectasis of variable severity is a usual accompani-
ment to both obliterative and exudative bronchiolitis and the relationship between 
large and small airways disease will be explored. The instances in which HRCT 
findings of obliterative and exudative bronchiolitis co-exist are relatively few, and 
the differential diagnosis for this situation will be considered. In practice, HRCT 
will often show signs of bronchiolitis (whether obliterative or exudative) limited to 
a segment or even subsegment, and the interpretation of the clinical significance 
of such a chance finding is sometimes a difficult judgement. 
Learning Objectives:
1. To become familiar with the direct and indirect signs of small airway 
involvement on CT.
2. To know how to correlate these signs with the pathological changes.
3. To understand the differential diagnosis with other diseases that can show 
similar CT findings.
A‑474	 08:58 
From pattern to diagnosis 
C. Beigelman; Paris/FR 
Various schemes of classification of SAD have been proposed according to clinical, 
pathologic or imaging criteria that are confusing. An optimal approach, mainly based 
on CT analysis of direct and indirect features, usually allows the recognition of the 
two main types of SAD, namely inflammatory/exudative and fibrotic/constrictive/
obliterative bronchiolitis. A miscellaneous group that corresponds to bronchiolar 
involvement in diverse diffuse lung diseases may also be individualised. Direct signs 
of SAD that refer to direct visualisation of diseased bronchioles strongly suggest 
inflammatory bronchiolitis. They mainly consist in centrilobular nodules with tree 
in bud appearance. Conversely, indirect signs mainly represented by mosaic at-
tenuation, air trapping, bronchial wall thickening and dilation characterise fibrotic 
bronchiolitis. Volumetric acquisition, performed a dose reaching that obtained 
with classical HRCT protocols, may be of interest in several ways. Particularly, 
maximum intensity projection tool may facilitate the recognition of the tree in bud 
pattern. The minimum intensity projection mode may optimise the recognition of 
the mosaic attenuation pattern requiring an appropriate contrast resolution, as 
well as the analysis of proximal airways. Expiratory CT, optimally performed on a 
dynamic mode, may be useful in some conditions at a dose equivalent to around 2 
chest x-rays. A combination of post-processing tools from a volumetric acquisition 
performed with carefully chosen parameters might therefore appear useful in the 
evaluation of SAD. Furthermore, additional co-existing findings such as ground glass 
opacity or other features of interstitial pneumonias may be detected. Their analysis 
may help to recognise the cause of SAD in addition to clinical data. 
Learning Objectives:
1. To learn about the different types of SAD and to become familiar with the 
terminology used to describe them.
2. To understand how CT can help to classify these different types of SAD.
3. To learn how CT can contribute to the specific diagnosis.
A‑475	 09:21 
Beyond morphology 
H.-U. Kauczor; Heidelberg/DE (Hans‑Ulrich.Kauczor@med.uni‑heidelberg.de) 
Structural changes associated with SAD are difficult to depict directly on CT. Indirect 
signs of SAD, such as mosaic attenuation on an inspiratory scan and/or air trapping on 
an expiratory scan, are common findings. They nicely illustrate the structure-function 
relationship between obstruction or expiratory collapse of the small airways and the 
subsequent effects on ventilation (local hyperinflation) and perfusion (hypoxic vaso-
constriction). These “functional” signs are thought to be more sensitive than the direct 
visualisation of the underlying structural changes. Careful interpretation and software 
tools help to generate data about disease extent as well as global and regional lung 
function. Beyond paired inspiratory-expiratory CT scanning, dynamic expiratory cine 
as well as perfusion and ventilation imaging on the basis of both, CT and MRI, can 
be applied to increase sensitivity, specificity and accuracy of the diagnosis of SAD. 
Some of them are ready for routine clinical use, such as dynamic expiratory cine 
CT, cine MRI during continuous breathing as well as gadolinium-enhanced perfusion 
MRI. Future developments in the fields of CT and MRI will provide novel technical 
approaches for functional imaging of SAD. These will include novel applications of dual 
energy/spectral CT using iodine-enhancement for perfusion and xenon-enhancement 
for ventilation enhancement as well as ventilation MRI using hyperpolarised gases 
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after apparently curative chemoradiation. The potential contribution of newer tech-
niques (including perfusion CT, diffusion-weighted MR, PET CT, USPIO-enhanced 
MR for lymph node imaging etc) will be discussed. 
08:30 - 10:00 Room G/H 
Neuro 
RC 1511 
Epilepsy 
Moderator: 
B. Gómez‑Ansón; Barcelona/ES 
A‑480	 08:30 
Chairman’s introduction 
B. Gómez-Ansón; Barcelona/ES (bgomeza@santpau.cat) 
Intractable epilepsy is a common and relevant medical condition, where imaging 
has made a tremendous impact. Neuoradiology (MRI) has improved diagnosis in 
patients with epilepsy, making it possible to recognise underlying pathologies that 
may have different, curative treatment options. This is the case of hippocampal 
sclerosis, and of abnormalities of cortical development, conditions with very different 
treatment options, and prognosis. In addition, MRI has added in the recognition and 
characterisation of neoplasms in the context of epilepsy. Finally, neuroradiology has 
demonstrated to be a valuable tool for surgical treatment of patients with epilepsy. 
New MR techniques add anatomical detail and more precise risk assessment of 
postsurgical deficits, thus providing important information for patients´management. 
In this RC, a general insight of imaging in epilepsy, including indications, protocols, 
and the most common neuroradiological conditions to be identified, will be covered. 
Particular interest will be given to tumours as a cause of epilepsy, and to their more 
relevant neuroradiological aspects. Finally, the contributions of different imaging 
techniques in the specific context of epilepsy surgery will be reviewed. 
Session Objectives:
1. To get a general insight of imaging in epilepsy.
2. To understand how neuroradiology improves the diagnosis and management 
of patients with tumours and epilepsy.
3. To learn about the contribution of imaging in the context of surgery for 
intractable epilepsy.
A‑481	 08:35 
A. Tumour as a cause of epilepsy 
M. Stajgis; Poznan/PL (stajgis@o2.pl) 
Brain tumours are a common cause of epilepsy more often in adults, less in children. 
Tumours detected in patients with chronic epilepsy are predominantly located in the 
brain cortex area, affecting the temporal lobe most often. Any benign or malignant 
brain tumour can be responsible for seizures, but some are more frequently as-
sociated with epileptic symptoms. Low-grade astrocytomas, oligodendrogliomas, 
gangliomas, dysembryoplastic neuroepithelial tumours (DNETs) and glioblastomas 
multiforme are the tumours significantly often presenting with seizures in adult 
population. Brain tumour-related epileptogenesis in not fully understood yet, but 
one can list a number of factors playing an important role in this process, including: 
disruption of physiological neuronal structure, tumour affection on the release of 
neurotransmitters and abnormal electrical activity of the brain. Different imaging 
techniques are widely used for evaluation for neoplasms in epileptic patients. CT 
is reserved for acute conditions, one must remember to exclude other possible 
aetiologies of seizures like haemorrhage, trauma or inherited malformations. 
MRI remains the gold standard in imaging investigation of patients with epilepsy. 
Conventional pre- and post-contrast SE sequences are mandatory to perform in 
every subject. Newer and more sophisticated techniques such as diffusion-weighted 
imaging (DWI), functional studies (fMRI), spectroscopy (MRS) and PET are helpful 
in qualification for surgery and preoperative functional mapping. 
Learning Objectives:
1. To be aware of the common neoplasms that may cause epilepsy.
2. To understand why and how a neoplasm can cause epilepsy.
3. To be familiar with different imaging techniques for evaluating for neoplasms 
in epilepsy patients.
of CT for rectal cancer is disappointing. Accurate assessment of local spread can 
only be achieved in advanced tumours. The value of CT as an investigation tool 
for staging rectal cancer has to be seen in the detection of distant metastases. 
New approaches with perfusion technique may lead to an increased relevance of 
CT in the preoperative assessment of rectal cancer. 
Learning Objectives:
1. To describe the technique of endorectal ultrasound illustrated with both 
normal and abnormal findings.
2. To discuss the role of endorectal ultrasound in rectal cancer staging.
3. To describe state-of-the-art CT techniques for local staging of rectal cancer.
4. To discuss the role of optimised CT techniques in rectal cancer staging.
A‑478	 09:00 
B. Staging with MRI 
L.C.O. Blomqvist; Stockholm/SE (lennart.k.blomqvist@ki.se) 
MRI has become established as the modality of choice for preoperative local staging of 
rectal cancer. The most important general advantages of MRI compared to other cross-
sectional imaging modalities are the soft tissue contrast resolution between the propria 
muscle layer of the rectum and the perirectal fat, the ability to visualise the different pelvic 
compartments including the visceral pelvic (mesorectal) fascia and the surrounding 
tissues in the pelvis. High resolution T2-weighted sequences sagittal, transaxial and 
perpendicular to the tumour is the basic standard for morphological evaluation of the 
tumour, the distance of the tumour to the anal verge and for evaluation of extramural 
extension and the distance to the circumferential resection margin. Presence of other 
adverse features such as extramural venous invasion and local lymph node metastases 
is also noted. The MR-images are ideally demonstrated by the radiologist in a local 
multidisciplinary conference to make sure that the information is used to select the best 
possible treatment for the patient. When neo-adjuvant treatment is administered, MRI 
is usually performed both before and after treatment to assess treatment response. 
When planning surgery, both the pre- as well as the post-treatment images should be 
available for surgical planning. Finally in this lecture, the potential benefits of 3 T com-
pared to 1.5 T for pre-operative imaging of rectal cancer as well as the present role of 
additional techniques, such as diffusion-weighted imaging (DWI) and specific contrast 
agents that have been evaluated for assessment of rectal cancer will be addressed. 
Learning Objectives:
1. To describe optimised MR techniques for rectal cancer staging.
2. To understand the role of the radiologist in the context of the multidisciplinary 
assessment and correct triaging of patients with rectal cancer.
3. To discuss the follow-up of patients post neoadjuvant chemoradiation.
4. To discuss the potential impact of modern MR imaging techniques in 
improving rectal cancer staging (3 Tesla, diffusion-weighted MR, USPIO-
enhanced MRI for lymph node imaging etc).
A‑479	 09:22 
C. Monitoring therapy and detection of local recurrence 
R.G.H. Beets-Tan; Maastricht/NL (r.beets.tan@mumc.nl) 
Locally recurrent rectal cancer is the main concern after rectal cancer surgery and 
has long been regarded as a rarely curable disease. Patients were treated palliatively, 
and subsequent median survival was 14 months and the 5-year survival rate was 5%. 
However, during the past 20-30 years, more patients were considered candidates for 
curative treatment due to better treatment options. Patients with distant recurrences 
from colorectal cancer, especially those in the liver or lung, have improved chances for 
cure with better imaging, better surgery and alternative minimal invasive treatment. In 
the follow-up after colorectal cancer surgery it is thus important to detect recurrences 
at an early stage. Besides CEA, imaging is often used as a surveillance tool. It is still 
unclear which is the most cost-efficient (imaging) tool for monitoring distant and local 
recurrences. This lecture aims at providing the evidence for surveillance by imaging 
and reviewing the guidelines for the detection of recurrences after colorectal cancer 
surgery. It will also discuss the role of MRI for establishing resectability of locally 
recurrent rectal cancer and the imaging patterns and features of recurrent disease. 
Learning Objectives:
1. To understand the evidence base for follow-up after treatment of primary 
rectal cancer.
2. To review the guidelines for imaging of local recurrence and distant disease.
3. To understand the patterns of recurrent disease.
Panel discussion: 
What are the clinicians really expecting from us: the main questions/
answers 09:44
The chairperson and speakers will discuss an integrated approach to the imaging of 
rectal cancer based on the range of currently available techniques and therapeutic 
options. The use of imaging in post treatment patients will be discussed along with 
the potential for MRI to triage and follow-up patients in whom surgery is withheld 
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08:30 - 10:00 Room I/K 
Cardiac 
RC 1503 
Imaging advanced stages of ischaemic heart 
disease 
Moderator: 
J.‑N. Dacher; Rouen/FR 
A‑484	 08:30 
A. CT: angiography, function and perfusion 
G. Feuchtner; Innsbruck/AT (Gudrun.Feuchtner@i‑med.ac.at) 
Multislice coronary computed tomography angiography (CTA) is an accurate tool in 
the non-invasive work-up of patients with suspected coronary artery disease (CAD). 
Its strength comprises a high sensitivity in detecting coronary stenosis > 50% and 
an excellent negative predictive value. The stringent limitation of CTA lies in its 
confinement to anatomic grading of coronary stenosis and a lack of information 
regarding whether a stenosis causes reversible myocardial ischaemia indicating 
the need for coronary revascularisation. Recently published data in animals and 
humans indicate that myocardial computed tomography perfusion (CTP) imaging 
is feasible, promising and accurate. The advantage of CTA is the comprehensive 
evaluation of coronary arteries and myocardial perfusion defects from the same 
datasets, which permits both visualisation of coronary anatomy and physiology. 
Further, CT provides information about regional and global myocardial function. The 
aim of this course is to understand basic principles of CT perfusion and functional 
imaging, to learn "how-to" perform CTP and comprehensive CTA/CTP scans, to 
review current scientific evidence and to discuss potential clinical applications. 
Learning Objectives:
1. To review the performance of CT in CAD.
2. To understand the role of functional assessment and how it can help in 
reaching the correct diagnosis.
3. To review the current data supporting the use of CTA perfusion.
A‑485	 09:00 
B. MR perfusion imaging: how much quantification do we need? 
L. Natale; Rome/IT (lnatale@rm.unicatt.it) 
Nuclear medicine tests (SPECT and PET), MRI and more recently MDCT have been 
involved in myocardial perfusion imaging. In clinical practice, perfusion analysis is 
routinely performed with qualitative or semiquantitative assessment, both based 
on relative evaluation of uptake or enhancement of myocardium, considering a 
remote region as normal. However, the assumption of part of myocardium as 
normal can be wrong and cause false negatives. Absolute quantification has been 
introduced mostly with PET perfusion imaging (water, ammonia and rubidium), 
but its incremental value for the clinical decision making has not been widely 
investigated. More recently, MR perfusion imaging has been used for quantitative 
analysis with different technical approach. There are some clinical scenarios where 
quantification can change the clinical interpretation: 1. multivessel coronary artery 
disease (CAD), 2. balanced multivessel CAD, 3. exclusion of CAD in symptomatic 
patients, 4. microvascular disease, 5. revascularised patients. However, there are 
still some limitations in the use of absolute quantification: first, the setting of cut-
off value for normal or abnormal perfusion; second, some clinical situations, such 
as heart failure patients, where perfusion is reduced and heterogeneous. Finally, 
studies concerning the prognostic value and the cost-effectiveness are needed. 
Learning Objectives:
1. To review the different quantification techniques and indices available.
2. To become familiar with the strengths and limitations of the various 
quantification techniques.
3. To understand the current and future role of MR perfusion imaging in risk 
stratification of patients with CAD.
A‑486	 09:30 
C. Imaging patients after bypass surgery 
K.-F. Kreitner; Mainz/DE (kreitner@radiologie.klinik.uni‑mainz.de) 
Besides drug therapy, the mainstays in the treatment of coronary heart disease 
(CHD) are interventional therapy and coronary bypass surgery. The need to image 
coronary bypass grafts is based on their limited lifetime: the occlusion rate at 10 
years ranges between 5 and 15% for arterial, and between 40 and 50% for venous 
A‑482	 08:58 
B. Non-neoplastic causes of epilepsy 
M.A. Papathanasiou; Athens/GR (matpapath@hotmail.com) 
Epilepsy is a common disorder with a prevalence of up to 1% in the general 
population. Epilepsies are broadly classified into generalized and focal. Though 
most generalised seizures are controlled pharmaceutically, 30% of focal seizures 
are medically intractable. In this subset of patients, the overall sensitivity of MRI 
in identifying responsible substrates is approximately 80%. The purpose of neu-
roimaging in epilepsy patients is to identify underlying structural abnormalities that 
require specific treatment (usually surgical) and to aid in formulating a syndromic 
or aetiologic diagnosis. In this presentation imaging findings of the most common 
non-neoplastic lesions responsible for focal epilepsy, namely: a. hippocampal 
sclerosis, b. malformations of cortical development, c. vascular abnormalities and 
e. gliosis, will be discussed along with their differential diagnosis and pertinent 
imaging pitfalls. Since routine MR imaging is suboptimal in identifying epileptogenic 
substrates, imaging should be tailored accordingly. Hippocampal sclerosis, the 
most common cause of mesial temporal lobe epilepsy, is best demonstrated when 
the temporal lobes are imaged with thin sections in coronal plane perpendicular 
to the longitudinal axis of the hippocampus. Inversion recovery sequences best 
demonstrate morphology and volume loss in the hippocampus, mammilary body 
and fornix. T2 and FLAIR images best demonstrate the increased signal due to 
gliosis. For malformations of cortical development FLAIR is useful in assessing 
hyperintense signal. T1 gradient volume sequences can demonstrate subtle devel-
opmental malformations. Finally, because many epileptogenic lesions are subtle 
and easily overlooked, a systematic diagnostic approach to MRI interpretation in 
the clinical setting of epilepsy is helpful and will be discussed. 
Learning Objectives:
1. To learn the characteristics of non-neoplastic causes of epilepsy.
2. To learn the characteristic neuroimaging findings that may be useful in 
establishing differential diagnoses.
3. To be aware of differences in diagnosis depending on age.
A‑483	 09:21 
C. Multimodality epilepsy protocol 
L. Stenberg; Lund/SE (lars.stenberg@med.lu.se) 
Epilepsy surgery is an effective and safe therapy for selected patients with intrac-
table localisation-related epilepsy. When morphological MRI fails to reveal focal, 
structural pathology (e.g. tumour, dysplasia, etc). as the putative aetiology for the 
seizures, other modalities may be taken into account. In the absence of structural 
pathology it is essential to identify the epileptogenic zone as exactly as possible 
in order to (a) increase the chance of a good outcome (reduction or termination of 
seizures) and (b) limit post-surgical sequelae. This lecture will cover some modali-
ties that may add valuable information in this process. The need to individualise the 
pre-surgical evaluation and the concept of a multimodality epilepsy protocol will be 
discussed. The main focus will be on SPECT (single-photon-emission computed 
tomography), functional MRI, PET (positron-emission tomography) and the added 
value of co-registration on morphological MRI (e.g. SISCOM). Briefly, ictal SPECT 
may help to identify focal areas of hyperperfusion (ictal zones). Functional MRI is 
used for several reasons. One is to determine language laterality (dominant hemi-
sphere); another is to localise eloquent cortical structures to aid the planning of the 
surgical approach. PET may detect hypometabolic areas corresponding to areas 
involved in epilepsy. MRS (magnetic resonance spectroscopy), MEG (magnetoen-
cephalography) and intradural EEG-registration and stimulation will be mentioned. 
Learning Objectives:
1. To understand which different modalities can be used in diagnosing epilepsy.
2. To learn the protocols of different modalities.
3. To consolidate the best neuroimaging protocols for evaluating different forms 
of epilepsy.
Panel discussion: 
Imaging epilepsy? 09:44
The term epilepsy covers a wide spectrum of symptoms and underlying etiologies. 
An essential part of the work-up of patients with epilepsy includes the radiological 
examination. In recent years more sophisticated methods radiological methods have 
emerged and the discussion will focus on how these new advanced techniques 
may help finding underlying causes and be of help in the pre-surgical work-up. 
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A‑489	 08:58 
Excellence in teleradiology: key issues in workflow management 
J. Schillebeeckx; Bonheiden/BE (jan.schillebeeckx@imelda.be) 
The healthcare market is undergoing significant change. The market is evolving from 
a provider centric to a patient centric model, requiring relevant data to converge at 
patient level in a timely and structured fashion. The push towards setting up col-
laborative networks for radiology is strong in most European countries. The most 
important challenge for teleradiology is to ensure that it develops in a manner that 
benefits patient care and ensures overall patient safety, and does not in any way 
reduce the quality of radiology services provided to the citizen. Therefore, these 
collaborative networks require more than just IT infrastructure with IT support. But 
as important is case management, workflow management and the administrative 
and management support that provides all the stakeholders with operational, 
analytical and statistical QA reports. Through a centrally operated hub, the radiol-
ogy workflow is optimised to ensure throughput of cases, involving radiologists in 
the network, with the difference that only the services are provided by the Hub to 
the network, not the medical acts, which remain in the hands of the radiologists. 
Learning Objectives:
1. To learn about the technical needs of a teleradiology infrastructure adapted 
to a distributed environment.
2. To understand that teleradiology involves much more than just technology. 
Optimising the workflow and time management are also important.
3. To appreciate how creating collaborative networks can improve the efficiency 
of radiology procedures and bring improved work/life balance to radiologists.
A‑490	 09:21 
Dedicated solutions for specific clinical scenarios 
H. Billing; Barcelona/ES (hb@telemedicineclinic.com) 
To make teleradiology an integrated part of clinical radiology, it must change from 
being a provider of radiology reports into a close collaboration with the client 
radiology department. There are many different aspects on workflow in a clinical 
setting and the teleradiology service should adapt to these specific needs in order 
to make a seamless collaboration. However, there are advantages with the global 
aspects of teleradiology that could improve diagnostic accuracy and efficiency in 
the clinical setting that should be woven into the collaboration. 
Learning Objectives:
1. To understand the need for close communication between remote radiologists 
and local clinicians. Different clinical scenarios need different solutions.
2. To be aware of the need for local adaptation of service vs. the advantages of 
global solutions.
3. To appreciate that there are specific workflow needs for different kinds of 
clinical work.
Panel discussion: 
To what extent has teleradiology demonstrated it can improve radiological 
services? 09:44
Teleradiology services have developed substantially over the last few years from limited 
use between hospitals and tertiary care centres for second opinions and patient transfer 
to the international provision of reporting services. There is no doubt that teleradiology 
provides a valuable service in some circumstances, but it also has a number of inherent 
limitations regarding the proper provision of imaging services to the patient and therefore 
may increase risks for the patient. We will highlight the problems that have arisen and 
reiterate key parts of the guidelines which were developed for the benefit of patient care. 
08:30 - 10:00 Room N/O 
Head and Neck 
RC 1508 
Common pains in the head and neck 
Moderator: 
K. Hrabák; Budapest/HU 
A‑491	 08:30 
A. Salivary colic 
T. Beale; London/UK (timothy.beale@royalfree.nhs.uk) 
This lecture will demonstrate a multimodality approach to the imaging of salivary 
colic. The relevant US and MRI salivary anatomy will be highlighted and the ultra-
sound, computed tomography and magnetic resonance appearances of salivary 
grafts. respectively. Graft sclerosis develops in 38% of nonoccluded venous bypass 
vessels after 5 years and in 75% after 10 years. This sclerosis causes more than 
50% luminal narrowing in approximately half of the affected vessels. Non-invasive 
imaging of coronary bypass grafts by MD-CT require information about the opera-
tive procedure. With the increasing implementation of 64slice CT scanners and 
beyond, it is possible to scan the heart and the full anatomic extent of grafts with 
sub-millimeter slice-thickness within a single breath-hold. When analysing the grafts, 
three graft segments should be assessed: the origin or proximal anastomosis, the 
body of the graft and the cardiac anastomosis, either single or sequential. Recent 
studies have shown that graft patency and the presence of significant graft stenosis 
can be assessed with an accuracy of 100% using most recent MD-CT technology 
(256/320 slice CT or dual source CT). The assessment of native coronaries with 
respect to the progression of CAD may still be problematic in cases with severe 
calcifications of the native coronary arteries. In these cases, MR perfusion imaging 
in combination with Cine and late gadolinium enhancement (LGE) imaging may 
be helpful in detecting newly developed, stress-induced myocardial ischaemia. 
Learning Objectives:
1. To review the indications of CTA for bypass graft assessment.
2. To understand the clinical impact of CTA in this subgroup of patients.
3. To elucidate possible indications for MR imaging in patients after bypass 
grafting.
08:30 - 10:00 Room L/M 
Professional Challenges Session 
PC 15 
Teleradiology: for better or for worse 
Moderator: 
L. Donoso; Barcelona/ES 
A‑487	 08:30 
Chairman’s introduction 
L. Donoso; Barcelona/ES (ldonoso@clinic.ub.es) 
Teleradiology services have developed substantially over the last few years from 
limited use between hospitals and tertiary care centres for second opinions and 
patient transfer to the international provision of reporting services There is no doubt 
that teleradiology provides a valuable service in some circumstances, but it also has 
a number of inherent limitations regarding the proper provision of imaging services 
to the patient and therefore may increase risks for the patient. We will highlight the 
problems that have arisen and to reiterate key parts of the guidelines which were 
developed for the benefit of patient care. 
Session Objectives:
1. To learn about the e-health regulatory initiatives at the European level.
2. To understand the importance of proper workflow management.
3. To become familiar with different scenarios in which teleradiology can be used.
4. To appreciate the implications for patient care of using teleradiology.
A‑488	 08:35 
Are we safeguarding patients’ rights? 
D. Caramella; Pisa/IT (davide.caramella@med.unipi.it) 
It is now well understood that teleradiology cannot be considered just as ‘telere-
porting’, i.e. the simple interpretations of images remotely acquired and sent as a 
message in the bottle. Teleradiology procedures, being medical acts, must ensure 
the full involvement of the interpreting radiologist in all phases of the well established 
practice of diagnostic imaging: appropriateness check, personalised acquisition 
protocols, access to clinical history and prior imaging examinations, communica-
tion with referring physician and patient. Any obstacle that teleradiology causes to 
these activities may put our patients at risk (and therefore may expose us at liability 
suits). The presentation will describe the organisational as well as technological 
remedies for reducing such risk. 
Learning Objectives:
1. To appreciate that radiological procedures are medical acts, not just 
reporting.
2. To understand the difference between locally delivered radiological services 
and teleradiology.
3. To recognise potential risks for the patients when using teleradiology.
4. To learn about the strategies for reducing such risks.
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08:30 - 10:00 Room P 
Physics in Radiology 
RC 1513 
Simulations make us understand x-ray imaging 
Moderators: 
K. Bacher; Gent/BE 
S. Barter; Cambridge/UK 
A‑494	 08:30 
A. Monte Carlo simulations of x-ray tubes and x-ray spectra 
M. Koutalonis; London/UK (Manthos.Koutalonis@bartsandthelondon.nhs.uk) 
For several decades, Monte Carlo simulation has been recognised as a powerful 
technique to simulate the transport of radiation in media, as well as to provide 
solutions for calculations too complex for classical approaches. Several general 
purpose codes and databases providing particle interaction cross-sections have 
been developed, and with the increase in computing power, simulation has become 
more and more popular within the field of medical imaging. Using Monte Carlo 
simulation methods, the different steps involved in the formation of a medical 
image can be analysed in detail, and the whole system optimised. A topic that 
has deserved particular attention in the past is the simulation of x-ray tubes and 
x-ray spectra, which is the first step in the simulation of a medical imaging system. 
When simulating an x-ray tube, various complex phenomena need to be taken into 
account, such as the electron multiple scattering, bremsstrahlung interactions, 
characteristic x-rays emitted from the K-shell and Auger electrons emitted during 
a photon interaction. Together with the simulation of the target material and the 
filtration of the x-ray beam through permanent (e.g. a Be window) and added 
filtration (e.g. Al, Mo, Rh, Ag, etc)., this technique can lead to a good estimation 
of the emitted x-ray spectrum, a task which is hard to achieve with experimental 
methods. This review will provide an overview of the basic knowledge necessary 
to start the simulation of an x-ray tube as well as of how to accelerate the calcula-
tions. Emphasis will be given to mammographic x-ray tubes. 
Learning Objectives:
1. To understand the basics of Monte Carlo simulations of x-ray tubes and 
x-ray spectra.
2. To learn why and how to start a Monte Carlo software platform.
3. To learn how to accelerate Monte Carlo calculations.
A‑495	 09:00 
B. Monte Carlo simulations of virtual patients (anthropomorphic 
phantoms) 
P.R. Bakic; Philadelphia, PA/US (Predrag.Bakic@uphs.upenn.edu) 
Breast cancer screening and diagnostic imaging, as all clinical imaging, are increas-
ingly multimodality. A number of new imaging modalities have been developed, 
including digital breast tomosynthesis and dedicated breast CT. They have shown 
promise in early studies; however, their technological complexity present obstacle 
for optimisation. The ultimate technology tests are clinical trials, which are, however, 
challenging, particularly for breast cancer screening, as large studies are needed 
due to the small number of detected lesions. Clinical trials are costly, long, and 
they involve repeated exposure of women to radiation. As an alternative, we have 
been developing virtual clinical trials, based upon our virtual breast phantoms and 
simulation of phantom images. This talk will describe the development of anthro-
pomorphic computer breast phantoms, and illustrate their use in the analysis of 
phantom digital mammography and digital breast tomosynthesis images. Different 
currently used phantom designs will be compared in terms of their flexibility and 
realism. Specific phantom requirements related to different imaging modalities will 
be emphasised. The role of phantoms in tissue-specific analysis of the radiation 
dose during mammography will be discussed. In addition to the anthropomorphic 
phantoms for breast imaging, the use of virtual patients in various clinical imaging 
disciplines will also be illustrated. 
Learning Objectives:
1. To learn about requirements for anthropomorphic phantoms (virtual 
patients).
2. To understand the value of anthropomorphic phantoms for breast imaging.
3. To compare advantages and disadvantages of several types of 
anthropomorphic phantoms.
4. To learn how to estimate typical patient doses from simulations with virtual 
phantoms.
colic will be shown and techniques for optimising the imaging of salivary colic given. 
The use of US, CT, MRI, and both MRI and conventional sialography in the imaging 
of salivary colic will be discussed. The role of interventional sialography and mini-
mally invasive techniques in benign salivary gland obstruction will be demonstrated. 
Learning Objectives:
1. To review the role of imaging in the evaluation of salivary colic.
2. To understand the advantages and limitations of the different available 
imaging techniques.
3. To become familiar with MR sialography technique and how it compares with 
conventional sialography.
4. To learn the indications and limitations of interventional sialography.
A‑492	 09:00 
B. Trigeminal neuralgia 
B.F. Schuknecht; Zurich/CH (image‑solution@ggaweb.ch) 
Trigeminal neuralgia is defined as recurrent episodes of lancinating pain most 
common in the second (V2) or third division (V3) of the trigeminal nerve. The 
pathogenesis is a neurovascular conflict by an artery or vein associated with focal 
demyelination of sensory fibers at the glia-Schwann cell junction. Apposition of 
demyelinated fibers induces abnormal generation and transmission of impulses. 
MR Imaging is based on high-resolution 3D sequences: CISS/Fiesta/3D T2Space 
with coronal and sagittal oblique MPR and a 3D TOF intracranial sequence with 
axial and coronal thin MIP reconstruction to delineate the course of vessels along 
the trigeminal nerve form the pons, and glia Schwann cell junction to the Gasse-
rian ganglion. The brainstem and brain are assessed by T2, Flair and 3D isotropic 
Gd-enhanced T1 sequences; the viscerocranium is examined by a noncontrast 
and coronal T1 Gd fat suppressed sequence. Analysis of images is focussed on 
recognition of displacement and distortion of the proximal trigeminal nerve by the 
SCA, rarely by the AICA, BA or petrosal, pontomesencephalic or peduncular vein. 
Correlation of the circumferential site of distortion at the root entry zone with the 
somatopic representation of fibres increases the, in general, low specificity of the 
neurovascular contact. Ruling our compressive tumours, neoplastic infiltration, 
inflammation or demyelination and delineating a neurovascular conflict stratifies 
patients for potential microvascular decompression in case of failure of medication. 
Learning Objectives:
1. To review the critical diagnostic criteria and pathophysiology of trigeminal 
neuralgia.
2. To learn how to tailor an MR imaging exam.
3. To become familiar with the most common causes.
4. To understand the value of imaging in patient management.
A‑493	 09:30 
C. Painful swallowing 
M. Becker; Geneva/CH (minerva.becker@hcuge.ch) 
The purpose of this lecture is to provide an overview of the key imaging features of 
painful swallowing with or without associated mucosal pathology. In the presence of 
a mucosal lesion, painful swallowing is most often caused by infectious, neoplastic 
or traumatic lesions of the pharynx itself, whereas in the absence of mucosal altera-
tions, painful swallowing is the result of functional disorders (dysfunction of the 
cricopharyngeus muscle), infectious, inflammatory or neoplastic diseases affecting 
adjacent neck spaces (retropharyngeal and paraphyrngeal space), neurologic 
impairment (glossopharyngeal neuralgia), carotidodynia and Eagle’s syndrome. 
The indications for CT, MRI, US and videofluoroscopy will be reviewed and their 
respective role in the detection and precise description of the underlying cause. 
Major emphasis will be put on how to report the findings in a comprehensive way. 
Learning Objectives:
1. To recognise the most common causes of painful swallowing in patients with 
a normal pharynx at clinical examination.
2. To review the role of different imaging techniques in the diagnosis and 
treatment of painful swallowing.
3. To review the key imaging techniques in the diagnosis and treatment of 
painful swallowing.
4. To review the key imaging features of the most common causes of painful 
swallowing as seen with the respective imaging techniques.
M
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The typical HRCT features of interstitial lung disease are ground-glass opacity, 
consolidation, pulmonary nodules, tree-in but sign, bronchiolar wall thickening, 
mucoid impaction, air trapping, septal thickening, mosaic perfusion and honey 
combing. Most frequent diseases in children to be dealt with are bronchiectasis, 
cystic fibrosis, asthma, constrictive bronchiolitis, bronchiolitis obliterans and extrinsic 
allergic alveolitis and they will be demonstrated with use of a systematic approach. 
Learning Objectives:
1. To understand the role of chest CT.
2. To learn about the typical CT findings of the interstitial lung disease.
3. To become familiar with the most frequent diseases and learn about a 
systematic approach.
A‑499	 09:30 
C. MRI of the chest in children 
M.U. Puderbach; Heidelberg/DE (m.puderbach@dkfz.de) 
Diseases of the respiratory system are of great importance in paediatrics. Early 
detection and follow-up of infectious, congenital and environmental diseases in 
young patients is crucial for adequate treatment and improved outcome. Here, 
imaging techniques play an indispensable role. In the past the interest was focused 
on morphological aspects of pulmonary tissue. Here, computed tomography (CT) 
serves as the gold standard. In the course of the development of MRI, MR imaging of 
the lung played a subordinate role. This was caused by several technical problems: 
1. low signal to noise ratio because of low proton density of the lung, 2. artefacts 
because of cardiac and breathing motion, 3. susceptibility artefacts because of air-
soft tissue transition. Despite these inherent difficulties of MRI of the lung, significant 
progress has been made recently. Although spatial resolution is lower than at CT, 
MRI allows for the visualisation of the lung parenchyma using ultra-short echo time 
(TE). Furthermore, MRI has the advantages to evaluate different tissue aspects 
(T1w, T2w, fat suppression) and to improve lesion characterisation. In addition, 
MRI is capable to assess lung function, e.g. perfusion, angiography, ventilation 
and respiratory mechanics. Using up to date scanner systems a complete study 
of the chest including morphological and functional imaging can be performed in 
less than 30 minutes. Especially diseases that go along with pulmonary structure 
augmentation and/or involve vascular structures can be studied by MRI. 
Learning Objectives:
1. To learn about MR techniques available for chest imaging in children.
2. To learn about specific clinical scenarios where MRI is helpful.
3. To understand the strengths and weaknesses of chest MRI with the help of 
case-based illustrations.
10:30 - 12:00 Room B 
Interactive Teaching Session 
E³ 1620 
Common radiological problems: cognitive decline 
and dementia 
A‑500	 10:30 
Common radiological problems: cognitive decline and dementia 
B. Gómez-Ansón1, F. Barkhof2; 1Barcelona/ES, 2Amsterdam/NL 
(bgomeza@santpau.cat) 
With advances in healthcare and age, the prevalence of dementia increases ex-
ponentially, with ~20% of subjects over 85 years becoming demented. While the 
guidelines differ by country, many recommend imaging at least once during the 
work-up of patients suspected of dementia. Beyond exclusion of surgically treatable 
disorders (e.g. tumour, subdural haematoma or hydrocephalus), imaging can now 
be used to positively determine the underlying disorder (e.g. hippocampal atrophy 
in Alzheimer‘s disease). While MRI is the modality of choice, multislice CT with 
multiplanar reformats provides a robust and quick alternative to assess general 
cortical atrophy, hippocampal atrophy and vascular pathology. SPECT and PET 
should be reserved for second line investigation, e.g. suspicion of frontotemporal 
lobar degeneration (FLTD) lacking characteristic atrophy on structural imaging. The 
advent of amyloid imaging using PIB-PET provides a future tool to secure a diag-
nosis of Alzheimer through molecular imaging, but its value over CSF examination 
needs to be determined. Increasing insights are being gained into the aetiology, 
clinical features and imaging findings in other neurodegenerative diseases, e.g. 
Lewy-body dementia. Structural imaging plays an essential role in establishing the 
diagnosis of vascular dementia (VaD), and cases of mixed dementia. Serial MRI is 
A‑496	 09:30 
C. Monte Carlo simulations of x-ray detectors and x-ray images 
K. Smans, H. Bosmans; Leuven/BE (kristien.smans@gmail.com) 
During the lecture we will present and validate methods to simulate radiographic 
images with the Monte Carlo software MCNP/MCNPX in a time efficient way. We 
will start the lecture by introducing three image detector models that can be used in 
MCNP/MCNPX. The first detector model that will be presented is the standard semi-
deterministic radiography tally, which has been used in previous image simulation 
studies. Furthermore, we will present two alternative stochastic detector models: a 
perfect energy integrating detector and a detector based on the energy absorbed 
in the detector material. The image detector models will be validated by compar-
ing calculated scatter-to-primary ratios (SPRs) with published and experimentally 
acquired SPR values. Subsequently, we will introduce a method to modify the im-
ages, generated with the MCNP/MCNPX image detector models, for the physical 
characteristics of a computed radiography (CR) imaging systems. The method 
presented in this lecture takes into account the signal intensity variations due to 
the heel effect along the anode-cathode axis, the spatial resolution characteristics 
of the imaging system and the various sources of image noise. To demonstrate 
the accuracy of our model we will compare the threshold-contrast detectability 
in simulated and experimentally acquired images of a contrast-detail phantom. 
Learning Objectives:
1. To learn basic methods for simulating imaging detectors.
2. To learn how to simulate x-ray images.
3. To learn how to validate Monte Carlo simulations of an x-ray imaging system.
08:30 - 10:00 Room Q 
Paediatric 
RC 1512 
Chest imaging: what to use and when to use it 
Moderator: 
M. Raissaki; Iraklion/GR 
A‑497	 08:30 
A. Thoracic trauma and foreign body inhalation 
M.L. Lobo; Lisbon/PT (mluisalobo@gmail.com) 
Thoracic trauma in children is most commonly seen in a polytrauma context, and 
is associated with significant morbidity and mortality. Blunt trauma accounts for the 
majority of cases, often resultant from motor vehicle accident and pedestrian crash. 
Common thoracic injuries include pulmonary contusion, rib fractures, pneumothorax 
and haemothorax. Diaphragmatic and mediastinal injuries, such as aortic rupture and 
tracheobrocheal tear, are rare but potentially life threatening. Different patterns of injury 
are seen in children due to anatomical and physiological differences, and these should 
be recognised. Chest radiography is the first and most important imaging modality. 
MDCT allows accurate diagnosis for most traumatic injuries, and is usually performed 
for severe chest and/or polytrauma. Adapted paediatric protocols are essential. Foreign 
body inhalation is a common paediatric domestic accident, with potential serious or even 
fatal consequences. Clinical history is the key for the diagnosis. With a definite history, 
bronchoscopy is the modality of choice for both diagnosis and treatment. However, in 
many cases the aspiration event is not witnessed and the diagnosis is often delayed 
or overlooked. The majority of aspirated foreign bodies are non-opaque and imaging 
findings largely result from complete or incomplete airway obstruction. Chest radiog-
raphy is the first imaging modality. Expiratory films (or lateral decubitus or fluoroscopy) 
are very useful to demonstrate air-trapping. Chest MDCT offer excellent details of the 
tracheobronchial tree and pulmonary parenchyma, and is usually reserved for more 
complex cases and/or long-standing foreign bodies. 
Learning Objectives:
1. To become familiar with lesions observed in thoracic trauma.
2. To learn about strategies for imaging.
3. To become familiar with the classical and atypical signs of foreign body 
inhalation.
A‑498	 09:00 
B. Infiltrative diseases of the chest 
G. Staatz; Mainz/DE (staatz@radiologie.klinik.uni‑mainz.de) 
High-resolution CT of the chest is the imaging technique of choice for the evaluation 
of most infiltrative diseases of the chest. In children dose-adapted protocols should 
be used and recommendations for suitable protocols will be given in the course. 
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A‑503	 14:45 
B. Mediastinal mass 
J. Vilar; Valencia/ES (vilarjlu@gmail.com) 
The mediastinum is a region of the thorax that separates both lungs and com-
municates with the neck and the abdomen. These two anatomic features are very 
important to understand the behaviour of some diseases and their radiological 
manifestations. Most asymptomatic mediastinal masses are benign, while clinical 
symptoms might raise the possibility of a malignant lesion. Imaging plays a very 
important role, especially CT and MRI. In the presence of a mediastinal mass we 
must ask ourselves two questions: 1. Where is the mass located? The classic 
divisions of the mediastinum in compartments remains very useful, because it 
narrows the differential diagnosis. 2. Is the lesion cystic or solid? Pure mediastinal 
cysts are benign and their characterisation depends on their location. Thymic cyst 
(anterior mediastinum), bronchogenic and duplication cysts (middle mediastinum) 
and menyngoceles (posterior mediastinum). Solid lesions may be benign or 
malignant while some lesions may have a cystic component. Solid lesions of the 
anterior mediastinum are usually thymomas, germ cell tumours or lymphomas. In 
the middle mediastinum most masses are of lymphatic origin but we should also 
include aortic or oesophageal pathology. Intrathoracic thyroid usually follows the 
trachea and thus is situated in the upper-middle mediastinum although posterior 
and anterior extensions may occur. In the posterior mediastinum most masses 
are of neural origin. There are some locations that will typically indicate specific 
diagnosis or a narrow differential. Such is the case of the cardiophrenic angle 
masses, juxtadiaphragmatic lesions and thoracic inlet pathology. 
Learning Objectives:
1. To learn how to detect and characterise a pulmonary nodule.
2. To learn how to detect and characterise a mediastinal mass.
3. To learn how to apply adequate protocols according to the clinical situation.
14:00 - 15:30 Room C 
Interactive Teaching Session 
E³ 1720b 
Colorectal cancer: what the radiologist must report 
A‑504	 14:00 
Colorectal cancer: what the radiologist must report 
R.G.H. Beets-Tan1, C. Hoeffel2; 1Maastricht/NL, 2Reims/FR 
(r.beets.tan@mumc.nl) 
Colorectal cancer is common. Approximately 280,000 new cases occur each year 
in the 500 million population of the 27 states which comprise the EU. After lung, 
it is the second commonest cause of cancer death resulting in approximately 
140,000 deaths per annum. These relatively high mortality figures are a reflection 
of the fact that the disease is often advanced at the time of presentation. Efforts to 
reduce mortality, therefore centre on early detection as well as accurate staging. 
The latter is particularly important in rectal cancer-the commonest site for colonic 
cancer. Detection depends on presentation, which is often protean or non-existent; 
hence, the introduction of screening programs. Typical diagnostic tools include the 
barium oenema, optical colonoscopy and CT colonography. The limitations of the 
barium enema have been exposed by optical colonoscopy and it can no longer be 
advocated in this role. CT colonography, however, rivals optical colonoscopy in the 
detection of polyps and tumours, although of course has no therapeutic potential. 
Major advances in the treatment of rectal cancer include total mesorectal excision 
(TME) of the rectum as well as neo-adjuvant therapies such as chemo-radiation. 
Their use depends on highly accurate staging of the primary disease, which can 
only be achieved by MR examination, although of course CT or PET/CT is required 
for the assessment of more distant metastatic disease. Finally, once treated, it is 
essential that these patients are followed-up; usually by a regime of colonoscopy 
and CT. These issues will be discussed in an interactive lecture. 
Learning Objectives:
1. To review the genetic and environmental factors predisposing to colorectal 
cancer and to consider the significance of colorectal cancer in overall health 
terms.
2. To understand the rationale of screening and to discuss the role of CT 
colonography and its relation to other screening tests such as FOB test and 
colonoscopy.
3. To learn the principles and rationale for accurate preoperative imaging of 
rectal cancer.
very sensitive to the degenerative process underlying neurodegenerative disorders, 
providing insights into their pathogenesis and offers a possibility to determine the 
effects of putative new treatments in randomised clinical trials. 
Learning Objectives:
1. To learn about the usefulness of imaging in patients with dementia.
2. To be able to approach conventional CT and MRI examinations for patients 
with cognitive decline and dementia.
3. To become familiar with the most common types of dementia and their 
characteristic imaging findings.
4. To appreciate the role of imaging in early diagnosis of dementia and in 
differentiating the vascular and neurodegenerative disease dementia.
5. To understand the indications for SPECT and PET in dementia.
12:30 - 13:30 Room Z 
The Beauty of Basic Knowledge: Interpretation of the Chest 
Radiograph 
MC 21E 
Decreased opacity of the lung(s) 
A‑501	 12:30 
Decreased opacity of the lung(s) 
J. Cáceres; Barcelona/ES (josecac@gmail.com) 
Decreased opacity of the lung may be a bilateral or unilateral process. If unilateral, it 
may involve an entire lung, a lobe or a segment. Faulty radiological technique must 
always be excluded. The most common cause of unilateral decreased opacity is a 
previous mastectomy. Bilateral decreased opacity occurs in COPD and asthma. It 
is also caused by decreased blood flow in the lung/s. Expiratory films separate the 
true lung causes from all the others, by demonstrating air trapping. 
Learning Objectives:
1. To learn useful signs to recognise emphysema.
2. To evaluate unilateral hyperlucent lung.
3. To evaluate localised areas of increased lucency.
14:00 - 15:30 Room B 
Interactive Teaching Session 
E³ 1720a 
Common radiological problems: incidental chest 
lesions 
A‑502	 14:00 
A. Solitary pulmonary nodule 
E. Castañer; Sabadell/ES (ecastaner@tauli.cat) 
Pulmonary nodules are spherical radiographic opacities (solid and subsolid) that 
measure up to 30 mm in diameter. Extremely common in clinical practice, pulmo-
nary nodules, especially small ones under 1 cm in diameter, are a challenge to 
manage. It is important to identify malignant nodules because they are potentially 
curable. The first step in assessing a pulmonary nodule on a chest radiograph 
is to determine that it is indeed a lung nodule rather than a pleural or chest wall 
abnormality. It is essential to review images from previous examinations, because 
a solid nodule that remains stable for at least 2 years is probably benign. Topics 
discussed in this talk include the importance of nodule size, growth rate, margin 
morphology, density (solid, ground-glass and part solid), calcifications or fatty com-
ponents within the nodules, the significance of cavitations or bubble-like densities, 
enhancement patterns at dynamic contrast-enhanced CT, and findings on positron 
emission tomography (PET). The talk also covers the current guidelines for the 
management of incidentally detected nodules (solid and subsolid). 
Learning Objectives:
1. To learn how to detect and characterise a pulmonary nodule.
2. To learn how to detect and characterise a mediastinal mass.
3. To learn how to apply adequate protocols according to the clinical situation.
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adenomatous polyposis with prior history of abdominal surgery is highly suggestive 
of mesenteric fibromatosis. 
Learning Objectives:
1. To review the imaging modalities used in the diagnosis of various solid 
peritoneal and mesenteric masses.
2. To learn about differential diagnostic clues.
3. To become familiar with radiological-pathologic correlations.
A‑507	 16:30 
B. Imaging of cystic mesenteric or omental masses 
C. Stoupis; Maennedorf/CH (c.stoupis@spitalmaennedorf.ch) 
This presentation has the purpose to familiarise radiologists with the spectrum of 
mesenteric and omental cystic masses, demonstrating the additional correlation 
with the underlying pathology. Cystic masses of the mesentery or omentum are not 
common lesions; however, radiologists should be aware of these entities as well 
as with other cystic lesion of the abdomen. Important tool for the diagnosis is to 
determine the organ from which the mass originates. Common types of mesenteric 
and cystic masses include lymphangioma, enteric duplication cyst, enteric cyst, 
mesothelial cyst and non-pancreatic pseudocyst. Other entities such as cystic 
mesothelioma, cystic spindle cell tumour and cystic teratoma could be located in 
the mesentery also. Due to the overlap in the imaging features, not always the final 
diagnosis could be reached by imaging only and therefore histologic examination 
is necessary to establish the diagnosis. However, it is important for the radiologist 
to define the cystic nature of the mass and demonstrate the potential mesenteric 
or omental origin, targeting to the correct differential diagnosis of the cystic lesion. 
Learning Objectives:
1. To review the imaging findings of cystic mesenteric or omental masses.
2. To learn to correlate imaging findings with the underlying pathology.
3. To appreciate the accuracy of imaging modalities and difficulties in 
differential diagnosis.
A‑508	 17:00 
C. Patterns of peritoneal carcinomatosis 
P.K. Prassopoulos; Alexandroupolis/GR (pprasopo@med.duth.gr) 
Cancer cells from intraabdominal neoplasms, carried by peritoneal fluid throughout 
the abdominal cavity, result in widespread metastases in the form of implants, the so-
called peritoneal carcinomatosis. The location of implants development is governed 
mostly by peritoneal fluid circulation and by specific anatomic pathways formed 
by peritoneal reflections. The most common sites where the peritoneal fluid may 
temporarily arrested facilitating implantation of cancer cells include cul-de-sac, distal 
small bowel mesentery, right paracolic gutter, posterior sub-hepatic space, greater 
omentum and sub-phrenic spaces. The role of imaging is to disclose the presence 
and extent of the disease - i.e. fundamental in candidates for cytoreductive sur-
gery - to monitor response to treatment and to reveal recurrences. MDCT with thin 
collimation and i.v. contrast material supplemented by multiplanar reconstructions 
is the primary imaging modality for the investigation of peritoneal carcinomatosis. 
Ascitis, contrast enhanced smooth, nodular, or plaque-like peritoneal thickening, 
peritoneal nodules, plaques or masses, rounded, ill-defined soft-tissue or cystic 
mesenteric masses, mesenteric fixation with increased attenuation values and 
thickening, irregular soft-tissue permeation of omental fat or confluent solid omental 
masses are the most frequent CT findings of peritoneal carcinomatosis. CT has a 
sensitivity and specificity between 85 and 95%, depending on the size/location of 
implants and examination protocol used. MR imaging employing a post- gadolin-
ium-enhanced 3d FLASH sequence with fat saturation may alternatively be used 
and it is advantageous in cases of diffused layered type of peritoneal/mesenteric 
involvement. Diffusion MRI may be of value in post-treatment imaging evaluation. 
Learning Objectives:
1. To learn about the various imaging findings of peritoneal carcinomatosis.
2. To learn about the accuracy of different imaging modalities in disease staging.
3. To appreciate the role of imaging techniques in the evaluation of response 
to treatment.
16:00 - 17:30 Room B 
Interactive Teaching Session 
E³ 1820 
Female pelvic infections: what the radiologist must 
report 
A‑505	 16:00 
Female pelvic infections: what the radiologist must report 
J.A. Spencer1, R. Forstner2; 1Leeds/UK, 2Salzburg/AT 
(johnaspencer50@hotmail.com) 
Most episodes of infection within the female pelvic organs are simply diagnosed on 
clinical grounds and resolve over time with or without antibiotic therapy. Infection 
which drains spontaneously usually resolves with these simple measures. Infection 
trapped within the female pelvic organs results in pyometra and/or tuboovarian 
abscess. These complications may require imaging. More severe infections may 
discharge internally with the development of a pelvic abscess or dissemination to 
the peritoneal cavity. Chronic infection may result in fibrosis with stricture forma-
tion in the female pelvic organs or the adjacent bowel, bladder and ureters. This 
involvement may result in lower GI or urinary tract symptoms. Other secondary 
effects include lymphadenopathy which can be cystic/necrotic and venous throm-
bosis with iliac and/or ascending ovarian vein thrombosis. Factors predisposing to 
complicated infection include: recurrent infections, previous surgery/radiotherapy, 
intrauterine devices, instrumentation, immunocompromise. US is the first line imag-
ing test, ideally from the transvaginal route. This may be poorly tolerated by women 
with severe infection/pelvic peritonitis. MR imaging is useful for sonographically 
indeterminate pelvic masses. Women with pelvic or generalised peritonitis may 
be suspected to have appendicitis or diverticulitis. Diagnosis may therefore arise 
from emergency CT. Both US and CT are used for aspiration or drainage of pelvic 
infections. A variety of endocavitary and percutaneous approaches are available. 
Learning Objectives:
1. To become familiar with the clinical spectrum of infection and inflammation of 
the female genital tract.
2. To understand their pathways of spread.
3. To recognise typical imaging findings of pelvic inflammatory disease and 
pelvic abscesses and the role of image-guided intervention.
4. To consider the appearances of unusual infections and the differential 
diagnosis of female pelvic infections.
16:00 - 17:30 Room C 
Abdominal and Gastrointestinal 
RC 1801 
Peritoneum and mesentery 
Moderator: 
F.‑T. Fork; Malmö/SE 
A‑506	 16:00 
A. Primary solid peritoneal and mesenteric tumours 
M. Zins; Paris/FR (mzins@hpsj.fr) 
Primary solid tumours of the peritoneum and mesentery occur much less frequently 
than metastatic disease in the same location. However, these rare primary neo-
plasms (peritoneal mesothelioma, primary peritoneal serous carcinoma, desmo-
plastic small round cell tumour, mesenchymal tumours, mesenteric fibromatosis 
or mesenteric desmoid tumour, mesenteric sarcoma, etc.) are often first detected 
at CT and should be considered in the absence of a known primary organ-based 
malignancy. CT appearance combined with patient's relevant clinical and demo-
graphic data can help narrow the differential diagnosis for a primary peritoneal or 
mesenteric tumour in many cases; Diffuse sheetlike thickening of the peritoneum 
and stellate appearance of the mesentery at CT or MRI are suggestive of primary 
malignant mesothelioma in older men with high level of asbestos exposure. Ab-
sence of an ovarian mass is mandatory in suggesting the diagnosis of primary 
peritoneal serous carcinoma in a post-menopausal woman. Desmoplastic small 
round cell tumour occurs in young men and often presents with a large primary 
peritoneal mass with calcification. A solid mesenteric mass at CT or MRI, regard-
less of its pre- and post-contrast appearance, occurring in a patient with familial 
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Learning Objectives:
1. To understand newer techniques with micro catheters, drug-eluting beads, 
rotational angiography and flat panel CT.
2. To understand the technique and results of TACE and RF ablation of 
colorectal metastases.
3. To understand the technique and results of interventional treatment of 
endocrine tumour metastases.
A‑511	 16:21 
Embolisation of HCC with drug eluting beads 
K. Malagari; Athens/GR (kmalag@otenet.gr) 
Drug eluting beads have proved predictable pharmacokinetics and achievement 
of higher doses of the chemotherapeutic, prolonged contact time with cancer cells. 
In addition, research data today have shown response, and tolerance benefit of 
drug eluting beads compared to conventional chemoembolisation for the more 
advanced subgroup of BCLC - class B patients. For diameters larger than 100 μm 
DC Bead loaded with doxorubicin have proven to be more effective with respect to 
local response, recurrence rates and time to progression (TTP) compared to bland 
embolisation with similar diameters. In this session results of studies on DC Bead 
loaded with doxorubicin for the treatment of HCC will be discussed, and guidelines 
for optimal clinical use will be presented. 
Learning Objectives:
1. To appreciate the difference between conventional TACE and TACE with 
drug eluting beads.
2. To understand the technique and experimental results.
3. To learn about the results of clinical trials in HCC.
A‑512	 16:39 
Selective internal radiotherapy 
J.I. Bilbao; Pamplona/ES (jibilbao@unav.es) 
Selective internal radiotherapy, also called radioembolisation (RE), consists in 
the delivery of beta-radiation to liver tumours using microspheres loaded with 
yttrium-90 (Y90) that are injected into the hepatic artery or its branches. Y90 is a 
pure beta-emitting radioisotope, with a limited tissue penetration (average: 2.5 mm 
and maximal: 11 mm) and a half life of 64 hours. Y90 can be either incorporated or 
labelled into glass or resin microspheres (25 µm). Once the particles are infused 
into the hepatic artery, they travel to the distal tumoural arterioles, from where the 
beta-emissions from the isotope irradiate the tumour. With traditional external beam 
radiation, doses are limited to 30-40 Gray (Gy) due to the risk of radiation-induced 
liver disease that may occur with higher doses. With RE, tumours can receive a 
higher dose of radiation due to their preferentially arterial vascularisation and a 
higher tolerance of the non-tumoural liver parenchyma to this form of radiation. 
RE has shown an encouraging antitumoural activity with a good safety profile in 
patients with hepatocellular carcinoma, even in the presence of portal vein throm-
bosis or invasion. Local tumour growth control is achieved in the majority of patients 
although response rates using volumetric criteria are achieved in only 20-40% of 
patients. In liver-predominant unresectable metastases, there is promising evidence 
that RE combined with systemic chemotherapy significantly extends the time to 
progression of liver metastases and increases objective response rates as well as 
enabling patients to receive systemic chemotherapy for a longer period of time. 
Learning Objectives:
1. To learn about the technique, legal and safety requirements in the cathlab.
2. To understand the diagnostic and interventional procedures before 
radioembolisation.
3. To learn about the results of clinical trials in HCC and liver metastases.
A‑513	 16:57 
Combined therapies before and after ablation 
R. Lencioni; Pisa/IT (lencioni@med.unipi.it) 
Image-guided RFA is currently established as the standard of care for patients 
with early-stage HCC when transplantation or resection is precluded. However, 
histologic data from liver specimens of patients who underwent RFA as bridge 
treatment for transplantation showed that the rate of complete tumour eradication 
is highly dependent on the size and the presence of large abutting vessels. Com-
bined percutaneous-transcatheter approaches that aim at increasing the ablation 
volume by minimising heat loss due to perfusion-mediated tissue cooling have 
been developed, using either a balloon catheter occlusion of the tumour arterial 
supply at the time of the RFA or by performing a prior TACE. Experimental stud-
ies in animal tumour models have shown that lowering the temperature threshold 
at which cell death occurs by combining sublethal heating with cell exposure to 
16:00 - 17:30 Room D1 
Special Focus Session 
SF 18a 
Transarterial treatment of liver tumours: major 
advances 
Moderator: 
J. Lammer; Vienna/AT 
A‑509	 16:00 
Chairman’s introduction 
J. Lammer; Vienna/AT (Johannes.Lammer@akhwien.at) 
Hepatocellular carcinoma (HCC) is an increasingly common tumour with a poor 
prognosis and limited systemic treatment options; approximately 80% of patients 
die within a year of the diagnosis. In men, it is the fifth most common cancer 
worldwide and the third leading cause of cancer-related death. The Barcelona 
Clinic Liver Cancer (BCLC) tumour staging is considered the most conceptually 
useful in HCC. It includes the clinical performance of the patient, the stage of the 
liver cirrhosis and of the tumour, and includes treatment options. In stage A (early 
stage) ablation therapy (radiofrequency, laser, cryotherapy and electroporation), 
liver resection and transplantation are the treatment options of choice. In stage B 
(intermediate stage) transarterial chemoembolisation (TACE, precision TACE with 
drug eluting beads) or radioembolisation with yttrium-90 microsphere brachytherapy 
are the treatment options. For stage C (advanced stage) systemic therapy with 
sorafenib is recommended. In patients with metastatic disease confined to the liver 
surgery is first choice treatment. However, if surgery is not indicated and systemic 
chemotherapy failed tumour ablation with radiofrequency, laser, cryotherapy and 
electroporation, TACE and radioembolisation are further treatment options. Tumours 
most commonly treated by ablation, TACE and radioembolisation are metastases 
of colorectal and breast cancer, melanoma of the skin and retina. The purpose 
of the special focus session is to highlight the treatment which can be offered by 
intervention radiology. 
Session Objectives:
1. To understand the treatment options.
2. To understand BCLC staging of HCC.
3. To review the accepted indications of TACE and tumour ablation.
A‑510	 16:03 
Advances in chemoembolisation of liver metastases 
M.A. Funovics; Vienna/AT (martin@funovics.com) 
Trans-arterial chemoembolisation takes advantage of the largely portal vascu-
larisation of liver tissue, while metastatic tissue is supplied almost exclusively 
by hepatic arteries. The benefit of intra-arterial application of chemotherapeutic 
drugs is proportional to the first pass extraction of the drug by the target tissue 
and inversely proportional to the body clearance of the drug. These figures vary 
greatly with different chemical properties of the drug. Intratumoural drug con-
centration after transarterial application (compared to intravenous application) is 
approximately 20x for THP-adriamycine, 5x - 10x for 5 FU, 6x - 8x for mitomycine, 
4x for cisplatin or oxaliplatin, and 2x for doxorubicin. Several trials support supe-
riority of intraarterial 5 FU over i.v. application in response rate, and partly with a 
moderate survival benefit. However, with the advent of novel chemotherapeutics 
(mainly oxalyplatin, irinotecan), response rates of i.v. chemotherapy approached 
the results after i.a. 5 FU. More recently, i.a. oxaliplatin has shown a 45% response 
rate in a multicenter trial on non-responders to i.v. oxalyplatin. Also, combinations 
of i.a. oxalyplatin and i.v. 5 FU and cetuximab have achieved promising response 
rates as first line therapy. Even though intraarterial chemoembolisation alone can 
achieve promising response rates, the actual survival benefits are limited to date. 
Also, the beneficial effect of additional embolization (over conventional arterial 
injection) remains largely unproven for a large number of different embolisation 
agents in hepatic metastases. In an attempt to further increase tumour uptake, 
chemotherapeutic agents (anthracyclines and irinotecan) have been electrostatically 
coupled to microspheres. Irinotecan-eluting microspheres have been untilized in 
the treatment of CRC metastases in smaller case series. Due to the high paren-
chymal drug uptake, appropriate medications to mitigate postembolization side 
effects need to be emphasised. While the initial response rates were over 60% 
(according to EASL), tumour progression was observed within 6 months in the 
majority of responders, suggesting potential stimulation of angiogenesis at the 
tumour boarders. Potentially, adjuvant antiangiogenic treatment can provide an 
overadditive effect in these patients. 
M
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Learning Objectives:
1. To become familiar with the basic principles of diagnosing bone tumours.
2. To learn how to determine the biological activity of bone neoplasms and 
tumour-like lesions on the basis of radiographic findings.
3. To understand the role of CT and MRI in the diagnosis of bone tumours.
4. To recognise imaging patterns on the basis of radiologic-pathologic 
correlation.
A‑516	 16:28 
B. Staging and intervention 
S. James; Birmingham/UK (steven.james@roh.nhs.uk) 
Primary bone tumours require both local staging and the identification of distant 
metastases to guide management. MR imaging is the modality of choice to 
determine local disease extent and allows excellent depiction of intra- and extra-
osseous disease. Chest CT enables pulmonary metastases to be identified and 
bone scintigraphy allows evaluation of the presence of bone metastases. The 
roles of whole body MRI and PET/CT in the staging of bone tumours will also be 
discussed. Whilst imaging may allow a narrow differential diagnosis to be reached, 
histological confirmation of the nature of the lesion is required pre-operatively to plan 
appropriate treatment. Image-guided biopsy may be performed using fluoroscopy, 
CT, MRI and occasionally ultrasound guidance. The relative values of each of these 
techniques will be covered. Percutaneous therapies are increasingly being utilised 
in the treatment of a number of primary bone tumours. Radiofrequency ablation 
is the method of choice for osteoid osteoma and is now used in the treatment 
of chondroblastoma. Alternatives include microwave therapy, cryotherapy and 
sclerotherapy. These percutaneous techniques may also be used for local disease 
control where disease recurrence is encountered. 
Learning Objectives:
1. To understand the role of radiographs, MRI, CT and bone scintigraphy in the 
staging of primary bone tumours.
2. To appreciate the principles and techniques of percutaneous bone biopsy.
3. To be aware of the indications, technique and outcome of percutaneous 
therapies in the treatment of bone tumours.
A‑517	 16:51 
C. New techniques (including DWI) 
S. Pans; Leuven/BE (Steven.Pans@uz.kuleuven.ac.be) 
Magnetic resonance imaging (MRI) has evolved to become the most important 
diagnostic method for local staging of primary bone tumours and for detecting 
postoperative tumour relapse. It allows accurate preoperative staging of local 
tumour extent and helps to obtain adequate safety margins. MRI is a noninvasive 
technique that can be used to obtain information regarding tumour vascularisation, 
metabolism, and pathophysiology, and allows early assessment of therapeutic 
effects of cancer drugs. One approach is dynamic contrast-enhanced (DCE) MRI, 
which measures tumour vascular characteristics after administration of a contrast 
medium. MRI enhanced with small-molecular-weight contrast agents is extensively 
used in the clinic to differentiate benign from malignant lesions, as well as to moni-
tor tumour microvascular characteristics during treatment. Diffusion-weighted MRI 
(DWI) is a more recent technique and it allows noninvasive characterisation of 
biologic tissues based on the random microscopic motion of water proton mea-
surement. Several studies have shown that DWI allows early detection of tumour 
response to chemotherapy. The use of water diffusion is a surrogate marker used 
to distinguish highly cellular regions of tumour from acellular and necrotic regions. 
Whole body diffusion-weighted sequence (WB DWI) is a new promising technique 
feasible to evaluate multifocal disease. DWI has revealed great potential in the 
evaluation of patients with cancer or benign disease, as it supplies both quantita-
tive and qualitative information of the whole body. This presentation will focus on 
the potential role of DWI in combination of DCE MRI in bone tumours as well as 
on the possibilities of WB DWI. 
Learning Objectives:
1. To learn about new techniques in the diagnosis and follow-up of bone 
tumours.
2. To appreciate the integration of DWI in whole-body MRI.
3. To become familiar with diffusion-weighted imaging in bone tumours.
Panel discussion: 
What is the clinical impact of advanced imaging, and when should what 
kind of advanced/sophisticated imaging be used? 17:14
In this integrated refresher course, the impact of basic and advanced imaging on 
the entire process, from diagnosis to treatment of bone tumours, will be addressed. 
Diagnosis is based on understanding the imaging features from a histopathologic 
chemotherapeutic agents is an attractive alternate strategy to increase tumour 
necrosis. The efficacy of a combination therapy, including RFA plus the intraarterial 
administration of drug-eluting beads has been recently demonstrated, while the 
use of intravenously administered, thermally sensitive drug carriers is currently 
being explored. Despite the advances in local treatment, the long-term outcome 
of treated patients remains unsatisfactory because new tumours emerge in about 
80% of the cases within 5 years. Clinical trials evaluating the usefulness of adjuvant 
molecular targeted therapies with anti-angiogenic and anti-proliferative activity in 
preventing early recurrence after successful ablation are ongoing. 
Learning Objectives:
1. To understand the pros and cons of TACE before and/or after tumour 
ablation.
2. To understand the technique of a combined approach.
3. To learn about indications and results.
Panel discussion: 
Which treatment option is the best for the various stages of 
disease? 17:15
In early HCC (BCLC A) tumour ablation is a curative treatment option. In intermedi-
ate stage HCC (BCLC B) TACE or radioembolisation are the treatment options. 
Interventional treatment of advanced HCC is under debate. Borderline cases 
should be discussed. In patients with liver metastases tumour ablation and TACE 
with drug eluting beads offer new options for patients after unsuccessful first line 
chemotherapy. The place of interventional therapy will be discussed. 
16:00 - 17:30 Room E1 
Musculoskeletal 
RC 1810 
Bone tumours 
Moderator 
J.L. Bloem; Leiden/NL 
A‑514	 16:00 
Chairman’s introduction 
J.L. Bloem; Leiden/NL (j.l.bloem@lumc.nl) 
In this integrated refresher course, the impact of basic and advanced imaging on 
the entire process from diagnosis to treatment of bone tumours will be addressed. 
Diagnosis is based on understanding the imaging features from a histopathologic 
perspective. Staging, biopsy and image-guided treatment require an integration of 
imaging findings with basic knowledge of surgical-oncological principles, as well 
as skills. Can technically driven development of advanced MR techniques change 
how we diagnose, monitor therapy and determine prognosis. Techniques and 
procedures that improve patient outcome in a cost-effective way will be identified 
based on 3 presentations and a panel discussion. 
A‑515	 16:05 
A. Diagnosis: from radiographs to MRI 
K. Wörtler; Munich/DE (woertler@roe.med.tum.de) 
The diagnosis of a bone tumour is based on clinical findings, the age of the patient, 
the location of the lesion, its radiologic appearance, and, if imaging does not al-
low for a specific diagnosis, its histopathologic features. Radiography remains the 
initial imaging modality for evaluation of the localisation of the lesion with respect 
to the longitudinal and axial planes of the involved bone, for the depiction of matrix 
mineralisations, and for estimation of biologic activity by analysing the patterns of 
bone destruction and periosteal response. CT can add „radiographic“ information 
particularly in regions of complex skeletal anatomy such as the spine, pelvis and 
shoulder girdle. MR imaging has classically been used to determine the local extent 
of a bone tumour (local staging). In addition to radiography and/or CT, it can at 
times also be valuable in establishing the differential diagnosis, especially in cystic 
bone lesions and cartilaginous tumours. Whole-body applications have recently 
gained importance in demonstrating the presence and extent of bone (marrow) 
involvement in benign and malignant systemic/polyostotic tumourous diseases. This 
course reviews the basic principles of diagnosing bone tumours in a multimodality 
approach (with an emphasis on conventional radiography). The different steps of 
morphologic analysis as well as the advantages and disadvantages of the individual 
imaging techniques are illustrated on the basis of pathologically confirmed cases. 
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review: (1) the biological rationale for using perfusion imaging in brain tumours, (2) 
methods available for the imaging of microvascular structure and function in brain 
tumours. We will discuss the relevant advantages and disadvantages of T1 versus 
T2 weighted acquisition strategies. (3) A detailed review of methods for dynamic 
contrast enhanced imaging and its analysis, (4) a review of current evidence for 
clinical application focusing on: (a) distinguishing abscess from tumour, (b) distin-
guishing tumour types, (c) distinguishing glioblastoma from solitary metastases, (d) 
predicting grade, histological subtype and prognosis in glioblastoma, (e) monitoring 
radiotherapy and predicting radiotherapy response, (f) applications in clinical trials 
of novel therapeutic agents, particularly antiangiogenic agents. 
Learning Objectives:
1. To understand the different methods available for perfusion imaging of brain 
tumours and their advantages and disadvantages.
2. To understand the clinical uses of perfusion imaging in neuro-oncology.
3. To understand the benefits of perfusion imaging in clinical trials of novel 
therapeutic agents.
4. To get an insight into the potential advances in perfusion imaging as they 
relate to neuro-oncology.
A‑521	 16:51 
Stroke and vascular diseases 
J. Vymazal, J. Keller, A. Rulseh, J. Tintera; Prague/CZ 
(Josef.Vymazal@homolka.cz) 
Early diagnosis and treatment of acute stroke is crucial for a favourable prognosis. 
While non-contrast MRI is much more sensitive to ischaemia in comparison with 
non-contrast CT, perfusion studies make both techniques comparable. Ultrafast CT 
scanners cover most of the brain with perfusion imaging; the scanning is faster and 
quality imaging results depend less on patient co-operation than in MRI. However, 
MRI enables diffusion imaging adding more specific information to the diagnostic 
process. Because of the short time window to eventual vascular intervention, in 
many institutions CT is the technique of choice. Besides depiction of hyperacute 
stroke by means of diffusion weighted imaging, MRI has the advantage of perform-
ing a contrast agent-free perfusion study using a promising new technique called 
arterial spin labelling (ASL). Thus, an MRI perfusion study can be performed even in 
patients with impaired renal functions where iodine and gadolinium-based contrast 
agents may be dangerous. 
Learning Objectives:
1. To understand the role of perfusion imaging in the management of acute 
stroke.
2. To be able to distinguish the advantages and disadvantages of CT vs MRI in 
perfusion imaging.
3. To develop insight into the use of non-contrast arterial spin labelling 
technique in vascular diseases.
Panel discussion: 
Guidelines, recommendations, hints and tips to get more from perfusion 
imaging in CNS pathologies 17:14
Perfusion imaging is an emerging non-invasive tool that enables evaluation of brain 
function via assessment of various hemodynamic measurements such as cerebral 
blood volume, cerebral blood flow, and mean transit time. These techniques have 
become important clinical tools in the diagnosis and treatment of patients with 
CNS disorders via evaluation of brain tissue during cerebrovascular diseases, non-
invasive histopathologic assessment of tumours, evaluation of neurodegenerative 
conditions and assessment of the effects of drugs. 
16:00 - 17:30 Room G/H 
Neuro 
RC 1811 
Spinal cord 
Moderator: 
M. Muto; Naples/IT 
A‑522	 16:00 
A. Myelitis vs myelopathy 
M. Gallucci; L’Aquila/IT (massimo.gallucci@cc.univaq.it) 
The term myelopathy indicates every generic form of pathological involvement of 
the spinal cord. Under this definition, even the category of myelitis is enclosed. 
Nonetheless, usually the term myelitis is restricted to inflammatory forms that 
involve a segmental extension of the spinal cord: the so-called “transverse myeli-
tis”. Symptoms are not specific for aetiology in most cases, and MRI is the most 
perspective. Staging, biopsy and image-guided treatment require an integration of 
imaging findings with basic knowledge of surgical-oncological principles, as well as 
skills. Techniques and procedures that improve patient outcome in a cost-effective 
way will be identified, based on three presentations and a panel discussion. Can 
technically-driven development of advanced MR techniques change how we 
diagnose and monitor therapy, and determine prognosis? 
16:00 - 17:30 Room F2 
Special Focus Session 
SF 18b 
Brain perfusion made easy: CT/MR? 
Moderator: 
E.T. Tali; Ankara/TR 
A‑518	 16:00 
Chairman’s introduction 
E.T. Tali; Ankara/TR (turgut.tali@gmail.com) 
Perfusion imaging is helpful to analyse and assist in judging the biological behaviour 
(especially haemodynamic features) of central nervous system diseases. Qualita-
tive and quantitative information can be obtained to evaluate pathoanatomical 
structures and pathophysiological changes of the lesions. Cerebral blood flow 
(CBF), cerebral blood volume (CBV), mean transient time (MTT), permeability 
surface (PS), regional blood volume, microvascular permeability measurements 
and more information can be obtained for the diagnosis and differential diagnosis 
of the diseases. Advantages and disadvantages of the CT perfusion imaging (CTP) 
and magnetic resonance perfusion imaging (MRP) in the different diseases will be 
evaluated in detail. Hints and tips for the better applications and postprocessing 
will also be discussed. 
Session Objectives:
1. To become familiar with perfusion imaging techniques.
2. To become familiar with the benefits of perfusion imaging.
3. To learn about the potential applications.
A‑519	 16:05 
Techniques for CT and MR, post-processing, radiation 
R.A. Meuli; Lausanne/CH (reto.meuli@chuv.ch) 
Brain perfusion can be assessed by CT and MR. For CT, two major techniques 
are used. First, Xenon CT is an equilibrium technique based on a freely diffusible 
tracer. First pass of iodinated contrast injected intravenously is a second method, 
more widely available. Both methods are proven to be robust and quantitative, 
thanks to the linear relationship between contrast concentration and x-ray attenu-
ation. For the CT methods, concern regarding x-ray doses delivered to the patients 
need to be addressed. MR is also able to assess brain perfusion using the first 
pass of gadolinium based contrast agent injected intravenously. This method has 
to be considered as a semi-quantitative because of the non linear relationship 
between contrast concentration and MR signal changes. Arterial spin labeling 
is another MR method assessing brain perfusion without injection of contrast. In 
such case, the blood flow in the carotids is magnetically labelled by an external 
radiofrequency pulse and observed during its first pass through the brain. Each 
of this various CT and MR techniques have advantages and limits that will be il-
lustrated and summarised. 
Learning Objectives:
1. To understand and compare the different techniques for brain perfusion 
imaging.
2. To learn about the methods of acquisition and post-processing of brain 
perfusion by first pass of contrast agent for CT and MR.
3. To learn about non contrast MR methods (arterial spin labelling).
A‑520	 16:28 
Brain tumours 
A. Jackson; Manchester/UK (Alan.Jackson@manchester.ac.uk) 
This presentation will discuss the current ‘state of the art’ in the use of perfusion 
imaging techniques in neuro-oncology. The term “perfusion imaging” is commonly 
used but is in fact a misnomer since perfusion and blood flow are not the only imag-
ing biomarkers of microvascular structure and function in common use. Indeed, in 
oncological applications measurements of proportional blood volume, endothelial 
capillary permeability or vessel size can be of equal or greater importance. We will 
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Learning Objectives:
1. To understand the pathophysiology of spinal vascular anomalies.
2. To learn the key imaging findings in different vascular diseases of the spinal 
cord.
3. To consolidate the best neuroimaging protocols and comprehend the 
concepts of CTA, MRA and angiography in evaluation of spinal vascular 
diseases.
16:00 - 17:30 Room I/K 
Chest 
RC 1804 
The new faces of pulmonary infection 
Moderator: 
B. Feragalli; Chieti/IT 
A‑525	 16:00 
A. Aspergillosis in the immunocompromised patient 
S.J. Copley; London/UK (suecopley@hotmail.com) 
Aspergillus is a genus of around 200 fungi (moulds) which are ubiquitous in the 
environment. The common species affecting humans are A. fumigatus, A. flavus, 
A. niger and A. terreus. Aspergillus fumigatus is exceptional among microorgan-
isms in being both a primary and opportunistic pathogen as well as a major al-
lergen. Reproduction is by spore formation which is prolific and therefore human 
respiratory tract exposure is almost constant. The spectrum of aspergillus infec-
tion includes aspergilloma (mycetoma), chronic pulmonary aspergillosis, chronic 
necrotising pulmonary aspergillosis (subacute invasive, chronic airway invasive), 
invasive pulmonary aspergillosis (angioinvasive, non-angioinvasive including acute 
tracheobronchitis, exudative bronchiolitis and bronchopneumonia), and allergic 
disease (allergic bronchopulmonary aspergillosis (ABPA) and bronchocentric 
granulomatosis). Immunocompromised individuals are particularly susceptible 
to invasive aspergillosis. The risk factors for invasive aspergillosis include: pro-
found neutropenia, haematopoietic stem cell transplant recipients, solid organ 
transplantation, potent immunosupressive therapy, prolonged corticosteroid use 
and AIDS. Invasive aspergillosis can be further subdivided into angioinvasive and 
non-angioinvasive forms. The imaging features of angioinvasive aspergillosis are 
characterised on CT by nodules with a ‘halo’ of surrounding ground glass opacity 
due to alveolar haemorrhage. In the context of neutrophil recovery, nodules may 
demonstrate cavitation. Airway invasive aspergillosis may manifest as areas of 
consolidation (bronchopneumonia), nodular ‘tree-in-bud’ densities on CT (exudative 
bronchiolitis), or an acute tracheobronchitis with large airway thickening. 
Learning Objectives:
1. To review the epidemiology and clinical settings of aspergillosis.
2. To understand the role of imaging in immunocompromised patients.
3. To understand radiological findings of pulmonary aspergillosis.
A‑526	 16:30 
B. The changing patterns of pulmonary tuberculosis 
W.F.M. De Wever; Leuven/BE (walter.dewever@uzleuven.be) 
Tuberculosis (TB) is an airborne infectious disease caused by Mycobacterium 
tuberculosis and is a major cause of morbidity and mortality. Worldwide, there were 
9.4 million new TB cases in 2008 and more than two billion people were infected 
with TB bacilli. The estimated global incidence rate fell to 139 cases per 100.000. 
Falling rates are stabilising in Europe. Tuberculosis is developing new faces due 
to changes in host cellular immunity, such as HIV infection, immunosuppressive 
therapy, malignancy and due to multi-drug resistance. Chest radiography plays a 
major role in screening, diagnosis, and response to treatment of patients with TB; 
however, radiographs may be normal or show only mild or nonspecific findings in 
active disease. CT and high-resolution CT (HRCT) are more sensitive than chest 
radiography in the detection and characterisation of parenchymal disease, small 
foci of cavitation, mediastinal lymphadenopathy, and pleural complications. Based 
on these findings, HRCT is useful in determining disease activity and plays also an 
important role in the management of TB. Radiological manifestations of primary 
tuberculosis are lymph node enlargement, airspace consolidation and pleural ef-
fusion. The most common findings of post-primary tuberculosis are centrilobular 
nodules, branching linear and nodular opacities, patchy or lobular areas of con-
solidation, and cavitation. Miliary tuberculosis results from acute haematogenous 
dissemination of TB bacilli in lungs and other organs and CT-findings consist of 
innumerable small nodules randomly distributed throughout both lungs. Airway 
tuberculosis is characterised by circumferential wall thickening and luminal nar-
rowing, with involvement of a long segment of the bronchi. 
sensitive diagnostic tool. Radiological semiotics are always useful and often very 
specific in addressing the diagnosis: some fundamental concepts include the 
peculiar pattern of vasogenic oedema, which, in opposition to what happens in 
the brain, tends to involve the central grey more than the peripheral white matter. 
Distribution pattern of the lesion can also often address to aetiological diagnosis. 
In fact, lesions selectively involving posterior or lateral columns, asymmetrically, 
and sparing the central grey matter, are more typical expression of demyelinating-
inflammatory diseases (multiple sclerosis, ADEM, Devic’s disease, LES, Behcet’s 
disease), while selective and symmetrical involvement of both posterior columns, 
extended for more than 2 myelomers, and possibly associated with involvement of 
lateral columns, is typical expression of combined sclerosis (B12 vitamin deficit). 
Ischaemic lesions are also usually symmetrical, but they involve both grey and 
white matter, extending to the anterior two-third of the cord, or, sometimes, remain 
limited to the central grey matter. On the other hand, selective involvement of the 
anterior horns is typical of poliomyelitis. 
Learning Objectives:
1. To learn to differentiate between myelitis and myelopathy.
2. To learn the imaging patterns of myelitis and myelopathy.
3. To consolidate knowledge of the best neuroimaging protocols for evaluating 
patients with suspected myelitis and myelopathy.
A‑523	 16:30 
B. Spinal intradural tumours 
J.W.M. Van Goethem, C. Venstermans, F. De Belder, L. van den Hauwe, 
P.M. Parizel; Antwerp/BE (johan.vangoethem@ua.ac.be) 
Spinal tumours are uncommon lesions and affect only a minority of the population. 
However, these lesions can cause significant morbidity in terms of limb dysfunc-
tion and can be associated with mortality as well. In establishing the differential 
diagnosis for a spinal lesion, location is the most important feature. MR imaging, 
which plays the central role in the imaging of spinal tumours, easily allows tumours 
to be classified as extradural, intradural-extramedullary or intramedullary. Although 
this classification is somewhat of an oversimplification, since lesions can reside 
in several compartments, it is very useful in tumour characterisation. In general, 
extradural lesions are the most common (60% of all spinal tumours), with the 
majority of lesions originating from the vertebrae. Intradural tumours are rare, 
and the majority is extramedullary (30% of all spinal tumours), with meningiomas, 
nerve sheath tumours (schwannomas and neurofibromas) and drop metastases 
being the most frequent. Intramedullary tumours are uncommon spinal tumours 
(10% of all spinal tumours), and occur most often in the cervical spinal cord. Astro-
cytomas and ependymomas comprise the majority of the intramedullary tumours, 
with ependymomas occurring with about double the frequency of astrocytomas. 
Learning Objectives:
1. To review the most common spinal cord tumours.
2. To learn the key imaging findings in different spinal cord neoplasm.
3. To understand how to create the optimal MR imaging protocol for 
preoperative planning of spinal cord tumours.
A‑524	 17:00 
C. Vascular disorders of the spinal cord 
R.J. Nijenhuis1, T. Krings2, M. Mull3, A.K. Thron3, J.T. Wilmink1, W.H. Backes1; 
1Maastricht/NL, 2Toronto, ON/CA, 3Aachen/DE (nijenhuis@rad.unimaas.nl) 
Vascular spinal cord malformations are rare entities with unspecific neurological 
presentations leading often to a late diagnosis. Delay in diagnosis can be hazardous 
to patient outcome as these abnormalities can lead to paraparesis if not treated 
properly. Apart from confirming the presence of a vascular spinal cord malforma-
tion, the lesion also has to be classified to a specific subtype as this determines 
the choice of therapy. The vascular spinal cord lesions can be differentiated in pial 
and dural arteriovenous shunting lesions depending on the vessels feeding the 
shunt. Pial arteriovenous malformations are supplied by arteries normally feed-
ing the neural tissue. Dural arteriovenous fistulae (DAVF) are the most common 
encountered vascular spinal cord lesions and are supplied by radiculomenigeal 
arteries. MRI is the modality that should be used first to identify the vascular lesion 
and rule out other potential differential diagnosis (e.g. tumour, ischaemia, myelitis 
and degenerative disease). When a vascular spinal cord malformation is suggested 
on MRI, catheter angiography has to be performed to classify the vascular lesion. 
Recently, non-invasive imaging techniques such as MR and CT angiography have 
be used to depict the origin level of the vascular lesion. Especially, for localising 
the level of a DAVF they have proven to have additional value in reducing catheter 
angiography examination time by guiding the interventionalist to a specific region. In 
most cases the treatment of vascular spinal cord malformations will be endovascular 
with a combined or surgical approach in selected cases. 
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A‑529	 16:05 
A. Expected changes after treatment 
R. Hermans; Leuven/BE (Robert.Hermans@uzleuven.be) 
Early stage head and neck cancer can be cured by surgery or radiotherapy. The 
choice depends on the functional and cosmetic result to be expected, tumour histol-
ogy, patient’s condition and preference, and institutional policy. In advanced lesions, 
nowadays concomitant chemoradiotherapy is offered, with surgery reserved for 
salvage. A relatively high locoregional control rate can be obtained, at the expense 
of acute and late toxic side effects, and a higher incidence of treatment complica-
tions. On post-therapeutic imaging studies, treatment-induced tissue changes are 
often visible; these changes should not be misinterpreted as evidence of persis-
tent or recurrent tumour, or treatment complication. After radiotherapy, the visible 
changes depend on the radiation dose and rate, the irradiated tissue volume, and 
the time elapsed since the end of treatment. Basically, thickening of the laryngeal 
and pharyngeal walls, increased attenuation of fat planes, postirradiation sialad-
enitis, lymphatic tissue atrophy, and retropharyngeal oedema will be seen. These 
irradiation-induced tissue changes usually appear symmetrical. The acute effects 
of radiotherapy occur during or immediately after treatment, and usually settle 
spontaneously. Complications of radiotherapy are usually seen months to years 
after the end of treatment. The limits of surgery are determined by safeguarding 
critical functions and maintaining a cosmetically acceptable appearance. Exten-
sive resections are possible by the use of various reconstructive materials. Most 
surgical complications occur early after treatment, and are dealt with on a clinical 
basis. Imaging may be required, for example, in case of a postoperative collection, 
for fistula detection and follow-up, or to confirm flap failure because of necrosis. 
Learning Objectives:
1. To learn about the current treatment options in head and neck cancer.
2. To understand the expected tissue changes on imaging studies after 
radiotherapy for head and neck cancer.
3. To appreciate the expected imaging findings after surgery for head and neck 
cancer.
A‑530	 16:28 
B. Surveillance imaging, tumour recurrence and treatment complications 
A.D. King; Hong Kong/CN (king2015@cuhk.edu.hk) 
There is no clear consensus regarding optimal time points for surveillance, but 
clinical assessments are more frequent in year 1 and are performed over at 
least 2-3 years, during which time most locoregional failures and second primary 
tumours are detected. Ideally for imaging surveillance at least one post-treatment 
baseline head and neck scan (MRI/CT) should be performed at 3-6 months, and 
often closer surveillance is desirable. Candidates for salvage surgery after (chemo)
radiotherapy undergo a post-treatment scan at 6-8 weeks, followed by regular 
scans (4-6 months in year 1; 6-12 months thereafter, the exact time period being 
tailored to the patient). A residual mass after (chemo)radiotherapy may be caused 
by cancer, benign treatment mass (BTM), or both. In the later post-treatment period 
residual/recurrent cancer (homogeneous moderately contrast-enhancing expansile 
mass of intermediate T2 signal) can be distinguished from a BTM (retracted/straight 
edged non-enhancing fibrotic scar tissue of low T1 and T2 signal). Earlier stages are 
more problematic when both cancer and BTMs form expansile masses of marked/
moderate contrast-enhancement and high/ moderate T2 signal. This limitation 
has focused attention on functional imaging techniques. 18 F FDG-PET has a high 
negative predictive value for cancer at ≥ 3 months. Functional MR techniques are 
showing promise for even earlier post-treatment assessment using DWI, MRS 
and DCE. The delayed effects of treatment cause a wide range of complications. 
Osteoradionecrosis, chondronecrosis, muscle denervation, inflammatory polyps 
and radiation-induced tumours may to be mistaken for tumour recurrence. Features 
of these treatment-induced complications will be illustrated. 
Learning Objectives:
1. To become familiar with the ideal time points for follow-up.
2. To become familiar with morphological and functional changes occurring 
with tumour recurrence.
3. To understand treatment complications and to differentiate them from tumour 
recurrence.
A‑531	 16:51 
C. Predicting outcome after radiation therapy in head and neck cancer: 
what is evidence-based? 
R. Maroldi; Brescia/IT (maroldi@med.unibs.it) 
The most recent advances of radiotherapy techniques are characterised by the 
increased precision with which the radiation energy is released to the target, the 
reduced collateral damage to adjacent non-neoplastic tissues, and the synergic 
Learning Objectives:
1. To review the current demographics of pulmonary tuberculosis in Europe.
2. To understand the role of imaging in patients with tuberculosis.
3. To understand radiological findings of pulmonary tuberculosis.
A‑527	 17:00 
C. Emerging viral infections 
C.J. Herold; Vienna/AT (Christian.Herold@meduniwien.ac.at) 
Viral agents are part of the spectrum of organisms which cause community acquired 
pneumonias. Furthermore, they are thought to function as a trigger for bacterial 
infections in the hospital or health care setting. In addition, viruses play a significant 
role as causative agents for infections in the immunocompromized host. Within 
the last years, outbreaks of viral infections have challenged regional, national and 
even global health care systems, have effected thousands of individuals and have 
resulted in significant morbidity and mortality. Most of the involved viral agents 
represented emerging organisms with an unpredictable impact on individual and 
society health. The radiologic community has learned several lessons from the 
documented outbreaks, and radiologists around the world have contributed to the 
early diagnosis of the disease, the monitoring of its course, and the documenta-
tion of complications as well as of response to therapy. Thus, imaging plays an 
important role in the diagnosis and management of these patients. In this course, 
epidemiologic aspects, patho-physiology and clinical features of emerging viral 
infections will be presented. In addition, their radiologic features and the role of 
radiology in diagnosis and management will be discussed. Attendees will learn how 
to understand, recognize, report and follow patients with emerging viral infections. 
Learning Objectives:
1. To review the epidemiology and etiology of viral infections.
2. To become familiar with radiological patterns of different viral pneumonias 
and pulmonary infections.
3. To understand the role of imaging in patients suspected of having viral 
infections.
16:00 - 17:30 Room N/O 
Head and Neck 
RC 1808 
Management of the post-treatment head and neck: a 
diagnostic dilemma 
Moderator:
R. Maroldi; Brescia/IT 
A‑528	 16:00 
Chairman’s introduction 
R. Maroldi; Brescia/IT (maroldi@med.unibs.it) 
Major changes in the treatment of head and neck neoplasms encompass the 
advances of endoscopic-based surgical techniques, mainly for nasosinusal and 
laryngeal tumours, and the application of sophisticated radiation therapy techniques, 
combined with chemotherapy. As most tumours arise from the mucosa of the upper 
aero-digestive tract, clinical surveillance is necessary to detect superficial recur-
rences, while morphological and ‘functional’ imaging techniques are indispensable 
to detect subclinical extra-mucosal and nodal recurrences. How can imaging 
techniques discriminate recurrence, inflammation, necrosis or scar? Key points 
include the knowledge of the normal appearance of tissues (morphology and sig-
nals) on CT, MRI, and PET-CT after surgery and chemo-radiotherapy. Specifically, 
when non-surgical treatment has been used, that means to become familiar with 
the expected changes both of tumour and adjacent tissues. Morphology-based 
imaging techniques are often inadequate to discriminate small recurrences from 
vascularised scar tissue (enhancing). CT or MRI do require to be integrated by 
information provided by functional-based imaging techniques, FDG-PET-CT being 
the most established. Recently, a great interest among radiologists is focused on 
the application of DCE-CT or DCE-MRI and DWI-MRI in the follow-up of head and 
neck neoplasms. In fact, several studies have credited these techniques for provid-
ing functional information about tissues (perfusion, water exchange) that help to 
discriminate scar from recurrences. Obviously, the horizon pursued is to combine 
morphology and functional data in a single examination. Though clearly promising, 
these new techniques share significant limitations, like the reproducibility of CT and 
MR-based functional results, their introduction and feasibility in the day practice. 
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A‑533	 16:30 
B. Dual energy CT and time resolved CT 
K. Nikolaou; Munich/DE (konstantin.nikolaou@med.uni‑muenchen.de) 
Today, CT angiography (CTA) is considered as a safe, non-invasive and well-
established procedure for vascular imaging. Modern multi-slice CT technology 
allows for coverage of larger vascular territories - even the whole body - in just 
several seconds. Further technical improvements such as wide detectors of up 
to 16 cm width or moving table techniques are making new applications possible, 
such as perfusion imaging, or time-resolved CT angiography. Especially with the 
moving table technique (the so-called „shuttle-mode“), vascular territories of up to 
50 cm can be covered in a dynamic fashion, which can be helpful in the diagnosis 
of aortic dissections or peripheral vascular occlusive disease. On the other side, 
radiation exposure has to be maintained within a reasonable range applying these 
repeated acquisition modes. Another interesting field opening new options in CTA 
is dual energy CT (DECT). A number of technical setups may allow for spectral 
CT imaging, such as systems with two tubes (dual source CT), CT systems with 
switching kV modes or with special detectors. In vascular applications, DECT is 
especially helpful for automated bone removal, plaque removal, and potentially 
for „perfusion“ imaging (iodine mapping). In this course, the basics of modern CT 
angiography will be highlighted, with a special focus on new applications such as 
time-resolved CTA and dual energy CTA. 
Learning Objectives:
1. To learn the basic principles of dual energy CT and time resolved CT and its 
advantages for vascular imaging.
2. To review imaging protocols, results and radiation exposure aspects.
3. To learn about future developments and advantages in comparison with 
MRA.
A‑534	 17:00 
C. Flat panel CT (C-arm CT) 
H. Rousseau; Toulouse/FR (rousseau.h@chu‑toulouse.fr) 
Angio-3D with digital flat-panel detector has recently been adapted for use with 
C-arm systems and provides a higher detector quantum efficiency (DQE) than 
conventional detectors based on II camera. This configuration represents the next 
generation of imaging technology available in the interventional radiology suite and 
is predicted to be the platform for many of the three-dimensional (3D) roadmapping 
and navigational tools that will emerge in parallel with its integration. It provides 
projection radiography, fluoroscopy, digital subtraction angiography, and volumetric 
computed tomography (CT) capabilities with the ability for immediate multiplanar 
post-treatment assessment in a single patient setup, within the interventional suite. 
Such capabilities allow the interventionalist to perform intraprocedural volumetric 
imaging without the need for patient transportation. The clinical benefits of 2D an-
giography with these new systems have been assessed in the fields of cardiology 
and interventional radiology. These key features alone may translate to a reduction 
in the use of iodinated contrast media, a decrease in the radiation dose to the pa-
tient and operator, and an increase in the safety and performance of interventional 
procedures. Proper use of this new technology requires an understanding of both 
its capabilities and limitations. This article provides an overview of the potential 
of this new technology. 
Learning Objectives:
1. To learn the basic principles of flat panel CT.
2. To review imaging protocols, results and radiation exposure aspects.
3. To become familiar with the most common applications.
effect of chemo-radiotherapy. As the treatment planning becomes progressively 
‘tailored’, strong predictive factors for the individual tumour arising in a specific 
patient have to be identified. These factors would ideally provide a quantitative 
assessment of the risks of both relapsing (in the primary, nodal or distant sites) 
and developing treatment-related (early or late) complications. Predictors are 
related to tumour’s characteristics (biology, metabolism, site, volume and spread) 
and to patient’s overall clinical conditions. Imaging-based predictive factors have 
been founded upon morphological findings (2D, volume) until the development 
of new techniques, which analyse ‘functional’ parameters like FDG-PET-CT, the 
most established, and perfusion-CT or DWI-MRI. Evidence of level A has been 
provided on the impact of negative predictive value of FDG-PET-CT in ruling out 
residual disease, whilst there is no clear data regarding the role of pre-treatment 
intensity of glucose metabolism (SUV) in predicting the outcome after radiotherapy. 
This limitation can be addressed to the enrolment of tumours arising in various 
sites in the head and neck. A major disadvantage common not only in PET stud-
ies but also in most DCE and DWI-MRI studies. Perfusion-CT and DWI-MR are 
promising techniques, as they provide information about neo-angiogenesis and 
water-flow in submicroscopic tissue compartments. However, these techniques 
still require randomised trials and confirmation studies about the reproducibility 
of their interesting results. 
Learning Objectives:
1. To become familiar with the prognostic significance of MR imaging-
determined tumour parameters.
2. To become familiar with the prognostic significance of CT imaging-
determined tumour parameters.
3. To discuss what is evidence-based, including future perspectives.
Panel discussion: 
Recurrence, inflammation, necrosis or scar: is imaging useful? 17:14
In the follow-up after minimal invasive surgical techniques or chemo-radiation, a 
major limitation of standard morphological imaging is the differentiation of the highly 
vascularised scar tissue (enhancing, with mass effect) from persistent or recurrent 
neoplasm. Is it time for integrating standard imaging with the functional information 
provided by DWI and/or CT or MR perfusion techniques? Which evidence level are 
we at presently? Is it now feasible in daily practice? 
16:00 - 17:30 Room P 
Vascular 
RC 1815 
Advances in vascular imaging 
Moderator: 
P.M.T. Pattynama; Gouda/NL 
A‑532	 16:00 
A. Vascular imaging at 3 T 
H. Hoppe; Berne/CH (hanno.hoppe@web.de) 
Three-Tesla MRI scanners offer an increased signal and contrast for MR-angi-
ography (MRA) compared to 1.5-Tesla machines. MRA can be performed within 
a shorter time enabling the acquisition of temporally resolved three-dimensional 
datasets with high spatial resolution. Due to high signal and contrast the dose 
of gadolinium may be reduced. Furthermore, novel imaging protocols for MRA 
at 3.0-Tesla with intravasal contrast agents and prolonged enhancement during 
high-spatial-resolution steady-state enable new possibilities for angiography of 
the upper and lower extremities including veins and vessels below the knee, spi-
nal arteries, vascular malformations, and double-gated angiography of coronary 
arteries and bypass vessels to compensate for the complex cardiac motion pat-
tern. A 3.0-Tesla MRI system equipped with a matrix coil system allows for whole 
body MRA with continuous table movement, which is an applicable technique for 
imaging peripheral vessels without the need for planning different steps and field 
of view positioning, thereby considerably reducing the examination time. Phase 
contrast magnetic resonance angiography may develop into an important, non-
invasive method for obtaining quantitative information on blood flow. In addition, 
non-enhanced three-dimensional MR angiography using turbo spin echo (TSE) 
imaging with non-selective refocusing pulses may be a promising imaging technique 
for vascular imaging in patients with renal insufficiency. 
Learning Objectives:
1. To learn the major advantages of vascular imaging at 3 T.
2. To become familiar with imaging protocols for vascular imaging.
3. To learn about future developments.
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A‑537	 16:28 
B. Intraoperative imaging for surgeons 
A. Pietrabissa; Pisa/IT (andrea.pietrabissa@gmail.com) 
The advent of minimally invasive surgery has made even more important the 
place of preoperative imaging assessment of patients selected for this type of 
surgery. In fact, the loss of tactile feed-back and the bi-dimensional intraopera-
tive vision have limited the capability of surgeons to assess extent and anatomic 
relationship of a given disease, particularly cancer. Preoperative planning can be 
further enhanced by the use of 3D models of the target anatomy, derived from CT 
scan dataset. In addition, dedicated technology can be implemented to introduce 
mixed reality environments in the operative room. Using 3D helmets with built-in 
microcameras, the surgeons’ view of the operative field can be fused with the 
preoperative 3D anatomy of the patient. Localiser should be used, either infrared 
based or electromagnetic. The last step would be intraoperative navigation. This 
offers special problems to be addressed, due to organ shifting and soft tissue in 
the setting of abdominal surgery. 
Learning Objectives:
1. To understand why surgeons will need more intraoperative guidance.
2. To learn about the role of robotics and augmented reality for the general 
surgeon.
3. To become familiar with patient-specific simulation.
4. To appreciate the place of surgical training and credentialing.
A‑538	 16:51 
C. Images and models for CAS 
H.U. Lemke; Berlin/DE (hulemke@cars‑int.org) 
The appropriate use of information and communication technology (ICT) and as-
sociated systems is considered by many experts as a significant contribution to 
improve workflow and quality of care in clinical settings. A conceptual design and 
prototypical implementation of such an infrastructure, i.e. a therapy Imaging and 
model management system (TIMMS) will be introduced as a solution to a patient-
specific medicine. A TIMMS is an information technology concept and framework 
for the collection, organisation, and utilisation of medical information from sources 
such as the electronic medical record, PACS, etc. TIMMS was originally designed 
as a surgical assist system, but has many general medical uses as well, including 
all forms of model-guided medicine and may therefore be generalised to a medi-
cal information and model management system. The architectural framework and 
a number of individual ICT components of a TIMMS have been realised. These 
include standardised interfaces for communication of patient-specific and workflow 
models, thereby creating a unified environment for the input and output of data, 
including the representation and display of information and images, as well as the 
electromechanical control of interventional and navigational devices. In conclu-
sion, the patient-specific model (PSM) is the central construct for a patient within 
a personalised medicine environment in order to provide a clinician with a real-time 
representation of critical information about the patient. The required information 
concerning the patient for model-guided therapy is extracted by TIMMS agents 
and assembled within the framework of an active PSM and workflow manage-
ment system. 
Learning Objectives:
1. To become familiar with the problem of integration of image information for 
knowledge models of patients.
2. To become familiar with the concept of ‘from image-guided to model-guided 
surgery’.
3. To learn about selected examples from ENT, neuro- and cardiovascular 
surgery.
4. To learn about IT infrastructures and standards for enabling image-guided 
and model-guided surgery.
Panel discussion: 
The take-home points 17:14
1. Image sharing in teleradiology
2. Surgical workflow
3. Image and model-guided surgery
4. Patient-specific model 
16:00 - 17:30 Room Q 
Computer Applications 
RC 1805 
Image sharing 
Moderator: 
D. Caramella; Pisa/IT 
A‑535	 16:00 
Chairman’s introduction 
D. Caramella; Pisa/IT 
The introduction of picture archiving and communication systems (PACS), through a 
much more effective image sharing, has dramatically changed the role of radiology 
both within the hospital and on a geographic perspective. Historically, the latter has 
become apparent first with the early implementation of teleradiology applications. 
Physicians and the general public have understood that digital images can be read, 
processed, and stored independently on the site of production. Therefore, telecon-
sultation and telereporting activities have been carried out among medical users, and 
generic users have learnt to include radiological images in their own on-line personal 
health records. Only later the full potentialities of multidisciplinary image sharing 
within the hospital have been discovered, and now it is increasingly common to see 
advanced integration between radiologists and surgeons for planning and guiding 
surgical interventions. During this session, the lecturers - exceptionally expert in 
their respective fields - will give insights into image sharing: from the geographical 
applications (teleradiology) to the hospital-based applications, with specific reference 
to the support to surgeons (intraoperative guidance and model-guided surgery). 
Session Objectives:
1. To become familiar with models of PACS and imaging networks.
2. To understand the evolution of teleradiology.
3. To understand the utilisation of general public communication tools.
A‑536	 16:05 
A. Image data beyond radiology: new techniques 
F.H. Barneveld Binkhuysen1, E.R. Ranschaert2; 1Soest/NL, 
2’s‑Hertogenbosch/NL (ranschaert@telenet.be) 
Medical imaging is part of a changing medical environment, a changing patient envi-
ronment and consequently a new medical world. In the recent decennium one of the 
most important changes in radiology is the conversion from analogue to digital. In no 
time medical images have become interchangeable through the digital highway and 
could be post-processed in a different location. Teleradiology has become a reality 
since then. We have seen the maturation of commercial international teleradiology 
companies offering a wide portfolio of services. Another aspect is the availability 
of image data for all medical specialties beyond radiology and beyond the regular 
medical disciplines. An increasing number of surgical or oncological specialties and 
even pharmaceutical companies increasingly use image data to prepare a strategy 
for operative procedures, to choose the right therapy, to decide which prosthesis to 
the best to use, for follow-up or for post-processing purposes. They are supported 
by many new techniques and software. An increasing number of medical computer 
applications such as complex navigation and visualisation tools based upon digital 
images is already in clinical use or under development. Another trend is the increasing 
interest in E-health and telemedicine in Europe, also among European policy makers. 
Now we see mobile health that brings care directly into the patient environment. The 
purpose of this presentation is to give a comprehensive overview of and insight into 
these new developments and to create awareness among radiologists of the increas-
ing importance of integration of medical imaging in a multidisciplinary environment. 
Learning Objectives:
1. To review remote consultation.
2. To review second/expert reading.
3. To understand image data beyond radiology.
4. To understand communication, visualisation and navigation.
